VARIDT - Variability of Drug Transporter Database Title - Synonyms of DTs and their corresponding drugs Version 1.8.1 (2019.08.20) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Any question about data provided here, please contact with: Dr. Yin (yinjiayi@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn) -------------------------------------------------------------------------------------------------------- Abbreviations: TRANSPID VARIDT Drug Transporter (DT) ID GENENAME DT Gene Name PROTNAME DT Protein Name SYNONYMS DT Synonyms VADRUGID Drug (Transported by This DT) ID DRUGNAME Drug (Transported by This DT) Name DRUGSYNO Drug (Transported by This DT) Synonyms -------------------------------------------------------------------------------------------------------- DTD0001 TRANSPID DTD0001 DTD0001 GENENAME ABCC1 DTD0001 PROTNAME Multidrug resistance-associated protein 1 DTD0001 SYNONYMS ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1 DTD0001 VADRUGID DR00135 DTD0001 DRUGNAME Colchicine DTD0001 DRUGSYNO (S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide; 7-alpha-H-Colchicine; 7.alpha.H-Colchicine; 7alphaH-Colchicine; Benzo(a)heptalen-9(5H)-one; Binds to tubulin; C 9754; Colchicin; Colchicin [German]; Colchicina; Colchicina [Italian]; Colchicine (JP15/USP); Colchicine (TN); Colchicine [JAN]; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer; Colchicine, Colchicum autumnale; Colchicinum; Colchineos; Colchisol; Colchysat; Colcin; Colcrys; Colsaloid; Colstat; Condylon; Goutnil; Inhibits microtubular assembly; Kolkicin; LOC; MPC-004; N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide; N-Acetyl trimethylcolchicinic acid methylether; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; Spindle poison DTD0001 VADRUGID DR00143 DTD0001 DRUGNAME Vincristine DTD0001 DRUGSYNO 22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH DTD0001 VADRUGID DR00284 DTD0001 DRUGNAME Daunorubicin DTD0001 DRUGSYNO (+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103 DTD0001 VADRUGID DR00386 DTD0001 DRUGNAME Idarubicin DTD0001 DRUGSYNO (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN) DTD0001 VADRUGID DR00269 DTD0001 DRUGNAME Mitoxantrone DTD0001 DRUGSYNO 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate) DTD0001 VADRUGID DR00595 DTD0001 DRUGNAME Chlorpheniramine DTD0001 DRUGSYNO 1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine; 1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine; 3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; 3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; 4-Chloropheniramine; Aller-Chlor; Allergican; Allergisan; Antagonate; CHLORPHENIRAMINE (SEE ALSO: CHLORPHENIRAMINE MALEATE (CAS113-92-8)); Chlo-amine; Chlor-Pro; Chlor-Trimeton (TN); Chlor-Trimeton Repetabs; Chlor-Tripolon (TN); Chlor-trimeton; Chloropheniramine; Chlorophenylpyridamin; Chlorophenylpyridamine; Chloropiril; Chloroprophenpyridamine; Chlorphenamine; Chlorphenamine (INN); Chlorphenamine [INN]; Chlorphenaminum; Chlorphenaminum [INN-Latin]; Chlorpheniraminum; Chlorprophenpyridamine; Clofeniramina; Clofeniramina (TN); Clorfenamina; Clorfenamina [INN-Spanish]; Clorfeniramina; Clorfeniramina [Italian]; Cloropiril; Comakin (TN); Gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine; Gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine; Gen-Allerate; Haynon; Hayon; Histadur; ISOCLOR; Kloromin; Novo-Pheniram; Pediacare Allergy Formula; Phenetron; PiriIton; Piriton; Piriton (TN); Polaronil; Telachlor; Teldrin; [3H]Chlorpheniramine DTD0001 VADRUGID DR00264 DTD0001 DRUGNAME Verapamil DTD0001 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0001 VADRUGID DR01485 DTD0001 DRUGNAME Leukotriene E4 DTD0001 DRUGSYNO Leukotriene E4; leukotriene E4; Leukotriene E; UNII-8EYT8ATL7G; 75715-89-8; 8EYT8ATL7G; CHEMBL509456; CHEBI:15650; OTZRAYGBFWZKMX-FRFVZSDQSA-N; 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C23H37NO5S; (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid; [3H]LTE4; AC1NQXPM; LEUKOTRIEN E4; BSPBio_001370; leukotriene E DTD0001 VADRUGID DR01378 DTD0001 DRUGNAME 99mTc-sestamibi DTD0001 DRUGSYNO Sestamibi; RP-30; Tc-MIBI; Technetium-99m sestamibi DTD0001 VADRUGID DR00342 DTD0001 DRUGNAME Paclitaxel DTD0001 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0001 VADRUGID DR00251 DTD0001 DRUGNAME Docetaxel DTD0001 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0001 VADRUGID DR01203 DTD0001 DRUGNAME Dactinomycin DTD0001 DRUGSYNO 1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97 DTD0001 VADRUGID DR01460 DTD0001 DRUGNAME Phenethyl isothiocyanate DTD0001 DRUGSYNO Phenethyl-isothiocyanate DTD0001 VADRUGID DR00112 DTD0001 DRUGNAME Irinotecan DTD0001 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0001 VADRUGID DR00287 DTD0001 DRUGNAME Resveratrol DTD0001 DRUGSYNO (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4′,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol DTD0001 VADRUGID DR00225 DTD0001 DRUGNAME Quercetin DTD0001 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0001 VADRUGID DR00319 DTD0001 DRUGNAME Citalopram DTD0001 DRUGSYNO 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram DTD0001 VADRUGID DR00208 DTD0001 DRUGNAME Estradiol-17beta-glucuronide DTD0001 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0001 VADRUGID DR00312 DTD0001 DRUGNAME Arsenite DTD0001 DRUGSYNO 13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion) DTD0001 VADRUGID DR00344 DTD0001 DRUGNAME Fluo-3 DTD0001 DRUGSYNO 121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051 DTD0001 VADRUGID DR01215 DTD0001 DRUGNAME Chlorcyclizine DTD0001 DRUGSYNO 1-(4-Chlorobenzhydryl)-4-methylpiperazine; Alergicide; Chlorcycline; Chlorcyclizine [INN:BAN]; Chlorcyclizinum; Chlorcyclizinum [INN-Latin]; Chlorocycline; Chlorocyclizine; Clorciclizina; Clorciclizina [DCIT]; Clorciclizinio [INN-Spanish]; Compound 47-282; Di-Paralene; Di-paralen; Diparalene; HSDB 3217; Histachlorazene; Histantin; Histantine; N-Methyl-N'-(4-chlorobenzhydryl)piperazine; NSC 25246; Perazyl; Piparalene; Trihistan; chlorcyclizine DTD0001 VADRUGID DR00548 DTD0001 DRUGNAME Ethacrynic acid DTD0001 DRUGSYNO (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; (2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid; (2,3-Dichloro-4-[2-methylenebutyryl]phenoxy)acetic acid; (4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid; 2,3-Dichloro-4(2-methylene-butyryl)phenoxy] acetic acid; 2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid; 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; Acide etacrynique; Acide etacrynique [INN-French]; Acido etacrinico; Acido etacrinico [INN-Spanish]; Acidum etacrynicum; Acidum etacrynicum [INN-Latin]; Crinuryl; E0526; Edecril; Edecrin; Edecrin (TN); Edecrina; Endecril; Etacrinic acid; Etacrynic Acid; Etacrynic acid (JP15/INN); Etakrinic acid; Ethacrinic acid; Ethacrinique (acide); Ethacryinic Acid; Ethacrynate; Ethacrynic Acid, Sodium Salt; Ethacrynic acid (USP); Ethacrynic acid [USAN:BAN]; Hidromedin; Hydromedin; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]; Kyselina ethakrynova; Kyselina ethakrynova [Czech]; MK 595; MK-595; Methylenebutyryl phenoxyacetic acid; Methylenebutyrylphenoxyacetic acid; Mingit; Otacril; Reomax; Taladren; Uregit; [2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid; [2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid;[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid; [2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; [4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid DTD0001 VADRUGID DR00039 DTD0001 DRUGNAME Glutathione DTD0001 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0001 VADRUGID DR00299 DTD0001 DRUGNAME Indinavir DTD0001 DRUGSYNO (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253 DTD0001 VADRUGID DR00290 DTD0001 DRUGNAME Lopinavir DTD0001 DRUGSYNO A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346 DTD0001 VADRUGID DR00309 DTD0001 DRUGNAME Saquinavir DTD0001 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0001 VADRUGID DR00301 DTD0001 DRUGNAME Doxorubicin DTD0001 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0001 VADRUGID DR00308 DTD0001 DRUGNAME Vinblastine DTD0001 DRUGSYNO (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine DTD0001 VADRUGID DR00147 DTD0001 DRUGNAME Ivermectin DTD0001 DRUGSYNO IVERMECTIN; Ivermectin B1a; Dihydroavermectin B1a; 22,23-Dihydroavermectin B1a; 71827-03-7; avermectin H2B1a; UNII-91Y2202OUW DTD0001 VADRUGID DR00162 DTD0001 DRUGNAME Etoposide DTD0001 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0001 VADRUGID DR00082 DTD0001 DRUGNAME Methotrexate DTD0001 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0001 VADRUGID DR00044 DTD0001 DRUGNAME Topotecan DTD0001 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0001 VADRUGID DR00291 DTD0001 DRUGNAME Cisplatin DTD0001 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0001 VADRUGID DR01698 DTD0001 DRUGNAME Glutathione-S-S-glutathione DTD0001 DRUGSYNO oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H DTD0001 VADRUGID DR00846 DTD0001 DRUGNAME Flutamide DTD0001 DRUGSYNO 1A Brand of Flutamide; 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide; 4'-Nitro-3'-(trifluoromethyl)isobutyranilide; 4'-Nitro-3'-trifluoromethylisobutyramilide; 4'-Nitro-3'-trifluoromethylisobutyranilide; 4-Nitro-3-(trifluoromethyl)isobutyranilide; Alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide; Alphapharm Brand of Flutamide; Apimid; Apo Flutamide; Apo-Flutamide; ApoFlutamide; Apogepha Brand of Flutamide; Apotex Brand of Flutamide; Azupharma Brand of Flutamide; Cebatrol; Cebatrol, veterinary; Cell pharm Brand of Flutamide; Chephasaar Brand of Flutamide; Chimax; Chiron Brand of Flutamide; Ciclum Brand of Flutamide; Cytamid; Drogenil; Esparma Brand of Flutamide; Essex Brand of Flutamide; Eulexin; Eulexin (TN); Eulexin, Flutamin, Drogenil,Flutamide; Eulexine; F 9397; F0663; Fluken; Flulem; Flumid; Fluta 1A Pharma; Fluta GRY; Fluta cell; Fluta-GRY; Fluta-cell; FlutaGRY; Flutacell; Flutamida; Flutamida [INN-Spanish]; Flutamide (AR inhibitor); Flutamide (JAN/USP/INN); Flutamide USP25; Flutamide [USAN:BAN:INN]; Flutamide(pubertal study); Flutamidum; Flutamidum [INN-Latin]; Flutamin; Flutandrona; Flutaplex; Flutexin; Fugerel; Gry Brand of Flutamide; Ham's F-12 medium; Hexal Brand of Flutamide; InibsaBrand of Flutamide; Ipsen Brand of Flutamide; Juta Brand of Flutamide; Kendrick Brand of Flutamide; Lemery Brand of Flutamide; M-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-(8CI); M-propionotoluidide,alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro; METHOXYCHLOR; NFBA; NK-601; Niftholide; Niftolid; Niftolide; Novo Flutamide; Novo-Flutamide; NovoFlutamide; Novopharm Brand of Flutamide; Odyne; Oncosal; PMS Flutamide; PMS-Flutamide; PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN; Pharmascience Brand of Flutamide; Prasfarma Brand of Flutamide; Prostacur; Prostandril; Prostica; Prostogenat; Q Pharm Brand of Flutamide; Q-Pharm Brand of Flutamide; SCH13521; Sch 13521; Sch-13521; Schering Brand of Flutamide; Schering Plough Brand of Flutamide; Schering-Plough Brand of Flutamide; TAD Brand of Flutamide; Tedec Meiji Brand of Flutamide; Testotard DTD0001 VADRUGID DR00226 DTD0001 DRUGNAME Saxagliptin DTD0001 DRUGSYNO (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN) DTD0001 VADRUGID DR00134 DTD0001 DRUGNAME Folic acid DTD0001 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0001 VADRUGID DR00431 DTD0001 DRUGNAME Phenytoin DTD0001 DRUGSYNO 2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil DTD0001 VADRUGID DR00161 DTD0001 DRUGNAME SN-38 DTD0001 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0001 VADRUGID DR00015 DTD0001 DRUGNAME Adefovir DTD0001 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0001 VADRUGID DR00547 DTD0001 DRUGNAME Fluorescein DTD0001 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0001 VADRUGID DR00638 DTD0001 DRUGNAME Grepafloxacin DTD0001 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN) DTD0001 VADRUGID DR00313 DTD0001 DRUGNAME Cefadroxil DTD0001 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0001 VADRUGID DR00170 DTD0001 DRUGNAME Epirubicin DTD0001 DRUGSYNO (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697 DTD0001 VADRUGID DR01513 DTD0001 DRUGNAME Dehydroepiandrosterone sulfate DTD0001 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0001 VADRUGID DR01473 DTD0001 DRUGNAME Zoledronic acid DTD0001 DRUGSYNO Aclasta; Reclast; ZOL; Zometa; Novartis brand of zoledronic acid; Zoledronic acid; Zometa Concentrate; Bisphosphonate 3; CGP 42446; CGP 42446A; Aclasta (TN); CGP 42'446; CGP-42446; KS-1132; Reclast (TN); Zoledronic acid (INN); Zoledronic acid [USAN:INN]; Zomera (TN); Zometa (Novartis); Zometa (TN); CGP-42'446; Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid); (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid; (1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate; 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid; 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid DTD0001 VADRUGID DR00019 DTD0001 DRUGNAME Estrone sulfate DTD0001 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0001 VADRUGID DR00067 DTD0001 DRUGNAME Aminohippuric acid DTD0001 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0002 TRANSPID DTD0002 DTD0002 GENENAME ABCC2 DTD0002 PROTNAME Multidrug resistance-associated protein 2 DTD0002 SYNONYMS ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2 DTD0002 VADRUGID DR00119 DTD0002 DRUGNAME Arsenic trioxide DTD0002 DRUGSYNO Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic oxide (As2O3); Arsenic trioxide (JP15/USAN); Arsenic trioxide [JAN]; Arsenic trioxide [UN1561] [Poison]; Arsenic(3+); Arsenic(III) trioxide; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Arsenox; Arsentrioxide; Naonobin; Oxyde Arsenieux; Oxyde Arsenieux [ISO-French]; Oxygen(2-); Trisenox; Trisenox (TN); Trixenox DTD0002 VADRUGID DR00143 DTD0002 DRUGNAME Vincristine DTD0002 DRUGSYNO 22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH DTD0002 VADRUGID DR00269 DTD0002 DRUGNAME Mitoxantrone DTD0002 DRUGSYNO 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate) DTD0002 VADRUGID DR00513 DTD0002 DRUGNAME Sulfinpyrazone DTD0002 DRUGSYNO (+/-)-SULFINPYRAZONE; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]; 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl) pyrazolidine; 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione; 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione; 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione; Anturan; Anturane; Anturane (TN); Anturanil; Anturano; Anturen; Anturidin; Apo Sulfinpyrazone; Apo-Sulfinpyrazone; Apotex Brand of Sulfinpyrazone; Diphenylpyrazone; Enturan; Enturen; G 28,315; G 28315; Novartis Brand of Sulfinpyrazone; Novopyrazone; Nu Pharm Brand of Sulfinpyrazone; Nu Sulfinpyrazone; Nu-Pharm Brand of Sulfinpyrazone; Nu-Sulfinpyrazone; Sulfinpirazona; Sulfinpirazona [INN-Spanish]; Sulfinpyrazine; Sulfinpyrazon; Sulfinpyrazone (JP15/USP/INN); Sulfinpyrazone (SPZ); Sulfinpyrazone [USAN:INN:JAN]; Sulfinpyrazonum; Sulfinpyrazonum [INN-Latin]; Sulfoxyphenylpyrazolidin; Sulfoxyphenylpyrazolidine; Sulphinpyrazone; USAF GE-13 DTD0002 VADRUGID DR00519 DTD0002 DRUGNAME Tauroursodeoxycholate DTD0002 DRUGSYNO TUDCA; Tauroursodeoxycholic acid DTD0002 VADRUGID DR01440 DTD0002 DRUGNAME 5-methyltetrahydrofolate DTD0002 DRUGSYNO 5-methyl-THF; 5-methyl-tetrahydrofolate; 5-methyltetrahydrofolate; N5-methylfolate DTD0002 VADRUGID DR00342 DTD0002 DRUGNAME Paclitaxel DTD0002 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0002 VADRUGID DR00251 DTD0002 DRUGNAME Docetaxel DTD0002 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0002 VADRUGID DR01318 DTD0002 DRUGNAME Genistein-7-glucoside DTD0002 DRUGSYNO 1POG3SCN5T; 4',5,7-trihydroxyisoflavone 7-D-glucoside; BRN 0064479; C21H20O10; CHEBI:27514; Genistein 7-O-beta-D-glucoside; Genistein 7-glucoside; Genistein glucoside; Genistein, 7-O-beta-D-glucoside; Genistein, 7-beta-D-glucopyranoside; Genistein-7-glucoside; Genisteol 7-monoglucoside; Genistin; Genistine; Genistoside; Glucopyranoside, genistein-7, beta-D-; Glucosyl-7-genistein; Isoflavone, 4',5,7-trihydroxy-, 7-D-glucoside; MFCD00016883; NSC 5112; UNII-1POG3SCN5T; ZCOLJUOHXJRHDI-CMWLGVBASA-N; genistein 7-O-glucoside DTD0002 VADRUGID DR01460 DTD0002 DRUGNAME Phenethyl isothiocyanate DTD0002 DRUGSYNO Phenethyl-isothiocyanate DTD0002 VADRUGID DR01604 DTD0002 DRUGNAME Alpha-Zearalenol DTD0002 DRUGSYNO alpha-Zearalenol; trans-Zearalenol; cis-Zearalenol; alpha zearalenol; UNII-59D4EVJ5KC; Zearalenol; 59D4EVJ5KC; CHEMBL371463; CHEBI:35065; A-ZEARALENOL; (3S,7R,11E)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-1-one; .alpha.-Zearalenol; (-)-; A-Zearalenol; (2E,7R,11S)-7,15,17-trihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraen-13-one; 36J; AC1NR4TQ; SCHEMBL343610; SCHEMBL109175; BIDD:ER0100; SGCUT00105; DTXSID8022402; FPQFYIAXQDXNOR-QDKLYSGJSA-N DTD0002 VADRUGID DR00013 DTD0002 DRUGNAME Nilotinib DTD0002 DRUGSYNO Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716 DTD0002 VADRUGID DR00112 DTD0002 DRUGNAME Irinotecan DTD0002 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0002 VADRUGID DR00238 DTD0002 DRUGNAME Leucovorin DTD0002 DRUGSYNO 5-formyltetrahydrofolate; Citrovorum factor; Folinic acid DTD0002 VADRUGID DR00316 DTD0002 DRUGNAME Oxaliplatin DTD0002 DRUGSYNO ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138 DTD0002 VADRUGID DR01166 DTD0002 DRUGNAME Phenolphthalein DTD0002 DRUGSYNO 1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-; 1977/9/8; 3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone; 3,3-Bis(4-hydroxyphenyl)phthalide; Alophen; Chocolax; Colax; Correctol; Dihydroxyphthalophenone; Doxidan; Espotabs; Euchessina; Evac-Q-Kit; Evac-Q-Kwik; Evac-Q-Tabs; Evac-U-Gen; Ex-Lax; Feen-A-Mint Gum; FemiLax; Fenolftalein; Fenolftaleina; Koprol; Lax-Pills; Laxin; Laxogen; Lilo; Medilax; Phenolax; Phenolphtaleine; Phenophthalein; Phillips Gelcaps; Phthalimetten; Phthalin; Purga; Purgen; Purgophen; Spulmako-lax; Trilax; phenolphthalein DTD0002 VADRUGID DR00066 DTD0002 DRUGNAME Cidofovir DTD0002 DRUGSYNO (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid DTD0002 VADRUGID DR00247 DTD0002 DRUGNAME Vasopressin DTD0002 DRUGSYNO ADH (hormone); American Pharmaceutical Brand of Vasopressin; American Regent Brand of Vasopressin; Antidiuretic Hormones; Antidiuretic hormone; Beta Hypophamine; Beta-Hypophamine; Inyectable de vasopresina; Inyectable de vasopresina [INN-Spanish]; Leiormone; Monarch Brand of Vasopressin; Parke-Davis Brand of Vasopressin (USP); Pitressin; Pitressin (TN); Pituitrin; Solute injectable de vasopressine; Solute injectable de vasopressine [INN-French]; Tonephin; Vasopressin (JP15/USP); Vasopressin (USP); Vasopressin Monarch Brand; Vasopressin injection; Vasopressina; Vasopressina [DCIT]; Vasopressine; Vasopressini injectio; Vasopressini injectio [INN-Latin]; Vasopressins; Vasopressinum DTD0002 VADRUGID DR00208 DTD0002 DRUGNAME Estradiol-17beta-glucuronide DTD0002 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0002 VADRUGID DR00252 DTD0002 DRUGNAME Bilirubin DTD0002 DRUGSYNO 21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49 DTD0002 VADRUGID DR00950 DTD0002 DRUGNAME Phlorizin DTD0002 DRUGSYNO 1-Propanone, 1-(2-(b; 1-[2-(beta-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone; 2'-(beta-D-Glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone; 60-81-1; AI3-19835; CHEBI:8113; CHEMBL245067; CU9S17279X; EINECS 200-487-1; Floridzin; IOUVKUPGCMBWBT-QNDFHXLGSA-N; NSC 2833; Phloretin 2'-glucoside; Phloretin-2'-O-beta-glucoside; Phloretin-2'-beta-glucoside; Phlorhizin; Phloridzin; Phloridzin dihydrate; Phloridzosid; Phlorizin; Phlorizine; Phlorizoside; Phlorrhizen; Phlorrhizin; UNII-CU9S17279X DTD0002 VADRUGID DR00213 DTD0002 DRUGNAME Sincalide DTD0002 DRUGSYNO CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated) DTD0002 VADRUGID DR00206 DTD0002 DRUGNAME Pitavastatin calcium DTD0002 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0002 VADRUGID DR00395 DTD0002 DRUGNAME Carbamazepine DTD0002 DRUGSYNO Carbamazepine (iv, epilepsy); Carbamazepine (iv, epilepsy), Lundbeck; Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals DTD0002 VADRUGID DR00399 DTD0002 DRUGNAME Valproic Acid DTD0002 DRUGSYNO 2 PP (base); 2-Propylpentanoic acid; 2-Propylvaleric acid; 2-n-Propyl-n-valeric acid; 4-Heptanecarboxylic acid; Abbott 44090; Acide valproique; Acide valproique [INN-French]; Acido valproico; Acido valproico [INN-Spanish]; Acidum valproicum; Acidum valproicum [INN-Latin]; Alti-Valproic; Avugane; Baceca; Convulex; Convulex (TN); Convulsofin; Depacon (TN); Depakene; Depakene (TN); Depakin; Depakin chrono; Depakine; Depakine chrono; Depakote (TM); Depakote (TN); Depakote ER (TN); Deproic; Di-n-propylacetic acid; Di-n-propylessigsaeure; Di-n-propylessigsaure; Di-n-propylessigsaure [German]; Dipropyl Acetate; Dipropylacetate; Dipropylacetic acid; Dom-Valproic; Encorate (TN); Epilim (TN); Epival (TN); Ergenyl; G2M-777; Kyselina 2-propylvalerova; Kyselina 2-propylvalerova [Czech]; Med Valproic; Mylproin; Myproic Acid; N-DPA; N-Dipropylacetic acid; Novo-Valproic; Nu-Valproic; PMS-Valproic Acid; Penta-Valproic; Propylvaleric acid; Savicol; Semisodium Valproate; Stavzor; Stavzor (TN); VPA; Valproate; Valproic Acid, Sodium Salt (2:1); Valproic acid (USP); Valproic acid USP; Valproic acid USP24; Valproic acid [USAN:INN:BAN]; Valproinsaeure; Vupral; Winthrop (TN) DTD0002 VADRUGID DR00232 DTD0002 DRUGNAME Probenecid DTD0002 DRUGSYNO 4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid DTD0002 VADRUGID DR00914 DTD0002 DRUGNAME Glycyrrhizin DTD0002 DRUGSYNO Uralsaponin A; glycyrrhizin; Glycyrrhizic acid; AC1L2TF0; Glycyrrhizin (JAN); Glycyrrhizinate; ZINC96319491; AKOS037514680; AKOS016036159; 3-Hydroxy-11 oxoolean-12-en-30-oic acid-3-O-glucuronopyranosyl-(1-2)glucuronopyranoside; D00157; C02284; beta-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-; (3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucuronosyl-beta-D-glucosiduronic acid DTD0002 VADRUGID DR00010 DTD0002 DRUGNAME Enalapril DTD0002 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0002 VADRUGID DR00347 DTD0002 DRUGNAME Olmesartan medoxomil DTD0002 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0002 VADRUGID DR01319 DTD0002 DRUGNAME Temocaprilate DTD0002 DRUGSYNO (+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate DTD0002 VADRUGID DR00071 DTD0002 DRUGNAME Valsartan DTD0002 DRUGSYNO (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan DTD0002 VADRUGID DR00039 DTD0002 DRUGNAME Glutathione DTD0002 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0002 VADRUGID DR00299 DTD0002 DRUGNAME Indinavir DTD0002 DRUGSYNO (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253 DTD0002 VADRUGID DR00290 DTD0002 DRUGNAME Lopinavir DTD0002 DRUGSYNO A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346 DTD0002 VADRUGID DR00332 DTD0002 DRUGNAME Ritonavir DTD0002 DRUGSYNO 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN] DTD0002 VADRUGID DR00309 DTD0002 DRUGNAME Saquinavir DTD0002 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0002 VADRUGID DR00301 DTD0002 DRUGNAME Doxorubicin DTD0002 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0002 VADRUGID DR00308 DTD0002 DRUGNAME Vinblastine DTD0002 DRUGSYNO (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine DTD0002 VADRUGID DR00140 DTD0002 DRUGNAME Ezetimibe DTD0002 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0002 VADRUGID DR00045 DTD0002 DRUGNAME Pravastatin DTD0002 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0002 VADRUGID DR00223 DTD0002 DRUGNAME Rosuvastatin DTD0002 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0002 VADRUGID DR00201 DTD0002 DRUGNAME Sulfasalazine DTD0002 DRUGSYNO 13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral DTD0002 VADRUGID DR00162 DTD0002 DRUGNAME Etoposide DTD0002 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0002 VADRUGID DR00082 DTD0002 DRUGNAME Methotrexate DTD0002 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0002 VADRUGID DR00318 DTD0002 DRUGNAME Pemetrexed DTD0002 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0002 VADRUGID DR00102 DTD0002 DRUGNAME Dinoprostone DTD0002 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0002 VADRUGID DR00136 DTD0002 DRUGNAME Regorafenib DTD0002 DRUGSYNO 24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB DTD0002 VADRUGID DR01439 DTD0002 DRUGNAME Belotecan DTD0002 DRUGSYNO Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022 DTD0002 VADRUGID DR01383 DTD0002 DRUGNAME Camptothecin DTD0002 DRUGSYNO camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat DTD0002 VADRUGID DR01218 DTD0002 DRUGNAME Mycophenolic acid DTD0002 DRUGSYNO (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acide mycophenolique; Acido micofenolico; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum; CCRIS 5565; Lilly-68618; Ly 68618; Melbex; Micofenolico acido; Micofenolico acido [Spanish]; Mycophenoic acid; Mycophenolate; Mycophenolsaeure; Myfortic; NSC 129185; NSC-129185; UNII-HU9DX48N0T; mycophenolic acid DTD0002 VADRUGID DR00291 DTD0002 DRUGNAME Cisplatin DTD0002 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0002 VADRUGID DR01698 DTD0002 DRUGNAME Glutathione-S-S-glutathione DTD0002 DRUGSYNO oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H DTD0002 VADRUGID DR01605 DTD0002 DRUGNAME Taxifolin DTD0002 DRUGSYNO TAXIFOLIN; (+)-Taxifolin; dihydroquercetin; Distylin; Taxifoliol; (2R,3R)-Dihydroquercetin; (+)-Dihydroquercetin; TAXIFOLIN-(+); Lavitol; Lariksin; taxifolin (dihydroquercetin); 3,5,7,3',4'-Pentahydroxyflavanone; UNII-9SOB9E3987; trans-Dihydroquercetin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; (+)-trans-Taxifolin; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone DTD0002 VADRUGID DR01006 DTD0002 DRUGNAME Acetaminophen DTD0002 DRUGSYNO 103-90-2; 4'-Hydroxyacetanilide; 4-Acetamidophenol; A-Per; APAP; Abenol; Abensanil; Abrol; Abrolet; Acamol; Accu-Tap; Acenol; Acephen; Acertol; Aceta Elixir; Acetaco; Acetagesic; Acetalgin; Acetaminofen; Acetamol; Acetavance; Acetofen; Actamin; Actifed Plus; Actimol; Afebrin; Afebryl; Aferadol; Algesidal; Algina; Algomol; Algotropyl; Alpiny; Alpinyl; Alvedon; Amadil; Aminofen; Anacin 3; Anaflon; Analter; Anapap; Andox; Anelix; Anhiba; Antidol; Anuphen; Apacet; Apadon; Apamide; Apitrelal; Arfen; Arthralgen; Asetam; Asomal; Aspac; Aspirin free anacin; Asplin; Atasol; Atralidon; Babikan; Bacetamol; Banesin; Bayer Select; Benmyo; Biocetamol; Cadafen; Calapol; Calmanticold; Calonal; Calpol; Capital; Captin; Causalon; Cefalex; Cetadol; Clixodyne; Codabrol; Codalgin; Codapane; Codicet; Codisal; Codoliprane; Cofamol; Conacetol; Cosutone; Cuponol; Curadon; Curpol; Custodial; D oliprane; Dafalgan; Darocet; Darvocet; Datril; Daygrip; Deminofen; Democyl; Demogripal; Desfebre; Dhamol; Dimindol; Dirox; Disprol; Dolcor; Dolefin; Dolegrippin; Dolgesic; Doliprane; Dolko; Dolofugin; Doloreduct; Dolorfug; Dolorstop; Dolotec; Dolprone; Dorocoff; Dresan; Dristancito; Duaneo; Dularin; Duorol; Duracetamol; Durapan; Dymadon; Dymadon Co; Dypap; Ecosetol; Elixodyne; Empracet; Enelfa; Eneril; Excipain; Exdol; Fanalgic; Farmadol; Febranine; Febrectal; Febrectol; Febrex; Febricet; Febridol; Febrilix; Febrin; Febrinol; Febrolin; Fendon; Fensum; Fepanil; Fevor; Finimal; Finiweh; Fluparmol; Fortalidon P; Gattaphen T; Gelocatil; Geluprane; Genapap; Genebs; Gripin Bebe; Grippostad; Gynospasmine; Hedex; Helon N; Homoolan; Ildamol; Inalgex; Infadrops; Influbene N; Injectapap; Janupap; Jin Gang; Kataprin; Korum; Labamol; Lekadol; Lemgrip; Lemsip; Lestemp; Liqiprine; Liquagesic; Lonarid; Lonarid Mono; Lupocet; Lyteca; Lyteca Syrup; Magnidol; Malex N; Malgis; Malidens; Maxadol; Medocodene; Mexalen; Minafen; Minoset; Miralgin; Momentum; Multin; N-(4-Hydroxyphenyl)acetamide; N-Acetyl-p-aminophenol; NEBS; Napafen; Naprinol; Nealgyl; NeoCitran; Neodol; Neodolito; Neopap; Neotrend; Neuridon; NilnOcen; Nina; Nobedon; Nodolex; Noral; Ofirmev; Oltyl; Oralgan; Ortensan; Oxycocet; Paceco; Pacemo; Pacemol; Pacet; Pacimol; Paedialgon; Paedol; Painex; Paldesic; Pamol; Panacete; Panadeine; Panadeine Co; Panadiene; Panadol; Panale ve; Panaleve; Panamax; Panasorb; Panasorbe; Panets; Panex; Panodil; Panofen; Pantalgin; Paracemol; Paracenol; Paracet; Paracetamol; Paracetamole; Paracetamolo; Paracetanol; Paracetol; Paracin; Paracod; Paracodol; Parador; Paradrops; Parakapton; Parake; Paralen; Paralief; Paralink; Paralyoc; Paramol; Paramolan; Paranox; Parapan; Parasedol; Parasin; Paraspen; Parcetol; Parelan; Parmol; Parogal; Paroma; Pasolind; Pasolind N; Pediapirin; Pediatrix; Pedric; Perfalgan; Phendon; Phenipirin; Phogoglandin; Pinex; Piramin; Pirinasol; Plicet; Polmofen; Predimol; Predualito; Prodol; Prompt; Prontina; Puernol; Pulmofen; Pyrigesic; Pyrinazine; Pyromed; Redutemp; Reliv; Remedol; Rivalgyl; Robigesic; Rounox; RubieMol; Rubophen; Rupemol; Salzone; Sanicet; Sanicopyrine; Scanol; Scentalgyl; Schmerzex; Sedalito; Semolacin; Servigesic; Seskamol; Setakop; Setamol; Setol; Sifenol; Sinaspril; Sinedol; Sinmol; Spalt N; Stanback; Stopain; Sunetheton; Supadol mono; Supofen; Suppap; TYL; Tabalgin; Tachiprina; Tapanol; Tapar; Tazamol; Temlo; Tempanal; Tempra; Termacet; Termalgin; Termalgine; Termofren; Tiffy; Titralgan; Toximer P; Tralgon; Treupel N; Treupel mon; Treuphadol; Tricoton; Tussapap; Ty lenol; Tylenol; Tylex; Tylex CD; Tylol; Tymol; Ultracet; Upsanol; Utragin; Valadol; Valgesic; Valorin; Veralgina; Vermidon; Verpol; Vips; Viruflu; Vivimed; Volpan; Zatinol; Zolben; acetaminophen; p-Acetamidophenol; p-Acetaminophenol; p-Hydroxyacetanilide DTD0002 VADRUGID DR00304 DTD0002 DRUGNAME Sorafenib DTD0002 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum DTD0002 VADRUGID DR00153 DTD0002 DRUGNAME Fluorouracil DTD0002 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0002 VADRUGID DR00243 DTD0002 DRUGNAME Mycophenolate mofetil DTD0002 DRUGSYNO 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF DTD0002 VADRUGID DR00195 DTD0002 DRUGNAME Rhodamine 123 DTD0002 DRUGSYNO RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes DTD0002 VADRUGID DR00196 DTD0002 DRUGNAME Rifampicin DTD0002 DRUGSYNO 1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN) DTD0002 VADRUGID DR00053 DTD0002 DRUGNAME Sodium taurocholate DTD0002 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0002 VADRUGID DR00134 DTD0002 DRUGNAME Folic acid DTD0002 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0002 VADRUGID DR00391 DTD0002 DRUGNAME Cerivastatin DTD0002 DRUGSYNO . DTD0002 VADRUGID DR00420 DTD0002 DRUGNAME Nelfinavir DTD0002 DRUGSYNO ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen DTD0002 VADRUGID DR00431 DTD0002 DRUGNAME Phenytoin DTD0002 DRUGSYNO 2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil DTD0002 VADRUGID DR00448 DTD0002 DRUGNAME Cyclosporine DTD0002 DRUGSYNO cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A) DTD0002 VADRUGID DR00471 DTD0002 DRUGNAME Phenobarbital DTD0002 DRUGSYNO 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione; 5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione; 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-Ethyl-5-phenylbarbituric acid; 5-Phenyl-5-ethylbarbituric acid;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; Acido 5-fenil-5-etilbarbiturico; Acido 5-fenil-5-etilbarbiturico [Italian]; Adonal; Aephe nal; Aephenal; Agrypnal; Amylofene; Antrocol; Aphenylbarbit; Aphenyletten; Arco-Lase Plus; Austrominal; Barbapil; Barbellen; Barbellon; Barbenyl; Barbilehae; Barbilehae (barbilettae); Barbinal; Barbipenyl; Barbiphen; Barbiphenyl; Barbipil; Barbita; Barbivis; Barbonal; Barbophen; Bardorm; Bartol; Bialminal; Blu-phen; Cabronal; Calmetten; Calminal; Cardenal; Chardonna-2; Chinoin; Codibarbita; Component of Antrocol; Component of Bronkotabs; Component of Hecadrol; Component of Primatene P; Component of Slowten; Component of Tedral; Component of Valpin 50-PB; Coronaletta; Cratecil; Damoral; Dezibarbitur; Donphen; Dormina; Dormiral; Dormital; Doscalun; Duneryl; Elixir of phenobarbital; Ensobarb; Ensodorm; Epanal; Epidorm; Epilol; Episedal; Epsylone; Eskabarb; Etilfen; Euneryl; Ezibarbitur; Fen osed; Fenbital; Fenemal; Fenobarbital; Fenobarbital [INN-Spanish]; Fenobarbitale; Fenobarbitale [DCIT]; Fenosed; Fenylettae; Gardenal; Gardepanyl; Glysoletten; Gustase-Plus; Haplopan; Haplos; Helional; Hennoletten; Henotal; Hypnaletten; Hypnette; Hypno-Tablinetten; Hypnogen; Hypnolone; Hypnoltol; Hysteps; Le phebar; Lefebar; Leonal; Lephebar; Lepinal; Lepinaletten; Levsin PB Drops and Tablets; Linasen; Liquital; Lixophen; Lubergal; Lubrokal; Lumen; Lumesettes; Lumesyn; Luminal; Luminal (TN); Lumofridetten; Luphenil; Luramin; Molinal; Neurobarb; Nirvonal; Noptil; Nova-Pheno; Nunol; PHOB; PUBERTAL PHENOBARBITAL STUDY; Pamine PB; Parkotal; Pharmetten; Phazyme-PB; Phen-Bar; Phenaemal; Phenemal; Phenemalum; Phenobal; Phenobarb; Phenobarbital (JP15/USP/INN); Phenobarbital (PB); Phenobarbital [USAN:INN:JAN]; Phenobarbital, Monosodium Salt; Phenobarbitalum; Phenobarbitalum [INN-Latin]; Phenobarbitalum [INN]; Phenobarbitol; Phenobarbitone; Phenobarbitonum; Phenobarbituric acid; Phenobarbyl; Phenoluric; Phenolurio; Phenomet; Phenonyl; Phenoturic; Phenyl-ethyl-barbituric acid; Phenylaethylbarbitursaeure; Phenylethyl barbituric acid; Phenylethylbarbiturate; Phenylethylbarbituric acid; Phenylethylbarbitursaeure; Phenylethylmalonylurea; Phenyletten; Phenylral; Phenyral; Polcominal; Promptonal; SK-Phenobarbital; Seda-Tablinen; Seda-tabl inen; Sedabar; Sedicat; Sedizorin; Sedlyn; Sedofen; Sedonal; Sedonal (sedative); Sedonettes; Sedophen; Sevenal; Solfoton; Solfoton talpheno; Solu-Barb; Sombutol; Somnolens; Somnoletten; Somnosan; Somonal; Spasepilin; Starifen; Starilettae; Stental; Stental Extentabs; Stental exte ntabs; Talpheno; Teolaxin; Teoloxin; Thenobarbital; Theoloxin; Theominal; Triabarb; Tridezibarbitur; Triphenatol; Valprin 50-PB; Versomnal; Zadoletten; Zadonal DTD0002 VADRUGID DR00161 DTD0002 DRUGNAME SN-38 DTD0002 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0002 VADRUGID DR00015 DTD0002 DRUGNAME Adefovir DTD0002 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0002 VADRUGID DR00325 DTD0002 DRUGNAME Acyclovir DTD0002 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0002 VADRUGID DR00547 DTD0002 DRUGNAME Fluorescein DTD0002 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0002 VADRUGID DR01640 DTD0002 DRUGNAME Scutellarin DTD0002 DRUGSYNO Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl DTD0002 VADRUGID DR00638 DTD0002 DRUGNAME Grepafloxacin DTD0002 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN) DTD0002 VADRUGID DR00657 DTD0002 DRUGNAME Cholic acid DTD0002 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0002 VADRUGID DR01163 DTD0002 DRUGNAME Octreotide DTD0002 DRUGSYNO Octreotide; Octreotide acetate; Octreotidum; Octreotida; 79517-01-4; Sandostatin; UNII-RWM8CCW8GP; SMS 201-995; Longastatin; RWM8CCW8GP; SMS-201-995; CHEMBL1680; Octreotidum [Latin]; MFCD00871400; Octreotida [Spanish]; Octrotide; Octreotide [USAN:INN:BAN]; Octreotide-LAR; AC1L9M4X; Octreotide, >=98% (HPLC); SCHEMBL10044649; DEQANNDTNATYII-OULOTJBUSA-N; HMS2090C09; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide DTD0002 VADRUGID DR00958 DTD0002 DRUGNAME Raltitrexed DTD0002 DRUGSYNO (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; 112887-68-0; C21H22N4O6S; CHEBI:5847; CHEMBL225071; D 1694; D-1694; D1694; DSSTox_CID_26482; DSSTox_GSID_46482; DSSTox_RID_81653; FCB9EGG971; ICI D1694; ICI-D-1694; ICI-D1694; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; NCGC00229704-01; NSC-639186; Raltitrexed (Tomudex); Tomudex; UNII-FCB9EGG971; ZD 1694; ZD-16; ZD-1694; ZD1694 DTD0002 VADRUGID DR00856 DTD0002 DRUGNAME Mesalazine DTD0002 DRUGSYNO 2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206 DTD0002 VADRUGID DR00313 DTD0002 DRUGNAME Cefadroxil DTD0002 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0002 VADRUGID DR00050 DTD0002 DRUGNAME Erythromycin DTD0002 DRUGSYNO A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid DTD0002 VADRUGID DR00553 DTD0002 DRUGNAME Ceftriaxone DTD0002 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine DTD0002 VADRUGID DR00367 DTD0002 DRUGNAME Azithromycin DTD0002 DRUGSYNO Azasite (TN); Azibiot; Azifine; Azithramycine; Azithromycin (INN); Azithromycin (TN); Zitrocin DTD0002 VADRUGID DR00170 DTD0002 DRUGNAME Epirubicin DTD0002 DRUGSYNO (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697 DTD0002 VADRUGID DR00576 DTD0002 DRUGNAME Telithromycin DTD0002 DRUGSYNO (1R,2R,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6R,7R,8R,10S,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2S,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; 11,12-Dideoxy-3-des(2,6-dideoxy-3-C,3-O-dimethyl-alpha-L-altropyranosyloxy)-6-O-methyl-3-oxo-12,11-(oxycarbonylimino)-N11-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]erythromycin A; HMR 3647; HMR-3647; HMR3647; Ketek; Ketek (TN); Levviax; RU 66647; RU-66647; RU66647; TEL; Telithromycin (JAN/USAN/INN); Telithromycin [USAN:BAN:INN] DTD0002 VADRUGID DR01237 DTD0002 DRUGNAME Technetium (99MTC) mebrofenin DTD0002 DRUGSYNO F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52 DTD0002 VADRUGID DR01256 DTD0002 DRUGNAME Succimer DTD0002 DRUGSYNO (2R,3S)-rel-2,3-Dimercaptosuccinic acid; (R*,S*)-2,3-Dimercaptobutanedioic acid; 304-55-2; BRN 1725150; Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel-; Butanedioic acid, 2,3-dimercapto-, (R*,S*)-; CHEBI:63623; Chemet; DMSA; DX1U2629QE; Dim-sa; Dimercaptosuccinic acid; EINECS 206-155-2; HSDB 6783; Ro 1-7977; Succimer; Succimer [USAN:INN:BAN]; Succimero; Succimero [INN-Spanish]; Succimerum; Succimerum [INN-Latin]; UNII-DX1U2629QE; meso-2,3-Dimercaptobernsteinsaeure; meso-2,3-Dimercaptosuccinic acid; meso-Dimercaptosuccinic acid DTD0002 VADRUGID DR00712 DTD0002 DRUGNAME Ampicillin DTD0002 DRUGSYNO 6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil DTD0002 VADRUGID DR01316 DTD0002 DRUGNAME Cefodizime DTD0002 DRUGSYNO AC1NSFIB; CDZM; CHEBI:63214; CHEMBL2303613; Cefodizima; Cefodizima [INN-Spanish]; Cefodizime; Cefodizime (INN); Cefodizime Acid; Cefodizime [INN:BAN]; Cefodizimum; Cefodizimum [INN-Latin]; Cefodizme; DTXSID2022757; Diezime; EC 700-301-3; EX-A1379; HR 221 [AS SODIUM]; HR-221; HR-221 [As Sodium]; J-700161; Modivid; Neucef; S-771221B [As Sodium]; SCHEMBL151101; THR 221 [AS SODIUM]; THR-221; THR-221 [As Sodium]; Timecef; UNII-Z31298J4HQ; Z31298J4HQ DTD0002 VADRUGID DR01165 DTD0002 DRUGNAME Gatifloxacin DTD0002 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN) DTD0002 VADRUGID DR00688 DTD0002 DRUGNAME Gemifloxacin DTD0002 DRUGSYNO 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid; 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; Factiv; Factiv (TN); Factive; Factive (TN); Gemifloxacin (INN); Gemifloxacin [INN]; Gemifloxacin mesilate; LB 20304; LB 20304a; LB-20304; SB 265805; SB-265805 DTD0002 VADRUGID DR01725 DTD0002 DRUGNAME Olamufloxacin DTD0002 DRUGSYNO Olamufloxacin; HSR-903; UNII-LJG8KL1435; HSR 903; LJG8KL1435; J-502473; (S)-5-Amino-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; (S)-(-)-5-Amino-7-(7-amino-5-azaspiro[2,4]hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid; 5-amino-7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-quinoline-3-carboxylic acid; Olamufloxacin [INN]; AC1Q5RCW; AC1L9XAZ; SCHEMBL1851976 DTD0002 VADRUGID DR01257 DTD0002 DRUGNAME Gadobenate dimeglumine DTD0002 DRUGSYNO Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2) DTD0002 VADRUGID DR00569 DTD0002 DRUGNAME Glycocholic acid DTD0002 DRUGSYNO Glycocholate; cholylglycine DTD0002 VADRUGID DR00401 DTD0002 DRUGNAME Talinolol DTD0002 DRUGSYNO (+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin] DTD0002 VADRUGID DR01513 DTD0002 DRUGNAME Dehydroepiandrosterone sulfate DTD0002 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0002 VADRUGID DR01545 DTD0002 DRUGNAME Pitavastatin DTD0002 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0002 VADRUGID DR01407 DTD0002 DRUGNAME Pemirolast DTD0002 DRUGSYNO Pemirolastum; Pemirox; Pemirolast [INN]; Pemiroplast Potassium; Alamast (TN); Alegysal (TN); Pemirolast (INN); Pemirolastum [INN-Latin]; Pemirox (TN); 9-TBX; 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one; 9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one DTD0002 VADRUGID DR00019 DTD0002 DRUGNAME Estrone sulfate DTD0002 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0002 VADRUGID DR01463 DTD0002 DRUGNAME (-)-Epicatechin DTD0002 DRUGSYNO (-)-Epicatechin; Epicatechin; 490-46-0; L-Epicatechin; (-)-Epicatechol; l-Acacatechin; (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; Epicatechol; l-Epicatechol; (-)epicatechin; (2R,3R)-(-)-Epicatechin; UNII-34PHS7TU43; epi-Catechin; epi-Catechol; CCRIS 7097; EINECS 207-710-1; NSC 81161; Epicatechol, (-)-; CHEBI:90; 34PHS7TU43; PFTAWBLQPZVEMU-UKRRQHHQSA-N; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol; AK105372; C15H14O6 DTD0002 VADRUGID DR01381 DTD0002 DRUGNAME BQ-123 DTD0002 DRUGSYNO BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp) DTD0002 VADRUGID DR00067 DTD0002 DRUGNAME Aminohippuric acid DTD0002 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0002 VADRUGID DR00988 DTD0002 DRUGNAME Chelerythrine DTD0002 DRUGSYNO broussonpapyrine; cheleritrine; chelerythrine hydroxide; toddalin DTD0003 TRANSPID DTD0003 DTD0003 GENENAME ABCB1 DTD0003 PROTNAME P-glycoprotein 1 DTD0003 SYNONYMS ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1 DTD0003 VADRUGID DR00037 DTD0003 DRUGNAME Cimetidine DTD0003 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0003 VADRUGID DR00263 DTD0003 DRUGNAME Nizatidine DTD0003 DRUGSYNO (E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Acinon; Acinon (TN); Antizid; Axid; Axid (TN); Axid Ar; Calmaxid; Cronizat; Distaxid; Galitidin; Gastrax; LY 139037; LY-139037; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin; Naxidine; Niatidine; Nizatidina; Nizatidina [Spanish]; Nizatidine (JAN/USP/INN); Nizatidine [USAN:BAN:INN:JAN]; Nizatidinum; Nizatidinum [Latin]; Nizax; Nizaxid; Panaxid; Splendil ER; Tazac; Tazac (TN); Ulcosol; Ulxid; ZE-101; ZL-101; Zanizal; Zinga DTD0003 VADRUGID DR00154 DTD0003 DRUGNAME Tretinoin DTD0003 DRUGSYNO 302-79-4; ATRA; Aberel; Airol; Aknefug; Aknoten; All-trans Retinoic Acid; Alltrans-retinoic acid; Atralin; Avitoin; Cordes vas; Dermairol; Effederm; Epi-aberel; Eudyna; Renova; Retin-A; Retin-A Micro; Retinoic acid; Retinoic acid, all-trans-; Retionic acid; TRETINON; Tretin M; Tretinoin; Vesanoid; Vitamin A acid; Vitamin A acid, all-trans-; Vitamin A1 acid, all-trans-; all-(E)-Retinoic acid; all-trans-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; all-trans-Vitamin A1 acid; beta-Ra; beta-Retinoic acid; trans-Retinoic acid; tretinoin DTD0003 VADRUGID DR00118 DTD0003 DRUGNAME Sphingosine-1-phosphate DTD0003 DRUGSYNO (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate DTD0003 VADRUGID DR00135 DTD0003 DRUGNAME Colchicine DTD0003 DRUGSYNO (S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide; 7-alpha-H-Colchicine; 7.alpha.H-Colchicine; 7alphaH-Colchicine; Benzo(a)heptalen-9(5H)-one; Binds to tubulin; C 9754; Colchicin; Colchicin [German]; Colchicina; Colchicina [Italian]; Colchicine (JP15/USP); Colchicine (TN); Colchicine [JAN]; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer; Colchicine, Colchicum autumnale; Colchicinum; Colchineos; Colchisol; Colchysat; Colcin; Colcrys; Colsaloid; Colstat; Condylon; Goutnil; Inhibits microtubular assembly; Kolkicin; LOC; MPC-004; N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide; N-Acetyl trimethylcolchicinic acid methylether; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; Spindle poison DTD0003 VADRUGID DR00119 DTD0003 DRUGNAME Arsenic trioxide DTD0003 DRUGSYNO Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic oxide (As2O3); Arsenic trioxide (JP15/USAN); Arsenic trioxide [JAN]; Arsenic trioxide [UN1561] [Poison]; Arsenic(3+); Arsenic(III) trioxide; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Arsenox; Arsentrioxide; Naonobin; Oxyde Arsenieux; Oxyde Arsenieux [ISO-French]; Oxygen(2-); Trisenox; Trisenox (TN); Trixenox DTD0003 VADRUGID DR00204 DTD0003 DRUGNAME Ponatinib DTD0003 DRUGSYNO Iclusig (TN) DTD0003 VADRUGID DR00021 DTD0003 DRUGNAME Teniposide DTD0003 DRUGSYNO 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide DTD0003 VADRUGID DR00143 DTD0003 DRUGNAME Vincristine DTD0003 DRUGSYNO 22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH DTD0003 VADRUGID DR00397 DTD0003 DRUGNAME Vindesine DTD0003 DRUGSYNO 3-(Aminocarbonyl)-O(sup 4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-(aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-carbamoyl-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; DAVA; Desacetylvinblastine amide; Lilly 112531; Methyl (5S,7S,9S)-9-[(2b,3b,4b,5a,12b,19a)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate; Methyl (5S,7S,9S)-9-[(2beta,3beta,4beta,5alpha,12beta,19alpha)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate; Vindesin; Vindesina; Vindesina [INN-Spanish]; Vindesine (USAN/INN); Vindesine [USAN:BAN:INN]; Vindesine [USAN:INN:BAN]; Vindesinum; Vindesinum [INN-Latin] DTD0003 VADRUGID DR00416 DTD0003 DRUGNAME Cytarabine DTD0003 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0003 VADRUGID DR00284 DTD0003 DRUGNAME Daunorubicin DTD0003 DRUGSYNO (+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103 DTD0003 VADRUGID DR00358 DTD0003 DRUGNAME Gilteritinib DTD0003 DRUGSYNO 6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide; ASP 2215; Gilteritinib; Gilteritinib (ASP-2215); Gilteritinib (ASP2215); Gilteritinib (USAN/INN); Gilteritinib [USAN:INN]; Gilteritinib(ASP2215); Xospata DTD0003 VADRUGID DR00386 DTD0003 DRUGNAME Idarubicin DTD0003 DRUGSYNO (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN) DTD0003 VADRUGID DR01370 DTD0003 DRUGNAME Midostaurin DTD0003 DRUGSYNO PKC412; 120685-11-2; Cgp 41251; 4'-N-Benzoylstaurosporine; CGP-41251; Benzoylstaurosporine; PKC-412; RYDAPT; PKC 412; UNII-ID912S5VON; N-Benzoylstaurosporine; ID912S5VON; CHEMBL608533; CHEBI:63452; Cgp 41 251; N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide; PKC-412(Midostaurin); Midostaurin (PKC412); Midostaurin (USAN/INN); Midostaurin [USAN:INN]; CGP 41231; Rydapt (TN); CPG 41251 DTD0003 VADRUGID DR00362 DTD0003 DRUGNAME Ivosidenib DTD0003 DRUGSYNO (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; Ivosidenib; Ivosidenib (USAN/INN); Ivosidenib [INN]; Ivosidenib [USAN]; Ivosidenib [WHO-DD]; Tibsovo DTD0003 VADRUGID DR00269 DTD0003 DRUGNAME Mitoxantrone DTD0003 DRUGSYNO 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate) DTD0003 VADRUGID DR00580 DTD0003 DRUGNAME Valspodar DTD0003 DRUGSYNO 3'-Keto-bmt(1)-val(2)-cyclosporin A; Amdray; Amdray (TN); PSC-833; PSC833; Psc 833; SDZ-PSC 833; Sdz psc 833; Sdz-psc-833; Valspodar (USAN/INN) DTD0003 VADRUGID DR00171 DTD0003 DRUGNAME Loperamide DTD0003 DRUGSYNO 2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide; 4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide; Apo-Loperamide; Diamide (TN); Diarr-Eze; Dimor (TN); Imodium (TN); Imodium A-D Caplets; Ioperamide; Kaopectate II; Loperacap; Loperamida; Loperamida [INN-Spanish]; Loperamide (INN); Loperamide Monohydrochloride; Loperamide [INN:BAN]; Loperamidum; Loperamidum [INN-Latin]; Lopex (TN); Maalox Anti-Diarrheal; Nu-Loperamide; PMS-Loperamide; Pepto (TN); Pepto Diarrhea Control; R-18553; Rho-Loperamide DTD0003 VADRUGID DR01340 DTD0003 DRUGNAME Nafoxidine DTD0003 DRUGSYNO Nafoxidine; 1845-11-0; Nafoxidine [INN]; Nafoxidinum [INN-Latin]; Nafoxidina [INN-Spanish]; UNII-4RIY10WM82; U-11000A; BRN 1440873; CHEMBL28211; 4RIY10WM82; CHEBI:34881; NSC 70735; C29H31NO2; JEYWNNAZDLFBFF-UHFFFAOYSA-N; 1-(2-(p-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)pyrrolidine; Pyrrolidine, 1-(2-(4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy)ethyl)-; 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine; Pyrrolidine, 1-(2-(p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl DTD0003 VADRUGID DR00035 DTD0003 DRUGNAME Axitinib DTD0003 DRUGSYNO AG 013736; AG-013736; AG-013736, Axitinib; AG-13736; AG013736; Axitinib (VEGFR inhibitor); N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide DTD0003 VADRUGID DR00454 DTD0003 DRUGNAME Sunitinib DTD0003 DRUGSYNO 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN) DTD0003 VADRUGID DR00579 DTD0003 DRUGNAME Dihydroergocristine DTD0003 DRUGSYNO Nehydrin DTD0003 VADRUGID DR00177 DTD0003 DRUGNAME Cetirizine DTD0003 DRUGSYNO (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; Cetiderm; Cetiderm (TN); Cetirizin; Cetirizina; Cetirizina [Spanish]; Cetirizine (INN); Cetirizine [INN:BAN]; Cetirizinum; Cetirizinum [Latin]; Cetrizine Hcl; Cetryn; Hitrizin Film Tablet; P-071; Reactine (TN); Setir; Virlix; Ziptek; Zirtek; Zyrlex; Zyrtec (TN); [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid DTD0003 VADRUGID DR00497 DTD0003 DRUGNAME Desloratadine DTD0003 DRUGSYNO 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; Aerius; Aerius (TN); Allex; Azomyr; Claramax; Claramax (TN); Clarinex; Clarinex (TN); Clarinex RediTabs; Denosin; Desalex; Descarboethoxyloratadine; Descarboethoxyoratidine; Desloratadine (USAN/INN); Desloratadine [USAN]; Desloratidine; Essex brand of desloratadine; NeoClarityn (TN); Neoclarityn; Opulis; Sch 34117; Sch-34117; Schering brand of desloratadine; Schering-Plough brand of desloratadine DTD0003 VADRUGID DR00026 DTD0003 DRUGNAME Fexofenadine DTD0003 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0003 VADRUGID DR01379 DTD0003 DRUGNAME Mequitazine DTD0003 DRUGSYNO Butix; Instotal; Kitazemin; Mequitazina; Mequitazinum; Metaplexan; Mircol; Primalan; Quitadrill; Vigigan; Virginan; Zesulan; Italfarmaco brand of mequitazine; Mequitazina [Spanish]; Mequitazine hydrochloride; Pierre Fabre brand of mequitazine; LM 209; Kitazemin (TN); LM-209; Mequitazina [INN-Spanish]; Mequitazinum [INN-Latin]; Mequitazine (JP15/INN); Mequitazine [INN:BAN:DCF:JAN]; Mequitazine tartrate, (R-(R*,R*))-isomer; 10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)-10H-phenothiazine; 10-(1-azabicyclo(2.2.2)oct-8-ylmethyl)phenothiazine; 10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine; 10-(3-Quinuclidinylmethyl)phenothiazine; 10H-Phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)-(9CI); 3-Methylquinuclidinyl-10-phenothiazine DTD0003 VADRUGID DR01395 DTD0003 DRUGNAME Triprolidine DTD0003 DRUGSYNO Actidil; Actidilat; Entra; Histafed; Myidyl; Tripolidina; Triprolidin; Triprolidinum; Venen; Triprolidine HCL; Triprolidine Monohydrochloride; Triprolidine hydrochloride; Triprolidine hydrochloride anhydrous; T 6764; Actidil (TN); Myidil (TN); Pro-Actidil; Pro-Entra; Tripolidina [INN-Spanish]; Triprolidine (INN); Triprolidine Hydrochloride (anhydrous); Triprolidine Monohydrochloride, Monohydrate; Triprolidine [INN:BAN]; Triprolidinum [INN-Latin]; Venen (TN); Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine; Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride; Trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene; Trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene; Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, monohydrate, stereoisomer; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1); (E)-2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine; (E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ium-1-ylprop-1-enyl]pyridine chloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride DTD0003 VADRUGID DR01665 DTD0003 DRUGNAME Beclomethasone dipropionate DTD0003 DRUGSYNO BECLOMETHASONE DIPROPIONATE; Beclometasone dipropionate; Beconase; Beclovent; Vancenase; Beclorhinol; Becloforte; Sanasthmyl; Beclazone; Sanasthmax; Propaderm; Beclomet; Vanceril; Aerobec; Becloturmant; Beclacin; Respocort; Entyderma; Korbutone; Viarox; Rino-clenil; Clenil-A; Beclometasone 17,21-dipropionate; Becotide; Aldecin; Turbinal; Aldecina; Rhinosol; Beclate; Atomase; Alanase; Benconase; Aldecine; Clenil; Spir; Beclocort Nasel; Beclomet Nasal; Propaderm Forte; Rhino Clenil; Inalone O; Inalone R; Qvar; QNASL; Beconase AQ; Qvar 80 DTD0003 VADRUGID DR00705 DTD0003 DRUGNAME Astemizole DTD0003 DRUGSYNO 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; AlacanBrand of Astemizole; Alermizol; Alonga Brand of Astemizole; Alonga, Astemizol; Astemina; Astemisan; Astemisol; Astemison; Astemizol; Astemizol Alonga; Astemizol [German]; Astemizol [INN-Spanish]; Astemizol ratiopharm; Astemizole (JAN/USP/INN); Astemizole Alacan Brand; Astemizole Alonga Brand; Astemizole Byk Brand; Astemizole Diba Brand; Astemizole Elfar Brand; Astemizole Esteve Brand; Astemizole Fustery Brand; Astemizole ICN Brand; Astemizole Janssen Brand; Astemizole Lesvi Brand; Astemizole McNeil Brand; Astemizole Medinsa Brand; Astemizole Merck Brand; Astemizole Senosiain Brand; Astemizole Septa Brand; Astemizole Smaller Brand; Astemizole Urbion Brand; Astemizole Vita Brand; Astemizole [USAN:BAN:INN]; Astemizole ratiopharm Brand; Astemizolum; Astemizolum [INN-Latin]; Astesen; Byk Brand of Astemizole; Diba Brand of Astemizole; Elfar Brand of Astemizole; Emdar; Esmacen;Fustermizol; Esteve Brand of Astemizole; Fustery Brand of Astemizole; GNF-PF-2461; HISMANAL (TN); Hestazol; Hestazol, Kelp, Laridal, Retolen, Wareezol, HSBD 6799, BRN 4830190; Hismanal; Histamen; Histaminos; Histazol; Hubermizol; ICN Brand of Astemizole; Janssen Brand of Astemizole; Kelp; Laridal; Lesvi Brand of Astemizole; MJD-30; McNeil Brand of Astemizole; Medinsa Brand of Astemizole; Merck Brand of Astemizole; Metodih; Metodik; Nono-Nastizol A; Novo-mastizol A; Paralergin; R 42512; R 43 512; R-43-512; R-43512; R43512; Ratiopharm Brand of Astemizole; Ratiopharm, Astemizol; Reig Jofre Brand of Astemizole; Retolen; Rifedot; Rimbol; Romadin; Senosiain Brand of Astemizole; Septa Brand of Astemizole; Simprox; Smaller Brand of Astemizole; Urbion Brand of Astemizole; Urdrim; Vita Brand of Astemizole; Wareezol; Waruzol; [3H]Astemizole DTD0003 VADRUGID DR00541 DTD0003 DRUGNAME Loratadine DTD0003 DRUGSYNO 1-Piperidenecarboxylic acid, 4-(8-chloro-5,6-duhydro-11H-benzo [5,6]cyclohepta[1,2-b]-pyridin-11-ylidene)-, ethyl ester; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester; 1-piperidinecarboxylic acid,4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-,ethyl ester; 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester; 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acidethyl ester; 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester; Aerotina; Alarin; Alavert; Alavert (TN); Alavert, Claritin, Loratadine; Alerpriv; AllergyX (TN); Allertidin; Anhissen; Bedix Loratadina; Biloina; Bonalerg; Children's Claritin; Civeran; Claratyne; Claratyne Cold; Claratyne Decongestant; Clarinase; Clarinase Reperabs; Claritin; Claritin (TN); Claritin D; Claritin Hives Relief; Claritin Hives Relief Reditab; Claritin Reditabs; Claritin reditab; Claritin-D (TN); Claritine (TN); Claritine;Clarityn; Clarityn (TN); Clarityne; Clarityne (TN); Clarityne Dy Repetabs; Clarityne-D; Clarium; Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate;Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylate; Flonidan (TN); Fristamin; Fristamin (TN); Histaloran; L 9664; Lergy; Lertamine; Lesidas; Lisino; Lomilan (TN); Loracert; Loradex; Loradif; Loranox; Lorantis; Lorastine; Loratadina; Loratadina [Spanish]; Loratadine (JAN/USAN/INN); Loratadine Redidose; Loratadine Wyeth Brand; Loratadine [USAN:BAN:INN]; Loratadinum; Loratadinum [Latin]; Loratidine; Loratyne; Loraver; Lorfast; Lorfast (TN); Loritine; Lowadina; Nularef; Optimin; Polaratyne; Pylor; Restamine; Rhinase; Rinolan (TN); Rinomex; Roletra; Roletra (TN); Sanelor; Sch 29851; Sch-29851; Sch29851; Sensibit; Sinhistan Dy; Sohotin; Symphoral (TN); Tadine; Talorat Dy; Tidilor (TN); Velodan; Versal; Wyeth Brand of Loratadine; Zeos DTD0003 VADRUGID DR00755 DTD0003 DRUGNAME Terfenadine DTD0003 DRUGSYNO 1-(4-tert-Butylphenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol; 1-(4-tert-butylphenyl)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-ol; 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol; 1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)butanol; 1-[4-(1,1-dimethylethyl)phenyl]-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol; Aldaban; Aliud Brand of Terfenadine; Allerplus; Alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol; Alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine butanol; Alpha-(4-[1,1-Dimethylethyl]phenyl)-4-[hydroxydiphenylmethyl]-1-piperidinebutanol; Alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Balkis Saft Spezial; Bial Brand of Terfenadine; Cantabria Brand of Terfenadine; Ct Arzneimittel Brand of Terfenadine; Ct-Arzneimittel Brand of Terfenadine; Cyater; Dolorgiet Brand of Terfenadine; Heumann Brand of Terfenadine; Hisfedin; Hoechst Brand of Terfenadine; MDL 9918; MDL-9918; Merck dura Brand of Terfenadine; Mundipharma Brand of Terfenadine; RMI 9918; RMI-9918; RMI9918; Rapidal; Ratiopharm Brand of Terfenadine; Seldane; Seldane (TN); Sigma Tau Brand of Terfenadine; Sigma-Tau Brand of Terfenadine; Stadapharm Brand of Terfenadine; T 9652; Teldane; Teldane (TN); Teldanex; Terdin; Terfedura; Terfemundin; Terfen; Terfenadin AL; Terfenadin Heumann; Terfenadin Stada; Terfenadin von ct; Terfenadin-ratiopharm; Terfenadina; Terfenadina [INN-Spanish]; Terfenadine (JAN/USAN/INN); Terfenadine [USAN:BAN:INN:JAN]; Terfenadinum; Terfenadinum [INN-Latin]; Terfenidine; Terfex; Ternadin; Triludan; Triludan (TN); Wolff Brand of Terfenadine DTD0003 VADRUGID DR00183 DTD0003 DRUGNAME Tacrine DTD0003 DRUGSYNO 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE (SEE ALSO 1684-40-8); 1,2,3,4-Tetrahydro-9-acridineamine; 1,2,3,4-Tetrahydro-acridin-9-ylamine; 1,2,3,4-Tetrahydroaminoacridine; 1,2,3,4-tetrahydroacridin-9-amine; 5-Amino-6,7,8,9-tetrahydroacridine (European); 9-AMINOTETRAHYDROACRIDINE; 9-Acridinamine, 1,2,3,4-tetrahydro-(9CI); 9-Amino-1,2,3,4-Tetrahydroacridine Hydrate Hydrochloride Hydrate; 9-amino-1,2,3,4-tetrahydroacridine; BBL001044; CS 12602; Cognex; Cognex (TN); Romotal; Tacrina; Tacrina [INN-Spanish]; Tacrinal; Tacrinal (TN); Tacrine (INN); Tacrine [INN:BAN]; Tacrine hydrochloride; Tacrinum; Tacrinum [INN-Latin]; Tenakrin; Tetrahydroaminacrine; Tetrahydroaminoacridine; Tetrahydroaminocrin; Tetrahydroaminocrine; Tha DTD0003 VADRUGID DR01345 DTD0003 DRUGNAME Okadaic acid DTD0003 DRUGSYNO 78111-17-8; CHEMBL280487; CHEBI:44658; C44H68O13; 9,10-Deepithio-9,10-didehydroacanthifolicin; Ocadaic Acid; OKA; (2R)-3-[(2S,5R,6R,8S)-8-[(2R,3E)-4-[(2R,4'aR,5R,6'S,8'R,8'aS)-8'-hydroxy-6'-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-7'-methylidene-hexahydro-3'H-spiro[oxolane-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl]-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid; UNII-1W21G5Q4N2; CCRIS 3329; HSDB 7243; 1W21G5Q4N2; 1jk7 DTD0003 VADRUGID DR00261 DTD0003 DRUGNAME Lenalidomide DTD0003 DRUGSYNO 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; ALBB-015321; CC 5013; CC-5013; CC-5013, Revlimid, Lenalidomide; CC5013; CDC 501; CDC-501; CDC-5013; Celgene brand of lenalidomide; ENMD-0997; IMID-5013; IMiD3; IMiD3cpd; Lenalidomide (Immunomodulator); Lenalidomide (USAN/INN); Lenalidomide [USAN]; Revamid; Revimid; Revlimid; Revlimid (Celgene); Revlimid (TN); Thalidomide analog CC-5013 DTD0003 VADRUGID DR00396 DTD0003 DRUGNAME Nifedipine DTD0003 DRUGSYNO AWD Pharma Brand of Nifedipine; Adalat; Adalat (TN); Adalat 10; Adalat 20; Adalat 5; Adalat CC; Adalat CR; Adalat Crono; Adalat FT; Adalat GITS; Adalat GITS 30; Adalat LA; Adalat LP; Adalat Oros; Adalat PA; Adalat Retard; Adalat XL; Adalate; Adalate LP; Adapine; Adapress; Adcock Ingram Brand of Nifedipine; Adipine XL; Afeditab; Afeditab CR; Afeditab CR (TN); Alat; Aldipin; Alfadal; Alonix; Alonix S; Alpha-Nifedipine Retard;Apo-Nifed; Angipec; Anifed; Anpine; Aprical; Aprical long; Bay-1040; Bay-a-1040; Bay1040; Bayer Brand of Nifedipine; Bonacid; Calcibloc; Calcigard; Calcilat; Camont; Cardifen; Cardilat; Cardionorm; Chronadalate; Chronadalate LP; Citilat; Coracten; Coracten XL; Coral; Cordafen; Cordaflex; Cordalat; Cordicant; Cordilan; Cordipin; Cordipine; Corinfar; Corotrend; Corynphar; Depin; Dignokonstant; Dilafed; Dipinkor; Duranifin; Ecodipi; Ecodipin; Ecodipin E; Emaberin; Fedcor; Fedcor Retard; Fenamon; Fenamon SR; Fenigidin; Fenihidin; Fenihidine; Fortipine LA; Glopir; Hadipin; Hexadilat; Infedipin; Introcar; KB-1712P; KRKA Brand of Nifedipine; Kordafen; Korinfar; Macorel; Megalat; Monohydrochloride, Nifedipine; Myogard; N 7634; N1fedilat; Nedipin; Nicardia; Nifangin; Nifar; Nifdemin; Nifebene; Nifecard; Nifecor; Nifedepat; Nifediac; Nifedical; Nifedical (TN); Nifedical XL; Nifedicor; Nifedin; Nifedine; Nifedipine (JP15/USP/INN); Nifedipine Bayer Brand; Nifedipine GTIS; Nifedipine KRKA Brand; Nifedipine Monohydrochloride; Nifedipine Orion Brand; Nifedipine Pfizer Brand; Nifedipine Retard; Nifedipine [USAN:BAN:INN:JAN]; Nifedipine-GTIS; Nifedipino; Nifedipino [INN-Spanish]; Nifedipinum; Nifedipinum [INN-Latin]; Nifedipres; Nifedirex LP; Nifelan; Nifelat; Nifelat Q; Nifelate; Nifensar XL; Nificard; Nifidine; Nifipen; Niphedipine; Orion Brand of Nifedipine; Orix; Oxcord; Pfizer Brand of Nifedipine; Pidilat; Procardia; Procardia (TN); Procardia XL; Sepamit; Slofedipine XL; Tensipine MR; Tibricol; Vascard; Zenusin DTD0003 VADRUGID DR01261 DTD0003 DRUGNAME Nadolol DTD0003 DRUGSYNO (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol; Alti-Nadolol (TN); Anabet; Anabet (TN); Apo-Nadol (TN); Corgard; Corgard (TN); Corgaretic; Corzide (TN); Nadic; Nadolol (JP15/USP/INN); Nadolol [USAN:BAN:INN:JAN]; Nadololum; Nadololum [INN-Latin]; Novo-Nadolol (TN); SQ 11725; SQ-11725; SQ11725; Solgol; Solgol (TN) DTD0003 VADRUGID DR00280 DTD0003 DRUGNAME Nicardipine DTD0003 DRUGSYNO 2-(Benzylmethylamino)ethylmethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cardene (TN); Cardene IV; Methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nicardipine (INN); Nicardipine LA; Nicardipine [INN:BAN]; Nicardipino; Nicardipino [INN-Spanish]; Nicardipinum; Nicardipinum [INN-Latin]; Y-93 DTD0003 VADRUGID DR00264 DTD0003 DRUGNAME Verapamil DTD0003 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0003 VADRUGID DR00148 DTD0003 DRUGNAME Digoxin DTD0003 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0003 VADRUGID DR00111 DTD0003 DRUGNAME Posaconazole DTD0003 DRUGSYNO Posaconazole; Noxafil; Sch 56592; Posaconazole SP; SCH56592; SCH-56592; UNII-6TK1G07BHZ; Schering 56592; CHEMBL1397; 6TK1G07BHZ; 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-1H-1,2,4-TRIAZOL-5(4H)-ONE DTD0003 VADRUGID DR01392 DTD0003 DRUGNAME Betamethasone DTD0003 DRUGSYNO betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Betamethazone; Rinderon; Visubeta; Celestene; Betnelan; Betapredol; Betacortril; Betacorlan; Methazon; Betsolan; Betamamallet; Hormezon; Betasolon; Betametasone; Cidoten; Bebate; Bedifos; Becort; beta-Methasone; Desacort-Beta; Rinderon A; beta-Methasone alcohol; Betametasona; Betafluorene; Betamethasonum; Celestone; Betamethasone cream; Betamethasone alcohol; Betametasone [DCIT]; 9alpha-Fluoro-16beta-methylprednisolone; Celestone Syrup and Tablets; Celeston; Celestona; Cellestoderm; Luxiqo; Betamethasone Base; Betamethasone Valearate; Betamethasonvalerat Mikron; LT00441022; SCH 4831; Beta-Methasone; Beta-Methasone alcohol; Betametasona [INN-Spanish]; Betamethasonum [INN-Latin]; Betnovate (TN); Celestone (TN); Diprolene (TN); Diprosone (TN); Lotrisone (TN); Rinderon (TN); SCH-4831; Betamethasone (JP15/USP/INN); Betamethasone [USAN:BAN:INN:JAN]; Betamethasone [USAN:INN:BAN:JAN]; Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone; 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol; 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione; 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-16beta-methylprednisolone; 9-alpha-Fluoro-16-beta-methylprednisolone; 9alpha-Fluoro-16 beta-methyl-prednisolone; Betamethasone sodium phosphate DTD0003 VADRUGID DR01408 DTD0003 DRUGNAME Ciclesonide DTD0003 DRUGSYNO Alvesco; Omnair; Omnaris; Osonase; Osonide; Alvesco HFA; Ciclesonide [INN]; Omnaris HFA; RPR 251526; Alvesco (TN); BTR-15; BTR-15K; BY-9010; BYK-20426; KS-1165; Omnaris (TN); Omniair (TN); TBN-15; B-9207-015; Ciclesonide (JAN/USAN/INN); (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate DTD0003 VADRUGID DR01643 DTD0003 DRUGNAME Fluticasone propionate DTD0003 DRUGSYNO FLUTICASONE PROPIONATE; Flovent; Cutivate; Flixotide; Flonase; Flixonase; Flovent HFA; Flunase; Flutide; Fluspiral; Flusonal; atemur; Flutivate; Fluinol; Axotide; Asmatil; Brethal; Flovent Diskus 50; Flixotide Disks; Flixotide Disk; Flovent Diskus; Flovent Diskus 100; Flovent Diskus 250; Flixotide Inhaler; Trialona; Rinosone; Inalacor; Cultivate; Ubizol; Zoflut; Flixonase Nasal Spray; Flonase Aq; Fluticasonpropionat Allen; Fluticasone (propionate); UNII-O2GMZ0LF5W; CCI-18781; CCI 18781; MFCD00866007; O2GMZ0LF5W DTD0003 VADRUGID DR00128 DTD0003 DRUGNAME Methylprednisolone DTD0003 DRUGSYNO Depo-medrol; M-predrol; Medrol; Medrol Acetate; Methylprednisolone Acetate DTD0003 VADRUGID DR00892 DTD0003 DRUGNAME Gallopamil DTD0003 DRUGSYNO (+/-)-Methoxyverapamil hydrochloride; 16662-47-8; 5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-; C28H40N2O5; CHEBI:34772; D 600; D600; GSK 796406; Gallopamil [INN:BAN]; Gallopamillum [INN-Latin]; Galopamilo; Galopamilo [INN-Spanish]; Methoxyverapamil; methoxyverapamil DTD0003 VADRUGID DR01161 DTD0003 DRUGNAME Ajmaline DTD0003 DRUGSYNO Ajmaline; Cardiorythmine; Ajmalin; Raugalline; Tachmalin; Gilurytmal; (+)-Ajmaline; Aritmina; Rauwolfine; Rhytmaton; Rauwolfin; Merabitol; Takycor; Siddiqui; Rytmalin; Ignazin; Ritmos; 4360-12-7; UNII-1PON08459R; 1PON08459R; Takhmalin; Cartagine; Tajmalin; NSC 15627; Ajmaline [JAN]; Ajmalan-17,21-diol; EINECS 224-439-4; NSC 628054; (17R,21alpha)-Ajmalan-17,21-diol; (17R,21-alpha)-Ajmalan-17,21-diol; AI3-62668; Ajmalan-17,21-diol, (17R,21alpha)-, compound with methanol (1:1); ZINC898188 DTD0003 VADRUGID DR00166 DTD0003 DRUGNAME Edoxaban DTD0003 DRUGSYNO Edoxaban DTD0003 VADRUGID DR00946 DTD0003 DRUGNAME Melagatran DTD0003 DRUGSYNO 159776-70-2; 2A9QP32MD4; C22H31N5O4; CHEBI:43966; H-319/68; MEL; MELAGATRAN (ASTRA-ZENECA); Melagatran; Melagatran (INN); Melagatran [INN]; N-((R)-(((2S)-2-((-p-Amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine; N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine; UNII-2A9QP32MD4; [((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID DTD0003 VADRUGID DR00393 DTD0003 DRUGNAME Atomoxetine DTD0003 DRUGSYNO (-)-Tomoxetine; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine; Atomoxetine (INN); Attentin (TN); Strattera (TN); Tomoxetin (TN); Tomoxetina; Tomoxetina [Spanish]; Tomoxetine; Tomoxetine [INN]; Tomoxetinum; Tomoxetinum [Latin] DTD0003 VADRUGID DR00501 DTD0003 DRUGNAME Desipramine DTD0003 DRUGSYNO (3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine; 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine; 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine; 5-(gamma-Methylaminopropyl)iminodibenzyl; DMI (pharmaceutical); DMI 50475; Demethylimipramine; Desimipramine; Desimpramine; Desipramin; Desipramina; Desipramina [INN-Spanish]; Desipramine (D4); Desipramine (INN); Desipramine Hcl; Desipramine [INN:BAN]; Desipraminum; Desipraminum [INN-Latin]; Desmethylimipramine; Dezipramine; Dimethylimipramine; Methylaminopropyliminodibenzyl; Monodemethylimipramine; N-(3-Methylaminopropyl)iminobibenzyl; Norimipramine; Norpramin (TN); Norpramine; Pentofran; Pertofrane (TN); Pertrofane; Sertofran; ZERO/006017 DTD0003 VADRUGID DR00285 DTD0003 DRUGNAME Silodosin DTD0003 DRUGSYNO (R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; 160970-64-9; CHEMBL24778; CUZ39LUY82; KAD 3213; KAD-3213; KMD 3213; KMD-3213; Q-102517; Rapaflo; Rapflo; Silodosin-d6; Silodyx; UNII-CUZ39LUY82; Urief; Urorec DTD0003 VADRUGID DR01260 DTD0003 DRUGNAME Tadalafil DTD0003 DRUGSYNO (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; ADCIRCA; Acdirca; Cialis; Cialis (TN); Cialis, GF 196960, IC 351, ICOS 351, Tadalafil; GF 196960; GF-196960; IC 351; IC-351; ICOS 351; Ic351; KS-1117; Lilly brand of tadalafil; Tadalafil (JAN/USAN/INN); Tadalafil [USAN]; Tadanafil DTD0003 VADRUGID DR00056 DTD0003 DRUGNAME Lamotrigine DTD0003 DRUGSYNO 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine; BW 430C; BW-430C; Crisomet; Desitin Brand of Lamotrigine; EUR-1048; Faes Brand of Lamotrigine; GI 267119X; GW 273293; Glaxo Wellcome Brand of Lamotrigine; GlaxoSmithKline Brand of Lamotrigine; Juste Brand of Lamotrigine; L 3791; Labileno; Lamictal; Lamictal (TN); Lamictal Cd; Lamictal ODT; Lamictal XR; Lamictin; Lamictin (TN); Lamiktal; Lamitor; Lamotrigina; Lamotrigina [Spanish]; Lamotrigine (JAN/USAN/INN); Lamotrigine [USAN:INN:BAN]; Lamotriginum; Lamotriginum [Latin] DTD0003 VADRUGID DR00462 DTD0003 DRUGNAME Olanzapine DTD0003 DRUGSYNO 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine; ALKS-7921; Eli Lilly brand of olanzapine; KS-1090; LY 170053; LY-170052; LY-170053; Lanzac; Lilly brand of olanzapine; Midax; Olansek; Olanzapina; Olanzapine (JAN/USAN/INN); Olanzapine (OLA); Olanzapine [USAN:INN]; Olanzapinum; Olzapin (TN); Rexapin (TN); Symbyax; Zalasta; Zalasta (TN); Zolafren (TN); Zydis; Zydis (TN); Zyprexa; Zyprexa (TN); Zyprexa Intramuscular; Zyprexa Velotab; Zyprexa Zydis DTD0003 VADRUGID DR00759 DTD0003 DRUGNAME Perphenazine DTD0003 DRUGSYNO 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina; 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]; 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine; 1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride; 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol; 2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; 2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine; 2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine; 2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine; 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol;2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol; 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol; 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol; 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; Apo-Perphenazine; Chlorperphenazine; Chlorpiprazine; Decentan; Emesinal; Etaperazin; Etaperazine; Ethaperazine; F-mon; Fentazin;PZC; Gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine; Gamma-[4-(beta-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine; P 6402; Perfenazina; Perfenazina [INN-Spanish]; Perfenazina [Italian]; Perfenazine; Perphenan; Perphenazin; Perphenazine (JP15/USP/INN); Perphenazine [INN:BAN:JAN]; Perphenazine [Trilafon]; Perphenazine maleate; Perphenazinum; Perphenazinum [INN-Latin]; SCH-3940; Sch 3940; Siquil (TN); Thilatazin; Tranquisan; Triavil (TN); Trifaron; Trilafon; Trilifan; Triphenot DTD0003 VADRUGID DR01271 DTD0003 DRUGNAME Levomepromazine DTD0003 DRUGSYNO 2-Methoxytrimeprazine; 60-99-1; 9G0LAW7ATQ; Arc-VI-C-5; Bayer 1213; CL 36467; CL 39743; Dedoran; EINECS 200-495-5; F-5116; Hirnamine; Levomepromazin; Levomepromazina; Levomepromazina [INN-Spanish]; Levomepromazinum; Levomepromazinum [INN-Latin]; Levopromazioni; Levoprome; Levotomin; METHOTRIMEPRAZINE; Methotrimeprazine; Methotrimeprazine (USP); Methotrimeprazine [USP]; Methoxytrimeprazine; Milezin; Minozinan; Neozine; Nirnamine; Nocinan; Nomizan; Nosinan; Nozinan; RP-7044; UNII-9G0LAW7ATQ; Veractil; XP03 DTD0003 VADRUGID DR00129 DTD0003 DRUGNAME Estradiol DTD0003 DRUGSYNO 17 beta-Estradiol; 17-.BETA.-Estradiol; 17-beta-OH-estradiol; 17-beta-estradiol; 17.beta.-Estradiol; 17.beta.-Oestradiol; 17b-Oestradiol; 17beta oestradiol; 17beta-Estradiol; 17beta-Oestradiol; 3,17-beta-Estradiol; 3,17-beta-Oestradiol; 3,17.beta.-Estradiol; 3,17beta-Estradiol; Activella (TN); Aerodiol; Alora; Alora (TN); Alpha-Estradiol; Alpha-Oestradiol; Altrad; AngeliQ (TN); Aquadiol; B-Estradiol; Bardiol; Beta-Oestradiol; Beta-estradiol; CMC_11154; Cis-Estradiol; Cis-Oestradiol; Climaderm; Climara; Climara (TN); Climara Forte; Component of Menrium; Compudose; Compudose 200; Compudose 365; Corpagen; D-3,17beta-Estradiol; D-Estradiol; D-Oestradiol; Dermestril; Destradiol; Dihydrofolliculin; Dihydromenformon; Dihydrotheelin; Dihydroxyesterin; Dihydroxyestrin; Dihydroxyoestrin; Dimenformon; Diogyn; Diogynets; Divigel; Divigel (TN); E 2; E 8875; E(sub 2); E0025; Elestrin; Elestrin (TN); Encore; Epiestriol 50; Esclim; Estrace; Estrace (TN); Estraderm; Estraderm (TN); Estraderm MX; Estraderm TTS; Estraderm TTS (TN); Estraderm TTS 100; Estraderm TTS 50; Estradiol [USAN:INN]; Estradiol acetate (TN); Estradiol cypionate (TN); Estradiol valerate (TN); Estradiol-17 beta; Estradiol-17-beta; Estradiol-17beta; Estradiol-3,17beta; Estradiolo; Estradiolo [DCIT]; Estradiolum; Estradiolum [INN]; Estradot; Estraldine; Estrapak 50; Estrasorb; Estrasorb (TN); Estrasorb Topical (TN); Estreva; Estrifam; Estring; Estring (TN); Estring vaginal ring; Estroclim; Estroclim 50; Estrodiolum; Estrofem (TN); Estrofem 2; Estrofem Forte; Estrogel; Estrogel (TN); Estrovite; EvaMist (TN); Evamist; Evorel; Extrasorb; Femanest; Femestral; Femestrol; Femogen; Fempatch; Femring (TN); Femtrace; Femtran; Follicyclin; Gelestra; Ginedisc; Ginosedol; GynPolar; Gynergon; Gynestrel; Gynodiol; Gynoestryl; Innofem; Innofem (TN); Lamdiol; Macrodiol; Macrol; Menest; Menorest; Menostar (TN); Microdiol; Nordicol; Oesclim; Oestergon; Oestradiol; Oestradiol Berco; Oestradiol R; Oestradiol-17-beta; Oestradiol-17beta; Oestradiolum; Oestrogel; Oestroglandol; Oestrogynal; Ovahormon; Ovasterol; Ovastevol; Ovociclina; Ovocyclin; Ovocycline; Ovocylin; Perlatanol; Polyestradiol; Primofol; Profoliol; Profoliol B; Progynon DH; Progynon-DH; Progynon;Syndiol; Progynova (TN); S-21400; SK-Estrogens; SL-1100; Sandrena 1; Sandrena Gel; Sisare Gel; Systen; Tradelia; Trial SAT; Trocosone; VIVELLE-DOT; Vagifem; Vagifem (TN); Vivelle; Vivelle (TN); Vivelle-Dot (TN); Zerella; Zesteem; Zesteen; Zumenon; [2,4,6,7-3H]-E2; [3H]-estradiol; [3H]]estradiol DTD0003 VADRUGID DR01285 DTD0003 DRUGNAME Ixabepilone DTD0003 DRUGSYNO Azaepothilone B; BMS-247550; Ixempra (TN) DTD0003 VADRUGID DR00120 DTD0003 DRUGNAME Lapatinib DTD0003 DRUGSYNO 4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline; FMM; GSK 572016; GSK572016; GW 572016; GW 572016X; GW572016; Lapatinib (ERBB2 inhibitor); Lapatinib (INN); Lapatinib Ditosylate; Lapatinib [INN]; Lapatinib tosilate hydrate; Lapatinib, Tykerb, GW572016; N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine; N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine; N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine; N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE; Tycerb; Tykerb (TN) DTD0003 VADRUGID DR00342 DTD0003 DRUGNAME Paclitaxel DTD0003 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0003 VADRUGID DR01288 DTD0003 DRUGNAME Palbociclib DTD0003 DRUGSYNO LQQ; 571190-30-2; 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE; 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one; G9ZF61LE7G; HMR-2934; Ibrance; PD 0332991; PD 332991; PD 332991, PD 0332991, PD0332991; PD-0332991; PD-332991; PD0332991; Palbociclib(PD0332991); UNII-G9ZF61LE7G DTD0003 VADRUGID DR01430 DTD0003 DRUGNAME Pirarubicin DTD0003 DRUGSYNO pirarubicin; Theprubicin; MFCD00869742; THP-doxorubicin; C32H37NO12; NCGC00167982-01; AC1LCS5T; Pirarubicin (JP17/INN); SCHEMBL15472856; CHEMBL1398373; EX-A494; AOB5649; KMSKQZKKOZQFFG-HSUXVGOQSA-N; ZINC3913909; AKOS015895621; NCGC00167982-02; BC225325; K234; D01885; 15207-EP2316833A1; 15207-EP2311829A1; 15207-EP2298765A1; 15207-EP2298748A2; 15207-EP2295427A1; 15207-EP2295416A2; 15207-EP2272827A1; 15207-EP2316832A1; 15207-EP2298778A1; 15207-EP2298768A1; 15207-EP2295426A1; 15207-EP2295055A2; 15207-EP2311808A1 DTD0003 VADRUGID DR00366 DTD0003 DRUGNAME Talazoparib DTD0003 DRUGSYNO (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one; (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one; (8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One; LT-673; Talazoparib; Talazoparib (BMN 673); Talazoparib [USAN:INN] DTD0003 VADRUGID DR00193 DTD0003 DRUGNAME Tamoxifen DTD0003 DRUGSYNO (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN) DTD0003 VADRUGID DR01170 DTD0003 DRUGNAME Toremifene DTD0003 DRUGSYNO (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1); 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC); 2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine; 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Acapodene; Acapodene (TN); Estrimex; FC-1157a; Fareston (TN); Farestone; GTX-006 (Acapodene); GTx 006; GTx-006; Toremifene (INN); Toremifene Base; Toremifene Citrate (1:1); Toremifene [INN:BAN]; Toremifeno; Toremifeno [Spanish]; Toremifenum; Toremifenum [Latin]; Z-Toremifene; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine DTD0003 VADRUGID DR00251 DTD0003 DRUGNAME Docetaxel DTD0003 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0003 VADRUGID DR00423 DTD0003 DRUGNAME Gefitinib DTD0003 DRUGSYNO 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839 DTD0003 VADRUGID DR00221 DTD0003 DRUGNAME Olaparib DTD0003 DRUGSYNO 4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one; 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one; AZD 2281; AZD-2281; AZD2281; Acylpiperazine analogue, 47; KU-0059436; KU-59436; Olaparib, KU-0059436, AZD2281,KU0059436, AZD2281 DTD0003 VADRUGID DR01424 DTD0003 DRUGNAME Droloxifene DTD0003 DRUGSYNO E-droloxifene; FK-435; K-060; K-060E; RP-60850; K-21.060E; 3-hydroxytamoxifen DTD0003 VADRUGID DR01627 DTD0003 DRUGNAME (Z)-endoxifen DTD0003 DRUGSYNO Endoxifen; Z-Endoxifen; 4-Hydroxy-N-desmethyltamoxifen; (E/Z)-Endoxifen; Endoxifen Z-Isomer; UNII-46AF8680RC; N-Desmethyl-4-hydroxytamoxifen; 110025-28-0; 4-Hydroxy-N-desmethyl-tamoxifen; CHEBI:80555; 46AF8680RC; 4OHNDtam; W-200834; N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture); (Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer); 4-hydroxy-N-desmethyltamoxifen, (Z)-isomer; (Z)-Endoxifen; Endoxifen(E/Z=1:1); 4-hydroxy-N-desmethyl tamoxifen; SCHEMBL10107920; CHEMBL1093458; GTPL10203; EX-A645 DTD0003 VADRUGID DR01487 DTD0003 DRUGNAME 4-Hydroxytamoxifen DTD0003 DRUGSYNO 4-Hydroxytamoxifen; Afimoxifene; (Z)-4-Hydroxytamoxifen; Hydroxytamoxifen; 4-Monohydroxytamoxifen; Tamogel; 68047-06-3; trans-4-Hydroxytamoxifen; Ici 79280; 68392-35-8; 65213-48-1; 4-OH-TAM; (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol; Z-4-hydroxytamoxifen; UNII-95K54647BZ; CHEMBL489; ICI 79,280; TAMOXIFEN, 4-HYDROXY-, (Z)-; BRN 4910749; (E/Z)-4-Hydroxy Tamoxifen; MLS000069742; C26H29NO2; CHEBI:44616; 95K54647BZ; SMR000058939; 4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol DTD0003 VADRUGID DR01203 DTD0003 DRUGNAME Dactinomycin DTD0003 DRUGSYNO 1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97 DTD0003 VADRUGID DR01387 DTD0003 DRUGNAME Dexniguldipine DTD0003 DRUGSYNO Dexniguldipine hydrochloride; BY-935; B-8509-035; B-859-35 DTD0003 VADRUGID DR01452 DTD0003 DRUGNAME S9788 DTD0003 DRUGSYNO S-9788; S9788; S 9788; CHEMBL85156; 140945-01-3; 6-(4-(2,2-di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine; 1,3,5-Triazine-2,4-diamine, 6-(4-((2,2-bis(4-fluorophenyl)ethyl)amino)-1-piperidinyl)-N,N'-di-2-propenyl-; AC1L32YH; SCHEMBL1527824; DTXSID80161502; GERNFWKTMKWULM-UHFFFAOYSA-N; BDBM50053888; LS-187603; LS-186957; N,N''-Diallyl-6-{4-[2,2-bis-(4-fluoro-phenyl)-ethylamino]-piperidin-1-yl}-[1,3,5]triazine-2,4-diamine; H2O DTD0003 VADRUGID DR00559 DTD0003 DRUGNAME Curcumin DTD0003 DRUGSYNO (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; CI Natural Yellow 3; Curcuma; Curcuma oil; Curcumin I; Curcumine; Diferaloylmethane; Diferuloylmethane; Gelbwurz; Golden seal; Haidr; Halad; Haldar; Halud; Hydrastis; Indian saffron; Indian turmeric; Kacha haldi; Kurkumin [Czech]; Merita earth; Natural yellow 3; Oils, curcuma; Orange Root; Safran d'Inde; Souchet; Terra Merita; Tumeric yellow; Turmeric; Turmeric extract; Turmeric oil; Turmeric yellow; Yellow Ginger; Yellow Root; Yellow puccoon; Yo-Kin DTD0003 VADRUGID DR01721 DTD0003 DRUGNAME BMS-3870032 DTD0003 DRUGSYNO SNS-032; BMS-387032; SNS 032; BMS 387032; N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; SNS-032 (BMS-387032); N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide; N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide; UNII-9979I93686; N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide; CHEMBL296468; SNS032; C17H24N4O2S2; BMS387032 DTD0003 VADRUGID DR01644 DTD0003 DRUGNAME Bouvardin DTD0003 DRUGSYNO Bouvardin; MLS002703036; NSC259968; NSC 259968; NSC-259968; AC1L8NRS; Neuro_000123; SCHEMBL8739404; SMR001566844; From fraction F049 of Bouvardia ternifolia; Cyclic(D-alanyl-L-alanyl-N, cyclic(54.fwdarw.63)-ether, (S)-; 17,24-dihydroxy-10-(4-methoxybenzyl)-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2~18,21~.1~23,27~]tritriaconta-18,20,23(31),24,26,32-hexaene-2,5,8,11,14,30-hexone DTD0003 VADRUGID DR01676 DTD0003 DRUGNAME Epothilone A DTD0003 DRUGSYNO Epothilone A; (-)-Epothilone A; Epo A; epothile; Epothilone-A; UNII-51E07YBX96; Epoa; 51E07YBX96; EP; Epothilones; Epothilon A; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione; 4,17-Dioxabicyclo[14.1.0]heptadecane-5,9-dione,7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-,(1S,3S,7S,10R,11S,12S,16R)- DTD0003 VADRUGID DR01613 DTD0003 DRUGNAME MG-132 DTD0003 DRUGSYNO MG-132; Z-Leu-leu-leu-al; MG132; Zlllal; MG 132; Z-LLL-CHO; Zlll-cho; Z-Leu-leu-leucinal; Z-Leu-Leu-Leu-H; Z-Leu-Leu-Leu-CHO; Carbobenzoxy-leucyl-leucyl-leucinal; UNII-RF1P63GW3K; Benzyloxycarbonyl-leu-leu-leu-aldehyde; Benzyloxycarbonyl-leucyl-leucyl-leucinal; Lll cpd; Carbobenzoxyl-leucinyl-leucinyl-leucinal-H; Cbz-Leu-Leu-Leu-H; Benzyloxycarbonylleucyl-leucyl-leucine aldehyde; benzyl (S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate; RF1P63GW3K DTD0003 VADRUGID DR01638 DTD0003 DRUGNAME N-desethyl sunitinib DTD0003 DRUGSYNO N-Desethyl Sunitinib; N-DesethylSunitinib; UNII-42LJ35612R; 42LJ35612R; C20H23FN4O2; N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; SCHEMBL2115189; CHEMBL3542344; DTXSID10437828 DTD0003 VADRUGID DR01354 DTD0003 DRUGNAME Nogalamycin DTD0003 DRUGSYNO AC1MBPR2 DTD0003 VADRUGID DR01558 DTD0003 DRUGNAME Nonactin DTD0003 DRUGSYNO nonactin; Werramycin-A; Antibiotic from Actinomycete; Upjohn 170t (high melting); UPJOHN 170T, high melting; UNII-TTP24WX8P7; 5342 PFW 19; TA-25-M-I; EINECS 229-911-3; A 4426; NSC 56409; E-79-C; NSC 52141; N-329-A; BRN 0076434; TTP24WX8P7; CHEBI:7614; GNF-PF-1094; 3584-A; NSC52141; 4,13,22,31,37,38,39,40-Octaoxapentacyclo(32.2.1.1(sup 7,10).1(sup 16,19).1(sup 25,28))tetracontane-3,12,21,30-tetrone, 2,5,11,14,20,23,29,32-octamethyl-, (1R-(1R*,2R*,5R*,7R*,10S*,11S*,14S*,16S*,19R*,20R*,23R*,25R*,28S*,29S*,32S*,34S*))- DTD0003 VADRUGID DR01388 DTD0003 DRUGNAME Silvestrol DTD0003 DRUGSYNO Naturally derived compounds (cancer); Naturally derived compounds (cancer), Bristol-Myers Squibb/National Cancer Institute DTD0003 VADRUGID DR01399 DTD0003 DRUGNAME Mithramycin DTD0003 DRUGSYNO NCGC00181319-05; NCGC00181319-01; DSSTox_CID_3492; DSSTox_RID_77052; Plicatomycin; DSSTox_GSID_23492; CAS-18378-89-7; AC1NR4RB; SCHEMBL4516; DTXSID6023492; Tox21_112787; Tox21_112751; NCGC00181319-08; NCGC00181319-06; NCGC00181319-03; NCGC00181319-04; NCGC00181319-02; NCGC00181319-07 DTD0003 VADRUGID DR00246 DTD0003 DRUGNAME Ranolazine DTD0003 DRUGSYNO (-)-Ranolazine; CVT-303; KEG-1295; Latixa; N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; RAN D; RS-43285; RS-43285-003; Ran4; Ranexa; Ranexa (TN); Ranexa, Ranolazine; Ranolazine (USAN/INN); Ranolazine 2HCl; Ranolazine dihydrochloride DTD0003 VADRUGID DR00014 DTD0003 DRUGNAME Simeprevir DTD0003 DRUGSYNO TMC436 DTD0003 VADRUGID DR00372 DTD0003 DRUGNAME Sofosbuvir DTD0003 DRUGSYNO HSDB 8226; Hepcinat; Hepcvir; Resof; SOFOSBUVIR; Sofosbuvir (PSI-7977, GS-7977); Sofosbuvir [USAN:INN]; Sovaldi (TN); SoviHep DTD0003 VADRUGID DR01308 DTD0003 DRUGNAME Glecaprevir DTD0003 DRUGSYNO A-1282576.0; ABT 493; ABT-493; ABT-493(Glecaprevir); CS-8098; D10814; DB13879; EX-A1940; Glecaprevir; Glecaprevir (USAN/INN); Glecaprevir [USAN]; HY-17634; J3.646.120I; K6BUU8J72P; SB19760; SCHEMBL883097; UNII-K6BUU8J72P; glecaprevirum DTD0003 VADRUGID DR01337 DTD0003 DRUGNAME Tenofovir alafenamide DTD0003 DRUGSYNO (S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate; AK109983; EL9943AG5J; GS 7340; GS-7339; GS-7340; GS7340; J4414G3BUK; L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester; TENOFOVIR ALAFENAMIDE; Tenofovir Alafenamide (GS-7340); Tenofovir Alafenamide [USAN:INN]; UNII-EL9943AG5J; UNII-J4414G3BUK; Vemlidy DTD0003 VADRUGID DR01689 DTD0003 DRUGNAME Tenofovir disoproxil DTD0003 DRUGSYNO Tenofovir disoproxil; PMPA prodrug; Bis(POC)PMPA; Tenofovir (Disoproxil); UNII-F4YU4LON7I; 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine; F4YU4LON7I; CHEBI:63717; tenofovir bis(isopropyloxycarbonyloxymethyl) ester; Tenofovir Disoproxil Fumarate; [[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphoryl]oxymethyl isopropyl carbonate DTD0003 VADRUGID DR00895 DTD0003 DRUGNAME Chlorambucil DTD0003 DRUGSYNO Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil DTD0003 VADRUGID DR00008 DTD0003 DRUGNAME Venetoclax DTD0003 DRUGSYNO Venclexta DTD0003 VADRUGID DR01270 DTD0003 DRUGNAME Ibrutinib DTD0003 DRUGSYNO Ibrutinib (BTK inhibitor); PCI-32765 DTD0003 VADRUGID DR00253 DTD0003 DRUGNAME Bosutinib DTD0003 DRUGSYNO 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile; 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propo; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; Bosutinib (BCR-ABL inhibitor 3rd gen); Bosutinib (USAN); PF-5208763; SKI 606; SKI-606; SKI606; Xy]-3-quinolinecarbonitrile DTD0003 VADRUGID DR01177 DTD0003 DRUGNAME Hydroxyurea DTD0003 DRUGSYNO 1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase DTD0003 VADRUGID DR00013 DTD0003 DRUGNAME Nilotinib DTD0003 DRUGSYNO Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716 DTD0003 VADRUGID DR00032 DTD0003 DRUGNAME Imatinib DTD0003 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0003 VADRUGID DR00064 DTD0003 DRUGNAME Indacaterol DTD0003 DRUGSYNO 5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol (USAN/INN); QAB-149 DTD0003 VADRUGID DR01363 DTD0003 DRUGNAME Tolafentrine DTD0003 DRUGSYNO BY-4070 DTD0003 VADRUGID DR01444 DTD0003 DRUGNAME NSC325663 DTD0003 DRUGSYNO 21-Cyanosaframycin-B; NSC 325663; 66082-27-7; C29H30N4O8; 21-cyanosaframycin B; AC1L2P2O; SCHEMBL637953; CHEMBL452709 DTD0003 VADRUGID DR01542 DTD0003 DRUGNAME Simvastatin acid DTD0003 DRUGSYNO Simvastatin acid; Tenivastatin; UNII-9L6M5TH46B; DIMETHYL-COMPACTIN; 9L6M5TH46B; (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; Tenivastatin [INN]; (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoic acid DTD0003 VADRUGID DR00112 DTD0003 DRUGNAME Irinotecan DTD0003 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0003 VADRUGID DR01269 DTD0003 DRUGNAME Flavonoids DTD0003 DRUGSYNO FAIMs, Novogen; Flavonoids (inflammatory disease/pain); Flavonoids (inflammatory disease/pain), Novogen DTD0003 VADRUGID DR00689 DTD0003 DRUGNAME Carvedilol DTD0003 DRUGSYNO (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol; Artist; Artist (TN); Atlana Pharma brand of carvedilol; BM 14190; BM-14-190; BM-14.190; BM-14190; Carloc (TN); Carvedilol (JAN/USAN/INN); Carvedilol [USAN:INN:BAN:JAN]; Carvedilol, (+-)-isomer; Carvedilol, (R)-isomer; Carvedilol, (S)-isomer; Carvedilol, 14C-labeled; Carvedilolum; Carvedilolum [Latin]; Coreg; Coreg (TN); Coreg CR; Coropres; Coropress; DQ 2466; DQ-2466; Dibloc; Dilatrend; Dilatrend (TN); EG-P042; Eucardic; Eucardic (TN); GlaxoSmithKline brand of carvedilol; Kredex; Lakeside brand of carvedilol; Querto; Roche brand of carvedilol; SK&F-105517; SKF 105517 DTD0003 VADRUGID DR00348 DTD0003 DRUGNAME Metildigoxin DTD0003 DRUGSYNO 4'''-Methyldigoxin; 4'''-O-Methyldigoxin; Betamethyl digoxin; Digoxin, 4'''-O-methyl-; Lanirapid; Lanitop; MEDIGOXIN; Medigossina; Medigossina [DCIT]; Medigoxina; Medigoxina [Spanish]; Methyldigoxin; Metildigoxin; Metildigoxin [INN:BAN:JAN]; Metildigoxina; Metildigoxina [INN-Spanish]; Metildigoxine; Metildigoxine [INN-French]; Metildigoxinum; Metildigoxinum [INN-Latin]; beta-Methyl Digoxin; beta-Methyldigoxin; beta-Metildigoxina; beta-Metildigoxina [Spanish] DTD0003 VADRUGID DR00225 DTD0003 DRUGNAME Quercetin DTD0003 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0003 VADRUGID DR00319 DTD0003 DRUGNAME Citalopram DTD0003 DRUGSYNO 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram DTD0003 VADRUGID DR00476 DTD0003 DRUGNAME Clomipramine DTD0003 DRUGSYNO 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine; 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 3-Chloroimipramine; 3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine; 5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-(8CI); Anafranil (TN); Anafranil (free base); Anafranil base; Chlomipramine; Chlorimipramine; Clomicalm; Clomipramina; Clomipramina [INN-Spanish]; Clomipramine (INN); Clomipramine [INN:BAN]; Clomipraminum; Clomipraminum [INN-Latin]; G 34586; Hydiphen; Monochlorimipramine DTD0003 VADRUGID DR00459 DTD0003 DRUGNAME Fluoxetine DTD0003 DRUGSYNO (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine;(+/-)-Fluoxetine; (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine; (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]; (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine; 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine; Animex-On; Dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine; Eufor; Floxetine; Fluoxetin; Fluoxetina; Fluoxetina [INN-Spanish]; Fluoxetina [Spanish]; Fluoxetine (Prozac); Fluoxetine (TN); Fluoxetine (USAN/INN); Fluoxetine Hcl; Fluoxetine [USAN:INN:BAN]; Fluoxetinum; Fluoxetinum [INN-Latin]; Fluval; Fontex; Lilly-110140; Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine; Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine; N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine; N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine; Portal; Prozac (TN); Prozac Weekly; Pulvules; Reconcile; Reneuron DTD0003 VADRUGID DR00086 DTD0003 DRUGNAME L-tryptophan DTD0003 DRUGSYNO (-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin] DTD0003 VADRUGID DR00403 DTD0003 DRUGNAME Paroxetine DTD0003 DRUGSYNO (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine; (-)-Paroxetine; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine; (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; (3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine; 3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride; Aropax; BRL 29060; BRL-29060; Casbol; FG 7051; FG-7051; Frosinor; Motivan; NNC-20-7051; Paroxetina; Paroxetina [INN-Spanish]; Paroxetine (TN); Paroxetine (USP/INN); Paroxetine Hcl; Paroxetine [USAN:INN:BAN]; Paroxetinum; Paroxetinum [INN-Latin]; PaxPar; Paxetil; Paxil; Paxil (TN); Paxil CR;Seroxat CR; Pexeva; Seroxat; Seroxat (TN); [3H]Paroxetine DTD0003 VADRUGID DR00486 DTD0003 DRUGNAME Protriptyline DTD0003 DRUGSYNO 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine; 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene; 5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene; 5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; Amimetilina; Apo-Imipramine; Apo-Trimip; Impril; Maximed; N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine; N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; Normethyl EX4442; Novo-Doxepin; Novo-Tripramine; Novopramine; Protriptilina; Protriptilina [INN-Spanish]; Protriptyline (INN); Protriptyline [INN:BAN]; Protriptylinum; Protriptylinum [INN-Latin]; Protryptyline; Rhotrimine; Triadapin 5; Triptil; Triptil hydrochloride; Triptyl; Vivactil; Vivactil (TN); Vivactyl DTD0003 VADRUGID DR00440 DTD0003 DRUGNAME Sertraline DTD0003 DRUGSYNO (+)-Sertraline; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; Apo-Sertraline; CP 51974; Lustral; Lustral (TN); SRE; Sertralina; Sertralina [Spanish]; Sertraline (INN); Sertraline (Zoloft); Sertraline [INN:BAN]; Sertraline [Zoloft]; Sertralinum; Sertralinum [Latin]; Zoloft (TN) DTD0003 VADRUGID DR01298 DTD0003 DRUGNAME Flupentixol DTD0003 DRUGSYNO 2-[4-[(3Z)-3-[2-(Trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; 4-(3-(2-(Trifluoromethyl)thioxanthen-9-ylidene)propyl)-1-piperazineethanol; 53772-82-0; ALPHA-FLUPENTHIXOL; EINECS 220-304-9; EINECS 258-756-4; Emergil; FA0UYH6QUO; FLUPENTHIXOL; Fluanxol; Flupenthixole; Flupentixol; Flupentixolum [INN-Latin]; Fluphenthixol; Fluxanxol; LC 44; N 7009; Siplaril; Siplarol; UNII-FA0UYH6QUO; cis-(Z)-Flupenthixol; cis-(Z)-Flupenthixol dihydrochloride; cis-Flupenthixol; cis-Flupentixol; flupentixolum DTD0003 VADRUGID DR00307 DTD0003 DRUGNAME Berberine DTD0003 DRUGSYNO 0I8Y3P32UF; 2086-83-1; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE; BRN 3570374; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; Berbamine sulphate acid; Berberal; Berberin; CHEBI:16118; CHEMBL12089; EINECS 218-229-1; ST055798; UNII-0I8Y3P32UF; Umbellatine DTD0003 VADRUGID DR00002 DTD0003 DRUGNAME Paraquat DTD0003 DRUGSYNO 1,1'-dimethyl-4,4' bipyridinium dichloride DTD0003 VADRUGID DR00334 DTD0003 DRUGNAME Valinomycin DTD0003 DRUGSYNO Antibiotic N-329 B; Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); Potassium ionophore I; UNII-N561YS75MN; Valinomicin; cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3; valino; valinomycin DTD0003 VADRUGID DR01273 DTD0003 DRUGNAME Azidopine DTD0003 DRUGSYNO 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-, 2-((4-azidobenzoyl)amino)ethyl ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-2-[(4-azidobenzoyl)amino]ethyl ethyl ester (9CI); 90523-31-2; AC1LCUW1; Azidopine; C11282; CHEBI:2952; CHEMBL1993397; GTPL6980; NCI60_005410; NSC-617999; NSC617999; O5-[2-[(4-azidobenzoyl)amino]ethyl] O3-ethyl 2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate DTD0003 VADRUGID DR01292 DTD0003 DRUGNAME Hoechst 33342 DTD0003 DRUGSYNO 2'-(4'-Ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bis-1H-benzimidazole trihydrochloride trihydrate; 2'-(4-Ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-1H,1'H-2,5'-bibenzo[d]imidazole; 2'-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-1H-benzimidazole; 2'-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-benzimidazole; 99KZS6CNZX; Bisbenzimide; Bisbenzimide (Hoechst 33258); CHEBI:51232; CHEMBL343002; EINECS 245-691-1; Ho 342; UNII-99KZS6CNZX; hoechst33342 DTD0003 VADRUGID DR01304 DTD0003 DRUGNAME Bcecf-Am DTD0003 DRUGSYNO 117464-70-7; 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester; 2',7'-bis(2-Carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester Mixed isomers; AKOS015916474; BCECF-AM solution; BCECF-AM solution (5 mM in DMSO), 1 mg in 0.25 ml DMSO; BCECF-acetoxymethyl; FT-0622598; I14-51975; J-100048; MFCD00036969; SCHEMBL15570087; Spiro(isobenzofuran-1(3H),9'-(9H)xanthene)-2',7'-dipropanoic acid; ZINC169730836 DTD0003 VADRUGID DR00790 DTD0003 DRUGNAME Staurosporine DTD0003 DRUGSYNO (+)-Staurosporine; 62996-74-1; 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-; AM-2282; Alkaloid AM-2282 from Streptomyces; Antibiotic 230; Antibiotic AM 2282; CCRIS 3272; CGP 39360; CHEBI:15738; CHEMBL388978; H88EPA0A3N; Staurosporin; UNII-H88EPA0A3N; staurosporine DTD0003 VADRUGID DR01514 DTD0003 DRUGNAME Bunitrolol DTD0003 DRUGSYNO Bunitrolol; 2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; Bunitrolol [INN]; Stresson; Bunitrololum [INN-Latin]; KO-1366; Bunitrolol HCl; BRN 2374567; 2-Nitrilo-N-tert-butylphenoxypropanolamine; Koe 1366; o-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; 2-Propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)-; (RS)-2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitril; 2-[3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile; Bunitrololum; BENZONITRILE, o-(3-(tert-BUTYLAMINO)-2-HYDROXYPROPOXY)- DTD0003 VADRUGID DR01411 DTD0003 DRUGNAME ABT-737 DTD0003 DRUGSYNO ABT-737; 852808-04-9; ABT 737; ABT737; UNII-Z5NFR173NV; Z5NFR173NV; 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide; CHEMBL376408; C42H45ClN6O5S2; 4-{4-[(4'-Chlorobiphenyl-2-Yl)methyl]piperazin-1-Yl}-N-{[4-({(1r)-3-(Dimethylamino)-1-[(Phenylthio)methyl]propyl}amino)-3-Nitrophenyl]sulfonyl}benzamide DTD0003 VADRUGID DR01427 DTD0003 DRUGNAME Calphostin C DTD0003 DRUGSYNO calphostin C; CHEMBL460433; UNII-I271P23G24; I271P23G24; CHEMBL1256495; Ucn 1028 C; UCN 1028C; BSPBio_001520; GTPL5156; SCHEMBL15185703; HSDB 7592; SRJYZPCBWDVSGO-NHCUHLMSSA-N; HMS1989L22; HMS3402L22; HMS1791L22; BDBM213748; Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester; Carbonic acid, (1R)-2-(12-((2R)-2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxy DTD0003 VADRUGID DR01358 DTD0003 DRUGNAME Niguldipine DTD0003 DRUGSYNO NIGULDIPINE; S(+)-niguldipine; UNII-Z81N45O25Z; S(+)-Niguldipine hydrochloride; 113165-32-5; Z81N45O25Z; (+)-NIGULDIPINE; Niguldipine [INN]; niguldipine[inn]; (S)-Niguldipine; Tocris-1123; Tocris-1124; AC1Q1ZUF; AC1L1TKT; S(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(4,4-diphenyl-1-piperidinyl)-propyl methyl ester hydrochloride; GTPL487; SCHEMBL245992; CHEMBL41929; CHEMBL405355; DTXSID60274008; CHEBI:103931; MFCD00873564; BDBM50034683; BDBM50453799; ZINC100001967; DB09239; NCGC00025015-01 DTD0003 VADRUGID DR01404 DTD0003 DRUGNAME Ximelagatran DTD0003 DRUGSYNO Exanta; Exarta; H 376/95; Ximelagatran [USAN:INN]; 192939-46-1; H 376-95; H 37695; Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-, ethyl ester; NCGC00183598-01; Ethyl (((1R)-1-cyclohexyl-2-((2S)-2-((4-(hydroxycarbamimidoyl)benzyl)carbamoyl)azetidin-1-yl-2-oxoethyl)amino)acetate; Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-(hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ethyl ester; H 376 95; Exanta (TN); Exarta (TN); Xi-melagatran; H-376/95; Ximelagatran (JAN/USAN/INN); Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester; Glycine, N-((1R)1-cyclohexyl-2-((2S)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester; Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-((hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ester ester; H376/95 DTD0003 VADRUGID DR00146 DTD0003 DRUGNAME Deflazacort DTD0003 DRUGSYNO Deflan (TN) DTD0003 VADRUGID DR00030 DTD0003 DRUGNAME Atorvastatin DTD0003 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0003 VADRUGID DR00186 DTD0003 DRUGNAME Relugolix DTD0003 DRUGSYNO Relumina; TAK-385 DTD0003 VADRUGID DR01295 DTD0003 DRUGNAME Clobazam DTD0003 DRUGSYNO Onfi; 1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; 1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-; 22316-47-8; 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione; 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione; BRN 0758410; CCRIS 7506; Chlorepin; Clobazam - Lundbeck; Clobazamum; Clobazamum [INN-Latin]; Clorepin; EINECS 244-908-7; Frisium; H 4723; H-4723; HR 376; LM 2717; LM-2717; NSC 336279; Onfi; RU-4723; UNII-2MRO291B4U; Urbadan; Urbanyl DTD0003 VADRUGID DR00180 DTD0003 DRUGNAME Levetiracetam DTD0003 DRUGSYNO (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetam levo-isomer; Etiracetam, S-isomer; Keppra; Keppra (TN); Keppra XR; Keppra, Keppra XR),Levetiracetam; L-059; Levetiracetam [INN]; Levetiracetamum [INN-Latin]; Levetiractam; Leviteracetam; SIB-S1; Torleva; UCB-22059; UCB-L 059; UCB-L059; Ucb L060 DTD0003 VADRUGID DR00453 DTD0003 DRUGNAME Oxcarbazepine DTD0003 DRUGSYNO 10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; Desitin brand of oxcarbazepine; Epilexter; Epliga; GP 47680; GP-47680; KIN-493; Novartis brand of oxcarbazepine; O0363; Oxacarbazepine; Oxaleptal (TN); Oxcarbamazepine; Oxcarbazepime; Oxcarbazepina; Oxcarbazepina [INN-Spanish]; Oxcarbazepine (USAN/INN); Oxcarbazepine [INN]; Oxcarbazepinum; Oxcarbazepinum [INN-Latin]; SPN-804; Timox; Trileptal; Trileptal (TN) DTD0003 VADRUGID DR00059 DTD0003 DRUGNAME Tolvaptan DTD0003 DRUGSYNO (-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide; 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine; Benzazepine derivative, 32; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; OPC 41061; OPC-41061; Samsca; Samsca (TN) DTD0003 VADRUGID DR00103 DTD0003 DRUGNAME Ethinyl estradiol DTD0003 DRUGSYNO 17 alpha-Ethinylestradiol; 17 alpha-Ethynylestradiol; 17 alpha-Ethynyloestradiol; 17 alpha-ethinyestradiol; 17-Ethinyl-3,17-estradiol; 17-Ethinyl-3,17-oestradiol; 17-Ethinylestradiol; 17-Ethynylestradiol; 17-Ethynyloestradiol; 17-alpha-Ethinyl-17-beta-estradiol; 17-alpha-Ethynyl-17-beta-oestradiol; 17-alpha-Ethynylestradiol; 17-alpha-Ethynylestradiol-17-beta; 17-alpha-Ethynylestradiol-l7-beta; 17-alpha-Ethynyloestradiol-17-beta; 17-alpha-ethynyl estradiol; 17.alpha.-Ethinyl-17.beta.-estradiol; 17.alpha.-Ethinylestradiol; 17.alpha.-Ethynyl-17.beta.-oestradiol; 17.alpha.-Ethynylestradiol; 17.alpha.-Ethynyloestradiol; 17a-Ethynylestradiol; 17alpha-Ethinyl estradiol; 17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol-17beta; 17alpha-Ethynylestradiol; 17alpha-Ethynyloestradiol; 17alpha-Ethynyloestradiol-17beta; Aethinyloestradiolum; Aethinyoestradiol; Aethinyoestradiol [German]; Amenoron; Amenorone; Anovlar; Certostat; Chee-O-Gen; Chee-O-Genf; Component of Demulen; Component of Oracon; Component of Ortrel; Cyclosa; Dicromil; Diognat-E; Diogyn E; Diogyn-E; Diprol; Dyloform; EE(sub 2); EE2; ETHINYLESTRADIOL; Effik Brand of Ethinyl Estradiol; Ertonyl; Esteed; Estigyn; Estinyl; Estinyl (TN); Eston-E; Estopherol; Estoral; Estoral (Orion); Estoral (VAN);Estradiol, Ethinyl; Estoral [Orion]; Estorals; Estradiol, Ethynyl; Ethidol; Ethinoral; Ethinyl E2; Ethinyl Estradiol Hemihydrate; Ethinyl Estradiol [USP]; Ethinyl Estradiol, (8 alpha)-Isomer; Ethinyl Oestradiol Effik; Ethinyl estradiol (USP); Ethinyl-Oestradiol Effik; Ethinyl-oestranol; Ethinylestradiol (JP15/INN); Ethinylestradiol Jenapharm; Ethinylestradiol [INN:BAN:JAN]; Ethinylestradiolum; Ethinylestradiolum [INN-Latin]; Ethinylestriol; Ethinyloestradiol; Ethinyloestradiol [Steroidal oestrogens]; Ethy 11; Ethynyl estradiol; Ethynylestradiol; Ethynylestradiol, Ethinyl Estradiol; Ethynyloestradiol; Eticyclin; Eticyclol; Eticylol; Etinestrol; Etinestryl; Etinilestradiol; Etinilestradiol [INN-Spanish]; Etinilestradiolo; Etinilestradiolo [DCIT]; Etinoestryl; Etistradiol; Etivex; Feminone; Follicoral; Ginestrene; Hemihydrate, Ethinyl Estradiol; Inestra; Jenapharm Brand of Ethinyl Estradiol; Jenapharm, Ethinylestradiol; Kolpolyn; Linoral; Lynoral;Menolyn; Microfollin; Microfollin Forte; Neo-Estrone; Nogest-S; Novestrol; OVULEN-21; OVULEN-28; Oradiol; Orestralyn; Orestrayln; Organon Brand of Ethinyl Estradiol; Ortho-Cyclen; PUBERTAL ETHINYL ESTRADIOL STUDY; Palonyl; Perovex; Primogyn; Primogyn C; Primogyn M; Progynon C; Progynon M; Prosexol; Schering Brand of Ethinyl Estradiol; Spanestrin; Ylestrol DTD0003 VADRUGID DR00733 DTD0003 DRUGNAME Dihydrotestosterone DTD0003 DRUGSYNO 17beta-Hydroxy-3-androstanone; 17beta-Hydroxy-5alpha-androstan-3-one; 17beta-Hydroxyandrostan-3-one; 4,5alpha-Dihydrotestosterone; 4-Dihydrotestosterone; 5-alpha-Dihydrotestosterone; 521-18-6; 5alpha-Androstan-17beta-ol-3-one; 5alpha-DHT; 5alpha-Dihydrotestosterone; Anaboleen; Anabolex; Andractim; Androlone; Androstanolona; Androstanolone; Androstanolonum; Cristerona MB; DHT; Dihydrotestosteron; LG 152; Neodrol; Proteina; Protona; STANOLONE; Stanaprol; Stanolon; Stanorone; Testosterone, dihydro-; [3H]dihydrotestosterone; dihydrotestosterone DTD0003 VADRUGID DR00212 DTD0003 DRUGNAME Clomiphene citrate DTD0003 DRUGSYNO Clomid; Clomiphene Citrate; Milophene; Serophene DTD0003 VADRUGID DR00049 DTD0003 DRUGNAME Levomilnacipran DTD0003 DRUGSYNO (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide; (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide; 96847-54-0; AC1OCEN8; CHEMBL99946; F 2695; F-2695; Fetzima; Levomilnacipran (USAN/INN); Levomilnacipran HCl; Levomilnacipran [USAN:INN]; Milnacipram; UGM0326TXX; UNII-UGM0326TXX DTD0003 VADRUGID DR01333 DTD0003 DRUGNAME Boceprevir DTD0003 DRUGSYNO (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; 3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide; 394730-60-0; 89BT58KELH; Boceprevir; CHEBI:68621; EBP 520; SCH 503034; SCH-503034; UNII-89BT58KELH; Victrelis DTD0003 VADRUGID DR00144 DTD0003 DRUGNAME Daclatasvir DTD0003 DRUGSYNO 1009119-64-5; 1214735-16-6; C40H50N8O6; CHEBI:82977; CHEMBL2023898; Daclatasvir (BMS-790052); Daclatasvir (USAN); Daclatasvir BMS 790052; EX-A410; KS-00000XPC; MLS006011140; SCHEMBL17897804; SCHEMBL2756027; cc-39; methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate DTD0003 VADRUGID DR01290 DTD0003 DRUGNAME Ledipasvir DTD0003 DRUGSYNO 013TE6E4WV; 1256388-51-8; CHEBI:85089; CHEMBL2374220; DTXSID90154829; EX-A411; GS 5885; GS-5885; GS5885; Ledipasvir (GS5885); Ledipasvir (USAN); Ledipasvir [USAN:INN]; MolPort-039-138-665; SCHEMBL15116943; SCHEMBL2706494; UNII-013TE6E4WV; WHO 9796; methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate DTD0003 VADRUGID DR01291 DTD0003 DRUGNAME Pibrentasvir DTD0003 DRUGSYNO 2WU922TK3L; A-1325912.0; ABT 530; ABT-530; ABT-530;Pibrentasvir; CHEMBL3545123; CS-8135; D10816; DB13878; Dimethyl N,N'-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis((6-fluoro-1H-benzimidazole-5,2-diyl)((2S)-pyrrolidine-2,1-diyl)((2S,3R)-3-methoxy-1-oxobutane-1,2-diyl)))biscarbamate; EX-A865; J-690144; J3.646.121G; Pibrentasvir; Pibrentasvir (JAN/USAN/INN); Pibrentasvir [USAN]; SCHEMBL17639956; SCHEMBL2756579; UNII-2WU922TK3L DTD0003 VADRUGID DR00702 DTD0003 DRUGNAME Telaprevir DTD0003 DRUGSYNO (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide; 402957-28-2; 655M5O3W0U; CHEBI:68595; CHEMBL231813; Incivek; Incivo; LY-570310; MP-424; S-Telaprevir; Telaprevir (VX-950); Telavic; UNII-655M5O3W0U; VRT-111950; VX 950; VX-950; VX-950(Telaprevir) DTD0003 VADRUGID DR00833 DTD0003 DRUGNAME Naringenin DTD0003 DRUGSYNO ( inverted exclamation markA)-Naringenin; (+/-)-Naringenin; (-)-Naringenin; (S)-Naringenin; 4',5,7-Trihydroxyflavanone; 4',7-Trihydroxyflavanone; 480-41-1; 5,7,4'-Trihydroxyflavanone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 67604-48-2; 93602-28-9; AK122638; BE-14348A; CHEBI:50202; CHEMBL32571; FTVWIRXFELQLPI-UHFFFAOYSA-N; Flavanone, 4',5,7-trihydroxy-; MFCD00006844; MLS000028739; MLS000738094; NARIGENIN; NSC 11855; NSC 34875; NSC11855; NSC34875; Naringenine; SMR000059039; Salipurol; naringenin; naringetol; salipurpol DTD0003 VADRUGID DR01314 DTD0003 DRUGNAME Velpatasvir DTD0003 DRUGSYNO GS 5816; GS-5816; GS5816; KCU0C7RS7Z; UNII-KCU0C7RS7Z; Velpatasvir; Velpatasvir [USAN:INN]; Verpatasvir; methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate DTD0003 VADRUGID DR01315 DTD0003 DRUGNAME Voxilaprevir DTD0003 DRUGSYNO 0570F37359; DB12026; GS-9857; J3.665.048F; SCHEMBL15412621; UNII-0570F37359; Voxilaprevir; Voxilaprevir (USAN/INN); Voxilaprevir [USAN:INN] DTD0003 VADRUGID DR01312 DTD0003 DRUGNAME Paritaprevir DTD0003 DRUGSYNO (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide; ABT 450; ABT-450; ABT450; CHEMBL3391662; EX-A2278; OU2YM37K86; Paritaprevir; Paritaprevir [USAN:INN]; Paritaprevir(ABT-450); Paritaprevir(Veruprevir ABT-450); SCHEMBL3069964; UNII-OU2YM37K86; Veruprevir; Veruprevir [INN]; Veruprevir anhydrous DTD0003 VADRUGID DR00075 DTD0003 DRUGNAME Asunaprevir DTD0003 DRUGSYNO BMS 650032; BMS-650032; Sunvepra DTD0003 VADRUGID DR01289 DTD0003 DRUGNAME Dasabuvir DTD0003 DRUGSYNO 1132935-63-7; ABT 333; ABT-333; ABT333; C26H27N3O5S; CHEBI:85182; DE54EQW8T1; Dasabuvir (ABT-333); Dasabuvir (USA; Dasabuvir [INN]; Dasabuvir [USAN:INN]; N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide; N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide; N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide; UNII-DE54EQW8T1 DTD0003 VADRUGID DR01311 DTD0003 DRUGNAME Ombitasvir DTD0003 DRUGSYNO 2302768XJ8; ABT 267; ABT-267; ABT-267;ABT267;ABT 267; ABT267; CHEBI:85183; CHEMBL3127326; CS-5330; DB09296; Ombitasvir; Ombitasvir (USAN); Ombitasvir [USAN:INN]; Ombitasvir pound>>ABT-267; Ombitasvir(ABT-267); SB16895; SCHEMBL8542284; UNII-2302768XJ8; ZINC150601177; dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamate DTD0003 VADRUGID DR00239 DTD0003 DRUGNAME Digitoxin DTD0003 DRUGSYNO 5.beta.-Card-20(22)-enolide, 3.beta.,14-dihydroxy-, 3-[tris-(digitoxoside)]; Acedoxin; Asthenthilo; Cardidigin; Cardigin; Cardiolanata; Carditalin; Carditoxin; Coramedan; Cristapurat; Crystalline digitalin; Crystodigin; Crystodigin (TN); De-Tone; Digicor; Digilanid; Digilong; Digimed; Digimerck; Digipural; Digisidin; Digitalin, crystalline; Digitaline (TN); Digitaline cristallisee; Digitaline nativelle; Digitalinum verum; Digitoksim; Digitoksin; Digitophyllin; Digitossina; Digitossina [DCIT]; Digitoxigenin tridigitoxoside; Digitoxigenin-tridigitoxosid; Digitoxigenin-tridigitoxosid [German]; Digitoxin (JP15/USP/INN); Digitoxin [INN:BAN:JAN]; Digitoxina; Digitoxina [INN-Spanish]; Digitoxine; Digitoxine [INN-French]; Digitoxinum; Digitoxinum [INN-Latin]; Digitoxoside; Digitoxosidum; Digitrin; Ditaven; Glucodigin; Inhibits Na+/K+ ATPase; LT00244784; Lanatoxin; Lanostabil; Mono-digitoxid; Mono-digitoxid [German]; Mono-glycocard; Monodigitoxoside; Myodigin; Natigal; Pandigal; Panlanat; Purodigin; Purodigin, crystalline; Purpurid; Tardigal; Tri-digitoxoside; Tri-digitoxoside [German]; Unidigin DTD0003 VADRUGID DR00629 DTD0003 DRUGNAME Aldosterone DTD0003 DRUGSYNO (+)-Aldosterone; (11BETA)-11,21-DIHYDROXY-3,20-DIOXOPREGN-4-EN-18-AL; (8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde; 11.beta.,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 18,11-halbacetal; 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al; 18-Aldocorticosterone; 18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione; 18-Oxocorticosterone; Aldocorten; Aldocortene; Aldocortin; Aldosterona; Aldosterona [INN-Spanish]; Aldosterone [INN:BAN:DCF]; Aldosterone, (+-)-Isomer; Aldosterone, (11 beta,17 alpha)-Isomer; Aldosteronum; Aldosteronum [INN-Latin]; D-Aldosterone; Electrocortin; Elektrocortin; Reichstein X DTD0003 VADRUGID DR00061 DTD0003 DRUGNAME Aliskiren fumarate DTD0003 DRUGSYNO (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide; (2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide; Aliskiren (USAN/INN); Octanamide, .delta.-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-.gamma.-hydroxy-4-methoxy-3-(3-methoxypropoxy)-.alpha.,.zeta.-bis(1-methylethyl)-, [.alpha.S-(alpha.R*,.gamma.R*,.delta.R*,.zeta.R*)]; Rasilez; Rasilez (TN); SPP 100; Tekturna (TN) DTD0003 VADRUGID DR00033 DTD0003 DRUGNAME Atenolol DTD0003 DRUGSYNO (+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten DTD0003 VADRUGID DR00521 DTD0003 DRUGNAME Clonidine DTD0003 DRUGSYNO 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets DTD0003 VADRUGID DR00656 DTD0003 DRUGNAME Diltiazem DTD0003 DRUGSYNO (+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; Acalix; Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; Adizem; Adizem (TN); Aldizem; Altiazem (TN); Angiozem (TN); Angizem (TN); Angizem CD (TN); Anoheal; Apo-Diltiaz; Cardil; Cardizem; Cardizem (Hydrochloride); Cardizem (TN); Cardizen LA; Cartia XT (TN); Citizem; D-cis-Diltiazem; Dilacor; Dilacor-XR; Dilatam (TN); Dilatem (TN); Dilcardia (TN); Dilcontin; Dilcontin SR (TN); Dilren; Dilt-cd; Dilta-Hexal; Diltelan (TN); Diltia; Diltiazem (INN); Diltiazem [INN:BAN]; Diltiazemum; Diltiazemum [INN-Latin]; Dilticard; Diltime (TN); Diltzac; Dilzem (TN); Dilzen; Dyalec (TN); Endrydil; Filazem (TN); Herben (TN); Incoril AP; MK-793 (Malate); Nu-Diltiaz; Progor (TN); RG 83606 (Hydrochloride); Surazem (TN); Tiamate (TN); Tiazac (TN); Tiazac Tildiem; Tiazac XC; Tiazac XC (TN); Tildiem (TN); Vasmulax (TN); Viazem; Viazem (TN); Zandil (TN); Zemtrial (TN); [(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate DTD0003 VADRUGID DR00613 DTD0003 DRUGNAME Dipyridamole DTD0003 DRUGSYNO 2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; Agilease; Anginal; Antistenocardin; Apo-Dipyridamole; Apo-Dipyridamole Fc; Apo-Dipyridamole Sc; Apotex Brand of Dipyridamole; Apricor; Ashbourne Brand of Dipyridamole; Belmac Brand of Dipyridamole; Berlin Chemie Brand of Dipyridamole; Berlin-Chemie Brand of Dipyridamole; Boehringer Ingelheim Brand of Dipyridamole; Cardioflux; Cardoxil; Cardoxin; Cerebrovase; Chilcolan; Cleridium; Cleridium 150; Coribon; Coridil; Coronarine; Corosan; Coroxin; Curantil; Curantyl; D 9766; Dipiridamol; Dipiridamol [INN-Spanish]; Dipyramidole; Dipyridamine; Dipyridamol; Dipyridamole (JP15/USP/INN); Dipyridamole [USAN:INN:BAN:JAN]; Dipyridamolum; Dipyridamolum [INN-Latin]; Dipyridan; Dipyudamine; Dypyridamol; Gulliostin; IPRAD Brand of Dipyridamole; Iv Persantine; Justpertin; Kurantil; Miosen; Natyl; Novo-Dipiradol; Novopharm Brand of Dipyridamole; Peridamol; Permiltin; Permole, Persantine, Dipyridan, Dipyridamole; Persantin; Persantine; Persantine (TN); Piroan; Prandiol; Prandiol 75; Protangix; RA-8; Stenocardil; Stenocardiol; Stimolcardio; Usaf Ge-12 DTD0003 VADRUGID DR00691 DTD0003 DRUGNAME Felodipine DTD0003 DRUGSYNO (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; (+/-)-ethylmethyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; 1A Brand of Felodipine; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-, ethyl methylester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-,ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester; 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid ethyl methyl ester; 4-(2,3-dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester; 5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; AE-641/11429675; AGON SR; AbZ Brand of Felodipine; Agon; Aliud Brand of Felodipine; Alphapharm Brand of Felodipine; Alpharma Brand of Felodipine; Astra Brand of Felodipine; AstraZeneca Brand of Felodipine; Aventis Brand of Felodipine; Azupharma Brand of Felodipine; BC Brand of Felodipine; Betapharm Brand of Felodipine; CGH-869; Ct Arzneimittel Brand of Felodipine; Ct-Arzneimittel Brand of Felodipine; Dl-Felodipine; Ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; F 9677; Felo Biochemie; Felo Puren; Felo-Puren; Felobeta; Felocor; Feloday; Felodipin 1A Pharma; Felodipin AL; Felodipin AZU; Felodipin AbZ; Felodipin Heumann; Felodipin Stada; Felodipin dura; Felodipin ratiopharm; Felodipin von ct; Felodipin-ratiopharm; Felodipina; Felodipina [INN-Spanish]; Felodipine (JAN/USP/INN); Felodipine [USAN:BAN:INN]; Felodipine [USAN:INN:BAN]; Felodipinum; Felodipinum [INN-Latin]; Felodur; FelodurER; Felogamma; Felogard; Fensel; Flodil; H 154 82; H 154-82; H 154/82; H 15482; H-154/82; Heumann Brand of Felodipine; Heumann, Felodipin; Hexal Brand of Felodipine; Hoechst Brand of Felodipine; Hydac; Lexxel; Logimax; Merck dura Brand of Felodipine; Modip; Munobal; Munobal Retard; Penedil; Perfudal; Pharmaceutica Astra Brand of Felodipine; Pharmacia Spain Brandof Felodipine; Plandil; Plendil; Plendil (TN); Plendil Depottab; Plendil ER; Plendil Retard; Plendil, Renedil, Feloday, Felodipine; Preslow; Prevex; Promed Brand of Felodipine; Ratiopharm Brand of Felodipine; Renedil; Splendil; Stadapharm Brand of Felodipine; TheraPharm Brand of Felodipine; Worwag Brand of Felodipine DTD0003 VADRUGID DR00429 DTD0003 DRUGNAME Losartan DTD0003 DRUGSYNO (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol; 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole; CL23623; Cozaar; Cozaar (TN); DUP 89; DuP-753; Hyzaar; LOSARTAN POTASSIUM; Lortaan; Losartan (INN); Losartan [INN:BAN]; Losartan monopotassium salt; Losartic; Losartic (TN); MK-954; MK954; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol DTD0003 VADRUGID DR00668 DTD0003 DRUGNAME Nisoldipine DTD0003 DRUGSYNO (+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester; 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Bay k 5552; Bay-k-5552; Baymycard; Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat;Methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nisocor; Nisoldipin; Nisoldipine (JAN/USAN/INN); Nisoldipine [USAN:BAN:INN:JAN]; Nisoldipino; Nisoldipino [INN-Spanish]; Nisoldipinum; Nisoldipinum [INN-Latin]; Sular; Sular (TN); Syscor; Zadipina DTD0003 VADRUGID DR00586 DTD0003 DRUGNAME Nitrendipine DTD0003 DRUGSYNO 1A Pharma, Nitren; AL, Nitrendipin; AbZ, Nitre; Acis, Nitren; Atid, Nitrendipin; Basics, Nitrendipin; Bay-e-5009; Baylotensin; Bayotensin; Baypress; Baypress (TN); Bayvit, Nitrendipino; Beta, Nitrendipin; Biochemie, Nitrendi; Bylotensin; Ct, nitrendipin von; Deiten; Gericin; Heumann, Nitrendipin; Jutapress; KSK, Nitrend; Lich, Nitren; Lindo, Nitrendipin; N-144; Nidrel; Niprina; Nitre AbZ; Nitre Puren; Nitre-Puren; NitrePuren; Nitregamma; Nitren 1A Pharma; Nitren Lich;Nitren acis; Nitrend KSK; Nitrendepat; Nitrendi Biochemie; Nitrendidoc; Nitrendimerck; Nitrendipin; Nitrendipin AL; Nitrendipin Apogepha; Nitrendipin Atid; Nitrendipin Basics; Nitrendipin Heumann; Nitrendipin Lindo; Nitrendipin Stada; Nitrendipin beta; Nitrendipin corax; Nitrendipin von ct; Nitrendipin-corax; Nitrendipincorax; Nitrendipino; Nitrendipino Bayvit; Nitrendipinum; Nitrensal; Nitrepin; Nitrepress; Pharma, Nitren 1A; Stada, Nitrendipin; Tensogradal; Trendinol; Vastensium; Von ct, nitrendipin DTD0003 VADRUGID DR00347 DTD0003 DRUGNAME Olmesartan medoxomil DTD0003 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0003 VADRUGID DR00636 DTD0003 DRUGNAME Reserpine DTD0003 DRUGSYNO 3P Reserp; Abesta; Abicol; Adelfan; Adelphin; Alkarau; Alkaserp; Alserin; Apoplon; Apoplon (TN); Apsical; Ascoserp; Ascoserpina; Austrapine; Banasil; Banisil; Benazyl; Bioserpine; Brinderdin; Briserine; Broserpine; Cam-Ap-Es; Cardioserpin; Carditivo; Carpacil; Carrserp; Darebon; Deserpine; Diupres 250; Diupres 500; Diupres-250; Diupres-500; Diurese-R; Diutensen-R; Dralserp; ENT 50146; Eberpine; Eberspine; Ebserpine; Elfanex; Elserpine; Enipresser; Esc aspere; Escaspere; Eserpine; Eskaserp; Eskaserpine; Gammaserpine; Gilucard; H 520; HYDRO-RESERP; Helfoserpin; Hexaplin; Hiposerpil; Hiserpia; Hydrap-ES; Hydromox R; Hydromox-R; Hydropine; Hydropres 25; Hydropres 50; Hydroserp; Hydrosine 25; Hypercal B; Hypersil; Hypersine; Hypertensan; Idoserp; Idsoserp; Interpina; Key-serpine; Kitine; Klimanosid; L"-Carpserp; L-Carpserp; Lemiserp; Loweser p; Loweserp; Mallopress; Maviserpin; Mayserpine; Mephaserpin; Modenol; Naquival; Nembuserpin; Neo-serp; Neose rfin; Neoserfin; Neoserp; Neoslowten; Orthoserpina; Perskleran; Pressimedin; Purserpine; Quiescin; R 0875; R-e-s; Rau sedyl; Rau-Sed; Raucap; Raudiford; Raudixin; Raudixoid; Raugal; Raulen; Rauloydin; Raumorine; Raunervil; Raunorine; Raunova; Raupasil; Raupoid; Raurine; Rausan; Rausedan; Rausedil; Rausedyl; Rauserpin; Rauserpine; Rauserpol; Rausingle; Rautrin; Rauvlid; Rauwasedin; Rauwilid; Rauwiloid; Rauwipur; Rauwita; Rauwoleaf; Rawilid; Recipin; Regroton; Renese R; Renese-R; Resaltex; Rese rpamed; Rese-lar; Resedrex; Resedril; Reser-ar; Reserbal; Resercaps; Resercen; Reserfia; Reserjen; Reserlor; Reserp; Reserpal; Reserpamed; Reserpanca; Reserpene; Reserpex; Reserpidefe; Reserpil; Reserpin; Reserpina; Reserpinum; Reserpka; Reserpoid; Reserpur; Reserutin; Resiatric; Residin; Residine; Resine; Resocalm; Resperin; Resperine; Respital; Restran; Rezerpin; Riserpa; Rivased; Rivasin; Rolserp; Roxel; Roxinoid; Roxynoid; Ryser; SK-Reserpine; Salupres; Sandril; Sandron; Se rpate; Sedaraupin; Sedaraupina; Sederaupin; Sedserp; Seominal; Ser-A-Gen; Serfin; Serfolia; Serolfia; Serpalan; Serpaloid; Serpaneurona; Serpanray; Serpasil; Serpasol; Serpate; Serpazil; Serpazol; Serpedin; Serpen; Serpena; Serpentil; Serpentin; Serpentina; Serpicon; Serpil; Serpiloid; Serpilum; Serpine; Serpipur; Serpivate; Serpivite; Serpogen; Serpoid; Serpone; Serpyrit; Sertabs; Sertens; Sertensin; Sertina; Supergan; T-Serp; Tefaserpina; Temposerpine; Tensanyl; Tenserpinie; Tensional; Tensionorme; Tepserpine; Terbolan; Transerpin; Triserpin; Tylandril; Unilord; Unipres; Usaf cb-27; V Serp; V-Serp; VI XO; VIXO; Veriloid; Vio-Serpine DTD0003 VADRUGID DR00900 DTD0003 DRUGNAME Timolol DTD0003 DRUGSYNO (-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole; (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; (S)-timolol; Apo-Timol; Apo-Timol (TN); Apo-Timop; Apo-Timop (TN); Aquanil; Betim; Betimol; Betimol (TN); Blocadren; Blocadren (TN); Gen-Timolol (TN); Istalol; Istalol (TN); L-714,465; MK-950; Novo-Timol; Nu-Timolol; Nu-Timolol (TN); Optimol; PMS-Timolol (TN); Phoxal-timolol; Phoxal-timolol (TN); Proflax; S(-)-Timolol maleate; S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole; TIM; Temserin; Tenopt; Tim-AK; Tim-AK (TN); Timacar; Timolol (INN); Timolol (TN); Timolol GFS; Timolol Maleate, (1:1) Salt; Timolol [USAN]; Timololum; Timololum [INN-Latin]; Timopic; Timoptic (TN); Timoptic OcuDose; Timoptic OcuDose. (TN); Timoptic-XE; Timoptic-XE (TN); Timoptol DTD0003 VADRUGID DR00693 DTD0003 DRUGNAME Prazosin DTD0003 DRUGSYNO 1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone DTD0003 VADRUGID DR00627 DTD0003 DRUGNAME Acebutolol DTD0003 DRUGSYNO (+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN) DTD0003 VADRUGID DR00528 DTD0003 DRUGNAME Propranolol DTD0003 DRUGSYNO (+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN) DTD0003 VADRUGID DR01235 DTD0003 DRUGNAME Celiprolol DTD0003 DRUGSYNO 3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea; BRN 2776298; CCRIS 3400; Celectol; Celiprolol [INN:BAN]; Celiprololum; Celiprololum [INN-Latin]; EINECS 260-497-7; N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea; RHC 5320 A; RHC-5320A; ST-1396; Selectol; UL/1677; Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-; celiprolol DTD0003 VADRUGID DR00811 DTD0003 DRUGNAME Alprenolol DTD0003 DRUGSYNO 1-(2-Allylphenoxy)-3-isopropylamino-2-propanol; 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol; 1-(o-Allylphenoxy)-3-isopropylamino)-2-propanol; 1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol; 1-[2-(propen-2-ylphenoxy)]-3-(isopropylamino)propan-2-ol; Alfeprol; Alfeprol [Russian]; Alpheprol; Alprenolol (INN); Alprenolol [INN:BAN]; Alprenololum; Alprenololum [INN-Latin]; Apllobal (TN); Aptine (TN); Aptol (TN); Duriles (TN); Gubernal (TN); H-56-28; Regletin (TN); Yobir; Yobir (TN) DTD0003 VADRUGID DR00588 DTD0003 DRUGNAME Abacavir DTD0003 DRUGSYNO (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol DTD0003 VADRUGID DR00584 DTD0003 DRUGNAME Amprenavir DTD0003 DRUGSYNO (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate; (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate; (3S)-tetrahydro-3-furyl N-[(1S,2R)-3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxy-propyl]carbamate; (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate; 4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide; AMV; Agenerase; Agenerase (TM); Agenerase (TN); Amprenavir (JAN/USAN/INN); Amprenavir [USAN]; Amprenavir[usan]; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA); Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin(HHA); DRG-0258; GNA & Amprenavir; HHA & Amprenavir; KVX-478; Prozei; Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate; VX 478; VX-478; VX478; Vertex; Vertex VX478; [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER DTD0003 VADRUGID DR00514 DTD0003 DRUGNAME Darunavir DTD0003 DRUGSYNO (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester DTD0003 VADRUGID DR00619 DTD0003 DRUGNAME Delavirdine DTD0003 DRUGSYNO (1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE; (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide); 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine; 1-(5-Methanesulphonamido)-1H-indol-2-yl-carbonyl)-4-[3-(isopropylamino)-2-pyridinyl]piperaz; 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine; BHAP-U 90152; DELAVIRDINE MESYLATE; DLV; Delavirdine (*Mesylate salt*); Delavirdine (INN); Delavirdine [INN]; Delavirdine(U-90152) & .a.IFN; N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide; N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide; N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide; N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide; N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; PNU-90152-T; Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-& alpha-Interferon; Rescriptor; Rescriptor (TM);Rescriptor (TN); SPP; U 90152; U-90152; U-90152S; U90152S (*Mesylate salt*) DTD0003 VADRUGID DR00383 DTD0003 DRUGNAME Dolutegravir DTD0003 DRUGSYNO DTG; S/GSK1349572 DTD0003 VADRUGID DR00412 DTD0003 DRUGNAME Efavirenz DTD0003 DRUGSYNO (-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; DMP 266; DMP-266; EFV; EFZ; Efavirenz (JAN/INN); Efavirenz, (S)-isomer; Eravirenz; L 743726; L-741211; L-743,726; L-743725; L-743726; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; Stocrin; Stocrin (TN); Strocin (TM); Sustiva; Sustiva (TM); Sustiva (TN); Zoxazin-2-one DTD0003 VADRUGID DR01274 DTD0003 DRUGNAME Fosamprenavir DTD0003 DRUGSYNO ((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-(phosphonooxy)propyl)carboxamide; (3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester; Amprenavir phosphate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester; Fosamprenavir (INN); Fosamprenavir [INN]; GW 433908; GW433908; GW433908A (*Sodium Salt*); GW433908G (*Calcium Salt*); Lexiva (TM); Lexiva (TN); Telzir; Telzir (TN); Telzir(TM); VX 175; VX-175; [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate DTD0003 VADRUGID DR00039 DTD0003 DRUGNAME Glutathione DTD0003 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0003 VADRUGID DR00299 DTD0003 DRUGNAME Indinavir DTD0003 DRUGSYNO (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253 DTD0003 VADRUGID DR00290 DTD0003 DRUGNAME Lopinavir DTD0003 DRUGSYNO A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346 DTD0003 VADRUGID DR00730 DTD0003 DRUGNAME Maraviroc DTD0003 DRUGSYNO 376348-65-1; 4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(321)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide; 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[321]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide; CHEBI:63608; CHEMBL1201187; CHEMBL256907; Celsentri; Celsentri (TN); Celsentri(TM); Exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[321]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide; Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(321)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide; MD6P741W8A; MVC; Maraviroc [USAN]; PRO 140 & Maraviroc; PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[321]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide; Selzentry; Selzentry (TN); Selzentry(TM); UK 427857; UK-427,857; UK-427,857 maraviroc (MVC); UK-427857; UNII-MD6P741W8A; [3H]maraviroc DTD0003 VADRUGID DR00447 DTD0003 DRUGNAME Nevirapine DTD0003 DRUGSYNO 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody); 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one; BI RG 587; BI-RG-587; BI-RG-587 & CD4-IgG; BIRG 0587; BIRG 587; BIRG-0587; BIRG-587; BIRG587; Cahill May Roberts Brand of Nevirapine; N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin; NEV; NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE; NVP; Nevirapine & CD4-IgG; Nevirapine & PRO 140; Nevirapine (JAN/USP/INN); Nevirapine [USAN:INN]; Promeco Brand of Nevirapine; Viramune; Viramune (TN); Viramune(TM); Viramune, BI-RG 587, Nevirapine DTD0003 VADRUGID DR00332 DTD0003 DRUGNAME Ritonavir DTD0003 DRUGSYNO 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN] DTD0003 VADRUGID DR00309 DTD0003 DRUGNAME Saquinavir DTD0003 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0003 VADRUGID DR00174 DTD0003 DRUGNAME Tenofovir DTD0003 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0003 VADRUGID DR00296 DTD0003 DRUGNAME Zidovudine DTD0003 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0003 VADRUGID DR01615 DTD0003 DRUGNAME Norbuprenorphine DTD0003 DRUGSYNO Norbuprenorphine; N-Desalkylbuprenorphine; Des(cyclopropylmethyl)buprenorphine; UNII-7E53B4O073; 7E53B4O073; 6,14-Ethenomorphinan-7-methanol, alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)-; AC1L3GBB; SCHEMBL14408877; CHEMBL1743323; YOYLLRBMGQRFTN-IOMBULRVSA-N; ZINC6031944; LS-67705; 6,14-ethenomorphinan-3-ol, 4,5-epoxy-18,19-dihydro-18-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-, (5alpha,6beta,14beta,18R)- DTD0003 VADRUGID DR01369 DTD0003 DRUGNAME Prostaglandin A2 DTD0003 DRUGSYNO medullin; PGA2 DTD0003 VADRUGID DR00301 DTD0003 DRUGNAME Doxorubicin DTD0003 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0003 VADRUGID DR00308 DTD0003 DRUGNAME Vinblastine DTD0003 DRUGSYNO (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine DTD0003 VADRUGID DR00140 DTD0003 DRUGNAME Ezetimibe DTD0003 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0003 VADRUGID DR00124 DTD0003 DRUGNAME Fluvastatin DTD0003 DRUGSYNO (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320 DTD0003 VADRUGID DR00410 DTD0003 DRUGNAME Lovastatin DTD0003 DRUGSYNO 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; 6 Methylcompactin; 6 alpha-Methylcompactin; 6-Methylcompactin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin; Advicor (TN); Altocor; Altocor (TN); Altoprev; Altoprev (TN); Artein; Belvas; Cholestra; Closterol; Colevix; Hipolip; Hipovastin; L-154803; Lestatin; Lipdip; Lipivas; Lipofren; Liposcler; Lovalip; Lovalord; Lovastatin & Primycin; Lovastatin (USP/INN); Lovastatin [USAN:BAN:INN]; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); Lovastatina; Lovastatina [Spanish]; Lovastatine; Lovastatine [French]; Lovastatinum; Lovastatinum [Latin]; Lovasterol; Lovastin; Lozutin; MK 803; MK-803; MK803; ML-530B; MSD 803; Mevacor; Mevacor (TN); Mevinacor; Mevinolin; Mevinolin from Aspergillus sp.; Mevlor; Monacolin K; Monakolin K; Nergadan; Paschol; Rextat; Rodatin; Rovacor; Sivlor;Taucor; Statosan (TN); Tecnolip; Teroltrat DTD0003 VADRUGID DR01679 DTD0003 DRUGNAME Lovastatin acid DTD0003 DRUGSYNO Lovastatin acid; Mevinolinic acid; Monacolinic K acid; MSD 803 acid; MSD 803 free acid; UNII-5CLV35Y90C; MK 819; L-154819; L 154819; 5CLV35Y90C; CHEBI:82985; (3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID; (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid DTD0003 VADRUGID DR00045 DTD0003 DRUGNAME Pravastatin DTD0003 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0003 VADRUGID DR00223 DTD0003 DRUGNAME Rosuvastatin DTD0003 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0003 VADRUGID DR00435 DTD0003 DRUGNAME Simvastatin DTD0003 DRUGSYNO (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate DTD0003 VADRUGID DR00069 DTD0003 DRUGNAME Cabergoline DTD0003 DRUGSYNO (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate; 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea; CG-101; Cabaser; Cabaser (TN); Cabaseril; Cabergolina; Cabergolina [Spanish]; Cabergoline (JAN/USAN/INN); Cabergoline [USAN:BAN:INN]; Cabergolinum; Cabergolinum [Latin]; Dostinex; Dostinex (TN); FCE-21336; Galastop; Sogilen DTD0003 VADRUGID DR00137 DTD0003 DRUGNAME Nintedanib DTD0003 DRUGSYNO (Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; 1160294-26-7; 656247-17-5; 928326-83-4; BIBF 1120; BIBF-1120; BIBF1120; CHEBI:85164; G6HRD2P839; Intedanib; Methyl (3z)-3-{[(4-{methyl[(4-Methylpiperazin-1-Yl)acetyl]amino}phenyl)amino](Phenyl)methylidene}-2-Oxo-2,3-Dihydro-1h-Indole-6-Carboxylate; Nintedanib (BIBF 1120); OFEV; UNII-G6HRD2P839; Vargatef DTD0003 VADRUGID DR00230 DTD0003 DRUGNAME Hydrocortisone DTD0003 DRUGSYNO 11-beta-Hydrocortisone; 11-beta-Hydroxycortisone; 11beta,17,21-Trihydroxyprogesterone; 11beta-Hydrocortisone; 11beta-Hydroxycortisone; 17-Hydroxycorticosterone; 17alpha-Hydroxycorticosterone; ACETASOL HC; ACETIC ACID W/ HYDROCORTISONE; Acticort; Acticort (TN); Aeroseb HC; Aeroseb-HC; Ala-Cort; Ala-Scalp; Alacort; Algicirtis; Alphaderm; Amberin; Anflam; Anti-inflammatory hormone; Anucort; Anucort-HC; Anusol HC (TN); AnusolHC; Aquacort; Aquanil HC; Balneol-hc; Barseb HC; Basan-Corti; Beta-hc; COR-OTICIN; CaldeCORT Spray; Cetacort; Chronocort; Clear aid; Cleiton; Cobadex; Colocort; Colocort (TN); Component of Lubricort; Component of Neo-Cort-Dome; Component of Otalgine; Corhydron; Cort-Dome; Cortanal; Cortef; Cortef (TN); Cortenema; Cortesal; Corticreme; Cortifair; Cortifan; Cortiment; Cortisol; Cortisol alcohol; Cortisol, Hydrocortisone; Cortisolonum; Cortisporin; Cortisporin Otico; Cortispray; Cortolotion; Cortonema; Cortoxide; Cortril; Cremesone; Cremicort-H; Cutisol; Cyclodextrin-encapsulated hydrocortisone; Delacort; Derm-Aid; Dermacort; Dermaspray; Dermil; Dermocortal; Dermolate; Dihydrocostisone; Dioderm; Dome-cort; Domolene-HC; Drotic; DuoCort; Ef corlin; Efcorbin; Efcortelan; Efcortelin; Eldecort; Eldercort; Epicort; Epicortisol; Epiderm H; Esiderm H; Evacort; Ficortril; Fiocortril; Flexicort; Foille Insetti; Genacort; Genacort (lotion); Glycort; Gyno-Cortisone; H 4001; H-Cort; HC #1; HC #4; HC (HYDROCORTISONE); HYDROCORTISONE AND ACETIC ACID; HYDROCORTISONE IN ABSORBASE; Heb Cort; Heb-Cort; Hi-cor; Hidalone; Hidro-Colisona; Hidrocortisona [INN-Spanish]; Hycort; Hycortol; Hycortole; Hydracort; Hydrasson; Hydro-Adreson; Hydro-Colisona; Hydro-RX; Hydrocortal; Hydrocorticosterone; Hydrocortisone (JP15/USP/INN); Hydrocortisone [INN:BAN:JAN]; Hydrocortisone alcohol; Hydrocortisone base; Hydrocortisone free alcohol; Hydrocortisone solution; Hydrocortisone-Water Soluble; Hydrocortisonum [INN-Latin]; Hydrocortisyl; Hydrocortone; Hydroskin; Hydroxycortisone; Hytisone; Hytone; Hytone (TN); Hytone lotion; Idrocortisone; Idrocortisone [DCIT]; Incortin-H; Incortin-hydrogen; Kendall's compound F; Komed HC; Kyypakkaus; Lacticare HC; Lacticare-HC; Lactisona; Lubricort; Maintasone; Medicort; Meusicort; Mildison; Milliderm; Neo-Cortef; Neosporin-H Ear; Nogenic HC; Nutracort; Nystaform-HC; ORLEX HC; Optef; Otocort; Otosone-F; Pediotic Suspension; Penecort; Permicort; Polcort H; Preparation H Hydrocortisone Cream; Prepcort; Prevex HC; Proctocort; Proctozone HC; Protocort; Rectasol-HC; Rectoid; Reichstein's substance M; Remederm HC; Sanatison; Scalp-Cort; Scalpicin Capilar; Schericur; Scheroson F; Sigmacort; Signef; Stie-cort; Stiefcorcil; Synacort; Systral Hydrocort; Tarcortin; Texacort; Texacort lotion 25; Timocort; Transderma H; Traumaide; Uniderm; VoSol HC; Vytone; Zenoxone; [3H]cortisol DTD0003 VADRUGID DR00438 DTD0003 DRUGNAME Prednisone DTD0003 DRUGSYNO (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione; (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione; (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione; 1,2-Dehydrocortisone; 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione; 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione; 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione; 1-Cortisone; 1-Dehydrocortisone; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione; 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione; Adasone; Ancortone; Apo-Prednisone; Bicortone; Cartancyl; Colisone; Cortan; Cortidelt; Cotone; Dacorten; Dacortin; Decortancyl; Decortin; Decortisyl; Dehydrocortisone; Dekortin; Dellacort; Dellacort A; Delta E; Delta E.; Delta cortelan; Delta(sup 1)-Cortisone; Delta(sup 1)-Dehydrocortisone; Delta(sup1)-Cortisone; Delta-1-Cortisone; Delta-1-Dehydrocortisone; Delta-Cortelan; Delta-Cortisone; Delta-Cortone; Delta-Dome; Delta-E; Delta1-Cortisone; Delta1-Dehydrocortisone; Deltacortene; Deltacortisone; Deltacortone; Deltasone; Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone; Deltison; Deltisona; Deltisone; Deltra; Di-Adreson; Diadreson; Econosone; Encorton; Encortone; Enkortolon; Enkorton; Fiasone; Hostacortin; In-Sone; Incocortyl; Juvason; Kortancyl; Liquid Pred; Lisacort; Lodotra; Me-Korti; Metacortandracin; Meticortelone (TN); Meticorten; Meticorten (TN); Meticorten (Veterinary); Metrevet (Veterinary); Nisona; Nizon; Novoprednisone; Nurison; Orasone; Origen Prednisone; P1276; Panafcort; Panasol; Paracort; Parmenison; Pehacort; Precort; Predeltin; Prednicen-M; Prednicorm; Prednicort; Prednicot; Prednidib; Prednilonga; Prednison; Prednisona; Prednisona [INN-Spanish]; Prednisone Intensol; Prednisone [INN:BAN]; Prednisonum; Prednisonum [INN-Latin]; Prednitone; Prednizon; Prednovister; Presone; Pronison; Pronisone; Rectodelt; Retrocortine; SK-Prednisone; Servisone; Sone; Sterapred; Supercortil; U 6020; Ultracorten; Ultracortene; Winpred; Wojtab; Zenadrid; Zenadrid (veterinary); Zenadrid [veterinary] DTD0003 VADRUGID DR00363 DTD0003 DRUGNAME Baloxavir marboxil DTD0003 DRUGSYNO (((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate; Baloxavir marboxil; Baloxavir marboxil (JAN/INN); Baloxavir marboxil [INN]; Xofluza (TN) DTD0003 VADRUGID DR00250 DTD0003 DRUGNAME Oseltamivir DTD0003 DRUGSYNO (-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir DTD0003 VADRUGID DR00147 DTD0003 DRUGNAME Ivermectin DTD0003 DRUGSYNO IVERMECTIN; Ivermectin B1a; Dihydroavermectin B1a; 22,23-Dihydroavermectin B1a; 71827-03-7; avermectin H2B1a; UNII-91Y2202OUW DTD0003 VADRUGID DR01425 DTD0003 DRUGNAME Ramosetron DTD0003 DRUGSYNO 132036-88-5; UNII-7ZRO0SC54Y; Ramosetron [INN]; 7ZRO0SC54Y; CHEMBL1643895; Ramosetron (INN); (1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone; Nor-YM 060; SCHEMBL16701; GTPL2301; DTXSID0043842; NTHPAPBPFQJABD-LLVKDONJSA-N; MolPort-019-991-383; CHEBI:135156; ZINC5116719; AC1L3355; BDBM50334454; 8235AH; AKOS015896003; SB19072; DB09290; SC-92398; AJ-53160; LS-187182; TL8000762; R-146; FT-0651831; D08466; A806353; (-)-(R)-1-Methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl ketone; Nasea (TN); YM060 DTD0003 VADRUGID DR00073 DTD0003 DRUGNAME Rifaximin DTD0003 DRUGSYNO Rifaximin; Rifaxidin; Rifacol; Xifaxan; Rifaximine; Rifamycin L 105; Rifamycin L 105SV; Rifaximina; Fatroximin; Normix; Rifaximinum; Rifamixin; Ritacol; Rifaximine [French]; Rifaximinum [Latin]; Rifaximina [Spanish]; Rifaximin [USAN:INN]; UNII-L36O5T016N; L 105SV; L 105 (Ansamacrolide antibiotic); L 105; C43H51N3O11; BRN 3584528; L36O5T016N; Rifaximin, 98%; Rifaximin (Xifaxan); MFCD00864973 DTD0003 VADRUGID DR01443 DTD0003 DRUGNAME Norverapamil DTD0003 DRUGSYNO Arverapamil; (R)-norverapamil; Agi-003; UNII-3J8P56R04P; (R)-(+)-Nor Verapamil Hydrochloride; 123932-43-4; 3J8P56R04P; Rezular; (+)-norverapamil; (R)-desmethylverapamil; (+)-desmethylverapamil; CHEBI:134082; ZINC13492624; AKOS030532539; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, (alphaR)-; UNII-957Z3K3R56 component UPKQNCPKPOLASS-AREMUKBSSA-N DTD0003 VADRUGID DR01267 DTD0003 DRUGNAME Asimadoline DTD0003 DRUGSYNO Asimadoline [INN]; EMD 61753; N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide DTD0003 VADRUGID DR01688 DTD0003 DRUGNAME Ebastine DTD0003 DRUGSYNO ebastine; Kestine; Ebastel; Ebastin; Evastel; Kestin; Bactil; Ebastinum [Latin]; LAS W-090; Ebastina [Spanish]; Estivan; UNII-TQD7Q784P1; RP 64305; 1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one; TQD7Q784P1; CHEMBL305660; 4-Diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine; C32H39NO2; MFCD00865661; 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone; NCGC00164603-01; RP-64305; 4'-tert-Butyl-4-(4-(diphenylmethoxy)piperidino)butyrophenone DTD0003 VADRUGID DR00162 DTD0003 DRUGNAME Etoposide DTD0003 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0003 VADRUGID DR00082 DTD0003 DRUGNAME Methotrexate DTD0003 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0003 VADRUGID DR01505 DTD0003 DRUGNAME Dolastatin 10 DTD0003 DRUGSYNO Dolastatin 10; Dolastatin-10; Dolostatin 10; UNII-EI946JT51X; CCRIS 7310; CHEBI:67357; NSC 376128; EI946JT51X; L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl- DTD0003 VADRUGID DR00572 DTD0003 DRUGNAME Chloroquine DTD0003 DRUGSYNO (+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline; Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244; {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine DTD0003 VADRUGID DR01464 DTD0003 DRUGNAME Cinchonidine DTD0003 DRUGSYNO CINCHONIDINE; Cinchonan-9-ol; cinchonine; alpha-Quinidine; 485-71-2; GNF-PF-5411; 118-10-5; MLS002637808; NSC5364; .alpha.-Quinidine; NSC 5364; Cinchonan-9-ol, (8.alpha.,9R)-; Cinchonan-9-ol, (9S)-; (8alpha,9R)Cinchonan-9-ol; a-quinidine; (8-alpha,9R)-Cinchonan-9-ol; EINECS 207-622-3; {5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}(quinolin-4-yl)methanol; SMR001488502; AI3-15317; 4-quinolyl-(5-vinylquinuclidin-2-yl)methanol; 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; (+)-Quinolin-4-yl(5-vinylquinuclidin-2-yl)methanol DTD0003 VADRUGID DR00623 DTD0003 DRUGNAME Mefloquine DTD0003 DRUGSYNO (+)-(11R,2'S)-erythro-Mefloquine; (+)-Mefloquine; (+)-Threo-Mefloquine; (-)-(11S,2'R)-erythro-Mefloquine; (-)-Mefloquine; (-)-Threo-Mefloquine; (DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol; Alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; Alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol; Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol; Lariam; Lariam (Hydrochloride); Lariam (TN); Mefaquin (TN); Mefloquin; Mefloquina; Mefloquina [INN-Spanish]; Mefloquine (USAN/INN); Mefloquine [USAN:INN:BAN]; Mefloquinone; Mefloquinum; Mefloquinum [INN-Latin]; Mephloquine; RO 13-7224; RO 13-7225; RTI1169-1-1; RTI1172-1-1; RTI1173-1-1; RTI1174-1-1; RTI1188-1-1; RTI1189-1-1; Racemic mefloquine; Ro 21-5998; Ro 21-5998 (Hydrochloride); Ro 215998; Ro-21-5998-001; SPB-80406; WR 142490; WR-142,490; WR-142490; WR-177,602; [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol DTD0003 VADRUGID DR00054 DTD0003 DRUGNAME Quinine DTD0003 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0003 VADRUGID DR01268 DTD0003 DRUGNAME Leupeptin DTD0003 DRUGSYNO (2S)-2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide; 2-(2-Acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methylvaleramide; 24365-55-7; AC1L97IT; Valeramide, 2-(2-acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl- DTD0003 VADRUGID DR01336 DTD0003 DRUGNAME Binimetinib DTD0003 DRUGSYNO 181R97MR71; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; 606143-89-9; ARRY 162; ARRY 438162; ARRY-162; ARRY-438162; Binimetinib (JAN/USAN); Binimetinib (MEK162, ARRY-162, ARRY-438162); Binimetinib [USAN:INN]; D0C4LF; MEK 162; MEK-162; MEK162; MEK162 (ARRY-162, ARRY-438162); MEK162(Binimetinib); NVP-ME; UNII-181R97MR71 DTD0003 VADRUGID DR00164 DTD0003 DRUGNAME Dabrafenib DTD0003 DRUGSYNO 1195765-45-7; CHEBI:75045; Dabrafenib (GSK2118436); Dabrafenib [USAN:INN]; GSK 2118436; GSK-2118436A; GSK2118436; GSK2118436A; N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide; QGP4HA4G1B; Tafinlar; UNII-QGP4HA4G1B DTD0003 VADRUGID DR00220 DTD0003 DRUGNAME Eliglustat tartrate DTD0003 DRUGSYNO Fabrazyme (TN) DTD0003 VADRUGID DR00136 DTD0003 DRUGNAME Regorafenib DTD0003 DRUGSYNO 24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB DTD0003 VADRUGID DR00981 DTD0003 DRUGNAME Eletriptan DTD0003 DRUGSYNO (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole; 3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole; 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole; 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole; Eletriptan (INN); Eletriptan [INN:BAN]; Eletriptanum; Relpax; Relpax (TN); UK 116044; UK-116044; UK-116044-04; UK116044 DTD0003 VADRUGID DR00331 DTD0003 DRUGNAME Sumatriptan DTD0003 DRUGSYNO (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide; 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide; 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide; GR 43175; GR 43175X; GR-43175; Imigran; Imigran (TN); Imitrex; Imitrex (TN); KS-1116; NP101; Sumatran; Sumatriptan (JAN/USP/INN); Sumatriptanum; Sumatriptanum [INN-Latin]; Sumax DTD0003 VADRUGID DR00267 DTD0003 DRUGNAME Indomethacin DTD0003 DRUGSYNO Aconip; Aconip (TN); Amuno; Apo-Indomethacin; Arthrexin; Artracin; Artrinovo; Artrivia; Bonidin; Bonidon; Bonidon Gel; Catlep; Chibro-amuno; Chrono-indicid; Chrono-indocid; Confortid; DESMETHYL INDOMETHACIN; Dolcidium; Dolcidium PL;Flexin continus; Dolovin; Durametacin; Elmetacin; Hicin; I 7378; IMN; IN1454; Idomethine; Imbrilon; Inacid; Indacin; Indameth; Indmethacine; Indo-Lemmon; Indo-Spray; Indo-phlogont; Indo-rectolmin; Indo-tablinen; Indochron E-R (TN); Indocid; Indocid (TN); Indocid (pharmaceutical); Indocid Pda; Indocid Sr; Indocin; Indocin (TN); Indocin I.V; Indocin I.V.; Indocin Sr; Indocin-SR (TN); Indolar SR; Indomecol; Indomed; Indomee; Indomet 140; Indometacin; Indometacin (JP15/INN); Indometacina; Indometacina [INN-Spanish]; Indometacine; Indometacine [INN-French]; Indometacinum; Indometacinum [INN-Latin]; Indometacyna; Indometacyna [Polish]; Indomethacin & MAP-30; Indomethacin (USP); Indomethacin [USAN:BAN]; Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin; Indomethacine; Indomethacinum; Indomethancin; Indomethazine; Indomethegan; Indomethine; Indometicina; Indometicina [Spanish]; Indomo; Indomod; Indoptic; Indoptol; Indorektal; Indoxen; Inflazon; Infrocin; Inteban sp; Lausit; Liometacen; Metacen; Metartril; Methazine; Metindol; Mezolin; Miametan; Mikametan; Mobilan; Novo-Methacin; Novomethacin; Reumacide; Rhemacin LA; Rheumacin LA; Sadoreum; Tannex; Vonum DTD0003 VADRUGID DR00016 DTD0003 DRUGNAME Meperidine DTD0003 DRUGSYNO 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]; 1-Methyl-4-phenylisonipecotic acid, ethyl ester;1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester; 4-Carbethoxy-1-methyl-4-phenylpiperidine; 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester; Demarol; Demerol; Demerol (TN); Dolcontral; Dolosal; Dolsin; Ethyl 1-methyl-4-phenylisonipecotate; Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate; Isonipecain; Isonipecaine; Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester; Lidol; Lydol; Meperidine solution; Meperidol; Methyl phenylpiperidine carbonic acid ethyl ester; N-Methyl-4-phenyl-4-carbethoxypiperidine; Nemerol; Operidine EPJ I; Operidine EPJ-I; Pethanol; Pethidin; Pethidine; Pethidine (INN); Pethidine DBL; Pethidine DBL (TN); Pethidineter; Pethidinum; Pethidinum [INN-Latin]; Petidina; Petidina [INN-Spanish]; Petydyna; Petydyna [Polish]; Phetidine; Piperosal; Pipersal; YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI) DTD0003 VADRUGID DR01286 DTD0003 DRUGNAME Pentazocine DTD0003 DRUGSYNO (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol; (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan; 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan; 2-(3,3-Dimethylallyl)cyclazocine; 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan; 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol; Algopent (free base); Fortal (TN); Fortalgesic; Fortalin; Fortral; Fortral (TN); Fortwin (TN); II-C-2; KF-1820; L-pentazocine; Lexir; Liticon; NIH 7958; Pentagin; Pentazocaine; Pentazocin; Pentazocina; Pentazocina [DCIT]; Pentazocine (JP15/USP/INN); Pentazocine [USAN:INN:BAN:JAN]; Pentazocine, Pentazocin, Sosegon, WIN 20228; Pentazocinum; Pentazocinum [INN-Latin]; Sosegon; Soseton; Sosigon; Talacen; Talacen (TN); Talwan; Talwin (TN); Talwin NX (TN); Talwin PX (TN); WIN 20228 DTD0003 VADRUGID DR01324 DTD0003 DRUGNAME Carfilzomib DTD0003 DRUGSYNO (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; 72X6E3J5AR; 868540-17-4; CHEBI:65347; CHEMBL451887; Carfilzomib; Carfilzomib (PR-171); DSSTox_CID_28616; DSSTox_GSID_48690; DSSTox_RID_82886; Kyprolis; N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide; NCGC00249613-01; PR-171; UNII-72X6E3J5AR DTD0003 VADRUGID DR00182 DTD0003 DRUGNAME Dasatinib DTD0003 DRUGSYNO (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel DTD0003 VADRUGID DR00379 DTD0003 DRUGNAME Melphalan DTD0003 DRUGSYNO (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid; (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine; AY3360000; Alanine Nitrogen Mustard; Alkeran; Alkeran (TN); At-290; CB 3025; CB-3025; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine; L-PAM; L-Phenylalanine mustard; L-Sarcolysin; L-Sarcolysine; L-Sarkolysin; Levofalan; Levofolan; Levopholan; MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)); Melfalan; Melfalano; Melfalano [INN-Spanish]; Melphalan (JP15/USP/INN); Melphalan [USAN:INN:BAN:JAN]; Melphalanum; Melphalanum [INN-Latin]; P-Bis(beta-chloroethyl)aminophenylalanine; P-Di-(2-chloroethyl)amino-L-phenylalanine; P-L-Sarcolysin; P-L-sarcolysine; P-N,N-bis(2-chloroethyl)amino-L-phenylalanine; P-N-Bis(2-chloroethyl)amino-L-phenylalanine; P-N-Di(chloroethyl)aminophenylalanine; P-N-di(chloroethyl)aminophenylala nine; Phenylalanine mustard; Phenylalanine nitrogen mu stard; Phenylalanine nitrogen mustard; SK-15673; TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN); TRANSGENIC MODEL EVALUATION (MELPHALAN) DTD0003 VADRUGID DR00181 DTD0003 DRUGNAME Panobinostat DTD0003 DRUGSYNO (E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE; (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide; Faridak; LBH 589; LBH-589; LBH-589B; LBH589; NVP-LBH-589; NVP-LBH589; Panobinostat, NVP-LBH589, LBH589 DTD0003 VADRUGID DR01331 DTD0003 DRUGNAME Bortezomib DTD0003 DRUGSYNO 179324-69-7; 69G8BD63PP; Boronic acid,; Bortezomib (PS-341); Bortezomib (Proteasome inhibitor); Bortezomib(JAN/USAN/INN); CHEMBL325041; DPBA; LPD 341; LPD-341; MLN-341; N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; PROSCRIPT BORONIC ACID; Peptide boronate; Pyz-Phe-boroLeu; UNII-69G8BD63PP; VELCADE (TN); Velcade; Velcade (TN); Velcade, MG-341, PS-341, Bortezomib; [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid; [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid DTD0003 VADRUGID DR00428 DTD0003 DRUGNAME Prednisolone DTD0003 DRUGSYNO Nanocort; Prednisolone (injectable liposome formulation, rheumatoid arthritis); Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus; Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos DTD0003 VADRUGID DR00354 DTD0003 DRUGNAME Afatinib DTD0003 DRUGSYNO (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide; BIBW 2992; BIBW-2992; EGFR inhibitor 2nd gens; Tomtovok; Tovok; Tovok (TN); Tovok, BIBW2992 DTD0003 VADRUGID DR00228 DTD0003 DRUGNAME Ceritinib DTD0003 DRUGSYNO 1032900-25-6; 5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrim; 5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine; 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine; AK174337; C28H36ClN5O3S; CHEBI:78432; CHEMBL2403108; Eritinib (LDK378); K418KG2GET; LDK 378; LDK-378; LDK378; LDK378(Ceritinib); NVP-LDK378-NX; UNII-K418KG2GET; ZYKADIA; ceritinib DTD0003 VADRUGID DR00523 DTD0003 DRUGNAME Crizotinib DTD0003 DRUGSYNO Xalkori (TN); novel ALK inhibitors DTD0003 VADRUGID DR00558 DTD0003 DRUGNAME Erlotinib DTD0003 DRUGSYNO 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; AQ4; CP 358,774; CP-358,774; CP-358774; Erlotinib Base; Erlotinib(Tarceva); Erlotinib, OS-774; Erlotinin; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; OSI 744; R 1415; Tarceva; Tarceva (TN); [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine DTD0003 VADRUGID DR01343 DTD0003 DRUGNAME Vinorelbine DTD0003 DRUGSYNO Eunades; Exelbine; NVB; Navelbine; Vinorelbin; Vinorelbina; Vinorelbinum; Navelbine base; Vinorelbina [Spanish]; Vinorelbine Ditartarate; Vinorelbine ditartrate; Vinorelbine tartrate; Vinorelbinum [Latin]; KW 2307; KW 2307 base; ANX-530; KW-2307; Navelbine (TN); SDP-012; Vinorelbine (INN); Vinorelbine [INN:BAN]; Aspidospermidine-3-carboxylic acid; Nor-5'-anhydrovinblastine; Methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; Methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate DTD0003 VADRUGID DR01439 DTD0003 DRUGNAME Belotecan DTD0003 DRUGSYNO Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022 DTD0003 VADRUGID DR00029 DTD0003 DRUGNAME Moxidectin DTD0003 DRUGSYNO C37H53NO8; Cydectin; Moxidectin [USAN:INN:BAN]; Moxidectina; Moxidectina [INN-Spanish]; Moxidectine; Moxidectine [INN-French]; Moxidectinum; Moxidectinum [INN-Latin]; NGU5H31YO9; ProHeart 6; UNII-NGU5H31YO9 DTD0003 VADRUGID DR00113 DTD0003 DRUGNAME Azathioprine DTD0003 DRUGSYNO 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine; 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine; 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine; 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine; 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(Methyl-p-nitro-5-imidazolyl)thiopurine; 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine; 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine; 6-[(1-Methyl-4-nitroimidazol-5-yl)-thio] purine; 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine; A 4638; AI-981/34845012; Azamun; Azamun (TN); Azamun [Czech]; Azanin; Azasan; Azasan (TN); Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine; Azathioprin; Azathioprine (JP15/USP/INN); Azathioprine [USAN:INN:BAN:JAN]; Azathioprine sodium; Azathioprinum; Azathioprinum [INN-Latin]; Azathiopurine; Azatiopr in; Azatioprin; Azatioprina; Azatioprina [INN-Spanish]; Azothioprine; B. W. 57-322; BW 57-322; BW 57322; BW-57-322; Ccucol; Cytostatics; Immuran; Imuran; Imuran (TN); Imurek; Imurel; Imurel (TN); Methylnitroimidazolylmercaptopurine; Muran; Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl); [Methyl(nitroimidazolyl)mercaptopurine] DTD0003 VADRUGID DR00262 DTD0003 DRUGNAME Sirolimus DTD0003 DRUGSYNO (-)-Rapamycin; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29; 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; AY 22989; AY-22989; Antibiotic AY 22989; DE-109; Heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy; LCP-Siro; MS-R001; Perceiva; RAP; RAPA; RPM; Rapammune; Rapamune; Rapamune (TN); Rapamycin; Rapamycin (TN); Rapamycin C-7, analog 4; Rapamycin Immunosuppressant Drug; Rapamycin from Streptomyces hygroscopicus; SIIA 9268A; SILA 9268A; Sirolimus (MTOR inhibitor); Sirolimus (RAPAMUNE); Sirolimus (USAN/INN); Sirolimus [USAN:BAN:INN]; Sirolimus, Rapamune,Rapamycin; WY-090217; Wy 090217 DTD0003 VADRUGID DR00406 DTD0003 DRUGNAME Tacrolimus DTD0003 DRUGSYNO (-)-FK 506; 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone; 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN; Advagraf; Advagraf (TN); FK 506; FK5; FK506; FR 900506; FR-900506; FR900506; Fk-506; Fujimycin; Graceptor; K506; L 679934; L-679934; LCP-Tacro; Modigraf; Prograf; Prograf (TN); Protopic; Protopic (TN); Protopy; Tacarolimus; Tacrolimus (INN); Tacrolimus (Prograf); Tacrolimus (anhydrous); Tacrolimus anhydrous; Tsukubaenolide DTD0003 VADRUGID DR01347 DTD0003 DRUGNAME Raloxifene DTD0003 DRUGSYNO Raloxifene (extended-release, CDT) DTD0003 VADRUGID DR00108 DTD0003 DRUGNAME Testosterone DTD0003 DRUGSYNO (17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone DTD0003 VADRUGID DR00265 DTD0003 DRUGNAME Lenvatinib DTD0003 DRUGSYNO 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide; E-7080, E7080; E7080 DTD0003 VADRUGID DR00044 DTD0003 DRUGNAME Topotecan DTD0003 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0003 VADRUGID DR01262 DTD0003 DRUGNAME Actinomycin D DTD0003 DRUGSYNO AC1O8OFK; CCG-35952; CCG-36086; NCIMech_000599 DTD0003 VADRUGID DR00291 DTD0003 DRUGNAME Cisplatin DTD0003 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0003 VADRUGID DR00781 DTD0003 DRUGNAME Mibefradil DTD0003 DRUGSYNO Calcium T-channel inhibitor (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics; Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer); Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics DTD0003 VADRUGID DR00001 DTD0003 DRUGNAME Fesoterodine fumarate DTD0003 DRUGSYNO Toviaz (TN) DTD0003 VADRUGID DR00357 DTD0003 DRUGNAME Vibegron DTD0003 DRUGSYNO Beova; Beova (TN); VIBEGRON; Vibegron (JAN/USAN); Vibegron [USAN:INN]; compound 7 [PMID: 26709102]; vibegronum DTD0003 VADRUGID DR00203 DTD0003 DRUGNAME Aspirin DTD0003 DRUGSYNO 2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate DTD0003 VADRUGID DR01344 DTD0003 DRUGNAME Nalbuphine DTD0003 DRUGSYNO Intapan; Nalbufina; Nalbuphinum; Intapan (TN); Nalbuphine (INN); Nubain (TN); (5alpha,6alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol; 17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alpha,14-triol DTD0003 VADRUGID DR00088 DTD0003 DRUGNAME Tramadol DTD0003 DRUGSYNO Conzip; Rybix Odt; Ryzolt; Tramadol Hydrochloride; Ultram; Ultram Er DTD0003 VADRUGID DR00141 DTD0003 DRUGNAME Methadone DTD0003 DRUGSYNO (+)-Methadone; (+-)-Methadone; (+/-)-Methadone; (+/-)-Tussal; (-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; (-)-Methadone; (6R)-Methadone; (R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; (R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone; (S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; 3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)-(9CI); 6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture; 6-(dimethylamino)-4,4-diphenylheptan-3-one; 6-Dimethylamino-4,4-diphenyl-3-heptanone; 6-dimethylamino-4,4-di(phenyl)heptan-3-one; 6S-Methadone; A 4624; AN 148; AN-148 (*Hydrochloride*); Adanon; Algovetin; Althose; Amidon; Amidone; Amidone (TN); Biscuits; D-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; D-Methadone; Dextromethadone; Diaminon; Dl-Methadone; Dollies; Dolly; Dolophin; Dolophine; Dolophine (*Hydrochloride*); Dolophine (TN); Fenadone (*Hydrochloride*); Heptadon (TN); Heptadone; Heptadone (*Hydrochloride*); Heptanon; Heptanon (*Hydrochloride*); Heptanon (pharmaceutical); Hoechst 10820; Hoescht 10820 (*Hydrochloride*); K 174; Ketalgin; L-(+)-Methadone; L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; L-Methadone; L-Polamidon; L-Polamivet; Levometadona; Levometadona [INN-Spanish]; Levomethadone [INN]; Levomethadonum; Levomethadonum [INN-Latin]; Levothyl; Metadona; Metadona [INN-Spanish]; Metadona [Spanish]; Metadone; Metadone [DCIT]; Metasedin; Methadon; Methadona; Methadona [Spanish]; Methadone (BAN); Methadone HCL Intensol; Methadone M; Methadone [INN:BAN]; Methadonum; Methadonum [INN-Latin]; Methadonum [Latin]; Methadose (TN); Methaquaione; Phenadone; Phenadone (*Hydrochloride*); Physeptone (TN); Polamidone; Polamivet; Racemic methadone; S-(+)-Methadone; Sedo-Rapide; Symoron (TN); Tussol; Westadone;Dolophine HCL DTD0003 VADRUGID DR00716 DTD0003 DRUGNAME Vecuronium DTD0003 DRUGSYNO (2A,3A,5A,16A,17A)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane; (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane; Norcuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate DTD0003 VADRUGID DR01649 DTD0003 DRUGNAME Metkephamid DTD0003 DRUGSYNO METKEFAMIDE; UNII-MNL20FXH9Y; MNL20FXH9Y; Metkephamid; Metkephamide; Metkefamida; Metkefamidum; L-Methioninamide, L-tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-; Metkefamidum [INN-Latin]; Metkefamida [INN-Spanish]; L-Tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-L-methioninamide; Metkefamide [INN]; AC1NUZ1B; SCHEMBL329997; CHEMBL2220405; CTK2F4766 DTD0003 VADRUGID DR00304 DTD0003 DRUGNAME Sorafenib DTD0003 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum DTD0003 VADRUGID DR00063 DTD0003 DRUGNAME Gemcitabine DTD0003 DRUGSYNO 2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei DTD0003 VADRUGID DR00153 DTD0003 DRUGNAME Fluorouracil DTD0003 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0003 VADRUGID DR00125 DTD0003 DRUGNAME Levodopa DTD0003 DRUGSYNO Levodopa (optimized formulation, Parkinson's disease); Levodopa (optimized formulation, Parkinson's disease), Orion; More effective levodopa (Parkinson's disease), Orion DTD0003 VADRUGID DR01623 DTD0003 DRUGNAME Eslicarbazepine acetate DTD0003 DRUGSYNO Eslicarbazepine acetate; BIA 2-093; Aptiom; Zebinix; Stedesa; Exalief; Eslicarbazepine (acetate); UNII-BEA68ZVB2K; BIA-2-093; (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; Sep 0002093; BIA 2093; BEA68ZVB2K; SEP-0002093; CHEMBL87992; Eslicarbazepine acetate [USAN]; CHEBI:87016; exelief; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate; Eslicarbazepine acetate (USAN) DTD0003 VADRUGID DR01713 DTD0003 DRUGNAME S-licarbazepine DTD0003 DRUGSYNO Eslicarbazepine; (S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; S-licarbazepine; UNII-S5VXA428R4; BIA 2-194; S-10-Monohydroxy-dihydro-carbamazepin; S5VXA428R4; S-(+)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide; (5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide; (10S)-10,11-Dihydro-10-hydroxy-5H-Dibenz[b,f]azepine-5-carboxamide; (S)-Licarbazepine; S(+)-Liscarbazepine; (10S)-10,11-Dihydro-10-hydroxy-5H-dibenz(b,f)azepine-5-carboxamide DTD0003 VADRUGID DR01372 DTD0003 DRUGNAME Topiramate DTD0003 DRUGSYNO Epitoma; Epitomax; TOR; Tipiramate; Tipiramato; Topamac; Topamax; Topimax; Topina; Topiramato; Topiramatum; Topomax; Cilag brandof topiramate; Janssen brand of topiramate; Ortho brand of topiramate; Tipiramate [French]; Tipiramato [Spanish]; Topamax Sprinkle; Topiramate tablet; Topiramatum [Latin]; Topiramic acid; McN 4853; RWJ 17021; KS-1122; KW-6485; McN-4853; RWJ-17021; Topamax (TN); Topamax, Topiramate; Topiramate (TPM); Topiramate / Placebo; Topiramato [INN-Spanish]; Topiramatum [INN-Latin]; USL-255; RWJ-17021-000; Topiramate [USAN:BAN:INN]; Topiramate (JAN/USAN/INN); Beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate; Beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI);Beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate; [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate; 2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-(beta)-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; 5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, beta DTD0003 VADRUGID DR00243 DTD0003 DRUGNAME Mycophenolate mofetil DTD0003 DRUGSYNO 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF DTD0003 VADRUGID DR00643 DTD0003 DRUGNAME Lansoprazole DTD0003 DRUGSYNO lansoprazole; Prevacid; Monolitum; Bamalite; Lansoprazol; Limpidex; Agopton; Ogastro; Opiren; Lanzor; Prevacid SoluTab; Takepron; Lanzopral; Zoton; Lansoprazolum; Lasoprol; Mesactol; Lansopep; Lanproton; Lancid; Ketian; Prezal; Lanston; Aprazol; Blason; Ulpax; Lanz; Pro Ulco; AG-1749; Compraz; Suprecid; Prosogan; Ilsatec; Promp; Zoprol; Dakar; Prevacid Iv; Ogast; Lanzol-30; AG 1749; Lansoprazol [INN-Spanish]; Lansoprazolum [INN-Latin]; Lansox; Lanzo; A-65006; Prevacid NapraPAC; Prevacid 24HR; Lansoprazole [USAN:BAN:INN]; HSDB 7204 DTD0003 VADRUGID DR01428 DTD0003 DRUGNAME Pirenzepine DTD0003 DRUGSYNO Gasteril; Gastrotsepin; Gastrozepin; Pirenzepin; Pirenzepina; Pirenzepinum; Pyrenzepine; Ulcosan; Pirenzepine Gastrozepin; Gastrozepin (TN); L-S 519; Pirenzepina [INN-Spanish]; Pirenzepine (INN); Pirenzepine [INN:BAN]; Pirenzepinum [INN-Latin]; 11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one; 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one; 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one; 5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one DTD0003 VADRUGID DR00163 DTD0003 DRUGNAME Ranitidine DTD0003 DRUGSYNO (E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic DTD0003 VADRUGID DR00233 DTD0003 DRUGNAME Romidepsin DTD0003 DRUGSYNO (1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; Antibiotic FR 901228; Chromadax; Chromadax (TN); Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide; FK 228; FK-228; FK-901228; FK228; FR 901228; FR-901228; FR901228; HDInhib_000006; Istodax; Istodax (TN); L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide; Romidepsin (USAN) DTD0003 VADRUGID DR00281 DTD0003 DRUGNAME Progesterone DTD0003 DRUGSYNO LPCN-1107; Progesterone (oral, preterm labor); Progesterone (oral, preterm labor), Lipocine DTD0003 VADRUGID DR00227 DTD0003 DRUGNAME Rivaroxaban DTD0003 DRUGSYNO XARELTO (TN) DTD0003 VADRUGID DR00795 DTD0003 DRUGNAME Bicalutamide DTD0003 DRUGSYNO (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide; Bicalutamide (JAN/USP/INN); Bicalutamide [USAN:INN:BAN]; Calutide (TN); Casodex; Casodex (TN); Casodex, Cosudex, Calutide, Kalumid, Bicalutamide; Cosudex; Cosudex (TN); KS-1161; Kalumid (TN); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Propanamide; Raffolutil; Zeneca brand of bicalutamide DTD0003 VADRUGID DR00195 DTD0003 DRUGNAME Rhodamine 123 DTD0003 DRUGSYNO RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes DTD0003 VADRUGID DR00322 DTD0003 DRUGNAME Baricitinib DTD0003 DRUGSYNO 1187594-09-7; Baricitinib (LY3009104, INCB028050); Baricitinib [USAN:INN]; C16H17N7O2S; INCB 028050; INCB-028050; INCB028050; ISP4442I3Y; J-503551; LY-3009104; LY3009104; Olumiant (TN); UNII-ISP4442I3Y; olumiant DTD0003 VADRUGID DR00311 DTD0003 DRUGNAME Ambrisentan DTD0003 DRUGSYNO (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; 2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; Ambrisentan [INN]; BSF 208075; BSF-208075; BSF208075; Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phe; Gilead brand of ambrisentan; LU 208075; LU-208075; LU208075; Letairis DTD0003 VADRUGID DR00080 DTD0003 DRUGNAME Riociguat DTD0003 DRUGSYNO 625115-55-1; Adempas; BAY 63-2521; CHEBI:76018; Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; RU3FE2Y4XI; Riociguat; Riociguat (BAY 63-2521); UNII-RU3FE2Y4XI; riociguatum DTD0003 VADRUGID DR00224 DTD0003 DRUGNAME Everolimus DTD0003 DRUGSYNO (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy; 40-O-(2-hydroxyethyl)-rapamycin; 42-O-(2-Hydroxyethyl)rapamycin; Afinitor; Afinitor (TN); CERTICAN(R); Certican; Certican (TN); Everolimus (JAN/USAN/INN); Everolimus [USAN]; MTOR kinase inhibitors; NVP-RAD-001; RAD 001; RAD-001; RAD-001C; RAD001; RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus; SDZ-RAD; Zortress DTD0003 VADRUGID DR00185 DTD0003 DRUGNAME Pazopanib hydrochloride DTD0003 DRUGSYNO 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN) DTD0003 VADRUGID DR00432 DTD0003 DRUGNAME Temsirolimus DTD0003 DRUGSYNO Torisel DTD0003 VADRUGID DR01299 DTD0003 DRUGNAME Sunitinib malate DTD0003 DRUGSYNO (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate; LVX8N1UT73; MFCD08282795; N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate; PHA-290940AD; SU 011248; SU010398; SU011248; SU011248 L-malate salt; SUNITINIB MALEATE; Sunitinib malate; Sunitinib malate [USAN]; UNII-LVX8N1UT73 DTD0003 VADRUGID DR00215 DTD0003 DRUGNAME Dexamethasone DTD0003 DRUGSYNO (3H)-Dexamethasone; 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol; 16.alpha.-Methyl-9.alpha.-fluoroprednisolone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone; 16alpha-Methyl-9alpha-fluoroprednisolone; 9-alpha-Fluoro-16-alpha-methylprednisolone; 9.alpha.-Fluoro-16.alpha.-methylprednisolone; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 9alpha-Fluoro-16alpha-methylprednisolone; Adexone; Aeroseb-D; Aeroseb-Dex; Alcon Brand of Dexamethasone; Anaflogistico; Aphtasolon; Aphthasolone; Auxiron; Azium; Azium (Veterinary); Bisu DS; Calonat; Corson; Corsone; Cortisumman; DXM; Decacort; Decacortin; Decaderm; Decadron; Decadron (TN); Decadron Tablets, Elixir; Decadron, Dexamethasone; Decadron-LA; Decagel; Decaject; Decaject L.A.; Decaject-L.A.; Decalix; Decameth; Decasone; Decaspray; Dectancyl; Dekacort; Delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol; Delta1-9alpha-Fluoro-16alpha-methylcortisol; Deltafluorene; Dergramin; Deronil; Desadrene; Desametasone; Desametasone [DCIT]; Desamethasone; Desameton; Deseronil; Dex-ide; Dexa Mamallet; Dexa-Cortidelt;Dexa-Cortisyl; Dexa-Mamallet; Dexa-Scheroson; Dexa-sine; Dexacen-4; Dexacort; Dexacortal; Dexacortin; Dexadeltone; Dexafarma; Dexair; Dexalona; Dexaltin; Dexametasona; Dexametasona [INN-Spanish]; Dexameth; Dexamethansone; Dexamethasone (JP15/USP/INN); Dexamethasone Base; Dexamethasone Intensol; Dexamethasone [INN:BAN:JAN]; Dexamethasone alcohol; Dexamethasonum; Dexamethasonum [INN-Latin]; Dexamethazone; Dexamonozon; Dexapolcort; Dexaprol; Dexason; Dexasone; Dexinolon; Dexinoral; Dexone; Dexone 0.5; Dexone 0.75; Dexone 1.5; Dexone 4; Dexonium; Dexpak; Dextelan; Dezone; Dinormon; Dxms; ECR Brand of Dexamethasone; Fluormethylprednisolone; Fluormone; Fluorocort; Fortecortin; Foy Brand of Dexamethasone; Gammacorten; Hexadecadrol; Hexadrol; Hexadrol Elixir; Hexadrol Tablets; Hl-dex; ICN Brand of Dexamethasone; IontoDex; Isopto-Dex; Lokalison F; Loverine; Luxazone; MK 125; Maxidex; Mediamethasone; Merck Brand of Dexamethasone; Merz Brand 1 of Dexamethasone; Merz Brand 2 of Dexamethasone; Methylfluorprednisolone; Mexidex; Millicorten; Mymethasone; OTO-104; Ocu-trol;Pet-Derm Iii; Oradexon; Pet Derm III; Policort; Posurdex; Prednisolon F; Prednisolone F; Prodex; SK-Dexamethasone; Spoloven; Sunia Sol D; Superprednol; Turbinaire; Visumetazone DTD0003 VADRUGID DR00502 DTD0003 DRUGNAME Chlorpromazine DTD0003 DRUGSYNO 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+); 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; 2-Chloropromazine; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Aminasine; Aminazin; Aminazine; Ampliactil; Amplicitil; Amplictil; BC 135; Chlor-PZ; Chlor-Promanyl; Chlordelazine; Chlorderazin; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; Chloropromazine; Chlorpromados; Chlorpromanyl (discontinued); Chlorpromazin; Chlorpromazine (USP/INN); Chlorpromazine Tannate; Chlorpromazine [USAN:INN:BAN]; Chlorpromazinum; Chlorpromazinum [INN-Latin]; Clorpromazina; Clorpromazina [INN-Spanish]; Clorpromazina [Italian]; Contomin; Cromedazine; Elmarin; Esmind; Fenactil; Fenaktyl; Fraction AB; HL 5746; JHICC02042; Largactil; Largactil (TN); Largactil Liquid; Largactil Oral Drops; Largactilothiazine; Largactyl; Megaphen; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; Novo-Chlorpromazine; Novomazina; Phenactyl; Phenathyl; Phenothiazine hydrochloride; Plegomasine; Plegomazin; Prazilpromactil; Proma; Promactil; Promazil; Propaphen; Propaphenin; Prozil; Psychozine; SKF 2601-A; SKF 2601A; SKF-2601; Sanopron; Thorazine; Thorazine (TN); Thorazine Spansule; Thorazine Suppositories; Thorazine hydrochloride; Torazina; Wintermin; Z80; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine DTD0003 VADRUGID DR00474 DTD0003 DRUGNAME Clozapine DTD0003 DRUGSYNO 3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine; 8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine; 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; Asaleptin; C 6305; CLOZARIL; Clopine (TN); Clorazil; Clozapin; Clozapina; Clozapina [INN-Spanish]; Clozapine (JAN/USP/INN); Clozapine [USAN:INN:BAN]; Clozapine(tautomer); Clozapinum; Clozapinum [INN-Latin]; Clozaril (TN); Denzapine (TN); Fazaclo; Fazaclo (TN); Fazaclo ODT; Froidir (TN); HF-1854; HF1854; Iprox; KS-1166; Klozapol (TN); LEX-123; LX 100-129; Leponex; Leponex (TN); Lepotex; W-801; Zaponex (TN) DTD0003 VADRUGID DR00426 DTD0003 DRUGNAME Haloperidol DTD0003 DRUGSYNO Aldo; Aloperidin; Aloperidin (TN); Aloperidol; Aloperidolo; Aloperidolo [DCIT]; Aloperidolo [Italian]; Aloperidon; Apo-Haloperidol; Bioperidolo; Bioperidolo (TN); Brotopon; Brotopon (TN); Dozic; Dozic (TN); Dozix; Duraperidol (TN); Einalon S; Einalon S (TN); Eukystol; Eukystol (TN); Fortunan; Galoperidol; H 1512; Haldol; Haldol (TN); Haldol La; Haldol Solutab; Halidol; Halojust; Halol; Halopal; Haloperido; Haloperidol (JP15/USP); Haloperidol (JP15/USP/INN); Haloperidol [USAN:INN:BAN:JAN]; Haloperidolum; Haloperidolum [INN-Latin]; Halopidol; Halopoidol; Halosten; Halosten (TN); Keselan; Keselan (TN); Lealgin compositum; Linton; Linton (TN);Novo-Peridol; McN-JR-1625; Mixidol; Pekuces; Peluces; Peluces (TN); Peridol; Pernox; Pms Haloperidol; R 1625; R-1625; Serenace; Serenace (TN); Serenase; Serenase (TN); Serenelfi; Sernas; Sernel; Sigaperidol; Sigaperidol (TN); Ulcolind; Uliolind; Vesalium DTD0003 VADRUGID DR00159 DTD0003 DRUGNAME Paliperidone DTD0003 DRUGSYNO Invega Sustenna; JNS-010; Paliperidone (depot injection, NanoCrystal); Paliperidone (depot injection, NanoCrystal), Johnson & Johnson; Paliperidone (injectable, NanoCrystal), Elan; Paliperidone palmitate; Xeplion DTD0003 VADRUGID DR01265 DTD0003 DRUGNAME Perazine DTD0003 DRUGSYNO PERAZINE; Pernazine; Taxilan; Psytomin; N-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine; P 725; 10-(3-(4-Methyl-1-piperazinyl)propyl)-10H-phenothiazine; N-Methyl-piperazinyl-N'-propyl-phenothiazin; UNII-8915147A2B; EINECS 201-578-9; Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; 10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; NSC638694; N-Methyl-piperazinyl-N'-propyl-phenothiazin [German]; N-Methyl-piperazinylpropyl-phenothiazine; NCGC00159492-02; 10H-Phenothiazine DTD0003 VADRUGID DR00484 DTD0003 DRUGNAME Pimozide DTD0003 DRUGSYNO 1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine; 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone; 1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; 1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine; 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one; 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one; ASTA Medica Brand of Pimozide; Antalon; Janssen Brand of Pimozide;Orap forte; McN-JR 6238; McN-JR-6238; Neoperidole; Opiran; Orap; Orap (TN); P 1793; Pharmascience Brand of Pimozide; Pimozida; Pimozida [INN-Spanish]; Pimozide (JAN/USP/INN); Pimozide [USAN:INN:BAN:JAN]; Pimozidum; Pimozidum [INN-Latin]; Primozida; Primozida [INN-Spanish]; R 6238; R-6238 DTD0003 VADRUGID DR00855 DTD0003 DRUGNAME Quetiapine DTD0003 DRUGSYNO 111974-69-7; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol; 2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; BGL0JSY5SI; C21H25N3O2S; CHEBI:8707; CHEMBL716; Co-Quetiapine; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-; Ketipinor (TN); NCGC00095911-03; Norsic; Norsic (TN); PD-172760; Quetiapina; Quetiapine (INN); Quetiapine [INN:BAN]; Quetiapine hemifumarate; Quetiapinum; Seroquel (Fumarate); Seroquel (TN); UNII-BGL0JSY5SI; URKOMYMAXPYINW-UHFFFAOYSA-N; quetiapine DTD0003 VADRUGID DR00384 DTD0003 DRUGNAME Risperidone DTD0003 DRUGSYNO 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one; 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; Belivon; Consta, Risperdal; KS-1106; R 62 766; R 64 766, Risperdal, Risperidone; R 64,766; R 64766; R-118; R-64,766; R-64-766; R-64766; R64,766; R64766; Risperdal; Risperdal (TN); Risperdal Consta; Risperdal M-Tab; Risperdone; Risperidal; Risperidal M-Tab; Risperidona; Risperidona [Spanish]; Risperidone (JAN/USAN/INN); Risperidone (RIS); Risperidone [USAN:BAN:INN]; Risperidone, placebo; Risperidonum; Risperidonum [Latin]; Risperin; Rispolept; Rispolin; Sequinan DTD0003 VADRUGID DR01717 DTD0003 DRUGNAME Saphris DTD0003 DRUGSYNO Asenapine maleate; Saphris; Asenapine (maleate); Org 5222; Sycrest; Org-5222; Asenapine maleate [USAN]; C17H16ClNO.C4H4O4; Asenapine/; Saphris (TN); EINECS 288-064-8; Org 5222 maleate; trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole maleate; (S,S)-Asenapine Maleate; SCHEMBL175228; Asenapine maleate (JAN/USAN); CHEBI:71248; GMDCDXMAFMEDAG-CHHFXETESA-N; ABP000604; s1283; MFCD00900588; Asenapine maleate, >=98% (HPLC); AKOS015951084; SCH-900274; MK-8274; CS-0859; HY-11100; AC-24116 DTD0003 VADRUGID DR01493 DTD0003 DRUGNAME Spiperone DTD0003 DRUGSYNO Spiperone; spiperone; Spiroperidol; Spiropitan; 749-02-0; Espiperona; Spiperonum; [3H]-spiperone; R 5147; Spiperonum [INN-Latin]; Espiperona [INN-Spanish]; E 525; UNII-4X6E73CJ0Q; NSC 170983; MLS000028615; Spiperone [USAN:INN:BAN:JAN]; 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(45)decan-4-one; 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[45]decan-4-one; 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane; EINECS 212-024-0; BRN 0632204; SMR000058674; [3H]-spiperone; SPIPERONE DTD0003 VADRUGID DR00785 DTD0003 DRUGNAME Thioridazine DTD0003 DRUGSYNO (+-)-Thioridazine; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine; 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; Aldazine; Dl-Thioridazine; Mallorol; Malloryl; Meleril; Mellaril; Mellaril (*Hydrochloride*); Mellaril (TN); Mellaril-S; Mellaril-S (TN); Mellarit; Mellerets; Mellerette; Melleretten; Melleril; Melleril (liquid); Melleryl; Metlaril; Novoridazine; Novoridazine (TN); Orsanil; Ridazine; Sonapax; Stalleril; TP-21; Thioridazin; Thioridazine (USP/INN); Thioridazine Hcl; Thioridazine Hcl Intensol; Thioridazine [USAN:INN:BAN]; Thioridazine prolongatum; Thioridazine, prolongatum; Thioridazinum; Thioridazinum [INN-Latin]; Thioril (TN); Thioxidazine; Thoridazine hydrochloride; Tioridazin; Tioridazina; Tioridazina [INN-Spanish] DTD0003 VADRUGID DR00810 DTD0003 DRUGNAME Ziprasidone DTD0003 DRUGSYNO Geodon; 146939-27-7; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 6-chloro-5-[2-[4-(7-thia-8-azabicyclo[430]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one; 6UKA5VEJ6X; C21H21ClN4OS; CHEBI:10119; CHEMBL708; CP 88059; CP 88059-01; CP-88,059; CP-88,059-01; CP-88,059-1; CP-88059-1; DSSTox_CID_3753; DSSTox_GSID_23753; DSSTox_RID_77186; Geodon; Geodon (TN); TC-5280; UNII-6UKA5VEJ6X; Zeldox; Zeldox (TN); Zipradon; Zipradon (TN); Ziprasidona; Ziprasidone (INN); Ziprasidone [INN:BAN]; Ziprasidone hydrochloride; Ziprasidone mesylate trihydrate; Ziprasidonum; Ziprazidone; ziprasidona; ziprasidonum; ziprazidone DTD0003 VADRUGID DR00664 DTD0003 DRUGNAME Trifluoperazine DTD0003 DRUGSYNO 10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine; 10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine; 10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE; 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride; 2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Apo-Trifluoperazine; Apo-trifluoperazine (TN); Calmazine; Eskazine; Eskazine (TN); Eskazinyl (TN); Fluoperazine; Flurazine; Jatroneural (TN); Modalina; Modalina (TN); NCI17474; Novo-Trifluzine; PMS Trifluoperazine; RP 7623; SKF 5019; Stelazine; Stelazine (*Dihydrochloride*); Stelazine (TN); Stelazine Concentrate; Stellazine; TFP; Terfluzine (TN); Trifluoperaz (TN); Trifluoperazin; Trifluoperazina; Trifluoperazina [INN-Spanish]; Trifluoperazina [Italian]; Trifluoperazine (INN); Trifluoperazine HCl; Trifluoperazine [INN:BAN]; Trifluoperazine dihydrochloride; Trifluoperazinum; Trifluoperazinum [INN-Latin]; Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Trifluoromethylperazine; Trifluoroperazine; Trifluoroperazine dihydrochloride; Trifluperazine; Triflurin; Trifluroperizine; Triftazin; Triftazine; Triperazine; Tripfluoperazine Hydrochloride; Triphtazin; Triphtazine; Triphthasine DTD0003 VADRUGID DR01259 DTD0003 DRUGNAME Amisulpride DTD0003 DRUGSYNO 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide; Aminosultopride; Amisulpiride; Amisulprida; Amisulprida [INN-Spanish]; Amisulpride (INN); Amisulpride [INN]; Amisulpridum; Amisulpridum [INN-Latin]; DAN 2163; DAN-2163; Deniban; Deniban (TN); SL-91.1077; Socian; Solian; Solian (TN); Solian, Amisulpride DTD0003 VADRUGID DR01294 DTD0003 DRUGNAME Trans-flupentixol DTD0003 DRUGSYNO (E)-4-(3-(2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol; (E)-Flupenthixol; 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)-, (E)-; 2-[4-[(3E)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; 2709-56-0; 53772-85-3; 895OJP78MJ; EINECS 258-759-0; FLUPENTHIXOL, Alpha; FLUPENTIXOLE; Flupenthixol, Beta; Flupentiol; UNII-895OJP78MJ; beta-Flupenthixol; trans-(E)-Flupentixol; trans-Flupentixol; trans-flupenthixol DTD0003 VADRUGID DR00836 DTD0003 DRUGNAME Bupropion DTD0003 DRUGSYNO Amfebutamon; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; (+-)-Bupropion; (-)-2-(tert-Butylamino)-3'-chloropropiophenone; (-)-2-(tert-Butylamino)-3'-chlorpropiophenon; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one; 1-Propanone; 2-(Tert-Butylamino)-3'-chloropropiophenone; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; 34841-39-9; 34911-55-2; AMFEBUTAMONE HCl; Alpha-(tert-Butylamino)-m-chloropropiophenone; Alpha-(tert-butylamino)-m-chloropropiophenone; Amfebutamon; Amfebutamona; Amfebutamona [INN-Spanish]; Amfebutamone; Amfebutamonum; Amfebutamonum [INN-Latin]; BRN 2101062; Bupropion (INN); Bupropion (Old RN); Bupropion (USAN); Bupropion Hcl; Bupropion SR; Bupropion [INN:BAN]; Bupropion hydrocloride; CHEBI:3219; CHEMBL894; Elont; Elontril; SNPPWIUOZRMYNY-UHFFFAOYSA-N; Wellbatrin; Zyban; alpha-(tert-butylamino)-m-chloropropiophenone; amfebutamonum; bupropion DTD0003 VADRUGID DR01626 DTD0003 DRUGNAME Genz 644282 DTD0003 DRUGSYNO GENZ-644282; Genz 644282; genz644282; UNII-717I541I2R; 717I541I2R; 2,3-dimethoxy-12-(2-(methylamino)ethyl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one; SCHEMBL241696; CHEMBL191958; EX-A481; AOB87160; BCP20983; ZINC6718458; SAR402674; AKOS030526835; CS-1525; SAR 402674; SAR-402674; HY-16228; Benzo(C)(1,3)benzodioxolo(5,6-H)(1,6)naphthyridin-13(12H)-one, 2,3-dimethoxy-12-(2-(methylamino)ethyl)-; BC600645; DA-42192; GENZ-644282/GENZ644282; FT-0700324; A3434; W-6112; A13206 DTD0003 VADRUGID DR00241 DTD0003 DRUGNAME Dabigatran DTD0003 DRUGSYNO Pradaxa (TN) DTD0003 VADRUGID DR00151 DTD0003 DRUGNAME Pomalidomide DTD0003 DRUGSYNO Actimid (TN); Pomalidomide (Immunomodulator) DTD0003 VADRUGID DR00211 DTD0003 DRUGNAME Apixaban DTD0003 DRUGSYNO 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd; Apixaban (JAN/USAN/INN); BMS 562247-01; BMS-562247; BMS-562247-01; BMS-562247-01, Apixaban; Eliquis (TN); GG2; Ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide DTD0003 VADRUGID DR00077 DTD0003 DRUGNAME Brilinta DTD0003 DRUGSYNO AR-C126532; AZD-6140; Brilique; Ticagrelor; Ticagrelor (USAN/INN) DTD0003 VADRUGID DR00245 DTD0003 DRUGNAME Clopidogrel DTD0003 DRUGSYNO Clopidogrel (captisol-enabled); Clopidogrel (captisol-enabled), The Medicines Co; Clopidogrel (captisol-enabled, cardiovascular disease), Cydex; Clopidogrel (captisol-enabled, cardiovascular disease), Prism Pharmaceuticals; PM-103 DTD0003 VADRUGID DR01279 DTD0003 DRUGNAME Phenprocoumon DTD0003 DRUGSYNO 2-hydroxy-3-(1-phenylpropyl)chromen-4-one; 3-(1'-Phenyl-propyl)-4-oxycoumarin; 3-(1'-Phenyl-propyl)-4-oxycoumarin [German]; 3-(1-Phenylpropyl)-4-hydroxycoumarin; 3-(alpha-Ethylbenzyl)-4-hydroxycoumarin; 3-(alpha-Phenylpropyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; 4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one; Falithiom; Falithrom; Falithrom (TN); Fencumar; Fenprocoumona; Fenprocoumona [INN-Spanish]; Fenprocumon; Fenprocumone; Fenprocumone [DCIT]; Hexal Brand of Phenprocoumon; Liquamar; Liquamar (TN); Marcoumar; Marcoumar (TN); Marcumar; Marcumar (TN); Marcuphen; Phenprocoumalol; Phenprocoumarol; Phenprocoumarole; Phenprocoumon (USAN/INN); Phenprocoumon [USAN:INN:BAN]; Phenprocoumone; Phenprocoumone [INN-French]; Phenprocoumonum; Phenprocoumonum [INN-Latin]; Phenprocumone; Phenprocumonum; Phenprogramma; Phenylpropylhydroxycumarinum; Ro 1-4849; Roche Brand of Phenprocoumon; U29342; Worwag Brand of Phenprocoumon DTD0003 VADRUGID DR00196 DTD0003 DRUGNAME Rifampicin DTD0003 DRUGSYNO 1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN) DTD0003 VADRUGID DR00271 DTD0003 DRUGNAME Empagliflozin DTD0003 DRUGSYNO (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; 864070-44-0; AK160980; BI 10773; BI-10773; BI10773; CHEBI:82720; Empagliflozin (BI 10773); HDC1R2M35U; JARDIANCE; UNII-HDC1R2M35U DTD0003 VADRUGID DR01403 DTD0003 DRUGNAME Substance P DTD0003 DRUGSYNO Substance P; 33507-63-0; Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2; CCRIS 7229; UNII-675VGV5J1D; EINECS 251-545-8; CHEMBL235363; 675VGV5J1D; 12769-48-1; P substance; Neurokinin P; Substanz-P; C63H98N18O13S; Substance P analogue; AC1Q5IQE; AC1L1VX3; tachykinin substance P (SP); SCHEMBL1116347; GTPL2098; ArgProLysProGlnGlnPhePheGlyLeuMet; MolPort-023-276-010; ADNPLDHMAVUMIW-CUZNLEPHSA-N; 2053AH; BDBM50001450; AKOS024456424; NCGC00167123-01; 11035-08-8; LS-147256; Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-amine DTD0003 VADRUGID DR00550 DTD0003 DRUGNAME Bromocriptine DTD0003 DRUGSYNO (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman; (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide; 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptin; 2-Bromo-alpha-ergokryptine; 2-Bromoergocryptine Methanesulfonate; 2-Bromoergokryptine; Alti-Bromocriptine; Apo-Bromocriptine; Bagren; Bromergocryptine; Bromocriptin; Bromocriptina; Bromocriptina [INN-Spanish]; Bromocriptine (USAN/INN); Bromocriptine [BAN]; Bromocriptine [USAN:BAN:INN]; Bromocriptine methanesulfonate; Bromocriptinum; Bromocriptinum [INN-Latin]; Bromocryptin; Bromocryptine; Bromoergocriptine; Bromoergocryptine; CB-154; Ergocryptine, 2-bromo-(8CI); Ergoset; Parlodel; Parlodel (TN); Parlodel Snaptabs DTD0003 VADRUGID DR00279 DTD0003 DRUGNAME Canagliflozin DTD0003 DRUGSYNO (1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene; 6S49DGR869; 842133-18-0; 928672-86-0; CHEBI:73274; Canagliflozin anhydrous; Canagliflozin hydrate; Invokana; JNJ 24831754ZAE; JNJ-28431754; TA 7284; TA-7284; UNII-6S49DGR869; canagliflozin hemihydrate DTD0003 VADRUGID DR00745 DTD0003 DRUGNAME Linagliptin DTD0003 DRUGSYNO (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; BI 1356; BI-1356; BI-1356-BS; Ondero; Ondero (TN) DTD0003 VADRUGID DR00226 DTD0003 DRUGNAME Saxagliptin DTD0003 DRUGSYNO (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN) DTD0003 VADRUGID DR00254 DTD0003 DRUGNAME Sitagliptin DTD0003 DRUGSYNO (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia DTD0003 VADRUGID DR01409 DTD0003 DRUGNAME Vildagliptin DTD0003 DRUGSYNO Equa; Galvu; Galvus; Jalra; Xiliarx; Galvus (TN); Vidagliptin (see Vildagliptin); Vildagliptin (JAN/USAN/INN); (2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile; (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile; 1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-(9CI) DTD0003 VADRUGID DR00216 DTD0003 DRUGNAME Betrixaban DTD0003 DRUGSYNO 74RWP7W0J9; Betrixaban (USAN); Betrixaban [USAN:INN]; Bevyxxa; D0J0BU; EX-A358; GTPL9602; MolPort-009-682-948; PRT 054021; PRT054021; QCR-99; SCHEMBL158591; UNII-74RWP7W0J9; ZINC3; betrixaban maleate; betrixaban/ DTD0003 VADRUGID DR01431 DTD0003 DRUGNAME Famciclovir DTD0003 DRUGSYNO FCV; Famciclovirum; Famvir; Oravir; BRL 42810; IN1338; Anti-Farnesyl Rabbit pAb; BRL-42810; Famciclovirum [INN-Latin]; Famvir (TN); Famciclovir [USAN:BAN:INN]; Famciclovir (JAN/USAN/INN); [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate; Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine; 1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester); 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester); 2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate; 2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate; 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate; 2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate; 9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine DTD0003 VADRUGID DR01414 DTD0003 DRUGNAME Beta-Carotene DTD0003 DRUGSYNO beta-carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Betacarotene; Provitamin A; Solatene; Carotaben; Provatene; all-trans-beta-Carotene; Serlabo; Natural Yellow 26; Karotin; KPMK; C.I. Food Orange 5; Solatene (caps); Karotin [Czech]; Food orange 5; Zlut prirodni 26; Betacarotenum [Latin]; Betacaroteno [Spanish]; Lucaratin; BetaVit; beta-Karotin; beta-Carotin; beta;-Carotene; beta-Carotene, all-trans-; .beta. Carotene; .beta.-Carotene; Betacarotenum [INN-Latin]; C.I. 75130; Betacaroteno [INN-Spanish]; Zlut prirodni 26 [Czech] DTD0003 VADRUGID DR00134 DTD0003 DRUGNAME Folic acid DTD0003 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0003 VADRUGID DR00470 DTD0003 DRUGNAME Amitriptyline DTD0003 DRUGSYNO 10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene; 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine; 10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene; 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine; 5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene; 5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene; 5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene; 5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene; Adepress; Adepril; Amitril; Amitriprolidine; Amitriptilina; Amitriptilina [INN-Spanish]; Amitriptilina [Italian]; Amitriptylin; Amitriptylin [German]; Amitriptyline (INN); Amitriptyline [INN:BAN]; Amitriptylinum; Amitriptylinum [INN-Latin]; Amitryptiline; Amitryptyline; Amytriptiline; Amytriptylin; Damilan; Damilen; Damitriptyline; Elanil; Elavil; Elavil (TN); Flavyl; Lantron; Laroxil; Laroxyl; Laroxyl (TN); MK 230; N 750; Proheptadiene; Redomex; Ro 4-1575; Sarotex; Seroten; Sylvemid; TP0; Triptanol; Triptilin; Triptisol; Tryptanol; [3-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-dimethyl-amine DTD0003 VADRUGID DR00552 DTD0003 DRUGNAME Imipramine DTD0003 DRUGSYNO 1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine; 10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine; 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2,2'-(3-Dimethylaminopropylimino)bibenzyl; 2,2'-(3-Dimethylaminopropylimino)dibenzyl; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine; 5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine; 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-(9CI); Antideprin; Antideprin (TN); Berkomine; Censtim; Censtin; Declomipramine; Deprimin (TN); Deprinol (TN); Depsonil (TN); Dimipressin; Dpid; Dyna-zina; Dynaprin; Dynaprin (TN); Eupramin; Eupramin (TN); G-22355; Imavate; Imidobenzyle; Imipramil (TN); Imipramin; Imipramina; Imipramina [INN-Spanish]; Imipramina [Italian]; Imipramine (INN); Imipramine [INN:BAN]; Imipraminum; Imipraminum [INN-Latin]; Imiprin; Imizin; Imizinum; Impramine; Intalpram; Iramil; Irmin; Irmin (TN); Janimine; Janimine (TN); Janimine (hydrochloride); Melipramin; Melipramin (TN); Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(gamma.-Dimethylaminopropyl)iminodibenzyl; Nelipramin; Norchlorimipramine; Norfranil; Pramine; Prazepine; Promiben;Psychoforin; SK-Pramine; Surplix; Surplix (TN); Timolet; Tofranil; Tofranil (free base); Tofranil (hydrochloride); Tofranil(TN); Tofranil, base; Tofraniln A DTD0003 VADRUGID DR00387 DTD0003 DRUGNAME Omeprazole DTD0003 DRUGSYNO (-)-Omeprazole; 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole; 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; AGI-010; AULCER; Antra; Antra MUPS; Audazol; Axagon; Belmazol; Ceprandal; DM-3458; Danlox; Demeprazol; Desec; Dizprazol; Dudencer; Elgam; Emeproton; Emilok; Epirazole; Erbolin; Esomeprazol; Esomeprazole; Esomperazole; Esopral; Exter; Gasec; Gastrimut; Gastroloc; Gibancer; H 168-68; H 168/68; H-168/68; Indurgan; Inhibitron; Inhipump; Lensor; Logastric; Lomac; Losec; Losec (TN); Losec, Omesec, Prilosec, Zegerid, Omeprazole; Lucen; Mepral; Miol; Miracid; Mopral; Morecon; Nexium; Nexium IV; Nilsec; Nopramin; Nuclosina; O0359; OMEP; OMZ; Ocid; Olexin; Olit; Omapren; Omebeta; Omebeta 20; Omed; Omegast; Omepradex; Omepral; Omeprazol; Omeprazol [INN-Spanish]; Omeprazole (JAN/USP/INN); Omeprazole [USAN:INN:BAN:JAN]; Omeprazole delayed-release; Omeprazole magnesium; Omeprazolum; Omeprazolum [INN-Latin]; Omeprazon; Omeprazone; Omeprol; Omesek; Omez; Omezol; Omezolan; Omid; Omisec; Omizac; Ompanyt; Ortanol; Osiren; Ozoken; Paprazol; Parizac; Pepticum; Pepticus; Peptilcer; Prazentol; Prazidec; Prazolit; Prilosec; Prilosec (TN); Prilosec OTC; Procelac; Proclor; Prysma; Ramezol; Regulacid; Result; SAN-15; Sanamidol; Secrepina; Tedec Ulceral; Ulceral; Ulcesep; Ulcometion; Ulcozol; Ulcsep; Ulsen; Ultop; Ulzol; Victrix; Zefxon; Zegerid; Zepral; Zimor; Zoltum DTD0003 VADRUGID DR00458 DTD0003 DRUGNAME Pantoprazole DTD0003 DRUGSYNO 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; Astropan; Astropan (TN); BY 1023; BY-1023; Controloc (TN); Inipomp (TN); Pantecta (TN); Pantoloc (TN); Pantopan (TN); Pantoprazol; Pantoprazol [INN-Spanish]; Pantoprazole (USAN/INN); Pantoprazole Na; Pantoprazole Sodium; Pantoprazole [USAN:BAN:INN]; Pantoprazolum; Pantoprazolum [INN-Latin]; Pantoprozole; Pantor; Pantor (TN); Pantotab (TN); Pantozol; Pantozol (TN); Protium; Protium (TN); Protonix; Protonix (TN); Protonix IV; SK&F 96022; SK&F-96022; SK-96022; SKF-96022; Somac; Somac (TN); Ulcepraz (TN) DTD0003 VADRUGID DR00391 DTD0003 DRUGNAME Cerivastatin DTD0003 DRUGSYNO . DTD0003 VADRUGID DR00420 DTD0003 DRUGNAME Nelfinavir DTD0003 DRUGSYNO ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen DTD0003 VADRUGID DR00430 DTD0003 DRUGNAME Fentanyl DTD0003 DRUGSYNO Abstral; Actiq; Duragesic-100; Duragesic-12; Duragesic-25; Duragesic-50; Duragesic-75; Fentanyl; Fentanyl Citrate; Fentanyl Citrate Preservative Free; Fentanyl-100; Fentanyl-12; Fentanyl-25; Fentanyl-37; Fentanyl-50; Fentanyl-62; Fentanyl-75; Fentanyl-87; Fentora; Lazanda; Onsolis; Sublimaze Preservative Free; Subsys DTD0003 VADRUGID DR00431 DTD0003 DRUGNAME Phenytoin DTD0003 DRUGSYNO 2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil DTD0003 VADRUGID DR00909 DTD0003 DRUGNAME Ondansetron DTD0003 DRUGSYNO (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one; 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one; 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one; Apo-ondansetron; DESMETHYLONDANSETRON; GR 38032; GR 38032X; GR-38032F; GR38032F; Novo-ondansetron; Ondansetron (JAN/USP/INN); Ondansetron (Zofran); Ondansetron [USAN:INN:BAN]; Ondansetron, (+,-)-Isomer; PHL-ondansetron; PMS-ondansetron; Ratio-ondansetron; SN-307; Sandoz ondansetron; ZOFRAN IN PLASTIC CONTAINER; Zofran; Zofran (TN); Zofran ODT; Zofran ODT (TN); Zophren; Zudan DTD0003 VADRUGID DR00448 DTD0003 DRUGNAME Cyclosporine DTD0003 DRUGSYNO cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A) DTD0003 VADRUGID DR00466 DTD0003 DRUGNAME Ivacaftor DTD0003 DRUGSYNO Kalydeco (TN) DTD0003 VADRUGID DR00467 DTD0003 DRUGNAME Morphine DTD0003 DRUGSYNO Astramorph Pf; Avinza; Depodur; Duramorph Pf; Infumorph; Kadian; Morphine Sulfate; Ms Contin; Oramorph Sr DTD0003 VADRUGID DR00684 DTD0003 DRUGNAME Midazolam DTD0003 DRUGSYNO 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate; 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride; 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine; 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine; Dazolam; Dormicum; Dormicum (TN); Hypnovel (TN); Midacum (TN); Midanium; Midazolam (JAN/INN); Midazolam Base; Midazolam [INN:BAN:JAN]; Midazolamum; Midazolamum [INN-Latin]; Midosed; Ro 21-3981; Versed; Versed (TN) DTD0003 VADRUGID DR00471 DTD0003 DRUGNAME Phenobarbital DTD0003 DRUGSYNO 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione; 5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione; 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-Ethyl-5-phenylbarbituric acid; 5-Phenyl-5-ethylbarbituric acid;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; Acido 5-fenil-5-etilbarbiturico; Acido 5-fenil-5-etilbarbiturico [Italian]; Adonal; Aephe nal; Aephenal; Agrypnal; Amylofene; Antrocol; Aphenylbarbit; Aphenyletten; Arco-Lase Plus; Austrominal; Barbapil; Barbellen; Barbellon; Barbenyl; Barbilehae; Barbilehae (barbilettae); Barbinal; Barbipenyl; Barbiphen; Barbiphenyl; Barbipil; Barbita; Barbivis; Barbonal; Barbophen; Bardorm; Bartol; Bialminal; Blu-phen; Cabronal; Calmetten; Calminal; Cardenal; Chardonna-2; Chinoin; Codibarbita; Component of Antrocol; Component of Bronkotabs; Component of Hecadrol; Component of Primatene P; Component of Slowten; Component of Tedral; Component of Valpin 50-PB; Coronaletta; Cratecil; Damoral; Dezibarbitur; Donphen; Dormina; Dormiral; Dormital; Doscalun; Duneryl; Elixir of phenobarbital; Ensobarb; Ensodorm; Epanal; Epidorm; Epilol; Episedal; Epsylone; Eskabarb; Etilfen; Euneryl; Ezibarbitur; Fen osed; Fenbital; Fenemal; Fenobarbital; Fenobarbital [INN-Spanish]; Fenobarbitale; Fenobarbitale [DCIT]; Fenosed; Fenylettae; Gardenal; Gardepanyl; Glysoletten; Gustase-Plus; Haplopan; Haplos; Helional; Hennoletten; Henotal; Hypnaletten; Hypnette; Hypno-Tablinetten; Hypnogen; Hypnolone; Hypnoltol; Hysteps; Le phebar; Lefebar; Leonal; Lephebar; Lepinal; Lepinaletten; Levsin PB Drops and Tablets; Linasen; Liquital; Lixophen; Lubergal; Lubrokal; Lumen; Lumesettes; Lumesyn; Luminal; Luminal (TN); Lumofridetten; Luphenil; Luramin; Molinal; Neurobarb; Nirvonal; Noptil; Nova-Pheno; Nunol; PHOB; PUBERTAL PHENOBARBITAL STUDY; Pamine PB; Parkotal; Pharmetten; Phazyme-PB; Phen-Bar; Phenaemal; Phenemal; Phenemalum; Phenobal; Phenobarb; Phenobarbital (JP15/USP/INN); Phenobarbital (PB); Phenobarbital [USAN:INN:JAN]; Phenobarbital, Monosodium Salt; Phenobarbitalum; Phenobarbitalum [INN-Latin]; Phenobarbitalum [INN]; Phenobarbitol; Phenobarbitone; Phenobarbitonum; Phenobarbituric acid; Phenobarbyl; Phenoluric; Phenolurio; Phenomet; Phenonyl; Phenoturic; Phenyl-ethyl-barbituric acid; Phenylaethylbarbitursaeure; Phenylethyl barbituric acid; Phenylethylbarbiturate; Phenylethylbarbituric acid; Phenylethylbarbitursaeure; Phenylethylmalonylurea; Phenyletten; Phenylral; Phenyral; Polcominal; Promptonal; SK-Phenobarbital; Seda-Tablinen; Seda-tabl inen; Sedabar; Sedicat; Sedizorin; Sedlyn; Sedofen; Sedonal; Sedonal (sedative); Sedonettes; Sedophen; Sevenal; Solfoton; Solfoton talpheno; Solu-Barb; Sombutol; Somnolens; Somnoletten; Somnosan; Somonal; Spasepilin; Starifen; Starilettae; Stental; Stental Extentabs; Stental exte ntabs; Talpheno; Teolaxin; Teoloxin; Thenobarbital; Theoloxin; Theominal; Triabarb; Tridezibarbitur; Triphenatol; Valprin 50-PB; Versomnal; Zadoletten; Zadonal DTD0003 VADRUGID DR01503 DTD0003 DRUGNAME Cepharanthine DTD0003 DRUGSYNO CEPHARANTHINE; Cepharanthin; (+)-Cepharanthine; O-Methylcepharanoline; Cepharantin; Cepharanthine [JAN]; UNII-7592YJ0J6T; CCRIS 6539; NSC 623442; BRN 0075231; 6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan; CHEBI:3546; 7592YJ0J6T; NSC623442; Cepharanthine (JAN); NSC-623442; ecaene (non-preferred name); DSSTox_RID_81253; DSSTox_CID_25957; DSSTox_GSID_45957; Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-; CAS-481-49-2; SR-01000779734; Cepharanthin,(S) DTD0003 VADRUGID DR00249 DTD0003 DRUGNAME Cannabidiol DTD0003 DRUGSYNO (-)-CBD; (-)-Cannabidiol; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; (-)-trans-Cannabidiol; 19GBJ60SN5; CBD; Epidiolex; GWP42003-P; QHMBSVQNZZTUGM-ZWKOTPCHSA-N; UNII-19GBJ60SN5; delta1(2)-trans-Cannabidiol DTD0003 VADRUGID DR00187 DTD0003 DRUGNAME Prucalopride DTD0003 DRUGSYNO 0A09IUW5TP; 179474-81-8; 4-Amino-5-chloro-2,3-dihydro-N-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide; 4-Amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide; 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; C18H26ClN3O3; CHEMBL117287; Motegrity; Prucalopride [USAN:INN:BAN]; R 093877; R-093877; R0-93877; R093877; UNII-0A09IUW5TP DTD0003 VADRUGID DR00638 DTD0003 DRUGNAME Grepafloxacin DTD0003 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN) DTD0003 VADRUGID DR00709 DTD0003 DRUGNAME Bepridil DTD0003 DRUGSYNO Bepadin; Bepadin (TN); Bepridil (INN); Beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine; CERM 1978; N-Benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]aniline hydrochloride; N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline; N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline; N-{3-[(2-methylpropyl)oxy]-2-pyrrolidin-1-ylpropyl}-N-(phenylmethyl)aniline; Vascor; Vascor (TN) DTD0003 VADRUGID DR00500 DTD0003 DRUGNAME Ergotamine DTD0003 DRUGSYNO (5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1); 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione; Avetol; Cornutamin; Cornutamine; ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3)); ETIN; Ergam; Ergate; Ergomar; Ergomar (TN); Ergonsvine; Ergostat; Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1); Ergotamin; Ergotamina [INN-Spanish]; Ergotamine (INN); Ergotamine [INN:BAN]; Ergotamine bitartrate; Ergotamine hemitartrate; Ergotamine tartrate; Ergotamine tartrate (VAN); Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate; Ergotamine, tartrate (2:1); Ergotamine, tartrate (2:1) (salt) (8CI); Ergotaminum [INN-Latin]; Ergotartrate; Ergoton-A; Exmigra; Femergin;Gynergen; Gotamine tartrate; Lingraine; Lingran; Medihaler ergotamine; Migretamine; Neo-ergotin; Rigetamin; Secagyn; Secupan; Temigran; Wigrettes DTD0003 VADRUGID DR00554 DTD0003 DRUGNAME Emetine DTD0003 DRUGSYNO EMETINE; Emetin; Cephaeline methyl ether; Methyl cephaeline; 6',7',10,11-Tetramethoxyemetan; Emetine hydrochloride; Emetine [BAN]; Cephaline-O-methyl ether; UNII-X8D5EPO80M; Emetan, 6',7',10,11-tetramethoxy-; HSDB 2150; TCMDC-125531; EINECS 207-592-1; BRN 0100829; X8D5EPO80M; CHEMBL50588; GNF-PF-196; Emetine dihydrochloride hydrate; Ipecine; Methylcephaeline; DSSTox_CID_2980; DSSTox_RID_76816; DSSTox_GSID_22980 DTD0003 VADRUGID DR01584 DTD0003 DRUGNAME Selamectin DTD0003 DRUGSYNO selamectin; UNII-A2669OWX9N; A2669OWX9N; UK-124,114; 25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22 23-dihydro-5-(hydroxyimino)-avermectin B1 monosaccharide; Stronghold; Revolution; 220119-17-5; 25-Cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-avermectin A1a DTD0003 VADRUGID DR00494 DTD0003 DRUGNAME Estrone DTD0003 DRUGSYNO (13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one; (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one;1,3,5(10)-Estratrien-3-ol-17-one; 1,3,5(10)-Oestratrien-3-ol-17-one; 3-Hydroxy-1,3,5(10)-estratrien-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; 3-Hydroxy-17-keto-oestra-1,3,5-triene; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-triene-17-one; 3-hydroxy-estra-1,3,5(10)-trien-17-one; Aquacrine; Crinovaryl; Cristallovar; Crystogen; Delta-1,3,5-Estratrien-3beta-ol-17-one; Delta-1,3,5-Oestratrien-3beta-ol-17-one; Delta-1,3,5-estratrien-3-beta-ol-17-one; Delta-1,3,5-oestratrien-3-beta-ol-17-one; Destrone; Disynformon; E 9750; E(sub 1); E0026; Endofolliculina; Esterone; Estrin; Estrogenic Substance; Estrol; Estron; Estrona; Estrona [INN-Spanish]; Estrona [Spanish]; Estrone (E1); Estrone (JAN/USP/INN); Estrone (TN); Estrone [USAN:INN]; Estrone, (+-)-Isomer; Estrone, (8 alpha)-Isomer; Estrone, (9 beta)-Isomer; Estrone-A; Estronum; Estronum [INN-Latin]; Estrovarin; Estrugenone; Estrusol; Fem-O-Gen; Femestrone inj.; Femestrone injection; Femidyn; Fermidyn; Folikrin; Folipex; Folisan; Follestrine; Follestrol; Follicular hormone; Folliculin; Folliculine; Folliculine benzoate; Follicunodis; Glandubolin; Hauck Brand of Estrone; Hiestrone; Hormestrin; Hormofollin; Hormovarine; Hyrex Brand of Estrone; Kestrone; Ketodestrin; Ketohydroxy-Estratriene; Ketohydroxyestrin; Ketohydroxyoestrin; Ketophydroxyestrin; Kolpon; Menagen; Menformon; Menformon A; Mestronaq; NATURAL ESTROGENIC SUBSTANCE-ESTRONE; OESTRONE; Oestrin; Oestroform;Oestronum; Oestrone [Steroidal oestrogens]; Oestrone, Estrone; Oestroperos; Ovex (tablets); Ovifollin; Penncap M; Perlatan; Solliculin; Theelin; Thelestrin; Thelykinin; Thynestron; Tokokin; Unden; Unden (pharmaceutical); Unden (pharmaceutical) (VAN); Unigen; Vortech Brand of Estrone; Wehgen; Wynestron; WynestronPencap M;CMC_13458; [2,4,6,7-3H]-E1 DTD0003 VADRUGID DR00711 DTD0003 DRUGNAME Vemurafenib DTD0003 DRUGSYNO PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN) DTD0003 VADRUGID DR00658 DTD0003 DRUGNAME Fluphenazine DTD0003 DRUGSYNO 1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine; 1-(2-Hydroxyethyl)-4-[3-(trifluoromethyl-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI); 10-(3'-(4"-(beta-Hydroxyethyl)-1"-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 10-(3'-(4''-(beta-Hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol; 2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethanol; 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-pipe razinyl)propyl)phenothiazine; 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol; 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol dihydrochloride; 4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol; 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-Piperazineethanol; 4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-[3-(2-Trifluoromethyl-10-phenothiazyl)-propyl]-1-piperazineethanol; Anatensol (TN); Apo-Fluphenazine; Dapotum; Dapotum (TN); Dapotum D (TN); Dapotum Injektion (TN); Decanoate (TN); Deconoate (TN); Elinol; Enanthate (TN); Fludecate (TN); Flufenazin; Flufenazina; Flufenazina [DCIT]; Flunanthate (TN); Fluorfenazine; Fluorophenazine; Fluorphenazine; Fluphenazine (INN); Fluphenazine [INN:BAN]; Fluphenazine hydrochloride; Fluphenazinum; Fluphenazinum [INN-Latin]; Ftorphenazine; Hydrochloride, Fluphenazine; Lyogen (TN); Modecate (TN); Moditen (TN); Moditen (Tabl or elixir); Moditen Enanthate Injection (TN); Moditen Hcl; Omca (TN); Pacinol; Permitil (TN); Permitil Concentrate; Phthorphenazine; Prolixin (TN); Prolixin Concentrate; Prolixine; S94; SQ 4918; Sediten (TN); Selecten (TN); Sevinol; Sevinol (TN); Sinqualone (TN); Siqualine; Siqualon; Trancin (TN); Triflumethazine; Vespazine; Yespazine DTD0003 VADRUGID DR01401 DTD0003 DRUGNAME Tenoxicam DTD0003 DRUGSYNO Artriunic; Liman; Mobiflex; Reutenox; Tenoxicamum; Tilcotil; Apotex brand of tenoxicam; Novag brand of tenoxicam; Novopharm brand of tenoxicam; Roche brand of tenoxicam; Solvay brand of tenoxicam; Apo-Tenoxicam; Mobiflex (TN); Novo-Tenoxicam; Ro 12-0068; Ro-120068; Tenoxicamum [INN-Latin]; Tilcotil (TN); Ro 12-0068/000; Ro-12-0068; Tenoxicam (JAN/USAN/INN); Tenoxicam [USAN:BAN:INN:JAN]; (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; 3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE; 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide1,1-dioxide; 4-Hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide DTD0003 VADRUGID DR00642 DTD0003 DRUGNAME Amiodarone DTD0003 DRUGSYNO (2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone; (2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone; (2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone; (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone; (2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone; (2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine; 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran; 2-Butyl-3-[3,5-diiodo-4-(2-di; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; 2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone; 2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone; 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; ASTA Medica Brand of Amiodarone Hydrochloride; Alphapharm Brand of Amiodarone Hydrochloride; Amidorone; Aminodarone; Amio-Aqueous IV; Amiobeta; Amiodarex; Amiodarona; Amiodarona [INN-Spanish]; Amiodarone (USAN/INN); Amiodarone Base; Amiodarone [USAN:BAN:INN]; Amiodarons; Amiodaronum; Amiodaronum [INN-Latin]; Amiohexal; Amjodaronum; Ancar; Aratac (TN); Aratac;Arycor; Armstrong Brand of Amiodarone Hydrochloride; Arycor (TN); Atlansil (TN); Berenguer Infale Brand of Amiodarone Hydrochloride; Betapharm Brand of Amiodarone Hydrochloride; Braxan; Corbionax; Cordarex; Cordarone; Cordarone (TN); Cordarone Intravenous; Ethylaminoethoxy)benzoyl]benzofuran; G Gam Brand of Amiodarone Hydrochloride; Hexal Brand of Amiodarone Hydrochloride; Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl; Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI); Kordaron; L 3428; L-3428; L3428; Labaz; Leurquin Brand of Amiodarone Hydrochloride; Ortacrone; Pacerone; Pacerone (TN); Pharma Investi Brand of Amiodarone Hydrochloride; Pms-Amiodarone; Rytmarone; SKF 33134-A; SKF 33134A; Sanofi Winthrop Brand of Amiodarone Hydrochloride; Sedacoron; Sedacorone; Tachydaron; Wyeth Brand of Amiodarone Hydrochloride DTD0003 VADRUGID DR00634 DTD0003 DRUGNAME Propafenone DTD0003 DRUGSYNO 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one; 1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride; 1-[2-(2-Hydroxy-3-[propylamino]-propoxy)phenyl]-3-phenyl-1-propanone; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one; Propafenon Hexal; Propafenon hexal (TN); Propafenona; Propafenona [INN-Spanish]; Propafenone (INN); Propafenone [INN:BAN]; Propafenone-HCl; Propafenonum; Propafenonum [INN-Latin]; Rythmol; Rythmol SR (TN); Rytmonorm (TN) DTD0003 VADRUGID DR00590 DTD0003 DRUGNAME Trimethoprim DTD0003 DRUGSYNO AZT + TMP/SMX (mixture) combination; Abaprim; Alcorim-F; Alprim; Anitrim; Antrima; Antrimox; Apo-Sulfatrim; BW 56-72; BW 5672; BW-56-72; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacterial [Antibiotic]; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Co-Trimoxizole; Colizole; Colizole DS; Component of Bactrim; Component of Septra; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; KSC-4-158; KUC103659N; Kombinax; Lagatrim; Lagatrim Forte; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrim (TN); Monotrimin; NIH 204; NIH 204 (VAN); Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Proloprim (TN); Protrin; Purbal; Resprim; ResprimForte; Roubac; Roubal; Salvatrim; Septrin DS; Septrin Forte; Septrin S; Setprin; Sinotrim; Smz-Tmp; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfamethoxazole & Trimethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; T 7883; TCMDC-125538; TMP; TMP/SMX (MIXTURE)); Tiempe; Tmp-Ratiopharm; Toprim; Trimanyl; Trimeth/Sulfa; Trimethioprim; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]; Trimethoprime; Trimethoprime [INN-French]; Trimethoprimum; Trimethoprimum [INN-Latin]; Trimethopriom; Trimetoprim; Trimetoprim [DCIT]; Trimetoprim [Polish]; Trimetoprima; Trimetoprima [INN-Spanish]; Trimexazole; Trimexol; Trimez-IFSA; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Trimpex (TN); Trimpex 200; Triprim; Triprim (TN); Trisul; Trisulcom; Trisulfam; Trisural; U-Prin; Uretrim; Uro-D S; Urobactrim; Utetrin; Velaten; WR 5949; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim DTD0003 VADRUGID DR00849 DTD0003 DRUGNAME Lidocaine DTD0003 DRUGSYNO 2-(Diethylamino)-2',6'-acetoxylidide; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide; 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide; After Burn Double Strength Gel; After Burn Double Strength Spray; After Burn Gel; After Burn Spray; Alfa-Dietilamino-2,6-dimetilacetanilide; Alfa-Dietilamino-2,6-dimetilacetanilide [Italian]; Alpha-(Diethylamino)-2,6-acetoxylidide; Alpha-Diethylamino-2,6-dimethylacetanilide; Alpha-Diethylaminoaceto-2,6-xylidide; Alphacaine; Anestacon; Anestacon Jelly; CDS1_000283; Cappicaine; Cito optadren; Cuivasil; Dalcaine; Dentipatch; Dentipatch (TN); DermaFlex; Diethylaminoaceto-2,6-xylidide; Dilocaine; Duncaine; ELA-Max; EMBOLEX; Emla Cream; Esracaine; Gravocain; Isicaina; Isicaine; Jetocaine; L-Caine; L1026_SIGMA; LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE); LIDOPEN; LQZ; Lanabiotic; Leostesin; Lida-Mantle; Lidocaina; Lidocaina [INN-Spanish]; Lidocaine (JP15/USP/INN); Lidocaine (VAN); Lidocaine Carbonate; Lidocaine Hydrocarbonate; Lidocaine Monohydrochloride; Lidocaine [USAN:INN:JAN]; Lidocainum; Lidocainum [INN-Latin]; Lidocaton; Lidoderm; Lidoject-1; Lidoject-2; Lignocaine; Lignocainum; Lingocaine; Maricaine; N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide; N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide; Norwood Sunburn Spray; Octocaine; Octocaine-100; Octocaine-50; Omega-Diethylamino-2,6-dimethylacetanilide; Remicaine; Rocephin Kit; Rucaina; Solarcaine aloe extraburn relief cream; Solcain; Xilina; Xilocaina; Xilocaina [Italian]; Xllina; Xycaine; Xylestesin; Xylesthesin; Xylocain; Xylocaine; Xylocaine (TN); Xylocaine 5% Spinal; Xylocaine CO2; Xylocaine Dental Ointment; Xylocaine Endotracheal; Xylocaine Test Dose; Xylocaine Viscous; Xylocaine-Mpf; Xylocaine-Mpf with Glucose; Xylocard; Xylocitin; Xyloneural (free base); Xylotox; Zilactin-L; Zingo DTD0003 VADRUGID DR01010 DTD0003 DRUGNAME Epinastine DTD0003 DRUGSYNO (+-)-Epinastine; 3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine; 3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine; 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine; Elestat (TN); Epinastina; Epinastina [Spanish]; Epinastine (INN); Epinastine [INN]; Epinastinum; Epinastinum [Latin]; Purivist; Purivist (TN); Relestat (TN); WAL 80; WAL 801; WAL 801CL; WAL-80 Cl DTD0003 VADRUGID DR01211 DTD0003 DRUGNAME Nimodipine DTD0003 DRUGSYNO 1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester;1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 2-Methoxyethyl-1-methylethyl ester; 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester; 3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester; 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester; 3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide; Admon; Almirall Brand of Nimodipine; Alpharma Brand of Nimodipine; Andromaco Brand of Nimodipine; Bay-E 9736; Bay-e-9736; Bayer Brand of Nimodipine; Bayvit Brand of Nimodipine; Brainal; Calnit; Cantabria Brand of Nimodipine; DRG-0139; EG-1961; Elan Brand of Nimodipine; Esteve Brand of Nimodipine; Hexal Brand of Nimodipine; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Kenesil; Modus; N-149; NIMOTOP (TN); NimoGel; Nimodipin Hexal; Nimodipin ISIS; Nimodipin-ISIS; NimodipinISIS; Nimodipine (USAN/INN); Nimodipine [USAN:BAN:INN]; Nimodipino; Nimodipino Bayvit; Nimodipino [INN-Spanish]; Nimodipinum; Nimodipinum [INN-Latin]; Nimotop; Nimotop (TN); Nimotop(TM); Nimotop, Nimodipine; Periplum; Periplum, Nimotop, BRN 0459792, DRG-0139; Remontal; Vita Brand of Nimodipine DTD0003 VADRUGID DR01468 DTD0003 DRUGNAME Amphotericin B DTD0003 DRUGSYNO amphotericin b; Amphotericine B; Amphotericin; Amfotericina B; Amphotericinum B; Fungizone; Halizon; Amphocin; AMPH-B; Liposomal Amphotericin B; Fungilin; Amphozone; Ambisome; Abelcet; Ampho-Moronal; Amphotericin-B; Amphortericin B; UNII-7XU7A7DROE; Amphotec; Abelecet; Mysteclin-F; MFCD00877763; 7XU7A7DROE; NCGC00090808-01; DSSTox_CID_2601; NSC 527017; DSSTox_RID_76653; DSSTox_GSID_22601; Amphomoronal; Fungisome; Fungisone; Amphotericinum B [INN-Latin]; Amfotericina B [INN-Spanish]; Amphotericine B [INN-French]; CCRIS 5963 DTD0003 VADRUGID DR00687 DTD0003 DRUGNAME Itraconazole DTD0003 DRUGSYNO (+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one; (1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one; 2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl); 4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; Canadiol; Cis-Itraconazole; Hyphanox; ITCZ; ITZ; Intraconazole; Itraconazol; Itraconazol [Spanish]; Itraconazole & Bovine Lactoferrin; Itraconazole & Nyotran; Itraconazole & Nyotran(Liposomal Nystatin); Itraconazole (JAN/USAN); Itraconazole [USAN:BAN:INN:JAN]; Itraconazole oral solution; Itraconazolum; Itraconazolum [Latin]; Itrizole; Itrizole (TN); Oriconazole; Oriconazole, R51211, Sporanox; Orungal; Prokanazol; R 51211; R-51211; Sempera; Spherazole; Sporal; Sporanos; Sporanox; Sporanox (TN); Sporonox; Triasporn DTD0003 VADRUGID DR00594 DTD0003 DRUGNAME Ketoconazole DTD0003 DRUGSYNO (+)-Ketoconazole; (+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine; (+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine; (+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; 1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine; CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE; Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine; Fungarest; Fungoral; K 1003; KCZ; KS-1205; KTZ; KW-1414; Ketoconazol; Ketoconazole [USAN:INN:BAN:JAN]; Ketoderm; Nizoral (TN); Nizoral, Extina, Xolegel, Kuric, Ketoconazole; Perkhotal (TN); R 41,400; R 41400; R-41400; R41,400; R41400 DTD0003 VADRUGID DR01367 DTD0003 DRUGNAME Cycloheximide DTD0003 DRUGSYNO naramycin A; NSC 185; FT 3422-2; NM-MCD 80 DTD0003 VADRUGID DR00922 DTD0003 DRUGNAME Diethylstilbestrol DTD0003 DRUGSYNO (E)-3,4-Bis(4-hydroxyphenyl)-3-hexene; (E)-4,4'-(hex-3-ene-3,4-diyl)diphenol; (E)-Diethylstilbestrol; 3,4'(4,4'-Dihydroxyphenyl)hex-3-ene; 3,4-Bis(p-hydroxyphenyl)-3-hexene; 3,4-bis(4-hydroxyphenyl)hex-3-ene; 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol; 4,4'-Dihydroxydiethylstilbene; 4,4'-hex-3-ene-3,4-diyldiphenol; APS Brand of Diethylstilbestrol; Acnestrol; Agostilben; Alpha,alpha'-Diethyl-4,4'-stilbenediol; Alpha,alpha'-Diethylstilbenediol; Anti gestil; Antigestil; Apstil; Bufon; Cis-Des; Cis-Diethylstilbesterol; Cis-Diethylstilbestrol; Climaterine; Co Pharma Brand of Diethylstilbestrol; Co-Pharma Brand of Diethylstilbestrol; Comestrol; Comestrol estrobene; Cyren; Cyren A; DES; DES (synthetic estrogen); Dawe's destrol; Desma; Destrol; Di-Estryl; DiBestrol "2" Premix; DiBestrol 2 Premix; Diaethylstilboestrolum; Diastyl; Dibestrol; Dibestrol '2' premix; Dicorvin; Diethylstilbesterol; Diethylstilbestrol (DES); Diethylstilbestrol (USP/INN); Diethylstilbestrol BP; Diethylstilbestrol [USAN:INN]; Diethylstilbestrol, (Z)-Isomer; Diethylstilbestrol, Disodium Salt; Diethylstilbestrolum; Diethylstilbestrolum [INN-Latin]; Diethylstilboesterol; Dietilestilbestrol; Dietilestilbestrol [INN-Spanish]; Dietilestilbestrol [Spanish]; Dietilstilbestrolo; Dietilstilbestrolo [DCIT]; Distilbene; Domestrol; Dyestrol; E-Diethylstilbestrol; Estilbin (MCO); Estilbin MCO; Estril; Estrobene; Estrogen, Stilbene; Estrogenine; Estromenin; Estrosyn; Fonatol; Gerda Brand of Diethylstilbestrol; Grafestrol; Gynopharm; Hi-Bestrol; Hibestrol; Idroestril; Iscovesco; MG 137; Makarol; Menostilbeen; Micrest; Microest; Milestrol; Neo-Oestranol 1; Neo-Oestranol I; Neo-oe stranol 1; New-Estranol 1; OeKolp; Oestrogenine; Oestrol vetag; Oestrolmensil; Oestromenin; Oestromensil; Oestromensyl; Oestromienin; Oestromon; Pabestrol; Palestrol; Percutatrine oestrogenique iscovesco; Protectona; Rumestrol 1; Rumestrol 2; ST IL; Sedestran; Serral; Sexocretin; Sibol; Sintestrol; Stibilium; Stil-Rol; Stilbene Estrogen; Stilbestroform; Stilbestrol; Stilbestrol (TN); Stilbestrone; Stilbetin; Stilboefral; Stilboestroform; Stilboestrol; Stilbofolin; Stilbofollin; Stilbol; Stilkap; Strobene; Synestrin; Synthestrin; Synthoestrin; Synthofolin; Syntofolin; TRANS-DIETHYSTILBESTEROL; TRANSGENIC MODEL EVALUATION (DES); Tampovagan; Tampovagan stilboestrol; Trans-Diethylstilbesterol; Trans-Diethylstilbestrol; Trans-Diethylstilboesterol; Tylosterone; Vagestrol DTD0003 VADRUGID DR01479 DTD0003 DRUGNAME Debrisoquine DTD0003 DRUGSYNO Debrisochinum; Debrisoquina; Debrisoquine; Debrisoquinum; Declinax; Equitonil; Isocaramidine; Tendor; DEBRISOQUIN SULFATE; Debrisoquin hemisulfate; Debrisoquine sulfate; Isocaramidine sulfate; Debrisoquina [INN-Spanish]; Debrisoquine [INN:BAN]; Debrisoquinum [INN-Latin]; Ro 5-3307/1; Sulfuric acid compound with 3,4-dihydro-2(1H)-isoquinolinecarboximidamide (1:1); 1,2,3, 4-Tetrahydro-isoquinoline-2-carboxamidine sulfate; 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-(7CI,8CI); 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1); 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1); 2-Amidino-1,2,3,4-tetrahydroisoquinoline; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1); 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide; 3,4-Dihydro-2(1H;)-isoquinoline carboxamidine sulfate; 3,4-dihydro-1H-isoquinoline-2-carboximidamide; 3,4-dihydroisoquinoline-2(1H)-carboximidamide DTD0003 VADRUGID DR01410 DTD0003 DRUGNAME Guanabenz DTD0003 DRUGSYNO GBZ; Guanabenzo; Guanabenzum; Wytensin; Guanabenz acetate; Guanabenz monoacetate; Wy 8678; Wy 8678 base; BR-750; Guanabenz [USAN:INN]; Guanabenz(USAN); Guanabenzo [INN-Spanish]; Guanabenzum [INN-Latin]; Wy-8678; Wytensin (TN); Guanabenz (USAN/INN); [(2,6-Dichlorobenzylidene)amino]guanidine; N-((2,6-Dichlorobenzylidene)amino)guanidine; Guanidine, ((2,6-dichlorobenzylidene)amino)-(8CI); N-(2,6-Dichlorobenzylidene)-N'-amidinohydrazine; ((2,6-Dichlorobenzylidene)amino)guanidine; 2,6-Dichlorobenzylideneaminoguanidine;2-((2,6-Dichlorophenyl)methylene)-hydrazinecarboximidamide; 2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine DTD0003 VADRUGID DR01385 DTD0003 DRUGNAME Labetalol DTD0003 DRUGSYNO Albetol; Ibidomide; Labetalolum; Labetolol; NORMOZIDE; AH 5158; AH-5158; Labetalol (INN); Labetalol [INN:BAN]; Labetalolum [INN-Latin]; Normodyne (TN); Sch-19927; Trandate (TN); 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide DTD0003 VADRUGID DR01352 DTD0003 DRUGNAME Pafenolol DTD0003 DRUGSYNO H-138/03; Pafenolol; Rac-N-[2-[4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]ethyl]-N'-isopropylurea DTD0003 VADRUGID DR01365 DTD0003 DRUGNAME ABT-263 DTD0003 DRUGSYNO Navitoclax; ABT 263; S1001_Selleck; ABT263, Navitoclax; 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-morpholin-4-yl-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide DTD0003 VADRUGID DR00963 DTD0003 DRUGNAME Domperidone DTD0003 DRUGSYNO 4-(5-Chloro-2-oxo-1-benzimidazolinyl)-1-[3-(2-oxobenzimidazolinyl)propyl]piperidine; 5-Chloro-1-(1-(3-(2-oxo-1-benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone; 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; 5-Chloro-1-[1-[3-(2-oxo-1-benzimidazolinyl)propyl]-4-piperidyl]-2-benzimidazolinone; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one; Costi (TN); D-122; Domperidon; Domperidona; Domperidona [INN-Spanish]; Domperidone (JAN/USAN/INN); Domperidone [USAN:BAN:INN:JAN]; Domperidonum; Domperidonum [INN-Latin]; HS-0067; KW 5338; KW-5338; Motilium; Motilium (TN); Motillium (TN); Motinorm (TN); NCI299589; Nauzelin; R 33,812; R-33,812; R-33812 DTD0003 VADRUGID DR01455 DTD0003 DRUGNAME Hydroxybupropion DTD0003 DRUGSYNO Hydroxybupropion DTD0003 VADRUGID DR01429 DTD0003 DRUGNAME CP-122721 DTD0003 DRUGSYNO CP-122721; UNII-R7OYP6N58F; R7OYP6N58F; CHEMBL319118; CHEMBL1917847; DSSTox_CID_27251; DSSTox_RID_82210; DSSTox_GSID_47251; SCHEMBL156646; DTXSID9047251; Tox21_300205; BDBM50067935; ZINC22441997; AKOS030542331; DB05421; NCGC00254228-01; NCGC00247927-01; CAS-145742-28-5; (2S,3S)-N-(2-methoxy-5-(trifluoromethoxy)benzyl)-2-phenylpiperidin-3-amine DTD0003 VADRUGID DR01592 DTD0003 DRUGNAME Desmethylsertraline DTD0003 DRUGSYNO Desmethylsertraline; Norsertraline; (1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine; UNII-CJJ71O9BE8; CJJ71O9BE8; CHEMBL40733; (1S,4S)-4-(3,4-Dichloro-phenyl)-1,2,3,4-tetrahydronaphthalen-1-amine; CHEMBL1743864; N-Demethylsertraline; N-Desmethylsertraline; Demethylsertraline; CP 62508; CP-53261; AC1L3FVW; AC1Q3O5M; SCHEMBL145234; NAP005; CTK8E0157; DTXSID60236666; SRPXSILJHWNFMK-ZBEGNZNMSA-N; ZINC6117444; PDSP2_001789; BDBM50367182; MFCD00871799; BDBM50028066; AKOS027382323 DTD0003 VADRUGID DR01419 DTD0003 DRUGNAME Methysergide DTD0003 DRUGSYNO Deseril; Desernil; Desernyl; Deseryl; Desril; Dimethylergometrin; Methylmethylergonovine; Methysergid; Methysergidum; Metisergide; Metisergido; Sansert; Methyllysergic acid butanolamide; Metisergide [DCIT]; UML 491; Deseril (TN); Methysergidum [INN-Latin]; Metisergido [INN-Spanish]; Sansert (TN); UML-491; Methysergide (USAN/INN); Methysergide [USAN:INN:BAN]; N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide; N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide; (+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide; (+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide; (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide; 1-Methyl-D-lysergic acid butanolamide; 1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide; 1-Methylmethylergonovine; 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide DTD0003 VADRUGID DR01494 DTD0003 DRUGNAME Roscovitine DTD0003 DRUGSYNO Seliciclib; roscovitine; 186692-46-6; R-Roscovitine; (R)-roscovitine; CYC202; CYC-202; CYC 202; 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine; UNII-0ES1C2KQ94; Roscovitine (Seliciclib,CYC202); NSC 701554; AL-39256; Roscovitine; CHEMBL14762; 0ES1C2KQ94; CHEBI:45307; NSC701554; NSC-701554; (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol; (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol; (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol; RRC; Rosco; M02443; BMK1-E12; CYC202, Seliciclib, R-roscovitine, Roscovitine; (2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol; 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol; 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol; 6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine DTD0003 VADRUGID DR01007 DTD0003 DRUGNAME Cortisone DTD0003 DRUGSYNO 11-dehydro-17-hydroxycorticosterone; 17-hydroxy-11-dehydrocorticosterone DTD0003 VADRUGID DR01664 DTD0003 DRUGNAME Crocin DTD0003 VADRUGID DR01481 DTD0003 DRUGNAME E-guggulsterone DTD0003 DRUGSYNO Guggulsterone E; (E)-Guggulsterone; E-Guggulsterone; Guggulsterones E; trans-Guggulsterone; 39025-24-6; Pregna-4,17-diene-3,16-dione; UNII-9B259YE66O; (17E)-Pregna-4,17(20)-diene-3,16-dione; Z-Guggulsterone; CHEMBL402063; 95975-55-6; 9B259YE66O; (8R,9S,10R,13S,14S,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; E-Guggulsteron; Pregna-4,17(20)-diene-3,16-dione; Guggulsterone, (E)-; Guglip; Z/E-Guggulsterone; Pregna-4,17(20)-diene-3,16-dione, (17E)-; Guggulsterone E; Guggulsterones Z; Cis-Guggulsterone; Trans-Guggulsterone; (17E)-pregna-4,17-diene-3,16-dione; (17Z)-Pregna-4,17(20)-diene-3,16-dione; (17Z)-pregna-4,17-diene-3,16-dione; (8R,9S,10R,13S,14S,17Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; (Z)-Guggulsterone; 4,17(20)-cis-Pregnadiene-3,16-dione; E-GUGGULSTERONE DTD0003 VADRUGID DR01353 DTD0003 DRUGNAME Isoxicam DTD0003 DRUGSYNO isoxicam; 34552-84-6; Maxicam; Isoxicamo; Isoxicamum; UNII-8XU734C4NG; Pacyl (antiinflammatory); Isoxicamum [INN-Latin]; Isoxicamo [INN-Spanish]; EINECS 252-084-5; W 8495; BRN 0577221; 8XU734C4NG; CHEBI:76163; C14H13N3O5S; NCGC00016829-05; CAS-34552-84-6; 4-Hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; 4-Hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; DSSTox_CID_25462; DSSTox_RID_80893; DSSTox_GSID_45462 DTD0003 VADRUGID DR00999 DTD0003 DRUGNAME Diazepam DTD0003 DRUGSYNO Diazepam (intranasal, epilepsy); 439-14-5; Amiprol; Ansiolin; Ansiolisina; Apaurin; Apozepam; Assival; Atensine; Atilen; Bensedin; Bialzepam; Calmocitene; Calmpose; Ceregulart; Condition; Diacepan; Diapam; Diazemuls; Diazepan; Diazetard; Dipezona; Domalium; Faustan; Kiatrium; Levium; Liberetas; Methyldiazepinone; Neurolytril; Paranten; Quetinil; Quiatril; Quievita; Relaminal; Relanium; Renborin; Ruhsitus; Sedipam; Seduksen; Seduxen; Serenack; Serenamin; Serenzin; Sibazon; Sonacon; Stesolid; Stesolin; Tensopam; Tranimul; Tranqdyn; Tranquirit; Umbrium; Unisedil; Valitran; Valium; diazepam DTD0003 VADRUGID DR01212 DTD0003 DRUGNAME Mitomycin DTD0003 DRUGSYNO Ametycin; 1950/7/7; 7-Amino-9alpha-methoxymitosane; Ametycin; Ametycine; C15H18N4O5; CCRIS 414; EINECS 200-008-6; HSDB 3239; MMC; Mit-C; Mitamycin; Mito-C; Mitocin C; Mitocin-C; Mitomicina; Mitomicina [INN-Spanish]; Mitomycin (TN); Mitomycin (USP/INN); Mitomycin C; Mitomycin C (JP15); Mitomycin C from Streptomyces caespitosus; Mitomycin C,; Mitomycin C, Streptomyces caespitosus; Mitomycin C, Streptomyces caespitosus, Carrier-Free; Mitomycin [USAN:INN:BAN]; Mitomycin-C; Mitomycine; Mitomycine [INN-French]; Mitomycins; Mitomycinum; Mitomycinum C; Mitomycinum [INN-Latin]; Mitomycyna C; Mitomycyna C [Polish]; Mitosol; Mitozytrex; Muamycin; Muamycin (TN); Mutamycin; Mytomycin; Mytozytrex; NCI-C04706; NSC 26980; NSC-26980; NSC26980; RCRA waste number U010; UNII-50SG953SK6; mitomycin C DTD0003 VADRUGID DR01350 DTD0003 DRUGNAME Flesinoxan DTD0003 DRUGSYNO Flesinoxan hydrochloride; DU-29373 DTD0003 VADRUGID DR01368 DTD0003 DRUGNAME Beclomethasone DTD0003 DRUGSYNO Anceron; Beclocort; Beclometason; Beclometasona; Beclometasonum; Becloval; Becodisks; Beconasol; Becotide; Inalone; Viarex; Beclometasondipropionat Mikron; Beclometasone [INN]; Vancenase AQ; B 0385; BMJ 5800; Beclometason (TN); Beclometasona [INN-Spanish]; Beclometasone (INN); Beclometasonum [INN-Latin]; Beconase (TN); Clipper (TN); Propaderm (TN); Vancenase (TN); (11beta,16beta)-9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; (8R,9S,10S,11S,13R,14R,16R,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9alpha-Chloro-11beta,17alpha,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9alpha-Chloro-16beta-methyl-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione; 9alpha-Chloro-16beta-methylprednisolone DTD0003 VADRUGID DR00046 DTD0003 DRUGNAME Levofloxacin DTD0003 DRUGSYNO (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-Ofloxacin; (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (R)-isomer; (S)-(-)-Ofloxacin; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; Aeroquin; Cravit; Cravit (TN); Cravit Ophthalmic; D-Levofloxacin; DR 3354; DR-3355; DR-3355: L-isomer of ofloxacin; DR3355; Elequine; Floxacin; Floxel; HR 355; HR-355; Iquix; Iquix (TN); L-Ofloxacin; LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER; LFX; LVX; Leroxacin; Lesacin; Levaquin; Levaquin (TN); Levofloxacin (INN); Levofloxacin [USAN:INN:JAN]; Levofloxacin tablet, suspension or intravenous; Levofloxacine; Levofloxacine [INN-French];Levofloxacino [INN-Spanish]; Levofloxacino; Levofloxacinum; Levofloxacinum [INN-Latin]; Levokacin; Levox; Levoxacin; MP-376; Mosardal; Nofaxin; Ofloxacin; Ofloxacin S-(-)-form; Oftaquix; Oftaquix (TN); Quixin; Quixin (TN); R-Ofloxacin; RWJ 25213-097; RWJ-25213; Reskuin; S-(-)-Ofloxacin; Tavanic; Tavanic (TN); Volequin DTD0003 VADRUGID DR00127 DTD0003 DRUGNAME Tetracycline DTD0003 DRUGSYNO (-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base) DTD0003 VADRUGID DR00455 DTD0003 DRUGNAME Dicloxacillin DTD0003 DRUGSYNO (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423 DTD0003 VADRUGID DR01204 DTD0003 DRUGNAME Norfloxacin DTD0003 DRUGSYNO 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN) DTD0003 VADRUGID DR00050 DTD0003 DRUGNAME Erythromycin DTD0003 DRUGSYNO A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid DTD0003 VADRUGID DR00553 DTD0003 DRUGNAME Ceftriaxone DTD0003 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine DTD0003 VADRUGID DR00367 DTD0003 DRUGNAME Azithromycin DTD0003 DRUGSYNO Azasite (TN); Azibiot; Azifine; Azithramycine; Azithromycin (INN); Azithromycin (TN); Zitrocin DTD0003 VADRUGID DR00190 DTD0003 DRUGNAME Amoxicillin DTD0003 DRUGSYNO (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN) DTD0003 VADRUGID DR00600 DTD0003 DRUGNAME Cefoperazone DTD0003 DRUGSYNO (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN) DTD0003 VADRUGID DR00360 DTD0003 DRUGNAME Omadacycline DTD0003 DRUGSYNO Amadacycline; Amadacycline (intravenous), Merck & Co; Amadacycline (intravenous), Paratek/Novartis; Amadacycline (oral), Merck & Co; Amadacycline (oral), Paratek/ Novartis; Antibacterial aminomethycyclines, Paratek/Bayer; MK-2764; Omadacycline; Omadacycline (intravenous), Merck & Co; Omadacycline (intravenous), Paratek; Omadacycline (intravenous), Paratek/ Novartis; Omadacycline (oral), Merck & Co; Omadacycline (oral), Paratek; Omadacycline (oral), Paratek/ Novartis; Omadacycline tosylate; P-000538; P-000642; P-001075; P-001207; P-001221; P-00136; P-002352; PTK-0796; PTK-796; Sancycline derivatives, Paratek; Tetracycline analogs, GlaxoSmithKline/Paratek; Tetracycline analogs, Paratek/Merck & Co;Tetracycline analogs (multi-drug-resistant infections), Paratek/Bayer DTD0003 VADRUGID DR00170 DTD0003 DRUGNAME Epirubicin DTD0003 DRUGSYNO (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697 DTD0003 VADRUGID DR00576 DTD0003 DRUGNAME Telithromycin DTD0003 DRUGSYNO (1R,2R,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6R,7R,8R,10S,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2S,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; 11,12-Dideoxy-3-des(2,6-dideoxy-3-C,3-O-dimethyl-alpha-L-altropyranosyloxy)-6-O-methyl-3-oxo-12,11-(oxycarbonylimino)-N11-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]erythromycin A; HMR 3647; HMR-3647; HMR3647; Ketek; Ketek (TN); Levviax; RU 66647; RU-66647; RU66647; TEL; Telithromycin (JAN/USAN/INN); Telithromycin [USAN:BAN:INN] DTD0003 VADRUGID DR01266 DTD0003 DRUGNAME Naloxegol DTD0003 DRUGSYNO NKTR-118 DTD0003 VADRUGID DR01284 DTD0003 DRUGNAME Trospium chloride DTD0003 DRUGSYNO trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio DTD0003 VADRUGID DR01264 DTD0003 DRUGNAME Apremilast DTD0003 DRUGSYNO Apremilast (USAN); CC-10004; N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide DTD0003 VADRUGID DR01413 DTD0003 DRUGNAME Beta-Acetyldigoxin DTD0003 DRUGSYNO Novodigal (TN) DTD0003 VADRUGID DR01283 DTD0003 DRUGNAME Tiapamil DTD0003 DRUGSYNO ORE-5002; Tiapamil (CNS disease); Tiapamil (CNS disease), Ore Pharmaceuticals DTD0003 VADRUGID DR01278 DTD0003 DRUGNAME Zolmitriptan DTD0003 DRUGSYNO (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; AscoTop; AscoTop (TN); BW-311C90; Flezol; KS-5072; Zolmitriptan RapidFilm; Zolmitriptan [USAN]; Zolmitriptane; Zolmitriptanum; Zomig; Zomig (TN); Zomig Nasal Spray; Zomig ZMT; Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan; Zomig-ZMT; Zomigon; Zomigon (TN); Zomigoro (TN) DTD0003 VADRUGID DR01293 DTD0003 DRUGNAME Pepstatin A DTD0003 DRUGSYNO 26305-03-3; 39324-30-6; Ahpatinin C; C34H63N5O9; CCRIS 3603; CHEMBL296588; DSSTox_CID_26095; DSSTox_GSID_46095; DSSTox_RID_81334; FAXGPCHRFPCXOO-LXTPJMTPSA-N; Ia Quinidine; Iboctadekin + rituximab; Iva-Val-Val-Sta-Ala-Sta-OH; MLS002222329; NCGC00161670-06; Pepstatin (VAN); Pepstatin (nonspecific); Pepstatina; Pepstatine; Pepstatinum; UNII-V6Y2T27Q1U; V6Y2T27Q1U DTD0003 VADRUGID DR01323 DTD0003 DRUGNAME Albendazole DTD0003 DRUGSYNO ((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle; ((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; (5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; Albendazol; Albendazol [INN-Spanish]; Albendazole (JAN/USP/INN); Albendazole Armstrong Brand; Albendazole Diba Brand; Albendazole Fustery Brand; Albendazole Hormona Brand; Albendazole Liferpal Brand; Albendazole Monohydrochloride; Albendazole Noe-Socopharm Brand; Albendazole Pfizer Brand; Albendazole Sanicoopa Brand; Albendazole Valdecasas Brand; Albendazole [USAN:INN:BAN:JAN]; Albendazolum; Albendazolum [INN-Latin]; Albendoral; Albenza; Albenza (TN); Albenza, Eskazole, Zentel, Andazol, Albendazole; Armstrong Brand of Albendazole; Bendapar; Bilutac; CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER; Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester; Diba Brand of Albendazole; Digezanol; Disthelm; Disthelm, Mediamix V; Endoplus; Eskazole; Eskazole (TN); Fustery Brand of Albendazole; Gascop; Hormona Brand of Albendazole; Liferpal Brand of Albendazole; Lurdex; Mediamix V Disthelm; Methyl 5-(propyl-thio)-2-benzimidazolecarbamate; Methyl 5-(propylthio)-2-benzimidazolecarbamate; Methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate; Methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate; Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate; Methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate; Methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl-5-[propylthio]-2-benzimidazole carbamate; MethylN-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate; Metiazol; Monohydrochloride, Albendazole; Noe Socopharm Brand of Albendazole; Noe-Socopharm Brand of Albendazole; O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate; Pfizer Brand of Albendazole; Proftril; SK&F 62979; SK&F-62979; SK&F62979; SKF 62979; SKF-62979; SKF62979; Sanicoopa Brand of Albendazole; Smith Kline & French Brand of Albendazole; SmithKline Beecham Brand of Albendazole; V Disthelm, Mediamix; Valbazen; Valdecasas Brand of Albendazole; Zental; Zentel; Zentel (TN); [5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester; [5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester DTD0003 VADRUGID DR01583 DTD0003 DRUGNAME Abamectin B1A DTD0003 DRUGSYNO AVERMECTIN B1A; abamectin component B1a; Avermectin B(1)a; Abamectine [French]; Abamectinum [Latin]; Abamectina [Spanish]; Caswell No. 063AB; Antibiotic C 076B1a; Abamectin komponente B1a; 5-O-Demethylavermectin A1a; UNII-K54ZMM929K; Avermectin; Avermectin A1a, 5-O-demethyl-; EINECS 265-610-3; Antibiotic C 076A1a, 5-O-demethyl-; K54ZMM929K; CHEBI:29534; Avermectin A(sub 1a), 5-O-demethyl-; DSSTox_CID_3892; DSSTox_RID_77221; DSSTox_GSID_23892; Abamectina; Abamectine; C48H72O14; Abamectin B1a DTD0003 VADRUGID DR01386 DTD0003 DRUGNAME Cefotetan DTD0003 DRUGSYNO Cefotetanum; Apatef (TN); Cefotan (TN); Cefotetan (JP15/USP/INN); (6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid DTD0003 VADRUGID DR00989 DTD0003 DRUGNAME Chloramphenicol DTD0003 DRUGSYNO Ak-chlor; Alficetyn; Alficetyn (TN); Alficetyn, Chlornitromycin, Chloromycetin, Chloramphenicol; Ambofen; Amphenicol; Amphicol; Amphicol (TN); Amseclor; Anacetin; Aquamycetin; Austracil; Austracol; Biocetin; Biomicin (TN); Biophenicol; Brochlor (TN); C.A.F; CAF; CAF (pharmaceutical); CHLOROPTIC S.O.P; CLM; Catilan; Cedoctine (TN); Ch loramex; Chemiceticol; Chemicetin; Chemicetina; Chlomin; Chlomycol; Chlora-tabs; Chloramex; Chloramex (TN); Chloramfenikol; Chloramfenikol [Czech]; Chloramficin; Chloramfilin; Chloramphenicol & VRC3375; Chloramphenicol (JP15/USP/INN); Chloramphenicol [INN:BAN:JAN]; Chloramphenicol crystalline; Chloramphenicolum; Chloramphenicolum [INN-Latin]; Chloramsaar; Chlorasol; Chlorbiotic (Veterinary); Chloricol; Chlormycetin R; Chlornitromycin; Chlornitromycin (TN); Chloro-25 vetag; Chloroamphenicol; Chlorocaps; Chlorocid; Chlorocid S; Chlorocide; Chlorocidin C; Chlorocidin C tetran; Chlorocol; Chlorofair; Chloroject L; Chloromax; Chloromycetin; Chloromycetin (TN); Chloromycetin® Chloromycetny; Chloromycetny [Polish]; Chloromyxin; Chloronitrin; Chloroptic; Chloroptic S.O.P.; Chlorovules; Chlorsig; Chlorsig (TN); Cidocetine; Ciplamycetin; Cloramfen; Cloramfenicol; Cloramfenicol [INN-Spanish]; Cloramfenicolo; Cloramfenicolo [DCIT]; Cloramficin; Cloramical; Cloramicol; Cloramidina; Cloranfenicol; Cloroamfenicolo; Cloroamfenicolo [Italian]; Clorocyn; Cloromisan; Cloromissan; Clorosintex; Comycetin; Cylphenicol; D(-)-threo-2-dichloroacetamido-1-p-nitrophen yl-propanediol; D(-)-threo-2-dichloroacetamido-1-p-nitrophenyl-propanediol; D(-)-threo-Chloramphenicol; D-(-)-Chloramphenicol; D-(-)-threo-Chloramphenicol; D-Chloramphenicol; D-threo-Chloramphenicol; Desphen; Detreomycin; Detreomycine; Dextromycetin; Dispersadron C (TN); Doctamicina; Duphenicol; Econochlor; Econochlor (TN); Elase-Chloromycetin; Embacetin; Emetren; Enicol; Enteromycetin; Erbaplast; Ertilen; F armicetina; Farmicetina; Fenicol; Fenicol (TN); Globenicol; Glorous; Golden Eye (TN); Halomycetin; Hortfenicol; I 337A; Interomycetine; Intramycetin; Intramyctin; Isicetin; Ismicetina; Isophenicol; Isopto fenicol; Isoptophenicol (TN); Juvamycetin; Kamaver; Kemicetina; Kemicetine; Kemicetine (TN); Kloramfenikol; Klorita; Klorocid S; Laevomycetin (TN); Laevomycetinum; Leukamycin; Leukomyan; Leukomycin; Levomicetina; Levomitsetin; Levomycetin; Loromicetina; Loromisan; Loromisin; Mastiphen; Mediamycetine; Medichol; Medicom (TN); Micloretin; Micochlorine; Micoclorina; Microcetina; Mychel; Mychel-Vet; Mycinol; Myscel; Nevimycin (TN); Normimycin V; Novochlorocap; Novomycetin; Novophenicol; Oftalent; Oftan Chlora (TN); Oleomycetin; Opclor; Opelor; Ophthochlor; Ophtochlor; Optomycin; Optrex Infected Eyes (TN); Orchadexoline (TN); Otachron; Otophen; Pantovernil; Paraxin; Pentamycetin; Phenicol (TN); Quemicetina; Renicol (TN); Rivomycin; Romphenil; Ronfenil; Ronphenil; Septicol; Sificetina; Silmycetin (TN); Sintomicetina; Sintomicetine R; Sno Phenicol; Sno-Phenicol; Stanomycetin; Synthomycetin; Synthomycetine; Synthomycine; Synthomycine (TN); Syntomycin; Tea-Cetin; Tega-Cetin; Tevcocin; Tevcosin; Tifomycin; Tifomycine (TN); Tifomycine;Tiromycetin; Treomicetina; U-6062; Unimycetin; Vernacetin (TN); Veticol; Veticol (TN); Vice ton; Viceton DTD0003 VADRUGID DR00713 DTD0003 DRUGNAME Clarithromycin DTD0003 DRUGSYNO clarithromycin; 81103-11-9; Biaxin; Clarithromycine; Klaricid; 6-O-Methylerythromycin; Clathromycin; 6-O-Methylerythromycin a; Abbott-56268; Macladin; Veclam; Kofron; Klacid; Clarith; Clarithromycinum; Naxy; A-56268; Erythromycin, 6-O-methyl-; TE-031; Claritromicina; Fromilid; Claridar; Bicrolid; Astromen; Claricide; Clacine; Abbotic; Mabicrol; Clambiotic; Klaciped; Heliclar; Claripen; Claribid; Clarem; Clacid; Clacee; Zeclar; Maclar; Klarid; Crixan; Klarin; Klabax; Cyllid; Mavid; Helas; Biaxin filmtab; Adel; Klax; Biaxin xl filmtab; Biaxin HP; Klaricid Pe DTD0003 VADRUGID DR00666 DTD0003 DRUGNAME Doxycycline DTD0003 DRUGSYNO (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS); 5-Hydroxy-alpha-6-deoxytetracycline; 6-Deoxyoxytetracycline; 6-Deoxytetracycline; 6-alpha-Deoxy-5-oxytetracycline; 6alpha-Deoxy-5-oxytetracycline; Alpha-6-Deoxy-5-hydroxytetracycline; Alpha-6-Deoxyoxytetracycline; Alpha-Doxycycline; Alti-Doxycycline; Apo-Doxy; Atridox; Azudoxat; BMY-28689; BU-3839T; DMSC (*Fosfatex); DOXCYCLINE ANHYDROUS; DOXY; DOXYCYCLINE CALCIUM; DOXYCYCLINE MONOHYDRATE; Deoxymykoin; Dossiciclina; Dossiciclina [DCIT]; Doxiciclina; Doxiciclina [INN-Spanish]; Doxiciclina [Italian]; Doxitard; Doxivetin; Doxy-Caps; Doxy-Puren; Doxy-Tabs; Doxycen; Doxychel; Doxychel (TN); Doxycin; Doxycyclin; Doxycycline (200mg/day) or Placebo; Doxycycline (INN); Doxycycline (TN); Doxycycline (anhydrous); Doxycycline (internal use); Doxycycline anhydrous; Doxycycline hyclate; Doxycycline-Chinoin; Doxycyclinum; Doxycyclinum [INN-Latin]; Doxysol; Doxytec; Doxytetracycline; GS-3065 (*monohydrate); Hydramycin; Investin; Jenacyclin; Liviatin; Monodox; Monodox (*monohydrate); Novo-Doxylin; Nu-Doxycycline; Oracea; Periostat (TN); Ronaxan; Spanor; Supracyclin; Vibra-tabs; Vibramycin; Vibramycin (*monohydrate); Vibramycin Novum; Vibramycine; Vibravenos; Vivox (*Hyclate) DTD0003 VADRUGID DR01165 DTD0003 DRUGNAME Gatifloxacin DTD0003 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN) DTD0003 VADRUGID DR01276 DTD0003 DRUGNAME Gramicidin D DTD0003 DRUGSYNO 1,10-anhydro(L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithine); Cyclo(L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl); Gramacidine S; Gramacidine S [INN-French]; Gramicidin A(1); Gramicidin C; Gramicidin Dubos; Gramicidin J; Gramicidin K; Gramicidin P; Gramicidin S; Gramicidin S [INN]; Gramicidin [INN:BAN]; Gramicidina D; Gramicidina S; Gramicidina S [INN-Spanish]; Gramicidina [INN-Spanish]; Gramicidine [INN-French]; Gramicidins; Gramicidinum S; Gramicidinum S [INN-Latin]; Gramicidinum [INN-Latin]; Gramicin S 1; Gramicin S-A; Gramoderm; Neosporin Ophthalmic Solution DTD0003 VADRUGID DR00791 DTD0003 DRUGNAME Sparfloxacin DTD0003 DRUGSYNO (cis)-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclohexyl-7-(cis-3,5-dimethylpiperazino)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid; AT 4140; AT-4140; CP 103826; CP-103826; Cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; DRG-0143; Esparfloxacino; Esparfloxacino [INN-Spanish]; Liposome-encapsulated sparfloxacin; PD 1315-1; PD 131501; PD-131501; PD131501; RP-64206; Respipac (TN); SPFX; Spara; Sparfloxacin & RU 40555; Sparfloxacin (JAN/USAN/INN); Sparfloxacin [USAN:BAN:INN:JAN]; Sparfloxacin, cis-isomer; Sparfloxacine; Sparfloxacine [INN-French]; Sparfloxacinum; Sparfloxacinum [INN-Latin]; Zagam; Zagam (TN) DTD0003 VADRUGID DR01326 DTD0003 DRUGNAME Thiamphenicol DTD0003 DRUGSYNO (+)-Thiamphenicol; 15318-45-3; Armai (TN); C12H15Cl2NO5S; D-Thiocymetin; D-Thiophenicol; Descocin; Dexawin; Dextrosulphenidol; EINECS 239-355-3; Efnicol; Hyrazin; Igralin; Macphenicol; Masatirin; Neomyson; RACEPHENICOL; Raceophenidol; Rincrol; SW 5063; Thiamcol; Thiamphenicol (Thiophenicol); Thiamphenicol [USAN:INN:BAN:JAN]; Thiamphenicolum; Thiamphenicolum [INN-Latin]; Thiocymetin; Thiocymetin (TN); Thiophenicol; Tiamfenicol [INN-Spanish]; Tiamfenicolo [DCIT]; UNII-FLQ7571NPM; Unaseran-D; Urfamicina; Urfamycine; WIN-5063-2; thiamphenicol DTD0003 VADRUGID DR01467 DTD0003 DRUGNAME Geneticin DTD0003 DRUGSYNO Geneticin; geneticin; antibiotic G 418; antibiotic G-418; UNII-A08F5XTI6G; 49863-47-0; BRN 1669188; A08F5XTI6G; O-2-Amino-2,7-dideoxy-D-glycero-alpha-D-gluco-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-D-streptamine; G 418 sulfate; G 418; G-418; C20H40N4O10; GET; D-Streptamine, O-2-amino-2,7-dideoxy-D-glycero-alpha-D-gluco-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-; AC1L3XFV; SCHEMBL5006573; CHEMBL215226; DTXSID10198129 DTD0003 VADRUGID DR01525 DTD0003 DRUGNAME Puromycin DTD0003 DRUGSYNO puromycin; Stylomycin; Puromycinum; Puromycine; Puromicina; UNII-4A6ZS6Q2CL; P-638; Stillomycin; CL 13900; 3123L; 4A6ZS6Q2CL; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; GNF-PF-2016; Puromycinum [INN-Latin]; Puromycine [INN-French]; Puromicina [INN-Spanish]; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Bacterenomycin DTD0003 VADRUGID DR00708 DTD0003 DRUGNAME Roxithromycin DTD0003 DRUGSYNO 9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; 9-[O-(2-methoxyethoxymethyl)-oxime] of erythromycin; Assoral; Biaxsig (TN); Coroxin (TN); Erythromycin 9-(-O-[2-methoxyethoxy]methyloxime);Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime); Overall; RC2952; RU 28965; RU 965; RU-28965; RU-965; RXM; Rossitrol; Roxar (TN); Roximycin (TN); Roxithromycin & Tumor Necrosis Factor; Roxithromycin (JP15/USAN/INN); Roxithromycin [USAN:INN:JAN]; Roxithromycine; Roxithromycine [French]; Roxithromycinum; Roxithromycinum [Latin]; Roxitromicina; Roxitromicina [Spanish]; Roxl-150 (TN); Roxo (TN); Rulid; Rulide; Rulide (TN); Surlid; Surlid (TN); Tirabicin (TN) DTD0003 VADRUGID DR01359 DTD0003 DRUGNAME Triflupromazine DTD0003 DRUGSYNO Adazine; Fluopromazine; Fluorofen; Neoprin; Nivoman; Psyquil; Siquil; Trifluopromazine; Triflupromazina; Triflupromazinum;Vesprin; Vetame; Fluopromazine monohydrochloride; Trifluopromazine hydrochloride; Triflupromazine [INN]; Triflupromazina [INN-Spanish]; Triflupromazinum [INN-Latin]; Vesprin (TN); Triflupromazine (USP/INN); N,N-Dimethyl-2-(trifluoromethyl)-10H-phenothiazine-10-propanamine; N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine; N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine hydrochloride; N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine; N,N-dimethyl-3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)-1-propanamine; 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine; 10-3-(Dimethylamino)propyl-2-(trifluoromethyl)phenothiazine; 2-(Trifluoromethyl)promazine; 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine DTD0003 VADRUGID DR00669 DTD0003 DRUGNAME Clofazimine DTD0003 DRUGSYNO (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (Pharmaceutical); B 663 (VAN); B 663, pharmaceutical; B-663; B. 663; CFZ; Chlofazimine; Clofazimina; Clofazimina [INN-Spanish]; Clofazimine (JAN/USP/INN); Clofazimine [USAN:INN:BAN]; Clofaziminum; Clofaziminum [INN-Latin]; G 30320; G-30,320; G-30320; Lampren; Lamprene; Lamprene (TN); Liposome-encapsulated clofazimine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine; N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine; N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; SMP2_000339 DTD0003 VADRUGID DR00390 DTD0003 DRUGNAME Fluvoxamine DTD0003 DRUGSYNO (1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine; 2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine; Dumirox; Dumyrox; Faverin; Floxyfral; Fluvoxamina; Fluvoxamina [INN-Spanish]; Fluvoxamine (INN); Fluvoxamine [INN:BAN]; Fluvoxamine-CR; Fluvoxaminum; Fluvoxaminum [INN-Latin]; Luvox (TN); Maveral DTD0003 VADRUGID DR00499 DTD0003 DRUGNAME Corticosterone DTD0003 DRUGSYNO (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE; (11beta)-11,21-Dihydroxypregn-4-ene-3,20-dione; 11,12-Dihydroxyprogesterone; 11,21-Dihydroxyprogesterone; 11-Hydroxycorticoaldosterone; 11-beta,21-Dihydroxypregn-3,20-dione; 11Beta,21-dihydroxypregn-4-ene-3,20-dione; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; 11beta,21-Dihydroxyprogesterone; 17-Deoxycortisol; 4-Pregnene-11beta,21-diol-3,20-dione; 50-22-6; CCRIS 6753; CHEBI:16827; Compound B; Corticosteron; Corticosterone; Kendall's compound B; NSC9705; Reichstein's B; Reichstein's substance H; UNII-W980KJ009P DTD0003 VADRUGID DR00401 DTD0003 DRUGNAME Talinolol DTD0003 DRUGSYNO (+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin] DTD0003 VADRUGID DR00036 DTD0003 DRUGNAME Cholesterol DTD0003 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0003 VADRUGID DR01305 DTD0003 DRUGNAME Bisantrene DTD0003 DRUGSYNO 39C34M111K; 78186-34-2; 9,10-Anthracendicarbaldehyde bis(2-imidazolin-2-ylhydrazon); 9,10-Anthracenedicarboxaldehyde, bis((4,5-dihydro-1H-imidazol-2-yl)hydrazone)-; BISANTRENE HYDROCHLORIDE; BRN 0966309; Bisantrene; Bisantrene [INN]; Bisantreno; Bisantreno [INN-Spanish]; Bisantrenum; Bisantrenum [INN-Latin]; CHEMBL25336; CL 216942; N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazono)methyl]-9-anthryl]methyleneamino]-4,5-dihydro-1H-imidazol-2-amine; NSC 337766; UNII-39C34M111K DTD0003 VADRUGID DR00257 DTD0003 DRUGNAME Biotin DTD0003 DRUGSYNO Biodermatin; Bioepiderm; Bios II; Biotin Forte; Factor S; Lutavit H2; Meribin; Rovimix H2 DTD0003 VADRUGID DR01398 DTD0003 DRUGNAME Aprepitant DTD0003 DRUGSYNO Aprepitant [USAN]; L 754030; MK 0869; Emend (TN); L-754030; MK-0869; ONO-7436; Aprepitant (JAN/USAN/INN); MK-869, L-754030, Emend, Aprepitant; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one DTD0003 VADRUGID DR01499 DTD0003 DRUGNAME Azasetron DTD0003 DRUGSYNO Azasetron; Nazasetron; Azasetron [INN]; C17H20ClN3O3; 123039-99-6; WUKZPHOXUVCQOR-UHFFFAOYSA-N; Azasetron (INN); 6-Chloro-4-methyl-3-oxo-N-(quinuclidin-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide; NCGC00024563-02; DSSTox_RID_81029; DSSTox_CID_25651; DSSTox_GSID_45651; (- )-6-Chloro-3,4-dihydro-4-methyl-3-oxo-N-3-quinuclidinyl-2H-1,4-benzoxazine-8-carboxamide; N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide DTD0003 VADRUGID DR01357 DTD0003 DRUGNAME Olopatadine DTD0003 DRUGSYNO Allelock; Opatanol; Pataday; Patanase; Patanol; OLOPATADINE HCl; OLOPATADINE HYDROCHLORIDE; ALO4943A; HCl of KW 4679; KW 4679; O0361; AL-4943A; ALO-4943A; Allelock (TN); KW-4679; KW-4943A; Olopatadine [INN:BAN]; Pataday (TN); Patanase (TN); Patanol S (TN); {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride; 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride DTD0003 VADRUGID DR01407 DTD0003 DRUGNAME Pemirolast DTD0003 DRUGSYNO Pemirolastum; Pemirox; Pemirolast [INN]; Pemiroplast Potassium; Alamast (TN); Alegysal (TN); Pemirolast (INN); Pemirolastum [INN-Latin]; Pemirox (TN); 9-TBX; 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one; 9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one DTD0003 VADRUGID DR01375 DTD0003 DRUGNAME Neostigmine DTD0003 DRUGSYNO Eustigmin; Eustigmine; Intrastigmina; Juvastigmin; Neostigmin; Neostigminum; Prostigmin; Prostigmine; Prozerin; Sulfonatooxymethane; Synstigmin; Syntostigmine; Vagostigmin; Vagostigmine; Neostigmine [BAN]; Neostigmine omega; M-Trimethylammoniumphenyldimethylcarbamate; Neostigmine (BAN); Prostigmin (TN); Vagostigmin (TN); [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester); Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-(9CI); (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester); 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium; 3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium DTD0003 VADRUGID DR01391 DTD0003 DRUGNAME Clomifene DTD0003 DRUGSYNO Androxal; Chlomaphene; Chloramifene; Cisclomifenum; Cisclomiphene; Clomifen; Clomifeno; Clomifenum; Clomifert; Clomiphene; Clostilbegit; Enclomifene; Enclomifeno; Enclomifenum; Enclomiphen; Enclomiphene; Klostilbegit; Transclomifenum; Transclomiphene; Zuclomifene; Zuclomifeno; Zuclomifenum; Zuclomiphene; Clomiphene B;Enclomiphene [USAN]; ISOMER B; Zuclomiphene [USAN]; Cis-Clomifene; Cis-Clomiphene; Clomid (TN); Clomifene (INN); Clomifene (TN); Clomifene [INN:BAN]; Clomifeno [INN-Spanish]; Clomifenum [INN-Latin]; En-Clomiphene; Enclomifeno [INN-Spanish]; Enclomifenum [INN-Latin]; Enclomiphene (USAN); Milophene (TN); RMI 16,289; RMI-16289; RMI-16312; Serophene (TN); Trans-Clomifene; Trans-Clomiphene; Zuclomifeno [INN-Spanish]; Zuclomifenum [INN-Latin]; Zuclomiphene (USAN); Cis-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Trans-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Cis-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; Trans-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; (E)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-isomer; 1-(p-(beta-Diethylaminoethoxy)-phenyl)-1,2-diphenylchloroethylene; 2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; 2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; 2-(p-(beta-Chloro-alpha-phenylstyryl)phenoxy)-triethylamine; 2-(p-(beta-chloro-alpha-phenylstyryl)phenoxy)triethylamine; 2-({4-[(Z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-N,N-diethylethanamine; 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine; 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-{4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy}-N,N-diethylethanamine DTD0003 VADRUGID DR01483 DTD0003 DRUGNAME Ingenol-3-angelate DTD0003 DRUGSYNO Picato; Ingenol 3-angelate; 75567-37-2; PEP-005; PEP005; 3-Angeloylingenol; UNII-7686S50JAH; PEP 005; 3-Ingenyl angelate; Ingenol-3-angelate; 7686S50JAH; Picato (TN); Euphorbia factor H1; Euphorbia factor An1; Ingenol mebutate [USAN:INN]; [dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] (Z)-2-methylbut-2-enoate; I3A; Ingenol-3- angelate; Ingenol mebutate (USAN); (Z)-2-methylbut-2-enoate; SCHEMBL2526605; GTPL7443; CHEMBL1863513; HSDB 8308; VDJHFHXMUKFKET-WDUFCVPESA-N; MolPort-003-941-761; AN-262; POL-103A DTD0003 VADRUGID DR01418 DTD0003 DRUGNAME Acrivastine DTD0003 DRUGSYNO Acrivastin; Acrivastina; Acrivastinum; Semprex; Acrivastina [Spanish]; Acrivastinum [Latin]; Benadryl allergy relief; BW 0270C; BW 825C; BW A825C; BW-825C; Acrivastine (USAN/INN); Acrivastine [USAN:INN:BAN]; E-(9CI); (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; (E,E)-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid; 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid DTD0003 VADRUGID DR01435 DTD0003 DRUGNAME Estriol DTD0003 DRUGSYNO Aacifemine; Destriol; Estratriol; Estriel; Estriolo; Gynaesan; Hemostyptanon; Holin; Hormomed; Hormonin; Klimoral; Oestratriol; Oestriol; Oestriolum; Orestin; Orgastyptin; Overstin; Ovestin; Ovestrion; Stiptanon; Synapause; Theelol; Thulol; Tridestrin; Trihydroxyestrin; Trihydroxyoestrin; Triodurin; Triovex; Deuslon A; Estriolo [Italian]; Folicular hormone; Follicular hormone hydrate; Oestriol [Steroidal oestrogens]; A 13610; E0218; OE3; Deuslon-A; Estriel (TN); Estriol [USAN:JAN]; Estriol, unconjugated; Ortho-Gynest; Estriol (JP15/USP); Estra-1,3,5(10)-trien-3,16alpha,17beta-triol; Estra-1,3,5(10)-triene-3,16,17-triol; Estra-1,3,5(10)-triene-3,16alpha,17beta-triol; Oestra-1,3,5(10)-triene-3,16alpha,17beta-triol; Oestra-1,3,5(10)-triene-3,16-alpha,17-beta-triol; Estra-1,3,5(10)-trien-3,16.alpha., 17.beta.-triol; Estra-1,3,5(10)-trien-3,16.alpha.,17.beta.-triol; Estra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; Estra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol; Oestra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; Oestra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol; (16.alpha.,17.beta.)-Estra-1,3,5(10)-triene-3,16,17-triol; (16.alpha.,17.beta.)-Oestra-1,3,5(10)-triene-3,16,17-triol; (16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol; (16alpha,17beta)-Oestra-1,3,5(10)-triene-3,16,17-triol; 1,3,5(10)-ESTRATRIENE-3,16,17-TRIOL; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol; 1,3,5(10)-Estratriene-3,16.alpha., 17.beta.-triol; 1,3,5(10)-Estratriene-3,16.alpha.,17.beta.-triol; 1,3,5(10)-Estratriene-3,16alpha,17beta-Triol; 1,3,5-Estratriene-3.beta.,16-.alpha.,17-.beta.-triol; 1,3,5-Estratriene-3beta,16alpha,17beta-triol; 1,3,5-Oestratriene-3-.beta.,16.alpha.,17.beta.-triol; 1,3,5-Oestratriene-3beta,16alpha,17beta-triol; 16,17-Epiestriol; 16-Epiestriol; 16-Hydroxyestradiol; 16-alpha,17-beta-Estriol; 16-alpha,17-beta-Oestriol; 16-alpha-Hydroxyestradiol; 16-alpha-Hydroxyoestradiol; 16.alpha.,17.beta.-Estriol; 16.alpha.,17.beta.-Oestriol; 16.alpha.-Estriol; 16.alpha.-Hydroxy-17.beta.-estradiol; 16.alpha.-Hydroxyestradiol; 16.alpha.-Hydroxyoestradiol; 16alpha,17beta-Estriol; 16alpha,17beta-Oestriol; 16alpha-Hydroxy-17beta-estradiol; 16alpha-Hydroxyestradiol; 16alpha-Hydroxyoestradiol; 3,16-alpha,17-beta-Estriol; 3,16-alpha,17-beta-Oestriol; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-estratriene; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-oestratriene; 3,16-alpha,17-beta-Trihydroxyestra-1,3,5(10)-triene; 3,16-alpha,17-beta-Trihydroxyoestra-1,3,5(10)-triene; 3,16.alpha.,17.beta.-Estriol; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-estratriene; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-oestratriene; 3,16.alpha.,17.beta.-Trihydroxy-1,3,5(10)-estratriene; 3,16.alpha.,17.beta.-Trihydroxyestra-1,3,5(10)-triene; 3,16alpha,17beta-Estriol; 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene; 3,16alpha,17beta-Trihydroxy-delta-1,3,5-oestratriene; 3,16alpha,17beta-trihydroxy-Delta(1,3,5)-estratriene DTD0003 VADRUGID DR00019 DTD0003 DRUGNAME Estrone sulfate DTD0003 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0003 VADRUGID DR01663 DTD0003 DRUGNAME Fucoxanthin DTD0003 DRUGSYNO Fucoxanthin; UNII-06O0TC0VSM; CCRIS 4055; all-trans-Fucoxanthin; BRN 0073179; 06O0TC0VSM; beta,beta-Carotene, 3'-(acetyloxy)-6',7'-didehydro-5,6-epoxy-5,5',6,6',7,8-hexahydro-3,5'-dihydroxy-8-oxo-, (3S,3'S,5R,5'R,6S,6'R)-; (3S,5R,6S,3'S,5'R,6'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,6-epoxy-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-3'-yl acetate; (3'S,5'R,6'R)-3'-acetoxy-5,6-epoxy-3,5'-dihydroxy-6',7'-didehydro-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-8-one DTD0003 VADRUGID DR01722 DTD0003 DRUGNAME Gepirone DTD0003 DRUGSYNO Gepirone; 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione; Gepirone ER; Gepironum [Latin]; Gepirone [INN]; Gepirona [Spanish]; UNII-JW5Y7B8Z18; BMY-13805; JW5Y7B8Z18; CHEMBL284092; MJ-13805; Variza; Ariza; Gepironum; AK115965; Gepirona; 4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione; Travivo; 2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-; BMY 13805; MJ 13805; gepiron ER; MJ 13805-1; ORG-13011(Gepirone); AC1L1IK6; AC1Q6F8Q DTD0003 VADRUGID DR01687 DTD0003 DRUGNAME Sitafloxacin DTD0003 DRUGSYNO Sitafloxacin; Gracevit; Sitafloxacin Sesquihydrate; UNII-3GJC60U4Q8; Sitafloxacin isomer II; DU-6859a; C19H18ClF2N3O3; 3GJC60U4Q8; 7-((S)-7-AMINO-5-AZASPIRO[2.4]HEPTAN-5-YL)-8-CHLORO-6-FLUORO-1-((1R,2S)-2-FLUOROCYCLOPROPYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; STFX; 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxo-quinoline-3-carboxylic acid DTD0003 VADRUGID DR01543 DTD0003 DRUGNAME Pazufloxacin DTD0003 DRUGSYNO Pazufloxacin; T-3761; Pazufloxacin [INN]; UNII-4CZ1R38NDI; CCRIS 7312; T 3761; 4CZ1R38NDI; C16H15FN2O4; NCGC00167534-01; DSSTox_CID_26697; DSSTox_RID_81831; DSSTox_GSID_46697; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)-; SMR000466380; (-)-(3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid DTD0003 VADRUGID DR01346 DTD0003 DRUGNAME Morphine-6-glucuronide DTD0003 DRUGSYNO Morphine-6-glucuronide; Morphine 6-glucuronide; 20290-10-2; UNII-64Y9KYM60R; Morphine 6-beta-D-glucopyranosiduronide; 64Y9KYM60R; CHEBI:80581; MORPHINE GLUCURONIDE; MORPHINE 6-GLUCURONIDE(MINOR); beta-D-Glucopyranosiduronic acid, (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl; Morphine 6-beta-D-Glucuronide; Glucopyranosiduronic acid, 7,8-didehydro-4,5-alpha-epoxy-3-hydroxy-17-methylmorphinan-6-alpha-yl-, beta-D-; Morphine glucuronide [INN]; morphine-glucuronide DTD0003 VADRUGID DR01628 DTD0003 DRUGNAME Guanfacine DTD0003 DRUGSYNO GUANFACINE; Tenex; Guanfacinum [INN-Latin]; Guanfacina [INN-Spanish]; Estulic; Intuniv; N-amidino-2-(2,6-dichlorophenyl)acetamide; CHEBI:5558; INJOMKTZOLKMBF-UHFFFAOYSA-N; SPD 503; C9H9Cl2N3O; N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide; Guanfacine Monohydrochloride; NCGC00015469-05; Lon798; Guanfacine (INN); Estulic (TN); Tenex (Salt/Mix); Estulic (Salt/Mix); Tocris-1030; Prestwick1_000339; Prestwick3_000339; Prestwick2_000339; Prestwick0_000339; Lopac-G-1043 DTD0003 VADRUGID DR01484 DTD0003 DRUGNAME Apafant DTD0003 DRUGSYNO Apafant; 105219-56-5; WEB-2086; Web 2086; Apafant [USAN:INN]; Apafantum [INN-Latin]; Apafanto [INN-Spanish]; WEB 2086BS; WEB2086; UNII-J613NI05SV; WEB 2086 BS; BRN 4302553; C22H22ClN5O2S; J613NI05SV; CHEMBL280164; NCGC00092377-03; NCGC00092377-02; Apafantum; Apafanto; DSSTox_CID_28900; DSSTox_RID_83168; DSSTox_GSID_48974; 4-(3-(4-(o-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepin-2-yl)propionyl)morpholine; [3H]apafant; Morpholine; Apafant (ophthalmic formulation), Santen DTD0003 VADRUGID DR01645 DTD0003 DRUGNAME Cephaeline DTD0003 DRUGSYNO Cephaeline; Cephaelin; 483-17-0; 7',10,11-Trimethoxyemetan-6'-ol; UNII-QA971541A1; Desmethylemetine; QA971541A1; Dihydropsychotrine; Cepheline; GNF-Pf-307; (1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol; NSC32944; Cephaelinel; (-)-Cephaeline; EINECS 207-591-6; Prestwick2_000428; Prestwick3_000428; Prestwick1_000428; Prestwick0_000428; AC1L9CF2; BSPBio_000416; SCHEMBL181711; SPBio_002355; CHEMBL255708 DTD0003 VADRUGID DR01537 DTD0003 DRUGNAME Coelenterazine DTD0003 DRUGSYNO coelenterazine; Coelenteramine; Oplophorus luciferin; UNII-3O1CB88RRD; CLZN; 8-benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one; coelenterate luciferin; Coelenterazine, native; 3O1CB88RRD; MFCD00467176; C-7001; C-7002; 8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-7H-imidazo[1,2-a]pyrazin-3-one; 8-Benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo-[1,2a]pyrazin-3(7H)-one; 2-(p-Hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo[1,2-a]pyrazin-3-(7H)-one DTD0003 VADRUGID DR01471 DTD0003 DRUGNAME AG1478 DTD0003 DRUGSYNO AG-1478; 153436-53-4; Tyrphostin AG 1478; N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 175178-82-2; Tyrphostin AG-1478; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; AG 1478; AG1478; TYRPHOSTIN; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-; UNII-SUH0SEZ9HY; SUH0SEZ9HY; AG-1478 hydrochloride; AG-1478 (Tyrphostin AG-1478); CHEMBL7917; CHEBI:75404; N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine; NSC-693255; AK-63142; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine; BRD6408; BRD-6408; SR-01000076156; NSC693255 DTD0004 TRANSPID DTD0004 DTD0004 GENENAME ABCG2 DTD0004 PROTNAME Breast cancer resistance protein DTD0004 SYNONYMS ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter DTD0004 VADRUGID DR00037 DTD0004 DRUGNAME Cimetidine DTD0004 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0004 VADRUGID DR00079 DTD0004 DRUGNAME Riboflavin DTD0004 DRUGSYNO (-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2 DTD0004 VADRUGID DR00118 DTD0004 DRUGNAME Sphingosine-1-phosphate DTD0004 DRUGSYNO (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate DTD0004 VADRUGID DR00130 DTD0004 DRUGNAME Leflunomide DTD0004 DRUGSYNO 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl; 4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl); 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide; 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide); 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide; 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide; 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide; AP-501/42475599; Alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide; Arava; Arava (TN); Arava, Leflunomide; Aventis Behring Brand of Leflunomide; Aventis Brand of Leflunomide; Aventis Pharma Brand of Leflunomide; HWA 486; HWA-486; Hoechst Brand of Leflunomide; L 5025; Leflunomid; Leflunomida; Leflunomida [INN-Spanish]; Leflunomide (JAN/USAN/INN); Leflunomide [USAN:INN]; Leflunomidum; Leflunomidum [INN-Latin]; Lefunamide; Lefunomide [Inn-Spanish]; N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide; N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide; RS-34821; SU 101; SU 101 (pharmaceutical); SU-101; SU101 DTD0004 VADRUGID DR00145 DTD0004 DRUGNAME Mercaptopurine DTD0004 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0004 VADRUGID DR00204 DTD0004 DRUGNAME Ponatinib DTD0004 DRUGSYNO Iclusig (TN) DTD0004 VADRUGID DR00021 DTD0004 DRUGNAME Teniposide DTD0004 DRUGSYNO 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide DTD0004 VADRUGID DR00143 DTD0004 DRUGNAME Vincristine DTD0004 DRUGSYNO 22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH DTD0004 VADRUGID DR01330 DTD0004 DRUGNAME Clofarabine DTD0004 DRUGSYNO (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN) DTD0004 VADRUGID DR00284 DTD0004 DRUGNAME Daunorubicin DTD0004 DRUGSYNO (+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103 DTD0004 VADRUGID DR00386 DTD0004 DRUGNAME Idarubicin DTD0004 DRUGSYNO (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN) DTD0004 VADRUGID DR00510 DTD0004 DRUGNAME Thioguanine DTD0004 DRUGSYNO 2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B DTD0004 VADRUGID DR00269 DTD0004 DRUGNAME Mitoxantrone DTD0004 DRUGSYNO 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate) DTD0004 VADRUGID DR00454 DTD0004 DRUGNAME Sunitinib DTD0004 DRUGSYNO 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN) DTD0004 VADRUGID DR00205 DTD0004 DRUGNAME Riluzole DTD0004 DRUGSYNO 2-Amino-6-(trifluoromethoxy)-benzothiazole; 2-Amino-6-(trifluoromethoxy)benzothiazole; 2-Amino-6-trifluoro-methoxybenzothiazole; 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; 2-amino-6-(trifluoromethoxyl)benzothiazole; 2-amino-6-trifluoromethoxybenzothiazole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 6-trifluoromethoxybenzothiazole-2-yl-amine; ALBB-006046; Amino-2 trifluoromethoxy-6 benzothiazole; Amino-2 trifluoromethoxy-6 benzothiazole [French]; BF-37; PK-26124; PK-26124, RP-54274, Rilutek, Riluzole; R-116; RP 54274; RP-54274; Rilutek; Rilutek (TN); Riluzol; Riluzol [INN-Spanish]; Riluzole (JAN/USAN/INN); Riluzole HCl; Riluzole [USAN:INN]; Riluzolum; Riluzolum [INN-Latin]; ZERO/001785 DTD0004 VADRUGID DR00280 DTD0004 DRUGNAME Nicardipine DTD0004 DRUGSYNO 2-(Benzylmethylamino)ethylmethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cardene (TN); Cardene IV; Methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nicardipine (INN); Nicardipine LA; Nicardipine [INN:BAN]; Nicardipino; Nicardipino [INN-Spanish]; Nicardipinum; Nicardipinum [INN-Latin]; Y-93 DTD0004 VADRUGID DR01382 DTD0004 DRUGNAME Alfuzosin DTD0004 DRUGSYNO Alfusosine; Alfuzosina; Alfuzosine; Alfuzosinum; Alphuzosine; Alfuzosina [Spanish]; Alfuzosine [French]; Alfuzosinum [Latin]; Alfuzosin (INN); Alfuzosin [INN:BAN]; Xatral (TN); N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide DTD0004 VADRUGID DR00819 DTD0004 DRUGNAME Apatinib DTD0004 DRUGSYNO Apatinib; Apatinib Mesylate; YN968D1; YN-968D1; UNII-TK02X14ASJ; YN 968D1; TK02X14ASJ; 3-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-, methanesulfonate (1:1); Rivoceranib mesylate; 3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-, methanesulfonate (1:1); Apatinib-YN968D1; Apatinib - YN968D1; Apatinib (YN968D1); MLS006011286; CHEMBL3545414; KS-00000TST; DTXSID80153427; HMS3655H12; BCP15234; AOB87128; BDBM50152828; s2221; AKOS026750547 DTD0004 VADRUGID DR00129 DTD0004 DRUGNAME Estradiol DTD0004 DRUGSYNO 17 beta-Estradiol; 17-.BETA.-Estradiol; 17-beta-OH-estradiol; 17-beta-estradiol; 17.beta.-Estradiol; 17.beta.-Oestradiol; 17b-Oestradiol; 17beta oestradiol; 17beta-Estradiol; 17beta-Oestradiol; 3,17-beta-Estradiol; 3,17-beta-Oestradiol; 3,17.beta.-Estradiol; 3,17beta-Estradiol; Activella (TN); Aerodiol; Alora; Alora (TN); Alpha-Estradiol; Alpha-Oestradiol; Altrad; AngeliQ (TN); Aquadiol; B-Estradiol; Bardiol; Beta-Oestradiol; Beta-estradiol; CMC_11154; Cis-Estradiol; Cis-Oestradiol; Climaderm; Climara; Climara (TN); Climara Forte; Component of Menrium; Compudose; Compudose 200; Compudose 365; Corpagen; D-3,17beta-Estradiol; D-Estradiol; D-Oestradiol; Dermestril; Destradiol; Dihydrofolliculin; Dihydromenformon; Dihydrotheelin; Dihydroxyesterin; Dihydroxyestrin; Dihydroxyoestrin; Dimenformon; Diogyn; Diogynets; Divigel; Divigel (TN); E 2; E 8875; E(sub 2); E0025; Elestrin; Elestrin (TN); Encore; Epiestriol 50; Esclim; Estrace; Estrace (TN); Estraderm; Estraderm (TN); Estraderm MX; Estraderm TTS; Estraderm TTS (TN); Estraderm TTS 100; Estraderm TTS 50; Estradiol [USAN:INN]; Estradiol acetate (TN); Estradiol cypionate (TN); Estradiol valerate (TN); Estradiol-17 beta; Estradiol-17-beta; Estradiol-17beta; Estradiol-3,17beta; Estradiolo; Estradiolo [DCIT]; Estradiolum; Estradiolum [INN]; Estradot; Estraldine; Estrapak 50; Estrasorb; Estrasorb (TN); Estrasorb Topical (TN); Estreva; Estrifam; Estring; Estring (TN); Estring vaginal ring; Estroclim; Estroclim 50; Estrodiolum; Estrofem (TN); Estrofem 2; Estrofem Forte; Estrogel; Estrogel (TN); Estrovite; EvaMist (TN); Evamist; Evorel; Extrasorb; Femanest; Femestral; Femestrol; Femogen; Fempatch; Femring (TN); Femtrace; Femtran; Follicyclin; Gelestra; Ginedisc; Ginosedol; GynPolar; Gynergon; Gynestrel; Gynodiol; Gynoestryl; Innofem; Innofem (TN); Lamdiol; Macrodiol; Macrol; Menest; Menorest; Menostar (TN); Microdiol; Nordicol; Oesclim; Oestergon; Oestradiol; Oestradiol Berco; Oestradiol R; Oestradiol-17-beta; Oestradiol-17beta; Oestradiolum; Oestrogel; Oestroglandol; Oestrogynal; Ovahormon; Ovasterol; Ovastevol; Ovociclina; Ovocyclin; Ovocycline; Ovocylin; Perlatanol; Polyestradiol; Primofol; Profoliol; Profoliol B; Progynon DH; Progynon-DH; Progynon;Syndiol; Progynova (TN); S-21400; SK-Estrogens; SL-1100; Sandrena 1; Sandrena Gel; Sisare Gel; Systen; Tradelia; Trial SAT; Trocosone; VIVELLE-DOT; Vagifem; Vagifem (TN); Vivelle; Vivelle (TN); Vivelle-Dot (TN); Zerella; Zesteem; Zesteen; Zumenon; [2,4,6,7-3H]-E2; [3H]-estradiol; [3H]]estradiol DTD0004 VADRUGID DR00120 DTD0004 DRUGNAME Lapatinib DTD0004 DRUGSYNO 4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline; FMM; GSK 572016; GSK572016; GW 572016; GW 572016X; GW572016; Lapatinib (ERBB2 inhibitor); Lapatinib (INN); Lapatinib Ditosylate; Lapatinib [INN]; Lapatinib tosilate hydrate; Lapatinib, Tykerb, GW572016; N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine; N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine; N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine; N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE; Tycerb; Tykerb (TN) DTD0004 VADRUGID DR00342 DTD0004 DRUGNAME Paclitaxel DTD0004 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0004 VADRUGID DR01288 DTD0004 DRUGNAME Palbociclib DTD0004 DRUGSYNO LQQ; 571190-30-2; 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE; 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one; G9ZF61LE7G; HMR-2934; Ibrance; PD 0332991; PD 332991; PD 332991, PD 0332991, PD0332991; PD-0332991; PD-332991; PD0332991; Palbociclib(PD0332991); UNII-G9ZF61LE7G DTD0004 VADRUGID DR01430 DTD0004 DRUGNAME Pirarubicin DTD0004 DRUGSYNO pirarubicin; Theprubicin; MFCD00869742; THP-doxorubicin; C32H37NO12; NCGC00167982-01; AC1LCS5T; Pirarubicin (JP17/INN); SCHEMBL15472856; CHEMBL1398373; EX-A494; AOB5649; KMSKQZKKOZQFFG-HSUXVGOQSA-N; ZINC3913909; AKOS015895621; NCGC00167982-02; BC225325; K234; D01885; 15207-EP2316833A1; 15207-EP2311829A1; 15207-EP2298765A1; 15207-EP2298748A2; 15207-EP2295427A1; 15207-EP2295416A2; 15207-EP2272827A1; 15207-EP2316832A1; 15207-EP2298778A1; 15207-EP2298768A1; 15207-EP2295426A1; 15207-EP2295055A2; 15207-EP2311808A1 DTD0004 VADRUGID DR00366 DTD0004 DRUGNAME Talazoparib DTD0004 DRUGSYNO (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one; (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one; (8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One; LT-673; Talazoparib; Talazoparib (BMN 673); Talazoparib [USAN:INN] DTD0004 VADRUGID DR00193 DTD0004 DRUGNAME Tamoxifen DTD0004 DRUGSYNO (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN) DTD0004 VADRUGID DR00251 DTD0004 DRUGNAME Docetaxel DTD0004 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0004 VADRUGID DR00423 DTD0004 DRUGNAME Gefitinib DTD0004 DRUGSYNO 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839 DTD0004 VADRUGID DR01390 DTD0004 DRUGNAME CP-724714 DTD0004 DRUGSYNO CP 724714; CP-724,714; CP724,714, CP-724,714; 2-Methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide; 2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide DTD0004 VADRUGID DR01459 DTD0004 DRUGNAME C-1311 DTD0004 DRUGSYNO XF-02; NSC-645809; C-1311; Imidacrine; Symadex; CHEMBL3545337; XJYNBZQTAZDMHZ-UHFFFAOYSA-N; Imidazoacridone dihydrocheloride hydrate; 138154-55-9; 5-((2-(diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one dihydrochloride hydrate DTD0004 VADRUGID DR01203 DTD0004 DRUGNAME Dactinomycin DTD0004 DRUGSYNO 1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97 DTD0004 VADRUGID DR01460 DTD0004 DRUGNAME Phenethyl isothiocyanate DTD0004 DRUGSYNO Phenethyl-isothiocyanate DTD0004 VADRUGID DR01700 DTD0004 DRUGNAME Azidothymidine monophosphate DTD0004 DRUGSYNO azidothymidine monophosphate; SCHEMBL17515060 DTD0004 VADRUGID DR01712 DTD0004 DRUGNAME Barasertib-hQPA DTD0004 DRUGSYNO AZD1152-HQPA; Barasertib (AZD1152-HQPA); AZD-1152HQPA; barasertib-hQPA; UNII-29P8LWS24N; INH 34; AZD1152 HPQA; 29P8LWS24N; CHEMBL215152; 2-[5-(7-{3-[Ethyl-(2-hydroxy-ethyl)-amino]-propoxy}-quinazolin-4-ylamino)-2H-pyrazol-3-yl]-N-(3-fluoro-phenyl)-acetamide; 2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide; 5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide; AZD 1152 DTD0004 VADRUGID DR01619 DTD0004 DRUGNAME BMS 536924 DTD0004 DRUGSYNO BMS-536924; BMS 536924; BMS536924; UNII-40E3AZG1MX; 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone; 40E3AZG1MX; CHEMBL401930; CS-0117; HY-10262; MLS006011171; SCHEMBL4132577; SCHEMBL15974144; BDBM27879; BCP02116; ZINC6718468; 2278AH; s1012; ABP000159; ZINC140935730; AKOS024458339; AKOS025149514; SB19378; RL03740; KIN0000061; NCGC00346460-05; NCGC00346460-02; SMR004702940; BMS-536924/BMS536924; A2238; X5078; SW218124-2; S-7752 DTD0004 VADRUGID DR01570 DTD0004 DRUGNAME Homocamptothecin DTD0004 DRUGSYNO homocamptothecin; UNII-5B3LFU8GLM; 5B3LFU8GLM; E-Homocamptothecin; E-Homocamptothecine; (20R)-Homocamptothecin; E-Homocamptothecin, (R)-; CHEMBL74190; SCHEMBL5860320; PAEZRCINULFAGO-OAQYLSRUSA-N; ZINC840834; 3H,15H-Oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy-, (5R)-; 3H,15H-Oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy-, (R)- DTD0004 VADRUGID DR01495 DTD0004 DRUGNAME JNJ 7706621 DTD0004 DRUGSYNO JNJ-7706621; 443797-96-4; JNJ7706621; 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide; UNII-74GK72DON8; RWJ-387252; 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide; CHEMBL191003; 74GK72DON8; 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide; JNJ 7706621; 4-(5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide DTD0004 VADRUGID DR01638 DTD0004 DRUGNAME N-desethyl sunitinib DTD0004 DRUGSYNO N-Desethyl Sunitinib; N-DesethylSunitinib; UNII-42LJ35612R; 42LJ35612R; C20H23FN4O2; N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; SCHEMBL2115189; CHEMBL3542344; DTXSID10437828 DTD0004 VADRUGID DR01601 DTD0004 DRUGNAME Pancratistatin DTD0004 DRUGSYNO Pancratistatin; (+)-Pancratistatin; NSC349156; MLS002701837; AC1L9BE4; SCHEMBL93612; CHEMBL419335; VREZDOWOLGNDPW-ALTGWBOUSA-N; ZINC4097654; (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one; NSC-349156; SMP1_000217; NCI60_003105; B844009K070; C08535 DTD0004 VADRUGID DR00372 DTD0004 DRUGNAME Sofosbuvir DTD0004 DRUGSYNO HSDB 8226; Hepcinat; Hepcvir; Resof; SOFOSBUVIR; Sofosbuvir (PSI-7977, GS-7977); Sofosbuvir [USAN:INN]; Sovaldi (TN); SoviHep DTD0004 VADRUGID DR01277 DTD0004 DRUGNAME Entecavir DTD0004 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0004 VADRUGID DR00116 DTD0004 DRUGNAME Lamivudine DTD0004 DRUGSYNO (+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix DTD0004 VADRUGID DR01337 DTD0004 DRUGNAME Tenofovir alafenamide DTD0004 DRUGSYNO (S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate; AK109983; EL9943AG5J; GS 7340; GS-7339; GS-7340; GS7340; J4414G3BUK; L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester; TENOFOVIR ALAFENAMIDE; Tenofovir Alafenamide (GS-7340); Tenofovir Alafenamide [USAN:INN]; UNII-EL9943AG5J; UNII-J4414G3BUK; Vemlidy DTD0004 VADRUGID DR00219 DTD0004 DRUGNAME Idelalisib DTD0004 DRUGSYNO (S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; 1146702-54-6; 5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE; 5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one; AK145603; CAL 101; CAL-101; CAL-101 (Idelalisib, GS-1101); CAL101; CHEBI:82701; CHEMBL2216870; GS-1101; Idelalisib; UNII-YG57I8T5M0; YG57I8T5M0; Zydelig DTD0004 VADRUGID DR00235 DTD0004 DRUGNAME Flavopiridol DTD0004 DRUGSYNO (-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one; 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE; 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one; Alvocidib [INN]; FLAVO; Flavopiridol; Flavopiridol hydrochloride; HMR-1275; HMR-1275, Alvocidib, L868275, Flavopiridol; L 868275; L-868275; L86-8275 DTD0004 VADRUGID DR00013 DTD0004 DRUGNAME Nilotinib DTD0004 DRUGSYNO Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716 DTD0004 VADRUGID DR00032 DTD0004 DRUGNAME Imatinib DTD0004 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0004 VADRUGID DR00112 DTD0004 DRUGNAME Irinotecan DTD0004 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0004 VADRUGID DR00316 DTD0004 DRUGNAME Oxaliplatin DTD0004 DRUGSYNO ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138 DTD0004 VADRUGID DR00287 DTD0004 DRUGNAME Resveratrol DTD0004 DRUGSYNO (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4′,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol DTD0004 VADRUGID DR00225 DTD0004 DRUGNAME Quercetin DTD0004 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0004 VADRUGID DR00027 DTD0004 DRUGNAME Ganciclovir DTD0004 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0004 VADRUGID DR00094 DTD0004 DRUGNAME Glibenclamide DTD0004 DRUGSYNO 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon DTD0004 VADRUGID DR00208 DTD0004 DRUGNAME Estradiol-17beta-glucuronide DTD0004 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0004 VADRUGID DR00336 DTD0004 DRUGNAME Hematoporphyrin DTD0004 DRUGSYNO 1,3,5,8-Tetramethyl-2,4-bis(alpha-hydroxyethyl)prophine-6,7-dipropionic acid; 2,18-Porphinedipropionic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl); 7,12-Bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid; HEMATOPORPHYRIN; HP; HP (VAN); Haematoporphyrin; Hematoporphyrin I; Hematoporphyrin IX; ISOHEMATOPORPHYRIN IX; NSC 267084; NSC 59265; NSC59265; Photodyn DTD0004 VADRUGID DR00206 DTD0004 DRUGNAME Pitavastatin calcium DTD0004 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0004 VADRUGID DR00646 DTD0004 DRUGNAME Chlorothiazide DTD0004 DRUGSYNO 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Aldoclor; Alurene; C 4911; Chloriazid; Chlorosal; Chlorothiazid; Chlorothiazide (JAN/USP/INN); Chlorothiazide [USAN:INN:BAN]; Chlorothiazidum; Chlorothiazidum [INN-Latin]; Chlorotiazida; Chlorthiazid; Chlorthiazide; Chlorthiazidum; Chlortiazid; Chlorurit; Chlotride; Chlrosal; Clorotiazida; Clorotiazida [INN-Spanish]; Clorotiazide; Clorotiazide [DCIT]; Clotride; Component of Aldoclor; Diupres; Diuresal; Diuril; Diuril (TN); Diuril Boluses; Diuril Boluses, Veterinary; Diuril, Chlotride, Chlorothiazide; Diurilix; Diurite; Diutrid; Flumen; Minzil; Neo-Dema; Salisan; Salunil; Saluretil; Saluric; Sk-chlorothiazide; Thiazide; Urinex; Warduzide; Yadalan DTD0004 VADRUGID DR00087 DTD0004 DRUGNAME Cladribine DTD0004 DRUGSYNO (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000 DTD0004 VADRUGID DR00613 DTD0004 DRUGNAME Dipyridamole DTD0004 DRUGSYNO 2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; Agilease; Anginal; Antistenocardin; Apo-Dipyridamole; Apo-Dipyridamole Fc; Apo-Dipyridamole Sc; Apotex Brand of Dipyridamole; Apricor; Ashbourne Brand of Dipyridamole; Belmac Brand of Dipyridamole; Berlin Chemie Brand of Dipyridamole; Berlin-Chemie Brand of Dipyridamole; Boehringer Ingelheim Brand of Dipyridamole; Cardioflux; Cardoxil; Cardoxin; Cerebrovase; Chilcolan; Cleridium; Cleridium 150; Coribon; Coridil; Coronarine; Corosan; Coroxin; Curantil; Curantyl; D 9766; Dipiridamol; Dipiridamol [INN-Spanish]; Dipyramidole; Dipyridamine; Dipyridamol; Dipyridamole (JP15/USP/INN); Dipyridamole [USAN:INN:BAN:JAN]; Dipyridamolum; Dipyridamolum [INN-Latin]; Dipyridan; Dipyudamine; Dypyridamol; Gulliostin; IPRAD Brand of Dipyridamole; Iv Persantine; Justpertin; Kurantil; Miosen; Natyl; Novo-Dipiradol; Novopharm Brand of Dipyridamole; Peridamol; Permiltin; Permole, Persantine, Dipyridan, Dipyridamole; Persantin; Persantine; Persantine (TN); Piroan; Prandiol; Prandiol 75; Protangix; RA-8; Stenocardil; Stenocardiol; Stimolcardio; Usaf Ge-12 DTD0004 VADRUGID DR00347 DTD0004 DRUGNAME Olmesartan medoxomil DTD0004 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0004 VADRUGID DR00636 DTD0004 DRUGNAME Reserpine DTD0004 DRUGSYNO 3P Reserp; Abesta; Abicol; Adelfan; Adelphin; Alkarau; Alkaserp; Alserin; Apoplon; Apoplon (TN); Apsical; Ascoserp; Ascoserpina; Austrapine; Banasil; Banisil; Benazyl; Bioserpine; Brinderdin; Briserine; Broserpine; Cam-Ap-Es; Cardioserpin; Carditivo; Carpacil; Carrserp; Darebon; Deserpine; Diupres 250; Diupres 500; Diupres-250; Diupres-500; Diurese-R; Diutensen-R; Dralserp; ENT 50146; Eberpine; Eberspine; Ebserpine; Elfanex; Elserpine; Enipresser; Esc aspere; Escaspere; Eserpine; Eskaserp; Eskaserpine; Gammaserpine; Gilucard; H 520; HYDRO-RESERP; Helfoserpin; Hexaplin; Hiposerpil; Hiserpia; Hydrap-ES; Hydromox R; Hydromox-R; Hydropine; Hydropres 25; Hydropres 50; Hydroserp; Hydrosine 25; Hypercal B; Hypersil; Hypersine; Hypertensan; Idoserp; Idsoserp; Interpina; Key-serpine; Kitine; Klimanosid; L"-Carpserp; L-Carpserp; Lemiserp; Loweser p; Loweserp; Mallopress; Maviserpin; Mayserpine; Mephaserpin; Modenol; Naquival; Nembuserpin; Neo-serp; Neose rfin; Neoserfin; Neoserp; Neoslowten; Orthoserpina; Perskleran; Pressimedin; Purserpine; Quiescin; R 0875; R-e-s; Rau sedyl; Rau-Sed; Raucap; Raudiford; Raudixin; Raudixoid; Raugal; Raulen; Rauloydin; Raumorine; Raunervil; Raunorine; Raunova; Raupasil; Raupoid; Raurine; Rausan; Rausedan; Rausedil; Rausedyl; Rauserpin; Rauserpine; Rauserpol; Rausingle; Rautrin; Rauvlid; Rauwasedin; Rauwilid; Rauwiloid; Rauwipur; Rauwita; Rauwoleaf; Rawilid; Recipin; Regroton; Renese R; Renese-R; Resaltex; Rese rpamed; Rese-lar; Resedrex; Resedril; Reser-ar; Reserbal; Resercaps; Resercen; Reserfia; Reserjen; Reserlor; Reserp; Reserpal; Reserpamed; Reserpanca; Reserpene; Reserpex; Reserpidefe; Reserpil; Reserpin; Reserpina; Reserpinum; Reserpka; Reserpoid; Reserpur; Reserutin; Resiatric; Residin; Residine; Resine; Resocalm; Resperin; Resperine; Respital; Restran; Rezerpin; Riserpa; Rivased; Rivasin; Rolserp; Roxel; Roxinoid; Roxynoid; Ryser; SK-Reserpine; Salupres; Sandril; Sandron; Se rpate; Sedaraupin; Sedaraupina; Sederaupin; Sedserp; Seominal; Ser-A-Gen; Serfin; Serfolia; Serolfia; Serpalan; Serpaloid; Serpaneurona; Serpanray; Serpasil; Serpasol; Serpate; Serpazil; Serpazol; Serpedin; Serpen; Serpena; Serpentil; Serpentin; Serpentina; Serpicon; Serpil; Serpiloid; Serpilum; Serpine; Serpipur; Serpivate; Serpivite; Serpogen; Serpoid; Serpone; Serpyrit; Sertabs; Sertens; Sertensin; Sertina; Supergan; T-Serp; Tefaserpina; Temposerpine; Tensanyl; Tenserpinie; Tensional; Tensionorme; Tepserpine; Terbolan; Transerpin; Triserpin; Tylandril; Unilord; Unipres; Usaf cb-27; V Serp; V-Serp; VI XO; VIXO; Veriloid; Vio-Serpine DTD0004 VADRUGID DR00693 DTD0004 DRUGNAME Prazosin DTD0004 DRUGSYNO 1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone DTD0004 VADRUGID DR00588 DTD0004 DRUGNAME Abacavir DTD0004 DRUGSYNO (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol DTD0004 VADRUGID DR00619 DTD0004 DRUGNAME Delavirdine DTD0004 DRUGSYNO (1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE; (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide); 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine; 1-(5-Methanesulphonamido)-1H-indol-2-yl-carbonyl)-4-[3-(isopropylamino)-2-pyridinyl]piperaz; 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine; BHAP-U 90152; DELAVIRDINE MESYLATE; DLV; Delavirdine (*Mesylate salt*); Delavirdine (INN); Delavirdine [INN]; Delavirdine(U-90152) & .a.IFN; N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide; N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide; N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide; N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide; N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; PNU-90152-T; Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-& alpha-Interferon; Rescriptor; Rescriptor (TM);Rescriptor (TN); SPP; U 90152; U-90152; U-90152S; U90152S (*Mesylate salt*) DTD0004 VADRUGID DR00039 DTD0004 DRUGNAME Glutathione DTD0004 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0004 VADRUGID DR00290 DTD0004 DRUGNAME Lopinavir DTD0004 DRUGSYNO A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346 DTD0004 VADRUGID DR00309 DTD0004 DRUGNAME Saquinavir DTD0004 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0004 VADRUGID DR00174 DTD0004 DRUGNAME Tenofovir DTD0004 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0004 VADRUGID DR00296 DTD0004 DRUGNAME Zidovudine DTD0004 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0004 VADRUGID DR00301 DTD0004 DRUGNAME Doxorubicin DTD0004 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0004 VADRUGID DR00308 DTD0004 DRUGNAME Vinblastine DTD0004 DRUGSYNO (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine DTD0004 VADRUGID DR00140 DTD0004 DRUGNAME Ezetimibe DTD0004 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0004 VADRUGID DR00124 DTD0004 DRUGNAME Fluvastatin DTD0004 DRUGSYNO (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320 DTD0004 VADRUGID DR00045 DTD0004 DRUGNAME Pravastatin DTD0004 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0004 VADRUGID DR00223 DTD0004 DRUGNAME Rosuvastatin DTD0004 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0004 VADRUGID DR00435 DTD0004 DRUGNAME Simvastatin DTD0004 DRUGSYNO (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate DTD0004 VADRUGID DR00201 DTD0004 DRUGNAME Sulfasalazine DTD0004 DRUGSYNO 13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral DTD0004 VADRUGID DR00162 DTD0004 DRUGNAME Etoposide DTD0004 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0004 VADRUGID DR00082 DTD0004 DRUGNAME Methotrexate DTD0004 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0004 VADRUGID DR00449 DTD0004 DRUGNAME Hydroxychloroquine DTD0004 DRUGSYNO 2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol; 2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol; 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol; 7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline; 7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline; 7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline; Gen-Hydroxychloroquine 200mg Tablets; HCQ; Hidroxicloroquina; Hidroxicloroquina [INN-Spanish]; Hydroxychlorochin; Hydroxychloroguine; Hydroxychloroquine (INN);Hydroxychloroquine [INN:BAN]; Hydroxychloroquine Sulfate (1:1) Salt; Hydroxychloroquinum; Hydroxychloroquinum [INN-Latin]; Idrossiclorochina; Idrossiclorochina [DCIT]; Oxichlorochinum; Oxichloroquine; Oxychlorochin; Oxychloroquine; Plaquenil (TN); Polirreumin; Polirreumin (TN); Quensyl; WIN 1258 DTD0004 VADRUGID DR00318 DTD0004 DRUGNAME Pemetrexed DTD0004 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0004 VADRUGID DR01336 DTD0004 DRUGNAME Binimetinib DTD0004 DRUGSYNO 181R97MR71; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; 606143-89-9; ARRY 162; ARRY 438162; ARRY-162; ARRY-438162; Binimetinib (JAN/USAN); Binimetinib (MEK162, ARRY-162, ARRY-438162); Binimetinib [USAN:INN]; D0C4LF; MEK 162; MEK-162; MEK162; MEK162 (ARRY-162, ARRY-438162); MEK162(Binimetinib); NVP-ME; UNII-181R97MR71 DTD0004 VADRUGID DR00164 DTD0004 DRUGNAME Dabrafenib DTD0004 DRUGSYNO 1195765-45-7; CHEBI:75045; Dabrafenib (GSK2118436); Dabrafenib [USAN:INN]; GSK 2118436; GSK-2118436A; GSK2118436; GSK2118436A; N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide; QGP4HA4G1B; Tafinlar; UNII-QGP4HA4G1B DTD0004 VADRUGID DR00136 DTD0004 DRUGNAME Regorafenib DTD0004 DRUGSYNO 24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB DTD0004 VADRUGID DR00182 DTD0004 DRUGNAME Dasatinib DTD0004 DRUGSYNO (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel DTD0004 VADRUGID DR00092 DTD0004 DRUGNAME Teriflunomide DTD0004 DRUGSYNO (2Z)-2-[hydroxy-[4-(trifluoromethyl)anilino]methylidene]-3-oxobutanenitrile; (Z)-2-Cyano-alpha'alpha'alpha-trifluoro-3-hydroxy-p-crotonotoluidide; 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide; 2-hydroxyethylidene-cyanoacetic acid-4-trifluoromethyl anilide; A 771726; A-771726; Active metabolite of leflunomide; Flucyamide; HMR 1726; HMR-1726; N-(4-Trifluoromethylphenyl)-2-cyano-2-hydroxycrotonamide; RS 61980; RS-61980; SU 20; SU-0020; Teriflunomide [INN] DTD0004 VADRUGID DR00354 DTD0004 DRUGNAME Afatinib DTD0004 DRUGSYNO (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide; BIBW 2992; BIBW-2992; EGFR inhibitor 2nd gens; Tomtovok; Tovok; Tovok (TN); Tovok, BIBW2992 DTD0004 VADRUGID DR00558 DTD0004 DRUGNAME Erlotinib DTD0004 DRUGSYNO 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; AQ4; CP 358,774; CP-358,774; CP-358774; Erlotinib Base; Erlotinib(Tarceva); Erlotinib, OS-774; Erlotinin; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; OSI 744; R 1415; Tarceva; Tarceva (TN); [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine DTD0004 VADRUGID DR01498 DTD0004 DRUGNAME BN-80915 DTD0004 DRUGSYNO BN-80915; R-1536; Diflomotecan; (+)-5(R)-Ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione DTD0004 VADRUGID DR01437 DTD0004 DRUGNAME UCN-01 DTD0004 DRUGSYNO UCN; UCN01; Ucn 01; KRX-0601; KW-2401; UCN-02; (5s,6r,7r,9r,16r)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one; 7-Hydroxystaurosporine; 7-hydroxystaurosporine (UCN-01) DTD0004 VADRUGID DR01439 DTD0004 DRUGNAME Belotecan DTD0004 DRUGSYNO Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022 DTD0004 VADRUGID DR01383 DTD0004 DRUGNAME Camptothecin DTD0004 DRUGSYNO camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat DTD0004 VADRUGID DR00029 DTD0004 DRUGNAME Moxidectin DTD0004 DRUGSYNO C37H53NO8; Cydectin; Moxidectin [USAN:INN:BAN]; Moxidectina; Moxidectina [INN-Spanish]; Moxidectine; Moxidectine [INN-French]; Moxidectinum; Moxidectinum [INN-Latin]; NGU5H31YO9; ProHeart 6; UNII-NGU5H31YO9 DTD0004 VADRUGID DR00108 DTD0004 DRUGNAME Testosterone DTD0004 DRUGSYNO (17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone DTD0004 VADRUGID DR00044 DTD0004 DRUGNAME Topotecan DTD0004 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0004 VADRUGID DR00291 DTD0004 DRUGNAME Cisplatin DTD0004 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0004 VADRUGID DR01423 DTD0004 DRUGNAME Lurtotecan DTD0004 DRUGSYNO OSI-211; Lurtotecan [INN]; 149882-10-0; UNII-4J1L80T08I; OSI 211; NX 211; GG 211; Gi 147211; 4J1L80T08I; C28H30N4O6; CHEMBL341028; 11H-1,4-Dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8H,14H)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (8S)-; GI-147211C; lurtotecan liposome; AC1L1U8C; SCHEMBL19208; CHEMBL305666; DTXSID30164422; GG-211; ZINC22010625; NX-211; GW-211; BDBM50036130; DB12222; LS-173358; Lurtotecan dihydrochloride; GI 147211C; GG-147211C; GI-147211; GI-147211A; GL-147211C; Liposomal lurtotecan DTD0004 VADRUGID DR01371 DTD0004 DRUGNAME 9-Aminocamptothecin DTD0004 DRUGSYNO IDEC-132; (S)-10-Amino-4-ethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione; 9-Amino-20(S)-camptothecin DTD0004 VADRUGID DR01349 DTD0004 DRUGNAME Karenitecin DTD0004 DRUGSYNO Karenitecin (TN) DTD0004 VADRUGID DR00304 DTD0004 DRUGNAME Sorafenib DTD0004 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum DTD0004 VADRUGID DR00153 DTD0004 DRUGNAME Fluorouracil DTD0004 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0004 VADRUGID DR01469 DTD0004 DRUGNAME Exatecan mesylate DTD0004 DRUGSYNO Exatecan mesylate; DX-8951; DX-8951a; DX-8951f; UM-1; UM-2 DTD0004 VADRUGID DR01275 DTD0004 DRUGNAME Entacapone DTD0004 DRUGSYNO (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; COM-998; Comtan; Comtan (TN); Comtess; Entacapona; Entacapona [INN-Spanish]; Entacapone (JAN/USAN/INN); Entacapone [USAN:INN]; Entacaponum; Entacaponum [INN-Latin]; KB475572; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; Novartis brand of entacapone; OR 611; OR-611; Orion brand of entacapone; Stalevo (TN) DTD0004 VADRUGID DR00243 DTD0004 DRUGNAME Mycophenolate mofetil DTD0004 DRUGSYNO 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF DTD0004 VADRUGID DR01195 DTD0004 DRUGNAME Rabeprazole DTD0004 DRUGSYNO 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; Aciphex (TN); CL23619; Dexrabeprazole; Eraloc; Eraloc (TN); LY307640; Pariet (TN); Rabeprazole (INN); Rabeprazole [BAN:INN]; Rabeprazole [INN:BAN]; Rablet (TN); Rebeprazole sodium DTD0004 VADRUGID DR00281 DTD0004 DRUGNAME Progesterone DTD0004 DRUGSYNO LPCN-1107; Progesterone (oral, preterm labor); Progesterone (oral, preterm labor), Lipocine DTD0004 VADRUGID DR00227 DTD0004 DRUGNAME Rivaroxaban DTD0004 DRUGSYNO XARELTO (TN) DTD0004 VADRUGID DR00795 DTD0004 DRUGNAME Bicalutamide DTD0004 DRUGSYNO (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide; Bicalutamide (JAN/USP/INN); Bicalutamide [USAN:INN:BAN]; Calutide (TN); Casodex; Casodex (TN); Casodex, Cosudex, Calutide, Kalumid, Bicalutamide; Cosudex; Cosudex (TN); KS-1161; Kalumid (TN); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Propanamide; Raffolutil; Zeneca brand of bicalutamide DTD0004 VADRUGID DR01167 DTD0004 DRUGNAME Menadione DTD0004 DRUGSYNO Aquakay; 1,4-Naphthalenedione, 2-methyl-,radical ion(1-); 2-Methyl-1,4-naftochinon; 2-Methyl-1,4-naftochinon [Czech]; 2-Methyl-1,4-naphthalenedione; 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthochinon [German]; 2-Methyl-1,4-naphthoquinone; 2-Methylnaphthoquinone; 2-methyl-1,4-naphthoquinone, 5; 2-methylnaphthalene-1,4-dione; 3-Methyl-1,4-naphthoquinone; 58-27-5; Aquakay; Aquinone; Ascorbic acid/menadione; Hemodal; Juva-K; K-Thrombyl; K-Vitan; Kaergona; Kanone; Kappaxan (VAN); Kappaxin; Kappaxin (TN); Karcon; Kareon; Kativ-G; Kayklot; Kaykot; Kayquinone; Kipca; Kipca, oil soluble; Kipca-Oil Soluble; Klottone; Klottone;Koaxin; Koaxin; Kolklot; M0373; Memodol; Menadion; Menadione (K3); Menadione (USP); Menadione [USAN:BAN]; Menadione semiquinone; Menadionum; Menaphthon; Menaphthone; Menaphtone; Menaquinone 0; Methyl-1,4-naphthalenedione; Methyl-1,4-naphthoquinone; Methylnaphthoquinone; Mitenon; Mitenone; Panosine; Prokayvit; Synkay; Thyloquinone; Triglycyl-lysine-vasopressin; Usaf; Usaf ek-5185; VK3; Vicasol; Vitamin K 3; Vitamin K0; Vitamin K2(0); Vitamin K3; Vitamin K3 : 2-Methyl-1,4-naphthoquinone; Vitamin-K3; menadione DTD0004 VADRUGID DR00195 DTD0004 DRUGNAME Rhodamine 123 DTD0004 DRUGSYNO RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes DTD0004 VADRUGID DR00641 DTD0004 DRUGNAME Genistein DTD0004 DRUGSYNO 4 inverted exclamation marka,5,7-Trihydroxyisoflavone; 4′,5,7-Trihydroxyisoflavone; 4',5, 7-Trihydroxyisoflavone; 4',5,7-Trihydroxy isoflavone; 4',5,7-Trihydroxyisoflavone; 4,5,7-Trihydroxyiso-flavone; 4,6,7-Trihydroxyisoflavone; 5,7,4'-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; Bonistein; C.I. 75610; Differenol A; ENDOCRINE DISRUPTOR (GENISTEIN) (SEE ALSO GENISTEIN (446-72-0)); G 6649; G10000; GEN; GENISTEIN (ENDOCRINE DISRUPTER); Genestein; Genisteol; Genisterin; IN1327; Lactoferrin-genistein; NPI 031L; PTI G4660 (Genistein); PTI-G4660; Prunetol; SIPI 807-1; SIPI-9764-I; STO514; Sophoricol; TNP00151 DTD0004 VADRUGID DR01478 DTD0004 DRUGNAME Quinacrine DTD0004 DRUGSYNO quinacrine; mepacrine; atabrine; Acrinamine; Acriquine; 83-89-6; Quinactine; Antimalarina; Haffkinine; Akrichin; Italchine; acrichine; Erion; Mepacrinum; Quinacrine hydrochloride; Mepacrine [INN:BAN]; St 439; Mepacrinum [INN-Latin]; Mepacrina [INN-Spanish]; atebrin; Malaricida; Methoquine; Palacrin; Italchin; Pentilen; Palusan; Atebrine; Metochin; Mecryl; Quinacrine, Mepacrine; 3-Chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine; 2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine; HSDB 3253 DTD0004 VADRUGID DR00932 DTD0004 DRUGNAME Coumestrol DTD0004 DRUGSYNO 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one; 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one; 3,9-Dihydroxycoumestan; 479-13-0; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-; 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-; 7,12-Dihydroxycoumestan; BRN 0266702; CCRIS 7311; CHEBI:3908; CHEMBL30707; COUMESTROL; Coumesterol; Cumoesterol; Cumoestrol; Cumostrol; EINECS 207-525-6; MLS000738006; NSC 22842; NSC22842; UNII-V7NW98OB34; V7NW98OB34; ZZIALNLLNHEQPJ-UHFFFAOYSA-N DTD0004 VADRUGID DR00322 DTD0004 DRUGNAME Baricitinib DTD0004 DRUGSYNO 1187594-09-7; Baricitinib (LY3009104, INCB028050); Baricitinib [USAN:INN]; C16H17N7O2S; INCB 028050; INCB-028050; INCB028050; ISP4442I3Y; J-503551; LY-3009104; LY3009104; Olumiant (TN); UNII-ISP4442I3Y; olumiant DTD0004 VADRUGID DR00080 DTD0004 DRUGNAME Riociguat DTD0004 DRUGSYNO 625115-55-1; Adempas; BAY 63-2521; CHEBI:76018; Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; RU3FE2Y4XI; Riociguat; Riociguat (BAY 63-2521); UNII-RU3FE2Y4XI; riociguatum DTD0004 VADRUGID DR00185 DTD0004 DRUGNAME Pazopanib hydrochloride DTD0004 DRUGSYNO 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN) DTD0004 VADRUGID DR01475 DTD0004 DRUGNAME Butyrate DTD0004 DRUGSYNO butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; 1-propanecarboxylic acid; Butanic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; CCRIS 6552; HSDB 940; butoic acid; Ethyacetic Acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H DTD0004 VADRUGID DR00836 DTD0004 DRUGNAME Bupropion DTD0004 DRUGSYNO Amfebutamon; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; (+-)-Bupropion; (-)-2-(tert-Butylamino)-3'-chloropropiophenone; (-)-2-(tert-Butylamino)-3'-chlorpropiophenon; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one; 1-Propanone; 2-(Tert-Butylamino)-3'-chloropropiophenone; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; 34841-39-9; 34911-55-2; AMFEBUTAMONE HCl; Alpha-(tert-Butylamino)-m-chloropropiophenone; Alpha-(tert-butylamino)-m-chloropropiophenone; Amfebutamon; Amfebutamona; Amfebutamona [INN-Spanish]; Amfebutamone; Amfebutamonum; Amfebutamonum [INN-Latin]; BRN 2101062; Bupropion (INN); Bupropion (Old RN); Bupropion (USAN); Bupropion Hcl; Bupropion SR; Bupropion [INN:BAN]; Bupropion hydrocloride; CHEBI:3219; CHEMBL894; Elont; Elontril; SNPPWIUOZRMYNY-UHFFFAOYSA-N; Wellbatrin; Zyban; alpha-(tert-butylamino)-m-chloropropiophenone; amfebutamonum; bupropion DTD0004 VADRUGID DR01400 DTD0004 DRUGNAME NB-506 DTD0004 DRUGSYNO J-107185; L-753000; N-[12-(beta-D-Glucopyranosyl)-1,11-dihydroxy-5,7-dioxo-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-6-yl]formamide; 6-(Formamido)-12-(beta-D-glucopyranosyl)-1,11-dihydroxy-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione DTD0004 VADRUGID DR01415 DTD0004 DRUGNAME Becatecarin DTD0004 DRUGSYNO BMS-181176; Becatecarin < USAN; DEAE-Rebeccamycin; XL-119; BMY-27557-01 (HCl); BMY-27557-14 (tartrate); 1,11-Dichloro-6-[2-(diethylamino)ethyl]-12-(4-O-methyl-beta-D-glucopyranosyl)-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione DTD0004 VADRUGID DR01696 DTD0004 DRUGNAME Benzoylphenylurea DTD0004 DRUGSYNO benzoylphenylurea; SCHEMBL83109 DTD0004 VADRUGID DR00211 DTD0004 DRUGNAME Apixaban DTD0004 DRUGSYNO 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd; Apixaban (JAN/USAN/INN); BMS 562247-01; BMS-562247; BMS-562247-01; BMS-562247-01, Apixaban; Eliquis (TN); GG2; Ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide DTD0004 VADRUGID DR01447 DTD0004 DRUGNAME E3040 DTD0004 DRUGSYNO E-3040; E 3040; CHEMBL105139; 145096-30-6; E3040; AC1L9EDQ; CHEBI:4732; 6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole; SCHEMBL6009376; DTXSID80162877; CHEBI:271098; 5,7-Dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-6-benzothiazolol; BDBM50037037; 6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-; C11593; L001447; 5,7-Dimethyl-2-methylamino-4-pyridin-3-ylmethyl-benzothiazol-6-ol; 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole DTD0004 VADRUGID DR00196 DTD0004 DRUGNAME Rifampicin DTD0004 DRUGSYNO 1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN) DTD0004 VADRUGID DR00271 DTD0004 DRUGNAME Empagliflozin DTD0004 DRUGSYNO (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; 864070-44-0; AK160980; BI 10773; BI-10773; BI10773; CHEBI:82720; Empagliflozin (BI 10773); HDC1R2M35U; JARDIANCE; UNII-HDC1R2M35U DTD0004 VADRUGID DR00279 DTD0004 DRUGNAME Canagliflozin DTD0004 DRUGSYNO (1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene; 6S49DGR869; 842133-18-0; 928672-86-0; CHEBI:73274; Canagliflozin anhydrous; Canagliflozin hydrate; Invokana; JNJ 24831754ZAE; JNJ-28431754; TA 7284; TA-7284; UNII-6S49DGR869; canagliflozin hemihydrate DTD0004 VADRUGID DR00133 DTD0004 DRUGNAME Metformin DTD0004 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0004 VADRUGID DR01221 DTD0004 DRUGNAME Rosiglitazone DTD0004 DRUGSYNO . DTD0004 VADRUGID DR01121 DTD0004 DRUGNAME Taurocholic acid DTD0004 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0004 VADRUGID DR00134 DTD0004 DRUGNAME Folic acid DTD0004 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0004 VADRUGID DR00458 DTD0004 DRUGNAME Pantoprazole DTD0004 DRUGSYNO 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; Astropan; Astropan (TN); BY 1023; BY-1023; Controloc (TN); Inipomp (TN); Pantecta (TN); Pantoloc (TN); Pantopan (TN); Pantoprazol; Pantoprazol [INN-Spanish]; Pantoprazole (USAN/INN); Pantoprazole Na; Pantoprazole Sodium; Pantoprazole [USAN:BAN:INN]; Pantoprazolum; Pantoprazolum [INN-Latin]; Pantoprozole; Pantor; Pantor (TN); Pantotab (TN); Pantozol; Pantozol (TN); Protium; Protium (TN); Protonix; Protonix (TN); Protonix IV; SK&F 96022; SK&F-96022; SK-96022; SKF-96022; Somac; Somac (TN); Ulcepraz (TN) DTD0004 VADRUGID DR00391 DTD0004 DRUGNAME Cerivastatin DTD0004 VADRUGID DR00557 DTD0004 DRUGNAME Hesperetin DTD0004 DRUGSYNO (-)-hesperetin; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one; (S)-2,3-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',5,7-Trihydroxy-4'-methoxyflavanone; 3',5,7-Trihydroxy-4-methoxyflavanone; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-(9CI); 5,7,3'-Trihydroxy-4'-methoxyflavanone; Cyanidanon 4'-methyl ether 1626; Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN); Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN) (8CI); Hesperin; Hesperitin; TNP00238; YSO2 DTD0004 VADRUGID DR00420 DTD0004 DRUGNAME Nelfinavir DTD0004 DRUGSYNO ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen DTD0004 VADRUGID DR01377 DTD0004 DRUGNAME Piritrexim DTD0004 DRUGSYNO Piritrexim; 72732-56-0; Piritrexim [INN]; Piritreximum [Latin]; Piritrexime [French]; 6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine; Piritrexima [Spanish]; BW 301U; UNII-MK2A783ZUT; BW-301U; TCMDC-137235; BRN 5768301; MK2A783ZUT; CHEMBL7492; 2,4-Diamino-5-methyl-6-(2,5-dimethoxybenzyl)pyrido(2,3-d)pyrimidine; 6-(2,5-DIMETHOXY-BENZYL)-5-METHYL-PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINE; 6-((2,5-Dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine DTD0004 VADRUGID DR00448 DTD0004 DRUGNAME Cyclosporine DTD0004 DRUGSYNO cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A) DTD0004 VADRUGID DR00161 DTD0004 DRUGNAME SN-38 DTD0004 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0004 VADRUGID DR00015 DTD0004 DRUGNAME Adefovir DTD0004 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0004 VADRUGID DR00325 DTD0004 DRUGNAME Acyclovir DTD0004 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0004 VADRUGID DR01640 DTD0004 DRUGNAME Scutellarin DTD0004 DRUGSYNO Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl DTD0004 VADRUGID DR00638 DTD0004 DRUGNAME Grepafloxacin DTD0004 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN) DTD0004 VADRUGID DR00681 DTD0004 DRUGNAME Diclofenac DTD0004 DRUGSYNO Diclofenac (sodium matrix patch, pain) DTD0004 VADRUGID DR00657 DTD0004 DRUGNAME Cholic acid DTD0004 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0004 VADRUGID DR01193 DTD0004 DRUGNAME Prasterone DTD0004 DRUGSYNO 17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone DTD0004 VADRUGID DR00958 DTD0004 DRUGNAME Raltitrexed DTD0004 DRUGSYNO (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; 112887-68-0; C21H22N4O6S; CHEBI:5847; CHEMBL225071; D 1694; D-1694; D1694; DSSTox_CID_26482; DSSTox_GSID_46482; DSSTox_RID_81653; FCB9EGG971; ICI D1694; ICI-D-1694; ICI-D1694; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; NCGC00229704-01; NSC-639186; Raltitrexed (Tomudex); Tomudex; UNII-FCB9EGG971; ZD 1694; ZD-16; ZD-1694; ZD1694 DTD0004 VADRUGID DR00908 DTD0004 DRUGNAME Eltrombopag DTD0004 DRUGSYNO Eltrombopag; Revolade; Promacta; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; UNII-S56D65XJ9G; SB497115; Eltrombopag-Isomer; SB-497115; SB 497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; SB-497115-GR; Eltrombopag (SB-497115-GR); 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; NCGC00274067-01 DTD0004 VADRUGID DR01362 DTD0004 DRUGNAME Befloxatone DTD0004 DRUGSYNO MD-370503 DTD0004 VADRUGID DR00783 DTD0004 DRUGNAME Ciprofloxacin DTD0004 DRUGSYNO 85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin DTD0004 VADRUGID DR00886 DTD0004 DRUGNAME Nitrofurantoin DTD0004 DRUGSYNO 1-(((5-nitro-2-furanyl)methylene)amino)-2,4-imidazolidinedione; 1-((5-Nitrofurfurylidene)amino)hydantoin; 1-(5-Nitro-2-furfurylidenamino)hydantoin; 1-(5-Nitro-2-furfurylideneamino)hydantoin; 1-[(5-:nitrofurfurylidene)amino]hydantoin; 1-[(5-Nitrofurfurylidene)amino]hydantoin; 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione; 1-[[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione; 1-{[(1E)-(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione; 1-{[(1E)-(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione; 5-Nitrofurantoin; Alfuran; Benkfuran; Berkfuran; Berkfurin; Ceduran; Chemiofuran; Cistofuran; Cyantin; Cystit; Dantafur; Fua Med; Fua-med; Fur-ren; Furabid; Furachel; Furadantin; Furadantin (TN); Furadantin Retard; Furadantina MC; Furadantine; Furadantine mc; Furadantine-MC; Furadantoin; Furadoine; Furadonin; Furadonine; Furadoninum; Furadontin; Furalan; Furaloid; Furantoin; Furatoin; Furedan; Furina; Furobactina; Furodantin; Furophen; Furophen T; Gerofuran; Ituran; Macpac; Macrobid; Macrobid (TN); Macrodantin; Macrodantin (TN); Macrodantina; Macrofuran; Macrofurin; N-(5-Nitro-2-furfurylidene)-1-aminohydantoin; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina [Polish]; N-(5-Nitrofurfurylidene)-1-aminohydantoin; N-(5-nitro-2-furfurylidene)-1-aminohyda ntoin; N-Toin; ND-3320; ND-7248; NITROFURANTION; NITROFURANTOIN MACROCRYSTALLINE; NITROFURANTOIN, MACROCRYSTALLINE; Nierofu; Nifurantin; Nifuretten; Nitoin; Nitrex; Nitro Macro (TN); Nitrofur-C; Nitrofuradantin; Nitrofurantoin (JAN/USP/INN); Nitrofurantoin [USAN:INN:BAN:JAN]; Nitrofurantoina; Nitrofurantoina [DCIT]; Nitrofurantoine; Nitrofurantoine [INN-French]; Nitrofurantoinum; Nitrofurantoinum [INN-Latin]; Novofuran; Orafuran; Parfuran; Phenurin; PiyEloseptyl; Ro-Antoin; Siraliden; Trantoin; Uerineks; Urantoin; Urantoin (TN); Urizept; Uro-Selz; Uro-Tablinen; Uro-tablineu; Urodil; Urodin; Urofuran; Urofurin; Urolisa; Urolong; Usaf ea-2; Welfurin; Zoofurin DTD0004 VADRUGID DR00127 DTD0004 DRUGNAME Tetracycline DTD0004 DRUGSYNO (-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base) DTD0004 VADRUGID DR01204 DTD0004 DRUGNAME Norfloxacin DTD0004 DRUGSYNO 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN) DTD0004 VADRUGID DR00050 DTD0004 DRUGNAME Erythromycin DTD0004 DRUGSYNO A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid DTD0004 VADRUGID DR01581 DTD0004 DRUGNAME HPPH DTD0004 DRUGSYNO CHEMBL500853; SCHEMBL12722713; EX-A2655; 14-Ethyl-9-(1-(hexyloxy)ethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid; HY-13722; 3-Phorbinepropanoic acid, 14-ethyl-9-[1-(hexyloxy)ethyl]-4,8,13,18-tetramethyl-20-oxo-, (3S,4S)-; CS-0007752 DTD0004 VADRUGID DR01287 DTD0004 DRUGNAME Ortataxel DTD0004 DRUGSYNO Hexanoic acid; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxy-baccatin-1,14-carbonate; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxybaccatin-1,14-carbonate; 186348-23-2; 8H61Y4E29N; BAY-59; Bay-59-8862; CHEMBL382300; DB11669; Genz29155; Hexanoic acid, 3-(((1,1-dimethylethoxy)carbonyl)amino)-2-hydroxy-5-methyl-,; IDN 5109; IDN-5109; IND-5109; IND5109; Ortataxel [INN]; SB-T 101131; SB-T-101131; SCHEMBL9932772; UNII-8H61Y4E29N; Z-3102; idn5109 DTD0004 VADRUGID DR01461 DTD0004 DRUGNAME AG 337 DTD0004 DRUGSYNO Thymitaq; AG-337; ZX-337; Nolatrexed (intravenous), EXIMIAS DTD0004 VADRUGID DR00170 DTD0004 DRUGNAME Epirubicin DTD0004 DRUGSYNO (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697 DTD0004 VADRUGID DR01258 DTD0004 DRUGNAME Chrysin DTD0004 DRUGSYNO 3CN01F5ZJ5; 480-40-0; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one; 5,7-Dihydroxy-2-phenyl-chromen-4-one; 5,7-Dihydroxyflavone; 5,7-dihydroxy-2-phenylchromen-4-one; BRN 0233276; CAS-480-40-0; CHEBI:75095; CHEMBL117; Chrysin, 99+%; Chrysine; Crysin; EINECS 207-549-7; FLAVONE, 5,7-DIHYDROXY-; MFCD00006834; NSC 407436; NSC-407436; NSC407436; RTIXKCRFFJGDFG-UHFFFAOYSA-N; UNII-3CN01F5ZJ5; chrysin DTD0004 VADRUGID DR01450 DTD0004 DRUGNAME J-107088 DTD0004 DRUGSYNO Edotecarin; Edotecarinum; UNII-1V8X590XDP; J-107088; PF-804950; CHEMBL435191; 1V8X590XDP; Edotecarina; E'dotecarine; Edotecarin [USAN:INN]; Edotecarinum [INN-Latin]; E'dotecarine [INN-French]; C29H28N4O11; Edotecarin (USAN/INN); J 107088; SCHEMBL5177060; ZINC3946372; BDBM50086570; DB04882; CS-6688; HY-13618; Z1880; D03954 DTD0004 VADRUGID DR01272 DTD0004 DRUGNAME Pyrimethamine DTD0004 DRUGSYNO 2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine; 5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; 5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine; AZT + Pyrimethamine combination; Aventis Brand of Pyrimethamine; BW 50-63; BW 5063; CRL-8131 & Pyrimethamine; CRL-8142 & Pyrimethamine; Chloridin; Chloridine; Chloridyn; Darachlor; Daraclor; Darapram; Daraprim; Daraprim (TN); Daraprime; Daraprin; Diaminopyritamin; EXR-101; Erbaprelina; Ethylpyrimidine; Fansidar (Pyrimethamine/Sulfadoxine); Glaxo Wellcome Brand of Pyrimethamine; GlaxoSmithKline Brand of Pyrimethamine; Khloridin; Lactoferrin B & Pyrimethamine; Lactoferrin H & Pyrimethamine; M alocid; Malacid; Malocid; Malocide; Maloprim; Pirimecidan; Pirimetamin; Pirimetamina; Pirimetamina [INN-Spanish]; Pirimetamina [Spanish]; Primethamine; Pyremethamine; Pyrimethamin; Pyrimethamine (JAN/USP/INN); Pyrimethamine (Pyr); Pyrimethamine Hcl; Pyrimethamine [USAN:INN:BAN:JAN]; Pyrimethaminum; Pyrimethaminum [INN-Latin]; RP 4753; TCMDC-123831; TCMDC-125860; Tindurin; Tindurine; Tinduring; WR 2978; Wellcome Brand of Pyrimethamine DTD0004 VADRUGID DR00604 DTD0004 DRUGNAME Cephalothin DTD0004 DRUGSYNO Cephalothin; Cephalothin Sodium; Cephalothin Sodium W/ Dextrose In Plastic Container; Cephalothin Sodium W/ Sodium Chloride In Plastic Container; Keflin; Keflin In Plastic Container; Seffin DTD0004 VADRUGID DR01366 DTD0004 DRUGNAME Dirithromycin DTD0004 DRUGSYNO Dirithromycine; Dirithromycinum; Diritromicina; Divitross; Dynabac; Noriclan; Valodin; Dirithromycine [French]; Dirithromycinum [Latin]; Diritromicina [Spanish]; LY 237216; AS-E 136; ASE-136; Dynabac (TN); LY-237216; Dirithromycin (USP/INN); Dirithromycin [USAN:BAN:INN]; (9S)-9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)ethylidene]erythromycin DTD0004 VADRUGID DR00517 DTD0004 DRUGNAME Ofloxacin DTD0004 DRUGSYNO (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (+/-)-Floxin; (-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; Bactocin; DEXTROFLOXACINE; DL 8280; DL-8280; DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin; Danoflox; Effexin; Exocin; Exocine; FLOXIN IN DEXTROSE 5%; FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; Flobacin; Flodemex; Flotavid; Flovid; Floxal; Floxil; Floxin; Floxin (TN); Floxin Otic (TN); Floxin otic; Floxstat; Fugacin; HOE 280; HOE-280;Hoe-280; Inoflox; Kinflocin; Kinoxacin; Liflox; Loxinter; Marfloxacin; Marfloxacin (TN); Medofloxine; Mergexin; Novecin; Nufafloqo; O 8757; O-Flox; OFLX; OFX; ORF 18489; ORF-28489; Obide; Occidal; Ocuflox; Ocuflox (TN); Ofcin; Oflin; Oflocee; Oflocet; Oflocin; Oflodal; Oflodex; Oflodura; Oflox; Ofloxacin (JP15/USP/INN); Ofloxacin Otic; Ofloxacin [USAN:BAN:INN:JAN]; Ofloxacin, (S)-Isomer; Ofloxacina; Ofloxacina [DCIT]; Ofloxacine; Ofloxacine [French]; Ofloxacino; Ofloxacino [Spanish]; Ofloxacinum; Ofloxacinum [Latin]; Ofloxin; Ofus; Onexacin; Operan; Orocin; Otonil; Oxaldin; PT 01; Pharflox; Praxin; Puiritol; Qinolon; Qipro; Quinolon; Quotavil; Rilox; Ru-43280; Sinflo; Tabrin; Taravid; Tariflox; Tarivid; Telbit; Tructum; Uro Tarivid; Viotisone; Visiren; WP-0405; XED; Zanocin DTD0004 VADRUGID DR01565 DTD0004 DRUGNAME Enrofloxacin DTD0004 DRUGSYNO Enrofloxacin; 93106-60-6; Baytril; Enrofloxacine; CFPQ; Enrofloxacinum; Enrofloxacino; endrofloxicin; BAY VP 2674; Bay-Vp-2674; Enrofloxacine [French]; Enrofloxacinum [Latin]; Enrofloxacino [Spanish]; UNII-3DX3XEK1BN; N-Ethylciprofloxacin; Baytril (TN); ERFX; Enrofloxacin [USAN:BAN:INN]; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; HSDB 6952; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 3DX3XEK1BN; Enrofloxacin (USAN/INN) DTD0004 VADRUGID DR01525 DTD0004 DRUGNAME Puromycin DTD0004 DRUGSYNO puromycin; Stylomycin; Puromycinum; Puromycine; Puromicina; UNII-4A6ZS6Q2CL; P-638; Stillomycin; CL 13900; 3123L; 4A6ZS6Q2CL; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; GNF-PF-2016; Puromycinum [INN-Latin]; Puromycine [INN-French]; Puromicina [INN-Spanish]; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Bacterenomycin DTD0004 VADRUGID DR01301 DTD0004 DRUGNAME Deoxycholic acid DTD0004 DRUGSYNO (3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-oic acid; 3,12-Dihydroxycholanic acid; 3alpha,12alpha-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid; 5-beta-Deoxycholic acid; 7-Deoxycholic acid; 7alpha-Deoxycholic acid; ATX-101; Choleic acid; Cholerebic; Cholic acid, deoxy-; Cholorebic; DEOXYCHOLIC ACID; Degalol; Deoxy cholic acid; Deoxycholatic acid; Desoxycholic acid; Desoxycholsaeure; Dihydroxycholanoic acid; Droxolan; Pyrochol; Septochol; Sodium deoxycholate; deoxycholate DTD0004 VADRUGID DR00618 DTD0004 DRUGNAME Vandetanib DTD0004 DRUGSYNO 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474 DTD0004 VADRUGID DR00209 DTD0004 DRUGNAME Verteporfin DTD0004 DRUGSYNO Visudyne (TN) DTD0004 VADRUGID DR00845 DTD0004 DRUGNAME Daidzein DTD0004 DRUGSYNO 7-Dihydroxyisoflavone; 4',7-Dihydroxy-iso-flavone; 4',7-Dihydroxyisoflavone; 4,7-Dihydroxyisoflavone; 486-66-8; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; 7,4'-Dihydroxyisoflavone; 7,4'-dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; BRN 0231523; CCRIS 7600; CHEMBL8145; DIADZEIN; Daidzein; Daidzeol; EINECS 207-635-4; K 251b; UNII-6287WC5J2L; d-(+)-alpha-methylbenzylamine DTD0004 VADRUGID DR00569 DTD0004 DRUGNAME Glycocholic acid DTD0004 DRUGSYNO Glycocholate; cholylglycine DTD0004 VADRUGID DR01454 DTD0004 DRUGNAME Protoporphyrin DTD0004 DRUGSYNO protoporphyrin IX; protoporphyrin; 553-12-8; Ooporphyrin; Protoporpyrin IX; Porphyrinogen IX; Protoporphyrin IX disodium; Kammerer's prophyrin; ppIX; Protoporphyrin IX (VAN); H2ppIX; Kammerer's porphyrin; MLS001074731; UNII-C2K325S808; NSC2632; NSC 2632; EINECS 209-033-7; 3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid; SMR000127405; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-diethenyl-3,8,13,17-tetramethyl-; CHEMBL267548; CHEBI:15430; C34H34N4O4 DTD0004 VADRUGID DR00172 DTD0004 DRUGNAME Uric acid DTD0004 DRUGSYNO urate DTD0004 VADRUGID DR00036 DTD0004 DRUGNAME Cholesterol DTD0004 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0004 VADRUGID DR01305 DTD0004 DRUGNAME Bisantrene DTD0004 DRUGSYNO 39C34M111K; 78186-34-2; 9,10-Anthracendicarbaldehyde bis(2-imidazolin-2-ylhydrazon); 9,10-Anthracenedicarboxaldehyde, bis((4,5-dihydro-1H-imidazol-2-yl)hydrazone)-; BISANTRENE HYDROCHLORIDE; BRN 0966309; Bisantrene; Bisantrene [INN]; Bisantreno; Bisantreno [INN-Spanish]; Bisantrenum; Bisantrenum [INN-Latin]; CHEMBL25336; CL 216942; N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazono)methyl]-9-anthryl]methyleneamino]-4,5-dihydro-1H-imidazol-2-amine; NSC 337766; UNII-39C34M111K DTD0004 VADRUGID DR01513 DTD0004 DRUGNAME Dehydroepiandrosterone sulfate DTD0004 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0004 VADRUGID DR01545 DTD0004 DRUGNAME Pitavastatin DTD0004 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0004 VADRUGID DR01434 DTD0004 DRUGNAME Trimetrexate DTD0004 DRUGSYNO TMQ; Trimetrexato; Trimetrexatum; JB 11; Jb-11; Trimetrexato [INN-Spanish]; Trimetrexatum [INN-Latin]; Trimetrexate (USAN/INN); Trimetrexate [USAN:BAN:INN]; 2,4-Diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline; 5-Methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4-quinazolinediamine; 5-methyl-6-({[3,4,5-tris(methyloxy)phenyl]amino}methyl)quinazoline-2,4-diamine; 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine; 6-[((3,4,5-Trimethoxyphenyl)amino)methyl]-5-methyl-2,4-quinazolinediamine DTD0004 VADRUGID DR00019 DTD0004 DRUGNAME Estrone sulfate DTD0004 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0004 VADRUGID DR01591 DTD0004 DRUGNAME Mycophenolic acid glucuronide DTD0004 DRUGSYNO MPAG; Mycophenolic acid glucosiduronate; mycophenolic acid glucuronide; UNII-54TS5J9T0K; 54TS5J9T0K; AC1O5XMV; BYFGTSAYQQIUCN-HGIHDBQLSA-N; Mycophenolic Acid ; A-D-Glucuronide; ZINC13550000; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[5-[(E)-6-hydroxy-3-methyl-6-oxohex-2-enyl]-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-4-yl]oxy]oxane-2-carboxylic acid; 5-[(2E)-5-Carboxy-3-methyl-2-penten-1-yl]-1,3-dihydro-6-methoxy-7-methyl-3-oxo-4-isobenzofuranyl DTD0004 VADRUGID DR01618 DTD0004 DRUGNAME Benzo(a)pyrene DTD0004 DRUGSYNO benzo[a]pyrene; 3,4-Benzopyrene; benzo[pqr]tetraphene; BENZO(A)PYRENE; 3,4-Benzpyrene; Benzpyrene; benzo[def]chrysene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; Benzo(d,e,f)chrysene; 3,4-Benz(a)pyrene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; CCRIS 76; Benzo[A]-Pyrene; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian] DTD0004 VADRUGID DR01339 DTD0004 DRUGNAME Gimatecan DTD0004 DRUGSYNO LBQ-707; ST-1480; ST-1481; Camptothecin analogs, Sigma-Tau; 7-cyano-camptothecin DTD0004 VADRUGID DR01557 DTD0004 DRUGNAME Oxfendazole DTD0004 DRUGSYNO Oxfendazole; Fenbendazole sulfoxide; Synanthic; Systamex; OFDZ; Systemax; Repidose; Oxfendazolum; Oxfendazol; Synanthic (Veterinary); RS-8858; fenbendazole S-oxide; RS 8858; 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole; Oxfendazol [INN-Spanish]; Oxfendazolum [INN-Latin]; UNII-OMP2H17F9E; HOE 8105; methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate; Oxfendazole [USAN:BAN:INN]; Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate; Oxfendazole (USP/INN) DTD0004 VADRUGID DR01453 DTD0004 DRUGNAME SJG-136 DTD0004 DRUGSYNO SG-2000; SJG-136; SP-2001 DTD0004 VADRUGID DR01405 DTD0004 DRUGNAME Phosphatidylserine DTD0004 DRUGSYNO distearoylphosphatidylserine; LifeExtension PS Caps DTD0004 VADRUGID DR01396 DTD0004 DRUGNAME Nifurtimox DTD0004 DRUGSYNO NIFURTIMOX; Lampit; Bayer 2502; 23256-30-6; BAY 2502; Nifurtimox [INN:BAN]; Nifurtimoxum [INN-Latin]; CCRIS 2201; EINECS 245-531-0; CHEBI:7566; C10H13N3O5S; 4-Thiomorpholinamine, 3-methyl-N-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide; 4-((5-Nitrofurfurylidene)amino)-3-methylthiomorpholine-1,1-dioxide; 3-Methyl-N-[(5-nitro-2-furanyl)methylene]-4-thiomorpholinamine 1,1-dioxide; 3-Methyl-4-(5'-nitrofurylidene-amino)-tetrahydro-4H-1,4-thiazine-1,1-dioxide DTD0004 VADRUGID DR01445 DTD0004 DRUGNAME Hypericin DTD0004 DRUGSYNO Hypericin; VIMRxyn; Synthetic hypericin, Nexell DTD0004 VADRUGID DR01715 DTD0004 DRUGNAME Parabis DTD0004 DRUGSYNO Dichlorophen; dichlorophene; Dichlorofen; Dichlorphen; 2,2'-Methylenebis(4-chlorophenol); Didroxane; Didroxan; Trivex; Difentan; Dicestal; Antiphen; Vermithana; Teniatol; Prevental; Teniotol; Embephen; Anthiphen; Teniathane; Taeniatol; Panacide; Cordocel; Palacel; Halenol; Parabis; Korium; Hyosan; Antifen; Dichlorophen B; Dichlorophene 10; Dichloorfeen; Gingivit; Wespuril; Gefir; Fungicide M; Plath-Lyse; DDDM; Bis(5-chloro-2-hydroxyphenyl)methane; Preventol GD; Fungicide GM; Preventol GDC; Diphenthane 70; Sandocide; Super mosstox DTD0004 VADRUGID DR01471 DTD0004 DRUGNAME AG1478 DTD0004 DRUGSYNO AG-1478; 153436-53-4; Tyrphostin AG 1478; N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 175178-82-2; Tyrphostin AG-1478; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; AG 1478; AG1478; TYRPHOSTIN; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-; UNII-SUH0SEZ9HY; SUH0SEZ9HY; AG-1478 hydrochloride; AG-1478 (Tyrphostin AG-1478); CHEMBL7917; CHEBI:75404; N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine; NSC-693255; AK-63142; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine; BRD6408; BRD-6408; SR-01000076156; NSC693255 DTD0005 TRANSPID DTD0005 DTD0005 GENENAME SLC22A7 DTD0005 PROTNAME Organic anion transporter 2 DTD0005 SYNONYMS NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2 DTD0005 VADRUGID DR00342 DTD0005 DRUGNAME Paclitaxel DTD0005 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0005 VADRUGID DR01277 DTD0005 DRUGNAME Entecavir DTD0005 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0005 VADRUGID DR00191 DTD0005 DRUGNAME Theophylline DTD0005 DRUGSYNO 1,3 Dimethylxanthine; 1,3-Dimethylxanthine; 1H-purine-2,6-dione; Accurbron; Acet-theocin; Aerobin; Aerolate; Aerolate III; Aerolate SR; Afonilm; Afonilum; Afonilum Retard; Aminophylline; Aquaphyllin; Armophylline; Asmalix; Asmax; Austyn; Bilordyl; Bronchodid Duracap; Bronchoparat; Bronchoretard; Bronkodyl; Bronkodyl SR; Bronkotabs; Cetraphylline; Choledyl SA; Chronophyllin; Constant T; Constant-T; ConstantT; Ct, theo von; Diffumal; Dimethylxanthine; Doraphyllin; Duraphyl; Duraphyllin; Egifilin; Elixex; Elixicon; Elixomin; Elixophyllin; Elixophyllin (TN); Elixophyllin SR; Elixophyllin(e); Elixophylline; Etheophyl; Euphylong; GS 2591A; Hylate; LASMA; LaBID; Labophylline; Lanophyllin; Liquophylline; Maphylline; Medaphyllin; Mudrane; Nuelin; Nuelin S.A; Nuelin S.A.; Nuelin SA; Optiphyllin; Parkophyllin; Physpan; Pro-vent; Pseudotheophylline; Pulmidur; Pulmo-Timelets; Quibron; Quibron T; Quibron T SR; Quibron T-SR; Quibron T/SR; Quibron TSR; Quibron-T; Quibron-T/SR; Quibron-t (TN); Respbid; Respicur; Respid; Slo Phyllin; Slo-bid; Slo-phyllin; SloPhyllin; Solosin; Somophyllin CRT; Somophyllin T; Somophyllin-CRT; Somophyllin-DF; Somophyllin-t; SomophyllinT; Spophyllin retard; Sustaire; Synophylate; T-Phyl; THEOBID JR; Talotren; Tefamin; Telb-DS; Telbans DrySyrup; Teocen 200; Teofilina; Teofilina [Polish]; Teofyllamin; Teolair; Teonova;Teosona; Tesona; Theacitin; Theal tablets; Theo 24; Theo Dur; Theo von ct; Theo-11; Theo-24; Theo-24 (TN); Theo-DS; Theo-Dur-Sprinkle; Theo-Nite; Theo-Organidin; Theo-Sav; Theo-dur; Theo24; Theobid; Theobid Duracap; Theobid Jr.; Theochron; Theocin; Theoclair-SR; Theoclear; Theoclear 80; Theoclear L.A.-130; Theoclear LA; Theoclear-200; Theoclear-80;Theodur G (TN); Theocontin; Theodel; Theodrip; Theodur; Theodur Dry Syrup; Theodur G; Theofol; Theograd; Theokin; Theolair; Theolair (TN); Theolair-SR; Theolix; Theolixir; Theona P; Theonite; Theopek; Theophyl; Theophyl-225; Theophyl-SR; Theophyline; Theophyllin; Theophylline (JP15); Theophylline-SR; Theophylline-[8-3H; Theoplus; Theospan; Theostat; Theostat 80; Theotard; Theovent; Uni-Dur; Unifyl; Unilong; Uniphyl; Uniphyl (TN); Uniphyllin; Uniphyllin continus; Uniphylline; Von ct, theo; X 115; Xanthium; Xantivent DTD0005 VADRUGID DR00272 DTD0005 DRUGNAME Bumetanide DTD0005 DRUGSYNO 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex DTD0005 VADRUGID DR00296 DTD0005 DRUGNAME Zidovudine DTD0005 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0005 VADRUGID DR00074 DTD0005 DRUGNAME Allopurinol DTD0005 DRUGSYNO 4-HPP; A 8003; AL-100; Adenock; Ailural; Ailurial; Allo-Puren; Allohexal; Allohexal (TN); Allohexan; Alloprin; Allopur; Allopurin; Allopurinol(I); Allopurinolum; Allorin; Allosig (TN); Allozym; Allpargin; Allural; Aloprim; Alopurinol; Aloral; Alositol; Aluline; Anoprolin; Anzief; Apo-Allopurinol; Apulonga; Apurin; Apurol; Atisuril; B. W. 56-158; BW 56-158; BW 56158; BW-56-158; Bleminol; Bloxanth; Caplenal; Capurate; Cellidrin; Cosuric; Dabrosin; Dabroson; Dura Al; Embarin; Epidropal; Epuric; Foligan; Geapur; Gichtex; Gotax; Hamarin; Hexanuret; Jenapurinol; Ketanrift; Ketobun-A; Ledopur; Lopurin; Lysuron; Milurit; Milurite; Miniplanor; Monarch; Nektrohan; Novopurol; Pan Quimica; Progout; Progout (TN); Pureduct; Puricos (TN); Purinol; Quimica, Pan; Remid; Riball; Rimapurinol; Roucol; Sigapurol; Suspendol; Takanarumin; Tipuric; Urbol; Uribenz; Uricemil; Uridocid; Uriprim; Uripurinol; Uritas; Urobenyl; Urolit; Urosin; Urtias; Urtias 100; Xanthomax; Xanturat; Xanturic; Zygout; Zyloprim; Zyloprim (TN); Zyloric; Zyloric (TN) DTD0005 VADRUGID DR00082 DTD0005 DRUGNAME Methotrexate DTD0005 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0005 VADRUGID DR00102 DTD0005 DRUGNAME Dinoprostone DTD0005 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0005 VADRUGID DR00203 DTD0005 DRUGNAME Aspirin DTD0005 DRUGSYNO 2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate DTD0005 VADRUGID DR00153 DTD0005 DRUGNAME Fluorouracil DTD0005 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0005 VADRUGID DR00163 DTD0005 DRUGNAME Ranitidine DTD0005 DRUGSYNO (E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic DTD0005 VADRUGID DR00007 DTD0005 DRUGNAME Prostaglandin f2Alpha DTD0005 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0005 VADRUGID DR01263 DTD0005 DRUGNAME Penciclovir DTD0005 DRUGSYNO 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one; 39809-25-1; 9-(4-HYDROXY-3-(HYDROXYMETHYL)BUT-1-YL)GUANINE; 9-(4-Hydroxy-3-(Hydroxymethyl)but-1-Yl)Guanine; 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine; 9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine; 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine; BRL 39123; BRL-39123; CCRIS 9213; Denavir; Denavir (TN); PE2; Penciceovir; Penciclovir [USAN:INN:BAN]; Penciclovirum; Penciclovirum [INN-Latin]; Pencyclovir; UNII-359HUE8FJC; Vectavir; penciclovir DTD0005 VADRUGID DR00325 DTD0005 DRUGNAME Acyclovir DTD0005 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0005 VADRUGID DR00127 DTD0005 DRUGNAME Tetracycline DTD0005 DRUGSYNO (-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base) DTD0005 VADRUGID DR00050 DTD0005 DRUGNAME Erythromycin DTD0005 DRUGSYNO A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid DTD0006 TRANSPID DTD0006 DTD0006 GENENAME SLC22A2 DTD0006 PROTNAME Organic cation transporter 2 DTD0006 SYNONYMS OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2 DTD0006 VADRUGID DR00037 DTD0006 DRUGNAME Cimetidine DTD0006 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0006 VADRUGID DR00023 DTD0006 DRUGNAME Memantine DTD0006 DRUGSYNO Memantine (extended release); Memantine (extended release), Forest; Memantine ER; Namenda XR DTD0006 VADRUGID DR00097 DTD0006 DRUGNAME Abemaciclib DTD0006 DRUGSYNO 1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio DTD0006 VADRUGID DR00110 DTD0006 DRUGNAME YM155 DTD0006 DRUGSYNO Sepantronium DTD0006 VADRUGID DR00116 DTD0006 DRUGNAME Lamivudine DTD0006 DRUGSYNO (+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix DTD0006 VADRUGID DR00316 DTD0006 DRUGNAME Oxaliplatin DTD0006 DRUGSYNO ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138 DTD0006 VADRUGID DR00207 DTD0006 DRUGNAME Amiloride DTD0006 DRUGSYNO 3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide; 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8)); Amiclaran; Amiclaran (TN); Amikal (Hydrochloride dihydrate); Amilorida; Amilorida [INN-Spanish]; Amiloride (INN); Amiloride (Na-Ca chanel blocker); Amiloride HCL; Amiloride [INN:BAN]; Amiloride hydrochloride hydrate; Amiloridum; Amiloridum [INN-Latin]; Amipramidin; Amipramizid; Amipramizide; Amiprazidine; Amyloride; Biduret (TN); Guanamprazin; Guanamprazine; MK-870 (Hydrochloride dihydrate); Midamor; Midamor (Hydrochloride dihydrate); N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride DTD0006 VADRUGID DR00189 DTD0006 DRUGNAME Serotonin DTD0006 DRUGSYNO 1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY DTD0006 VADRUGID DR00521 DTD0006 DRUGNAME Clonidine DTD0006 DRUGSYNO 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets DTD0006 VADRUGID DR00528 DTD0006 DRUGNAME Propranolol DTD0006 DRUGSYNO (+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN) DTD0006 VADRUGID DR00040 DTD0006 DRUGNAME Amantadine DTD0006 DRUGSYNO 1-Adamantamine; 1-Adamantanamine; 1-Adamantanamine (8CI); 1-Adamantylamine; 1-Aminoadamantane; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; ADAMANTANE,1-AMINO; Adamantamine; Adamantan-1-amine; Adamantan-1-ylamine; Adamantanamine; Adamantylamine; Amant; Amantadina; Amantadina [INN-Spanish]; Amantadine (INN); Amantadine Base; Amantadine [INN:BAN]; Amantadinum; Amantadinum [INN-Latin]; Amantidine; Aminoadamantane; BIA4304; Endantadine; Gen-Amantadine; Mantadine; OR14310; Pk-merz; Symadine; Symmetrel; Symmetrel (TN); TCMDC-125869; Tricyclo(3.3.1.1(3,7))-decan-1-amine; Tricyclo(3.3.1.1(sup 3,7))decan-1-amine; Tricyclo(3.3.1.1(sup 3.7))decan-1-amine; Tricyclo(3.3.1.13,7)decan-1-amine; Tricyclo[3.3.1.1(3,7)]decan-1-amine;Tricyclo[3.3.1.1(3,7)]decan-1-ylamine; Tricyclo[3.3.1.1(3,7)]decane-1-amine; Tricyclo[3.3.1.1(sup3,7)]decan-1-amine; Tricyclo[3.3.1.1^3,7]decan-1-amine; Tricyclo[3.3.1.1~3,7~]decan-1-amine; Wiregyt DTD0006 VADRUGID DR00054 DTD0006 DRUGNAME Quinine DTD0006 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0006 VADRUGID DR00102 DTD0006 DRUGNAME Dinoprostone DTD0006 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0006 VADRUGID DR00268 DTD0006 DRUGNAME Norepinephrine DTD0006 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0006 VADRUGID DR00291 DTD0006 DRUGNAME Cisplatin DTD0006 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0006 VADRUGID DR00283 DTD0006 DRUGNAME Dopamine DTD0006 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0006 VADRUGID DR00620 DTD0006 DRUGNAME Pramipexole DTD0006 DRUGSYNO (-)-Pramipexole; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; 111GE001; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; 2-amino-6-propylaminotetrahydrobenzothiazole; Mirapex; Mirapex (TN); Mirapexin (TN); Pramipexol; Pramipexole (USAN/INN); Pramipexole [USAN:INN]; Pramipexolum; SND-919; SUD919CL2Y; Sifrol(TN); U-98528E DTD0006 VADRUGID DR00217 DTD0006 DRUGNAME Gabapentin DTD0006 DRUGSYNO 1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID DTD0006 VADRUGID DR00278 DTD0006 DRUGNAME Famotidine DTD0006 DRUGSYNO (1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin DTD0006 VADRUGID DR00163 DTD0006 DRUGNAME Ranitidine DTD0006 DRUGSYNO (E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic DTD0006 VADRUGID DR00237 DTD0006 DRUGNAME Varenicline DTD0006 DRUGSYNO 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; CP 526555; Champix (TN); Chantix (TN); Varenicline (INN) DTD0006 VADRUGID DR00007 DTD0006 DRUGNAME Prostaglandin f2Alpha DTD0006 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0006 VADRUGID DR00133 DTD0006 DRUGNAME Metformin DTD0006 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0006 VADRUGID DR00106 DTD0006 DRUGNAME Tetraethylammonium DTD0006 DRUGSYNO 4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium DTD0006 VADRUGID DR00337 DTD0006 DRUGNAME N-methylpyridinium DTD0006 DRUGSYNO 1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl- DTD0006 VADRUGID DR00081 DTD0006 DRUGNAME Ergotidine DTD0006 DRUGSYNO 1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine DTD0006 VADRUGID DR00724 DTD0006 DRUGNAME Dofetilide DTD0006 DRUGSYNO 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide DTD0006 VADRUGID DR00121 DTD0006 DRUGNAME Choline DTD0006 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0007 TRANSPID DTD0007 DTD0007 GENENAME SLC47A1 DTD0007 PROTNAME Multidrug and toxin extrusion protein 1 DTD0007 SYNONYMS MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1 DTD0007 VADRUGID DR00037 DTD0007 DRUGNAME Cimetidine DTD0007 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0007 VADRUGID DR00097 DTD0007 DRUGNAME Abemaciclib DTD0007 DRUGSYNO 1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio DTD0007 VADRUGID DR00027 DTD0007 DRUGNAME Ganciclovir DTD0007 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0007 VADRUGID DR00002 DTD0007 DRUGNAME Paraquat DTD0007 DRUGSYNO 1,1'-dimethyl-4,4' bipyridinium dichloride DTD0007 VADRUGID DR00672 DTD0007 DRUGNAME Emtricitabine DTD0007 DRUGSYNO (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-.beta.-L-FTC; (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine; (-)-FTC; (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine; (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 2',3',5-FTC; 2',3'-Dideoxy-5-fluoro-3'-thiacytidine; 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine; 2'-Deoxy-5-fluoro-3'-thiacytidine; 2-FTC; 3'-Thia-2'.3'-dideoxy-5-fluorocytidine; 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine; 524W91; BW 1592; BW 524W91; BW-524W91; BW524W91; Beta-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine; Coviracil; Coviracil (TN); Coviracil(TM); DOTFC; DRG-0208; Emtricitabine (JAN/USAN/INN); Emtriva; Emtriva(TM); FTC; RCV; Racivir DTD0007 VADRUGID DR00572 DTD0007 DRUGNAME Chloroquine DTD0007 DRUGSYNO (+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline; Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244; {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine DTD0007 VADRUGID DR00044 DTD0007 DRUGNAME Topotecan DTD0007 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0007 VADRUGID DR01329 DTD0007 DRUGNAME Auranofin DTD0007 DRUGSYNO AURANOFIN; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; CTK8F7877; KS-00001FB9; MMV688978; AKOS026750078; FT-0662343 DTD0007 VADRUGID DR00133 DTD0007 DRUGNAME Metformin DTD0007 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0007 VADRUGID DR00292 DTD0007 DRUGNAME Procainamide DTD0007 DRUGSYNO 2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr DTD0007 VADRUGID DR00106 DTD0007 DRUGNAME Tetraethylammonium DTD0007 DRUGSYNO 4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium DTD0007 VADRUGID DR00337 DTD0007 DRUGNAME N-methylpyridinium DTD0007 DRUGSYNO 1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl- DTD0007 VADRUGID DR00325 DTD0007 DRUGNAME Acyclovir DTD0007 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0007 VADRUGID DR00724 DTD0007 DRUGNAME Dofetilide DTD0007 DRUGSYNO 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide DTD0007 VADRUGID DR01223 DTD0007 DRUGNAME Mephenoxalone DTD0007 DRUGSYNO 5-((2-Methoxyphenoxy)methyl)oxazolidin-2-one; 5-(o-Methoxyphenoxymethyl)-2-oxazolidinone; 5-(o-Methoxyphenoxymethyl)-2-oxazolidone; AHR 233; Alkapol peg-400; CL 27,319; Control-OM; Dorsiflex; Dorsilon; EINECS 200-723-3; Ekilan; Lenetran; Lenetran TAB; Lenetranat; MEPHENOXALONE; Mefenoxalona; Mefenoxalona [INN-Spanish]; Mefenoxalone; Mephenoxalone [INN:DCF]; Mephenoxalonum [INN-Latin]; Methoxadone; Methoxydon; Methoxydon(E); Methoxydone; Metoxadone; Moderamin; Placidex; Riself; Transpoise; Trepidone; Valanas; Xerene DTD0007 VADRUGID DR00330 DTD0007 DRUGNAME Cephalexin DTD0007 DRUGSYNO 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine DTD0007 VADRUGID DR01280 DTD0007 DRUGNAME Enoxacin DTD0007 DRUGSYNO 1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid; AT 2266; AT-2266; AT2266; Almitil; Almitil (TN); Bactidan; Bactidan (TN); Bactidron (TN); CI919; CL23362; Comprecin; Comprecin (TN); E0762; Enoksetin (TN); Enoram; Enoxacin (USAN/INN); Enoxacin Sesquihydrate; Enoxacin [USAN:BAN:INN:JAN]; Enoxacine; Enoxacine [French]; Enoxacino; Enoxacino [Spanish]; Enoxacinum; Enoxacinum [Latin]; Enoxen (TN); Enoxin; Enoxin (TN); Enoxor; Enoxor (TN); Enroxil (TN); Faulding Brand of Enoxacin; Flumark; Flumark (TN); Gyramid (TN); PD 107779; PD-107779; PD107779; Penetrex; Penetrex (TN); Pierre Fabre Brand of Enoxacin Sesquihydrate; Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate; Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate; Sesquihydrate, Enoxacin; Vinone (TN) DTD0007 VADRUGID DR01272 DTD0007 DRUGNAME Pyrimethamine DTD0007 DRUGSYNO 2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine; 5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; 5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine; AZT + Pyrimethamine combination; Aventis Brand of Pyrimethamine; BW 50-63; BW 5063; CRL-8131 & Pyrimethamine; CRL-8142 & Pyrimethamine; Chloridin; Chloridine; Chloridyn; Darachlor; Daraclor; Darapram; Daraprim; Daraprim (TN); Daraprime; Daraprin; Diaminopyritamin; EXR-101; Erbaprelina; Ethylpyrimidine; Fansidar (Pyrimethamine/Sulfadoxine); Glaxo Wellcome Brand of Pyrimethamine; GlaxoSmithKline Brand of Pyrimethamine; Khloridin; Lactoferrin B & Pyrimethamine; Lactoferrin H & Pyrimethamine; M alocid; Malacid; Malocid; Malocide; Maloprim; Pirimecidan; Pirimetamin; Pirimetamina; Pirimetamina [INN-Spanish]; Pirimetamina [Spanish]; Primethamine; Pyremethamine; Pyrimethamin; Pyrimethamine (JAN/USP/INN); Pyrimethamine (Pyr); Pyrimethamine Hcl; Pyrimethamine [USAN:INN:BAN:JAN]; Pyrimethaminum; Pyrimethaminum [INN-Latin]; RP 4753; TCMDC-123831; TCMDC-125860; Tindurin; Tindurine; Tinduring; WR 2978; Wellcome Brand of Pyrimethamine DTD0007 VADRUGID DR00019 DTD0007 DRUGNAME Estrone sulfate DTD0007 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0008 TRANSPID DTD0008 DTD0008 GENENAME SLCO1B1 DTD0008 PROTNAME Organic anion transporting polypeptide 1B1 DTD0008 SYNONYMS LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1 DTD0008 VADRUGID DR00035 DTD0008 DRUGNAME Axitinib DTD0008 DRUGSYNO AG 013736; AG-013736; AG-013736, Axitinib; AG-13736; AG013736; Axitinib (VEGFR inhibitor); N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide DTD0008 VADRUGID DR00454 DTD0008 DRUGNAME Sunitinib DTD0008 DRUGSYNO 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN) DTD0008 VADRUGID DR01485 DTD0008 DRUGNAME Leukotriene E4 DTD0008 DRUGSYNO Leukotriene E4; leukotriene E4; Leukotriene E; UNII-8EYT8ATL7G; 75715-89-8; 8EYT8ATL7G; CHEMBL509456; CHEBI:15650; OTZRAYGBFWZKMX-FRFVZSDQSA-N; 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C23H37NO5S; (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid; [3H]LTE4; AC1NQXPM; LEUKOTRIEN E4; BSPBio_001370; leukotriene E DTD0008 VADRUGID DR00155 DTD0008 DRUGNAME Ouabain DTD0008 DRUGSYNO 3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin DTD0008 VADRUGID DR00342 DTD0008 DRUGNAME Paclitaxel DTD0008 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0008 VADRUGID DR00251 DTD0008 DRUGNAME Docetaxel DTD0008 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0008 VADRUGID DR00423 DTD0008 DRUGNAME Gefitinib DTD0008 DRUGSYNO 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839 DTD0008 VADRUGID DR00014 DTD0008 DRUGNAME Simeprevir DTD0008 DRUGSYNO TMC436 DTD0008 VADRUGID DR00235 DTD0008 DRUGNAME Flavopiridol DTD0008 DRUGSYNO (-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one; 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE; 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one; Alvocidib [INN]; FLAVO; Flavopiridol; Flavopiridol hydrochloride; HMR-1275; HMR-1275, Alvocidib, L868275, Flavopiridol; L 868275; L-868275; L86-8275 DTD0008 VADRUGID DR01177 DTD0008 DRUGNAME Hydroxyurea DTD0008 DRUGSYNO 1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase DTD0008 VADRUGID DR00013 DTD0008 DRUGNAME Nilotinib DTD0008 DRUGSYNO Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716 DTD0008 VADRUGID DR00032 DTD0008 DRUGNAME Imatinib DTD0008 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0008 VADRUGID DR00407 DTD0008 DRUGNAME Nateglinide DTD0008 DRUGSYNO (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026 DTD0008 VADRUGID DR00149 DTD0008 DRUGNAME Eluxadoline DTD0008 DRUGSYNO MuDelta DTD0008 VADRUGID DR00208 DTD0008 DRUGNAME Estradiol-17beta-glucuronide DTD0008 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0008 VADRUGID DR00252 DTD0008 DRUGNAME Bilirubin DTD0008 DRUGSYNO 21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49 DTD0008 VADRUGID DR00305 DTD0008 DRUGNAME Bromsulphthalein DTD0008 DRUGSYNO BSP; bromosulfophthalein; sulfobromophthalein DTD0008 VADRUGID DR00344 DTD0008 DRUGNAME Fluo-3 DTD0008 DRUGSYNO 121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051 DTD0008 VADRUGID DR00213 DTD0008 DRUGNAME Sincalide DTD0008 DRUGSYNO CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated) DTD0008 VADRUGID DR00206 DTD0008 DRUGNAME Pitavastatin calcium DTD0008 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0008 VADRUGID DR00030 DTD0008 DRUGNAME Atorvastatin DTD0008 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0008 VADRUGID DR00222 DTD0008 DRUGNAME Torsemide DTD0008 DRUGSYNO 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea; 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea; 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulfonyl]urea; AC 4464; BM 02015; BM-02015; Demadex; Demadex (TN); Demadex, Torsemide; Dilutol; GJ-1090; JDL 464; JDL-464; KS-1123; Luprac; Luprac (TN); N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide; N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; PW-2132; Presoril; Sutril; TORSEMIDE; Toradiur; Torasemida; Torasemida [INN-Spanish]; Torasemide (JAN/INN); Torasemide N; Torasemidum; Torasemidum [INN-Latin]; Torem; Torocard; Torrem; Torsemide (USP); Torsemide [USAN]; Unat DTD0008 VADRUGID DR00273 DTD0008 DRUGNAME Danoprevir DTD0008 DRUGSYNO DANOPREVIR; ITMN-191; Danoprevir (ITMN-191); Danoprevir (RG7227); UNII-911Z9PCQ5F; ITMN 191; RO5190591; 911Z9PCQ5F; R 7227; RG7227; R7227; Intermune ITMN-191; ITMN B; Danoprevir [USAN:INN]; R-7227; (2R,6S,13aS,14aR,16aS,Z)-6-((tert-butoxycarbonyl)amino)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1; Danoprevir (ITMN191); MLS006011139; R 05190591; CHEMBL258734; C35H46FN5O9S; SCHEMBL2289034; AOB87156; ZINC29058869; s1183; RL05263 DTD0008 VADRUGID DR00010 DTD0008 DRUGNAME Enalapril DTD0008 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0008 VADRUGID DR00347 DTD0008 DRUGNAME Olmesartan medoxomil DTD0008 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0008 VADRUGID DR01528 DTD0008 DRUGNAME Temocapril DTD0008 DRUGSYNO Temocapril; Temocaprilum; 2-((2S,6R)-6-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-4-yl)acetic acid; UNII-18IZ008EU6; 18IZ008EU6; Temocapril [INN:BAN]; Temocaprilum [INN-Latin]; C23H28N2O5S2; 2-((2S,6R)-6-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)-5-OXO-2-(THIOPHEN-2-YL)-1,4-THIAZEPAN-4-YL)ACETIC ACID; (2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; Temocapril (INN); AC1L9FDI DTD0008 VADRUGID DR00071 DTD0008 DRUGNAME Valsartan DTD0008 DRUGSYNO (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan DTD0008 VADRUGID DR00514 DTD0008 DRUGNAME Darunavir DTD0008 DRUGSYNO (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester DTD0008 VADRUGID DR00290 DTD0008 DRUGNAME Lopinavir DTD0008 DRUGSYNO A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346 DTD0008 VADRUGID DR00309 DTD0008 DRUGNAME Saquinavir DTD0008 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0008 VADRUGID DR00140 DTD0008 DRUGNAME Ezetimibe DTD0008 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0008 VADRUGID DR00124 DTD0008 DRUGNAME Fluvastatin DTD0008 DRUGSYNO (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320 DTD0008 VADRUGID DR00410 DTD0008 DRUGNAME Lovastatin DTD0008 DRUGSYNO 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; 6 Methylcompactin; 6 alpha-Methylcompactin; 6-Methylcompactin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin; Advicor (TN); Altocor; Altocor (TN); Altoprev; Altoprev (TN); Artein; Belvas; Cholestra; Closterol; Colevix; Hipolip; Hipovastin; L-154803; Lestatin; Lipdip; Lipivas; Lipofren; Liposcler; Lovalip; Lovalord; Lovastatin & Primycin; Lovastatin (USP/INN); Lovastatin [USAN:BAN:INN]; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); Lovastatina; Lovastatina [Spanish]; Lovastatine; Lovastatine [French]; Lovastatinum; Lovastatinum [Latin]; Lovasterol; Lovastin; Lozutin; MK 803; MK-803; MK803; ML-530B; MSD 803; Mevacor; Mevacor (TN); Mevinacor; Mevinolin; Mevinolin from Aspergillus sp.; Mevlor; Monacolin K; Monakolin K; Nergadan; Paschol; Rextat; Rodatin; Rovacor; Sivlor;Taucor; Statosan (TN); Tecnolip; Teroltrat DTD0008 VADRUGID DR00045 DTD0008 DRUGNAME Pravastatin DTD0008 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0008 VADRUGID DR00223 DTD0008 DRUGNAME Rosuvastatin DTD0008 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0008 VADRUGID DR00435 DTD0008 DRUGNAME Simvastatin DTD0008 DRUGSYNO (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate DTD0008 VADRUGID DR00107 DTD0008 DRUGNAME Levothyroxine DTD0008 DRUGSYNO (-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI) DTD0008 VADRUGID DR00173 DTD0008 DRUGNAME Liothyronine DTD0008 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0008 VADRUGID DR00162 DTD0008 DRUGNAME Etoposide DTD0008 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0008 VADRUGID DR00082 DTD0008 DRUGNAME Methotrexate DTD0008 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0008 VADRUGID DR00102 DTD0008 DRUGNAME Dinoprostone DTD0008 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0008 VADRUGID DR00136 DTD0008 DRUGNAME Regorafenib DTD0008 DRUGSYNO 24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB DTD0008 VADRUGID DR00182 DTD0008 DRUGNAME Dasatinib DTD0008 DRUGSYNO (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel DTD0008 VADRUGID DR01351 DTD0008 DRUGNAME TR-14035 DTD0008 DRUGSYNO 232271-19-1; TR-14035; (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid; CHEMBL91485; N-(2,6-DICHLOROBENZOYL)-4-(2,6-DIMETHOXYPHENYL)-L-PHENYLALANINE; C24H21Cl2NO5; DRSJLVGDSNWQBI-SFHVURJKSA-N; TR 14035; SCHEMBL1222491; BDBM16801; CTK8C1530; MolPort-023-334-229; ZINC1490484; ANW-66841; N-Acyl-4-arylphenylalanine analogue.; AKOS016008162; CS-1812; CS-W000631; MP-2027; NCGC00390619-01; SB683698; HY-15770; AK-95353; AJ-26339; KB-210922; TC-155586; AB0077984; AX8237663; ST24020804; Z4458 DTD0008 VADRUGID DR00523 DTD0008 DRUGNAME Crizotinib DTD0008 DRUGSYNO Xalkori (TN); novel ALK inhibitors DTD0008 VADRUGID DR00262 DTD0008 DRUGNAME Sirolimus DTD0008 DRUGSYNO (-)-Rapamycin; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29; 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; AY 22989; AY-22989; Antibiotic AY 22989; DE-109; Heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy; LCP-Siro; MS-R001; Perceiva; RAP; RAPA; RPM; Rapammune; Rapamune; Rapamune (TN); Rapamycin; Rapamycin (TN); Rapamycin C-7, analog 4; Rapamycin Immunosuppressant Drug; Rapamycin from Streptomyces hygroscopicus; SIIA 9268A; SILA 9268A; Sirolimus (MTOR inhibitor); Sirolimus (RAPAMUNE); Sirolimus (USAN/INN); Sirolimus [USAN:BAN:INN]; Sirolimus, Rapamune,Rapamycin; WY-090217; Wy 090217 DTD0008 VADRUGID DR01349 DTD0008 DRUGNAME Karenitecin DTD0008 DRUGSYNO Karenitecin (TN) DTD0008 VADRUGID DR01490 DTD0008 DRUGNAME [D-Ala2, D-Leu5]-enkephalin DTD0008 DRUGSYNO Dadle; 63631-40-3; H-TYR-D-ALA-GLY-PHE-D-LEU-OH; DADL; (D-Ala2,D-Leu5)-Enkephalin; [D-Ala2, D-Leu5]-enkephalin; CHEMBL340032; BW-180C; Tyr-D-Ala-Gly-Phe-D-Leu; (2R,5S,11R,14S)-14-Amino-5-benzyl-15-(4-hydroxyphenyl)-2-isobutyl-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecan-1-oic acid; (2R)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid; UNII-HB4QD9GL6F; HB4QD9GL6F; DADLE-OH; AC1OCEJN; ZINC14952092; H-Tyr-D-Ala-Gly-Phe-D-Leu DTD0008 VADRUGID DR00304 DTD0008 DRUGNAME Sorafenib DTD0008 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum DTD0008 VADRUGID DR01275 DTD0008 DRUGNAME Entacapone DTD0008 DRUGSYNO (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; COM-998; Comtan; Comtan (TN); Comtess; Entacapona; Entacapona [INN-Spanish]; Entacapone (JAN/USAN/INN); Entacapone [USAN:INN]; Entacaponum; Entacaponum [INN-Latin]; KB475572; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; Novartis brand of entacapone; OR 611; OR-611; Orion brand of entacapone; Stalevo (TN) DTD0008 VADRUGID DR00243 DTD0008 DRUGNAME Mycophenolate mofetil DTD0008 DRUGSYNO 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF DTD0008 VADRUGID DR00288 DTD0008 DRUGNAME Bosentan DTD0008 DRUGSYNO 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN) DTD0008 VADRUGID DR00185 DTD0008 DRUGNAME Pazopanib hydrochloride DTD0008 DRUGSYNO 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN) DTD0008 VADRUGID DR00196 DTD0008 DRUGNAME Rifampicin DTD0008 DRUGSYNO 1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN) DTD0008 VADRUGID DR00446 DTD0008 DRUGNAME Repaglinide DTD0008 DRUGSYNO (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; 111GE012; 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid; 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid; AG-EE 388; AG-EE 388 ZW; AG-EE 623 ZW; AG-EE-388; AG-EE-623 ZW; AGEE-623ZW; Actulin; Glaxo Wellcome brand of replaginide; GlucoNorm; GlucoNorm (TN); NN-623; Novo Nordisk brand 2 of repaglinide; Novo Nordisk brand of repaglinide; NovoNorm; NovoNorm (TN); Prandin; Prandin (TN); Prandin, GlucoNorm, NovoNorm, Repaglinide; Repa-glinide; Repaglinida; Repaglinida [INN-Spanish]; Repaglinide (JAN/USP/INN); Repaglinide [USAN]; Repaglinide, (+-)-isomer; Repaglinidum; Repaglinidum [INN-Latin]; SMP-508 DTD0008 VADRUGID DR00053 DTD0008 DRUGNAME Sodium taurocholate DTD0008 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0008 VADRUGID DR01121 DTD0008 DRUGNAME Taurocholic acid DTD0008 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0008 VADRUGID DR00391 DTD0008 DRUGNAME Cerivastatin DTD0008 DRUGSYNO . DTD0008 VADRUGID DR00161 DTD0008 DRUGNAME SN-38 DTD0008 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0008 VADRUGID DR00547 DTD0008 DRUGNAME Fluorescein DTD0008 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0008 VADRUGID DR00711 DTD0008 DRUGNAME Vemurafenib DTD0008 DRUGSYNO PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN) DTD0008 VADRUGID DR00657 DTD0008 DRUGNAME Cholic acid DTD0008 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0008 VADRUGID DR00615 DTD0008 DRUGNAME Chenodeoxycholic acid DTD0008 DRUGSYNO (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol; 3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid; 3,7-Dihydroxycholan-24-oic acid; 3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid; 3-alpha,7-beta-Dihydroxycholanic acid; 3-alpha,7-beta-Dioxycholanic acid; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,7beta-Dihydroxy-5beta-cholanic acid; 5beta-Cholan-24-oic acid-3alpha,7beta-diol; 5beta-Cholanic Acid-3alpha,7beta-diol; 7-beta-Hydroxylithocholic acid; 7beta-Hydroxylithocholic acid; Acide ursodesoxycholique; Acide ursodesoxycholique [INN-French]; Acido ursodeossicolico; Acido ursodeossicolico [Italian]; Acido ursodeoxicolico; Acido ursodeoxicolico [INN-Spanish]; Acidum ursodeoxycholicum; Acidum ursodeoxycholicum [INN-Latin]; Actigall; Actigall (TN); Antigall; Arsacol; Chenodeoxycholic acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-(9CI); Cholit-ursan; Delursan; Deoxyursocholic Acid; Destolit; Deursil; Deursil (TN); Dom-ursodiol c; ISO-URSODEOXYCHOLIC ACID; IU5; Litursol; Lyeton; PHL-ursodiol c; PMS-ursodiol c; Peptarom; Sodium Ursodeoxycholate; Solutrat; U-9000; U0030; UDCA;UDCS; UrSO; Urosiol; Ursacholic Acid; Ursacol; Urso (TN); Urso 250; Urso DS; Urso Forte; Urso Forte (TN); Ursobilin; Ursochol; Ursodamor; Ursodeoxy cholic acid; Ursodeoxycholate; Ursodeoxycholic acid (JP15/INN); Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol; Ursodesoxycholicacid; Ursodexycholic Acid; Ursodiol; Ursodiol (USP); Ursodiol [USAN]; Ursofalk; Ursolvan; Ursosan; Ursosan (TN) DTD0008 VADRUGID DR00493 DTD0008 DRUGNAME Caspofungin DTD0008 DRUGSYNO Caspofungin; Cancidas; Cancidas (TN); Capsofungin; Caspofungin (INN); MK 0991; L 743872; AC1MCVUN; MK-0991; CHEMBL499808; SCHEMBL6726364; L-743872; JYIKNQVWKBUSNH-OGZDCFRISA-N; L-743,872; N-[(2-aminoethylamino)-[(1R)-3-amino-1-hydroxy-propyl]-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-trihydroxy-[(1R)-1-hydroxyethyl]-hexaoxo-[?]yl]-10,12-dimethyl-tetradecanamide; LS-187303; FT-0696944; L 743; D07626 DTD0008 VADRUGID DR01466 DTD0008 DRUGNAME YM758 DTD0008 DRUGSYNO YM 758 Phosphate; (R)-(-)-N-[2-[3-[(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)carbonyl]piperidino]ethyl]-4-fluorobenzamide monophosphate; YM 758; N-[2-[(3R)-3-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-1-piperidinyl]ethyl]-4-fluorobenzamide Phosphate DTD0008 VADRUGID DR00856 DTD0008 DRUGNAME Mesalazine DTD0008 DRUGSYNO 2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206 DTD0008 VADRUGID DR00488 DTD0008 DRUGNAME Benzylpenicillin DTD0008 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0008 VADRUGID DR00577 DTD0008 DRUGNAME Cefazolin DTD0008 DRUGSYNO (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN) DTD0008 VADRUGID DR00600 DTD0008 DRUGNAME Cefoperazone DTD0008 DRUGSYNO (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN) DTD0008 VADRUGID DR01617 DTD0008 DRUGNAME Primovist DTD0008 DRUGSYNO Eovist; Primovist; gadoxate disodium; AC1L9OPS; gadolinium ethoxybenzyl-DTPA; MOLI000482; 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; gadolinium(3+) DTD0008 VADRUGID DR01237 DTD0008 DRUGNAME Technetium (99MTC) mebrofenin DTD0008 DRUGSYNO F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52 DTD0008 VADRUGID DR01332 DTD0008 DRUGNAME Bromfenac DTD0008 DRUGSYNO 2-Amino-3-(4-bromobenzoyl)benzeneacetic acid; 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; AHR-10282; BROMFENAC SODIUM; Bromfenac (INN); Bromfenac [INN]; Bromfenaco; Bromfenaco [Spanish]; Bromfenacum; Bromfenacum [Latin]; Duract; Duract (TN); Sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate; Xibrom; Xibrom (TN); [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid; [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; {2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid DTD0008 VADRUGID DR01384 DTD0008 DRUGNAME Nafcillin DTD0008 DRUGSYNO Nafcilina; Nafcilline; Nafcillinum; Nallpen; Naphcillin; Naphthamidopenicillin; Unipen; NAFCILLIN SODIUM; Nafcillin sodium for injection; Nallpen In Plastic Container; Nafcilin-1; Nafcilina [INN-Spanish]; Nafcillin & VRC3375; Nafcillin (INN); Nafcillin [INN:BAN]; Nafcilline [INN-French]; Nafcillinum [INN-Latin]; Nafcillin, Monosodium Salt, Anhydrous; (2-Ethoxy-1-naphthyl)penicillin; (2-ethoxy-1-naphthalenyl)penicillin; (2S,5R,6R)-6-({[2-(ethyloxy)naphthalen-1-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(2-ethoxy-1-naphthamido)penicillanic acid; 6-[(2-Ethoxy-naphthalene-1-carbonyl)-amino]-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion; 6beta-(2-ethoxynaphthalene-1-carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid DTD0008 VADRUGID DR01257 DTD0008 DRUGNAME Gadobenate dimeglumine DTD0008 DRUGSYNO Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2) DTD0008 VADRUGID DR01322 DTD0008 DRUGNAME Cilostazol DTD0008 DRUGSYNO Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol DTD0008 VADRUGID DR00618 DTD0008 DRUGNAME Vandetanib DTD0008 DRUGSYNO 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474 DTD0008 VADRUGID DR00569 DTD0008 DRUGNAME Glycocholic acid DTD0008 DRUGSYNO Glycocholate; cholylglycine DTD0008 VADRUGID DR01513 DTD0008 DRUGNAME Dehydroepiandrosterone sulfate DTD0008 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0008 VADRUGID DR01545 DTD0008 DRUGNAME Pitavastatin DTD0008 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0008 VADRUGID DR01394 DTD0008 DRUGNAME Cefditoren DTD0008 DRUGSYNO Cefditoren [USAN:INN]; Meiact (TN); Spectracef (TN); (+)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-((Z)-2-(4-methyl-5-thiazolyl)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime); (6R-(3(Z),6alpha,7beta(Z)))-7-((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid DTD0008 VADRUGID DR00019 DTD0008 DRUGNAME Estrone sulfate DTD0008 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0008 VADRUGID DR01339 DTD0008 DRUGNAME Gimatecan DTD0008 DRUGSYNO LBQ-707; ST-1480; ST-1481; Camptothecin analogs, Sigma-Tau; 7-cyano-camptothecin DTD0008 VADRUGID DR01616 DTD0008 DRUGNAME Cholyl lysyl fluorescein DTD0008 VADRUGID DR01381 DTD0008 DRUGNAME BQ-123 DTD0008 DRUGSYNO BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp) DTD0008 VADRUGID DR01433 DTD0008 DRUGNAME Atrasentan DTD0008 DRUGSYNO Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid DTD0009 TRANSPID DTD0009 DTD0009 GENENAME SLC22A3 DTD0009 PROTNAME Organic cation transporter 3 DTD0009 SYNONYMS OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3 DTD0009 VADRUGID DR00076 DTD0009 DRUGNAME Epinephrine DTD0009 DRUGSYNO (-)-(R)-Epinephrine; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (-)-Adrenalin; (-)-Adrenaline; (-)-Epinephrine; (-)-R-Epinephrine; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; (R)-Adrenaline; (R)-Epinephrine; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1-Adrenalin; 1-Epinephrine; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; ADR ADRENALINE; ADROP; Adnephrine; Adrenal; Adrenalin; Adrenalin (TN); Adrenalin in Oil; Adrenalin-Medihaler; Adrenalina; Adrenalina [DCIT]; Adrenaline; Adrenaline (JP15); Adrenaline/Epinephrine; Adrenalinum; Adrenamine; Adrenan; Adrenapax; Adrenasol; Adrenatrate; Adrenine; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Adrin; Adrine; Ana-Guard; Antiasthmatique; Asmatane Mist; Asthma meter mist; Asthma-nefrin; Asthmahaler Mist; Asthmanefrin; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Bosmin; Brevirenin; Bronkaid; Bronkaid Mist; Bronkaid Suspension Mist; Bupivacaine Hcl and Epinephrine; Chelafrin; Citanest Forte; Corisol; D-Adrenaline; D-Epifrin; D-Epinephrine; Drenamist; Dylephrin; Dyspne-Inhal; EPI E Z PEN JR; EPIPEN E Z PEN; EPIPEN JR; Epi EZ Pen Jr; Epifrin; Epiglaufrin; Epinefrin; Epinefrin [Czech]; Epinefrina; Epinefrina [INN-Spanish]; Epinephran; Epinephrin; Epinephrine (USP); Epinephrine (USP/INN); Epinephrine [USAN:INN:JAN]; Epinephrine hydrochloride; Epinephrinum; Epinephrinum [INN-Latin]; Epipen; Epipen (TN); Epipen Auto-Injector; Epipen EZ Pen; Epipen Jr.; Epipen Jr. Auto-Injector; Epirenamine; Epirenan; Epirenin; Epitrate; Eppy; Esphygmogenina; Exadrin; Glaucon; Glaucosan; Glauposine; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hemisine; Hemostasin; Hemostatin; Hypernephrin; Hyporenin; IOP; Intranefrin; Iontocaine; Isoptoepinal; Kidoline; L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; L-Adrenalin; L-Adrenaline; L-Adrenaline Base; L-Epinehphrine; L-Epinephine; L-Epinephrine (synthetic); L-Epirenamine; L-Methylaminoethanolcatechol; L-epinephrine; Levo-Methylaminoethanolcatechol; Levoadrenaline; Levoepinephrine; Levorenen; Levorenin; Levorenine; Lyophrin; Medihaler-Epi; Metanephrin; Methylaminoethanolcatechol; Methylarterenol; Micronefrin; Micronephrine; Mucidrina; Myosthenine; Mytrate; Nephridine; Nieraline; Paranephrin; Primatene; Primatene Mist; R-(-)-Epinephrine; R-Adrenaline; Racemic Epinephrine; Racepinephrine; Renagladin; Renaglandin; Renaglandulin; Renaleptine; Renalina; Renoform; Renostypricin; Renostypticin; Renostyptin; SUS-PHRINE SULFITE-FREE; Scurenaline; Septocaine; Simplene; Sindrenina; Soladren; Sphygmogenin; Stryptirenal; Styptirenal; Supracapsulin; Supradin; Supranefran; Supranephrane; Supranephrine; Supranol; Suprarenaline; Suprarenin; Suprel; Surenine; Surrenine; Sus-Phrine; Susphrine; Sympathin I; Takamina; Takamine; Tokamina; Tonogen; Twinject; Twinject 0.15; Twinject 0.3; Twinject 0.30; Vaponefrin; Vasoconstrictine; Vasoconstrictor; Vasodrine; Vasoton; Vasotonin DTD0009 VADRUGID DR00084 DTD0009 DRUGNAME Amphetamine DTD0009 DRUGSYNO Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore DTD0009 VADRUGID DR00070 DTD0009 DRUGNAME Acetylcholine DTD0009 DRUGSYNO Miochol; Miochol-e DTD0009 VADRUGID DR01277 DTD0009 DRUGNAME Entecavir DTD0009 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0009 VADRUGID DR00521 DTD0009 DRUGNAME Clonidine DTD0009 DRUGSYNO 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets DTD0009 VADRUGID DR00528 DTD0009 DRUGNAME Propranolol DTD0009 DRUGSYNO (+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN) DTD0009 VADRUGID DR00268 DTD0009 DRUGNAME Norepinephrine DTD0009 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0009 VADRUGID DR00133 DTD0009 DRUGNAME Metformin DTD0009 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0009 VADRUGID DR00337 DTD0009 DRUGNAME N-methylpyridinium DTD0009 DRUGSYNO 1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl- DTD0009 VADRUGID DR00081 DTD0009 DRUGNAME Ergotidine DTD0009 DRUGSYNO 1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine DTD0009 VADRUGID DR01173 DTD0009 DRUGNAME Sodium chloride DTD0009 DRUGSYNO 7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling DTD0009 VADRUGID DR00028 DTD0009 DRUGNAME Etilefrine DTD0009 DRUGSYNO 2-Ethylamino-1-(3-hydroxyphenyl)ethanol Hydrochloride; 3-(2-(Ethylamino)-1-hydroxyethyl)phenol hydrochloride; 3-[2-(ethylamino)-1-hydroxyethyl]phenol hydrochloride; 534-87-2; 943-17-9; Apocretin; Circupon; Effontil; Effortilvet; Ethyl adrianol; Ethylephrine hydrochloride; Eti-Puren; Etilefrin Hydrochloride; Etilefrine HCl; Etilefrine hydrochloride; Etilefrine hydrochloride (TN); Funasol; Kertasin; Phetanol; Phetasin; Pulsamin; Tonus-Forte; Updormin; dl-Effortil hydrochloride; dl-Etilefrin hydrochloride; dl-N-Ethylnorphenylephrine h DTD0009 VADRUGID DR01303 DTD0009 DRUGNAME Guanidine DTD0009 DRUGSYNO (NH2)2C=NH; 4-03-00-00148 (Beilstein Handbook Reference); AC1L1G4E; AC1Q50DT; AC1Q50DU; Aminoformamidine; Aminomethanamidine; Carbamamidine; Carbamidine; GAI; Gu; Guanidin; Guanidine, Hydrochloride; Guanidine, free base;BRN 0506044; H2N-C(=NH)-NH2; HSDB 7603; Imidourea; Iminourea; JU58VJ6Y3B; NCIOpen2_007946; UNII-JU58VJ6Y3B; ZRALSGWEFCBTJO-UHFFFAOYSA-N; guanidine DTD0010 TRANSPID DTD0010 DTD0010 GENENAME SLC22A1 DTD0010 PROTNAME Organic cation transporter 1 DTD0010 SYNONYMS OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds DTD0010 VADRUGID DR00037 DTD0010 DRUGNAME Cimetidine DTD0010 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0010 VADRUGID DR00263 DTD0010 DRUGNAME Nizatidine DTD0010 DRUGSYNO (E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Acinon; Acinon (TN); Antizid; Axid; Axid (TN); Axid Ar; Calmaxid; Cronizat; Distaxid; Galitidin; Gastrax; LY 139037; LY-139037; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin; Naxidine; Niatidine; Nizatidina; Nizatidina [Spanish]; Nizatidine (JAN/USP/INN); Nizatidine [USAN:BAN:INN:JAN]; Nizatidinum; Nizatidinum [Latin]; Nizax; Nizaxid; Panaxid; Splendil ER; Tazac; Tazac (TN); Ulcosol; Ulxid; ZE-101; ZL-101; Zanizal; Zinga DTD0010 VADRUGID DR00416 DTD0010 DRUGNAME Cytarabine DTD0010 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0010 VADRUGID DR00026 DTD0010 DRUGNAME Fexofenadine DTD0010 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0010 VADRUGID DR00076 DTD0010 DRUGNAME Epinephrine DTD0010 DRUGSYNO (-)-(R)-Epinephrine; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (-)-Adrenalin; (-)-Adrenaline; (-)-Epinephrine; (-)-R-Epinephrine; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; (R)-Adrenaline; (R)-Epinephrine; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1-Adrenalin; 1-Epinephrine; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; ADR ADRENALINE; ADROP; Adnephrine; Adrenal; Adrenalin; Adrenalin (TN); Adrenalin in Oil; Adrenalin-Medihaler; Adrenalina; Adrenalina [DCIT]; Adrenaline; Adrenaline (JP15); Adrenaline/Epinephrine; Adrenalinum; Adrenamine; Adrenan; Adrenapax; Adrenasol; Adrenatrate; Adrenine; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Adrin; Adrine; Ana-Guard; Antiasthmatique; Asmatane Mist; Asthma meter mist; Asthma-nefrin; Asthmahaler Mist; Asthmanefrin; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Bosmin; Brevirenin; Bronkaid; Bronkaid Mist; Bronkaid Suspension Mist; Bupivacaine Hcl and Epinephrine; Chelafrin; Citanest Forte; Corisol; D-Adrenaline; D-Epifrin; D-Epinephrine; Drenamist; Dylephrin; Dyspne-Inhal; EPI E Z PEN JR; EPIPEN E Z PEN; EPIPEN JR; Epi EZ Pen Jr; Epifrin; Epiglaufrin; Epinefrin; Epinefrin [Czech]; Epinefrina; Epinefrina [INN-Spanish]; Epinephran; Epinephrin; Epinephrine (USP); Epinephrine (USP/INN); Epinephrine [USAN:INN:JAN]; Epinephrine hydrochloride; Epinephrinum; Epinephrinum [INN-Latin]; Epipen; Epipen (TN); Epipen Auto-Injector; Epipen EZ Pen; Epipen Jr.; Epipen Jr. Auto-Injector; Epirenamine; Epirenan; Epirenin; Epitrate; Eppy; Esphygmogenina; Exadrin; Glaucon; Glaucosan; Glauposine; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hemisine; Hemostasin; Hemostatin; Hypernephrin; Hyporenin; IOP; Intranefrin; Iontocaine; Isoptoepinal; Kidoline; L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; L-Adrenalin; L-Adrenaline; L-Adrenaline Base; L-Epinehphrine; L-Epinephine; L-Epinephrine (synthetic); L-Epirenamine; L-Methylaminoethanolcatechol; L-epinephrine; Levo-Methylaminoethanolcatechol; Levoadrenaline; Levoepinephrine; Levorenen; Levorenin; Levorenine; Lyophrin; Medihaler-Epi; Metanephrin; Methylaminoethanolcatechol; Methylarterenol; Micronefrin; Micronephrine; Mucidrina; Myosthenine; Mytrate; Nephridine; Nieraline; Paranephrin; Primatene; Primatene Mist; R-(-)-Epinephrine; R-Adrenaline; Racemic Epinephrine; Racepinephrine; Renagladin; Renaglandin; Renaglandulin; Renaleptine; Renalina; Renoform; Renostypricin; Renostypticin; Renostyptin; SUS-PHRINE SULFITE-FREE; Scurenaline; Septocaine; Simplene; Sindrenina; Soladren; Sphygmogenin; Stryptirenal; Styptirenal; Supracapsulin; Supradin; Supranefran; Supranephrane; Supranephrine; Supranol; Suprarenaline; Suprarenin; Suprel; Surenine; Surrenine; Sus-Phrine; Susphrine; Sympathin I; Takamina; Takamine; Tokamina; Tonogen; Twinject; Twinject 0.15; Twinject 0.3; Twinject 0.30; Vaponefrin; Vasoconstrictine; Vasoconstrictor; Vasodrine; Vasoton; Vasotonin DTD0010 VADRUGID DR00264 DTD0010 DRUGNAME Verapamil DTD0010 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0010 VADRUGID DR01355 DTD0010 DRUGNAME Formoterol DTD0010 DRUGSYNO Foradile; Formoterol tartrate; Oxeze Turbuhaler Foradil; MOLI000351; Atimos (TN); Atock (TN); Foradil (TN); Foradile (TN); Formoterol (INN); Modulite (TN); Oxeze (TN); Oxis (TN); Perforomist (TN); Formoterol, ((R*,R*)-(+-)-)-isomer; N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide; N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide; (+-)-2'-Hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide; 3-formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate DTD0010 VADRUGID DR01436 DTD0010 DRUGNAME Procaterol DTD0010 DRUGSYNO Meptin; Procaterolo; Procaterolum; Procaterol Monohydrochloride; Procaterolo [DCIT]; Procaterolum [Latin]; Meptin (TN); OPC-2009; Procaterol (INN); Procaterol [INN:BAN]; Procaterolum [INN-Latin]; (R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone; 5-[1-hydroxy-2-(propan-2-ylamino)butyl]quinoline-2,8-diol; 8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone; 8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one DTD0010 VADRUGID DR00971 DTD0010 DRUGNAME Terbutaline DTD0010 DRUGSYNO (+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol; (+-)-Terbutaline; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-(9CI); 5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL; 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; 5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol; Asthmasian; Asthmasian (TN); Brethaire; Brethaire (TN); Brethine; Brethine (TN); Brican; Bricanyl; Bricanyl (TN); Bricar; Bricaril; Bricyn; KWD 2019; KWD-2019; Terbutalin; Terbutalina; Terbutalina [DCIT]; Terbutaline (INN); Terbutaline [INN:BAN]; Terbutaline sulfate; Terbutalino; Terbutalino [INN-Spanish]; Terbutalinum; Terbutalinum [INN-Latin] DTD0010 VADRUGID DR00501 DTD0010 DRUGNAME Desipramine DTD0010 DRUGSYNO (3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine; 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine; 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine; 5-(gamma-Methylaminopropyl)iminodibenzyl; DMI (pharmaceutical); DMI 50475; Demethylimipramine; Desimipramine; Desimpramine; Desipramin; Desipramina; Desipramina [INN-Spanish]; Desipramine (D4); Desipramine (INN); Desipramine Hcl; Desipramine [INN:BAN]; Desipraminum; Desipraminum [INN-Latin]; Desmethylimipramine; Dezipramine; Dimethylimipramine; Methylaminopropyliminodibenzyl; Monodemethylimipramine; N-(3-Methylaminopropyl)iminobibenzyl; Norimipramine; Norpramin (TN); Norpramine; Pentofran; Pertofrane (TN); Pertrofane; Sertofran; ZERO/006017 DTD0010 VADRUGID DR00056 DTD0010 DRUGNAME Lamotrigine DTD0010 DRUGSYNO 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine; BW 430C; BW-430C; Crisomet; Desitin Brand of Lamotrigine; EUR-1048; Faes Brand of Lamotrigine; GI 267119X; GW 273293; Glaxo Wellcome Brand of Lamotrigine; GlaxoSmithKline Brand of Lamotrigine; Juste Brand of Lamotrigine; L 3791; Labileno; Lamictal; Lamictal (TN); Lamictal Cd; Lamictal ODT; Lamictal XR; Lamictin; Lamictin (TN); Lamiktal; Lamitor; Lamotrigina; Lamotrigina [Spanish]; Lamotrigine (JAN/USAN/INN); Lamotrigine [USAN:INN:BAN]; Lamotriginum; Lamotriginum [Latin] DTD0010 VADRUGID DR00759 DTD0010 DRUGNAME Perphenazine DTD0010 DRUGSYNO 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina; 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]; 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine; 1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride; 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol; 2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; 2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine; 2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine; 2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine; 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol;2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol; 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol; 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol; 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; Apo-Perphenazine; Chlorperphenazine; Chlorpiprazine; Decentan; Emesinal; Etaperazin; Etaperazine; Ethaperazine; F-mon; Fentazin;PZC; Gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine; Gamma-[4-(beta-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine; P 6402; Perfenazina; Perfenazina [INN-Spanish]; Perfenazina [Italian]; Perfenazine; Perphenan; Perphenazin; Perphenazine (JP15/USP/INN); Perphenazine [INN:BAN:JAN]; Perphenazine [Trilafon]; Perphenazine maleate; Perphenazinum; Perphenazinum [INN-Latin]; SCH-3940; Sch 3940; Siquil (TN); Thilatazin; Tranquisan; Triavil (TN); Trifaron; Trilafon; Trilifan; Triphenot DTD0010 VADRUGID DR00110 DTD0010 DRUGNAME YM155 DTD0010 DRUGSYNO Sepantronium DTD0010 VADRUGID DR00370 DTD0010 DRUGNAME Antiparasitics DTD0010 DRUGSYNO Antiparasitics, Immtech; DAP-092; DB-075; DB-244; DB-75; Furamidine; WR-199385 DTD0010 VADRUGID DR00070 DTD0010 DRUGNAME Acetylcholine DTD0010 DRUGSYNO Miochol; Miochol-e DTD0010 VADRUGID DR00116 DTD0010 DRUGNAME Lamivudine DTD0010 DRUGSYNO (+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix DTD0010 VADRUGID DR00032 DTD0010 DRUGNAME Imatinib DTD0010 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0010 VADRUGID DR00064 DTD0010 DRUGNAME Indacaterol DTD0010 DRUGSYNO 5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol (USAN/INN); QAB-149 DTD0010 VADRUGID DR00017 DTD0010 DRUGNAME Tiotropium DTD0010 DRUGSYNO (1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide; (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide; 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; BA 679 BR; BA 679BR; BA-679 BR; BA-679-BR; Spiriva; Spiriva (TN); Spiriva Handihaler; Spiriva Respimat; TIOTROPIUM BROMIDE; Tiotropium bromide [USAN:INN] DTD0010 VADRUGID DR00316 DTD0010 DRUGNAME Oxaliplatin DTD0010 DRUGSYNO ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138 DTD0010 VADRUGID DR00207 DTD0010 DRUGNAME Amiloride DTD0010 DRUGSYNO 3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide; 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8)); Amiclaran; Amiclaran (TN); Amikal (Hydrochloride dihydrate); Amilorida; Amilorida [INN-Spanish]; Amiloride (INN); Amiloride (Na-Ca chanel blocker); Amiloride HCL; Amiloride [INN:BAN]; Amiloride hydrochloride hydrate; Amiloridum; Amiloridum [INN-Latin]; Amipramidin; Amipramizid; Amipramizide; Amiprazidine; Amyloride; Biduret (TN); Guanamprazin; Guanamprazine; MK-870 (Hydrochloride dihydrate); Midamor; Midamor (Hydrochloride dihydrate); N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride DTD0010 VADRUGID DR00027 DTD0010 DRUGNAME Ganciclovir DTD0010 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0010 VADRUGID DR00319 DTD0010 DRUGNAME Citalopram DTD0010 DRUGSYNO 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram DTD0010 VADRUGID DR00307 DTD0010 DRUGNAME Berberine DTD0010 DRUGSYNO 0I8Y3P32UF; 2086-83-1; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE; BRN 3570374; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; Berbamine sulphate acid; Berberal; Berberin; CHEBI:16118; CHEMBL12089; EINECS 218-229-1; ST055798; UNII-0I8Y3P32UF; Umbellatine DTD0010 VADRUGID DR00561 DTD0010 DRUGNAME Phenformin DTD0010 DRUGSYNO 1-(diaminomethylidene)-2-phenethylguanidine; 1-Phenethylbiguanide; Azucaps; Beta-PEBG; Beta-Phenethybiguanide; Beta-Phenethylbiguanide; Cronoformin; D Bretard; DB Comb; DBI; DBI monohydrochloride; Db-retard; Debeone; Debeone (TN); Debinyl; Diabis; Dibein; Dibiraf; Dibotin; Dipar; Feguanide; Fenfoduron; Fenformin; Fenformina; Fenformina [INN-Spanish]; Fenormin; Glukopostin; Glyphen; Insoral; Lentobetic; Meltrol; Meltrol-50; N'-beta-Fenetilformamidiniliminourea; N'-beta-Fenetilformamidiniliminourea [Italian]; N'-beta-Phenethylformamidinylliminourea; N-(2-Phenylethyl)imidodicarbonimidic diamide; N-Phenethylbiguanide hydrochloride; Normoglucina; PHENFORMIN (SEE ALSO PHENFORMIN HYDROCHLORIDE 834-28-6); Pedg; Phenethyldiguanide; Phenformin (BAN); Phenformin [INN:BAN]; Phenformine; Phenformine HCl; Phenformine [INN-French]; Phenforminum; Phenforminum [INN-Latin]; Phenformix; Phenoformine hydrochloride; Phenylethylbiguanide; Retardo; W 32 DTD0010 VADRUGID DR01341 DTD0010 DRUGNAME Triamterene DTD0010 DRUGSYNO Ademin; Ademine; Amteren; Anjal; Dazid; Diarol; Dinazide; Diren; Ditak; Diucelpin; Diurene; Diutensat; Diuteren; Dyberzide; Dyren; Dyrenium; Dytac; Dytenzide; Esiteren; Hidiurese; Hydrene; Hypertorr; Isobar; Jatropur; Jenateren; Kalspare; Masuharmin; Nephral; Noridil; Noridyl; Pterofen; Pterophene; Renezide; Reviten; Taturil; Teriam; Teridin; Triamizide; Triampur; Triamteren; Triamterena; Triamterenum; Triamteril; Triamterine; Triamthiazid; Tricilone; Trispan; Triteren; Triurene; Trizid; Turfa; Uretren; Urocaudal; Goldshield Brand of Triamterene; Jorba Brand of Triamterene; Pter ophene; SmithKline Beecham Brand of Triamterene; TRIAMTERENE USP; Thiazid Wolff; Triamteril complex; Wellspring Brand of Triamterene; Fluss 40; SKF 8542; T 4143; Ademin(e); Apo-triazide; Dyrenium (TN); Pteridine deriv. 11; SALI-PUREN; SK&F 8542; SK-8542; Tri-Span; Triamterena [INN-Spanish]; Triamterenum [INN-Latin]; SK&F-8542; Triamterene (JP15/USP/INN); Triamterene [USAN:INN:BAN:JAN]; 2,4,7-Triamino-6-fenilpteridina; 2,4,7-Triamino-6-fenilpteridina [Italian]; 2,4,7-Triamino-6-phenylpteridine; 6-PHENYL-2,4,7-TRIAMINO PTERIDINE; 6-Phenyl-2,4,7-pteridinetriamine; 6-Phenyl-2,4,7-triaminopteridine; 6-phenylpteridine-2,4,7-triamine DTD0010 VADRUGID DR00087 DTD0010 DRUGNAME Cladribine DTD0010 DRUGSYNO (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000 DTD0010 VADRUGID DR01670 DTD0010 DRUGNAME (R)-Xamoterol DTD0010 DRUGSYNO . DTD0010 VADRUGID DR01671 DTD0010 DRUGNAME (S)-Xamoterol DTD0010 DRUGSYNO UNII-ZIB581LRDV; ZIB581LRDV; (S)-Xamoterol; Xamoterol, (S)-; 69630-22-4; SCHEMBL11533496; ZINC1532365; UNII-7HE0JQL703 component DXPOSRCHIDYWHW-AWEZNQCLSA-N; 4-Morpholinecarboxamide, N-(2-(((2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)- DTD0010 VADRUGID DR00033 DTD0010 DRUGNAME Atenolol DTD0010 DRUGSYNO (+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten DTD0010 VADRUGID DR00521 DTD0010 DRUGNAME Clonidine DTD0010 DRUGSYNO 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets DTD0010 VADRUGID DR00693 DTD0010 DRUGNAME Prazosin DTD0010 DRUGSYNO 1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone DTD0010 VADRUGID DR00627 DTD0010 DRUGNAME Acebutolol DTD0010 DRUGSYNO (+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN) DTD0010 VADRUGID DR00528 DTD0010 DRUGNAME Propranolol DTD0010 DRUGSYNO (+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN) DTD0010 VADRUGID DR00085 DTD0010 DRUGNAME Pentamidine DTD0010 DRUGSYNO 1,3-BIS(4-AMIDINOPHENOXY)PENTANE; 4, 4'-Diamidinodiphenoxypentane; 4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide; 4,4'-(Pentamethylenedioxy)dibenzamide; 4,4'-(Pentamethylenedioxy)dibenzamidine; 4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane; 4,4'-Diamidinodiphenoxypentane; 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide; 4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide; Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-(9CI); Lomidine; Lomidine (TN); MB 800; MB-800; Nebupent; Nebupent (*Isethionate); Nebupent (as isethionate); P,p'-(Pentamethylene-dioxy)bis-benzamidine; P,p'-(Pentamethylenedioxy)bis[benzamidine]; P,p'-(Pentamethylenedioxy)dibenzamidine; PENTAM; PENTAMIDINE ISETHIONATE; PNT; Pentacarinat; Pentacarinat (as isethionate); Pentam 300; Pentam 300 (*Isethionate); Pentam 300 (as isethionate); Pentamide; Pentamidin; Pentamidina; Pentamidina [DCIT]; Pentamidine (INN); Pentamidine Isethionate 2-Hydroxy-Ethanesulfonic Acid;Pentamidine [INN:BAN:DCF]; Pentamidine isetionate; Pentamidine mesylate; Pentamidinum; Pentamidinum [INN-Latin]; Pneumopent; RP 2512 (*Isethionate); RP-2512 DTD0010 VADRUGID DR00296 DTD0010 DRUGNAME Zidovudine DTD0010 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0010 VADRUGID DR00054 DTD0010 DRUGNAME Quinine DTD0010 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0010 VADRUGID DR00102 DTD0010 DRUGNAME Dinoprostone DTD0010 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0010 VADRUGID DR01282 DTD0010 DRUGNAME Naratriptan DTD0010 DRUGSYNO Amerge (TN); Amerge, Naramig,Naratriptan; Colatan; N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide; N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide; Naramig; Naramig (TN); Naratriptan (INN); Naratriptanum DTD0010 VADRUGID DR01281 DTD0010 DRUGNAME Rizatriptan DTD0010 DRUGSYNO MK 462 free base; Maxalt (TN); N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; Risatriptan; Rizaliv (TN); Rizalt (TN); Rizatriptan (INN); Rizatriptan [INN:BAN]; Rizatriptan benzoat; Rizatriptanum DTD0010 VADRUGID DR00331 DTD0010 DRUGNAME Sumatriptan DTD0010 DRUGSYNO (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide; 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide; 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide; GR 43175; GR 43175X; GR-43175; Imigran; Imigran (TN); Imitrex; Imitrex (TN); KS-1116; NP101; Sumatran; Sumatriptan (JAN/USP/INN); Sumatriptanum; Sumatriptanum [INN-Latin]; Sumax DTD0010 VADRUGID DR00268 DTD0010 DRUGNAME Norepinephrine DTD0010 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0010 VADRUGID DR00277 DTD0010 DRUGNAME Ipratropium DTD0010 DRUGSYNO (+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate DTD0010 VADRUGID DR00291 DTD0010 DRUGNAME Cisplatin DTD0010 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0010 VADRUGID DR00055 DTD0010 DRUGNAME Codeine DTD0010 DRUGSYNO (-)-Codeine; 76-57-3; CCRIS 7555; CHEBI:16714; CODEINE BASE; Codein; Codeine Anhydrate; Codeine anhydrous; Codeine polistirex; Codicept; Coducept; EINECS 200-969-1; HSDB 3043; Methylmorphine; Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-; Morphine 3-methyl ether; Morphine monomethyl ether; Morphine-3-methyl ester; Morphine-3-methyl ether; Norcodeine, N-methyl; Norcodine, N-methyl; O(3)-methylmorphine; O3-Methylmorphine; UNII-UX6OWY2V7J; UX6OWY2V7J; codeina; codeinum; l-Codeine DTD0010 VADRUGID DR00283 DTD0010 DRUGNAME Dopamine DTD0010 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0010 VADRUGID DR00620 DTD0010 DRUGNAME Pramipexole DTD0010 DRUGSYNO (-)-Pramipexole; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; 111GE001; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; 2-amino-6-propylaminotetrahydrobenzothiazole; Mirapex; Mirapex (TN); Mirapexin (TN); Pramipexol; Pramipexole (USAN/INN); Pramipexole [USAN:INN]; Pramipexolum; SND-919; SUD919CL2Y; Sifrol(TN); U-98528E DTD0010 VADRUGID DR01389 DTD0010 DRUGNAME Tyramine DTD0010 DRUGSYNO Tyramine; 4-(2-Aminoethyl)phenol; 51-67-2; 4-Hydroxyphenethylamine; p-Tyramine; 2-(4-Hydroxyphenyl)ethylamine; Uteramine; Tyramin; Tyrosamine; Tocosine; 4-Hydroxyphenylethylamine; Systogene; Phenol, 4-(2-aminoethyl)-; p-Hydroxyphenethylamine; Tenosin-wirkstoff; p-Hydroxyphenylethylamine; p-(2-Aminoethyl)phenol; 2-(p-Hydroxyphenyl)ethylamine; Phenethylamine, p-hydroxy-; p-beta-Aminoethylphenol; Phenol, p-(2-aminoethyl)-; Benzeneethanamine, 4-hydroxy-; Tyramine base; beta-Hydroxyphenylethylamine; NSC 249188; p-tyramine; [3H]tyramine DTD0010 VADRUGID DR01421 DTD0010 DRUGNAME Clidinium DTD0010 DRUGSYNO clidinium; N-Methyl quinuclidinyl benzilate; 7020-55-5; 3-hydroxy-1-methylquinuclidinium benzilate ester; 3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[222]octane; Ro-23773; 3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[222]octane; 1-Azoniabicyclo(222)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-; [3H]clidinium; (-)MQNB; Clidinium bromid; (1-methyl-1-azoniabicyclo[222]octan-8-yl) 2-hydroxy-2,2-di(phenyl)acetate; 3-Hydroxy-1-methylquinuclidinium benzilate (ester); Quinuclidinium,; Librax (TN); Benzilic acid, ester with 3-hydroxy-1-methylquinuclidinium; Quinuclidinium, 3-hydroxy-1-methyl-, benzilate (ester); (1-methyl-1-azoniabicyclo[222]octan-3-yl) 2-hydroxy-2,2-diphenylacetate DTD0010 VADRUGID DR00163 DTD0010 DRUGNAME Ranitidine DTD0010 DRUGSYNO (E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic DTD0010 VADRUGID DR01329 DTD0010 DRUGNAME Auranofin DTD0010 DRUGSYNO AURANOFIN; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; CTK8F7877; KS-00001FB9; MMV688978; AKOS026750078; FT-0662343 DTD0010 VADRUGID DR00237 DTD0010 DRUGNAME Varenicline DTD0010 DRUGSYNO 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; CP 526555; Champix (TN); Chantix (TN); Varenicline (INN) DTD0010 VADRUGID DR00007 DTD0010 DRUGNAME Prostaglandin f2Alpha DTD0010 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0010 VADRUGID DR01669 DTD0010 DRUGNAME Buformin DTD0010 DRUGSYNO Buformin; 1-Butylbiguanide; Buformine; Butyldiguanide; Butylbiguanide; Butformin; Butylbiguanidum; Glybigid; 1-Butyldiguanide; Glybigidum; N-Butylbiguanide; Buformina; Buforminum; Buformine [INN-French]; Buforminum [INN-Latin]; Buformina [INN-Spanish]; Silubin; Adebit; BIGUANIDE, 1-BUTYL-; Buformin [USAN:INN]; W 37; Buformin HCl; Imidodicarbonimidic diamide, N-butyl-; Sindiatil; Panformin; Diabrin; Biforon; Andere; UNII-W2115E9C7B; Buformine HCl; N-butylimidodicarbonimidic diamide; DBV hydrochloride; H 224 DTD0010 VADRUGID DR00133 DTD0010 DRUGNAME Metformin DTD0010 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0010 VADRUGID DR00254 DTD0010 DRUGNAME Sitagliptin DTD0010 DRUGSYNO (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia DTD0010 VADRUGID DR00644 DTD0010 DRUGNAME Disopyramide DTD0010 DRUGSYNO 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide; 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide; Alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide; Alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide; Alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridine acetamide; D 7644; Dicorantil; Disopiramida; Disopiramida [INN-Spanish]; Disopyramide (JP15/USAN/INN); Disopyramide Free Base; Disopyramide [USAN:BAN:INN:JAN]; Disopyramidum; Disopyramidum [INN-Latin]; Gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide; H 3292; Isorythm; Lispine; Norpace (TN); Ritmodan; Rythmodan; Rythmodan (TN); Rythmodan P; Rythmodan P (TN); Rythmodan-La; SC 7031; SC-7031; Searle 703; Xi-Disopyramide DTD0010 VADRUGID DR00292 DTD0010 DRUGNAME Procainamide DTD0010 DRUGSYNO 2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr DTD0010 VADRUGID DR00106 DTD0010 DRUGNAME Tetraethylammonium DTD0010 DRUGSYNO 4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium DTD0010 VADRUGID DR01420 DTD0010 DRUGNAME N1-methylnicotinamide DTD0010 DRUGSYNO Trigonellinamide; 1-methylnicotinamide; N(1)-Methylnicotinamide; N1-Methylnicotinamide; 3-(Aminocarbonyl)-1-methylpyridinium; 1-Methyl nicotinamide; 3-carbamoyl-1-methylpyridinium; 3106-60-3; Pyridinium, 3-carbamoyl-1-methyl-; UNII-UM47085BXC; N(sup 1)-Methylnicotinamide; 3-carbamoyl-1-methylpyridin-1-ium; BRN 3540351; 1-methylpyridine-3-carboxamide; UM47085BXC; CHEBI:16797; 1-methylpyridin-1-ium-3-carboxamide; CHEMBL1209652; Trigonellamide; Pyridinium, 3-(aminocarbonyl)-1-methyl-; 1-methyl-3-carbamoylpyridinium; 8GC; I-methyl n DTD0010 VADRUGID DR00536 DTD0010 DRUGNAME Tubocurarine DTD0010 DRUGSYNO (+)-Tubocurarine; (+)-Tubocurarine chloride; (+)-Tubocurarine chloride hydrochloride; 2,2',2'-trimethyl-6,6'-bis(methyloxy)tubocuraran-2,2'-diium-7',12'-diol dichloride; 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium; 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraran-2'-ium; Amelizol; Chlorure de tubocurarine; Chlorure de tubocurarine [INN-French]; Cloruro de tubocurarina; Cloruro de tubocurarina [INN-Spanish]; Curarin-haf; D-(+)-Tubocurarine chloride; D-7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium chloride; D-Paracurarine chloride; D-Tubocurarine; D-Tubocurarine chloride; D-Tubocurarine dichloride; D-Tubocurarine hydrochloride; Delacurarine; Delacurarine (TN); Dextrotubocurarine chloride; Intocostrine T; Isoquinoline alkaloid; Jex (TN); Jexin; Metubine (TN); Tubadil; Tubaine; Tubaine (TN); Tubarine; Tubarine (TN); Tubocuraranium, 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyl-, chloride, hydrochloride; Tubocurarin; Tubocurarina cloruro; Tubocurarina cloruro [DCIT]; Tubocurarine chloride; Tubocurarine chloride (INN); Tubocurarine chloride (TN); Tubocurarine chloride (anhydrous); Tubocurarine hydrochloride; Tubocurarine, chloride, hydrochloride, (+)-(8CI); Tubocurarini chloridum; Tubocurarini chloridum [INN-Latin]; Tubocurarinum; Tubocurarinum (TN) DTD0010 VADRUGID DR00661 DTD0010 DRUGNAME Phencyclidine DTD0010 DRUGSYNO 1-(1-Phenylcyclohexyl)piperidine; Angel dust; Aurora borealis; Busy bee; Cadillac; Cl-395; Crystal; Crystal joints; Cycline; Cyclones; Dust; Elephant tranquilizer; Embalming fluid; Fenciclidina; Goon; Horse tracks; Killer weed; Magic mist; Mist; Monkey dust; PCP (Anesthetic); Peace; Peace pill; Peace weed; Phencyclidinum; Piperidine, 1-(1-phenylcyclohexyl)-; Pits; Rocket fuel; Scuffle; Selma; Sheets; Sherman; Snorts; Supergrass; Superjoint; Superweed; Surfer; Tranks; Whack; Whacky weed; Wobble weed; Zombie dust DTD0010 VADRUGID DR01348 DTD0010 DRUGNAME Benzamil DTD0010 DRUGSYNO Benzamil; 2898-76-2; UNII-04659UUJ94; N-(N-Benzylamidino)-3,5-diamino-6-chloropyrazine carboxamide; GNF-Pf-192; CHEMBL212579; CHEBI:34558; 04659UUJ94; 3,5-Diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)pyrazinecarboxamide; 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide; Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)-; Spectrum3_001823; Prestwick1_000657; Prestwick3_000657; Prestwick2_000657; Prestwick0_000657; Lopac-B-2417; AC1L33CQ; Lopac0_000211; KBioGR_000300 DTD0010 VADRUGID DR00337 DTD0010 DRUGNAME N-methylpyridinium DTD0010 DRUGSYNO 1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl- DTD0010 VADRUGID DR00325 DTD0010 DRUGNAME Acyclovir DTD0010 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0010 VADRUGID DR01474 DTD0010 DRUGNAME Tetramethylammonium DTD0010 DRUGSYNO Tetramethylammonium; TETRAMETHYLAMMONIUM ION; tetramethylazanium; 51-92-3; N,N,N-trimethylmethanaminium; UNII-H0W55235FC; Tetramethylammonium octahydrotriborate; EINECS 235-626-5; CHEMBL46486; Methanaminium, N,N,N-trimethyl-, octahydrotriborate(1-); CHEBI:46020; Methanaminium, N,N,N-trimethyl-; H0W55235FC; Tetramethylammonium pentaiodide; Tetramethyl-Ammonium; Ammonium, (pentaiodide); AC1L1MEF; 19269-48-8; bmse000780; 64-20-0 (bromide); 75-59-2 (hydroxide); 75-57-0 (chloride); 75-58-1 (iodide); 12386-10-6; 373-68-2 (fluoride) DTD0010 VADRUGID DR00696 DTD0010 DRUGNAME Phenoxybenzamine DTD0010 DRUGSYNO 2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane; 688A; A 688; Bensylyt; Bensylyt NEN; Bensylyte; Benzyl(2-chloroethyl)-(1-methyl-2-phenoxyethyl)amine; Benzylyt; Dibenylene; Dibenylin; Dibenyline; Dibenziran; Dibenzylene; Dibenzylin; Dibenzyline (TN); Dibenzyran; Fenossibenzamina; Fenossibenzamina [DCIT]; Fenoxibenzamina; Fenoxibenzamina [INN-Spanish]; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine; N-(2-chloroethyl)-N-(phenylmethyl)-1-(phenyloxy)propan-2-amine; N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine; POB HCl; Phenoxybenzamine (INN);Phenoxybenzamine [INN:BAN]; Phenoxybenzamine Hcl; Phenoxybenzaminum; Phenoxybenzaminum [INN-Latin] DTD0010 VADRUGID DR00665 DTD0010 DRUGNAME Atropine DTD0010 DRUGSYNO (+,-)-Tropyl tropate; (+-)-atropine; (+-)-hyoscyamine; (+/-)-Atropine; (+/-)-Hyoscyamine; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane; (3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester); 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI); 1alphaH,5alphaH-Tropan-3alpha-ol; 1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester); 1alphaH,5alphaH-Tropan-3beta-ol; 2-Phenylhydracrylic acid 3-alpha-tropanyl ester; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate; A-Tropine; Anaspaz; Atropair; Atropen; Atropen (TN); Atropin; Atropin [German]; Atropin-flexiolen; Atropina; Atropina [Italian]; Atropine (USP); Atropine Care; Atropine Sulfate S.O.P.; Atropine [BAN]; Atropinium cation; Atropinium(1+); Atropinol; Atropt; Atrosulf; B eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Belladenal; Bellergal-S; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester; Beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]; Beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]; Cytospaz; D1-hyoscyamine; DL-Tropanyl 2-hydroxy-1-phenylpropionate; DL-Tropyl tropate; Dl-Hyoscyamine; Dl-Tropyltropate; Endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; Eyesules; Hyoscyamine; Hyoscyamine sulfate; I-Tropine; Isopto Atropine; Isopto-atropine; Lomotil (TN); Minims; Minims Atropine; NP-010662; Neo-Diophen; OR22908; Ocu-Tropine; Protamine & Atropine; Tropan-3alpha-ol; Tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate; Tropan-3beta-ol; Tropanol; Tropic acid, 3-alpha-tropanyl ester; Tropic acid, ester with tropine; Tropine (+/-)-tropate; Tropine tropate; Tropine, tropate (ester); Troyl tropate; Urised; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate DTD0010 VADRUGID DR00590 DTD0010 DRUGNAME Trimethoprim DTD0010 DRUGSYNO AZT + TMP/SMX (mixture) combination; Abaprim; Alcorim-F; Alprim; Anitrim; Antrima; Antrimox; Apo-Sulfatrim; BW 56-72; BW 5672; BW-56-72; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacterial [Antibiotic]; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Co-Trimoxizole; Colizole; Colizole DS; Component of Bactrim; Component of Septra; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; KSC-4-158; KUC103659N; Kombinax; Lagatrim; Lagatrim Forte; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrim (TN); Monotrimin; NIH 204; NIH 204 (VAN); Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Proloprim (TN); Protrin; Purbal; Resprim; ResprimForte; Roubac; Roubal; Salvatrim; Septrin DS; Septrin Forte; Septrin S; Setprin; Sinotrim; Smz-Tmp; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfamethoxazole & Trimethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; T 7883; TCMDC-125538; TMP; TMP/SMX (MIXTURE)); Tiempe; Tmp-Ratiopharm; Toprim; Trimanyl; Trimeth/Sulfa; Trimethioprim; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]; Trimethoprime; Trimethoprime [INN-French]; Trimethoprimum; Trimethoprimum [INN-Latin]; Trimethopriom; Trimetoprim; Trimetoprim [DCIT]; Trimetoprim [Polish]; Trimetoprima; Trimetoprima [INN-Spanish]; Trimexazole; Trimexol; Trimez-IFSA; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Trimpex (TN); Trimpex 200; Triprim; Triprim (TN); Trisul; Trisulcom; Trisulfam; Trisural; U-Prin; Uretrim; Uro-D S; Urobactrim; Utetrin; Velaten; WR 5949; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim DTD0010 VADRUGID DR01479 DTD0010 DRUGNAME Debrisoquine DTD0010 DRUGSYNO Debrisochinum; Debrisoquina; Debrisoquine; Debrisoquinum; Declinax; Equitonil; Isocaramidine; Tendor; DEBRISOQUIN SULFATE; Debrisoquin hemisulfate; Debrisoquine sulfate; Isocaramidine sulfate; Debrisoquina [INN-Spanish]; Debrisoquine [INN:BAN]; Debrisoquinum [INN-Latin]; Ro 5-3307/1; Sulfuric acid compound with 3,4-dihydro-2(1H)-isoquinolinecarboximidamide (1:1); 1,2,3, 4-Tetrahydro-isoquinoline-2-carboxamidine sulfate; 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-(7CI,8CI); 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1); 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1); 2-Amidino-1,2,3,4-tetrahydroisoquinoline; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1); 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide; 3,4-Dihydro-2(1H;)-isoquinoline carboxamidine sulfate; 3,4-dihydro-1H-isoquinoline-2-carboximidamide; 3,4-dihydroisoquinoline-2(1H)-carboximidamide DTD0010 VADRUGID DR00840 DTD0010 DRUGNAME Metoclopramide DTD0010 DRUGSYNO (metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; (metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide; 2-Methoxy-5-chloroprocainamide; 2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide; 4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; 4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide; 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp); 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide); 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide); 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide; 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; 5-Chloro-2-methoxyprocainamide; Apo-Metoclop; Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-(9CI); CLOPRA-YELLOW; Cerucal; Clopra; Clopra-Yellow; Clopromate; DEL 1267; Degan (TN); Duraclamid; Elieten; Elieten (TN); Emetid; Emitasol; Emperal; Eucil; Gastrese; Gastro-Timelets; Gastrobid; Gastromax; Gastronerton; Gastrosil; Gastrotablinen; Gastrotem; Imperan; Maxeran; Maxeran (TN); Maxolon; Maxolon (TN); Meclopran; Metaclopramide; Metaclopromide; Metamide; Methochlopramide; Methoclopramide; Metochlopramide; Metoclol; Metoclopramida; Metoclopramida [INN-Spanish]; Metoclopramide (JP15/INN); Metoclopramide Monohydrochloride, Monohydrate; Metoclopramide Omega; Metoclopramide [INN:BAN:JAN]; Metoclopramidum; Metoclopramidum [INN-Latin]; Metocobil; Metramid; Moriperan; Mygdalon; N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide; Neu-Sensamide; Nu-Metoclopramide; O-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-(8CI); Octamide; Parmid; Paspertin; Peraprin; Plasil; Plasil (pharmaceutical); Pms-Metoclopramide; Pramidin; Pramiel; Pramin; Primperan; Primperan (TN); Pylomid (TN); Reclomide; Reglan; Reglan (TN); Reliveran; Terperan; Terperan (TN) DTD0010 VADRUGID DR01284 DTD0010 DRUGNAME Trospium chloride DTD0010 DRUGSYNO trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio DTD0010 VADRUGID DR01250 DTD0010 DRUGNAME Spermidine DTD0010 DRUGSYNO 124S209; 1pot; 4-04-00-01300 (Beilstein Handbook Reference); =99% (GC); AC1L1AQB; ACMC-20ajn3; AI3-26636; AJ-26792; AKOS006222987; AN-22947; ATHGHQPFGPMSJY-UHFFFAOYSA-N; Aminopropylbutandiamine; BDBM50009353; BPBio1_001276; BRN 1698591; BSPBio_002613; Biomol-NT_000212; C00315; CCG-205124; CHEBI:16610; CHEMBL19612; CS-0013804; CTK3J1693; DB-026892; DB03566; DTXSID4036645; DivK1c_001007; EINECS 204-689-0; FT-0629162; GTPL2390; HY-B1776; IDI1_001007; KBio1_001007; KBio2_000345; KBio2_002913; KBio2_005481; KBio3_001833; KBioGR_001542; KBioSS_000345; LS-45643; Lopac-S-2501; Lopac0_001047; M923; MCULE-8096530192; MFCD00008229; MolPort-001-761-230; N-(3-Aminopropyl)-4-aminobutylamine; N-(4-Aminobutyl)-1,3-diaminopropane; NCGC00015937-01; NCGC00015937-02; NCGC00015937-03; NCGC00015937-04; NCGC00015937-05; NCGC00024903-01; NCGC00024903-02; NCGC00024903-03; NCI60_004294; NINDS_001007; NSC528399; PA(34); RTR-003757; SC-69371; SCHEMBL15618; SDCCGMLS-0066822.P001; SPBio_000947; SR0; ST24048721; ST45025991; Spectrum2_000874; Spectrum3_000977; Spectrum4_001101; Spectrum5_001561; Spectrum_000005; Spermidin; Spermidine 0.1 M solution; Spermidine hydrochloride; Spermidine, > Spermidine, analytical standard; TR-003757; Tocris-0959; U87FK77H25; UNII-U87FK77H25; ZINC1532612; bmse000116; bmse000951; bmse000955 DTD0010 VADRUGID DR01278 DTD0010 DRUGNAME Zolmitriptan DTD0010 DRUGSYNO (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; AscoTop; AscoTop (TN); BW-311C90; Flezol; KS-5072; Zolmitriptan RapidFilm; Zolmitriptan [USAN]; Zolmitriptane; Zolmitriptanum; Zomig; Zomig (TN); Zomig Nasal Spray; Zomig ZMT; Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan; Zomig-ZMT; Zomigon; Zomigon (TN); Zomigoro (TN) DTD0010 VADRUGID DR00883 DTD0010 DRUGNAME Camostat DTD0010 DRUGSYNO 0FD207WKDU; 4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate; 59721-28-7; C20H22N4O5; CCRIS 7219; CHEMBL85164; Camostat; Camostat (INN); Camostat [INN]; Camostatum; Camostatum [INN-Latin]; Dimethylcarbamoylmethyl 4-(4-guqnidinobenzoyloxy)phenylacetat; FOY 305; FOY-305; Foipan; UNII-0FD207WKDU; [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate; camostate; camostate-mesilate; foypan; p-Guanidinobenzoic acid, ester with (p-hydroxyphenyl)acetic acid, ester with N DTD0010 VADRUGID DR00121 DTD0010 DRUGNAME Choline DTD0010 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0010 VADRUGID DR01356 DTD0010 DRUGNAME Fenoterol DTD0010 DRUGSYNO Berotec; Berotek; Fenoterolum; Phenoterol; TH 1165A; Berotec (TN); Fenoterolum [INN-Latin]; P-Hydroxyphenylorciprenaline; Th-1165a; Fenoterol (USAN/INN); Fenoterol [USAN:BAN:INN]; P-Hydroxyphenyl-orciprenaline; 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane; 1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane; 3,5-Dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol; 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol; 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)benzene-1,3-diol; 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol; 5-{1-Hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol DTD0010 VADRUGID DR01393 DTD0010 DRUGNAME Oxyphenonium DTD0010 DRUGSYNO Argicillin; Atrenyl; Hydroxymethylgramicidin; Methacin; Methocidin; Methocidine; Methocidinum; Metocidina; Oxiphenonum; Spastrex;Oxyphenonium Chloride; Oxyphenonium Iodide; Methocidin [DCF:INN]; Methocidine [INN-French]; Methocidinum [INN-Latin]; Metocidina [INN-Spanish]; [2-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-ethyl]-diethyl-methyl-ammonium; 2-((Cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methylethanaminium; 2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium; 2-[2-cyclohexyl(hydroxy)phenylacetoxy]-n,n-diethyl-n-methylethanaminium DTD0010 VADRUGID DR01406 DTD0010 DRUGNAME Salbutamol DTD0010 DRUGSYNO Aerolin; Airomir; Almotex; Anebron; Asmadil; Asmanil; Asmasal; Asmatol; Asmaven; Asmidon; Asmol; Asthalin; Asthavent; Broncovaleas; Bronter; Bugonol; Bumol; Butamol; Butohaler; Butotal; Butovent; Buventol; Cetsim; Cobutolin; Dilatamol; Ecovent; Farcolin; Gerivent; Grafalin; Libretin; Medolin; Mozal; Novosalmol; Parasma; Pneumolat; Proventil; Respax; Respolin; Rotahaler; Sabutal; Sabutamol; Salamol; Salbetol; Salbron; Salbuhexal; Salbulin; Salbupur; Salbusian; Salbutalan; Salbutamolum; Salbutan; Salbutard; Salbutine; Salbutol; Salbuven; Salbuvent; Sallbupp; Salmaplon; Salomol; Salvent; Saventol; Servitamol; Solbutamol; Spreor; Sultanol; Suprasma; Suxar; Theosal; Tobybron; Vencronyl; Ventamol; Ventilan; Ventiloboi; Ventodisks; Ventoline; Volma; Volmax; Zaperin; Albuterol Sulphate; Albuterol [USAN]; Albuterol hemisulfate; Proventil HFA; Proventil Inhaler; Salbutamol Sulphate; Salbutamol sulfate; Sultanol N; Ventalin inhaler; Ventolin Inhaler; Ventolin Rotacaps; Volare albuterol HFA; AH 3365; S 8260; Aerolin (TN); Albuterol (USP); Alti-Salbutamol; Arubendol-Salbutamol; Asmol Uni-Dose; Asthalin (TN); Broncho-Spray; Buto-Asma; Dl-Albuterol; Dl-Salbutamol; ProAi (TN); Proventil (TN); Racemic-Salbutamol; Salbu-BASF; Salbu-Fatol; Salbutamolum [INN-Latin]; Ventolin (TN); Volare easi-breathe; R,S-Albuterol; Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha-diol; Alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol; DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine; Alpha'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; Alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; (alpha1-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol); 1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol; 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol; 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol; 4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol; 4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; 4-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol DTD0010 VADRUGID DR01412 DTD0010 DRUGNAME Glycopyrrolate DTD0010 DRUGSYNO GLYCOPYRROLATE; 596-51-0; Glycopyrrolate bromide; Robinul; Gastrodyn; Tarodyl; Nodapton; Tarodyn; Asecryl; Copyrrolate; Cuvposa; Glycopyrronii bromidum; AHR-504; ROBINUL FORTE; Robinal; Robanul; Bromuro de glicopirronio; Bromure de glycopyrronium; NVA-237; AHR 504; Glycopyrronii bromidum [INN-Latin]; EINECS 209-887-0; Bromure de glycopyrronium [INN-French]; Bromuro de glicopirronio [INN-Spanish]; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide DTD0012 TRANSPID DTD0012 DTD0012 GENENAME ABCC3 DTD0012 PROTNAME Multidrug resistance-associated protein 3 DTD0012 SYNONYMS ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D DTD0012 VADRUGID DR00021 DTD0012 DRUGNAME Teniposide DTD0012 DRUGSYNO 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide DTD0012 VADRUGID DR00026 DTD0012 DRUGNAME Fexofenadine DTD0012 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0012 VADRUGID DR00342 DTD0012 DRUGNAME Paclitaxel DTD0012 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0012 VADRUGID DR01708 DTD0012 DRUGNAME Monomethyl-auristatin-E DTD0012 DRUGSYNO Monomethyl auristatin E; UNII-V7I58RC5EJ; MMAE; V7I58RC5EJ; N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide; Monomethyl auristatin E (MMAE); Monomethylauristatin E; 4Q5; monomethyl-auristatin-e-mmae; MMAE, monomethyl auristatin E; SCHEMBL5402144; CHEMBL2103835; AOB5196; DASWEROEPLKSEI-UIJRFTGLSA-N; C39H67N5O7; MFCD22124498; ZINC85537145; s7721; CS-0837 DTD0012 VADRUGID DR00238 DTD0012 DRUGNAME Leucovorin DTD0012 DRUGSYNO 5-formyltetrahydrofolate; Citrovorum factor; Folinic acid DTD0012 VADRUGID DR00094 DTD0012 DRUGNAME Glibenclamide DTD0012 DRUGSYNO 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon DTD0012 VADRUGID DR00208 DTD0012 DRUGNAME Estradiol-17beta-glucuronide DTD0012 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0012 VADRUGID DR00914 DTD0012 DRUGNAME Glycyrrhizin DTD0012 DRUGSYNO Uralsaponin A; glycyrrhizin; Glycyrrhizic acid; AC1L2TF0; Glycyrrhizin (JAN); Glycyrrhizinate; ZINC96319491; AKOS037514680; AKOS016036159; 3-Hydroxy-11 oxoolean-12-en-30-oic acid-3-O-glucuronopyranosyl-(1-2)glucuronopyranoside; D00157; C02284; beta-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-; (3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucuronosyl-beta-D-glucosiduronic acid DTD0012 VADRUGID DR00412 DTD0012 DRUGNAME Efavirenz DTD0012 DRUGSYNO (-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; DMP 266; DMP-266; EFV; EFZ; Efavirenz (JAN/INN); Efavirenz, (S)-isomer; Eravirenz; L 743726; L-741211; L-743,726; L-743725; L-743726; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; Stocrin; Stocrin (TN); Strocin (TM); Sustiva; Sustiva (TM); Sustiva (TN); Zoxazin-2-one DTD0012 VADRUGID DR00597 DTD0012 DRUGNAME Etravirine DTD0012 DRUGSYNO 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile; 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE; 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile; 65B; DAPY deriv; Diaminopyrimidine deriv; ETR; Etravirine (JAN/USAN/INN); Intelence; Intelence (TN); Intelence(TM); R 165335; R-165335; R165335; R165335-TMC125; TMC 125; TMC-125; TMC-125/R-165335; TMC125 DTD0012 VADRUGID DR00140 DTD0012 DRUGNAME Ezetimibe DTD0012 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0012 VADRUGID DR00162 DTD0012 DRUGNAME Etoposide DTD0012 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0012 VADRUGID DR00082 DTD0012 DRUGNAME Methotrexate DTD0012 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0012 VADRUGID DR01698 DTD0012 DRUGNAME Glutathione-S-S-glutathione DTD0012 DRUGSYNO oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H DTD0012 VADRUGID DR01213 DTD0012 DRUGNAME Trabectedin DTD0012 DRUGSYNO Yondelis DTD0012 VADRUGID DR00153 DTD0012 DRUGNAME Fluorouracil DTD0012 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0012 VADRUGID DR00053 DTD0012 DRUGNAME Sodium taurocholate DTD0012 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0012 VADRUGID DR01121 DTD0012 DRUGNAME Taurocholic acid DTD0012 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0012 VADRUGID DR00134 DTD0012 DRUGNAME Folic acid DTD0012 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0012 VADRUGID DR00467 DTD0012 DRUGNAME Morphine DTD0012 DRUGSYNO Astramorph Pf; Avinza; Depodur; Duramorph Pf; Infumorph; Kadian; Morphine Sulfate; Ms Contin; Oramorph Sr DTD0012 VADRUGID DR00345 DTD0012 DRUGNAME Epipodophyllotoxins DTD0012 DRUGSYNO (-)-epipodophyllotoxin; 137513-EP2272827A1; 137513-EP2292088A1; AC1L2Y2E; AJ-42064; BRN 0099162; C22H22O8; CHEMBL282256; Epipodophyllotoxin; Etopside; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)-; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-beta,8a-alpha,9-beta))-; LS-70861; SCHEMBL5792464; VP16; ZINC2572657 DTD0012 VADRUGID DR01640 DTD0012 DRUGNAME Scutellarin DTD0012 DRUGSYNO Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl DTD0012 VADRUGID DR00313 DTD0012 DRUGNAME Cefadroxil DTD0012 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0012 VADRUGID DR01237 DTD0012 DRUGNAME Technetium (99MTC) mebrofenin DTD0012 DRUGSYNO F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52 DTD0012 VADRUGID DR00569 DTD0012 DRUGNAME Glycocholic acid DTD0012 DRUGSYNO Glycocholate; cholylglycine DTD0012 VADRUGID DR01513 DTD0012 DRUGNAME Dehydroepiandrosterone sulfate DTD0012 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0012 VADRUGID DR01616 DTD0012 DRUGNAME Cholyl lysyl fluorescein DTD0012 DRUGSYNO . DTD0013 TRANSPID DTD0013 DTD0013 GENENAME ABCB4 DTD0013 PROTNAME Multidrug resistance protein 3 DTD0013 SYNONYMS ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4 DTD0013 VADRUGID DR00264 DTD0013 DRUGNAME Verapamil DTD0013 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0013 VADRUGID DR00148 DTD0013 DRUGNAME Digoxin DTD0013 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0013 VADRUGID DR00285 DTD0013 DRUGNAME Silodosin DTD0013 DRUGSYNO (R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; 160970-64-9; CHEMBL24778; CUZ39LUY82; KAD 3213; KAD-3213; KMD 3213; KMD-3213; Q-102517; Rapaflo; Rapflo; Silodosin-d6; Silodyx; UNII-CUZ39LUY82; Urief; Urorec DTD0013 VADRUGID DR00342 DTD0013 DRUGNAME Paclitaxel DTD0013 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0013 VADRUGID DR00308 DTD0013 DRUGNAME Vinblastine DTD0013 DRUGSYNO (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine DTD0014 TRANSPID DTD0014 DTD0014 GENENAME ABCB11 DTD0014 PROTNAME Bile salt export pump DTD0014 SYNONYMS ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP DTD0014 VADRUGID DR00158 DTD0014 DRUGNAME Glimepiride DTD0014 DRUGSYNO 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea; 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea; 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide; 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro; 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide; 64598P; Amarel; Amaryl; Amaryl (TN); Amaryl, Glista OD, Glimepiride; Endial; Glimepirid; Glimepirida; Glimepirida [Spanish]; Glimepiride (JAN/USP/INN); Glimepiride [USAN:BAN:INN]; Glimepiridum; Glimepiridum [Latin]; Glimepride; Glimer; Glymepirid; HOE 490; Hoe-490; Novo-glimepiride; PMS-glimepiride; Ratio-glimepiride; Roname; Sandoz glimepiride; Solosa DTD0014 VADRUGID DR00329 DTD0014 DRUGNAME Glipizide DTD0014 DRUGSYNO 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea; 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea; Aldiab; Alphapharm Brand of Glipizide; CP 28,720; CP 28720; CP-28720; Digrin; Dipazide; G-117; Glibenese; Glibenese Brand of Glipizide; Glibetin; Glican; Glide; Glidiab; Glidiazinamide; Glipid; Glipizida; Glipizida [INN-Spanish]; Glipizide (USP/INN); Glipizide Extended-Release Tablets; Glipizide Kenfarma Brand; Glipizide [USAN:BAN:INN]; Glipizidum; Glipizidum [INN-Latin]; Gluco-Rite; Glucolip; Glucotrol; Glucotrol (TN); Glucotrol XL; Glucotrol XL, Glucotrol, Glipizide; Glucozide; Glupitel; Glupizide; Glyde; Glydiazinamide; Glypidizine; K 4024; K-4024; K4024; KS-1068; Kenfarma Brand of Glipizide; Lacer Brand of Glipizide; Lilly Brand of Glipizide; Melizide; Metaglip; Mindiab; Minidab; Minidiab; Minodiab; N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide; N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea; N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide; N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide; Napizide; Ozidia; Pfizer Brand 2 of Glipizide; PfizerBrand 1 of Glipizide; Samarium(III) ionophore I; Semiglynase; Sucrazide; TK 1320 DTD0014 VADRUGID DR00140 DTD0014 DRUGNAME Ezetimibe DTD0014 DRUGSYNO (-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient DTD0014 VADRUGID DR00045 DTD0014 DRUGNAME Pravastatin DTD0014 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0014 VADRUGID DR00053 DTD0014 DRUGNAME Sodium taurocholate DTD0014 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0014 VADRUGID DR01121 DTD0014 DRUGNAME Taurocholic acid DTD0014 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0015 TRANSPID DTD0015 DTD0015 GENENAME ABCC4 DTD0015 PROTNAME Multidrug resistance-associated protein 4 DTD0015 SYNONYMS ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B DTD0015 VADRUGID DR00145 DTD0015 DRUGNAME Mercaptopurine DTD0015 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0015 VADRUGID DR00510 DTD0015 DRUGNAME Thioguanine DTD0015 DRUGSYNO 2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B DTD0015 VADRUGID DR00948 DTD0015 DRUGNAME Glycodeoxycholic acid DTD0015 DRUGSYNO glycodeoxycholate DTD0015 VADRUGID DR01700 DTD0015 DRUGNAME Azidothymidine monophosphate DTD0015 DRUGSYNO azidothymidine monophosphate; SCHEMBL17515060 DTD0015 VADRUGID DR00112 DTD0015 DRUGNAME Irinotecan DTD0015 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0015 VADRUGID DR00238 DTD0015 DRUGNAME Leucovorin DTD0015 DRUGSYNO 5-formyltetrahydrofolate; Citrovorum factor; Folinic acid DTD0015 VADRUGID DR00287 DTD0015 DRUGNAME Resveratrol DTD0015 DRUGSYNO (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4′,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol DTD0015 VADRUGID DR00225 DTD0015 DRUGNAME Quercetin DTD0015 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0015 VADRUGID DR00027 DTD0015 DRUGNAME Ganciclovir DTD0015 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0015 VADRUGID DR00208 DTD0015 DRUGNAME Estradiol-17beta-glucuronide DTD0015 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0015 VADRUGID DR00295 DTD0015 DRUGNAME Cyclic adenosine monophosphate DTD0015 DRUGSYNO 3',5'-AMP; 3',5'-cyclic AMP; 60-92-4; Adenosine 3',5'-cyclic monophosphate; Adenosine 3',5'-cyclophosphate; Adenosine 3',5'-monophosphate; Adenosine 3',5'-phosphate; Adenosine cyclic 3',5'-monophosphate; Adenosine cyclic 3',5'-phosphate; Adenosine cyclic monophosphate; Adenosine cyclophosphate; Adenosine-3',5'-cyclophosphate; Cyclic AMP; Cyclic adenylic acid; [3H]cAMP; cAMP; cyclic 3',5'-AMP; cyclic 3',5'-Adenylic acid; cyclic Adenosine 3',5'-monophosphate; cyclic Adenosine 3',5'-phosphate DTD0015 VADRUGID DR01300 DTD0015 DRUGNAME 4-(2-Aminoethyl) benzenesulfonyl fluoride DTD0015 DRUGSYNO 4-(2-Aminoethyl)benzenesulfonyl fluoride; 4-(2-Aminoethyl)benzenesulfonylfluoride; 4-(2-aminoethyl)-benzenesulfonyl fluoride; 4-(2-aminoethyl)benzene-1-sulfonyl fluoride; 4-beta-Aminoethylbenzolsulfofluoride; AC1L1C1L; AC1Q4OX1; AEBSF; AEBSF.HCl; AES; Benzenesulfonyl fluoride, 4-(2-aminoethyl)-; C8H10FNO2S; CHEMBL1256178; Lopac-A-8456; Lopac0_000132; MGSKVZWGBWPBTF-UHFFFAOYSA-N; Pefabloc; SR-01000075690 DTD0015 VADRUGID DR00210 DTD0015 DRUGNAME Alprostadil DTD0015 DRUGSYNO (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros DTD0015 VADRUGID DR00087 DTD0015 DRUGNAME Cladribine DTD0015 DRUGSYNO (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000 DTD0015 VADRUGID DR00347 DTD0015 DRUGNAME Olmesartan medoxomil DTD0015 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0015 VADRUGID DR00588 DTD0015 DRUGNAME Abacavir DTD0015 DRUGSYNO (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol DTD0015 VADRUGID DR00039 DTD0015 DRUGNAME Glutathione DTD0015 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0015 VADRUGID DR00174 DTD0015 DRUGNAME Tenofovir DTD0015 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0015 VADRUGID DR00296 DTD0015 DRUGNAME Zidovudine DTD0015 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0015 VADRUGID DR00250 DTD0015 DRUGNAME Oseltamivir DTD0015 DRUGSYNO (-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir DTD0015 VADRUGID DR00082 DTD0015 DRUGNAME Methotrexate DTD0015 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0015 VADRUGID DR00102 DTD0015 DRUGNAME Dinoprostone DTD0015 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0015 VADRUGID DR01383 DTD0015 DRUGNAME Camptothecin DTD0015 DRUGSYNO camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat DTD0015 VADRUGID DR00044 DTD0015 DRUGNAME Topotecan DTD0015 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0015 VADRUGID DR00153 DTD0015 DRUGNAME Fluorouracil DTD0015 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0015 VADRUGID DR00715 DTD0015 DRUGNAME Sulindac DTD0015 DRUGSYNO (E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid; 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; Aclin; Aflodac; Alphapharm Brand of Sulindac; Apo Sulin; Apo-Sulin; Apotex Brand of Sulindac; Arthrobid; Arthrocine; Cahill May Roberts Brand of Sulindac; Chemia Brand of Sulindac; Chibret; Cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; Clinoril; Clinoril (TN); Copal; Copal resin; Copal rosin varnish; Copals; Gum copal; Kenalin; KendrickBrand of Sulindac; Klinoril; MK 231; MK-231; MK231; Merck Brand of Sulindac; Merck Sharp & Dohme Brand of Sulindac; Mobilin; Novo Sundac; Novo-Sundac; Novopharm Brand of Sulindac; Nu Pharm Brand of Sulindac; Nu Sulindac; Nu-Pharm Brand of Sulindac; Nu-Sulindac; Resin copal; S 8139; Sulindac (JAN/USP/INN); Sulindac [USAN:BAN:INN:JAN]; Sulindac sulfoxide; Sulindaco; Sulindaco [INN-Spanish]; Sulindacum; Sulindacum [INN-Latin]; Sulindal; Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid; [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid; {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid DTD0015 VADRUGID DR01489 DTD0015 DRUGNAME Hydroxycamptothecin DTD0015 DRUGSYNO 10-Hydroxycamptothecin; 19685-09-7; (S)-10-Hydroxycamptothecin; Hydroxycamptothecin; 10-hydroxycamptothecine; 10-Hydroxy camptothecin; Hydroxycamptothecine; Camptothecin, hydroxy-; 10-Hydroxy-Camptothecin; (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Camptothecin, 10-hydroxy-; Camptothecine, 10-hydroxy-; UNII-9Z01632KRV; NSC 107124; HCPT; (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-Hydroxycamptothecin hydrate; NSC107124 DTD0015 VADRUGID DR00007 DTD0015 DRUGNAME Prostaglandin f2Alpha DTD0015 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0015 VADRUGID DR01121 DTD0015 DRUGNAME Taurocholic acid DTD0015 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0015 VADRUGID DR00134 DTD0015 DRUGNAME Folic acid DTD0015 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0015 VADRUGID DR00161 DTD0015 DRUGNAME SN-38 DTD0015 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0015 VADRUGID DR00015 DTD0015 DRUGNAME Adefovir DTD0015 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0015 VADRUGID DR00657 DTD0015 DRUGNAME Cholic acid DTD0015 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0015 VADRUGID DR01193 DTD0015 DRUGNAME Prasterone DTD0015 DRUGSYNO 17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone DTD0015 VADRUGID DR00783 DTD0015 DRUGNAME Ciprofloxacin DTD0015 DRUGSYNO 85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin DTD0015 VADRUGID DR00313 DTD0015 DRUGNAME Cefadroxil DTD0015 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0015 VADRUGID DR00320 DTD0015 DRUGNAME Ceftizoxime DTD0015 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid DTD0015 VADRUGID DR00577 DTD0015 DRUGNAME Cefazolin DTD0015 DRUGSYNO (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN) DTD0015 VADRUGID DR00425 DTD0015 DRUGNAME Cyclophosphamide DTD0015 DRUGSYNO (+-)-Cyclophosphamide; (-)-Cyclophosphamide; (RS)-Cyclophosphamide; 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin; 4-Hydroxy-cyclophosphan-mamophosphatide; ASTA; ASTA B518; Asta B 518; B 518; B-518; Bis(2-Chloroethyl)phosphami de cyclic propanolamide; Bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; C 0768; CB 4564; CB-4564; Ciclofosfamida; Ciclofosfamida [INN-Spanish]; Ciclophosphamide; Ciclophosphamide [INN]; Clafen; Claphene; Cycloblastin; Cyclophosphamid; Cyclophosphamide (INN); Cyclophosphamide (TN); Cyclophosphamide (anhydrous form); Cyclophosphamide (anhydrous); Cyclophosphamide Sterile; Cyclophosphamide anhydrous; Cyclophosphamide, (+-)-Isomer; Cyclophosphamides; Cyclophosphamidum; Cyclophosphamidum [INN-Latin]; Cyclophosphan; Cyclophosphane; Cyclophosphanum; Cyclophosphoramide; Cyclostin; Cyklofosfamid; Cyklofosfamid [Czech]; Cytophosphan; Cytophosphane; Cytoxan; Cytoxan (TN); Cytoxan Lyoph; D,L-Cyclophosphamide; Endoxan; Endoxan (TN); Endoxan R; Endoxan-Asta; Endoxana; Endoxanal; Endoxane; Enduxan; Genoxal; Lyophilized Cytoxan; Mitoxan; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; Neosar; Neosar (TN); Occupation, cyclophosphamide exposure; Procytox; Procytox (TN); Revimmune; Revimmune (TN); SK 20501; Semdoxan; Sendoxan; Senduxan; Zyklophosphamid; Zyklophosphamid [German] DTD0015 VADRUGID DR01438 DTD0015 DRUGNAME Rubitecan DTD0015 DRUGSYNO 9-Nitrocamptothecin; 91421-42-0; Orathecin; 9-nitro-20(S)-camptothecin; Camptogen; 9-NC; RFS 2000; RFS-2000; UNII-H19C446XXB; Nitrocamptothecin; H19C446XXB; CHEBI:90225; C20H15N3O6; (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; NCGC00167969-01; (s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione; 9NC; Q-100889; (4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione; Inhaled Orathecin; L9NC; Rubitecan (inhaled); Aerosolized liposomal 9 nitro-20 (S) camptothecin; Rubitecan (inhaled), SuperGen; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin (9-NC) DTD0015 VADRUGID DR00569 DTD0015 DRUGNAME Glycocholic acid DTD0015 DRUGSYNO Glycocholate; cholylglycine DTD0015 VADRUGID DR01513 DTD0015 DRUGNAME Dehydroepiandrosterone sulfate DTD0015 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0015 VADRUGID DR00067 DTD0015 DRUGNAME Aminohippuric acid DTD0015 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0016 TRANSPID DTD0016 DTD0016 GENENAME ABCC5 DTD0016 PROTNAME Multidrug resistance-associated protein 5 DTD0016 SYNONYMS ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11 DTD0016 VADRUGID DR00145 DTD0016 DRUGNAME Mercaptopurine DTD0016 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0016 VADRUGID DR00112 DTD0016 DRUGNAME Irinotecan DTD0016 DRUGSYNO (+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin] DTD0016 VADRUGID DR00027 DTD0016 DRUGNAME Ganciclovir DTD0016 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0016 VADRUGID DR00295 DTD0016 DRUGNAME Cyclic adenosine monophosphate DTD0016 DRUGSYNO 3',5'-AMP; 3',5'-cyclic AMP; 60-92-4; Adenosine 3',5'-cyclic monophosphate; Adenosine 3',5'-cyclophosphate; Adenosine 3',5'-monophosphate; Adenosine 3',5'-phosphate; Adenosine cyclic 3',5'-monophosphate; Adenosine cyclic 3',5'-phosphate; Adenosine cyclic monophosphate; Adenosine cyclophosphate; Adenosine-3',5'-cyclophosphate; Cyclic AMP; Cyclic adenylic acid; [3H]cAMP; cAMP; cyclic 3',5'-AMP; cyclic 3',5'-Adenylic acid; cyclic Adenosine 3',5'-monophosphate; cyclic Adenosine 3',5'-phosphate DTD0016 VADRUGID DR00365 DTD0016 DRUGNAME Carboxydichlorofluorescein DTD0016 DRUGSYNO 5,6-carboxydichlorofluorescein DTD0016 VADRUGID DR00082 DTD0016 DRUGNAME Methotrexate DTD0016 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0016 VADRUGID DR00318 DTD0016 DRUGNAME Pemetrexed DTD0016 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0016 VADRUGID DR00063 DTD0016 DRUGNAME Gemcitabine DTD0016 DRUGSYNO 2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei DTD0016 VADRUGID DR00153 DTD0016 DRUGNAME Fluorouracil DTD0016 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0016 VADRUGID DR00134 DTD0016 DRUGNAME Folic acid DTD0016 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0016 VADRUGID DR00547 DTD0016 DRUGNAME Fluorescein DTD0016 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0016 VADRUGID DR00904 DTD0016 DRUGNAME Adenosine DTD0016 DRUGSYNO (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 9-(beta-D-Arabinofuranosyl)adenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine; Adenine 9-beta-D-arabinofuranoside; Adenine-9-beta-D-ribofuranoside; Adenosine, homopolymer; Beta-D-Ribofuranoside, adenine-9; EA6C60C2-6AFB-4264-A2F0-541373DB950E DTD0017 TRANSPID DTD0017 DTD0017 GENENAME ABCC6 DTD0017 PROTNAME Multidrug resistance-associated protein 6 DTD0017 SYNONYMS ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7 DTD0017 VADRUGID DR00284 DTD0017 DRUGNAME Daunorubicin DTD0017 DRUGSYNO (+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103 DTD0017 VADRUGID DR00327 DTD0017 DRUGNAME Benzbromarone DTD0017 DRUGSYNO (2-Ethyl-3-benzofuranyl)-(3,5-dibrom-4-hydroxyphenyl)keton; (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; 3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran; 3-[3,5-DIBROMO-4-HYDROXYBENZOYL]-2-ETHYLBENZOFURAN; AL, Benzbromaron; Acifugan; Aliud Brand of Benzbromarone; Azubromaron; Benzbromaron; Benzbromaron AL; Benzbromaron ratiopharm; Benzbromaron-ratiopharm; Benzbromarone (JP15/USAN/INN); Benzbromarone Aliud Brand; Benzbromarone Heumann Brand; Benzbromarone Sanfer Brand; Benzbromarone [USAN:INN:BAN]; Benzbromarone ratiopharm Brand; Benzbromaronratiopharm; Benzbromaronum; Benzbromaronum [INN-Latin]; Benzobromarona; Benzobromarona [INN-Spanish]; Besuric; Desuric; Exurate; Harolan; Heumann Brand of Benzbromarone; Hipurik; KETONE, 3,5-DIBROMO-4-HYDROXYPHENYL 2-ETHYL-3-BENZOFURANYL; L 2214; L 2214-Labaz; L-2214; L2214; MJ 10061; Methanone, (3; Minuric; NCI85433; Narcaricin; Normurat; Ratiopharm Brand of Benzbromarone; Sanfer Brand of Benzbromarone; Sanofi Winthrop Brand of Benzbromarone; Uricovac; Urinorm; Uroleap; Uroleap (TN) DTD0017 VADRUGID DR00291 DTD0017 DRUGNAME Cisplatin DTD0017 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0017 VADRUGID DR00345 DTD0017 DRUGNAME Epipodophyllotoxins DTD0017 DRUGSYNO (-)-epipodophyllotoxin; 137513-EP2272827A1; 137513-EP2292088A1; AC1L2Y2E; AJ-42064; BRN 0099162; C22H22O8; CHEMBL282256; Epipodophyllotoxin; Etopside; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)-; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-beta,8a-alpha,9-beta))-; LS-70861; SCHEMBL5792464; VP16; ZINC2572657 DTD0019 TRANSPID DTD0019 DTD0019 GENENAME SLC10A1 DTD0019 PROTNAME Sodium/taurocholate cotransporting polypeptide DTD0019 SYNONYMS Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1 DTD0019 VADRUGID DR00206 DTD0019 DRUGNAME Pitavastatin calcium DTD0019 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0019 VADRUGID DR00223 DTD0019 DRUGNAME Rosuvastatin DTD0019 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0019 VADRUGID DR00173 DTD0019 DRUGNAME Liothyronine DTD0019 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0019 VADRUGID DR00053 DTD0019 DRUGNAME Sodium taurocholate DTD0019 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0019 VADRUGID DR01121 DTD0019 DRUGNAME Taurocholic acid DTD0019 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0019 VADRUGID DR00391 DTD0019 DRUGNAME Cerivastatin DTD0019 DRUGSYNO . DTD0019 VADRUGID DR00019 DTD0019 DRUGNAME Estrone sulfate DTD0019 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0020 TRANSPID DTD0020 DTD0020 GENENAME SLC10A2 DTD0020 PROTNAME Apical sodium-dependent bile acid transporter DTD0020 SYNONYMS ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2 DTD0020 VADRUGID DR00948 DTD0020 DRUGNAME Glycodeoxycholic acid DTD0020 DRUGSYNO glycodeoxycholate DTD0020 VADRUGID DR00053 DTD0020 DRUGNAME Sodium taurocholate DTD0020 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0020 VADRUGID DR01121 DTD0020 DRUGNAME Taurocholic acid DTD0020 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0020 VADRUGID DR00657 DTD0020 DRUGNAME Cholic acid DTD0020 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0020 VADRUGID DR01301 DTD0020 DRUGNAME Deoxycholic acid DTD0020 DRUGSYNO (3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-oic acid; 3,12-Dihydroxycholanic acid; 3alpha,12alpha-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid; 5-beta-Deoxycholic acid; 7-Deoxycholic acid; 7alpha-Deoxycholic acid; ATX-101; Choleic acid; Cholerebic; Cholic acid, deoxy-; Cholorebic; DEOXYCHOLIC ACID; Degalol; Deoxy cholic acid; Deoxycholatic acid; Desoxycholic acid; Desoxycholsaeure; Dihydroxycholanoic acid; Droxolan; Pyrochol; Septochol; Sodium deoxycholate; deoxycholate DTD0021 TRANSPID DTD0021 DTD0021 GENENAME SLC15A1 DTD0021 PROTNAME Peptide transporter 1 DTD0021 SYNONYMS HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1 DTD0021 VADRUGID DR00275 DTD0021 DRUGNAME Bestatin DTD0021 DRUGSYNO ((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid; AC1L972Z; AKOS026750073; BDBM50010142; Bestatin (TN); C00732; CHEBI:140702; CHEBI:3070; CHEMBL476869; D00087; DTXSID4048430; GTPL5151; NCGC00161660-01; SCHEMBL25971; SureCN25971; UPCMLD-DP116; UPCMLD-DP116:001; Ubenimex (JP16/INN); Ubenimex (JP17/INN); ZINC01532730; ZINC1532730 DTD0021 VADRUGID DR00436 DTD0021 DRUGNAME Metoprolol DTD0021 DRUGSYNO (RS)-Metoprolol; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol; AstraZeneca Brand of Metaoprolol Tartrate; AstraZeneca Brand of Seloken; Beatrolol; Beloc Duriles; Beloc-Duriles; BelocDuriles; Betaloc; Betaloc (TN); Betaloc Astra; Betaloc-Astra; BetalocAstra; Betalok; CGP 2175; CGP-2175; CGP2175; Corvitol (TN); Dl-Metoprolol; Dutoprol; H 93 26; H 93-26; H 9326; LOPRESSIDONE; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; Lopresor; Lopresoretic; Lopressor; Lopressor (TN); Meijoprolol; Metohexal; Metoprolol (USAN/INN); Metoprolol [USAN:INN:BAN]; Metoprolol succinate; Metoprololum; Metoprololum [INN-Latin]; Metrol (TN); Metroprolol; Minax (TN); Neobloc (TN); Novartis Brand of Metprolol Tartrate; Preblok; Presolol; Selo-Zok; Selokeen (TN); Seloken; Seloken AstraZeneca Brand; Seroken; Spesicor; Spesikor; TOPROL-XL; Tartrate, Metoprolol; Toprol; Toprol-XL (TN) DTD0021 VADRUGID DR00003 DTD0021 DRUGNAME Lisdexamfetamine DTD0021 DRUGSYNO Lisdexamfetamine (INN); NRP104; Vyvanse (TN) DTD0021 VADRUGID DR00031 DTD0021 DRUGNAME Ramipril DTD0021 DRUGSYNO (2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name); (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid; (2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic; (2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p; (2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]; Acovil; Almirall Brand of Ramipril; Altace; Altace (TN); Astra Brand of Ramipril; AstraZeneca Brand of Ramipril; Aventis Brand of Ramipril; Aventis Pharma Brand of Ramipril; Carasel; Cardace; Delix; HOE 498; HOE498; Hoe-498; Hoechst Brand of Ramipril; Hypren; Hytren; Lostapres; Monarch Brand of Ramipril; N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid; Naprix; Pramace; Pramace (discontinued); Promed Brand of Ramipril; Quark; Ramace; Ramipril (USP/INN); Ramipril [USAN:INN:BAN]; Ramiprilum; Ramiprilum [Latin]; Ramipro, Tritace, Altace, Prilace, Ramipril; Triatec; Tritace; Tritace (TN); Vesdil; Zabien; [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; [2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen DTD0021 VADRUGID DR00404 DTD0021 DRUGNAME Valganciclovir DTD0021 DRUGSYNO 5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one; Cymeval; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester; L-Valine, ester with ganciclovir; RO1079070/194; RS 79070; Valcyte (TN); Valganciclovir (INN); Valganciclovir (Oral); Valganciclovir [INN:BAN]; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate DTD0021 VADRUGID DR00258 DTD0021 DRUGNAME Furosemide DTD0021 DRUGSYNO 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida DTD0021 VADRUGID DR00176 DTD0021 DRUGNAME Ribavirin DTD0021 DRUGSYNO 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN) DTD0021 VADRUGID DR00286 DTD0021 DRUGNAME Benazepril DTD0021 DRUGSYNO 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; Benazapril; Benazepril (INN); Benazepril Sandoz; Benazepril Sandoz (TN); Benazepril [INN:BAN]; Benazeprilum; Benazeprilum [Latin]; Benzazepril; CGS-14824-A; Forteekor [veterinary]; Forteekor [veterinary] (TN); Fortekor (TN); Lotensin (TN); [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid DTD0021 VADRUGID DR00628 DTD0021 DRUGNAME Captopril DTD0021 DRUGSYNO (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline; (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline; 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S); 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline; 3-Mercapto-2-methylpropionyl-proline; Acediur; Aceplus; Acepress; Acepril; Alopresin; Apopril; Apopril (TN); Asisten; C 4042; Capoten; Capoten (TN); Captolane; Captopril (JP15/USP/INN); Captopril [USAN:INN:BAN:JAN]; Captoprilum; Captoprilum [INN-Latin]; Captopryl; Captoril; Captril; Cesplon; D-2-Methyl-3-mercaptopropanoyl-L-proline; D-3-Mercapto-2-methylpropanoyl-L-proline; D-3-Mercapto-2-methylpropionylproline; Dilabar; Garranil; Garranil (discontinued); Hipertil; Hypertil; Isopresol; L-Captopril; Lopirin; Lopirin [Switzerland]; Lopril; MCO; N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline;(2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline; SA 333; SQ 14,225; SQ 14225; SQ-14,225; SQ-14,534; SQ-14225; SQ-14534; Tenosbon; Tensiomin; Tensobon; Tensoprel; X8Z; [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline DTD0021 VADRUGID DR00010 DTD0021 DRUGNAME Enalapril DTD0021 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0021 VADRUGID DR01416 DTD0021 DRUGNAME Enalaprilat DTD0021 DRUGSYNO EAL; Enalaprilate; Enalaprilatum; ENALAPRILAT INHIBITOR; Enalapril acid; Enalapril diacid; Enalaprilat anhydrous; Enalaprilic acid; Enalprilat hydrate; Enalprilate hydrate; Enalaprilat (USP); MK-422; Vasotec I.V.; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2); (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate; 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate DTD0021 VADRUGID DR01208 DTD0021 DRUGNAME Eprosartan DTD0021 DRUGSYNO (4-carboxybenzyl)imidazole-5-acrylic acid; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid; (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; (E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid; (E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; 133040-01-4; 2KH13Z0S0Y; 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; CHEBI:4814; CHEMBL813; Eprosartan (USAN/INN); Eprosartan [USAN:BAN:INN]; F 108566; F-108566; SK&F 108566; SK&F-108566; SK-108566; SKF-108566; Teveten; Teveten (TN); UNII-2KH13Z0S0Y; [3H]eprosartan DTD0021 VADRUGID DR00701 DTD0021 DRUGNAME Fosinopril DTD0021 DRUGSYNO fosinopril; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; C30H46NO7P; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; SR-05000001490; SCHEMBL15626; AC1L1K09; CHEMBL3306578; DTXSID1023079; HMS3715N21; HMS2089P08 DTD0021 VADRUGID DR00482 DTD0021 DRUGNAME Irbesartan DTD0021 DRUGSYNO 2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one; 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one; 2-butyl-3-[ p-(o-1 H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one; 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one; 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one; Aprovel; Aprovel (TN); Avalide (TN); Avapro; Avapro (TN); BMS 186295; BMS Brand of Irbesartan; BMS-186295; BMS-186295, SR-47436,Aprovel, Karvea, Irbesartan; Bristol Myers Brand of Irbesartan; Irbesarran; Irbesartan (JAN/USAN/INN); Irbesartan [USAN:INN]; Irbetan; Karvea; Karvea (TN); Lrbesartan; SR 47436; SR-47436; SanofiWinthrop Brand of Irbesartan DTD0021 VADRUGID DR00991 DTD0021 DRUGNAME Lisinopril DTD0021 DRUGSYNO (2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline; (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; 1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline; Acerbon; Acercomp; Alapril; Carace; Cipral; Cipril; Coric; Doneka; Hipril (TN); Inhibril; Inopril; LPR; Linopril; Linvas; Lipril; Lisinal; Lisinopril (INN); Lisinopril (anhydrous); Lisinopril anhydrous; Lisinoprilum; Lisinoprilum [Latin]; Lisipril; Lisoril; Lispril; Longes; Loril; Lysinopril; MK 521; MK 522; MK-521; N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; Noperten; Novatec; Presiten; Prinil; Prinivil; Prinivil (TN); Sinopril; Sinopryl; Tensopril; Tensopril (TN); Tensyn; Tersif; Vivatec; Zestril; Zestril (TN); [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE DTD0021 VADRUGID DR00429 DTD0021 DRUGNAME Losartan DTD0021 DRUGSYNO (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol; 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole; CL23623; Cozaar; Cozaar (TN); DUP 89; DuP-753; Hyzaar; LOSARTAN POTASSIUM; Lortaan; Losartan (INN); Losartan [INN:BAN]; Losartan monopotassium salt; Losartic; Losartic (TN); MK-954; MK954; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol DTD0021 VADRUGID DR00006 DTD0021 DRUGNAME Moexipril DTD0021 DRUGSYNO (3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexipril (INN); Moexipril [INN:BAN]; Moexiprilum; Moexiprilum [INN-Latin]; Perdix (TN); Uniretic; Univasc (TN) DTD0021 VADRUGID DR00058 DTD0021 DRUGNAME Perindopril DTD0021 DRUGSYNO (2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; ACEON; Aceon (TN); Acertil (TN); Armix (TN); Coverene (TN); Coverene Cor; Coverex; Coverex (TN); Coversum; Coversum (TN); Coversyl; Cpd with unspecified MF; DW-7950; Ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; McN-A-2833; Perindopril (USAN/INN); Prestarium; Prestarium (TN); Prexanil (TN); Prexum (TN); Procaptan (TN); S-9490; SED-9490 DTD0021 VADRUGID DR00095 DTD0021 DRUGNAME Spirapril DTD0021 DRUGSYNO (2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid; Espirapril [Spanish]; Not established; Renormax; Sandopril; Sch-33844; Setrilan; Spirapril (INN); Spirapril [INN:BAN]; Spiraprilum [Latin]; TI-211-950 DTD0021 VADRUGID DR01528 DTD0021 DRUGNAME Temocapril DTD0021 DRUGSYNO Temocapril; Temocaprilum; 2-((2S,6R)-6-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-4-yl)acetic acid; UNII-18IZ008EU6; 18IZ008EU6; Temocapril [INN:BAN]; Temocaprilum [INN-Latin]; C23H28N2O5S2; 2-((2S,6R)-6-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)-5-OXO-2-(THIOPHEN-2-YL)-1,4-THIAZEPAN-4-YL)ACETIC ACID; (2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; Temocapril (INN); AC1L9FDI DTD0021 VADRUGID DR01319 DTD0021 DRUGNAME Temocaprilate DTD0021 DRUGSYNO (+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate DTD0021 VADRUGID DR00240 DTD0021 DRUGNAME Trandolapril DTD0021 DRUGSYNO (2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; Gopten; Mavik; Mavik (TN); Odric; Odrik; Preran; RU 44570; RU-44570; RU44570; Trandolapril (JAN/INN); Trandolapril [INN:BAN]; Trandolaprilum; Trandolaprilum [Latin]; Udrik DTD0021 VADRUGID DR00071 DTD0021 DRUGNAME Valsartan DTD0021 DRUGSYNO (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan DTD0021 VADRUGID DR00201 DTD0021 DRUGNAME Sulfasalazine DTD0021 DRUGSYNO 13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral DTD0021 VADRUGID DR00250 DTD0021 DRUGNAME Oseltamivir DTD0021 DRUGSYNO (-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir DTD0021 VADRUGID DR00057 DTD0021 DRUGNAME Aminolevulinic acid DTD0021 DRUGSYNO 5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI) DTD0021 VADRUGID DR00215 DTD0021 DRUGNAME Dexamethasone DTD0021 DRUGSYNO (3H)-Dexamethasone; 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol; 16.alpha.-Methyl-9.alpha.-fluoroprednisolone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone; 16alpha-Methyl-9alpha-fluoroprednisolone; 9-alpha-Fluoro-16-alpha-methylprednisolone; 9.alpha.-Fluoro-16.alpha.-methylprednisolone; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 9alpha-Fluoro-16alpha-methylprednisolone; Adexone; Aeroseb-D; Aeroseb-Dex; Alcon Brand of Dexamethasone; Anaflogistico; Aphtasolon; Aphthasolone; Auxiron; Azium; Azium (Veterinary); Bisu DS; Calonat; Corson; Corsone; Cortisumman; DXM; Decacort; Decacortin; Decaderm; Decadron; Decadron (TN); Decadron Tablets, Elixir; Decadron, Dexamethasone; Decadron-LA; Decagel; Decaject; Decaject L.A.; Decaject-L.A.; Decalix; Decameth; Decasone; Decaspray; Dectancyl; Dekacort; Delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol; Delta1-9alpha-Fluoro-16alpha-methylcortisol; Deltafluorene; Dergramin; Deronil; Desadrene; Desametasone; Desametasone [DCIT]; Desamethasone; Desameton; Deseronil; Dex-ide; Dexa Mamallet; Dexa-Cortidelt;Dexa-Cortisyl; Dexa-Mamallet; Dexa-Scheroson; Dexa-sine; Dexacen-4; Dexacort; Dexacortal; Dexacortin; Dexadeltone; Dexafarma; Dexair; Dexalona; Dexaltin; Dexametasona; Dexametasona [INN-Spanish]; Dexameth; Dexamethansone; Dexamethasone (JP15/USP/INN); Dexamethasone Base; Dexamethasone Intensol; Dexamethasone [INN:BAN:JAN]; Dexamethasone alcohol; Dexamethasonum; Dexamethasonum [INN-Latin]; Dexamethazone; Dexamonozon; Dexapolcort; Dexaprol; Dexason; Dexasone; Dexinolon; Dexinoral; Dexone; Dexone 0.5; Dexone 0.75; Dexone 1.5; Dexone 4; Dexonium; Dexpak; Dextelan; Dezone; Dinormon; Dxms; ECR Brand of Dexamethasone; Fluormethylprednisolone; Fluormone; Fluorocort; Fortecortin; Foy Brand of Dexamethasone; Gammacorten; Hexadecadrol; Hexadrol; Hexadrol Elixir; Hexadrol Tablets; Hl-dex; ICN Brand of Dexamethasone; IontoDex; Isopto-Dex; Lokalison F; Loverine; Luxazone; MK 125; Maxidex; Mediamethasone; Merck Brand of Dexamethasone; Merz Brand 1 of Dexamethasone; Merz Brand 2 of Dexamethasone; Methylfluorprednisolone; Mexidex; Millicorten; Mymethasone; OTO-104; Ocu-trol;Pet-Derm Iii; Oradexon; Pet Derm III; Policort; Posurdex; Prednisolon F; Prednisolone F; Prodex; SK-Dexamethasone; Spoloven; Sunia Sol D; Superprednol; Turbinaire; Visumetazone DTD0021 VADRUGID DR01168 DTD0021 DRUGNAME Sulpiride DTD0021 DRUGSYNO (+/-)-Sulpiride; (RS)-(+/-)-sulpiride; (inverted question mark)-Sulpiride; Abilit; Aiglonyl; Alimoral; Allphar Brand of Sulpiride; Almirall Brand of Sulpiride; Areu Brand of Sulpiride; Arminol; Bosnyl (TN); Calmoflorine; Centrum Brand of Sulpiride; Championyl; Coolspan; Darleton; Deponerton; Desisulpid; Desitin Brand of Sulpiride; Desmenat; Digton; Dobren; Dogmatil; Dogmatil (TN); Dogmatyl; Dogmatyl (TN); Dolmatil; Dolorgiet Brand of Sulpiride; Dresent; Eglonil; Eglonyl; Eglonyl (TN); Ekilid; Enimon; Equilid; Erempharma Brand of Sulpiride; Eusulpid; Fardalan; Fidelan; Fumouzer Brand of Sulpiride; Guastil; Hennig Brand of Sulpiride; Hexal Brand of Sulpiride; Hoechst Brand of Sulpiride; Hormosan Brand of Sulpiride; Isnamide; Krewel Brand of Sulpiride; Kylistro; Lebopride; Levobren; Levopraid; Levosulpirida; Levosulpirida [INN-Spanish]; Levosulpiride [INN]; Levosulpiridum; Levosulpiridum [INN-Latin]; Lisopiride; Magnetic resonance imaging sulpiride; Mariastel; Meresa; Meresa (TN); Miradol; Mirbanil; Misulvan; N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; Neogama; Neuraxpharm (TN); Norestran; Normum; Nufarol; Omiryl; Omperan; Ozoderpin; Pharmacia Brand of Sulpiride; Pontiride; Psicocen; Psicofarma Brand of Sulpiride; Pyrikappl; Pyrkappl; R. D. 1403; R.D. 1403; RD 1403; RV-12309; Ratiopharm (TN); Restful; Rosemont Brand of Sulpiride; S 8010; Sanofi Synthelabo Brand of Sulpiride; Sanofi-Synthelabo Brand of Sulpiride; Sernevin; Splotin; Spyfarma Brand of Sulpiride; Stamonevrol; Sulp; Sulperide; Sulpirid; Sulpirid (TN); Sulpirida; Sulpirida [INN-Spanish]; Sulpiride (JP15/USAN/INN); Sulpiride [USAN:INN:BAN:JAN]; Sulpiridum; Sulpiridum [INN-Latin]; Sulpiryd (TN); Sulpitil; Sulpivert; Sulpor; Sulpride; Sulpyrid; Suprium; Sursumid; Synedil; Tepavil; Uriach Brand of Sulpiride; Valirem; Vertigo Meresa; Vertigo neogama; Vertigo-Meresa; Vertigo-neogama; Zemorcon DTD0021 VADRUGID DR00645 DTD0021 DRUGNAME Carnosine DTD0021 DRUGSYNO L-carnosine; beta-alanyl-L-histidine DTD0021 VADRUGID DR00078 DTD0021 DRUGNAME Valacyclovir DTD0021 DRUGSYNO 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN) DTD0021 VADRUGID DR00537 DTD0021 DRUGNAME Ceftibuten DTD0021 DRUGSYNO (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7432-S; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid; Antibiotic 7432S; CETB; Cedax; Cedax (TN); Ceftem; Ceftibuten [USAN:INN:BAN]; Ceftibuten(USAN/INN); Ceftibutene; Ceftibutene [INN-French]; Ceftibuteno; Ceftibuteno [INN-Spanish]; Ceftibutenum; Ceftibutenum [INN-Latin]; Cephalosporin 7432-S; Cephem; Ceprifran; Cis-Ceftibutin; Cis-ceftibuten; Isocef; Keimax; S 7432; Sch 39720; Sch-39720; Trans-Ceftibuten DTD0021 VADRUGID DR00551 DTD0021 DRUGNAME Cefamandole DTD0021 DRUGSYNO (6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid; (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; Cefadole; Cefamandole (USAN/INN); Cefamandolum DTD0021 VADRUGID DR00704 DTD0021 DRUGNAME Cefsulodin DTD0021 DRUGSYNO (6R,7R)-3-{[4-(aminocarbonyl)pyridinium-1-yl]methyl}-8-oxo-7-{[phenyl(sulfo)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; AC1NR4MP; Cefsulodin free acid (SCE-129), Antibiotic for Culture Media Use Only; DTXSID6022769; SCHEMBL65524 DTD0021 VADRUGID DR01360 DTD0021 DRUGNAME Ceronapril DTD0021 DRUGSYNO Ceranapril; SQ-29852 DTD0021 VADRUGID DR01164 DTD0021 DRUGNAME Midodrine DTD0021 DRUGSYNO (+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride; (+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride; (+-)-Midodrine hydrochloride; (+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol; (-)-Midodrin hydrochloride; (-)-Midodrine hydrochloride; (RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid; 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol; 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride; 1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide; 2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride; 2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride; 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide; 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride; A 4020 Linz; A-4020 Linz; Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride; Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride; Alphamine; Amatine; DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid; Gutron; Hipertan; MIDODRINE HYDROCHLORIDE; Metligene; Midamine; Midodrin; Midodrina; Midodrina [INN-Spanish]; Midodrine (INN); Midodrine HCL; Midodrine Monohydrochloride; Midodrine [BAN:INN]; Midodrine [INN:BAN]; Midodrine hydrochloride (JAN/USAN); Midodrine hydrochloride [USAN:JAN]; Midodrine hydrochloride [USAN]; Midodrinum; Midodrinum [INN-Latin]; N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide; N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide; Pro-Amatine; Pro-Amatine (TN); ProAmatine; Proamatine (TN); ST-1085; St 1085; St. Peter 224; TS 701; [+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol DTD0021 VADRUGID DR00259 DTD0021 DRUGNAME Cefaclor DTD0021 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472 DTD0021 VADRUGID DR00313 DTD0021 DRUGNAME Cefadroxil DTD0021 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0021 VADRUGID DR00330 DTD0021 DRUGNAME Cephalexin DTD0021 DRUGSYNO 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine DTD0021 VADRUGID DR00488 DTD0021 DRUGNAME Benzylpenicillin DTD0021 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0021 VADRUGID DR00455 DTD0021 DRUGNAME Dicloxacillin DTD0021 DRUGSYNO (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423 DTD0021 VADRUGID DR00546 DTD0021 DRUGNAME Cefixime DTD0021 DRUGSYNO (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef DTD0021 VADRUGID DR00553 DTD0021 DRUGNAME Ceftriaxone DTD0021 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine DTD0021 VADRUGID DR00190 DTD0021 DRUGNAME Amoxicillin DTD0021 DRUGSYNO (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN) DTD0021 VADRUGID DR00577 DTD0021 DRUGNAME Cefazolin DTD0021 DRUGSYNO (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN) DTD0021 VADRUGID DR00544 DTD0021 DRUGNAME Cephradine DTD0021 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; Anspor; Anspor (TN); CEPHRADINE SODIUM; Cefradin; Cefradina; Cefradina [INN-Spanish]; Cefradine (JAN/INN); Cefradinum; Cefradinum [INN-Latin]; Cephradin; Cephradine; Cephradine (USP); Cephradine (anhydrous); Cephradine [USAN:BAN]; Eskacef; SK&F D-39304; SK-D-39304; SKF D 39304; SQ 11436; SQ-11436; SQ-22022; Sefril; VELOSEF 125; VELOSEF 250; VELOSEF 500; Velosef; Velosef (TN) DTD0021 VADRUGID DR00539 DTD0021 DRUGNAME Cefmetazole DTD0021 DRUGSYNO (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; CMZ; CS 1170; CS-1170; Cefmetazole (USP/INN); Cefmetazole Monosodium Salt; Cefmetazole [USAN:INN]; Cefmetazolo; Cefmetazolo [INN-Spanish]; Cefmetazolum; Cefmetazolum [INN-Latin]; SKF 83088; U 72791; U-72791A DTD0021 VADRUGID DR00612 DTD0021 DRUGNAME Cephaloridine DTD0021 DRUGSYNO 50-59-9; Ampligram; Betaine cephaloridine; CHEBI:3537; Cefaloridin; Cefaloridina; Cefaloridina [INN-Spanish]; Cefaloridine; Cefaloridinum; Cefaloridinum [INN-Latin]; Cefalorizin; Ceflorin; Cepaloridin; Cepalorin; Cephalomycine; Cephaloridin; Cephaloridinum; Ceporan; Ceporin; Ceporine; Cilifor; Deflorin; Faredina; Glaxoridin; Intrasporin; Keflodin; Keflordin; Kefloridin; Kefspor; Lloncefal; Loridine; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH; Sasperin; Sefacin; UNII-LVZ1VC61HB; Verolgin; Vioviantine DTD0021 VADRUGID DR00712 DTD0021 DRUGNAME Ampicillin DTD0021 DRUGSYNO 6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil DTD0021 VADRUGID DR00692 DTD0021 DRUGNAME Cefdinir DTD0021 DRUGSYNO (-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; BMY 28488; CFDN; Cefdinir (JP15/USAN/INN); Cefdinir [USAN:INN]; Cefdinirum; Cefdinirum [INN-Latin]; Cefdinyl; Cefdirnir; Cefzon; Cefzon (TN); FK 482; FK-482; FR-80482; KS-1038; Omnicef; Omnicef (TN); Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir; PD 134393; PD-134393 DTD0021 VADRUGID DR00828 DTD0021 DRUGNAME Cefoxitin DTD0021 DRUGSYNO cefoxitin; Mefoxin; Cefoxitine; Cefoxitinum; Cefoxitina; CEPHOXITIN; Mefoxitin; Rephoxitin; UNII-6OEV9DX57Y; CHEMBL996; 6OEV9DX57Y; CFX; AK118716; DSSTox_CID_2764; DSSTox_RID_76721; DSSTox_GSID_22764; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7S)-; CAS-35607-66-0; NCGC00183034-01; ceftoxitin; Cefoxotin; 4kow DTD0021 VADRUGID DR00974 DTD0021 DRUGNAME Cefpodoxime DTD0021 DRUGSYNO (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CPDX; Cefpodoxim acid; Cefpodoxima; Cefpodoxima [Spanish]; Cefpodoxime (INN); Cefpodoxime [INN:BAN]; Cefpodoximum; Cefpodoximum [Latin]; Epoxim; Epoxim (TN); RU 51807; Vantin (TN) DTD0021 VADRUGID DR01519 DTD0021 DRUGNAME Cefuroxime axetil DTD0021 DRUGSYNO cefuroxime axetil; Ceftin; Zinnat; Elobact; Zinat; Cefuroxime 1-acetoxyethyl ester; Bioracef; CXM-AX; Coliofossim; Furoxime; Cetoxil; Celocid; Cethixim; Nivador; Medoxm; Kalcef; Zoref; Sharox-500; UNII-Z49QDT0J8Z; DRG-0157; SN 407; CCI 15641; CCI-15641; Cepazine; CCI 1564; BRN 6854419; Z49QDT0J8Z; CHEBI:3516; (RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate; C20H22N4O10S; Cefazine; Altacef DTD0021 VADRUGID DR01373 DTD0021 DRUGNAME Cephaloglycin DTD0021 DRUGSYNO CEG; Cefaloglicina; Cefaloglycin; Cefaloglycine; Cefaloglycinum; Cephaloglycine; Kafocin; Kefglycin; Cephaloglycinanhdyous; Cephaloglycin anhydrous; Cephaoglycin acid; Lilly 39435; Cefaloglicina [INN-Spanish]; Cefaloglycin (JAN); Cefaloglycine [INN-French]; Cefaloglycinum [INN-Latin]; Cephaloglycin (anhydrous); D-Cephaloglycine; D-(-)-Cephaloglycin; (6R,7R)-3-(acetoxymethyl)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-((Acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-acetoxymethyl-7beta-[(2R)-2-amino-2-phenylacetamido]-3,4-didehydrocepham-4-carboxylic acid; 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate (ester); 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)octane-2-carboxylic acid, acetate inner salt; 7-(2-D-alpha-Aminophenylacetamido)cephalosporanic acid; 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup3)-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenyl-acetamido)cephalosporanic acid DTD0021 VADRUGID DR00480 DTD0021 DRUGNAME Cyclacillin DTD0021 DRUGSYNO (1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid; AC 98; Aminocyclohexyl penicillin; Aminocyclohexylpenicillin; Bastcillin; C-12104; Calthor; Ciclacilina; Ciclacilina [INN-Spanish]; Ciclacillin; Ciclacillin (JP15/INN); Ciclacilline; Ciclacilline [INN-French]; Ciclacillinum; Ciclacillinum [INN-Latin]; Ciclacillum; Citosarin; Cyclacillin (USAN); Cyclacillin [USAN]; Cyclapen; Cyclapen (TN); Cyclapen-W; Cyclapen-W (TN); Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vastcillin (TN); Vipicil; WY 4508; WY4508; Wy-4508; Wyvital DTD0021 VADRUGID DR00961 DTD0021 DRUGNAME Flucloxacillin DTD0021 DRUGSYNO (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S(2alpha,5alpha,6beta)); 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido]-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 2039; FLOXACILLIN; Flopen (TN); Floxacillin (USAN); Floxacillin [USAN]; Floxapen; Floxapen (TN); Fluclox; Flucloxacilina; Flucloxacilina [INN-Spanish]; Flucloxacillin (INN); Flucloxacillin sodium; Flucloxacillin-Sodium; Flucloxacilline; Flucloxacilline [INN-French]; Flucloxacillinum; Flucloxacillinum [INN-Latin]; Fluorochloroxacillin; MFIPC; Rel-(2R,6S)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylato DTD0021 VADRUGID DR00857 DTD0021 DRUGNAME Piperacillin DTD0021 DRUGSYNO (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S-(2alpha,5alpha,6beta(S*)))-6-(((((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 4-ethyl-2,3-dioxopiperazine carbonyl ampicillin; 6-(D-(-)-alpha-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanicacid; 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid; Cl-227193; PIPC; PIPERACILLIN SODIUM; Peperacillin; Peracin; Peracin (TN); Piperacillin (INN); Piperacillin (anhydrous); Piperacillin Monosodium Salt; Piperacillin anhydrous; Pipercillin; Pipracil; Pipracil, Piper; Pipril; T-1220; Zobactin (TN) DTD0021 VADRUGID DR01338 DTD0021 DRUGNAME Metampicillin DTD0021 DRUGSYNO (2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-(methylideneamino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-[(2R)-2-(methylideneamino)-2-phenylacetamido]penicillanic acid; Blomopen; Bonopen; CHEBI:52060; Celinmicina; Elatocilline; G0H6U7VSTK; METHAMPICILLIN; Magnipen; Metampicilina; Metampicillina; Metampicilline; Metampicillinum; Micinovo; Pangocilin; Probiotic; Relyothenate; Ruticina; Rutizina; Sedomycin; Suvipen; UNII-G0H6U7VSTK; Viderpen; Viderpin; Vioplex; metampicillin; metampilene DTD0021 VADRUGID DR01243 DTD0021 DRUGNAME N-acetylaspartylglutamate DTD0021 DRUGSYNO NAAG; isospaglumic acid; spaglumic acid DTD0021 VADRUGID DR01586 DTD0021 DRUGNAME QSP DTD0021 DRUGSYNO . DTD0022 TRANSPID DTD0022 DTD0022 GENENAME SLC15A2 DTD0022 PROTNAME Peptide transporter 2 DTD0022 SYNONYMS Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2 DTD0022 VADRUGID DR00275 DTD0022 DRUGNAME Bestatin DTD0022 DRUGSYNO ((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid; AC1L972Z; AKOS026750073; BDBM50010142; Bestatin (TN); C00732; CHEBI:140702; CHEBI:3070; CHEMBL476869; D00087; DTXSID4048430; GTPL5151; NCGC00161660-01; SCHEMBL25971; SureCN25971; UPCMLD-DP116; UPCMLD-DP116:001; Ubenimex (JP16/INN); Ubenimex (JP17/INN); ZINC01532730; ZINC1532730 DTD0022 VADRUGID DR01277 DTD0022 DRUGNAME Entecavir DTD0022 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0022 VADRUGID DR00031 DTD0022 DRUGNAME Ramipril DTD0022 DRUGSYNO (2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name); (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid; (2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic; (2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p; (2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]; Acovil; Almirall Brand of Ramipril; Altace; Altace (TN); Astra Brand of Ramipril; AstraZeneca Brand of Ramipril; Aventis Brand of Ramipril; Aventis Pharma Brand of Ramipril; Carasel; Cardace; Delix; HOE 498; HOE498; Hoe-498; Hoechst Brand of Ramipril; Hypren; Hytren; Lostapres; Monarch Brand of Ramipril; N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid; Naprix; Pramace; Pramace (discontinued); Promed Brand of Ramipril; Quark; Ramace; Ramipril (USP/INN); Ramipril [USAN:INN:BAN]; Ramiprilum; Ramiprilum [Latin]; Ramipro, Tritace, Altace, Prilace, Ramipril; Triatec; Tritace; Tritace (TN); Vesdil; Zabien; [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; [2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen DTD0022 VADRUGID DR00286 DTD0022 DRUGNAME Benazepril DTD0022 DRUGSYNO 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; Benazapril; Benazepril (INN); Benazepril Sandoz; Benazepril Sandoz (TN); Benazepril [INN:BAN]; Benazeprilum; Benazeprilum [Latin]; Benzazepril; CGS-14824-A; Forteekor [veterinary]; Forteekor [veterinary] (TN); Fortekor (TN); Lotensin (TN); [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid DTD0022 VADRUGID DR00010 DTD0022 DRUGNAME Enalapril DTD0022 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0022 VADRUGID DR00701 DTD0022 DRUGNAME Fosinopril DTD0022 DRUGSYNO fosinopril; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; C30H46NO7P; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; SR-05000001490; SCHEMBL15626; AC1L1K09; CHEMBL3306578; DTXSID1023079; HMS3715N21; HMS2089P08 DTD0022 VADRUGID DR00006 DTD0022 DRUGNAME Moexipril DTD0022 DRUGSYNO (3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexipril (INN); Moexipril [INN:BAN]; Moexiprilum; Moexiprilum [INN-Latin]; Perdix (TN); Uniretic; Univasc (TN) DTD0022 VADRUGID DR00058 DTD0022 DRUGNAME Perindopril DTD0022 DRUGSYNO (2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; ACEON; Aceon (TN); Acertil (TN); Armix (TN); Coverene (TN); Coverene Cor; Coverex; Coverex (TN); Coversum; Coversum (TN); Coversyl; Cpd with unspecified MF; DW-7950; Ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; McN-A-2833; Perindopril (USAN/INN); Prestarium; Prestarium (TN); Prexanil (TN); Prexum (TN); Procaptan (TN); S-9490; SED-9490 DTD0022 VADRUGID DR00095 DTD0022 DRUGNAME Spirapril DTD0022 DRUGSYNO (2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid; Espirapril [Spanish]; Not established; Renormax; Sandopril; Sch-33844; Setrilan; Spirapril (INN); Spirapril [INN:BAN]; Spiraprilum [Latin]; TI-211-950 DTD0022 VADRUGID DR00240 DTD0022 DRUGNAME Trandolapril DTD0022 DRUGSYNO (2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; Gopten; Mavik; Mavik (TN); Odric; Odrik; Preran; RU 44570; RU-44570; RU44570; Trandolapril (JAN/INN); Trandolapril [INN:BAN]; Trandolaprilum; Trandolaprilum [Latin]; Udrik DTD0022 VADRUGID DR00057 DTD0022 DRUGNAME Aminolevulinic acid DTD0022 DRUGSYNO 5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI) DTD0022 VADRUGID DR00078 DTD0022 DRUGNAME Valacyclovir DTD0022 DRUGSYNO 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN) DTD0022 VADRUGID DR00537 DTD0022 DRUGNAME Ceftibuten DTD0022 DRUGSYNO (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7432-S; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid; Antibiotic 7432S; CETB; Cedax; Cedax (TN); Ceftem; Ceftibuten [USAN:INN:BAN]; Ceftibuten(USAN/INN); Ceftibutene; Ceftibutene [INN-French]; Ceftibuteno; Ceftibuteno [INN-Spanish]; Ceftibutenum; Ceftibutenum [INN-Latin]; Cephalosporin 7432-S; Cephem; Ceprifran; Cis-Ceftibutin; Cis-ceftibuten; Isocef; Keimax; S 7432; Sch 39720; Sch-39720; Trans-Ceftibuten DTD0022 VADRUGID DR00259 DTD0022 DRUGNAME Cefaclor DTD0022 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472 DTD0022 VADRUGID DR00313 DTD0022 DRUGNAME Cefadroxil DTD0022 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN) DTD0022 VADRUGID DR00330 DTD0022 DRUGNAME Cephalexin DTD0022 DRUGSYNO 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine DTD0022 VADRUGID DR00455 DTD0022 DRUGNAME Dicloxacillin DTD0022 DRUGSYNO (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423 DTD0022 VADRUGID DR00546 DTD0022 DRUGNAME Cefixime DTD0022 DRUGSYNO (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef DTD0022 VADRUGID DR00190 DTD0022 DRUGNAME Amoxicillin DTD0022 DRUGSYNO (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN) DTD0022 VADRUGID DR00544 DTD0022 DRUGNAME Cephradine DTD0022 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; Anspor; Anspor (TN); CEPHRADINE SODIUM; Cefradin; Cefradina; Cefradina [INN-Spanish]; Cefradine (JAN/INN); Cefradinum; Cefradinum [INN-Latin]; Cephradin; Cephradine; Cephradine (USP); Cephradine (anhydrous); Cephradine [USAN:BAN]; Eskacef; SK&F D-39304; SK-D-39304; SKF D 39304; SQ 11436; SQ-11436; SQ-22022; Sefril; VELOSEF 125; VELOSEF 250; VELOSEF 500; Velosef; Velosef (TN) DTD0022 VADRUGID DR00712 DTD0022 DRUGNAME Ampicillin DTD0022 DRUGSYNO 6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil DTD0022 VADRUGID DR00480 DTD0022 DRUGNAME Cyclacillin DTD0022 DRUGSYNO (1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid; AC 98; Aminocyclohexyl penicillin; Aminocyclohexylpenicillin; Bastcillin; C-12104; Calthor; Ciclacilina; Ciclacilina [INN-Spanish]; Ciclacillin; Ciclacillin (JP15/INN); Ciclacilline; Ciclacilline [INN-French]; Ciclacillinum; Ciclacillinum [INN-Latin]; Ciclacillum; Citosarin; Cyclacillin (USAN); Cyclacillin [USAN]; Cyclapen; Cyclapen (TN); Cyclapen-W; Cyclapen-W (TN); Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vastcillin (TN); Vipicil; WY 4508; WY4508; Wy-4508; Wyvital DTD0022 VADRUGID DR00654 DTD0022 DRUGNAME Moxalactam DTD0022 DRUGSYNO (6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 1-Oxacephalosporin; 7b-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7a-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid; 7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid; Disodium Moxalactam; Festamoxin; LMOX; Lamoxactam; Latamoxef (INN); Latamoxef [INN:BAN]; Latamoxefum; Latamoxefum [INN-Latin]; Lilly 127935; Ly127935; Moxalactam; Oxa-cephem; S-6059; Sid 734787 DTD0022 VADRUGID DR01338 DTD0022 DRUGNAME Metampicillin DTD0022 DRUGSYNO (2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-(methylideneamino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-[(2R)-2-(methylideneamino)-2-phenylacetamido]penicillanic acid; Blomopen; Bonopen; CHEBI:52060; Celinmicina; Elatocilline; G0H6U7VSTK; METHAMPICILLIN; Magnipen; Metampicilina; Metampicillina; Metampicilline; Metampicillinum; Micinovo; Pangocilin; Probiotic; Relyothenate; Ruticina; Rutizina; Sedomycin; Suvipen; UNII-G0H6U7VSTK; Viderpen; Viderpin; Vioplex; metampicillin; metampilene DTD0023 TRANSPID DTD0023 DTD0023 GENENAME SLC22A5 DTD0023 PROTNAME Organic cation/carnitine transporter 2 DTD0023 SYNONYMS CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5 DTD0023 VADRUGID DR00564 DTD0023 DRUGNAME Pyrilamide DTD0023 DRUGSYNO 2-((2-(Dimethylamino)ethyl)-(p-methoxybenzyl)amino)pyridine; 2-((p-Methoxybenzyl)(2-(dimethylamino)ethyl)amino)pyridine; 2-[(p-Methoxybenzyl)[2-(dimethylamino)ethyl]amino]pyridine; 2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine; 2-[[2-(Dimethylamino)ethyl]-(p-methoxybenzyl)amino]pyridine; 2-dimethylaminoethyl-p-anisyl-(2-pyridyl)amine; Afko-Hist; Anhistabs; Anhistol; Antalergan; Antallergan; Antamine; Anthisan; Copsamine; Coradon; Dipane; Dorantamin; Harvamine; Histacap; Histalon; Histapyran; Histasan; Isamin; Kriptin; Maranhist; Mepiramina; Mepiramina [INN-Spanish]; Mepiramine; Mepyramin; Mepyramin [German]; Mepyramine (INN); Mepyramine [INN:BAN]; Mepyraminum; Mepyraminum [INN-Latin]; Mepyren; N',N'-Dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine; N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine; N,N-dimethyl-N'-{[4-(methyloxy)phenyl]methyl}-N'-pyridin-2-ylethane-1,2-diamine; N-((4-Methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha.-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-(pyridylethylene)diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridyl-1,2-ethanediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-(para-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-Dimethylamino-aethyl-N-p-methoxy-benzyl-.alpha.-amino-pyridin-maleat; N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine; N-p-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; N-para-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; Neo-Bridal; Neoantergan; Neobridal; Nyscaps; P-Methoxy-benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin [German]; PYRA; Paraminyl; Parmal; Pyramal; Pyranisamine; Pyrilamide; Pyrilamine; Pyrilamine salt with fine resin; R.d. 2786; RP 2786; Stamine; Stangen; Statomin; Thylogen; Wait's green mountain antihistamine; [3H]mepyramine; [3H]pyrilamine DTD0023 VADRUGID DR00264 DTD0023 DRUGNAME Verapamil DTD0023 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0023 VADRUGID DR00084 DTD0023 DRUGNAME Amphetamine DTD0023 DRUGSYNO Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore DTD0023 VADRUGID DR01277 DTD0023 DRUGNAME Entecavir DTD0023 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0023 VADRUGID DR00017 DTD0023 DRUGNAME Tiotropium DTD0023 DRUGSYNO (1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide; (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide; 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; BA 679 BR; BA 679BR; BA-679 BR; BA-679-BR; Spiriva; Spiriva (TN); Spiriva Handihaler; Spiriva Respimat; TIOTROPIUM BROMIDE; Tiotropium bromide [USAN:INN] DTD0023 VADRUGID DR00350 DTD0023 DRUGNAME D-carnitine DTD0023 DRUGSYNO (+)-Carnitine; (3S)-3-hydroxy-4-(trimethylammonio)butanoate; (3S)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (S)-3-Hydroxy-4-(trimethylammonio)butanoate; CHEBI:11060; Carnitine D-form; D-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; D-carnitine; U9VY0ZOK7A; UNII-U9VY0ZOK7A DTD0023 VADRUGID DR00184 DTD0023 DRUGNAME Potassium chloride DTD0023 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0023 VADRUGID DR00054 DTD0023 DRUGNAME Quinine DTD0023 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0023 VADRUGID DR00255 DTD0023 DRUGNAME L-carnitine DTD0023 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0023 VADRUGID DR00277 DTD0023 DRUGNAME Ipratropium DTD0023 DRUGSYNO (+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate DTD0023 VADRUGID DR01232 DTD0023 DRUGNAME Acetylcarnitine DTD0023 DRUGSYNO (-)-Acetylcarnitine; (3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate; (R)-Acetylcarnitine; 3040-38-8; 6DH1W9VH8Q; ALCAR; Acetyl-L-(-)-carnitine; Acetyl-L-carnitine; Acetylcarnitine, L-; CAR(2:0); CHEBI:57589; Carnitine, acetyl-, L-; HSDB 7587; L-ACETYLCARNITINE; L-Acetyl carnitine; L-Carnitine acetyl ester; L-O-Acetylcarnitine; Levocarnitine acetyl; Nicetile; O-Acetyl-L-carnitine; R-Acetylcarnitine; RDHQFKQIGNGIED-MRVPVSSYSA-N; UNII-6DH1W9VH8Q; acetyl l-carnitine; acetyl-carnitine; acetylcarnitine DTD0023 VADRUGID DR00150 DTD0023 DRUGNAME Acetyl-l-carnitine DTD0023 DRUGSYNO (3S)-3-acetoxy-4-(trimethylammonio)butyrate; 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, hydroxide, inner salt, (R)-; 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt, (2S)-; 4398-79-2; 521T0J13MA; AC1L2BM0; Acetylcarnitine, (R)-Isomer; Acylcarnitine C2:0; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, acetate, L-; C9H18NO4; CAR(2:0); CHEBI:86045; DTXSID90196007; GTPL4520; O-acetyl-D-carnitine; SCHEMBL677128; UNII-521T0J13MA; acetyl-d-carnitine DTD0023 VADRUGID DR00369 DTD0023 DRUGNAME Beta-lactam antibiotics DTD0023 DRUGSYNO Beta-lactam antibiotics (bacterial infections) DTD0024 TRANSPID DTD0024 DTD0024 GENENAME SLC22A6 DTD0024 PROTNAME Organic anion transporter 1 DTD0024 SYNONYMS OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1 DTD0024 VADRUGID DR00101 DTD0024 DRUGNAME Edaravone DTD0024 DRUGSYNO (MCI-186); 1-Fenyl-3-methyl-2-pyrazolin-5-on; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 1-Phenyl-3-methyl-5-pyrazolone; 1-Phenyl-3-methylpyrazolone; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 3-Methyl-1-phenyl-5-pyrazolone; 3-Methyl-1-phenylpyrazol-5-one; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; AE-641/00371017; C.I. Developer 1; CDS1_000986; CI Developer 1; Developer Z; Edarabone; Edaravone; Edaravone (JAN/INN); Edaravone [INN]; Edaravone(jan); IN1263; M0687; MCI 186; Methylphenylpyrazolone; Monopyrazolone; Norantipyrine; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone; Radicut; Radicut (TN) DTD0024 VADRUGID DR00066 DTD0024 DRUGNAME Cidofovir DTD0024 DRUGSYNO (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid DTD0024 VADRUGID DR00027 DTD0024 DRUGNAME Ganciclovir DTD0024 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0024 VADRUGID DR00091 DTD0024 DRUGNAME Dimesna DTD0024 DRUGSYNO Tavocept (TN) DTD0024 VADRUGID DR00083 DTD0024 DRUGNAME Glutarate DTD0024 DRUGSYNO (C4-C6) Dibasic acids; 1,3-Propanedicarboxylic acid; 1,5-Pentanedioic acid; 110-94-1; AI3-24247; BRN 1209725; CAS-110-94-1; CHEBI:17859; Carboxylic acids, C6-18 and C5-15-di-; Carboxylic acids, di-, C4-6; DSSTox_CID_1654; DSSTox_GSID_21654; DSSTox_RID_76266; EINECS 203-817-2; GLUTARIC ACID; Glutaric acid, 99%; Glutarsaeure; H849F7N00B; HSDB 5542; JFCQEDHGNNZCLN-UHFFFAOYSA-N; MFCD00004410; NSC 9238; NSC9238; Pentandioate; Pentandioic acid; Pentanedioic acid; UNII-H849F7N00B; glutarate; n-Pyrotartaric acid; propane-1,3-dicarboxylic acid DTD0024 VADRUGID DR00229 DTD0024 DRUGNAME Ochratoxin A DTD0024 DRUGSYNO (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY DTD0024 VADRUGID DR00343 DTD0024 DRUGNAME 6-Carboxyfluorescein DTD0024 DRUGSYNO 3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-6-carboxylic acid; 3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6-carboxylic acid; 5(6)-carboxy fluorescein; 6-Carboxyfluorescein; 6-Carboxyfluorescein, 96%; 6-FAM; FLUOS; J-100061; Spiro(isobenzofuran-1(3H),9'-(9H)xanthene)-6-carboxylic acid, 3',6'-dihydroxy-3-oxo-; Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 3',6'-dihydroxy-3-oxo-; carboxyfluorescein DTD0024 VADRUGID DR00258 DTD0024 DRUGNAME Furosemide DTD0024 DRUGSYNO 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida DTD0024 VADRUGID DR00210 DTD0024 DRUGNAME Alprostadil DTD0024 DRUGSYNO (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros DTD0024 VADRUGID DR00347 DTD0024 DRUGNAME Olmesartan medoxomil DTD0024 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0024 VADRUGID DR00174 DTD0024 DRUGNAME Tenofovir DTD0024 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0024 VADRUGID DR00175 DTD0024 DRUGNAME Zalcitabine DTD0024 DRUGSYNO 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; 2',3'-DIDEOXYCYTIDINE; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 2,3-dideoxycytidine; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; Beta-D-2',3'-Dideoxycytidine; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Beta-D-DDC; Cytidine, 2',3'-dideoxy & Interferon alpha; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; D 5782; DDC (DDC); DS-4152 & ddC; DdC; DdC & GM-CSF; DdC & IFN-alpha; DdC & Interferon alpha; DdC & NP (from PHCA or HSA); DdC & sCD4; DdC (Antiviral); DdCyd; Dideoxycytidine; HIVID; Hivid (TN); Hivid(TM); Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Interferon AD + ddC; KS-1130; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; PC-SOD & ddC; Ro 24-2027/000; Ro-24-2027/000; SRI-7707; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Zalcitabine (JAN/USP/INN); Zalcitabine [USAN:INN:BAN]; Zalcitibine DTD0024 VADRUGID DR00296 DTD0024 DRUGNAME Zidovudine DTD0024 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0024 VADRUGID DR00250 DTD0024 DRUGNAME Oseltamivir DTD0024 DRUGSYNO (-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir DTD0024 VADRUGID DR00082 DTD0024 DRUGNAME Methotrexate DTD0024 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0024 VADRUGID DR00102 DTD0024 DRUGNAME Dinoprostone DTD0024 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0024 VADRUGID DR01218 DTD0024 DRUGNAME Mycophenolic acid DTD0024 DRUGSYNO (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acide mycophenolique; Acido micofenolico; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum; CCRIS 5565; Lilly-68618; Ly 68618; Melbex; Micofenolico acido; Micofenolico acido [Spanish]; Mycophenoic acid; Mycophenolate; Mycophenolsaeure; Myfortic; NSC 129185; NSC-129185; UNII-HU9DX48N0T; mycophenolic acid DTD0024 VADRUGID DR00278 DTD0024 DRUGNAME Famotidine DTD0024 DRUGSYNO (1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin DTD0024 VADRUGID DR01200 DTD0024 DRUGNAME Meropenem DTD0024 DRUGSYNO (1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate; (2S,3R,4R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid; (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid; MEPM; MERONEM; Mepem (TN); Meronem; Meronem (TN); Meropen; Meropen (TN); Meropenem (INN); Meropenem anhydrous; Merrem; Merrem (TN); Merrem I.V. (TN); Neopenem (TN); SM-7338 DTD0024 VADRUGID DR00007 DTD0024 DRUGNAME Prostaglandin f2Alpha DTD0024 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0024 VADRUGID DR00015 DTD0024 DRUGNAME Adefovir DTD0024 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0024 VADRUGID DR00096 DTD0024 DRUGNAME Trifluridine DTD0024 DRUGSYNO 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN) DTD0024 VADRUGID DR00325 DTD0024 DRUGNAME Acyclovir DTD0024 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0024 VADRUGID DR00547 DTD0024 DRUGNAME Fluorescein DTD0024 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0024 VADRUGID DR00259 DTD0024 DRUGNAME Cefaclor DTD0024 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472 DTD0024 VADRUGID DR00320 DTD0024 DRUGNAME Ceftizoxime DTD0024 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid DTD0024 VADRUGID DR00190 DTD0024 DRUGNAME Amoxicillin DTD0024 DRUGSYNO (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN) DTD0024 VADRUGID DR00577 DTD0024 DRUGNAME Cefazolin DTD0024 DRUGSYNO (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN) DTD0024 VADRUGID DR00172 DTD0024 DRUGNAME Uric acid DTD0024 DRUGSYNO urate DTD0024 VADRUGID DR00067 DTD0024 DRUGNAME Aminohippuric acid DTD0024 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0025 TRANSPID DTD0025 DTD0025 GENENAME SLC22A8 DTD0025 PROTNAME Organic anion transporter 3 DTD0025 SYNONYMS OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3 DTD0025 VADRUGID DR00037 DTD0025 DRUGNAME Cimetidine DTD0025 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0025 VADRUGID DR00145 DTD0025 DRUGNAME Mercaptopurine DTD0025 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0025 VADRUGID DR00101 DTD0025 DRUGNAME Edaravone DTD0025 DRUGSYNO (MCI-186); 1-Fenyl-3-methyl-2-pyrazolin-5-on; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 1-Phenyl-3-methyl-5-pyrazolone; 1-Phenyl-3-methylpyrazolone; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 3-Methyl-1-phenyl-5-pyrazolone; 3-Methyl-1-phenylpyrazol-5-one; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; AE-641/00371017; C.I. Developer 1; CDS1_000986; CI Developer 1; Developer Z; Edarabone; Edaravone; Edaravone (JAN/INN); Edaravone [INN]; Edaravone(jan); IN1263; M0687; MCI 186; Methylphenylpyrazolone; Monopyrazolone; Norantipyrine; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone; Radicut; Radicut (TN) DTD0025 VADRUGID DR00066 DTD0025 DRUGNAME Cidofovir DTD0025 DRUGSYNO (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid DTD0025 VADRUGID DR00027 DTD0025 DRUGNAME Ganciclovir DTD0025 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0025 VADRUGID DR00086 DTD0025 DRUGNAME L-tryptophan DTD0025 DRUGSYNO (-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin] DTD0025 VADRUGID DR00091 DTD0025 DRUGNAME Dimesna DTD0025 DRUGSYNO Tavocept (TN) DTD0025 VADRUGID DR00229 DTD0025 DRUGNAME Ochratoxin A DTD0025 DRUGSYNO (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY DTD0025 VADRUGID DR01234 DTD0025 DRUGNAME Phenolsulfonphthalein DTD0025 DRUGSYNO 3,3-Bis(4-hydroxyphenyl)-3H-benzo[c][1,2]oxathiole 1,1-dioxide; 4,4'-(3H-2,1-Benzoxathiol-3-ylidene)diphenol S,S-dioxide; BRN 0326470; EINECS 205-609-7; Fenolipuna; I6G9Y0J1OJ; MFCD00003552; NSC 10459; NSC10459; PHENOL RED; PSP; PSP (indicator); Phenol Red, ACS reagent; Phenol red; Phenol, 4,4'-(1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis-; Phenolred; Phenolsulfonephthalein; Phenolsulphonphthalein; Phenosulfophthalein; Sulfonphthal; Sulphental; Sulphonthal; UNII-I6G9Y0J1OJ; phenolsulfonphthalein DTD0025 VADRUGID DR00206 DTD0025 DRUGNAME Pitavastatin calcium DTD0025 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0025 VADRUGID DR00272 DTD0025 DRUGNAME Bumetanide DTD0025 DRUGSYNO 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex DTD0025 VADRUGID DR00646 DTD0025 DRUGNAME Chlorothiazide DTD0025 DRUGSYNO 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Aldoclor; Alurene; C 4911; Chloriazid; Chlorosal; Chlorothiazid; Chlorothiazide (JAN/USP/INN); Chlorothiazide [USAN:INN:BAN]; Chlorothiazidum; Chlorothiazidum [INN-Latin]; Chlorotiazida; Chlorthiazid; Chlorthiazide; Chlorthiazidum; Chlortiazid; Chlorurit; Chlotride; Chlrosal; Clorotiazida; Clorotiazida [INN-Spanish]; Clorotiazide; Clorotiazide [DCIT]; Clotride; Component of Aldoclor; Diupres; Diuresal; Diuril; Diuril (TN); Diuril Boluses; Diuril Boluses, Veterinary; Diuril, Chlotride, Chlorothiazide; Diurilix; Diurite; Diutrid; Flumen; Minzil; Neo-Dema; Salisan; Salunil; Saluretil; Saluric; Sk-chlorothiazide; Thiazide; Urinex; Warduzide; Yadalan DTD0025 VADRUGID DR00258 DTD0025 DRUGNAME Furosemide DTD0025 DRUGSYNO 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida DTD0025 VADRUGID DR00347 DTD0025 DRUGNAME Olmesartan medoxomil DTD0025 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0025 VADRUGID DR00071 DTD0025 DRUGNAME Valsartan DTD0025 DRUGSYNO (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan DTD0025 VADRUGID DR00174 DTD0025 DRUGNAME Tenofovir DTD0025 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0025 VADRUGID DR00296 DTD0025 DRUGNAME Zidovudine DTD0025 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0025 VADRUGID DR00045 DTD0025 DRUGNAME Pravastatin DTD0025 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0025 VADRUGID DR00223 DTD0025 DRUGNAME Rosuvastatin DTD0025 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0025 VADRUGID DR00074 DTD0025 DRUGNAME Allopurinol DTD0025 DRUGSYNO 4-HPP; A 8003; AL-100; Adenock; Ailural; Ailurial; Allo-Puren; Allohexal; Allohexal (TN); Allohexan; Alloprin; Allopur; Allopurin; Allopurinol(I); Allopurinolum; Allorin; Allosig (TN); Allozym; Allpargin; Allural; Aloprim; Alopurinol; Aloral; Alositol; Aluline; Anoprolin; Anzief; Apo-Allopurinol; Apulonga; Apurin; Apurol; Atisuril; B. W. 56-158; BW 56-158; BW 56158; BW-56-158; Bleminol; Bloxanth; Caplenal; Capurate; Cellidrin; Cosuric; Dabrosin; Dabroson; Dura Al; Embarin; Epidropal; Epuric; Foligan; Geapur; Gichtex; Gotax; Hamarin; Hexanuret; Jenapurinol; Ketanrift; Ketobun-A; Ledopur; Lopurin; Lysuron; Milurit; Milurite; Miniplanor; Monarch; Nektrohan; Novopurol; Pan Quimica; Progout; Progout (TN); Pureduct; Puricos (TN); Purinol; Quimica, Pan; Remid; Riball; Rimapurinol; Roucol; Sigapurol; Suspendol; Takanarumin; Tipuric; Urbol; Uribenz; Uricemil; Uridocid; Uriprim; Uripurinol; Uritas; Urobenyl; Urolit; Urosin; Urtias; Urtias 100; Xanthomax; Xanturat; Xanturic; Zygout; Zyloprim; Zyloprim (TN); Zyloric; Zyloric (TN) DTD0025 VADRUGID DR00250 DTD0025 DRUGNAME Oseltamivir DTD0025 DRUGSYNO (-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir DTD0025 VADRUGID DR00082 DTD0025 DRUGNAME Methotrexate DTD0025 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0025 VADRUGID DR00102 DTD0025 DRUGNAME Dinoprostone DTD0025 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0025 VADRUGID DR00278 DTD0025 DRUGNAME Famotidine DTD0025 DRUGSYNO (1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin DTD0025 VADRUGID DR00163 DTD0025 DRUGNAME Ranitidine DTD0025 DRUGSYNO (E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic DTD0025 VADRUGID DR00007 DTD0025 DRUGNAME Prostaglandin f2Alpha DTD0025 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0025 VADRUGID DR00226 DTD0025 DRUGNAME Saxagliptin DTD0025 DRUGSYNO (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN) DTD0025 VADRUGID DR00254 DTD0025 DRUGNAME Sitagliptin DTD0025 DRUGSYNO (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia DTD0025 VADRUGID DR00015 DTD0025 DRUGNAME Adefovir DTD0025 DRUGSYNO ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid DTD0025 VADRUGID DR00325 DTD0025 DRUGNAME Acyclovir DTD0025 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0025 VADRUGID DR00078 DTD0025 DRUGNAME Valacyclovir DTD0025 DRUGSYNO 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN) DTD0025 VADRUGID DR00707 DTD0025 DRUGNAME Trichloromethiazide DTD0025 DRUGSYNO (+-)-6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-,1,1-dioxide; 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide; 3-Dichloromethylhydrochlorothiazide; 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide; 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide; 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide; 6-Chloro-3-[dichloromethyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide; 6-Chloro-3-dichloromethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide; 6-Chloro-3-dichloromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide; Achletin; Achletin (TN); Anistadin; Aponorin; Aquazide; Carvacron; Chlopolidine; Ciba 7057-Su; Cretonin; Diu-Hydrin; Diu-Hydrin (TN); Diurazida; Diurese; Diuroral;Esmarin; Eurinol; Fluitran; Flurese; Flurese (VAN); Flutra; Gangesol; Hydrotrichlorothiazide; Intromene; Isestran; Jones Brand of Trichloromethiazide; Kubacron; Metahydrin; Metatensin; Nakva; Naqua; Naqua (TN); Naquasone; Salurin (wadel); Schebitran; Schering Brand of Trichlormethiazide; Tachionin; Tolcasone; Trichlordiuride; Trichlorex; Trichlormas; Trichlormetazid; Trichlormethiazid; Trichlormethiazide (JP15/USP/INN); Trichlormethiazide W/ Reserpine; Trichlormethiazide [INN:JAN]; Trichlormethiazidum; Trichlormethiazidum [INN-Latin]; Trichloromethiadiazide; Trichloromethiazide; Trichloromethiazide, 6; Triclordiuride; Triclormetiazida; Triclormetiazida[INN-Spanish]; Triclormetiazide; Triclormetiazide [DCIT]; Triclormetiazide [Italian]; Triflumen (TN); Triflumen;American Urologicals Brand of Trichloromethiazide DTD0025 VADRUGID DR01194 DTD0025 DRUGNAME Cefotiam DTD0025 DRUGSYNO (6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7b-[2-(aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid; 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid; Abbott-48999; Aspil; Aspil (TN); CEFOTIAM HYDROCHLORIDE; CGP 14221E; CGP-14221-E; CTM; Cefotiam (INN); Cefotiam [INN:BAN]; Cefotiamum; Cefotiamum [INN-Latin]; Ceradolan; Haloapor; SCE-963 DTD0025 VADRUGID DR01193 DTD0025 DRUGNAME Prasterone DTD0025 DRUGSYNO 17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone DTD0025 VADRUGID DR00783 DTD0025 DRUGNAME Ciprofloxacin DTD0025 DRUGSYNO 85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin DTD0025 VADRUGID DR00259 DTD0025 DRUGNAME Cefaclor DTD0025 DRUGSYNO (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472 DTD0025 VADRUGID DR00320 DTD0025 DRUGNAME Ceftizoxime DTD0025 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid DTD0025 VADRUGID DR00127 DTD0025 DRUGNAME Tetracycline DTD0025 DRUGSYNO (-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base) DTD0025 VADRUGID DR00488 DTD0025 DRUGNAME Benzylpenicillin DTD0025 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0025 VADRUGID DR00577 DTD0025 DRUGNAME Cefazolin DTD0025 DRUGSYNO (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN) DTD0025 VADRUGID DR00612 DTD0025 DRUGNAME Cephaloridine DTD0025 DRUGSYNO 50-59-9; Ampligram; Betaine cephaloridine; CHEBI:3537; Cefaloridin; Cefaloridina; Cefaloridina [INN-Spanish]; Cefaloridine; Cefaloridinum; Cefaloridinum [INN-Latin]; Cefalorizin; Ceflorin; Cepaloridin; Cepalorin; Cephalomycine; Cephaloridin; Cephaloridinum; Ceporan; Ceporin; Ceporine; Cilifor; Deflorin; Faredina; Glaxoridin; Intrasporin; Keflodin; Keflordin; Kefloridin; Kefspor; Lloncefal; Loridine; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH; Sasperin; Sefacin; UNII-LVZ1VC61HB; Verolgin; Vioviantine DTD0025 VADRUGID DR00692 DTD0025 DRUGNAME Cefdinir DTD0025 DRUGSYNO (-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; BMY 28488; CFDN; Cefdinir (JP15/USAN/INN); Cefdinir [USAN:INN]; Cefdinirum; Cefdinirum [INN-Latin]; Cefdinyl; Cefdirnir; Cefzon; Cefzon (TN); FK 482; FK-482; FR-80482; KS-1038; Omnicef; Omnicef (TN); Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir; PD 134393; PD-134393 DTD0025 VADRUGID DR01322 DTD0025 DRUGNAME Cilostazol DTD0025 DRUGSYNO Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol DTD0025 VADRUGID DR00172 DTD0025 DRUGNAME Uric acid DTD0025 DRUGSYNO urate DTD0025 VADRUGID DR00019 DTD0025 DRUGNAME Estrone sulfate DTD0025 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0025 VADRUGID DR00067 DTD0025 DRUGNAME Aminohippuric acid DTD0025 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0026 TRANSPID DTD0026 DTD0026 GENENAME SLC22A11 DTD0026 PROTNAME Organic anion transporter 4 DTD0026 SYNONYMS OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4 DTD0026 VADRUGID DR01302 DTD0026 DRUGNAME Levocetirizine DTD0026 DRUGSYNO (-)-Cetirizine; (-)-Cetirizine Dihydrochloride; (2-(4-((R-p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; (R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid; (R)-Cetirizine dihydrochloride; 6U5EA9RT2O; Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-; Levocetirizine; Levocetirizine HCl; UNII-6U5EA9RT2O; Xarlin; Xyzal; cetirizine-d4; levocetrizine DTD0026 VADRUGID DR00229 DTD0026 DRUGNAME Ochratoxin A DTD0026 DRUGSYNO (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY DTD0026 VADRUGID DR00272 DTD0026 DRUGNAME Bumetanide DTD0026 DRUGSYNO 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex DTD0026 VADRUGID DR00296 DTD0026 DRUGNAME Zidovudine DTD0026 DRUGSYNO 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin] DTD0026 VADRUGID DR00045 DTD0026 DRUGNAME Pravastatin DTD0026 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0026 VADRUGID DR00005 DTD0026 DRUGNAME L-glutamic acid DTD0026 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0026 VADRUGID DR00082 DTD0026 DRUGNAME Methotrexate DTD0026 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0026 VADRUGID DR00102 DTD0026 DRUGNAME Dinoprostone DTD0026 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0026 VADRUGID DR00007 DTD0026 DRUGNAME Prostaglandin f2Alpha DTD0026 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0026 VADRUGID DR00127 DTD0026 DRUGNAME Tetracycline DTD0026 DRUGSYNO (-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base) DTD0026 VADRUGID DR00172 DTD0026 DRUGNAME Uric acid DTD0026 DRUGSYNO urate DTD0026 VADRUGID DR00019 DTD0026 DRUGNAME Estrone sulfate DTD0026 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0027 TRANSPID DTD0027 DTD0027 GENENAME SLC22A12 DTD0027 PROTNAME Urate anion exchanger 1 DTD0027 SYNONYMS OAT4L; OATL4; Organic anion transporter 4-like protein; RST; Renal-specific transporter; SLC22A12; Solute carrier family 22 member 12; URAT1 DTD0027 VADRUGID DR00157 DTD0027 DRUGNAME Orotate DTD0027 DRUGSYNO 2,4-dioxo-1H-pyrimidine-6-carboxylate; 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate; 21317-EP2281559A1; 21317-EP2284172A1; 21317-EP2314295A1; 4-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-2,6-dioxo-, ion(1-); 73-97-2; AC1LSPNG; AG-G-93379; CHEBI:30839; CJ-15820; CTK5D9013; DTXSID80363448; Orotic acidanion; PXQPEWDEAKTCGB-UHFFFAOYSA-M DTD0027 VADRUGID DR00123 DTD0027 DRUGNAME Oxypurinol DTD0027 DRUGSYNO Oxypurinol (intravenous) DTD0027 VADRUGID DR00172 DTD0027 DRUGNAME Uric acid DTD0027 DRUGSYNO urate DTD0028 TRANSPID DTD0028 DTD0028 GENENAME SLC47A2 DTD0028 PROTNAME Multidrug and toxin extrusion protein 2 DTD0028 SYNONYMS Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2 DTD0028 VADRUGID DR00037 DTD0028 DRUGNAME Cimetidine DTD0028 DRUGSYNO 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex DTD0028 VADRUGID DR00097 DTD0028 DRUGNAME Abemaciclib DTD0028 DRUGSYNO 1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio DTD0028 VADRUGID DR00027 DTD0028 DRUGNAME Ganciclovir DTD0028 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0028 VADRUGID DR00044 DTD0028 DRUGNAME Topotecan DTD0028 DRUGSYNO (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin] DTD0028 VADRUGID DR00133 DTD0028 DRUGNAME Metformin DTD0028 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0028 VADRUGID DR00292 DTD0028 DRUGNAME Procainamide DTD0028 DRUGSYNO 2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr DTD0028 VADRUGID DR00106 DTD0028 DRUGNAME Tetraethylammonium DTD0028 DRUGSYNO 4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium DTD0028 VADRUGID DR00337 DTD0028 DRUGNAME N-methylpyridinium DTD0028 DRUGSYNO 1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl- DTD0028 VADRUGID DR00325 DTD0028 DRUGNAME Acyclovir DTD0028 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0028 VADRUGID DR00724 DTD0028 DRUGNAME Dofetilide DTD0028 DRUGSYNO 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide DTD0028 VADRUGID DR00019 DTD0028 DRUGNAME Estrone sulfate DTD0028 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0029 TRANSPID DTD0029 DTD0029 GENENAME SLCO1A2 DTD0029 PROTNAME Organic anion transporting polypeptide 1A2 DTD0029 SYNONYMS OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2 DTD0029 VADRUGID DR00026 DTD0029 DRUGNAME Fexofenadine DTD0029 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0029 VADRUGID DR01261 DTD0029 DRUGNAME Nadolol DTD0029 DRUGSYNO (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol; Alti-Nadolol (TN); Anabet; Anabet (TN); Apo-Nadol (TN); Corgard; Corgard (TN); Corgaretic; Corzide (TN); Nadic; Nadolol (JP15/USP/INN); Nadolol [USAN:BAN:INN:JAN]; Nadololum; Nadololum [INN-Latin]; Novo-Nadolol (TN); SQ 11725; SQ-11725; SQ11725; Solgol; Solgol (TN) DTD0029 VADRUGID DR00382 DTD0029 DRUGNAME Montelukast DTD0029 DRUGSYNO (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid; Apxi toxin; Brondilat; Brondilat (TN); MK 0476; MK-0476; Montair; Montelukast (INN); Montelukast [INN:BAN]; Singulair (TN); Singular; Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid DTD0029 VADRUGID DR00519 DTD0029 DRUGNAME Tauroursodeoxycholate DTD0029 DRUGSYNO TUDCA; Tauroursodeoxycholic acid DTD0029 VADRUGID DR00155 DTD0029 DRUGNAME Ouabain DTD0029 DRUGSYNO 3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin DTD0029 VADRUGID DR00895 DTD0029 DRUGNAME Chlorambucil DTD0029 DRUGSYNO Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil DTD0029 VADRUGID DR01177 DTD0029 DRUGNAME Hydroxyurea DTD0029 DRUGSYNO 1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase DTD0029 VADRUGID DR00032 DTD0029 DRUGNAME Imatinib DTD0029 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0029 VADRUGID DR00048 DTD0029 DRUGNAME Urea DTD0029 DRUGSYNO . DTD0029 VADRUGID DR00208 DTD0029 DRUGNAME Estradiol-17beta-glucuronide DTD0029 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0029 VADRUGID DR00305 DTD0029 DRUGNAME Bromsulphthalein DTD0029 DRUGSYNO BSP; bromosulfophthalein; sulfobromophthalein DTD0029 VADRUGID DR00072 DTD0029 DRUGNAME Lifitegrast DTD0029 DRUGSYNO SAR-1118; SAR-1119; SHP606; SPD606; Xiidra DTD0029 VADRUGID DR00206 DTD0029 DRUGNAME Pitavastatin calcium DTD0029 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0029 VADRUGID DR00030 DTD0029 DRUGNAME Atorvastatin DTD0029 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0029 VADRUGID DR00232 DTD0029 DRUGNAME Probenecid DTD0029 DRUGSYNO 4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid DTD0029 VADRUGID DR00033 DTD0029 DRUGNAME Atenolol DTD0029 DRUGSYNO (+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten DTD0029 VADRUGID DR00010 DTD0029 DRUGNAME Enalapril DTD0029 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0029 VADRUGID DR00248 DTD0029 DRUGNAME Telmisartan DTD0029 DRUGSYNO 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086 DTD0029 VADRUGID DR00627 DTD0029 DRUGNAME Acebutolol DTD0029 DRUGSYNO (+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN) DTD0029 VADRUGID DR01235 DTD0029 DRUGNAME Celiprolol DTD0029 DRUGSYNO 3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea; BRN 2776298; CCRIS 3400; Celectol; Celiprolol [INN:BAN]; Celiprololum; Celiprololum [INN-Latin]; EINECS 260-497-7; N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea; RHC 5320 A; RHC-5320A; ST-1396; Selectol; UL/1677; Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-; celiprolol DTD0029 VADRUGID DR00514 DTD0029 DRUGNAME Darunavir DTD0029 DRUGSYNO (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester DTD0029 VADRUGID DR00309 DTD0029 DRUGNAME Saquinavir DTD0029 DRUGSYNO (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN) DTD0029 VADRUGID DR00223 DTD0029 DRUGNAME Rosuvastatin DTD0029 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0029 VADRUGID DR00107 DTD0029 DRUGNAME Levothyroxine DTD0029 DRUGSYNO (-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI) DTD0029 VADRUGID DR00173 DTD0029 DRUGNAME Liothyronine DTD0029 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0029 VADRUGID DR00082 DTD0029 DRUGNAME Methotrexate DTD0029 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0029 VADRUGID DR00102 DTD0029 DRUGNAME Dinoprostone DTD0029 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0029 VADRUGID DR01351 DTD0029 DRUGNAME TR-14035 DTD0029 DRUGSYNO 232271-19-1; TR-14035; (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid; CHEMBL91485; N-(2,6-DICHLOROBENZOYL)-4-(2,6-DIMETHOXYPHENYL)-L-PHENYLALANINE; C24H21Cl2NO5; DRSJLVGDSNWQBI-SFHVURJKSA-N; TR 14035; SCHEMBL1222491; BDBM16801; CTK8C1530; MolPort-023-334-229; ZINC1490484; ANW-66841; N-Acyl-4-arylphenylalanine analogue.; AKOS016008162; CS-1812; CS-W000631; MP-2027; NCGC00390619-01; SB683698; HY-15770; AK-95353; AJ-26339; KB-210922; TC-155586; AB0077984; AX8237663; ST24020804; Z4458 DTD0029 VADRUGID DR00195 DTD0029 DRUGNAME Rhodamine 123 DTD0029 DRUGSYNO RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes DTD0029 VADRUGID DR00328 DTD0029 DRUGNAME Quinolones DTD0029 DRUGSYNO AC1MI0KP DTD0029 VADRUGID DR00053 DTD0029 DRUGNAME Sodium taurocholate DTD0029 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0029 VADRUGID DR01121 DTD0029 DRUGNAME Taurocholic acid DTD0029 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0029 VADRUGID DR00442 DTD0029 DRUGNAME Rocuronium DTD0029 DRUGSYNO (2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane; Esmeron (TN); Zemuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate DTD0029 VADRUGID DR00638 DTD0029 DRUGNAME Grepafloxacin DTD0029 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN) DTD0029 VADRUGID DR00657 DTD0029 DRUGNAME Cholic acid DTD0029 DRUGSYNO (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate DTD0029 VADRUGID DR00905 DTD0029 DRUGNAME Sotalol DTD0029 DRUGSYNO 4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide; 4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid; Beta-Cardone; Betapace (TN); Betapace AF (TN); D,l-Sotalol; Darob mite; Darob mite (TN); MJ-1999; Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-(9CI); N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide; N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide; Sotacor (TN); Sotalex (TN); Sotalol (INN); Sotalol Monohydrochloride; Sotalol [INN:BAN]; Sotalolum; Sotalolum [INN-Latin] DTD0029 VADRUGID DR01385 DTD0029 DRUGNAME Labetalol DTD0029 DRUGSYNO Albetol; Ibidomide; Labetalolum; Labetolol; NORMOZIDE; AH 5158; AH-5158; Labetalol (INN); Labetalol [INN:BAN]; Labetalolum [INN-Latin]; Normodyne (TN); Sch-19927; Trandate (TN); 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide DTD0029 VADRUGID DR00783 DTD0029 DRUGNAME Ciprofloxacin DTD0029 DRUGSYNO 85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin DTD0029 VADRUGID DR00046 DTD0029 DRUGNAME Levofloxacin DTD0029 DRUGSYNO (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-Ofloxacin; (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (R)-isomer; (S)-(-)-Ofloxacin; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; Aeroquin; Cravit; Cravit (TN); Cravit Ophthalmic; D-Levofloxacin; DR 3354; DR-3355; DR-3355: L-isomer of ofloxacin; DR3355; Elequine; Floxacin; Floxel; HR 355; HR-355; Iquix; Iquix (TN); L-Ofloxacin; LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER; LFX; LVX; Leroxacin; Lesacin; Levaquin; Levaquin (TN); Levofloxacin (INN); Levofloxacin [USAN:INN:JAN]; Levofloxacin tablet, suspension or intravenous; Levofloxacine; Levofloxacine [INN-French];Levofloxacino [INN-Spanish]; Levofloxacino; Levofloxacinum; Levofloxacinum [INN-Latin]; Levokacin; Levox; Levoxacin; MP-376; Mosardal; Nofaxin; Ofloxacin; Ofloxacin S-(-)-form; Oftaquix; Oftaquix (TN); Quixin; Quixin (TN); R-Ofloxacin; RWJ 25213-097; RWJ-25213; Reskuin; S-(-)-Ofloxacin; Tavanic; Tavanic (TN); Volequin DTD0029 VADRUGID DR01204 DTD0029 DRUGNAME Norfloxacin DTD0029 DRUGSYNO 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN) DTD0029 VADRUGID DR01280 DTD0029 DRUGNAME Enoxacin DTD0029 DRUGSYNO 1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid; AT 2266; AT-2266; AT2266; Almitil; Almitil (TN); Bactidan; Bactidan (TN); Bactidron (TN); CI919; CL23362; Comprecin; Comprecin (TN); E0762; Enoksetin (TN); Enoram; Enoxacin (USAN/INN); Enoxacin Sesquihydrate; Enoxacin [USAN:BAN:INN:JAN]; Enoxacine; Enoxacine [French]; Enoxacino; Enoxacino [Spanish]; Enoxacinum; Enoxacinum [Latin]; Enoxen (TN); Enoxin; Enoxin (TN); Enoxor; Enoxor (TN); Enroxil (TN); Faulding Brand of Enoxacin; Flumark; Flumark (TN); Gyramid (TN); PD 107779; PD-107779; PD107779; Penetrex; Penetrex (TN); Pierre Fabre Brand of Enoxacin Sesquihydrate; Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate; Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate; Sesquihydrate, Enoxacin; Vinone (TN) DTD0029 VADRUGID DR01284 DTD0029 DRUGNAME Trospium chloride DTD0029 DRUGSYNO trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio DTD0029 VADRUGID DR01165 DTD0029 DRUGNAME Gatifloxacin DTD0029 DRUGSYNO (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN) DTD0029 VADRUGID DR00507 DTD0029 DRUGNAME Lomefloxacin DTD0029 DRUGSYNO (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride; DM 10 (bactericide); DM-10; LFLX; Lomefloxacin (USAN); Lomefloxacin [USAN:BAN:INN]; Lomefloxacine; Lomefloxacine [French]; Lomefloxacino; Lomefloxacino [Spanish]; Lomefloxacinum; Lomefloxacinum[Latin]; Maxaquin (TN); Maxaquin (hydrochloride); NY-198 (hydrochloride); Okacyn (TN); SC 4711; SC 47111A; SC-4711; SC-47111 (hydrochloride); SC-47111A; SC-47111B (mesylate); Uniquin (TN) DTD0029 VADRUGID DR00569 DTD0029 DRUGNAME Glycocholic acid DTD0029 DRUGSYNO Glycocholate; cholylglycine DTD0029 VADRUGID DR00401 DTD0029 DRUGNAME Talinolol DTD0029 DRUGSYNO (+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin] DTD0029 VADRUGID DR01513 DTD0029 DRUGNAME Dehydroepiandrosterone sulfate DTD0029 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0029 VADRUGID DR01545 DTD0029 DRUGNAME Pitavastatin DTD0029 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0029 VADRUGID DR00019 DTD0029 DRUGNAME Estrone sulfate DTD0029 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0029 VADRUGID DR01381 DTD0029 DRUGNAME BQ-123 DTD0029 DRUGSYNO BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp) DTD0029 VADRUGID DR01433 DTD0029 DRUGNAME Atrasentan DTD0029 DRUGSYNO Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid DTD0029 VADRUGID DR00067 DTD0029 DRUGNAME Aminohippuric acid DTD0029 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0030 TRANSPID DTD0030 DTD0030 GENENAME SLCO1B3 DTD0030 PROTNAME Organic anion transporting polypeptide 1B3 DTD0030 SYNONYMS LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3 DTD0030 VADRUGID DR00454 DTD0030 DRUGNAME Sunitinib DTD0030 DRUGSYNO 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN) DTD0030 VADRUGID DR00026 DTD0030 DRUGNAME Fexofenadine DTD0030 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0030 VADRUGID DR00148 DTD0030 DRUGNAME Digoxin DTD0030 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0030 VADRUGID DR00984 DTD0030 DRUGNAME Warfarin DTD0030 DRUGSYNO (-)-Warfarin; (S)-Warfarin; 200 coumarin; Arab Rat Death; Arab rat deth; Athrombine-K; Brumolin; CBKinase1_000192; CBKinase1_012592; CO-Rax; Choice; Choice (TN); Coumadin; Coumadin (TN); Coumafen; Coumafene; Coumafene [French]; Coumaphen; Coumaphene; Coumarins; Coumefene; Cov-R-Tox; D-Con; Dethmor; Dethnel; Dicusat E; Eastern states duocide; Fasco fascrat powder; Frass-Ratron; Jantoven (TN); Kumader; Kumadu; Kumatox; Kypfarin; Latka 42; Latka 42 [Czech]; Liqua-tox; Maag Rattentod Cum; Mar-Frin; Marevan (TN); Martin's mar-frin; Maveran; Mouse pak; PS104_SUPELCO; Panwarfin; Place-pax; Prothromadin; RAX; Rac-Warfarin; Rat & mice bait; Rat-B-gon; Rat-Gard; Rat-Kill; Rat-Mix; Rat-Ola; Rat-Trol; Rat-a-way; Rat-o-cide #2; Ratorex; Ratoxin; Ratron; Ratron G; Rats-no-more; Ratten-Koederrohr; Rattenstreupulver Neu Schacht; Rattenstreupulver new schacht; Rattentraenke; Rattunal; Ro-Deth; Rodafarin; Rodafarin C; Rodex blox; Rosex; Rough & ready mouse mix; Sofarin; Solfarin; Sorexa plus; Spray-trol brand roden-trol; Temus W; Tox-hid; Twin light rat away; Vampirinip II; Vampirinip iii; W.A.R.F. 42; WARF compound 42; Waran (TN); Warf 10; Warf 42; Warfarat; Warfarin (INN); Warfarin (and salts of); Warfarin Q; Warfarin [BSI:ISO]; Warfarin [INN:BAN]; Warfarin plus; Warfarin plus [discontinued]; Warfarin titrated to an INR of 2.5-3.0; Warfarin(R); Warfarina; Warfarina [INN-Spanish]; Warfarine; Warfarine [INN-French]; Warfarine [ISO-French]; Warfarinum; Warfarinum [INN-Latin]; Warficide; Zoocoumarin; Zoocoumarin [Netherlands and USSR]; Zoocoumarin [Russian] DTD0030 VADRUGID DR00155 DTD0030 DRUGNAME Ouabain DTD0030 DRUGSYNO 3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin DTD0030 VADRUGID DR00342 DTD0030 DRUGNAME Paclitaxel DTD0030 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0030 VADRUGID DR00251 DTD0030 DRUGNAME Docetaxel DTD0030 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0030 VADRUGID DR00423 DTD0030 DRUGNAME Gefitinib DTD0030 DRUGSYNO 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839 DTD0030 VADRUGID DR01177 DTD0030 DRUGNAME Hydroxyurea DTD0030 DRUGSYNO 1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase DTD0030 VADRUGID DR00013 DTD0030 DRUGNAME Nilotinib DTD0030 DRUGSYNO Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716 DTD0030 VADRUGID DR00032 DTD0030 DRUGNAME Imatinib DTD0030 DRUGSYNO 112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571 DTD0030 VADRUGID DR00407 DTD0030 DRUGNAME Nateglinide DTD0030 DRUGSYNO (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026 DTD0030 VADRUGID DR00208 DTD0030 DRUGNAME Estradiol-17beta-glucuronide DTD0030 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0030 VADRUGID DR00252 DTD0030 DRUGNAME Bilirubin DTD0030 DRUGSYNO 21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49 DTD0030 VADRUGID DR00305 DTD0030 DRUGNAME Bromsulphthalein DTD0030 DRUGSYNO BSP; bromosulfophthalein; sulfobromophthalein DTD0030 VADRUGID DR00344 DTD0030 DRUGNAME Fluo-3 DTD0030 DRUGSYNO 121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051 DTD0030 VADRUGID DR00364 DTD0030 DRUGNAME Amanitin DTD0030 DRUGSYNO alpha-amanitin DTD0030 VADRUGID DR00213 DTD0030 DRUGNAME Sincalide DTD0030 DRUGSYNO CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated) DTD0030 VADRUGID DR00206 DTD0030 DRUGNAME Pitavastatin calcium DTD0030 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0030 VADRUGID DR00030 DTD0030 DRUGNAME Atorvastatin DTD0030 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0030 VADRUGID DR00273 DTD0030 DRUGNAME Danoprevir DTD0030 DRUGSYNO DANOPREVIR; ITMN-191; Danoprevir (ITMN-191); Danoprevir (RG7227); UNII-911Z9PCQ5F; ITMN 191; RO5190591; 911Z9PCQ5F; R 7227; RG7227; R7227; Intermune ITMN-191; ITMN B; Danoprevir [USAN:INN]; R-7227; (2R,6S,13aS,14aR,16aS,Z)-6-((tert-butoxycarbonyl)amino)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1; Danoprevir (ITMN191); MLS006011139; R 05190591; CHEMBL258734; C35H46FN5O9S; SCHEMBL2289034; AOB87156; ZINC29058869; s1183; RL05263 DTD0030 VADRUGID DR00010 DTD0030 DRUGNAME Enalapril DTD0030 DRUGSYNO (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN) DTD0030 VADRUGID DR00347 DTD0030 DRUGNAME Olmesartan medoxomil DTD0030 DRUGSYNO Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil DTD0030 VADRUGID DR00248 DTD0030 DRUGNAME Telmisartan DTD0030 DRUGSYNO 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086 DTD0030 VADRUGID DR00071 DTD0030 DRUGNAME Valsartan DTD0030 DRUGSYNO (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan DTD0030 VADRUGID DR00039 DTD0030 DRUGNAME Glutathione DTD0030 DRUGSYNO 5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione DTD0030 VADRUGID DR00124 DTD0030 DRUGNAME Fluvastatin DTD0030 DRUGSYNO (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320 DTD0030 VADRUGID DR00045 DTD0030 DRUGNAME Pravastatin DTD0030 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0030 VADRUGID DR00223 DTD0030 DRUGNAME Rosuvastatin DTD0030 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0030 VADRUGID DR00173 DTD0030 DRUGNAME Liothyronine DTD0030 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0030 VADRUGID DR00162 DTD0030 DRUGNAME Etoposide DTD0030 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0030 VADRUGID DR00082 DTD0030 DRUGNAME Methotrexate DTD0030 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0030 VADRUGID DR00182 DTD0030 DRUGNAME Dasatinib DTD0030 DRUGSYNO (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel DTD0030 VADRUGID DR00523 DTD0030 DRUGNAME Crizotinib DTD0030 DRUGSYNO Xalkori (TN); novel ALK inhibitors DTD0030 VADRUGID DR00108 DTD0030 DRUGNAME Testosterone DTD0030 DRUGSYNO (17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone DTD0030 VADRUGID DR00304 DTD0030 DRUGNAME Sorafenib DTD0030 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum DTD0030 VADRUGID DR00243 DTD0030 DRUGNAME Mycophenolate mofetil DTD0030 DRUGSYNO 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF DTD0030 VADRUGID DR00233 DTD0030 DRUGNAME Romidepsin DTD0030 DRUGSYNO (1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; Antibiotic FR 901228; Chromadax; Chromadax (TN); Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide; FK 228; FK-228; FK-901228; FK228; FR 901228; FR-901228; FR901228; HDInhib_000006; Istodax; Istodax (TN); L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide; Romidepsin (USAN) DTD0030 VADRUGID DR00288 DTD0030 DRUGNAME Bosentan DTD0030 DRUGSYNO 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN) DTD0030 VADRUGID DR00196 DTD0030 DRUGNAME Rifampicin DTD0030 DRUGSYNO 1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN) DTD0030 VADRUGID DR00053 DTD0030 DRUGNAME Sodium taurocholate DTD0030 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0030 VADRUGID DR01121 DTD0030 DRUGNAME Taurocholic acid DTD0030 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0030 VADRUGID DR00391 DTD0030 DRUGNAME Cerivastatin DTD0030 DRUGSYNO . DTD0030 VADRUGID DR00161 DTD0030 DRUGNAME SN-38 DTD0030 DRUGSYNO (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J DTD0030 VADRUGID DR00547 DTD0030 DRUGNAME Fluorescein DTD0030 DRUGSYNO fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow DTD0030 VADRUGID DR00485 DTD0030 DRUGNAME Indocyanine green DTD0030 DRUGSYNO 3599-32-4; AC1L2DMU; Cardiogreen; F9995-0163; GTPL4844; Indocyanine green; KS-00000YFZ; MOLI001001; sodium 4-(2-((1E,3E,5E,7E)-7-(1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-2(3H)-ylidene)hepta-1,3,5-trienyl)-1,1-dimethyl-1H-benzo[e]indolium-3-yl)butane-1-sulfonate; sodium 4-[2-[(1E,3E,5E,7Z)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-dimethylbenzo[e]indol-3-ium-3-yl]butane-1-sulfonate DTD0030 VADRUGID DR00711 DTD0030 DRUGNAME Vemurafenib DTD0030 DRUGSYNO PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN) DTD0030 VADRUGID DR00681 DTD0030 DRUGNAME Diclofenac DTD0030 DRUGSYNO Diclofenac (sodium matrix patch, pain) DTD0030 VADRUGID DR00856 DTD0030 DRUGNAME Mesalazine DTD0030 DRUGSYNO 2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206 DTD0030 VADRUGID DR00488 DTD0030 DRUGNAME Benzylpenicillin DTD0030 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0030 VADRUGID DR00050 DTD0030 DRUGNAME Erythromycin DTD0030 DRUGSYNO A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid DTD0030 VADRUGID DR00553 DTD0030 DRUGNAME Ceftriaxone DTD0030 DRUGSYNO (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine DTD0030 VADRUGID DR00600 DTD0030 DRUGNAME Cefoperazone DTD0030 DRUGSYNO (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN) DTD0030 VADRUGID DR01617 DTD0030 DRUGNAME Primovist DTD0030 DRUGSYNO Eovist; Primovist; gadoxate disodium; AC1L9OPS; gadolinium ethoxybenzyl-DTPA; MOLI000482; 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; gadolinium(3+) DTD0030 VADRUGID DR00539 DTD0030 DRUGNAME Cefmetazole DTD0030 DRUGSYNO (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; CMZ; CS 1170; CS-1170; Cefmetazole (USP/INN); Cefmetazole Monosodium Salt; Cefmetazole [USAN:INN]; Cefmetazolo; Cefmetazolo [INN-Spanish]; Cefmetazolum; Cefmetazolum [INN-Latin]; SKF 83088; U 72791; U-72791A DTD0030 VADRUGID DR01237 DTD0030 DRUGNAME Technetium (99MTC) mebrofenin DTD0030 DRUGSYNO F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52 DTD0030 VADRUGID DR01257 DTD0030 DRUGNAME Gadobenate dimeglumine DTD0030 DRUGSYNO Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2) DTD0030 VADRUGID DR01322 DTD0030 DRUGNAME Cilostazol DTD0030 DRUGSYNO Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol DTD0030 VADRUGID DR00618 DTD0030 DRUGNAME Vandetanib DTD0030 DRUGSYNO 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474 DTD0030 VADRUGID DR00569 DTD0030 DRUGNAME Glycocholic acid DTD0030 DRUGSYNO Glycocholate; cholylglycine DTD0030 VADRUGID DR01513 DTD0030 DRUGNAME Dehydroepiandrosterone sulfate DTD0030 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0030 VADRUGID DR01545 DTD0030 DRUGNAME Pitavastatin DTD0030 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0030 VADRUGID DR00019 DTD0030 DRUGNAME Estrone sulfate DTD0030 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0030 VADRUGID DR01381 DTD0030 DRUGNAME BQ-123 DTD0030 DRUGSYNO BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp) DTD0030 VADRUGID DR01433 DTD0030 DRUGNAME Atrasentan DTD0030 DRUGSYNO Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid DTD0031 TRANSPID DTD0031 DTD0031 GENENAME SLCO2B1 DTD0031 PROTNAME Organic anion transporting polypeptide 2B1 DTD0031 SYNONYMS KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1 DTD0031 VADRUGID DR00026 DTD0031 DRUGNAME Fexofenadine DTD0031 DRUGSYNO 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN) DTD0031 VADRUGID DR00148 DTD0031 DRUGNAME Digoxin DTD0031 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0031 VADRUGID DR00382 DTD0031 DRUGNAME Montelukast DTD0031 DRUGSYNO (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid; Apxi toxin; Brondilat; Brondilat (TN); MK 0476; MK-0476; Montair; Montelukast (INN); Montelukast [INN:BAN]; Singulair (TN); Singular; Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid DTD0031 VADRUGID DR00094 DTD0031 DRUGNAME Glibenclamide DTD0031 DRUGSYNO 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon DTD0031 VADRUGID DR00305 DTD0031 DRUGNAME Bromsulphthalein DTD0031 DRUGSYNO BSP; bromosulfophthalein; sulfobromophthalein DTD0031 VADRUGID DR00072 DTD0031 DRUGNAME Lifitegrast DTD0031 DRUGSYNO SAR-1118; SAR-1119; SHP606; SPD606; Xiidra DTD0031 VADRUGID DR00206 DTD0031 DRUGNAME Pitavastatin calcium DTD0031 DRUGSYNO 147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W DTD0031 VADRUGID DR00030 DTD0031 DRUGNAME Atorvastatin DTD0031 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0031 VADRUGID DR00061 DTD0031 DRUGNAME Aliskiren fumarate DTD0031 DRUGSYNO (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide; (2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide; Aliskiren (USAN/INN); Octanamide, .delta.-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-.gamma.-hydroxy-4-methoxy-3-(3-methoxypropoxy)-.alpha.,.zeta.-bis(1-methylethyl)-, [.alpha.S-(alpha.R*,.gamma.R*,.delta.R*,.zeta.R*)]; Rasilez; Rasilez (TN); SPP 100; Tekturna (TN) DTD0031 VADRUGID DR00248 DTD0031 DRUGNAME Telmisartan DTD0031 DRUGSYNO 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086 DTD0031 VADRUGID DR00332 DTD0031 DRUGNAME Ritonavir DTD0031 DRUGSYNO 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN] DTD0031 VADRUGID DR00124 DTD0031 DRUGNAME Fluvastatin DTD0031 DRUGSYNO (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320 DTD0031 VADRUGID DR00045 DTD0031 DRUGNAME Pravastatin DTD0031 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0031 VADRUGID DR00223 DTD0031 DRUGNAME Rosuvastatin DTD0031 DRUGSYNO (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522 DTD0031 VADRUGID DR00005 DTD0031 DRUGNAME L-glutamic acid DTD0031 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0031 VADRUGID DR00201 DTD0031 DRUGNAME Sulfasalazine DTD0031 DRUGSYNO 13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral DTD0031 VADRUGID DR00162 DTD0031 DRUGNAME Etoposide DTD0031 DRUGSYNO (-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal DTD0031 VADRUGID DR00318 DTD0031 DRUGNAME Pemetrexed DTD0031 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0031 VADRUGID DR00102 DTD0031 DRUGNAME Dinoprostone DTD0031 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0031 VADRUGID DR00168 DTD0031 DRUGNAME Latanoprost DTD0031 DRUGSYNO AR-202; Catioprost; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; L1167_SIGMA; Latanoprost (JAN/USAN/INN); Latanoprost free acid; Nova-21027; PHXA-41; PhXA34 [as 15(R,S)-isomer]; PhXA41; Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; XA-41; XA41; Xalatan; Xalatan (TN) DTD0031 VADRUGID DR01327 DTD0031 DRUGNAME Abiraterone acetate DTD0031 DRUGSYNO CB-7630; JNJ-212082; Zytiga DTD0031 VADRUGID DR00288 DTD0031 DRUGNAME Bosentan DTD0031 DRUGSYNO 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN) DTD0031 VADRUGID DR00093 DTD0031 DRUGNAME Latanoprostene bunod DTD0031 DRUGSYNO BOL-303259-X; BOL-303259-X1; NCX-116; NO donors (glaucoma), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/ Bausch & Lomb; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), Pfizer; Nitric oxide-donating prostaglandin F2-alpha analogs (eye disease), NicOx/Pfizer; PF-03187207; PF-3187207 DTD0031 VADRUGID DR00053 DTD0031 DRUGNAME Sodium taurocholate DTD0031 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0031 VADRUGID DR01121 DTD0031 DRUGNAME Taurocholic acid DTD0031 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0031 VADRUGID DR00391 DTD0031 DRUGNAME Cerivastatin DTD0031 DRUGSYNO . DTD0031 VADRUGID DR00442 DTD0031 DRUGNAME Rocuronium DTD0031 DRUGSYNO (2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane; Esmeron (TN); Zemuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate DTD0031 VADRUGID DR01640 DTD0031 DRUGNAME Scutellarin DTD0031 DRUGSYNO Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl DTD0031 VADRUGID DR00908 DTD0031 DRUGNAME Eltrombopag DTD0031 DRUGSYNO Eltrombopag; Revolade; Promacta; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; UNII-S56D65XJ9G; SB497115; Eltrombopag-Isomer; SB-497115; SB 497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; SB-497115-GR; Eltrombopag (SB-497115-GR); 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; NCGC00274067-01 DTD0031 VADRUGID DR00856 DTD0031 DRUGNAME Mesalazine DTD0031 DRUGSYNO 2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206 DTD0031 VADRUGID DR00488 DTD0031 DRUGNAME Benzylpenicillin DTD0031 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0031 VADRUGID DR00401 DTD0031 DRUGNAME Talinolol DTD0031 DRUGSYNO (+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin] DTD0031 VADRUGID DR01513 DTD0031 DRUGNAME Dehydroepiandrosterone sulfate DTD0031 DRUGSYNO Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate DTD0031 VADRUGID DR01545 DTD0031 DRUGNAME Pitavastatin DTD0031 DRUGSYNO Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN) DTD0031 VADRUGID DR00019 DTD0031 DRUGNAME Estrone sulfate DTD0031 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0031 VADRUGID DR01462 DTD0031 DRUGNAME M17055 DTD0031 DRUGSYNO M-12285; M-17000; M-17055; MD-31 DTD0034 TRANSPID DTD0034 DTD0034 GENENAME SLC18A2 DTD0034 PROTNAME Vesicular amine transporter 2 DTD0034 SYNONYMS Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter DTD0034 VADRUGID DR00256 DTD0034 DRUGNAME Methamphetamine DTD0034 DRUGSYNO (+)-(S)-Deoxyephedrine; (+)-(S)-N-alpha-Dimethylphenethylamine; (+)-2-(N-Methylamino)-1-phenylpropane; (+)-Methylamphetamine; (+)-N,alpha-Dimethyl-beta-phenylethylamine; (+)-N,alpha-Dimethylphenethylamine; (+)-N-Methylamphetamine; (+)-methamphetamine; (2S)-N-methyl-1-phenylpropan-2-amine; (S)-(+)-Deoxyephedrine; (S)-(+)-Methamphetamine; (S)-(+)-N,alpha,dimethylphenethylamine; (S)-Methamphetamine; (S)-Methylamphetamine; (S)-N,alpha-Dimethylbenzeneethanamine; (S)-N,alpha-Dimethylbenzeneethanoamine; (alphaS)-N,alpha-dimethylbenzeneethanamine; 1-Phenyl-2-methylamino-propan; 1-Phenyl-2-methylamino-propan [German]; 1-Phenyl-2-methylaminopropane; 2S-(+)-Methamphetamine; Benzeneethanamine, N,alpha-dimethyl-, (S)-(9CI); Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-(9CI); Crank; Crank [Street Name]; Crystal Meth; Crystal Meth [Street Name]; D-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropan; D-1-Phenyl-2-methylaminopropan [German]; D-1-Phenyl-2-methylaminopropane; D-Deoxyephedrine; D-Desoxyephedrine; D-Methamphetamine; D-Methylamphetamine; D-N,.alpha.-Dimethylphenethylamine; D-N,alpha-dimethylphenethylamine; D-N-Methylamphetamine; D-Phenylisopropylmethylamine;Desoxyn (TN); Desohyephedrine; Desyphed; Desyphed hydrochloride; ICE [Street Name]; L-Methamphetamine; Metamfetamina; Metamfetamina [INN-Spanish]; Metamfetamine; Metamfetamine (INN); Metamfetamine [INN];Metamfetaminum [Latin]; Metamfetamine-m; Metamfetaminum; Metamfetaminum [INN-Latin]; Metamphetamine; Metanfetamina [INN-Spanish]; Metanfetamina [Spanish]; Meth; Meth (Street Name); Methamphetamine, its salts, isomers, and salts of its isomers; Methamphetaminum; Methamphetaminum [INN-Latin]; Methamphetaminum [JP]; Methyl-.beta.-phenylisopropylamine; Methyl-beta-phenylisopropylamine; Methylamphetamine; N-Methyl-1-phenyl-2-propanamine; N-Methyl-beta-phenylisopropylamin; N-Methyl-beta-phenylisopropylamin [German]; N-Methyl-beta-phenylisopropylamine; N-Methylamphetamine; Norodin; Phenethylamine, N,alpha-dimethyl-, (S)-(+)-(8CI); S-(+)-Methamphetamine; Speed; Speed [Street Name]; Stimulex DTD0034 VADRUGID DR00189 DTD0034 DRUGNAME Serotonin DTD0034 DRUGSYNO 1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY DTD0034 VADRUGID DR00268 DTD0034 DRUGNAME Norepinephrine DTD0034 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0034 VADRUGID DR00283 DTD0034 DRUGNAME Dopamine DTD0034 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0034 VADRUGID DR00081 DTD0034 DRUGNAME Ergotidine DTD0034 DRUGSYNO 1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine DTD0035 TRANSPID DTD0035 DTD0035 GENENAME SLC30A8 DTD0035 PROTNAME Zinc transporter 8 DTD0035 SYNONYMS SLC30A8; Solute carrier family 30 member 8; ZNT8; ZnT-8 DTD0035 VADRUGID DR00068 DTD0035 DRUGNAME Zinc salts DTD0035 DRUGSYNO . DTD0036 TRANSPID DTD0036 DTD0036 GENENAME ABCA1 DTD0036 PROTNAME ATP-binding cassette sub-family A member 1 DTD0036 SYNONYMS ABC-1; ABC1; ABCA1; ATP-binding cassette 1; ATP-binding cassette transporter 1; CERP; Cholesterol efflux regulatory protein; HDLDT1; TGD DTD0036 VADRUGID DR00651 DTD0036 DRUGNAME Fenofibric acid DTD0036 DRUGSYNO 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid; 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid; 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid; AK117112; BGF9MN2HU1; BRN 2058973; C17H15ClO4; CCRIS 7302; CHEBI:83469; CHEMBL981; EINECS 255-626-9; FNF Acid; LF 153; LF 178 acid; NSC 281318; Procetofenic acid; Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-; Trilipix; UNII-BGF9MN2HU1; W-106287; alpha 1081 DTD0036 VADRUGID DR00036 DTD0036 DRUGNAME Cholesterol DTD0036 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0038 TRANSPID DTD0038 DTD0038 GENENAME ABCA12 DTD0038 PROTNAME ATP-binding cassette sub-family A member 12 DTD0038 SYNONYMS ABC12; ABCA12; ARCI4A; ARCI4B; ATP-binding cassette 12; ATP-binding cassette transporter 12; ICR2B; LI2 DTD0038 VADRUGID DR00036 DTD0038 DRUGNAME Cholesterol DTD0038 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0040 TRANSPID DTD0040 DTD0040 GENENAME ABCA2 DTD0040 PROTNAME ATP-binding cassette sub-family A member 2 DTD0040 SYNONYMS ABC2; ABCA2; ATP-binding cassette 2; ATP-binding cassette transporter 2; KIAA1062 DTD0040 VADRUGID DR00036 DTD0040 DRUGNAME Cholesterol DTD0040 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0041 TRANSPID DTD0041 DTD0041 GENENAME ABCA3 DTD0041 PROTNAME ATP-binding cassette sub-family A member 3 DTD0041 SYNONYMS ABC-C transporter; ATP-binding cassette transporter 3; ATP-binding cassette 3; ABC3 DTD0041 VADRUGID DR00269 DTD0041 DRUGNAME Mitoxantrone DTD0041 DRUGSYNO 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate) DTD0042 TRANSPID DTD0042 DTD0042 GENENAME ABCA4 DTD0042 PROTNAME ATP-binding cassette sub-family A member 4 DTD0042 SYNONYMS ABC10; ABCA4; ABCR; ARMD2; CORD3; FFM; RIM ABC transporter; RIM protein; RP19; Retinal-specific ATP-binding cassette transporter; RmP; STGD; STGD1; Stargardt disease protein DTD0042 VADRUGID DR00294 DTD0042 DRUGNAME Phosphatidylethanolamine DTD0042 DRUGSYNO Cephalin DTD0043 TRANSPID DTD0043 DTD0043 GENENAME ABCA5 DTD0043 PROTNAME ATP-binding cassette sub-family A member 5 DTD0043 SYNONYMS ABC13; ABCA5; EST90625; HTC3; KIAA1888 DTD0043 VADRUGID DR00036 DTD0043 DRUGNAME Cholesterol DTD0043 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0046 TRANSPID DTD0046 DTD0046 GENENAME ABCA8 DTD0046 PROTNAME ATP-binding cassette sub-family A member 8 DTD0046 SYNONYMS ABCA8; KIAA0822; ATP-binding cassette A member 8 DTD0046 VADRUGID DR00229 DTD0046 DRUGNAME Ochratoxin A DTD0046 DRUGSYNO (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY DTD0046 VADRUGID DR00053 DTD0046 DRUGNAME Sodium taurocholate DTD0046 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0046 VADRUGID DR00019 DTD0046 DRUGNAME Estrone sulfate DTD0046 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0046 VADRUGID DR00067 DTD0046 DRUGNAME Aminohippuric acid DTD0046 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0051 TRANSPID DTD0051 DTD0051 GENENAME ABCB5 DTD0051 PROTNAME ATP-binding cassette sub-family B member 5 DTD0051 SYNONYMS ABCB5; ABCB5 P-gp; ABCB5alpha; ABCB5beta; EST422562; P-glycoprotein ABCB5 DTD0051 VADRUGID DR00301 DTD0051 DRUGNAME Doxorubicin DTD0051 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0051 VADRUGID DR00300 DTD0051 DRUGNAME Fostamatinib DTD0051 DRUGSYNO 901119-35-5; Fostamatinib [USAN:INN]; R 788; R-788; R-788 Free acid; R-935788 Free acid; R788; R7935788; SQ8A3S5101; Tavalisse; UNII-SQ8A3S5101 DTD0052 TRANSPID DTD0052 DTD0052 GENENAME ABCB6 DTD0052 PROTNAME ATP-binding cassette sub-family B member 6 DTD0052 SYNONYMS ABCB6; LAN; MTABC3; Mitochondrial ABC transporter 3; Mt-ABC transporter 3; P-glycoprotein-related protein; PRP; UMAT; Ubiquitously-expressed mammalian ABC half transporter DTD0052 VADRUGID DR00341 DTD0052 DRUGNAME Tomatine DTD0052 DRUGSYNO (3beta,5alpha,22beta,25S)-Spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl)-(1-3))-O-(beta-D-glucopyranosyl-(1-4)-beta-D-Galactopyr; A''-Tomatidine; Lycopersicin; Tomatidine, glycoside; Tomatin; Tomatine; alpha-Tomatine; beta-D-Galactopyranoside, (3beta,5alpha,22beta,25S)-spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4)- DTD0052 VADRUGID DR00209 DTD0052 DRUGNAME Verteporfin DTD0052 DRUGSYNO Visudyne (TN) DTD0054 TRANSPID DTD0054 DTD0054 GENENAME ABCB8 DTD0054 PROTNAME ATP-binding cassette sub-family B member 8 DTD0054 SYNONYMS ABCB8; EST328128; M-ABC1; MABC1; Mitochondrial ATP-binding cassette 1 DTD0054 VADRUGID DR00301 DTD0054 DRUGNAME Doxorubicin DTD0054 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0055 TRANSPID DTD0055 DTD0055 GENENAME ABCB9 DTD0055 PROTNAME TAP-like protein DTD0055 SYNONYMS ABC transporter 9 protein; ABCB9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; EST122234; KIAA1520; TAPL; hABCB9 DTD0055 VADRUGID DR00342 DTD0055 DRUGNAME Paclitaxel DTD0055 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0055 VADRUGID DR00251 DTD0055 DRUGNAME Docetaxel DTD0055 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0056 TRANSPID DTD0056 DTD0056 GENENAME ABCC10 DTD0056 PROTNAME Multidrug resistance-associated protein 7 DTD0056 SYNONYMS ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7 DTD0056 VADRUGID DR00342 DTD0056 DRUGNAME Paclitaxel DTD0056 DRUGSYNO 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel DTD0056 VADRUGID DR00193 DTD0056 DRUGNAME Tamoxifen DTD0056 DRUGSYNO (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN) DTD0056 VADRUGID DR00251 DTD0056 DRUGNAME Docetaxel DTD0056 DRUGSYNO (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L DTD0056 VADRUGID DR00174 DTD0056 DRUGNAME Tenofovir DTD0056 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0057 TRANSPID DTD0057 DTD0057 GENENAME ABCC11 DTD0057 PROTNAME Multidrug resistance-associated protein 8 DTD0057 SYNONYMS ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW DTD0057 VADRUGID DR00174 DTD0057 DRUGNAME Tenofovir DTD0057 DRUGSYNO (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid DTD0057 VADRUGID DR00175 DTD0057 DRUGNAME Zalcitabine DTD0057 DRUGSYNO 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; 2',3'-DIDEOXYCYTIDINE; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 2,3-dideoxycytidine; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; Beta-D-2',3'-Dideoxycytidine; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Beta-D-DDC; Cytidine, 2',3'-dideoxy & Interferon alpha; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; D 5782; DDC (DDC); DS-4152 & ddC; DdC; DdC & GM-CSF; DdC & IFN-alpha; DdC & Interferon alpha; DdC & NP (from PHCA or HSA); DdC & sCD4; DdC (Antiviral); DdCyd; Dideoxycytidine; HIVID; Hivid (TN); Hivid(TM); Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Interferon AD + ddC; KS-1130; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; PC-SOD & ddC; Ro 24-2027/000; Ro-24-2027/000; SRI-7707; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Zalcitabine (JAN/USP/INN); Zalcitabine [USAN:INN:BAN]; Zalcitibine DTD0057 VADRUGID DR00082 DTD0057 DRUGNAME Methotrexate DTD0057 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0057 VADRUGID DR01193 DTD0057 DRUGNAME Prasterone DTD0057 DRUGSYNO 17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone DTD0061 TRANSPID DTD0061 DTD0061 GENENAME ABCC8 DTD0061 PROTNAME Sulfonylurea receptor 1 DTD0061 SYNONYMS ATP-binding cassette sub-family C member 8; ABCC8; ABC36; HRINS; SUR; SUR1; HHF1; TNDM2; SUR1delta2 DTD0061 VADRUGID DR00104 DTD0061 DRUGNAME Tolbutamide DTD0061 DRUGSYNO 1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea; Aglicid; Apo-Tolbutamide; Apotex Brand of Tolbutamide; Arcosal; Arkozal; Artosin; Artozin; Aventis Brand of Tolbutamide; Beglucin; Berlin-Chemie Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamid; Butamide; Butamide Brand of Tolbutamide; Butamidum; D 860; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; HLS 831; Hoechst Brand of Tolbutamide; Ipoglicone; Mobenol; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-(p-tolylsulfonyl)-N'-n-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-4-Methylbenzolsulfonyl-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-Butyl-N'-toluene-p-sulfonylurea; N-n-Butyl-N'-tosylurea; Novo-Butamide; Orabet; Oralin; Oramide; Orezan; Orinase; Orinase (TN); Orinaz; Oterben; Pfizer Brand of Tolbutamide; Pramidex; R.A.N. Brand of Tolbutamide; Rastinon; Restinon; Sk-tolbutamide; T 0891; TOLBUTAMIDE USP; Tarasina; Tol-Tab; Tolbet;Tolbusal; Tolbutamid; Tolbutamid R.A.N.; Tolbutamida; Tolbutamida [INN-Spanish]; Tolbutamide (JP15/USP/INN); Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Tolbutamide [INN:BAN:JAN]; Tolbutamidum; Tolbutamidum [INN-Latin]; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; U 2043; Valdecasas Brand of Tolbutamide; Willbutamide; Yamanouchi Brand of Tolbutamide DTD0062 TRANSPID DTD0062 DTD0062 GENENAME ABCC9 DTD0062 PROTNAME Sulfonylurea receptor 2 DTD0062 SYNONYMS ATP-binding cassette sub-family C member 9; ABCC9; SUR2; ABC37; CANTU; CMD1O; ATFB12 DTD0062 VADRUGID DR00104 DTD0062 DRUGNAME Tolbutamide DTD0062 DRUGSYNO 1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea; Aglicid; Apo-Tolbutamide; Apotex Brand of Tolbutamide; Arcosal; Arkozal; Artosin; Artozin; Aventis Brand of Tolbutamide; Beglucin; Berlin-Chemie Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamid; Butamide; Butamide Brand of Tolbutamide; Butamidum; D 860; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; HLS 831; Hoechst Brand of Tolbutamide; Ipoglicone; Mobenol; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-(p-tolylsulfonyl)-N'-n-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-4-Methylbenzolsulfonyl-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-Butyl-N'-toluene-p-sulfonylurea; N-n-Butyl-N'-tosylurea; Novo-Butamide; Orabet; Oralin; Oramide; Orezan; Orinase; Orinase (TN); Orinaz; Oterben; Pfizer Brand of Tolbutamide; Pramidex; R.A.N. Brand of Tolbutamide; Rastinon; Restinon; Sk-tolbutamide; T 0891; TOLBUTAMIDE USP; Tarasina; Tol-Tab; Tolbet;Tolbusal; Tolbutamid; Tolbutamid R.A.N.; Tolbutamida; Tolbutamida [INN-Spanish]; Tolbutamide (JP15/USP/INN); Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Tolbutamide [INN:BAN:JAN]; Tolbutamidum; Tolbutamidum [INN-Latin]; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; U 2043; Valdecasas Brand of Tolbutamide; Willbutamide; Yamanouchi Brand of Tolbutamide DTD0071 TRANSPID DTD0071 DTD0071 GENENAME ABCG1 DTD0071 PROTNAME ATP-binding cassette sub-family G member 1 DTD0071 SYNONYMS ABC8; ABCG1; ATP-binding cassette transporter 8; WHITE1; WHT1; White protein homolog DTD0071 VADRUGID DR00036 DTD0071 DRUGNAME Cholesterol DTD0071 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0079 TRANSPID DTD0079 DTD0079 GENENAME SLC10A7 DTD0079 PROTNAME Sodium/bile acid cotransporter 7 DTD0079 SYNONYMS Na(+)/bile acid cotransporter 7; Solute carrier family 10 member 7; SLC10A7; PSEC0051; C4orf13 DTD0079 VADRUGID DR00317 DTD0079 DRUGNAME Iron monocation DTD0079 DRUGSYNO 3ZhP; ATW 230; ATW 432; Ancor B; Ancoren 80/150; Armco iron; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; Carbonyl iron; Copy Powder CS 105-175; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; Diseases (animal), iron overload; Diseases, iron overload; EF 1000; EF 250; EFV 200/300; EFV 250; EFV 250/400; Ed-In-Sol; Eisen; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Feronate; Ferretts; Ferro-Caps; Ferro-Time; Ferrous iron; Ferrousal; Ferrovac E; Ferrum; GS 6; HF 2 (element); HL (iron); HQ (metal); HS (iron); HS 4849; Hemocyte; Hierro; Hoeganaes ATW 230; Hoeganaes EH; Iron; Iron (Fe); Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron standard for AAS; Iron(1+); Iron(1+) ion; Iron(III) nitrate solution; Iron, elemental; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); LOHA; NC 100; PZh-1M3; PZh-2; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; PZhO; Remko; SUY-B 2; Siderol; Vitedyn-Slo; Yieronia DTD0081 TRANSPID DTD0081 DTD0081 GENENAME SLC11A2 DTD0081 PROTNAME Natural resistance-associated macrophage protein 2 DTD0081 SYNONYMS AHMIO1; DCT1; DMT-1; DMT1; Divalent cation transporter 1; Divalent metal transporter 1; NRAMP 2; NRAMP2; SLC11A2; Solute carrier family 11 member 2 DTD0081 VADRUGID DR00338 DTD0081 DRUGNAME Manganese DTD0081 DRUGSYNO Colloidal manganese; Cutaval; MANGANESE COMPOUNDS; Magnacat; Mangan; Mangan [Polish]; Mangan nitridovany; Mangan nitridovany [Czech]; Manganese; Manganese element; Manganese fume; Manganese ion(4 ); Manganese metal alloy; Manganese(1-); Manganese(4 ); Manganese(7+); Manganese, 99+%, powder, -40 mesh; Manganese, elemental; Manganese, ion (Mn1-); Manganese, ion (Mn4 ); Manganese-55; Teprosyn M; Tronamang; manganeso; manganide; manganum DTD0081 VADRUGID DR00317 DTD0081 DRUGNAME Iron monocation DTD0081 DRUGSYNO 3ZhP; ATW 230; ATW 432; Ancor B; Ancoren 80/150; Armco iron; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; Carbonyl iron; Copy Powder CS 105-175; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; Diseases (animal), iron overload; Diseases, iron overload; EF 1000; EF 250; EFV 200/300; EFV 250; EFV 250/400; Ed-In-Sol; Eisen; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Feronate; Ferretts; Ferro-Caps; Ferro-Time; Ferrous iron; Ferrousal; Ferrovac E; Ferrum; GS 6; HF 2 (element); HL (iron); HQ (metal); HS (iron); HS 4849; Hemocyte; Hierro; Hoeganaes ATW 230; Hoeganaes EH; Iron; Iron (Fe); Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron standard for AAS; Iron(1+); Iron(1+) ion; Iron(III) nitrate solution; Iron, elemental; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); LOHA; NC 100; PZh-1M3; PZh-2; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; PZhO; Remko; SUY-B 2; Siderol; Vitedyn-Slo; Yieronia DTD0082 TRANSPID DTD0082 DTD0082 GENENAME SLC12A1 DTD0082 PROTNAME Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 DTD0082 SYNONYMS BSC1; Kidney-specific Na-K-Cl symporter; NKCC2; SLC12A1; Solute carrier family 12 member 1 DTD0082 VADRUGID DR00184 DTD0082 DRUGNAME Potassium chloride DTD0082 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0082 VADRUGID DR01173 DTD0082 DRUGNAME Sodium chloride DTD0082 DRUGSYNO 7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling DTD0083 TRANSPID DTD0083 DTD0083 GENENAME SLC12A2 DTD0083 PROTNAME Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 DTD0083 SYNONYMS Basolateral Na-K-Cl symporter; Solute carrier family 12 member 2; SLC12A2; NKCC1 DTD0083 VADRUGID DR00184 DTD0083 DRUGNAME Potassium chloride DTD0083 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0083 VADRUGID DR01173 DTD0083 DRUGNAME Sodium chloride DTD0083 DRUGSYNO 7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling DTD0084 TRANSPID DTD0084 DTD0084 GENENAME SLC12A3 DTD0084 PROTNAME Thiazide-sensitive sodium-chloride cotransporter DTD0084 SYNONYMS NCC; NCCT; Na-Cl cotransporter; Na-Cl symporter; SLC12A3; Solute carrier family 12 member 3; TSC DTD0084 VADRUGID DR01032 DTD0084 DRUGNAME Metolazone DTD0084 DRUGSYNO 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide; 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide; Diulo; Metalazone; Metalozone; Metenix; Metolazona; Metolazona [INN-Spanish]; Metolazone (JAN/USP/INN); Metolazone [USAN:BAN:INN:JAN]; Metolazonum; Metolazonum [INN-Latin]; Microx; Mykrox; Mykrox (TN); Mykrox, Zaroxolyn, Diulo, Metolazone; Oldren; SR 720-22; SR-720-22; Xuret; Zaroxolyn; Zaroxolyn (TN) DTD0084 VADRUGID DR00272 DTD0084 DRUGNAME Bumetanide DTD0084 DRUGSYNO 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex DTD0085 TRANSPID DTD0085 DTD0085 GENENAME SLC12A4 DTD0085 PROTNAME Electroneutral potassium-chloride cotransporter 1 DTD0085 SYNONYMS Erythroid K-Cl cotransporter 1; hKCC1; KCC1; SLC12A4; Solute carrier family 12 member 4 DTD0085 VADRUGID DR00184 DTD0085 DRUGNAME Potassium chloride DTD0085 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0086 TRANSPID DTD0086 DTD0086 GENENAME SLC12A5 DTD0086 PROTNAME Electroneutral potassium-chloride cotransporter 2 DTD0086 SYNONYMS hKCC2; Neuronal K-Cl cotransporter; K-Cl cotransporter 2; KCC2; KIAA1176; Solute carrier family 12 member 5 DTD0086 VADRUGID DR00184 DTD0086 DRUGNAME Potassium chloride DTD0086 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0087 TRANSPID DTD0087 DTD0087 GENENAME SLC12A6 DTD0087 PROTNAME Electroneutral potassium-chloride cotransporter 3 DTD0087 SYNONYMS ACCPN; K-Cl cotransporter 3; KCC3; KCC3A; KCC3B; SLC12A6; Solute carrier family 12 member 6 DTD0087 VADRUGID DR00184 DTD0087 DRUGNAME Potassium chloride DTD0087 DRUGSYNO 11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl] DTD0088 TRANSPID DTD0088 DTD0088 GENENAME SLC12A7 DTD0088 PROTNAME Electroneutral potassium-chloride cotransporter 4 DTD0088 SYNONYMS K-Cl cotransporter 4; KCC4; SLC12A7; Solute carrier family 12 member 7 DTD0088 VADRUGID DR01254 DTD0088 DRUGNAME Cation chloride DTD0088 DRUGSYNO . DTD0089 TRANSPID DTD0089 DTD0089 GENENAME SLC12A8 DTD0089 PROTNAME Cation-chloride cotransporter 9 DTD0089 SYNONYMS Solute carrier family 12 member 8; SLC12A8; CCC9 DTD0089 VADRUGID DR00719 DTD0089 DRUGNAME Nicotinamide mononucleotide DTD0089 DRUGSYNO Beta-NMN; Beta-Nicotinamide mononucleotide; Beta-Nicotinamide ribonucleotide; Nicotinamide D-ribonucleotide; Nicotinamide mononucleotide; Nicotinamide nucleotide; Nicotinamide ribonucleotide; Nicotinamide ribotide DTD0091 TRANSPID DTD0091 DTD0091 GENENAME SLC13A1 DTD0091 PROTNAME Sodium/sulfate cotransporter 1 DTD0091 SYNONYMS NAS1; NASI1; NaSi-1; SLC13A1; Solute carrier family 13 member 1; Na(+)/sulfate cotransporter; hNaSi-1; Renal sodium/sulfate cotransporter DTD0091 VADRUGID DR00060 DTD0091 DRUGNAME Sulfate DTD0091 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0092 TRANSPID DTD0092 DTD0092 GENENAME SLC13A2 DTD0092 PROTNAME Sodium/dicarboxylate cotransporter 1 DTD0092 SYNONYMS NADC1; Na(+)/dicarboxylate cotransporter 1; NaDC-1; SDCT1; SLC13A2; Solute carrier family 13 member 2; Renal sodium/dicarboxylate cotransporter DTD0092 VADRUGID DR01245 DTD0092 DRUGNAME Dicarboxylate DTD0092 DRUGSYNO 1,3-Propanedioic acid; 9KX7ZMG0MK; AI3-15375; BRN 1751370; CHEBI:30794; Carboxyacetic acid; DICARBOXYLIC ACID C3; Dicarboxylate; Dicarboxylic acid; Dicarboxymethane; EINECS 205-503-0; Kyselina malonova; Kyselina malonova [Czech]; METAHNEDICARBOXYLIC ACID; MFCD00002707; Malonic acid; Malonic acid, 99%; Methanedicarbonic acid; Methanedicarboxylic acid; NSC 8124; NSC8124; OFOBLEOULBTSOW-UHFFFAOYSA-N; PROPANEDIOLIC ACID; Thallium malonate; UNII-9KX7ZMG0MK; USAF EK-695; alpha,omega-Dicarboxylic acid; malonic acid; propanedioic acid DTD0093 TRANSPID DTD0093 DTD0093 GENENAME SLC13A3 DTD0093 PROTNAME Sodium/dicarboxylate cotransporter 3 DTD0093 SYNONYMS ARLIAK; NADC3; Na(+)/dicarboxylate cotransporter 3; NaDC-3; SDCT2; SLC13A3; Solute carrier family 13 member 3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2 DTD0093 VADRUGID DR00139 DTD0093 DRUGNAME Alpha-ketoglutaric acid DTD0093 DRUGSYNO 2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate DTD0093 VADRUGID DR01245 DTD0093 DRUGNAME Dicarboxylate DTD0093 DRUGSYNO 1,3-Propanedioic acid; 9KX7ZMG0MK; AI3-15375; BRN 1751370; CHEBI:30794; Carboxyacetic acid; DICARBOXYLIC ACID C3; Dicarboxylate; Dicarboxylic acid; Dicarboxymethane; EINECS 205-503-0; Kyselina malonova; Kyselina malonova [Czech]; METAHNEDICARBOXYLIC ACID; MFCD00002707; Malonic acid; Malonic acid, 99%; Methanedicarbonic acid; Methanedicarboxylic acid; NSC 8124; NSC8124; OFOBLEOULBTSOW-UHFFFAOYSA-N; PROPANEDIOLIC ACID; Thallium malonate; UNII-9KX7ZMG0MK; USAF EK-695; alpha,omega-Dicarboxylic acid; malonic acid; propanedioic acid DTD0093 VADRUGID DR01246 DTD0093 DRUGNAME Succinate DTD0093 DRUGSYNO . DTD0094 TRANSPID DTD0094 DTD0094 GENENAME SLC13A4 DTD0094 PROTNAME Na(+)/sulfate cotransporter SUT-1 DTD0094 SYNONYMS NaS2; SLC13A4; SUT-1; SUT1; Solute carrier family 13 member 4 DTD0094 VADRUGID DR00060 DTD0094 DRUGNAME Sulfate DTD0094 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0095 TRANSPID DTD0095 DTD0095 GENENAME SLC13A5 DTD0095 PROTNAME Sodium-coupled citrate transporter DTD0095 SYNONYMS EIEE25; INDY; Na(+)/citrate cotransporter; SLC13A5; Sodium-dependent citrate; NaCT transporter; Solute carrier family 13 member 5; mIndy DTD0095 VADRUGID DR00139 DTD0095 DRUGNAME Alpha-ketoglutaric acid DTD0095 DRUGSYNO 2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate DTD0095 VADRUGID DR01246 DTD0095 DRUGNAME Succinate DTD0095 DRUGSYNO . DTD0095 VADRUGID DR01247 DTD0095 DRUGNAME Citrate DTD0096 TRANSPID DTD0096 DTD0096 GENENAME SLC14A1 DTD0096 PROTNAME Urea transporter 1 DTD0096 SYNONYMS HUT11; HsT1341; JK; RACH1; RACH2; SLC14A1; Solute carrier family 14 member 1; UT-B1; UT1; UTE; Urea transporter, erythrocyte DTD0096 VADRUGID DR00349 DTD0096 DRUGNAME Thiourea DTD0096 DRUGSYNO 2-Thiopseudourea; 2-Thiourea; Carbamimidothioic acid; Caswell No. 855; Isothiourea; Pseudothiourea; Pseudourea, 2-thio-; RCRA waste no. U219;.beta.-Thiopseudourea; RCRA waste number U219; Sulfourea; Sulfouren; Sulourea; THIOUREA; Thiocarbamid; Thiocarbamide; Thiocarbonic acid diamide; Thioharnstoff; Thiokarbamid; Thiomocovina; Thiomocovina [Czech]; Thiurea; Thiuronium; Tsizp 34; Urea, 2-thio-; Urea, thio-; beta-Thiopseudourea; carbonothioic diamide; sulfocarbamide; thio-urea DTD0096 VADRUGID DR00721 DTD0096 DRUGNAME Methylurea DTD0096 DRUGSYNO 1-Methylurea; 1-Methylurea;1-Methylurea; 3-methyl-urea; 598-50-5; AC1L1XZ6; ACMC-1AKB9; AI3-15088; CCRIS 9137; CH3NHCONH2; CHEBI:44383; CTK1H1160; DTXSID5060510; EC 209-935-0; EINECS 209-935-0; GTPL4662; KSC271C6B; Methyl urea; Methylharnstoff; Methylharnstoff [German]; Methylmocovina; Methylmocovina [Czech]; Methylurea, 97%; Monomethylurea; N-Methylurea; N-Methylurea, 97%; N-methyl urea; UNII-VZ89YBW3P8; Urea, methyl-; VZ89YBW3P8; XGEGHDBEHXKFPX-UHFFFAOYSA-N; bmse000738; methyl-urea; methylisourea; urea, N-methyl- DTD0097 TRANSPID DTD0097 DTD0097 GENENAME SLC14A2 DTD0097 PROTNAME Urea transporter 2 DTD0097 SYNONYMS HUT2; SLC14A2; Solute carrier family 14 member 2; UT-A2; UT2; UTA; UTR; Urea transporter, kidney; hUT-A6 DTD0097 VADRUGID DR00721 DTD0097 DRUGNAME Methylurea DTD0097 DRUGSYNO 1-Methylurea; 1-Methylurea;1-Methylurea; 3-methyl-urea; 598-50-5; AC1L1XZ6; ACMC-1AKB9; AI3-15088; CCRIS 9137; CH3NHCONH2; CHEBI:44383; CTK1H1160; DTXSID5060510; EC 209-935-0; EINECS 209-935-0; GTPL4662; KSC271C6B; Methyl urea; Methylharnstoff; Methylharnstoff [German]; Methylmocovina; Methylmocovina [Czech]; Methylurea, 97%; Monomethylurea; N-Methylurea; N-Methylurea, 97%; N-methyl urea; UNII-VZ89YBW3P8; Urea, methyl-; VZ89YBW3P8; XGEGHDBEHXKFPX-UHFFFAOYSA-N; bmse000738; methyl-urea; methylisourea; urea, N-methyl- DTD0098 TRANSPID DTD0098 DTD0098 GENENAME SLC15A3 DTD0098 PROTNAME Peptide/histidine transporter 2 DTD0098 SYNONYMS OCTP; Osteoclast transporter; PHT2; PTR3; Peptide transporter 3; Solute carrier family 15 member 3; SLC15A3 DTD0098 VADRUGID DR00282 DTD0098 DRUGNAME L-histidine DTD0098 DRUGSYNO Histidine DTD0099 TRANSPID DTD0099 DTD0099 GENENAME SLC15A4 DTD0099 PROTNAME Peptide transporter 4 DTD0099 SYNONYMS FP12591; PHT1; PTR4; Peptide/histidine transporter 1; SLC15A4; Solute carrier family 15 member 4; hPHT1 DTD0099 VADRUGID DR00375 DTD0099 DRUGNAME Peptides DTD0099 DRUGSYNO Peptides (drug-resistant bacterial infections); Peptides (drug-resistant bacterial infections), BioAMPS International; V13K DTD0099 VADRUGID DR00282 DTD0099 DRUGNAME L-histidine DTD0099 DRUGSYNO Histidine DTD0100 TRANSPID DTD0100 DTD0100 GENENAME SLC16A1 DTD0100 PROTNAME Monocarboxylate transporter 1 DTD0100 SYNONYMS HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1 DTD0100 VADRUGID DR00556 DTD0100 DRUGNAME Salicylic acid DTD0100 DRUGSYNO 2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon DTD0100 VADRUGID DR00293 DTD0100 DRUGNAME Pyroglutamic acid DTD0100 DRUGSYNO 5-oxoproline; PCA; pidolic acid DTD0100 VADRUGID DR00030 DTD0100 DRUGNAME Atorvastatin DTD0100 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0100 VADRUGID DR00301 DTD0100 DRUGNAME Doxorubicin DTD0100 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0100 VADRUGID DR01241 DTD0100 DRUGNAME Milchsaure DTD0100 DRUGSYNO (+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid DTD0100 VADRUGID DR01397 DTD0100 DRUGNAME Pyruvic acid DTD0100 DRUGSYNO BTS; Brenztraubensaeure; Acetylformic acid; Acide pyruvique; Pyroracemic acid; CH3COCOOH; A-Ketopropionic acid; Alpha-Ketopropionic acid; Alpha-Oxopropionsaeure; Alpha-keto propionic acid; Alpha-ketopropionic acid; P-9250; Pyruvic acid (8CI); Pyruvic acid (natural); Propanoic acid, 2-oxo-(9CI); 2-Ketopropionic acid; 2-Oxopropanoate; 2-Oxopropanoic acid; 2-Oxopropansaeure; 2-Oxopropionic acid; 2-Oxopropionsaeure; 2-oxo(1-14c)propanoic acid; 2-oxo-propionic acid DTD0100 VADRUGID DR01475 DTD0100 DRUGNAME Butyrate DTD0100 DRUGSYNO butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; 1-propanecarboxylic acid; Butanic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; CCRIS 6552; HSDB 940; butoic acid; Ethyacetic Acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H DTD0100 VADRUGID DR00089 DTD0100 DRUGNAME Gabapentin enacarbil DTD0100 DRUGSYNO ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512 DTD0100 VADRUGID DR00987 DTD0100 DRUGNAME Gamma-hydroxybutyric acid DTD0100 DRUGSYNO 3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Anetamin; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; EB 27; GHB; Gam-OH; Gamma OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-Hydroxybutyric acid, sodium salt; Gamma-OH; Hydroxyb; Oxy-n-butyric acid; Oxybate; Oxybate sodium; SHB; Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; Sodium Oxybate (4-hydroxybutanoic acid); Somsanit; Utyric acid monosodium salt; WY 3478; Xyrem; Xyrem (TN) DTD0100 VADRUGID DR00257 DTD0100 DRUGNAME Biotin DTD0100 DRUGSYNO Biodermatin; Bioepiderm; Bios II; Biotin Forte; Factor S; Lutavit H2; Meribin; Rovimix H2 DTD0100 VADRUGID DR01497 DTD0100 DRUGNAME Glycolic acid DTD0100 DRUGSYNO glycolic acid; 2-Hydroxyacetic acid; hydroxyacetic acid; 79-14-1; Glycollic acid; Hydroxyethanoic acid; Acetic acid, hydroxy-; glycolate; Caswell No. 470; alpha-Hydroxyacetic acid; Kyselina glykolova; Kyselina glykolova [Czech]; Kyselina hydroxyoctova; HOCH2COOH; 2-Hydroxyethanoic acid; Kyselina hydroxyoctova [Czech]; Glycocide; EPA Pesticide Chemical Code 000101; GlyPure; HSDB 5227; NSC 166; Acetic acid, 2-hydroxy-; AI3-15362; UNII-0WT12SX38S; GlyPure 70; BRN 1209322; GLYCOLLATE; C2H4O3; Acetic acid, hydroxy-, homopolymer; EINECS 201- DTD0101 TRANSPID DTD0101 DTD0101 GENENAME SLC16A10 DTD0101 PROTNAME Monocarboxylate transporter 10 DTD0101 SYNONYMS Aromatic amino acid transporter 1; Solute carrier family 16 member 10; T-type amino acid transporter 1; SLC16A10; MCT10; TAT1 DTD0101 VADRUGID DR00086 DTD0101 DRUGNAME L-tryptophan DTD0101 DRUGSYNO (-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin] DTD0103 TRANSPID DTD0103 DTD0103 GENENAME SLC16A12 DTD0103 PROTNAME Monocarboxylate transporter 12 DTD0103 SYNONYMS CJMG; CRT2; CTRCT47; Creatine transporter 2; MCT 12; MCT12; SLC16A12; Solute carrier family 16 member 12 DTD0103 VADRUGID DR00034 DTD0103 DRUGNAME Creatine ALS-08 DTD0103 DRUGSYNO AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; ALS-02; ALS-05; ALS-08; Creatine; Creatine (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; HD-02; PD-01, Avicena; PD-02; PD-04; PD-06 DTD0107 TRANSPID DTD0107 DTD0107 GENENAME SLC16A3 DTD0107 PROTNAME Monocarboxylate transporter 4 DTD0107 SYNONYMS MCT 4; MCT4; SLC16A3; Solute carrier family 16 member 3 DTD0107 VADRUGID DR01241 DTD0107 DRUGNAME Milchsaure DTD0107 DRUGSYNO (+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid DTD0109 TRANSPID DTD0109 DTD0109 GENENAME SLC16A5 DTD0109 PROTNAME Monocarboxylate transporter 6 DTD0109 SYNONYMS Monocarboxylate transporter 5; MCT 5; MCT 6; Solute carrier family 16 member 5; SLC16A5; MCT5; MCT6 DTD0109 VADRUGID DR00407 DTD0109 DRUGNAME Nateglinide DTD0109 DRUGSYNO (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026 DTD0109 VADRUGID DR00272 DTD0109 DRUGNAME Bumetanide DTD0109 DRUGSYNO 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex DTD0109 VADRUGID DR00232 DTD0109 DRUGNAME Probenecid DTD0109 DRUGSYNO 4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid DTD0110 TRANSPID DTD0110 DTD0110 GENENAME SLC16A6 DTD0110 PROTNAME Monocarboxylate transporter 7 DTD0110 SYNONYMS SLC16A6; MCT7; Solute carrier family 16 member 6 DTD0110 VADRUGID DR01252 DTD0110 DRUGNAME Monocarboxylic acids DTD0110 DRUGSYNO . DTD0111 TRANSPID DTD0111 DTD0111 GENENAME SLC16A7 DTD0111 PROTNAME Monocarboxylate transporter 2 DTD0111 SYNONYMS Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2 DTD0111 VADRUGID DR00556 DTD0111 DRUGNAME Salicylic acid DTD0111 DRUGSYNO 2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon DTD0111 VADRUGID DR00225 DTD0111 DRUGNAME Quercetin DTD0111 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0111 VADRUGID DR00030 DTD0111 DRUGNAME Atorvastatin DTD0111 DRUGSYNO (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel DTD0111 VADRUGID DR00399 DTD0111 DRUGNAME Valproic Acid DTD0111 DRUGSYNO 2 PP (base); 2-Propylpentanoic acid; 2-Propylvaleric acid; 2-n-Propyl-n-valeric acid; 4-Heptanecarboxylic acid; Abbott 44090; Acide valproique; Acide valproique [INN-French]; Acido valproico; Acido valproico [INN-Spanish]; Acidum valproicum; Acidum valproicum [INN-Latin]; Alti-Valproic; Avugane; Baceca; Convulex; Convulex (TN); Convulsofin; Depacon (TN); Depakene; Depakene (TN); Depakin; Depakin chrono; Depakine; Depakine chrono; Depakote (TM); Depakote (TN); Depakote ER (TN); Deproic; Di-n-propylacetic acid; Di-n-propylessigsaeure; Di-n-propylessigsaure; Di-n-propylessigsaure [German]; Dipropyl Acetate; Dipropylacetate; Dipropylacetic acid; Dom-Valproic; Encorate (TN); Epilim (TN); Epival (TN); Ergenyl; G2M-777; Kyselina 2-propylvalerova; Kyselina 2-propylvalerova [Czech]; Med Valproic; Mylproin; Myproic Acid; N-DPA; N-Dipropylacetic acid; Novo-Valproic; Nu-Valproic; PMS-Valproic Acid; Penta-Valproic; Propylvaleric acid; Savicol; Semisodium Valproate; Stavzor; Stavzor (TN); VPA; Valproate; Valproic Acid, Sodium Salt (2:1); Valproic acid (USP); Valproic acid USP; Valproic acid USP24; Valproic acid [USAN:INN:BAN]; Valproinsaeure; Vupral; Winthrop (TN) DTD0111 VADRUGID DR01241 DTD0111 DRUGNAME Milchsaure DTD0111 DRUGSYNO (+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid DTD0111 VADRUGID DR00663 DTD0111 DRUGNAME Ibuprofen DTD0111 DRUGSYNO ACHES-N-PAIN; Act-3; Act-3 (TN); Actiprofen; Adex 200; Adran; Advil; Advil (TN); Ak+C2278tren; Aktre (TN); Alaxan; Alaxan (TN); Algofen; Algoflex (TN); Alivium (TN); Am-Fam 400; Amelior; Amersol; Amibufen; Anafen; Anco; Andran; Anflagen; Antagil; Antalfene; Antarene; Antiflam; Apsifen; Apsifen-F; Arthrofen (TN); Artofen; Artril; Artril 300; Balkaprofen; Betaprofen; Bloom; Bluton; Bonifen (TN); Brofen; Brufanic; Brufen; Brufen (TN); Brufen 400; Bruflam; Brufort; Buburone; Bufeno; Bufigen; Bugesic (TN); Bukrefen; Bupron; Buracaps; Burana; Burana (TN); Butylenin; Caldolor (TN); Calprofen (TN); Cap-Profen; Carol;Cesra; Citalgan; Cobo; Codral; Combiflam; Cunil; DOLO PUREN; Daiprophen; Dalsy; Dalsy (TN); Dansida; Deep Relief; Dentigoa; Dibufen; Dignoflex; Dismenol (TN); Diverin (TN); Dolgirid; Dolgit; Dolgit (TN); Dolibu; Dolmaral; Dolo-Dolgit; Dolo-Spedifen (TN); Dolocyl; Dolofen; Dolofen-F; Dolofin; Dolofort; Dolofort (TN); Dologel; Dolomax; Doloraz (TN); Doloren; Dolormin; Dolormin (TN); Doltibil; Dolven; Donjust B; Dorival; Dorival (TN); Drin; Duafen; Duobrus; Dura-Ibu; Dysdolen; Easifon; Ebufac; Ebufac (TN); Emflam; Emflam-200; EmuProfen (TN); Epobron; Eputex; Ergix; Espidifen (TN); Esprenit; Eve (TN); Exneural; Faspic; Femadon; Femafen; Femapirin; Femidol; Fenbid (TN); Fenbid;Fendol; Fenpaed (TN); Fenspan; Fibraflex; Finalflex (TN); Galprofen (TN); Gelufene; Gofen; Grefen; Gynofug; Haltran; Hedex (TN); Herron Blue (TN); I 4883; I-profen (TN); IB-100; IBU-Ratiopharm (TN); IBUFEN (TN); IP 82; IP-82; IP82; Ibalgin (TN); Ibol; Ibren; Ibu; Ibu-Attritin; Ibu-Tab; Ibu-Tab 200; Ibu-Vivimed (TN); Ibu-slo; Ibu-slow; IbuHEXAL (TN); Ibubest; Ibubeta; Ibucasen; Ibudol; Ibudolor; Ibufen; Ibuflamar; Ibufug; Ibugel; Ibugel (TN); Ibugen; Ibugesic; Ibuhexal; Ibulagic; Ibular; Ibulav; Ibuleve; Ibuleve (TN); Ibulgan; Ibum (TN); Ibumax (TN); Ibumed; Ibumerck; Ibumetin; Ibumetin (TN); Ibupirac; Ibuprin; Ibuprocin; Ibuprofene; Ibuprofeno; Ibuprofenum; Ibuprohm; Ibuprom (TN); Ibuprophen; Ibuprosyn (TN); Ibusal; Ibutid; Ibux (TN); Ibuxin (TN); Ifen; Inabrin; Inflam; Inoven; Ipren; Ipren (TN); Irfen; Isodol; Jenaprofen; Junifen; Kesan; Kratalgin; Kratalgin (TN); Lamidon; Lebrufen; Librofem; Lidifen; Liptan; Lopane; Malafene; Manypren; Medicol (TN); Medipren; Melfen; Mensoton; Midol; Midol 200; Moment; Moment (TN); Motrin; Motrin (TN); Motrin IB; Mynosedin; Nagifen-D; Napacetin; Narfen; Narfen (TN); Neo-Helvagit; Neo-Mindol; Neobrufen; Neobrufen (TN); Neofen (TN); Nerofen; Noalgil; Nobafon; Nobfelon; Nobfen; Nobgen; Noritis; Norton; Norvectan (TN); Novadol; Novo-Profen; Novogent; Novogent N; Novoprofen; Nuprilan; Nuprin; Nuprin (TN); Nureflex (TN); Nurofen; Nurofen (TN); Optifen; Opturem; Oralfene; Orbifen (TN); Ostarin; Ostofen; Ozonol; Paduden; Panafen; Panafen (TN); Pantrop; Paxofen; Pedia-Profen; PediaProfen; Perifar (TN); Perofen; Proartinal; Profen; Profin (TN); Proflex; Provon; Quadrax; R.D. 13621; RD 13621; Rafen; Ranofen; Ratiodolor (TN); Rebugen; Relcofen; Retard (TN); Rhinadvil; Rimafen (TN); Rofen; Roidenin; Rufen; Rufin; Rupan; Sadefen; Salivia; Salprofen; Salvarina (TN); Seclodin; Sednafen; Seklodin; Seskafen; Siyafen; Solpaflex; Solpaflex (TN); Solufen; Spedifen (TN); Speedpain NANO (TN); Spidifen (TN); Stelar; Sugafen; Suprafen; Suspren; Syntofene; Tab-Profen; Tabalon; Tabalon 400; Tatanal; Tempil; Tofen; Togal N; Tonal; Trendar; U 18573; U-18,573; U-18573; UCB 79171; Unipron; Upfen; Upfen (TN); Uprofen; Urem; VUFB 9649; Zafen; Zofen DTD0111 VADRUGID DR00720 DTD0111 DRUGNAME Propicillin DTD0111 DRUGSYNO (1-Phenoxypropyl)penicillin; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxybutanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 551-27-9; 6beta-(2-phenoxybutanamido)-2,2-dimethylpenam-3alpha-carboxylic acid; 8X1R260V33; AC1L3P0Y; AC1Q5QWR; CHEBI:52429; EINECS 208-995-5; NCGC00160673-01; Propicilina; Propicilina [INN-Spanish]; Propicillin (BAN); Propicillin [INN:BAN:DCF]; Propicilline; Propicilline [INN-French]; Propicillinum; Propicillinum [INN-Latin]; UNII-8X1R260V33; phenoxypropylpenicillin DTD0112 TRANSPID DTD0112 DTD0112 GENENAME SLC16A8 DTD0112 PROTNAME Monocarboxylate transporter 3 DTD0112 SYNONYMS MCT 3; MCT3; REMP; SLC16A8; Solute carrier family 16 member 8 DTD0112 VADRUGID DR00333 DTD0112 DRUGNAME Phenylacetic acid DTD0112 DRUGSYNO .alpha.-Toluic acid; .omega.-Phenylacetic acid; 2-Phenylacetic acid; Acetic acid, phenyl-; Benzenacetic acid; Benzeneacetic acid; Benzylcarboxylic acid; Benzylformic acid; Kyselina fenyloctova; Kyselina fenyloctova [Czech]; PHENYL ACETIC ACID; PHENYL-ACETIC ACID; PHENYLACETIC ACID; Phenylacetic acid (natural); Phenylethanoic acid; Phenyllacetic acid; alpha-Toluic acid; omega-Phenylacetic acid; phenylacetate DTD0113 TRANSPID DTD0113 DTD0113 GENENAME SLC16A9 DTD0113 PROTNAME Monocarboxylate transporter 9 DTD0113 SYNONYMS C10orf36; MCT 9; MCT9; SLC16A9; Solute carrier family 16 member 9 DTD0113 VADRUGID DR00255 DTD0113 DRUGNAME L-carnitine DTD0113 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0113 VADRUGID DR00172 DTD0113 DRUGNAME Uric acid DTD0113 DRUGSYNO urate DTD0114 TRANSPID DTD0114 DTD0114 GENENAME SLC17A1 DTD0114 PROTNAME Sodium-dependent phosphate transport protein 1 DTD0114 SYNONYMS NAPI-1; NPT-1; NPT1; Na(+)/PI cotransporter 1; Na/Pi-4; Renal Na(+)-dependent phosphate cotransporter 1; Renal sodium-dependent phosphate transport protein 1; Renal sodium-phosphate transport protein 1; SLC17A1; Sodium/phosphate cotransporter 1; Solute carrier family 17 member 1 DTD0114 VADRUGID DR00132 DTD0114 DRUGNAME Phosphate DTD0114 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0114 VADRUGID DR00203 DTD0114 DRUGNAME Aspirin DTD0114 DRUGSYNO 2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate DTD0115 TRANSPID DTD0115 DTD0115 GENENAME SLC17A2 DTD0115 PROTNAME Sodium-dependent phosphate transport protein 3 DTD0115 SYNONYMS NPT3; Na(+/PI cotransporter 3; SLC17A2; Sodium/phosphate cotransporter 3; Solute carrier family 17 member 2 DTD0115 VADRUGID DR00067 DTD0115 DRUGNAME Aminohippuric acid DTD0115 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0116 TRANSPID DTD0116 DTD0116 GENENAME SLC17A3 DTD0116 PROTNAME Sodium-dependent phosphate transport protein 4 DTD0116 SYNONYMS GOUT4; NPT4; Na(+)/PI cotransporter 4; SLC17A3; Sodium/phosphate cotransporter 4; Solute carrier family 17 member 3; UAQTL4 DTD0116 VADRUGID DR00132 DTD0116 DRUGNAME Phosphate DTD0116 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0116 VADRUGID DR00067 DTD0116 DRUGNAME Aminohippuric acid DTD0116 DRUGSYNO 4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate DTD0117 TRANSPID DTD0117 DTD0117 GENENAME SLC17A4 DTD0117 PROTNAME Probable small intestine urate exporter DTD0117 SYNONYMS KAIA2138; SLC17A4; Solute carrier family 17 member 4 DTD0117 VADRUGID DR00556 DTD0117 DRUGNAME Salicylic acid DTD0117 DRUGSYNO 2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon DTD0117 VADRUGID DR00132 DTD0117 DRUGNAME Phosphate DTD0117 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0117 VADRUGID DR00045 DTD0117 DRUGNAME Pravastatin DTD0117 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0117 VADRUGID DR00203 DTD0117 DRUGNAME Aspirin DTD0117 DRUGSYNO 2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate DTD0117 VADRUGID DR00663 DTD0117 DRUGNAME Ibuprofen DTD0117 DRUGSYNO ACHES-N-PAIN; Act-3; Act-3 (TN); Actiprofen; Adex 200; Adran; Advil; Advil (TN); Ak+C2278tren; Aktre (TN); Alaxan; Alaxan (TN); Algofen; Algoflex (TN); Alivium (TN); Am-Fam 400; Amelior; Amersol; Amibufen; Anafen; Anco; Andran; Anflagen; Antagil; Antalfene; Antarene; Antiflam; Apsifen; Apsifen-F; Arthrofen (TN); Artofen; Artril; Artril 300; Balkaprofen; Betaprofen; Bloom; Bluton; Bonifen (TN); Brofen; Brufanic; Brufen; Brufen (TN); Brufen 400; Bruflam; Brufort; Buburone; Bufeno; Bufigen; Bugesic (TN); Bukrefen; Bupron; Buracaps; Burana; Burana (TN); Butylenin; Caldolor (TN); Calprofen (TN); Cap-Profen; Carol;Cesra; Citalgan; Cobo; Codral; Combiflam; Cunil; DOLO PUREN; Daiprophen; Dalsy; Dalsy (TN); Dansida; Deep Relief; Dentigoa; Dibufen; Dignoflex; Dismenol (TN); Diverin (TN); Dolgirid; Dolgit; Dolgit (TN); Dolibu; Dolmaral; Dolo-Dolgit; Dolo-Spedifen (TN); Dolocyl; Dolofen; Dolofen-F; Dolofin; Dolofort; Dolofort (TN); Dologel; Dolomax; Doloraz (TN); Doloren; Dolormin; Dolormin (TN); Doltibil; Dolven; Donjust B; Dorival; Dorival (TN); Drin; Duafen; Duobrus; Dura-Ibu; Dysdolen; Easifon; Ebufac; Ebufac (TN); Emflam; Emflam-200; EmuProfen (TN); Epobron; Eputex; Ergix; Espidifen (TN); Esprenit; Eve (TN); Exneural; Faspic; Femadon; Femafen; Femapirin; Femidol; Fenbid (TN); Fenbid;Fendol; Fenpaed (TN); Fenspan; Fibraflex; Finalflex (TN); Galprofen (TN); Gelufene; Gofen; Grefen; Gynofug; Haltran; Hedex (TN); Herron Blue (TN); I 4883; I-profen (TN); IB-100; IBU-Ratiopharm (TN); IBUFEN (TN); IP 82; IP-82; IP82; Ibalgin (TN); Ibol; Ibren; Ibu; Ibu-Attritin; Ibu-Tab; Ibu-Tab 200; Ibu-Vivimed (TN); Ibu-slo; Ibu-slow; IbuHEXAL (TN); Ibubest; Ibubeta; Ibucasen; Ibudol; Ibudolor; Ibufen; Ibuflamar; Ibufug; Ibugel; Ibugel (TN); Ibugen; Ibugesic; Ibuhexal; Ibulagic; Ibular; Ibulav; Ibuleve; Ibuleve (TN); Ibulgan; Ibum (TN); Ibumax (TN); Ibumed; Ibumerck; Ibumetin; Ibumetin (TN); Ibupirac; Ibuprin; Ibuprocin; Ibuprofene; Ibuprofeno; Ibuprofenum; Ibuprohm; Ibuprom (TN); Ibuprophen; Ibuprosyn (TN); Ibusal; Ibutid; Ibux (TN); Ibuxin (TN); Ifen; Inabrin; Inflam; Inoven; Ipren; Ipren (TN); Irfen; Isodol; Jenaprofen; Junifen; Kesan; Kratalgin; Kratalgin (TN); Lamidon; Lebrufen; Librofem; Lidifen; Liptan; Lopane; Malafene; Manypren; Medicol (TN); Medipren; Melfen; Mensoton; Midol; Midol 200; Moment; Moment (TN); Motrin; Motrin (TN); Motrin IB; Mynosedin; Nagifen-D; Napacetin; Narfen; Narfen (TN); Neo-Helvagit; Neo-Mindol; Neobrufen; Neobrufen (TN); Neofen (TN); Nerofen; Noalgil; Nobafon; Nobfelon; Nobfen; Nobgen; Noritis; Norton; Norvectan (TN); Novadol; Novo-Profen; Novogent; Novogent N; Novoprofen; Nuprilan; Nuprin; Nuprin (TN); Nureflex (TN); Nurofen; Nurofen (TN); Optifen; Opturem; Oralfene; Orbifen (TN); Ostarin; Ostofen; Ozonol; Paduden; Panafen; Panafen (TN); Pantrop; Paxofen; Pedia-Profen; PediaProfen; Perifar (TN); Perofen; Proartinal; Profen; Profin (TN); Proflex; Provon; Quadrax; R.D. 13621; RD 13621; Rafen; Ranofen; Ratiodolor (TN); Rebugen; Relcofen; Retard (TN); Rhinadvil; Rimafen (TN); Rofen; Roidenin; Rufen; Rufin; Rupan; Sadefen; Salivia; Salprofen; Salvarina (TN); Seclodin; Sednafen; Seklodin; Seskafen; Siyafen; Solpaflex; Solpaflex (TN); Solufen; Spedifen (TN); Speedpain NANO (TN); Spidifen (TN); Stelar; Sugafen; Suprafen; Suspren; Syntofene; Tab-Profen; Tabalon; Tabalon 400; Tatanal; Tempil; Tofen; Togal N; Tonal; Trendar; U 18573; U-18,573; U-18573; UCB 79171; Unipron; Upfen; Upfen (TN); Uprofen; Urem; VUFB 9649; Zafen; Zofen DTD0118 TRANSPID DTD0118 DTD0118 GENENAME SLC17A5 DTD0118 PROTNAME Vesicular H(+)/Aspartate-glutamate cotransporter DTD0118 SYNONYMS AST; H(+)/nitrate cotransporter; ISSD; Membrane glycoprotein HP59; NSD; SD; SIASD; SLC17A5; SLD; Sialin; Solute carrier family 17 member 5; H(+)/sialic acid cotransporter DTD0118 VADRUGID DR01243 DTD0118 DRUGNAME N-acetylaspartylglutamate DTD0118 DRUGSYNO NAAG; isospaglumic acid; spaglumic acid DTD0118 VADRUGID DR00009 DTD0118 DRUGNAME Nitrate DTD0118 DRUGSYNO 14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V) DTD0119 TRANSPID DTD0119 DTD0119 GENENAME SLC17A6 DTD0119 PROTNAME Vesicular glutamate transporter 2 DTD0119 SYNONYMS DNPI; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; SLC17A6; Solute carrier family 17 member 6; VGluT2 DTD0119 VADRUGID DR00132 DTD0119 DRUGNAME Phosphate DTD0119 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0119 VADRUGID DR00005 DTD0119 DRUGNAME L-glutamic acid DTD0119 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0120 TRANSPID DTD0120 DTD0120 GENENAME SLC17A7 DTD0120 PROTNAME Vesicular glutamate transporter 1 DTD0120 SYNONYMS BNPI; Brain-specific Na(+)-dependent inorganic phosphate cotransporter; SLC17A7; Solute carrier family 17 member 7; VGluT1 DTD0120 VADRUGID DR00132 DTD0120 DRUGNAME Phosphate DTD0120 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0120 VADRUGID DR00005 DTD0120 DRUGNAME L-glutamic acid DTD0120 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0121 TRANSPID DTD0121 DTD0121 GENENAME SLC17A8 DTD0121 PROTNAME Vesicular glutamate transporter 3 DTD0121 SYNONYMS DFNA25; SLC17A8; Solute carrier family 17 member 8; VGluT3 DTD0121 VADRUGID DR00005 DTD0121 DRUGNAME L-glutamic acid DTD0121 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0123 TRANSPID DTD0123 DTD0123 GENENAME SLC18A1 DTD0123 PROTNAME Vesicular amine transporter 1 DTD0123 SYNONYMS Chromaffin granule amine transporter; Solute carrier family 18 member 1; VAT1; VMAT1; SLC18A1 DTD0123 VADRUGID DR00189 DTD0123 DRUGNAME Serotonin DTD0123 DRUGSYNO 1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY DTD0123 VADRUGID DR00268 DTD0123 DRUGNAME Norepinephrine DTD0123 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0123 VADRUGID DR00283 DTD0123 DRUGNAME Dopamine DTD0123 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0123 VADRUGID DR00081 DTD0123 DRUGNAME Ergotidine DTD0123 DRUGSYNO 1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine DTD0124 TRANSPID DTD0124 DTD0124 GENENAME SLC18A3 DTD0124 PROTNAME Vesicular acetylcholine transporter DTD0124 SYNONYMS CMS21; SLC18A3; Solute carrier family 18 member 3; VAChT DTD0124 VADRUGID DR00070 DTD0124 DRUGNAME Acetylcholine DTD0124 DRUGSYNO Miochol; Miochol-e DTD0125 TRANSPID DTD0125 DTD0125 GENENAME SLC18B1 DTD0125 PROTNAME MFS-type transporter SLC18B1 DTD0125 SYNONYMS C6orf192; SLC18B1; Solute carrier family 18 member B1; dJ55C23.6 DTD0125 VADRUGID DR01249 DTD0125 DRUGNAME Spermine DTD0125 DRUGSYNO 1,4-Bis(aminopropyl) butanediamine; 1,4-Bis(aminopropyl)butanediamine; 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-; 1,4-Diaminobutane, N,N'-bis; 4,9-Diaza-1,12-dodecanediamine; 4,9-Diazadodecamethylenediamine; 4,9-Diazadodecane-1,12-diamine; 71-44-3; Diaminopropyltetramethylenediamine; N,N'-Bis(3-aminopropyl)-1,4-butanediamine; N,N'-Bis(3-aminopropyl)butane-1,4-diamine; N1,N1'-(Butane-1,4-diyl)bis(propane-1,3-diamine); Spermin; Spermine Derivative; Spermine, puriss; UNII-2FZ7Y3VOQX; gerontine; musculamine; neuridine; spermine DTD0125 VADRUGID DR01250 DTD0125 DRUGNAME Spermidine DTD0125 DRUGSYNO 124S209; 1pot; 4-04-00-01300 (Beilstein Handbook Reference); =99% (GC); AC1L1AQB; ACMC-20ajn3; AI3-26636; AJ-26792; AKOS006222987; AN-22947; ATHGHQPFGPMSJY-UHFFFAOYSA-N; Aminopropylbutandiamine; BDBM50009353; BPBio1_001276; BRN 1698591; BSPBio_002613; Biomol-NT_000212; C00315; CCG-205124; CHEBI:16610; CHEMBL19612; CS-0013804; CTK3J1693; DB-026892; DB03566; DTXSID4036645; DivK1c_001007; EINECS 204-689-0; FT-0629162; GTPL2390; HY-B1776; IDI1_001007; KBio1_001007; KBio2_000345; KBio2_002913; KBio2_005481; KBio3_001833; KBioGR_001542; KBioSS_000345; LS-45643; Lopac-S-2501; Lopac0_001047; M923; MCULE-8096530192; MFCD00008229; MolPort-001-761-230; N-(3-Aminopropyl)-4-aminobutylamine; N-(4-Aminobutyl)-1,3-diaminopropane; NCGC00015937-01; NCGC00015937-02; NCGC00015937-03; NCGC00015937-04; NCGC00015937-05; NCGC00024903-01; NCGC00024903-02; NCGC00024903-03; NCI60_004294; NINDS_001007; NSC528399; PA(34); RTR-003757; SC-69371; SCHEMBL15618; SDCCGMLS-0066822.P001; SPBio_000947; SR0; ST24048721; ST45025991; Spectrum2_000874; Spectrum3_000977; Spectrum4_001101; Spectrum5_001561; Spectrum_000005; Spermidin; Spermidine 0.1 M solution; Spermidine hydrochloride; Spermidine, > Spermidine, analytical standard; TR-003757; Tocris-0959; U87FK77H25; UNII-U87FK77H25; ZINC1532612; bmse000116; bmse000951; bmse000955 DTD0126 TRANSPID DTD0126 DTD0126 GENENAME SLC19A1 DTD0126 PROTNAME Folate transporter 1 DTD0126 SYNONYMS CHMD; FLOT1; FOLT; IFC-1; IFC1; Intestinal folate carrier 1; Placental folate transporter; REFC; RFC; RFC1; Reduced folate carrier protein; SLC19A1; Solute carrier family 19 member 1 DTD0126 VADRUGID DR00041 DTD0126 DRUGNAME Pralatrexate DTD0126 DRUGSYNO Folotyn (TN) DTD0126 VADRUGID DR00082 DTD0126 DRUGNAME Methotrexate DTD0126 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0126 VADRUGID DR00318 DTD0126 DRUGNAME Pemetrexed DTD0126 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0126 VADRUGID DR00134 DTD0126 DRUGNAME Folic acid DTD0126 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0127 TRANSPID DTD0127 DTD0127 GENENAME SLC19A2 DTD0127 PROTNAME Thiamine transporter 1 DTD0127 SYNONYMS SLC19A2; Solute carrier family 19 member 2; TC1; THMD1; THT1; TRMA; ThTr-1; ThTr1; Thiamine carrier 1 DTD0127 VADRUGID DR00133 DTD0127 DRUGNAME Metformin DTD0127 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0128 TRANSPID DTD0128 DTD0128 GENENAME SLC19A3 DTD0128 PROTNAME Thiamine transporter 2 DTD0128 SYNONYMS BBGD; SLC19A3; Solute carrier family 19 member 3; THMD2; ThTr-2; ThTr2 DTD0128 VADRUGID DR00133 DTD0128 DRUGNAME Metformin DTD0128 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0128 VADRUGID DR00117 DTD0128 DRUGNAME Vitamin B1 DTD0128 DRUGSYNO 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride DTD0129 TRANSPID DTD0129 DTD0129 GENENAME SLC1A1 DTD0129 PROTNAME Excitatory amino acid transporter 3 DTD0129 SYNONYMS DCBXA; EAAC1; EAAT3; Excitatory amino-acid carrier 1; Neuronal and epithelial glutamate transporter; SCZD18; SLC1A1; Sodium-dependent glutamate/aspartate transporter 3; Solute carrier family 1 member 1 DTD0129 VADRUGID DR00005 DTD0129 DRUGNAME L-glutamic acid DTD0129 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0130 TRANSPID DTD0130 DTD0130 GENENAME SLC1A2 DTD0130 PROTNAME Excitatory amino acid transporter 2 DTD0130 SYNONYMS EAAT2; EIEE41; GLT-1; GLT1; Glutamate/aspartate transporter II; HBGT; SLC1A2; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2 DTD0130 VADRUGID DR00005 DTD0130 DRUGNAME L-glutamic acid DTD0130 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0131 TRANSPID DTD0131 DTD0131 GENENAME SLC1A3 DTD0131 PROTNAME Excitatory amino acid transporter 1 DTD0131 SYNONYMS EA6; EAAT1; GLAST; GLAST-1; GLAST1; SLC1A3; Sodium-dependent glutamate/aspartate transporter 1; Solute carrier family 1 member 3 DTD0131 VADRUGID DR00005 DTD0131 DRUGNAME L-glutamic acid DTD0131 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0132 TRANSPID DTD0132 DTD0132 GENENAME SLC1A4 DTD0132 PROTNAME Alanine/serine/cysteine/threonine transporter 1 DTD0132 SYNONYMS ASCT-1; ASCT1; Neutral amino acid transporter A; SATT; SLC1A4; SPATCCM; Solute carrier family 1 member 4 DTD0132 VADRUGID DR00142 DTD0132 DRUGNAME L-alanine DTD0132 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0132 VADRUGID DR00047 DTD0132 DRUGNAME D-serine DTD0132 DRUGSYNO (2R)-2-amino-3-hydroxy-propanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; (2R)-serine; (R)-2-Amino-3-hydroxypropionic acid; (R)-2-amino-3-hydroxypropanoic acid; (R)-Serine; 1K77H2Z9B1; AI3-18476; CHEBI:16523; CHEMBL285123; D-2-Amino-3-hydroxypropanoic acid; D-2-Amino-3-hydroxypropionic Acid; D-Ser; D-Serin; D-Serine, 98%; DSN; EINECS 206-229-4; MFCD00004269; MTCFGRXMJLQNBG-UWTATZPHSA-N; NCGC00094363-03; NSC 77689; NSC77689; Serine D-form; Serine, D-; UNII-1K77H2Z9B1; [3h]-d-serine; d-(+)-serine; serine d- DTD0133 TRANSPID DTD0133 DTD0133 GENENAME SLC1A5 DTD0133 PROTNAME Alanine/serine/cysteine/threonine transporter 2 DTD0133 SYNONYMS AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5 DTD0133 VADRUGID DR00027 DTD0133 DRUGNAME Ganciclovir DTD0133 DRUGSYNO 2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan DTD0133 VADRUGID DR00404 DTD0133 DRUGNAME Valganciclovir DTD0133 DRUGSYNO 5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one; Cymeval; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester; L-Valine, ester with ganciclovir; RO1079070/194; RS 79070; Valcyte (TN); Valganciclovir (INN); Valganciclovir (Oral); Valganciclovir [INN:BAN]; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate DTD0133 VADRUGID DR00242 DTD0133 DRUGNAME Glycine DTD0133 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0133 VADRUGID DR00255 DTD0133 DRUGNAME L-carnitine DTD0133 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0133 VADRUGID DR00024 DTD0133 DRUGNAME L-glutamine DTD0133 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0133 VADRUGID DR00325 DTD0133 DRUGNAME Acyclovir DTD0133 DRUGSYNO 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension DTD0133 VADRUGID DR00078 DTD0133 DRUGNAME Valacyclovir DTD0133 DRUGSYNO 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN) DTD0133 VADRUGID DR00047 DTD0133 DRUGNAME D-serine DTD0133 DRUGSYNO (2R)-2-amino-3-hydroxy-propanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; (2R)-serine; (R)-2-Amino-3-hydroxypropionic acid; (R)-2-amino-3-hydroxypropanoic acid; (R)-Serine; 1K77H2Z9B1; AI3-18476; CHEBI:16523; CHEMBL285123; D-2-Amino-3-hydroxypropanoic acid; D-2-Amino-3-hydroxypropionic Acid; D-Ser; D-Serin; D-Serine, 98%; DSN; EINECS 206-229-4; MFCD00004269; MTCFGRXMJLQNBG-UWTATZPHSA-N; NCGC00094363-03; NSC 77689; NSC77689; Serine D-form; Serine, D-; UNII-1K77H2Z9B1; [3h]-d-serine; d-(+)-serine; serine d- DTD0133 VADRUGID DR00244 DTD0133 DRUGNAME L-threonine DTD0133 DRUGSYNO Threonine DTD0133 VADRUGID DR01184 DTD0133 DRUGNAME Nitric oxide DTD0133 DRUGSYNO HNO; ()NO; 10102-43-9; AC1L3QHF; Bioxyde d'azote; Bioxyde d'azote [French]; CHEBI:16480; CHEMBL1200689; CTK0H7679; DTXSID1020938; EDRF; Endogenous Nitrate Vasodilator; Endothelium-Derived Nitric Oxide; Endothelium-derived relaxing factor (EDRF); INOmax; INOmax (TN); Mononitrogen monoxide; Monoxide, Mononitrogen; Monoxide, Nitrogen; Monoxido de nitrogeno; Monoxyde d'azote; NITRIC-OXIDE; NO(); Nitrate Vasodilator, Endogenous; Nitric Oxide, Endothelium Derived; Nitric Oxide, Endothelium-Derived; Nitric oxide; Nitric oxide (JAN); Nitric oxide 10% by volume or more; Nitric oxide trimer; Nitric oxide, 985%; Nitric oxide, compressed [UN1660] [Poison gas]; Nitrogen monoxide; Nitrogen oxide (NO); Nitrogen(II) oxide; Nitrosoradical; Nitrosyl; Nitrosyl hydride; Nitrosyl hydride ((NO)H); Nitrosyl radical; Nitroxide radical; Nitroxyl; OHM 11771; Oxide, Nitric; Oxido de nitrogeno(II); Oxido nitrico; Oxidonitrogen; Oxoazanyl; Oxyde azotique; Oxyde nitrique [French]; Stickmonoxyd; Stickmonoxyd [German]; Stickstoff(II)-oxid; Stickstoffmonoxid; Vasodilator, Endogenous Nitrate; [NO]; endothelium-derived relaxing factor; monoxido de nitrogeno; monoxyde d'azote; nitric oxide; nitrogen monoxide; nitrogen protoxide; nitrosyl; oxido de nitrogeno(II); oxido nitrico; oxidonitrogen; oxoazanyl; oxyde azotique DTD0134 TRANSPID DTD0134 DTD0134 GENENAME SLC1A6 DTD0134 PROTNAME Excitatory amino acid transporter 4 DTD0134 SYNONYMS EAAT4; SLC1A6; Sodium-dependent glutamate/aspartate transporter; Solute carrier family 1 member 6 DTD0134 VADRUGID DR00005 DTD0134 DRUGNAME L-glutamic acid DTD0134 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0135 TRANSPID DTD0135 DTD0135 GENENAME SLC1A7 DTD0135 PROTNAME Excitatory amino acid transporter 5 DTD0135 SYNONYMS EAAT5; Retinal glutamate transporter; SLC1A7; Solute carrier family 1 member 7 DTD0135 VADRUGID DR00005 DTD0135 DRUGNAME L-glutamic acid DTD0135 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0136 TRANSPID DTD0136 DTD0136 GENENAME SLC20A1 DTD0136 PROTNAME Sodium-dependent phosphate transporter 1 DTD0136 SYNONYMS GLVR-1; GLVR1; Gibbon ape leukemia virus receptor 1; Leukemia virus receptor 1 homolog; PIT1; Phosphate transporter 1; PiT-1; SLC20A1; Solute carrier family 20 member 1 DTD0136 VADRUGID DR00132 DTD0136 DRUGNAME Phosphate DTD0136 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0137 TRANSPID DTD0137 DTD0137 GENENAME SLC20A2 DTD0137 PROTNAME Sodium-dependent phosphate transporter 2 DTD0137 SYNONYMS GLVR-2; GLVR2; Gibbon ape leukemia virus receptor 2; IBGC1; IBGC3; MLVAR; Phosphate transporter 2; PiT-2; Pit2; RAM1; Ram-1; SLC20A2; Solute carrier family 20 member 2; hPit2 DTD0137 VADRUGID DR00132 DTD0137 DRUGNAME Phosphate DTD0137 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0139 TRANSPID DTD0139 DTD0139 GENENAME SLC22A13 DTD0139 PROTNAME Organic cation transporter-like 3 DTD0139 SYNONYMS OAT10; OCTL1; OCTL3; ORCTL-3; ORCTL3; SLC22A13; Solute carrier family 22 member 13 DTD0139 VADRUGID DR00352 DTD0139 DRUGNAME Aspartic acid DTD0139 DRUGSYNO (2S)-2-aminobutanedioic acid; (2S)-Aspartic acid; (S)-2-Aminosuccinic acid; (S)-Aminobutanedioic acid; (S)-Aspartic acid; Acidum asparticum; Aminosuccinic acid; Asparagic acid; Asparaginic acid; Asparaginsaeure [German]; Aspartate, L-; Aspartic acid, L-; Aspatofort; Butanedioic acid, amino-, (S); H-Asp-OH; L-(+)-Aspartic acid; L-2-Aminobutanedioic acid; L-Aminosuccinic acid; L-Asp; L-Asparagic acid; L-Asparaginic acid; L-Asparaginsaeure; L-Asparaginsyra; L-Aspartinsaeure; L-aspartate; L-aspartic acid; aspartate; aspartic acid DTD0139 VADRUGID DR00005 DTD0139 DRUGNAME L-glutamic acid DTD0139 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0142 TRANSPID DTD0142 DTD0142 GENENAME SLC22A16 DTD0142 PROTNAME Fly-like putative transporter 2 DTD0142 SYNONYMS OCT6; CT2; Carnitine transporter 2; FLIPT2; Flipt 2; HEL-S-18; OKB1; Organic cation transporter OKB1; SLC22A16; Solute carrier family 22 member 16; dJ261K5.1; Organic cation/carnitine transporter 6 DTD0142 VADRUGID DR00301 DTD0142 DRUGNAME Doxorubicin DTD0142 DRUGSYNO 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox DTD0142 VADRUGID DR00255 DTD0142 DRUGNAME L-carnitine DTD0142 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0145 TRANSPID DTD0145 DTD0145 GENENAME SLC22A20 DTD0145 PROTNAME Organic anion transporter 6 DTD0145 SYNONYMS SLC22A20; SLC22A20P; OAT6; Solute carrier family 22 member 20; Solute carrier family 22 member 20 pseudogene DTD0145 VADRUGID DR00019 DTD0145 DRUGNAME Estrone sulfate DTD0145 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0146 TRANSPID DTD0146 DTD0146 GENENAME SLC22A23 DTD0146 PROTNAME Solute carrier family 22 member 23 DTD0146 SYNONYMS C6orf85; SLC22A23; Solute carrier 22 member 23 DTD0146 VADRUGID DR00855 DTD0146 DRUGNAME Quetiapine DTD0146 DRUGSYNO 111974-69-7; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol; 2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; BGL0JSY5SI; C21H25N3O2S; CHEBI:8707; CHEMBL716; Co-Quetiapine; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-; Ketipinor (TN); NCGC00095911-03; Norsic; Norsic (TN); PD-172760; Quetiapina; Quetiapine (INN); Quetiapine [INN:BAN]; Quetiapine hemifumarate; Quetiapinum; Seroquel (Fumarate); Seroquel (TN); UNII-BGL0JSY5SI; URKOMYMAXPYINW-UHFFFAOYSA-N; quetiapine DTD0151 TRANSPID DTD0151 DTD0151 GENENAME SLC22A4 DTD0151 PROTNAME Organic cation/carnitine transporter 1 DTD0151 SYNONYMS DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H DTD0151 VADRUGID DR00416 DTD0151 DRUGNAME Cytarabine DTD0151 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0151 VADRUGID DR00264 DTD0151 DRUGNAME Verapamil DTD0151 DRUGSYNO (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil DTD0151 VADRUGID DR00054 DTD0151 DRUGNAME Quinine DTD0151 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0151 VADRUGID DR00255 DTD0151 DRUGNAME L-carnitine DTD0151 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0151 VADRUGID DR00277 DTD0151 DRUGNAME Ipratropium DTD0151 DRUGSYNO (+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate DTD0151 VADRUGID DR00217 DTD0151 DRUGNAME Gabapentin DTD0151 DRUGSYNO 1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID DTD0151 VADRUGID DR00106 DTD0151 DRUGNAME Tetraethylammonium DTD0151 DRUGSYNO 4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium DTD0152 TRANSPID DTD0152 DTD0152 GENENAME SLC22A9 DTD0152 PROTNAME Organic anion transporter 7 DTD0152 SYNONYMS OAT7; SLC22A9; Solute carrier family 22 member 9; UST3; UST3H DTD0152 VADRUGID DR00045 DTD0152 DRUGNAME Pravastatin DTD0152 DRUGSYNO (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten DTD0155 TRANSPID DTD0155 DTD0155 GENENAME SLC22B3 DTD0155 PROTNAME Synaptic vesicle glycoprotein 2C DTD0155 SYNONYMS KIAA1054; SV2C; Synaptic vesicle glycoprotein SV2C DTD0155 VADRUGID DR00283 DTD0155 DRUGNAME Dopamine DTD0155 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0158 TRANSPID DTD0158 DTD0158 GENENAME SLC23A1 DTD0158 PROTNAME Sodium-dependent vitamin C transporter 1 DTD0158 SYNONYMS Na(+)/L-ascorbic acid transporter 1; SLC23A1; SVCT1; Solute carrier family 23 member 1; YSPL3; Yolk sac permease-like molecule 3; hSVCT1 DTD0158 VADRUGID DR00289 DTD0158 DRUGNAME Vitamin C DTD0158 DRUGSYNO (2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one; 3-Keto-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone (enol form); Acid Ascorbic; Acide ascorbique; Acide ascorbique [INN-French]; Acido ascorbico; Acido ascorbico [INN-Spanish]; Acidum ascorbicum; Acidum ascorbicum [INN-Latin]; Acidum ascorbinicum; Adenex; Allercorb; Antiscorbic vita min; Antiscorbic vitamin; Antiscorbutic factor; Antiscorbutic vitamin; Arco-cee; Ascoltin; Ascoltin (TN); Ascor-B.I.D.; Ascor-b.i.d; Ascorb; Ascorbajen; Ascorbate; Ascorbic Acid, Monosodium Salt; Ascorbic acid; Ascorbic acid (JP15/USP/INN); Ascorbic acid [BAN:INN:JAN]; Ascorbic acid [INN:BAN:JAN]; Ascorbicab; Ascorbicap; Ascorbicap (TN); Ascorbicin; Ascorbinsaeure; Ascorbutina; Ascorbyl radical; Ascorin; Ascorteal; Ascorvit; C-Level; C-Long; C-Quin; C-Span; C-Vimin; CE-VI-Sol; Cantan; Cantaxin; Catavin C; Ce lent; Ce-Mi-Lin; Cebicure; Cebid; Cebion; Cebione; Cecon; Cee-Vite; Cee-caps td; Cegiolan; Ceglion; Celaskon; Celin; Cemagyl; Cemill; Cenetone; Cenolate; Cereon; Cergona; Cescorbat; Cetamid; Cetane-Caps TC; Cetane-Caps TD; Cetebe; Cetemican; Cevalin; Cevatine; Cevex; Cevi-Bid; Cevibid; Cevimin; Cevital; Cevitamic acid; Cevitamin; Cevitan; Cevitex; Cewin; Ciamin; Cipca; Citriscorb; Colascor; Component of Cortalex; Component of E and C-Level; Component of Endoglobin Forte; Component of Ferancee; Concemin; Cortalex; Davitamon C; Dora-C-500; Duoscorb; Ferancee; Ferrous ascorbate; Hicee; Hybrin; IDO-C; Iron(II) ascorbate; Iron-ascorbic acid complexes;L-Ascorbic acid; Kyselina askorbova; Kyselina askorbova [Czech]; L(+)-Ascorbic acid; L-(+)-Ascorbic Acid; L-3-Ketothreohexuronic acid lactone; L-3-ketothreohexuronic acid; L-Ascorbic acid, free radical form; L-Lyxoascorbic acid; L-Threoascorbic acid; L-Xyloascorbic acid; L-ascorbate; L-ascorbic acid; L-threo-Hex-2-enonic acid, gamma-lactone; L-threo-ascorbic acid; L-threo-hex-1-eofuranos-3-ulose; L-threo-hex-2-enono-1,4-lactone; Laroscorbine; Lemascorb; Liqui-Cee; Magnesium Ascorbicum; Magnorbin; Meri-C; Monodehydroascorbic acid; Natrascorb; Natrascorb injectable; Oral Vitamin C; Planavit C; Proscorbin; Redoxon; Ribena; Roscorbi c; Roscorbic; Scorbacid; Scorbu-C; Secorbate; Semidehydroascorbate; Sodascorbate; Sodium Ascorbate (Ascorbic Acid); Stuartinic; Sunkist; Testascorbic; Tolfrinic; Vicelat; Vicin; Vicomin C; Viforcit; Viscorin; Vitace; Vitacee; Vitacimin; Vitacin; Vitamin-C; Vitamisin; Vitascorbol; Xitix DTD0159 TRANSPID DTD0159 DTD0159 GENENAME SLC23A2 DTD0159 PROTNAME Sodium-dependent vitamin C transporter 2 DTD0159 SYNONYMS KIAA0238; NBTL1; Na(+)/L-ascorbic acid transporter 2; Nucleobase transporter-like 1 protein; SLC23A2; SVCT2; Solute carrier family 23 member 2; YSPL2; Yolk sac permease-like molecule 2; hSVCT2 DTD0159 VADRUGID DR00289 DTD0159 DRUGNAME Vitamin C DTD0159 DRUGSYNO (2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one; 3-Keto-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone (enol form); Acid Ascorbic; Acide ascorbique; Acide ascorbique [INN-French]; Acido ascorbico; Acido ascorbico [INN-Spanish]; Acidum ascorbicum; Acidum ascorbicum [INN-Latin]; Acidum ascorbinicum; Adenex; Allercorb; Antiscorbic vita min; Antiscorbic vitamin; Antiscorbutic factor; Antiscorbutic vitamin; Arco-cee; Ascoltin; Ascoltin (TN); Ascor-B.I.D.; Ascor-b.i.d; Ascorb; Ascorbajen; Ascorbate; Ascorbic Acid, Monosodium Salt; Ascorbic acid; Ascorbic acid (JP15/USP/INN); Ascorbic acid [BAN:INN:JAN]; Ascorbic acid [INN:BAN:JAN]; Ascorbicab; Ascorbicap; Ascorbicap (TN); Ascorbicin; Ascorbinsaeure; Ascorbutina; Ascorbyl radical; Ascorin; Ascorteal; Ascorvit; C-Level; C-Long; C-Quin; C-Span; C-Vimin; CE-VI-Sol; Cantan; Cantaxin; Catavin C; Ce lent; Ce-Mi-Lin; Cebicure; Cebid; Cebion; Cebione; Cecon; Cee-Vite; Cee-caps td; Cegiolan; Ceglion; Celaskon; Celin; Cemagyl; Cemill; Cenetone; Cenolate; Cereon; Cergona; Cescorbat; Cetamid; Cetane-Caps TC; Cetane-Caps TD; Cetebe; Cetemican; Cevalin; Cevatine; Cevex; Cevi-Bid; Cevibid; Cevimin; Cevital; Cevitamic acid; Cevitamin; Cevitan; Cevitex; Cewin; Ciamin; Cipca; Citriscorb; Colascor; Component of Cortalex; Component of E and C-Level; Component of Endoglobin Forte; Component of Ferancee; Concemin; Cortalex; Davitamon C; Dora-C-500; Duoscorb; Ferancee; Ferrous ascorbate; Hicee; Hybrin; IDO-C; Iron(II) ascorbate; Iron-ascorbic acid complexes;L-Ascorbic acid; Kyselina askorbova; Kyselina askorbova [Czech]; L(+)-Ascorbic acid; L-(+)-Ascorbic Acid; L-3-Ketothreohexuronic acid lactone; L-3-ketothreohexuronic acid; L-Ascorbic acid, free radical form; L-Lyxoascorbic acid; L-Threoascorbic acid; L-Xyloascorbic acid; L-ascorbate; L-ascorbic acid; L-threo-Hex-2-enonic acid, gamma-lactone; L-threo-ascorbic acid; L-threo-hex-1-eofuranos-3-ulose; L-threo-hex-2-enono-1,4-lactone; Laroscorbine; Lemascorb; Liqui-Cee; Magnesium Ascorbicum; Magnorbin; Meri-C; Monodehydroascorbic acid; Natrascorb; Natrascorb injectable; Oral Vitamin C; Planavit C; Proscorbin; Redoxon; Ribena; Roscorbi c; Roscorbic; Scorbacid; Scorbu-C; Secorbate; Semidehydroascorbate; Sodascorbate; Sodium Ascorbate (Ascorbic Acid); Stuartinic; Sunkist; Testascorbic; Tolfrinic; Vicelat; Vicin; Vicomin C; Viforcit; Viscorin; Vitace; Vitacee; Vitacimin; Vitacin; Vitamin-C; Vitamisin; Vitascorbol; Xitix DTD0168 TRANSPID DTD0168 DTD0168 GENENAME SLC25A10 DTD0168 PROTNAME Mitochondrial dicarboxylate carrier DTD0168 SYNONYMS DIC; SLC25A10; Solute carrier family 25 member 10 DTD0168 VADRUGID DR00132 DTD0168 DRUGNAME Phosphate DTD0168 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0168 VADRUGID DR00060 DTD0168 DRUGNAME Sulfate DTD0168 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0169 TRANSPID DTD0169 DTD0169 GENENAME SLC25A11 DTD0169 PROTNAME Mitochondrial 2-oxoglutarate/malate carrier DTD0169 SYNONYMS OGC; OGCP; SLC20A4; SLC25A11; Solute carrier family 25 member 11 DTD0169 VADRUGID DR00139 DTD0169 DRUGNAME Alpha-ketoglutaric acid DTD0169 DRUGSYNO 2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate DTD0170 TRANSPID DTD0170 DTD0170 GENENAME SLC25A12 DTD0170 PROTNAME Calcium-binding mitochondrial carrier protein Aralar1 DTD0170 SYNONYMS AGC1; ARALAR; ARALAR1; EIEE39; Mitochondrial aspartate glutamate carrier 1; SLC25A12; Solute carrier family 25 member 12 DTD0170 VADRUGID DR00005 DTD0170 DRUGNAME L-glutamic acid DTD0170 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0171 TRANSPID DTD0171 DTD0171 GENENAME SLC25A13 DTD0171 PROTNAME Calcium-binding mitochondrial carrier protein Aralar2 DTD0171 SYNONYMS ARALAR2; CTLN2; Citrin; Mitochondrial aspartate glutamate carrier 2; SLC25A13; Solute carrier family 25 member 13 DTD0171 VADRUGID DR00005 DTD0171 DRUGNAME L-glutamic acid DTD0171 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0175 TRANSPID DTD0175 DTD0175 GENENAME SLC25A16 DTD0175 PROTNAME Graves disease carrier protein DTD0175 SYNONYMS D10S105E; GDA; GDC; Graves disease autoantigen; HGT.1; ML7; SLC25A16; Solute carrier family 25 member 16; hML7; Mitochondrial solute carrier protein homolog DTD0175 VADRUGID DR00302 DTD0175 DRUGNAME Coenzyme A DTD0175 DRUGSYNO 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A DTD0176 TRANSPID DTD0176 DTD0176 GENENAME SLC25A17 DTD0176 PROTNAME Peroxisomal membrane protein PMP34 DTD0176 SYNONYMS 34 kDa peroxisomal membrane protein; PMP34; SLC25A17; Solute carrier family 25 member 17 DTD0176 VADRUGID DR00100 DTD0176 DRUGNAME Adenosine monophosphate DTD0176 DRUGSYNO (S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(dihydrogen phosphate); 1H-Pyrazolo(4,3-d)pyrimidine, 7-amino-3-beta-D-ribofuranosyl-, 5'-(dihydrogen phosphate)-, hydrate; 5'-AMP; 5'-Adenylic acid, homopolymer; 5'-Deoxy-5'-thioadenosine 5'-monophosphate; 5'-O-phosphonatoadenosine; 5'-O-phosphonoadenosine; 5'-Thio-5'-adenylic acid; 5'-adenosine monophosphate; 5'-adenylic acid; 7-Amino-3-beta-D-ribofuranosyl-1H-pyrazolo(4,3-d)pyrimidine 5'-(dihydrogen phosphate) hydrate; 7A8E6D15-9136-44C1-88C9-E1A224638E56; 7gpb; 8-Aminoadenosine 5'-monophosphate; 8gpb; A-5mp; ADENOSINE-5'-PHOSPHATE; AMP; AMP (VAN); AMP (nucleotide); AMP dianion; ASMP; Adenine polynucleotides; Adenosine 5'-(dihydrogen phosphate); Adenosine 5'-monophosphate; Adenosine 5'-monophosphoric acid; Adenosine 5'-phosphate; Adenosine 5'-phosphoric acid; Adenosine Monophosphate (Amp); Adenosine phosphate; Adenosine phosphate (USAN/INN); Adenosine phosphate [USAN:BAN:INN]; Adenosine phosphate [USAN:INN:BAN]; Adenosine, mono(dihydrogen phosphate) (ester); Adenosine-5'-monophosphate; Adenosine-5'-monophosphoric acid; Adenosine-5'P; Adenosine-5-monophosphate dianion; Adenosine-5-monophosphate(2-); Adenosine-5-monophosphoric acid; Adenosine-5-phosphate; Adenosine-monophosphate; Adenosine-phosphate; Adenosini phosphas; Adenosini phosphas [INN-Latin]; Adenovite; Adenyl; Adenyl (TN);Adenylic acid (VAN); Adenylate; Adenylic acid; Ado5'P; Cardiomone; Ergadenylic acid; Formycin 5'-monophosphate hydrate; Formycin 5'-phosphate; Formycin 5'-phosphate hydrate; Formycin A 5'-monophosphate hydrate; Fosfato de adenosina; Fosfato de adenosina [INN-Spanish]; GAMMA-ARSONO-BETA, GAMMA-METHYLENEADENOSINE-5'-DIPHOSPHATE; Lycedan; Monophosphadenine; Muscle adenylic acid; Muskeladenosin-phosphorsaeure; Muskeladenylsaeure; My-B-Den; Myoston; PAdo; POLY A; Phosaden; Phosphaden; Phosphate d'adenosine; Phosphate d'adenosine [INN-French]; Phosphentaside; Polyadenylic acids; Vitamin B8; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate DTD0176 VADRUGID DR00302 DTD0176 DRUGNAME Coenzyme A DTD0176 DRUGSYNO 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A DTD0177 TRANSPID DTD0177 DTD0177 GENENAME SLC25A18 DTD0177 PROTNAME Mitochondrial glutamate carrier 2 DTD0177 SYNONYMS GC-2; GC2; Glutamate/H(+) symporter 2; SLC25A18; Solute carrier family 25 member 18 DTD0177 VADRUGID DR00005 DTD0177 DRUGNAME L-glutamic acid DTD0177 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0178 TRANSPID DTD0178 DTD0178 GENENAME SLC25A19 DTD0178 PROTNAME Mitochondrial thiamine pyrophosphate carrier DTD0178 SYNONYMS DNC; MCPHA; MUP1; Mitochondrial uncoupling protein 1; SLC25A19; Solute carrier family 25 member 19; THMD3; THMD4; TPC DTD0178 VADRUGID DR00335 DTD0178 DRUGNAME Thiamine pyrophosphate DTD0178 DRUGSYNO B-Neurox; Berolase; Biosyth; Bioxylasi; Bivitasi; Co-Bi; Co-carboxylase; Cocarbina; Cocarboxil; Cocarboxilasa; Cocarboxylasum; Cocarboxylasum [INN-Latin]; Coenbione; Coxylase; Diphosphothiamin; Diphosphothiamine; Farmaneurina; Metabolase; Nutrase; Pyrolase; Pyruvodehydrase; TDP (thiamin ester); TPP (coenzyme); Thiamine pyrophosphate; Thiamine pyrophosphate chloride; Thiamine pyrophosphoric ester; Thiamine-PP; Thiaminediphosphate; Thiaminepyrophosphate; Thiaminpyrophosphate; UNII-XMK8K8EVIU; cocarboxylase DTD0179 TRANSPID DTD0179 DTD0179 GENENAME SLC25A2 DTD0179 PROTNAME Mitochondrial ornithine transporter 2 DTD0179 SYNONYMS ORC2; ORNT2; SLC25A2; Solute carrier family 25 member 2 DTD0179 VADRUGID DR00188 DTD0179 DRUGNAME Arginine DTD0179 DRUGSYNO 1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ & argininhydrochlorid DTD0180 TRANSPID DTD0180 DTD0180 GENENAME SLC25A20 DTD0180 PROTNAME Carnitine/acylcarnitine translocase DTD0180 SYNONYMS CAC; CACT; Mitochondrial carnitine/acylcarnitine carrier protein; SLC25A20; Solute carrier family 25 member 20 DTD0180 VADRUGID DR00255 DTD0180 DRUGNAME L-carnitine DTD0180 DRUGSYNO (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT DTD0182 TRANSPID DTD0182 DTD0182 GENENAME SLC25A21 DTD0182 PROTNAME Mitochondrial 2-oxodicarboxylate carrier DTD0182 SYNONYMS ODC; ODC1; SLC25A21; Solute carrier family 25 member 21 DTD0182 VADRUGID DR00139 DTD0182 DRUGNAME Alpha-ketoglutaric acid DTD0182 DRUGSYNO 2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate DTD0182 VADRUGID DR00218 DTD0182 DRUGNAME Alpha-oxoadipic acid DTD0182 DRUGSYNO 2-Oxoadipate; 2-ketoadipate; Alpha-ketoadipic acid DTD0183 TRANSPID DTD0183 DTD0183 GENENAME SLC25A22 DTD0183 PROTNAME Mitochondrial glutamate carrier 1 DTD0183 SYNONYMS EIEE3; GC-1; GC1; Glutamate/H(+) symporter 1; NET44; SLC25A22; Solute carrier family 25 member 22 DTD0183 VADRUGID DR00005 DTD0183 DRUGNAME L-glutamic acid DTD0183 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0184 TRANSPID DTD0184 DTD0184 GENENAME SLC25A23 DTD0184 PROTNAME Calcium-binding mitochondrial carrier protein SCaMC-3 DTD0184 SYNONYMS APC2; MCSC2; Mitochondrial ATP-Mg/Pi carrier protein 2; Mitochondrial Ca(2+)-dependent solute carrier protein 2; SCAMC3; SCaMC-3; SLC25A23; Small calcium-binding mitochondrial carrier protein 3; Solute carrier family 25 member 23 DTD0184 VADRUGID DR00132 DTD0184 DRUGNAME Phosphate DTD0184 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0185 TRANSPID DTD0185 DTD0185 GENENAME SLC25A24 DTD0185 PROTNAME Calcium-binding mitochondrial carrier protein SCaMC-1 DTD0185 SYNONYMS APC1; MCSC1; Mitochondrial ATP-Mg/Pi carrier protein 1; Mitochondrial Ca(2+)-dependent solute carrier protein 1; SCAMC-1; SCAMC1; SLC25A24; Small calcium-binding mitochondrial carrier protein 1; Solute carrier family 25 member 24 DTD0185 VADRUGID DR00132 DTD0185 DRUGNAME Phosphate DTD0185 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0186 TRANSPID DTD0186 DTD0186 GENENAME SLC25A25 DTD0186 PROTNAME Calcium-binding mitochondrial carrier protein SCaMC-2 DTD0186 SYNONYMS APC3; KIAA1896; MCSC; MCSC3; Mitochondrial ATP-Mg/Pi carrier protein 3; Mitochondrial Ca(2+)-dependent solute carrier protein 3; PCSCL; SCAMC-2; SCAMC2; SLC25A25; Small calcium-binding mitochondrial carrier protein 2; Solute carrier family 25 member 25 DTD0186 VADRUGID DR00132 DTD0186 DRUGNAME Phosphate DTD0186 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0187 TRANSPID DTD0187 DTD0187 GENENAME SLC25A26 DTD0187 PROTNAME S-adenosylmethionine mitochondrial carrier protein DTD0187 SYNONYMS COXPD28; Mitochondrial S-adenosylmethionine transporter; SAMC; SLC25A26; Solute carrier family 25 member 26 DTD0187 VADRUGID DR00105 DTD0187 DRUGNAME S-adenosylmethionine DTD0187 DRUGSYNO 29908-03-0; 6EZ5466ZUX; Active methionine; Adenosine, 5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, inner salt, (3S)-; AdoMet; CCRIS 7130; CHEBI:67040; EINECS 249-946-8; K093C397UL; L-Methionine, S-adenosyl-; L-S-Adenosylmethionine; Methionine, S-adenosyl-; Methioninyladenylate; S Amet; S-adenosyl-L-methioninate; S-adenosyl-L-methionine; SAM; UNII-6EZ5466ZUX; UNII-7LP2MPO46S; UNII-K093C397UL; adenosylmethionine; s-(5-adenosyl)l-methionine DTD0190 TRANSPID DTD0190 DTD0190 GENENAME SLC25A29 DTD0190 PROTNAME Mitochondrial ornithine transporter 3 DTD0190 SYNONYMS C14orf69; CACL; CACT-like; Carnitine/acylcarnitine translocase-like; Mitochondrial basic amino acids transporter; Mitochondrial carnitine/acylcarnitine carrier protein CACL; ORNT3; SLC25A29; Solute carrier family 25 member 29 DTD0190 VADRUGID DR00188 DTD0190 DRUGNAME Arginine DTD0190 DRUGSYNO 1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ & argininhydrochlorid DTD0190 VADRUGID DR00115 DTD0190 DRUGNAME Lysine DTD0190 DRUGSYNO Enisyl DTD0190 VADRUGID DR00192 DTD0190 DRUGNAME L-homoarginine DTD0190 DRUGSYNO Homoarginine DTD0191 TRANSPID DTD0191 DTD0191 GENENAME SLC25A3 DTD0191 PROTNAME Phosphate carrier protein DTD0191 SYNONYMS OK/SW-cl.48; PHC; PTP; Phosphate transport protein; SLC25A3; Solute carrier family 25 member 3 DTD0191 VADRUGID DR00132 DTD0191 DRUGNAME Phosphate DTD0191 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0194 TRANSPID DTD0194 DTD0194 GENENAME SLC25A32 DTD0194 PROTNAME Mitochondrial folate transporter/carrier DTD0194 SYNONYMS MFT; MFTC; RREI; SLC25A32; Solute carrier family 25 member 32 DTD0194 VADRUGID DR00134 DTD0194 DRUGNAME Folic acid DTD0194 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0205 TRANSPID DTD0205 DTD0205 GENENAME SLC25A42 DTD0205 PROTNAME Mitochondrial coenzyme A transporter SLC25A42 DTD0205 SYNONYMS SLC25A42; Solute carrier family 25 member 42 DTD0205 VADRUGID DR00302 DTD0205 DRUGNAME Coenzyme A DTD0205 DRUGSYNO 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A DTD0222 TRANSPID DTD0222 DTD0222 GENENAME SLC25A6 DTD0222 PROTNAME Adenine nucleotide translocator 3 DTD0222 SYNONYMS AAC3; ADP/ATP translocase 3; ANT 3; ANT3; ANT3Y; ADP,ATP carrier protein 3; SLC25A6; Solute carrier family 25 member 6; ADP,ATP carrier protein, isoform T2 DTD0222 VADRUGID DR00126 DTD0222 DRUGNAME Adenine DTD0222 DRUGSYNO 1,6-Dihydro-6-Imnopurine; 1,6-Dihydro-6-iminopurine; 1H-Purin-6-amine; 1H-Purin-6-amine (9CI); 1H-Purine, 6-amino; 2'-DEOXY-ADENOSINE-3'-5'-DIPHOSPHATE; 3,6-Dihydro-6-iminopurine; 4, Vitamin B; 6-Amino-1H-purine; 6-Amino-3H-purine; 6-Amino-7H-purine; 6-Amino-9H-purine; 6-Aminopurine; 7H-Purin-6-amine; 9H-Purin-6-amine; AD2; ADE; ALBB-005925; ANE; Adenin; Adenine (8CI); Adenine (JAN/USP); Adenine [JAN]; Adenine-8-14C; Adenine-ring; Adeninimine; B 4, Vitamin; Leuco-4; Leucon (TN); Pedatisectine B; Purine, 6; USAF CB-18; Vitamin B 4; Vitamin B4; Vitamin-B4 DTD0227 TRANSPID DTD0227 DTD0227 GENENAME SLC26A1 DTD0227 PROTNAME Sulfate anion transporter 1 DTD0227 SYNONYMS CAON; SAT-1; SAT1; SLC26A1; Solute carrier family 26 member 1 DTD0227 VADRUGID DR00022 DTD0227 DRUGNAME Oxalate DTD0227 DRUGSYNO oxalate2- DTD0227 VADRUGID DR00060 DTD0227 DRUGNAME Sulfate DTD0227 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0227 VADRUGID DR00138 DTD0227 DRUGNAME Bicarbonate DTD0227 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0230 TRANSPID DTD0230 DTD0230 GENENAME SLC26A2 DTD0230 PROTNAME Sulfate transporter DTD0230 SYNONYMS D5S1708; DTD; DTDST; Diastrophic dysplasia protein; EDM4; MST153; MSTP157; SLC26A2; Solute carrier family 26 member 2 DTD0230 VADRUGID DR00060 DTD0230 DRUGNAME Sulfate DTD0230 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0234 TRANSPID DTD0234 DTD0234 GENENAME SLC26A6 DTD0234 PROTNAME Anion exchange transporter DTD0234 SYNONYMS Pendrin-L1; Pendrin-like protein 1; SLC26A6; Solute carrier family 26 member 6 DTD0234 VADRUGID DR00022 DTD0234 DRUGNAME Oxalate DTD0234 DRUGSYNO oxalate2- DTD0234 VADRUGID DR00060 DTD0234 DRUGNAME Sulfate DTD0234 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0234 VADRUGID DR00138 DTD0234 DRUGNAME Bicarbonate DTD0234 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0235 TRANSPID DTD0235 DTD0235 GENENAME SLC26A7 DTD0235 PROTNAME Anion exchange transporter DTD0235 SYNONYMS SLC26A7; SUT2; Solute carrier family 26 member 7 DTD0235 VADRUGID DR00022 DTD0235 DRUGNAME Oxalate DTD0235 DRUGSYNO oxalate2- DTD0235 VADRUGID DR00060 DTD0235 DRUGNAME Sulfate DTD0235 DRUGSYNO 14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI) DTD0235 VADRUGID DR00138 DTD0235 DRUGNAME Bicarbonate DTD0235 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0235 VADRUGID DR00009 DTD0235 DRUGNAME Nitrate DTD0235 DRUGSYNO 14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V) DTD0237 TRANSPID DTD0237 DTD0237 GENENAME SLC26A9 DTD0237 PROTNAME Anion transporter/exchanger protein 9 DTD0237 SYNONYMS Solute carrier family 26 member 9; SLC26A9 DTD0237 VADRUGID DR00138 DTD0237 DRUGNAME Bicarbonate DTD0237 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0238 TRANSPID DTD0238 DTD0238 GENENAME SLC27A1 DTD0238 PROTNAME Fatty acid transport protein 1 DTD0238 SYNONYMS ACSVL5; FATP; FATP-1; FATP1; Long-chain fatty acid transport protein 1; SLC27A1; Solute carrier family 27 member 1 DTD0238 VADRUGID DR00152 DTD0238 DRUGNAME Oleic acid DTD0238 DRUGSYNO (Z)-Octadec-9-enoic acid; 9-Octadecenoic acid (Z)-; Century cd fatty acid; Cis-9-Octadecenoic acid; Elaidoic acid; Emersol 205; Emersol 210; Emersol 211; Emersol 213; Emersol 233LL; Emersol 6321; Extraolein 90; Glycon RO; Glycon wo; Groco 2; Groco 4; Groco 5l; Groco 6; Industrene 105; Industrene 205; Industrene 206; L'Acide oleique; Metaupon; Oelsauere; Oleine 7503; Oleinic acid; Pamolyn; Pamolyn 100; Tego-oleic 130; Vopcolene 27; Wecoline OO; Z-9-Octadecenoic acid; cis-Octadec-9-enoic acid; cis-Oleic acid; oleate DTD0244 TRANSPID DTD0244 DTD0244 GENENAME SLC28A1 DTD0244 PROTNAME Concentrative nucleoside transporter 1 DTD0244 SYNONYMS CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1 DTD0244 VADRUGID DR00416 DTD0244 DRUGNAME Cytarabine DTD0244 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0244 VADRUGID DR00321 DTD0244 DRUGNAME Uridine DTD0244 DRUGSYNO 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; AI3-52690; C9H12N2O6; CHEBI:16704; DRTQHJPVMGBUCF-XVFCMESISA-N; EINECS 200-407-5; MLS000069625; SMR000058222; UNII-WHI7HQ7H85; Uracil riboside; Uracil-1-beta-d-ribofuranoside; Urd; Uridin; WHI7HQ7H85; b-Uridine; beta-Uridine; d-uridine DTD0244 VADRUGID DR00063 DTD0244 DRUGNAME Gemcitabine DTD0244 DRUGSYNO 2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei DTD0244 VADRUGID DR00096 DTD0244 DRUGNAME Trifluridine DTD0244 DRUGSYNO 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN) DTD0245 TRANSPID DTD0245 DTD0245 GENENAME SLC28A2 DTD0245 PROTNAME Concentrative nucleoside transporter 2 DTD0245 SYNONYMS CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2 DTD0245 VADRUGID DR00145 DTD0245 DRUGNAME Mercaptopurine DTD0245 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0245 VADRUGID DR01277 DTD0245 DRUGNAME Entecavir DTD0245 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0245 VADRUGID DR00321 DTD0245 DRUGNAME Uridine DTD0245 DRUGSYNO 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; AI3-52690; C9H12N2O6; CHEBI:16704; DRTQHJPVMGBUCF-XVFCMESISA-N; EINECS 200-407-5; MLS000069625; SMR000058222; UNII-WHI7HQ7H85; Uracil riboside; Uracil-1-beta-d-ribofuranoside; Urd; Uridin; WHI7HQ7H85; b-Uridine; beta-Uridine; d-uridine DTD0245 VADRUGID DR00176 DTD0245 DRUGNAME Ribavirin DTD0245 DRUGSYNO 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN) DTD0245 VADRUGID DR01175 DTD0245 DRUGNAME Didanosine DTD0245 DRUGSYNO 69655-05-6; 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine; 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE; 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one; BMY 40900; BMY-40900; CHEBI:490877; DDI; DIDEOXYINOSINE; DRG-0016; DSSTox_CID_2927; Didanosina; Didanosina [INN-Spanish]; Didanosinum; Didanosinum [INN-Latin]; Inosine, 2',3'-dideoxy-; K3GDH6OH08; NCGC00090691-03; NCGC00159514-02; NSC 612049; UNII-K3GDH6OH08; Videx; Videx EC; ddIno; didanosine DTD0246 TRANSPID DTD0246 DTD0246 GENENAME SLC28A3 DTD0246 PROTNAME Concentrative Na(+)-nucleoside cotransporter 3 DTD0246 SYNONYMS CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3 DTD0246 VADRUGID DR00145 DTD0246 DRUGNAME Mercaptopurine DTD0246 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0246 VADRUGID DR01330 DTD0246 DRUGNAME Clofarabine DTD0246 DRUGSYNO (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN) DTD0246 VADRUGID DR00510 DTD0246 DRUGNAME Thioguanine DTD0246 DRUGSYNO 2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B DTD0246 VADRUGID DR01277 DTD0246 DRUGNAME Entecavir DTD0246 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0246 VADRUGID DR00176 DTD0246 DRUGNAME Ribavirin DTD0246 DRUGSYNO 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN) DTD0247 TRANSPID DTD0247 DTD0247 GENENAME SLC29A1 DTD0247 PROTNAME Equilibrative nucleoside transporter 1 DTD0247 SYNONYMS ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1 DTD0247 VADRUGID DR00145 DTD0247 DRUGNAME Mercaptopurine DTD0247 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0247 VADRUGID DR00416 DTD0247 DRUGNAME Cytarabine DTD0247 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0247 VADRUGID DR01330 DTD0247 DRUGNAME Clofarabine DTD0247 DRUGSYNO (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN) DTD0247 VADRUGID DR01277 DTD0247 DRUGNAME Entecavir DTD0247 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0247 VADRUGID DR00176 DTD0247 DRUGNAME Ribavirin DTD0247 DRUGSYNO 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN) DTD0247 VADRUGID DR00153 DTD0247 DRUGNAME Fluorouracil DTD0247 DRUGSYNO 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup DTD0247 VADRUGID DR00096 DTD0247 DRUGNAME Trifluridine DTD0247 DRUGSYNO 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN) DTD0247 VADRUGID DR00923 DTD0247 DRUGNAME Tecadenoson DTD0247 DRUGSYNO CVT-510; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol; 204512-90-3; AC1L4KMO; Adenosine, N-(3R)-tetrahydro-3-furanyl)-; Adenosine, N-(3R)-tetrahydro-3-furanyl-; BDBM50138530; BDBM50224766; CHEMBL356254; CHEMBL392149; CS-0016174; CVT-510; D06019; DB04954; DTXSID80174415; GTPL5592; GZ1X96601Z; HY-19661; LS-190860; N-(3-Tetrahydrofuranyl)-6-aminopurine riboside; N6-[3-(R)-tetrahydrofuranyl]adenosine; SCHEMBL246787; Selenocompounds; Tecadenoson (USAN/INN); Tecadenoson [USAN:INN]; UNII-GZ1X96601Z DTD0247 VADRUGID DR00904 DTD0247 DRUGNAME Adenosine DTD0247 DRUGSYNO (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 9-(beta-D-Arabinofuranosyl)adenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine; Adenine 9-beta-D-arabinofuranoside; Adenine-9-beta-D-ribofuranoside; Adenosine, homopolymer; Beta-D-Ribofuranoside, adenine-9; EA6C60C2-6AFB-4264-A2F0-541373DB950E DTD0248 TRANSPID DTD0248 DTD0248 GENENAME SLC29A2 DTD0248 PROTNAME Equilibrative nucleoside transporter 2 DTD0248 SYNONYMS 36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2 DTD0248 VADRUGID DR00145 DTD0248 DRUGNAME Mercaptopurine DTD0248 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0248 VADRUGID DR00416 DTD0248 DRUGNAME Cytarabine DTD0248 DRUGSYNO (beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil DTD0248 VADRUGID DR01330 DTD0248 DRUGNAME Clofarabine DTD0248 DRUGSYNO (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN) DTD0248 VADRUGID DR01277 DTD0248 DRUGNAME Entecavir DTD0248 DRUGSYNO 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676 DTD0248 VADRUGID DR00096 DTD0248 DRUGNAME Trifluridine DTD0248 DRUGSYNO 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN) DTD0249 TRANSPID DTD0249 DTD0249 GENENAME SLC29A3 DTD0249 PROTNAME Equilibrative nucleoside transporter 3 DTD0249 SYNONYMS Solute carrier family 29 member 3; hENT3; SLC29A3; ENT3; HJCD; PHID; HCLAP DTD0249 VADRUGID DR00718 DTD0249 DRUGNAME Tubercidin DTD0249 DRUGSYNO Sparsamycin A DTD0249 VADRUGID DR00087 DTD0249 DRUGNAME Cladribine DTD0249 DRUGSYNO (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000 DTD0249 VADRUGID DR00717 DTD0249 DRUGNAME Cordycepin DTD0249 DRUGSYNO 3'-deoxyadenosine DTD0250 TRANSPID DTD0250 DTD0250 GENENAME SLC29A4 DTD0250 PROTNAME Equilibrative nucleoside transporter 4 DTD0250 SYNONYMS ENT4; PMAT; Plasma membrane monoamine transporter; SLC29A4; Solute carrier family 29 member 4; hENT4 DTD0250 VADRUGID DR00189 DTD0250 DRUGNAME Serotonin DTD0250 DRUGSYNO 1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY DTD0250 VADRUGID DR00133 DTD0250 DRUGNAME Metformin DTD0250 DRUGSYNO 1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor DTD0250 VADRUGID DR00081 DTD0250 DRUGNAME Ergotidine DTD0250 DRUGSYNO 1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine DTD0251 TRANSPID DTD0251 DTD0251 GENENAME SLC2A1 DTD0251 PROTNAME Glucose transporter type 1 DTD0251 SYNONYMS CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1 DTD0251 VADRUGID DR00011 DTD0251 DRUGNAME 2-Deoxyglucose DTD0251 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0251 VADRUGID DR00225 DTD0251 DRUGNAME Quercetin DTD0251 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0251 VADRUGID DR00260 DTD0251 DRUGNAME Dehydroascorbic acid DTD0251 DRUGSYNO dehydroascorbate DTD0251 VADRUGID DR00312 DTD0251 DRUGNAME Arsenite DTD0251 DRUGSYNO 13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion) DTD0251 VADRUGID DR00165 DTD0251 DRUGNAME D-glucose DTD0251 DRUGSYNO (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; 2280-44-6; CPC hydrate; Cartose Cerelose; Clearsweet 95; Clintose L; D-Glc; D-Glcp; D-Glucopyranose; D-Glucopyranose, anhydrous; D-Glucopyranoside; D-glucose-ring; DSSTox_CID_2910; EINECS 218-914-5; Glc; Glc-OH; Glucodin; Glucopyranose; Glucopyranose, D-; Glucopyranoside; Glucose 40; Glucose solution; Meritose; Meritose 200; Roferose ST; Staleydex 130; Staleydex 95M; glc-ring DTD0252 TRANSPID DTD0252 DTD0252 GENENAME SLC2A10 DTD0252 PROTNAME Glucose transporter type 10 DTD0252 SYNONYMS ATORS; ATS; GLUT-10; GLUT10; SLC2A10; Solute carrier family 2, facilitated glucose transporter member 10 DTD0252 VADRUGID DR00011 DTD0252 DRUGNAME 2-Deoxyglucose DTD0252 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0254 TRANSPID DTD0254 DTD0254 GENENAME SLC2A12 DTD0254 PROTNAME Glucose transporter type 12 DTD0254 SYNONYMS GLUT-12; GLUT12; SLC2A12; Solute carrier family 2, facilitated glucose transporter member 12 DTD0254 VADRUGID DR00011 DTD0254 DRUGNAME 2-Deoxyglucose DTD0254 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0256 TRANSPID DTD0256 DTD0256 GENENAME SLC2A14 DTD0256 PROTNAME Glucose transporter type 14 DTD0256 SYNONYMS GLUT-14; GLUT14; SLC2A14; SLC2A3P3; Solute carrier family 2, facilitated glucose transporter member 14 DTD0256 VADRUGID DR00011 DTD0256 DRUGNAME 2-Deoxyglucose DTD0256 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0256 VADRUGID DR00260 DTD0256 DRUGNAME Dehydroascorbic acid DTD0256 DRUGSYNO dehydroascorbate DTD0257 TRANSPID DTD0257 DTD0257 GENENAME SLC2A2 DTD0257 PROTNAME Glucose transporter type 2 DTD0257 SYNONYMS Solute carrier family 2, facilitated glucose transporter member 2; GLUT-2; SLC2A2; GLUT2 DTD0257 VADRUGID DR00011 DTD0257 DRUGNAME 2-Deoxyglucose DTD0257 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0258 TRANSPID DTD0258 DTD0258 GENENAME SLC2A3 DTD0258 PROTNAME Glucose transporter type 3 DTD0258 SYNONYMS GLUT-3; GLUT3; SLC2A3; Solute carrier family 2, facilitated glucose transporter member 3 DTD0258 VADRUGID DR00011 DTD0258 DRUGNAME 2-Deoxyglucose DTD0258 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0262 TRANSPID DTD0262 DTD0262 GENENAME SLC2A4 DTD0262 PROTNAME Glucose transporter type 4 DTD0262 SYNONYMS GLUT-4; GLUT4; SLC2A4; Solute carrier family 2, facilitated glucose transporter member 4 DTD0262 VADRUGID DR00011 DTD0262 DRUGNAME 2-Deoxyglucose DTD0262 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0263 TRANSPID DTD0263 DTD0263 GENENAME SLC2A5 DTD0263 PROTNAME Glucose transporter type 5 DTD0263 SYNONYMS Fructose transporter; GLUT-5; GLUT5; SLC2A5; Solute carrier family 2, facilitated glucose transporter member 5 DTD0263 VADRUGID DR00043 DTD0263 DRUGNAME Fructose DTD0263 DRUGSYNO (3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, > D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose DTD0264 TRANSPID DTD0264 DTD0264 GENENAME SLC2A6 DTD0264 PROTNAME Glucose transporter type 6 DTD0264 SYNONYMS GLUT-6; GLUT6; HSA011372; SLC2A6; Solute carrier family 2, facilitated glucose transporter member 6 DTD0264 VADRUGID DR00011 DTD0264 DRUGNAME 2-Deoxyglucose DTD0264 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0265 TRANSPID DTD0265 DTD0265 GENENAME SLC2A7 DTD0265 PROTNAME Glucose transporter type 7 DTD0265 SYNONYMS GLUT-7; GLUT7; SLC2A7; Solute carrier family 2, facilitated glucose transporter member 7 DTD0265 VADRUGID DR00011 DTD0265 DRUGNAME 2-Deoxyglucose DTD0265 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0265 VADRUGID DR00043 DTD0265 DRUGNAME Fructose DTD0265 DRUGSYNO (3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, > D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose DTD0266 TRANSPID DTD0266 DTD0266 GENENAME SLC2A8 DTD0266 PROTNAME Glucose transporter type 8 DTD0266 SYNONYMS GLUT-8; GLUT8; GLUTX1; Glucose transporter type X1; SLC2A8; Solute carrier family 2, facilitated glucose transporter member 8 DTD0266 VADRUGID DR00011 DTD0266 DRUGNAME 2-Deoxyglucose DTD0266 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0269 TRANSPID DTD0269 DTD0269 GENENAME SLC30A1 DTD0269 PROTNAME Zinc transporter 1 DTD0269 SYNONYMS SLC30A1; Solute carrier family 30 member 1; ZNT1; ZRC1; ZnT-1 DTD0269 VADRUGID DR00068 DTD0269 DRUGNAME Zinc salts DTD0269 DRUGSYNO . DTD0270 TRANSPID DTD0270 DTD0270 GENENAME SLC30A10 DTD0270 PROTNAME Zinc transporter 10 DTD0270 SYNONYMS HMDPC; HMNDYT1; Manganese transporter SLC30A10; SLC30A10; Solute carrier family 30 member 10; ZNT10; ZnT-10 DTD0270 VADRUGID DR00068 DTD0270 DRUGNAME Zinc salts DTD0270 DRUGSYNO . DTD0271 TRANSPID DTD0271 DTD0271 GENENAME SLC30A2 DTD0271 PROTNAME Zinc transporter 2 DTD0271 SYNONYMS PP12488; SLC30A2; Solute carrier family 30 member 2; TNZD; ZNT2; ZnT-2 DTD0271 VADRUGID DR00068 DTD0271 DRUGNAME Zinc salts DTD0271 DRUGSYNO . DTD0272 TRANSPID DTD0272 DTD0272 GENENAME SLC30A3 DTD0272 PROTNAME Zinc transporter 3 DTD0272 SYNONYMS SLC30A3; Solute carrier family 30 member 3; ZNT3; ZnT-3 DTD0272 VADRUGID DR00068 DTD0272 DRUGNAME Zinc salts DTD0272 DRUGSYNO . DTD0273 TRANSPID DTD0273 DTD0273 GENENAME SLC30A4 DTD0273 PROTNAME Zinc transporter 4 DTD0273 SYNONYMS SLC30A4; Solute carrier family 30 member 4; ZNT4; ZnT-4 DTD0273 VADRUGID DR00068 DTD0273 DRUGNAME Zinc salts DTD0273 DRUGSYNO . DTD0274 TRANSPID DTD0274 DTD0274 GENENAME SLC30A5 DTD0274 PROTNAME Zinc transporter 5 DTD0274 SYNONYMS SLC30A5; Solute carrier family 30 member 5; ZNT5; ZNTL1; ZTL1; ZnT-5; ZnT-like transporter 1; hZTL1 DTD0274 VADRUGID DR00068 DTD0274 DRUGNAME Zinc salts DTD0274 DRUGSYNO . DTD0275 TRANSPID DTD0275 DTD0275 GENENAME SLC30A6 DTD0275 PROTNAME Zinc transporter 6 DTD0275 SYNONYMS MST103; MSTP103; SLC30A6; Solute carrier family 30 member 6; ZNT6; ZnT-6 DTD0275 VADRUGID DR00068 DTD0275 DRUGNAME Zinc salts DTD0275 DRUGSYNO . DTD0276 TRANSPID DTD0276 DTD0276 GENENAME SLC30A7 DTD0276 PROTNAME Zinc transporter 7 DTD0276 SYNONYMS SLC30A7; Solute carrier family 30 member 7; ZNT7; ZNTL2; ZnT-7; Znt-like transporter 2 DTD0276 VADRUGID DR00068 DTD0276 DRUGNAME Zinc salts DTD0276 DRUGSYNO . DTD0277 TRANSPID DTD0277 DTD0277 GENENAME SLC30A9 DTD0277 PROTNAME Zinc transporter 9 DTD0277 SYNONYMS BILAPES; C4orf1; GAC63; HuEL; Human embryonic lung protein; SLC30A9; Solute carrier family 30 member 9; ZNT9; ZnT-9 DTD0277 VADRUGID DR00068 DTD0277 DRUGNAME Zinc salts DTD0277 DRUGSYNO . DTD0278 TRANSPID DTD0278 DTD0278 GENENAME SLC31A1 DTD0278 PROTNAME High affinity copper uptake protein 1 DTD0278 SYNONYMS COPT1; CTR1; Copper transporter 1; SLC31A1; Solute carrier family 31 member 1; hCTR1 DTD0278 VADRUGID DR00316 DTD0278 DRUGNAME Oxaliplatin DTD0278 DRUGSYNO ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138 DTD0278 VADRUGID DR01187 DTD0278 DRUGNAME Cupric sulfate DTD0278 DRUGSYNO 7758-98-7; All Clear Root Destroyer; BCS copper fungicide; Blue copper (VAN); Blue stone; Bonide Root Destroyer; CUPRIC SULFATE; Copper II sulfate; Copper Sulfate Powder; Copper monosulfate; Copper sulfate; Copper sulfate (1:1); Copper sulfate (CuSO; Copper sulphate; Copper(2+) sulfate; Copper(II) sulfate; Copper(ii) sulfate, anhydrous; CuSO4; Cupric sulfate anhydrous; Cupric sulphate; Cupricsulfate; Delcup; Hylinec; Incracide 10A; Incracide E 51; Kupfersulfat [German]; Monocopper sulfate; Sulfuric acid copper(2+) salt (1:1); Trinagle DTD0278 VADRUGID DR00469 DTD0278 DRUGNAME Carboplatin DTD0278 DRUGSYNO (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum; 1,1-Cyclobutanedicarboxylate diammine platinum (II); 1,1-Cyclobutanedicarboxylate diammine platinum(II); Azanide; C 2538; Carbopaltin; Carboplatin (JAN/USP/INN); Carboplatin (USAN); Carboplatin [USAN:INN:BAN:JAN]; Carboplatine; Carboplatine [French]; Carboplatino; Carboplatino [Spanish]; Carboplatinum; Carboplatinum [Latin]; Cbdca; Cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II); Cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato) platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diammine(cyclobutanedicarboxylato)platinumII; Cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum; Cyclobutane-1,1-dicarboxylate; Cyclobutane-1,1-dicarboxylic acid; Diammine(1,1-cyclobutanedicarboxylato)platinum (II); Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum; Diammine-1,1-cyclobutane dicarboxylate platinum II; Diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum; Ercar; IUPAC: Azane; JM 8; JM-8; Paraplatin; Paraplatin (TN); Paraplatin, Carboplatin; Paraplatin-AQ; Platinum(+2) Cation; Platinum(2+); Platinum(II), (1, 1-cyclobutanedicar; Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2); Platinum, {diammine[1,1-cyclobut DTD0278 VADRUGID DR00291 DTD0278 DRUGNAME Cisplatin DTD0278 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0280 TRANSPID DTD0280 DTD0280 GENENAME SLC31A2 DTD0280 PROTNAME Probable low affinity copper uptake protein 2 DTD0280 SYNONYMS Copper transporter 2; hCTR2; COPT2; CTR2; SLC31A2; Solute carrier family 31 member 2 DTD0280 VADRUGID DR00291 DTD0280 DRUGNAME Cisplatin DTD0280 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0281 TRANSPID DTD0281 DTD0281 GENENAME SLC32A1 DTD0281 PROTNAME Vesicular inhibitory amino acid transporter DTD0281 SYNONYMS GABA and glycine transporter; SLC32A1; Solute carrier family 32 member 1; VGAT; VIAAT; Vesicular GABA transporter; hVIAAT DTD0281 VADRUGID DR00831 DTD0281 DRUGNAME Gamma-aminobutyric acid DTD0281 DRUGSYNO 1956/12/2; 3-Carboxypropylamine; 4-Aminobutanoic acid; 4-amino-butanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminalon; Butyric acid, 4-amino-; GABA; GAMMA-AMINO-BUTANOIC ACID; Gaballon; Gamarex; Gamastan; Gammagee; Gammalon; Gammalone; Gammar; Gammasol; Gamulin; Immu-G; Mielogen; Mielomade; Piperidic acid; Piperidinic acid; Reanal; butanoic acid, 4-amino-; gamma-Amino butyric acid; gamma-Aminobutanoic acid; gamma-Aminobuttersaeure; gamma-Aminobutyric acid; gamma-amino-n-butyric acid; gamma-aminobutyric acid; omega-Aminobutyric acid DTD0284 TRANSPID DTD0284 DTD0284 GENENAME SLC34A1 DTD0284 PROTNAME Sodium-dependent phosphate transport protein 2A DTD0284 SYNONYMS FRTS2; HCINF2; NPHLOP1; NPT2; NPTIIa; Na(+)-dependent phosphate cotransporter 2A; Na(+)/Pi cotransporter 2A; NaPi-2a; NaPi-3; SLC11; SLC34A1; Sodium-phosphate transport protein 2A; Sodium/phosphate cotransporter 2A; Solute carrier family 34 member 1 DTD0284 VADRUGID DR00339 DTD0284 DRUGNAME Calcium phosphate DTD0284 DRUGSYNO Bonarka; Calcigenol simple; Calcium orthophosphate; Calcium phosphate; Calcium phosphate (3:2); Calcium phosphate (Ca3(PO4)2); Calcium phosphate tribasic; Calcium tertiary phosphate; Natural whitlockite; Phosphoric acid, calcium salt; Phosphoric acid, calcium salt (2:3); Synthos; TRICALCIUM PHOSPHATE; Tertiary calcium phosphate; Tribasic calcium phosphate; Tricalcium diphosphate; Tricalcium orthophosphate; beta-TCP; beta-Tricalcium phosphate DTD0285 TRANSPID DTD0285 DTD0285 GENENAME SLC34A2 DTD0285 PROTNAME Sodium-dependent phosphate transport protein 2B DTD0285 SYNONYMS NAPI-3B; NAPI-IIb; NPTIIb; Na(+)-dependent phosphate cotransporter 2B; Na(+)/Pi cotransporter 2B; NaPi-2b; NaPi3b; SLC34A2; Sodium-phosphate transport protein 2B; Sodium/phosphate cotransporter 2B; Solute carrier family 34 member 2 DTD0285 VADRUGID DR00376 DTD0285 DRUGNAME Sodium phosphate dibasic/Sodium phosphate monobasic DTD0285 DRUGSYNO Anhydrous sodium acid phosphate; Dibasic sodium phosphate; Dipotassium phosphate anhydrous; Monobasic potassium acid phosphate; Monobasic sodium phosphate; Phosphate; Potassium phosphate; Sodium phosphate DTD0286 TRANSPID DTD0286 DTD0286 GENENAME SLC34A3 DTD0286 PROTNAME Sodium-dependent phosphate transport protein 2C DTD0286 SYNONYMS HHRH; NPT2C; NPTIIC; Na(+)-dependent phosphate cotransporter 2C; Na(+)/Pi cotransporter 2C; NaPi-2c; SLC34A3; Sodium-phosphate transport protein 2C; Sodium/inorganic phosphate cotransporter IIC; Sodium/phosphate cotransporter 2C; Solute carrier family 34 member 3 DTD0286 VADRUGID DR00355 DTD0286 DRUGNAME Calcium phosphate dihydrate DTD0286 DRUGSYNO Calcium phosphate dihydrate DTD0287 TRANSPID DTD0287 DTD0287 GENENAME SLC35A1 DTD0287 PROTNAME CMP-sialic acid transporter DTD0287 SYNONYMS CDG2F; CMP-SA-Tr; CMP-Sia-Tr; CMPST; CST; SLC35A1; Solute carrier family 35 member A1; hCST DTD0287 VADRUGID DR00114 DTD0287 DRUGNAME CMP-sialic acid DTD0287 DRUGSYNO (2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid; 3063-71-6; CHEBI:16556; CMP acetylneuraminic acid; CMP-N-acetyl-beta-neuraminate; CMP-N-acetylneuraminate; CMP-NeuNAc; CMP-Sialic acid; CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID; Cmp-D-N-acetylneuraminic acid; Cmp-nana; NCC; cytidine monophosphate N-acetylneuraminic acid DTD0295 TRANSPID DTD0295 DTD0295 GENENAME SLC35B4 DTD0295 PROTNAME UDP-xylose and UDP-N-acetylglucosamine transporter DTD0295 SYNONYMS SLC35B4; Solute carrier family 35 member B4; YEA; YEA4; YEA4 homolog DTD0295 VADRUGID DR00090 DTD0295 DRUGNAME UDP-xylose DTD0295 DRUGSYNO AC1L2DQI; CHEBI:16082; DB01713; GTPL4730; J-700264; Mono-a-D-xylopyranosyl ester; P1-a-D-xylopyranosyl ester; UDP-ALPHA-D-XYLOPYRANOSE; UDP-D-xylose; UDP-a-D-xylose; UDP-alpha-D-xylose; UDP-xylose; UDPxylose; UDX; URIDINE DIPHOSPHATE XYLOSE; URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE; Udp xylose; Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-xylopyranosyl ester; Uridine 5'-diphosphoric acid beta-a; Uridine 51-pyrophosphate, a-D-xylopyranosyl ester; ZINC8551129; uridine 5'-[3-(alpha-D-xylopyranosyl) dihydrogen diphosphate] DTD0296 TRANSPID DTD0296 DTD0296 GENENAME SLC35C1 DTD0296 PROTNAME GDP-fucose transporter 1 DTD0296 SYNONYMS CDG2C; FUCT1; SLC35C1; Solute carrier family 35 member C1 DTD0296 VADRUGID DR00160 DTD0296 DRUGNAME GDP-fucose DTD0296 DRUGSYNO GDP-L-fucose; guanosine diphosphate fucose DTD0299 TRANSPID DTD0299 DTD0299 GENENAME SLC35D2 DTD0299 PROTNAME UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter DTD0299 SYNONYMS HFRC; HFRC1; Homolog of Fringe connection protein 1; SLC35D2; SQV7-like protein; SQV7L; Solute carrier family 35 member D2; UDP-galactose transporter-related protein 8; UGTrel8 DTD0299 VADRUGID DR00178 DTD0299 DRUGNAME UDP-glucose DTD0299 DRUGSYNO uridine diphosphate glucose DTD0305 TRANSPID DTD0305 DTD0305 GENENAME SLC35E4 DTD0305 PROTNAME Solute carrier family 35 member E4 DTD0305 SYNONYMS SLC35E4; Solute carrier 35 member E4 DTD0305 VADRUGID DR00335 DTD0305 DRUGNAME Thiamine pyrophosphate DTD0305 DRUGSYNO B-Neurox; Berolase; Biosyth; Bioxylasi; Bivitasi; Co-Bi; Co-carboxylase; Cocarbina; Cocarboxil; Cocarboxilasa; Cocarboxylasum; Cocarboxylasum [INN-Latin]; Coenbione; Coxylase; Diphosphothiamin; Diphosphothiamine; Farmaneurina; Metabolase; Nutrase; Pyrolase; Pyruvodehydrase; TDP (thiamin ester); TPP (coenzyme); Thiamine pyrophosphate; Thiamine pyrophosphate chloride; Thiamine pyrophosphoric ester; Thiamine-PP; Thiaminediphosphate; Thiaminepyrophosphate; Thiaminpyrophosphate; UNII-XMK8K8EVIU; cocarboxylase DTD0308 TRANSPID DTD0308 DTD0308 GENENAME SLC35F3 DTD0308 PROTNAME Putative thiamine transporter SLC35F3 DTD0308 SYNONYMS SLC35F3; Solute carrier family 35 member F3 DTD0308 VADRUGID DR00117 DTD0308 DRUGNAME Vitamin B1 DTD0308 DRUGSYNO 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride DTD0318 TRANSPID DTD0318 DTD0318 GENENAME SLC36A1 DTD0318 PROTNAME Proton-coupled amino acid transporter 1 DTD0318 SYNONYMS LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1 DTD0318 VADRUGID DR00270 DTD0318 DRUGNAME Vigabatrin DTD0318 DRUGSYNO (R,S)-4-Amino-5-hexenoic acid; (inverted question mark)-gamma-Vinyl GABA; 4-Amino-5-hexenoic acid; 4-Aminohexenoic acid; 4-aminohex-5-enoic acid; Acid, gamma-Vinyl-gamma-Aminobutyric; Aventis Brand of Vigabatrin; CPP-109; GVG; Gamma Vinyl GABA; Gamma Vinyl gamma Aminobutyric Acid; Gamma-Vinyl GABA; Gamma-Vinyl-GABA; Gamma-Vinyl-gamma-Aminobutyric Acid; Hexenoic acid, 4-amino; Hoechst Brand of Vigabatrin; M071754; MDL 71,754; MDL 71754; MDL-71754; RMI 71754; RMI-71754; RMI-71890; Sabril; Sabril (TN); Sabrilex; Sabrilex (TN); V 8261; V8261_SIGMA; Vigabatrin (JAN/USAN/INN); Vigabatrin Aventis Brand; Vigabatrin Hoechst Brand; Vigabatrin Yamanouchi Brand; Vigabatrin [USAN:BAN:INN]; Vigabatrin [USAN:INN:BAN]; Vigabatrina; Vigabatrina [Spanish]; Vigabatrine; Vigabatrine [French]; Vigabatrinum; Vigabatrinum [Latin]; Yamanouchi Brand of Vigabatrin DTD0318 VADRUGID DR00197 DTD0318 DRUGNAME Cycloserine DTD0318 DRUGSYNO (+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D; Alpha-Cycloserine; C 3909; C-9390; C-9400; Cicloserina; Cicloserina [INN-Spanish]; Cicloserina [Italian]; Closerin; Closina; Cyclo-D-serine; Cyclorin; Cycloserine (JP15/USP/INN); Cycloserine [INN:BAN:JAN]; Cycloserinum; Cycloserinum [INN-Latin]; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-CS; D-amino-3-isoxazolidinone; D-cycloserine; DRG-0195; E-733-A; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; Farmiserina; I-1431; K-300; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamicina [Italian]; Oxamycin; PA 94; PA-94; R(+)-4-Amino-3-isoxazolidinone; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; RO-1-9213; SC-49088; Seromycin; Seromycin (TN); Tebemicina; Tisomycin; Wasserina DTD0318 VADRUGID DR00242 DTD0318 DRUGNAME Glycine DTD0318 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0318 VADRUGID DR00179 DTD0318 DRUGNAME L-proline DTD0318 DRUGSYNO (-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin] DTD0318 VADRUGID DR00004 DTD0318 DRUGNAME Gaboxadol DTD0318 DRUGSYNO 4,5,6,7-Tetrahydroisoxazole(5,4-c)pyridin-3-ol; 4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol; 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one; Gaboxadol (USAN/INN); Gaboxadol [USAN:INN]; Gaboxadolum; Gaboxadolum [Latin]; Isoxazolo(5,4-c)pyridin-3(2H)-one, 4,5,6,7-tetrahydro-, hydrate; LU 2030; LU-2-030; Lu 02-030; Lu-02-030; MK-0928; THIP DTD0318 VADRUGID DR00374 DTD0318 DRUGNAME Amino acids DTD0318 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0318 VADRUGID DR00057 DTD0318 DRUGNAME Aminolevulinic acid DTD0318 DRUGSYNO 5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI) DTD0319 TRANSPID DTD0319 DTD0319 GENENAME SLC36A2 DTD0319 PROTNAME Proton-coupled amino acid transporter 2 DTD0319 SYNONYMS PAT2; Proton/amino acid transporter 2; SLC36A2; Solute carrier family 36 member 2; TRAMD1; Tramdorin-1 DTD0319 VADRUGID DR00197 DTD0319 DRUGNAME Cycloserine DTD0319 DRUGSYNO (+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D; Alpha-Cycloserine; C 3909; C-9390; C-9400; Cicloserina; Cicloserina [INN-Spanish]; Cicloserina [Italian]; Closerin; Closina; Cyclo-D-serine; Cyclorin; Cycloserine (JP15/USP/INN); Cycloserine [INN:BAN:JAN]; Cycloserinum; Cycloserinum [INN-Latin]; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-CS; D-amino-3-isoxazolidinone; D-cycloserine; DRG-0195; E-733-A; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; Farmiserina; I-1431; K-300; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamicina [Italian]; Oxamycin; PA 94; PA-94; R(+)-4-Amino-3-isoxazolidinone; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; RO-1-9213; SC-49088; Seromycin; Seromycin (TN); Tebemicina; Tisomycin; Wasserina DTD0320 TRANSPID DTD0320 DTD0320 GENENAME SLC36A3 DTD0320 PROTNAME Proton-coupled amino acid transporter 3 DTD0320 SYNONYMS PAT3; Proton/amino acid transporter 3; SLC36A3; Solute carrier family 36 member 3; TRAMD2; Tramdorin-2; tramdorin2 DTD0320 VADRUGID DR00374 DTD0320 DRUGNAME Amino acids DTD0320 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0321 TRANSPID DTD0321 DTD0321 GENENAME SLC36A4 DTD0321 PROTNAME Proton-coupled amino acid transporter 4 DTD0321 SYNONYMS PAT4; Proton/amino acid transporter 4; SLC36A4; Solute carrier family 36 member 4 DTD0321 VADRUGID DR00086 DTD0321 DRUGNAME L-tryptophan DTD0321 DRUGSYNO (-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin] DTD0321 VADRUGID DR00179 DTD0321 DRUGNAME L-proline DTD0321 DRUGSYNO (-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin] DTD0322 TRANSPID DTD0322 DTD0322 GENENAME SLC37A1 DTD0322 PROTNAME Glycerol-3-phosphate permease DTD0322 SYNONYMS G-3-P permease; G3PP; Glucose-6-phosphate exchanger SLC37A1; SLC37A1; Solute carrier family 37 member 1 DTD0322 VADRUGID DR00132 DTD0322 DRUGNAME Phosphate DTD0322 DRUGSYNO 14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V) DTD0322 VADRUGID DR00098 DTD0322 DRUGNAME Glucose-6-phosphate DTD0322 DRUGSYNO 299-31-0; 6-O-phosphono-D-glucopyranose; AC1L1LI0; AC1Q28E3; CHEBI:4170; D-Glucopyranose 6-phosphoric acid; D-glucopyranose 6-phosphate; D-glucopyranose, 6-(dihydrogen phosphate); D-glucose-6-P; D-glucose-6P; GTPL4647; Glc6P; Glucose 6-(dihydrogen phosphate); Glucose 6-phosphate; Robison ester; SCHEMBL48379; a-D-glucose 6- phosphate; {[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid DTD0325 TRANSPID DTD0325 DTD0325 GENENAME SLC37A4 DTD0325 PROTNAME Glucose-6-phosphate translocase DTD0325 SYNONYMS G6PT; G6PT1; G6PT2; G6PT3; GSD1b; GSD1c; GSD1d; Glucose-5-phosphate transporter; Glucose-6-phosphate exchanger SLC37A4; PRO0685; SLC37A4; Solute carrier family 37 member 4; TRG-19; TRG19; Transformation-related gene 19 protein DTD0325 VADRUGID DR00098 DTD0325 DRUGNAME Glucose-6-phosphate DTD0325 DRUGSYNO 299-31-0; 6-O-phosphono-D-glucopyranose; AC1L1LI0; AC1Q28E3; CHEBI:4170; D-Glucopyranose 6-phosphoric acid; D-glucopyranose 6-phosphate; D-glucopyranose, 6-(dihydrogen phosphate); D-glucose-6-P; D-glucose-6P; GTPL4647; Glc6P; Glucose 6-(dihydrogen phosphate); Glucose 6-phosphate; Robison ester; SCHEMBL48379; a-D-glucose 6- phosphate; {[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid DTD0326 TRANSPID DTD0326 DTD0326 GENENAME SLC38A1 DTD0326 PROTNAME Sodium-coupled neutral amino acid transporter 1 DTD0326 SYNONYMS ATA1; Amino acid transporter A1; N-system amino acid transporter 2; NAT2; SLC38A1; SNAT1; Solute carrier family 38 member 1; System A amino acid transporter 1; System N amino acid transporter 1 DTD0326 VADRUGID DR00142 DTD0326 DRUGNAME L-alanine DTD0326 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0326 VADRUGID DR00024 DTD0326 DRUGNAME L-glutamine DTD0326 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0327 TRANSPID DTD0327 DTD0327 GENENAME SLC38A10 DTD0327 PROTNAME Putative sodium-coupled neutral amino acid transporter 10 DTD0327 SYNONYMS PP1744; SLC38A10; Solute carrier family 38 member 10 DTD0327 VADRUGID DR00352 DTD0327 DRUGNAME Aspartic acid DTD0327 DRUGSYNO (2S)-2-aminobutanedioic acid; (2S)-Aspartic acid; (S)-2-Aminosuccinic acid; (S)-Aminobutanedioic acid; (S)-Aspartic acid; Acidum asparticum; Aminosuccinic acid; Asparagic acid; Asparaginic acid; Asparaginsaeure [German]; Aspartate, L-; Aspartic acid, L-; Aspatofort; Butanedioic acid, amino-, (S); H-Asp-OH; L-(+)-Aspartic acid; L-2-Aminobutanedioic acid; L-Aminosuccinic acid; L-Asp; L-Asparagic acid; L-Asparaginic acid; L-Asparaginsaeure; L-Asparaginsyra; L-Aspartinsaeure; L-aspartate; L-aspartic acid; aspartate; aspartic acid DTD0327 VADRUGID DR00005 DTD0327 DRUGNAME L-glutamic acid DTD0327 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0328 TRANSPID DTD0328 DTD0328 GENENAME SLC38A11 DTD0328 PROTNAME Putative sodium-coupled neutral amino acid transporter 11 DTD0328 SYNONYMS AVT2; SLC38A11; Solute carrier family 38 member 11 DTD0328 VADRUGID DR00374 DTD0328 DRUGNAME Amino acids DTD0328 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0329 TRANSPID DTD0329 DTD0329 GENENAME SLC38A2 DTD0329 PROTNAME Sodium-coupled neutral amino acid transporter 2 DTD0329 SYNONYMS ATA2; Amino acid transporter A2; KIAA1382; PRO1068; Protein 40-9-1; SAT2; SLC38A2; SNAT2; Solute carrier family 38 member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2 DTD0329 VADRUGID DR00142 DTD0329 DRUGNAME L-alanine DTD0329 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0329 VADRUGID DR00024 DTD0329 DRUGNAME L-glutamine DTD0329 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0330 TRANSPID DTD0330 DTD0330 GENENAME SLC38A3 DTD0330 PROTNAME Sodium-coupled neutral amino acid transporter 3 DTD0330 SYNONYMS G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3 DTD0330 VADRUGID DR00142 DTD0330 DRUGNAME L-alanine DTD0330 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0330 VADRUGID DR00024 DTD0330 DRUGNAME L-glutamine DTD0330 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0330 VADRUGID DR00134 DTD0330 DRUGNAME Folic acid DTD0330 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0330 VADRUGID DR01160 DTD0330 DRUGNAME Aminosalicylic acid DTD0330 DRUGSYNO 2-Hydroxy-4-aminobenzoic acid; 4-Aminosalicylic acid; 65-49-6; APAS; Aminopar; Aminosalicylate Sodium; Aminosalicylic Acid Resin Complex; Aminosalicylic acid; Aminox; Apacil; Benzoic acid, 4-amino-2-hydroxy-; Deapasil; Entepas; Ferrosan; Gabbropas; Hellipidyl; Osacyl; P-AMINOSALICYLIC ACID; PAS (acid); PAS-C; PASK; Pamacyl; Pamisyl; Para-Pas; Paramycin; Parasal; Parasalicil; Parasalindon; Pasa; Pasalon; Pasara; Pascorbic; Pasdium; Pasem; Paser; Pasmed; Pasnodia; Pasolac; Propasa; Rezipas; Sanipirol-4 DTD0331 TRANSPID DTD0331 DTD0331 GENENAME SLC38A4 DTD0331 PROTNAME Sodium-coupled neutral amino acid transporter 4 DTD0331 SYNONYMS ATA3; Amino acid transporter A3; NAT3; Na(+)-coupled neutral amino acid transporter 4; PAAT; SLC38A4; SNAT4; Solute carrier family 38 member 4; System A amino acid transporter 3; System N amino acid transporter 3 DTD0331 VADRUGID DR00142 DTD0331 DRUGNAME L-alanine DTD0331 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0331 VADRUGID DR00024 DTD0331 DRUGNAME L-glutamine DTD0331 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0332 TRANSPID DTD0332 DTD0332 GENENAME SLC38A5 DTD0332 PROTNAME Sodium-coupled neutral amino acid transporter 5 DTD0332 SYNONYMS JM24; SLC38A5; SN2; SNAT5; Solute carrier family 38 member 5; System N transporter 2; pp7194 DTD0332 VADRUGID DR00142 DTD0332 DRUGNAME L-alanine DTD0332 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0332 VADRUGID DR00024 DTD0332 DRUGNAME L-glutamine DTD0332 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0333 TRANSPID DTD0333 DTD0333 GENENAME SLC38A6 DTD0333 PROTNAME Probable sodium-coupled neutral amino acid transporter 6 DTD0333 SYNONYMS N-system amino acid transporter 1; NAT-1; NAT1; Na(+)-coupled neutral amino acid transporter 6; SLC38A6; SNAT6; Solute carrier family 38 member 6 DTD0333 VADRUGID DR00374 DTD0333 DRUGNAME Amino acids DTD0333 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0334 TRANSPID DTD0334 DTD0334 GENENAME SLC38A7 DTD0334 PROTNAME Putative sodium-coupled neutral amino acid transporter 7 DTD0334 SYNONYMS SLC38A7; SNAT7; Solute carrier family 38 member 7 DTD0334 VADRUGID DR00464 DTD0334 DRUGNAME Anastrozole DTD0334 DRUGSYNO 1,3-benzenediacetonitrile, a, a,a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl); 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile; Alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Alpha,alpha,alpha',alpha'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Anastrazole; Anastrole; Anastrozol; Anastrozole (JAN/USAN/INN); Anastrozole [USAN:INN:BAN]; Arimidex; Arimidex (TN); Arimidex (Zeneca); Arimidex, Anastrozole; Asiolex; Astra brand of anastrozole; AstraZeneca brand of anastrozole; ZD 1033; ZD-1033; ZD1033; Zeneca ZD 1033; Zeneca brand of anastrozole DTD0334 VADRUGID DR00024 DTD0334 DRUGNAME L-glutamine DTD0334 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0335 TRANSPID DTD0335 DTD0335 GENENAME SLC38A8 DTD0335 PROTNAME Putative sodium-coupled neutral amino acid transporter 8 DTD0335 SYNONYMS FVH2; SLC38A8; Solute carrier family 38 member 8 DTD0335 VADRUGID DR00005 DTD0335 DRUGNAME L-glutamic acid DTD0335 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0336 TRANSPID DTD0336 DTD0336 GENENAME SLC38A9 DTD0336 PROTNAME Sodium-coupled neutral amino acid transporter 9 DTD0336 SYNONYMS SLC38A9; Solute carrier family 38 member 9; URLC11; Up-regulated in lung cancer 11 DTD0336 VADRUGID DR00188 DTD0336 DRUGNAME Arginine DTD0336 DRUGSYNO 1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ & argininhydrochlorid DTD0337 TRANSPID DTD0337 DTD0337 GENENAME SLC39A1 DTD0337 PROTNAME Zrt- and Irt-like protein 1 DTD0337 SYNONYMS IRT1; SLC39A1; Solute carrier family 39 member 1; ZIP-1; ZIP1; ZIRTL; Zinc transporter ZIP1; Zinc-iron-regulated transporter-like; hZIP1 DTD0337 VADRUGID DR00068 DTD0337 DRUGNAME Zinc salts DTD0337 DRUGSYNO . DTD0338 TRANSPID DTD0338 DTD0338 GENENAME SLC39A10 DTD0338 PROTNAME Zrt- and Irt-like protein 10 DTD0338 SYNONYMS KIAA1265; LZT-Hs2; SLC39A10; Solute carrier family 39 member 10; ZIP-10; ZIP10; Zinc transporter ZIP10 DTD0338 VADRUGID DR00068 DTD0338 DRUGNAME Zinc salts DTD0338 DRUGSYNO . DTD0339 TRANSPID DTD0339 DTD0339 GENENAME SLC39A11 DTD0339 PROTNAME Zrt- and Irt-like protein 11 DTD0339 SYNONYMS C17orf26; SLC39A11; Solute carrier family 39 member 11; ZIP-11; ZIP11; Zinc transporter ZIP11 DTD0339 VADRUGID DR00068 DTD0339 DRUGNAME Zinc salts DTD0339 DRUGSYNO . DTD0340 TRANSPID DTD0340 DTD0340 GENENAME SLC39A12 DTD0340 PROTNAME Zrt- and Irt-like protein 12 DTD0340 SYNONYMS LIV-1 subfamily of ZIP zinc transporter 8; LZT-Hs8; SLC39A12; Solute carrier family 39 member 12; ZIP-12; ZIP12; Zinc transporter ZIP12; bA570F3.1 DTD0340 VADRUGID DR00068 DTD0340 DRUGNAME Zinc salts DTD0340 DRUGSYNO . DTD0341 TRANSPID DTD0341 DTD0341 GENENAME SLC39A13 DTD0341 PROTNAME Zrt- and Irt-like protein 13 DTD0341 SYNONYMS EDSSPD3; LIV-1 subfamily of ZIP zinc transporter 9; LZT-Hs9; SCDEDS; SLC39A13; Solute carrier family 39 member 13; ZIP-13; ZIP13; Zinc transporter ZIP13 DTD0341 VADRUGID DR00068 DTD0341 DRUGNAME Zinc salts DTD0341 DRUGSYNO . DTD0342 TRANSPID DTD0342 DTD0342 GENENAME SLC39A14 DTD0342 PROTNAME Zrt- and Irt-like protein 14 DTD0342 SYNONYMS HCIN; HMNDYT2; KIAA0062; LIV-1 subfamily of ZIP zinc transporter 4; LZT-Hs4; NET34; SLC39A14; Solute carrier family 39 member 14; ZIP-14; ZIP14; Zinc transporter ZIP14; cig19 DTD0342 VADRUGID DR00068 DTD0342 DRUGNAME Zinc salts DTD0342 DRUGSYNO . DTD0343 TRANSPID DTD0343 DTD0343 GENENAME SLC39A2 DTD0343 PROTNAME Zrt- and Irt-like protein 2 DTD0343 SYNONYMS 6A1; Eti-1; SLC39A2; Solute carrier family 39 member 2; ZIP-2; ZIP2; Zinc transporter ZIP2; hZIP2 DTD0343 VADRUGID DR00068 DTD0343 DRUGNAME Zinc salts DTD0343 DRUGSYNO . DTD0344 TRANSPID DTD0344 DTD0344 GENENAME SLC39A3 DTD0344 PROTNAME Zrt- and Irt-like protein 3 DTD0344 SYNONYMS SLC39A3; Solute carrier family 39 member 3; ZIP-3; ZIP3; Zinc transporter ZIP3 DTD0344 VADRUGID DR00068 DTD0344 DRUGNAME Zinc salts DTD0344 DRUGSYNO . DTD0345 TRANSPID DTD0345 DTD0345 GENENAME SLC39A4 DTD0345 PROTNAME Zrt- and Irt-like protein 4 DTD0345 SYNONYMS AEZ; AWMS2; SLC39A4; Solute carrier family 39 member 4; ZIP-4; ZIP4; Zinc transporter ZIP4 DTD0345 VADRUGID DR00068 DTD0345 DRUGNAME Zinc salts DTD0345 DRUGSYNO . DTD0346 TRANSPID DTD0346 DTD0346 GENENAME SLC39A5 DTD0346 PROTNAME Zrt- and Irt-like protein 5 DTD0346 SYNONYMS LZT-Hs7; MYP24; SLC39A5; Solute carrier family 39 member 5; ZIP-5; ZIP5; Zinc transporter ZIP5 DTD0346 VADRUGID DR00068 DTD0346 DRUGNAME Zinc salts DTD0346 DRUGSYNO . DTD0347 TRANSPID DTD0347 DTD0347 GENENAME SLC39A6 DTD0347 PROTNAME Zrt- and Irt-like protein 6 DTD0347 SYNONYMS Estrogen-regulated protein LIV-1; LIV-1; LIV1; SLC39A6; Solute carrier family 39 member 6; ZIP-6; ZIP6; Zinc transporter ZIP6 DTD0347 VADRUGID DR00068 DTD0347 DRUGNAME Zinc salts DTD0347 DRUGSYNO . DTD0348 TRANSPID DTD0348 DTD0348 GENENAME SLC39A7 DTD0348 PROTNAME Zrt- Irt-like protein 7 DTD0348 SYNONYMS D6S115E; D6S2244E; H2-KE4; HKE4; Histidine-rich membrane protein Ke4; KE4; RING5; Really interesting new gene 5 protein; SLC39A7; Solute carrier family 39 member 7; ZIP7; Zinc transporter SLC39A7 DTD0348 VADRUGID DR00068 DTD0348 DRUGNAME Zinc salts DTD0348 DRUGSYNO . DTD0349 TRANSPID DTD0349 DTD0349 GENENAME SLC39A8 DTD0349 PROTNAME Zrt- and Irt-like protein 8 DTD0349 SYNONYMS BCG-induced integral membrane protein in monocyte clone 103 protein; BIGM103; CDG2N; LIV-1 subfamily of ZIP zinc transporter 6; LZT-Hs6; PP3105; SLC39A8; Solute carrier family 39 member 8; ZIP-8; ZIP8; Zinc transporter ZIP8 DTD0349 VADRUGID DR00068 DTD0349 DRUGNAME Zinc salts DTD0349 DRUGSYNO . DTD0350 TRANSPID DTD0350 DTD0350 GENENAME SLC39A9 DTD0350 PROTNAME Zrt- and Irt-like protein 9 DTD0350 SYNONYMS SLC39A9; Solute carrier family 39 member 9; ZIP-9; ZIP9; Zinc transporter ZIP9 DTD0350 VADRUGID DR00068 DTD0350 DRUGNAME Zinc salts DTD0350 DRUGSYNO . DTD0351 TRANSPID DTD0351 DTD0351 GENENAME SLC3A1 DTD0351 PROTNAME Neutral and basic amino acid transport protein rBAT DTD0351 SYNONYMS ATR1; CSNU1; D2h; NBAT; RBAT; SLC3A1; Solute carrier family 3 member 1; b(0),+-type amino acid transport protein DTD0351 VADRUGID DR00374 DTD0351 DRUGNAME Amino acids DTD0351 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0352 TRANSPID DTD0352 DTD0352 GENENAME SLC3A2 DTD0352 PROTNAME Lymphocyte activation antigen 4F2 DTD0352 SYNONYMS Solute carrier family 3 member 2; 4F2 cell-surface antigen heavy chain; 4F2hc; 4F2 heavy chain antigen; Lymphocyte activation antigen 4F2 large subunit; 4F2; 4T2HC; CD98HC; MDU1; NACAE; SLC3A2 DTD0352 VADRUGID DR01251 DTD0352 DRUGNAME Polyamine DTD0352 DRUGSYNO . DTD0353 TRANSPID DTD0353 DTD0353 GENENAME SLC40A1 DTD0353 PROTNAME Iron-regulated transporter 1 DTD0353 SYNONYMS FPN1; Ferroportin-1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3; SLC40A1; Solute carrier family 40 member 1 DTD0353 VADRUGID DR00068 DTD0353 DRUGNAME Zinc salts DTD0353 DRUGSYNO . DTD0358 TRANSPID DTD0358 DTD0358 GENENAME SLC42A2 DTD0358 PROTNAME Ammonium transporter Rh type B DTD0358 SYNONYMS RHBG; Rh family type B glycoprotein; Rh type B glycoprotein; Rhesus blood group family type B glycoprotein; SLC42A2 DTD0358 VADRUGID DR00194 DTD0358 DRUGNAME Ammonia DTD0358 DRUGSYNO Ammonia N13 DTD0359 TRANSPID DTD0359 DTD0359 GENENAME SLC42A3 DTD0359 PROTNAME Ammonium transporter Rh type C DTD0359 SYNONYMS C15orf6; CDRC2; PDRC2; RHCG; RHGK; Rh family type C glycoprotein; Rh glycoprotein kidney; Rh type C glycoprotein; Rhesus blood group family type C glycoprotein; SLC42A3; Tumor-related protein DRC2 DTD0359 VADRUGID DR00194 DTD0359 DRUGNAME Ammonia DTD0359 DRUGSYNO Ammonia N13 DTD0360 TRANSPID DTD0360 DTD0360 GENENAME SLC43A1 DTD0360 PROTNAME L-type amino acid transporter 3 DTD0360 SYNONYMS LAT3; Large neutral amino acids transporter small subunit 3; PB39; POV1; Prostate cancer overexpressed gene 1 protein; R00504; SLC43A1; Solute carrier family 43 member 1 DTD0360 VADRUGID DR00266 DTD0360 DRUGNAME L-phenylalanine DTD0360 DRUGSYNO (2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin] DTD0360 VADRUGID DR00214 DTD0360 DRUGNAME L-isoleucine DTD0360 DRUGSYNO (2S,3S)-2-Amino-3-methylpentanoic acid; (S)-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; 2S,3S-Isoleucine; 443-79-8; 73-32-5; Acetic acid, amino-sec-butyl-; CCRIS 5229; H-Ile-OH; ISOLEUCINE, L-; Isoleucina [Spanish]; Isoleucine; Isoleucine (VAN); Isoleucinum [Latin]; L-(+)-Isoleucine; L-Ile; L-Norvaline, 3-methyl-, erythro-; Norvaline, 3-methyl-; Pentanoic acid, 2-amino-3-methyl-; Valeric acid, 2-amino-3-methyl-; alpha-Amino-beta-methylvaleric acid; erythro-L-Isoleucine; iso-leucine; l-isoleucine DTD0360 VADRUGID DR00303 DTD0360 DRUGNAME L-leucine DTD0360 DRUGSYNO (2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine DTD0360 VADRUGID DR00236 DTD0360 DRUGNAME L-valine DTD0360 DRUGSYNO (2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; (S)-Valine; (S)-alpha-Amino-beta-methylbutyric acid; 2-Amino-3-methylbutanoic acid, (S)-; 2-Amino-3-methylbutyric acid; 2-Amino-3-methylbutyric acid, (S)-; 72-18-4; Butanoic acid, 2-amino-3-methyl-; Butanoic acid, 2-amino-3-methyl-, (S)-; H-Val-OH; L(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; L-valin; VALINE, L-; Valina [Spanish]; Valine; Valine (VAN); Valine [USAN:INN]; Valinum [Latin] DTD0361 TRANSPID DTD0361 DTD0361 GENENAME SLC43A2 DTD0361 PROTNAME L-type amino acid transporter 4 DTD0361 SYNONYMS LAT4; Large neutral amino acids transporter small subunit 4; SLC43A2; Solute carrier family 43 member 2 DTD0361 VADRUGID DR00266 DTD0361 DRUGNAME L-phenylalanine DTD0361 DRUGSYNO (2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin] DTD0361 VADRUGID DR00214 DTD0361 DRUGNAME L-isoleucine DTD0361 DRUGSYNO (2S,3S)-2-Amino-3-methylpentanoic acid; (S)-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; 2S,3S-Isoleucine; 443-79-8; 73-32-5; Acetic acid, amino-sec-butyl-; CCRIS 5229; H-Ile-OH; ISOLEUCINE, L-; Isoleucina [Spanish]; Isoleucine; Isoleucine (VAN); Isoleucinum [Latin]; L-(+)-Isoleucine; L-Ile; L-Norvaline, 3-methyl-, erythro-; Norvaline, 3-methyl-; Pentanoic acid, 2-amino-3-methyl-; Valeric acid, 2-amino-3-methyl-; alpha-Amino-beta-methylvaleric acid; erythro-L-Isoleucine; iso-leucine; l-isoleucine DTD0361 VADRUGID DR00303 DTD0361 DRUGNAME L-leucine DTD0361 DRUGSYNO (2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine DTD0361 VADRUGID DR00236 DTD0361 DRUGNAME L-valine DTD0361 DRUGSYNO (2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; (S)-Valine; (S)-alpha-Amino-beta-methylbutyric acid; 2-Amino-3-methylbutanoic acid, (S)-; 2-Amino-3-methylbutyric acid; 2-Amino-3-methylbutyric acid, (S)-; 72-18-4; Butanoic acid, 2-amino-3-methyl-; Butanoic acid, 2-amino-3-methyl-, (S)-; H-Val-OH; L(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; L-valin; VALINE, L-; Valina [Spanish]; Valine; Valine (VAN); Valine [USAN:INN]; Valinum [Latin] DTD0362 TRANSPID DTD0362 DTD0362 GENENAME SLC43A3 DTD0362 PROTNAME Equilibrative nucleobase transporter 1 DTD0362 SYNONYMS EEG1; ENBT1; FOAP-13; PRO1659; PSEC0252; Protein FOAP-13; SEEEG-1; SLC43A3; Solute carrier family 43 member 3 DTD0362 VADRUGID DR00145 DTD0362 DRUGNAME Mercaptopurine DTD0362 DRUGSYNO 1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine DTD0363 TRANSPID DTD0363 DTD0363 GENENAME SLC44A1 DTD0363 PROTNAME Choline transporter-like protein 1 DTD0363 SYNONYMS CD92; CDw92; CHTL1; CTL1; SLC44A1; Solute carrier family 44 member 1 DTD0363 VADRUGID DR00121 DTD0363 DRUGNAME Choline DTD0363 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0364 TRANSPID DTD0364 DTD0364 GENENAME SLC44A2 DTD0364 PROTNAME Choline transporter-like protein 2 DTD0364 SYNONYMS CTL2; PP1292; SLC44A2; Solute carrier family 44 member 2 DTD0364 VADRUGID DR00121 DTD0364 DRUGNAME Choline DTD0364 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0366 TRANSPID DTD0366 DTD0366 GENENAME SLC44A4 DTD0366 PROTNAME Choline transporter-like protein 4 DTD0366 SYNONYMS C6orf29; CTL4; DFNA72; NG22; SLC44A4; Solute carrier family 44 member 4; TPPT; TPPT1; Thiamine pyrophosphate transporter 1; hTPPT1 DTD0366 VADRUGID DR00070 DTD0366 DRUGNAME Acetylcholine DTD0366 DRUGSYNO Miochol; Miochol-e DTD0366 VADRUGID DR00117 DTD0366 DRUGNAME Vitamin B1 DTD0366 DRUGSYNO 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride DTD0366 VADRUGID DR00121 DTD0366 DRUGNAME Choline DTD0366 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0367 TRANSPID DTD0367 DTD0367 GENENAME SLC44A5 DTD0367 PROTNAME Choline transporter-like protein 5 DTD0367 SYNONYMS CTL5; SLC44A5; Solute carrier family 44 member 5 DTD0367 VADRUGID DR00121 DTD0367 DRUGNAME Choline DTD0367 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0368 TRANSPID DTD0368 DTD0368 GENENAME SLC45A1 DTD0368 PROTNAME Proton-associated sugar transporter A DTD0368 SYNONYMS DNB5; DNb-5; Deleted in neuroblastoma 5 protein; IDDNPF; PAST-A; SLC45A1; Solute carrier family 45 member 1 DTD0368 VADRUGID DR00011 DTD0368 DRUGNAME 2-Deoxyglucose DTD0368 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0369 TRANSPID DTD0369 DTD0369 GENENAME SLC45A2 DTD0369 PROTNAME Membrane-associated transporter protein DTD0369 SYNONYMS 1A1; AIM1; MATP; Melanoma antigen AIM1; OCA4; Protein AIM-1; SHEP5; SLC45A2; Solute carrier family 45 member 2 DTD0369 VADRUGID DR00131 DTD0369 DRUGNAME Sucrose DTD0369 DRUGSYNO 57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar DTD0370 TRANSPID DTD0370 DTD0370 GENENAME SLC45A3 DTD0370 PROTNAME Solute carrier family 45 member 3 DTD0370 SYNONYMS IPCA-2; IPCA-6; IPCA-8; IPCA6; PCANAP2; PCANAP6; PCANAP8; PRST; Prostate cancer-associated protein 6; Prostein; SLC45A3 DTD0370 VADRUGID DR00131 DTD0370 DRUGNAME Sucrose DTD0370 DRUGSYNO 57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar DTD0371 TRANSPID DTD0371 DTD0371 GENENAME SLC45A4 DTD0371 PROTNAME Solute carrier family 45 member 4 DTD0371 SYNONYMS KIAA1126; SLC45A4; Solute carrier 45 member 4 DTD0371 VADRUGID DR00131 DTD0371 DRUGNAME Sucrose DTD0371 DRUGSYNO 57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar DTD0372 TRANSPID DTD0372 DTD0372 GENENAME SLC46A1 DTD0372 PROTNAME Proton-coupled folate transporter DTD0372 SYNONYMS G21; HCP1; Heme carrier protein 1; PCFT; PCFT/HCP1; SLC46A1; Solute carrier family 46 member 1 DTD0372 VADRUGID DR00041 DTD0372 DRUGNAME Pralatrexate DTD0372 DRUGSYNO Folotyn (TN) DTD0372 VADRUGID DR00082 DTD0372 DRUGNAME Methotrexate DTD0372 DRUGSYNO (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate DTD0372 VADRUGID DR00318 DTD0372 DRUGNAME Pemetrexed DTD0372 DRUGSYNO (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN] DTD0372 VADRUGID DR00134 DTD0372 DRUGNAME Folic acid DTD0372 DRUGSYNO (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M DTD0376 TRANSPID DTD0376 DTD0376 GENENAME SLC49A1 DTD0376 PROTNAME Feline leukemia virus subgroup C receptor-related protein 1 DTD0376 SYNONYMS AXPC1; FLVCR; FLVCR1; Feline leukemia virus subgroup C receptor; MFSD7B; PCA; PCARP; SLC49A1; hFLVCR DTD0376 VADRUGID DR00225 DTD0376 DRUGNAME Quercetin DTD0376 DRUGSYNO 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine DTD0376 VADRUGID DR00312 DTD0376 DRUGNAME Arsenite DTD0376 DRUGSYNO 13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion) DTD0381 TRANSPID DTD0381 DTD0381 GENENAME SLC4A10 DTD0381 PROTNAME Sodium-driven chloride bicarbonate exchanger DTD0381 SYNONYMS NBCn2; NCBE; SLC4A10; Solute carrier family 4 member 10 DTD0381 VADRUGID DR00038 DTD0381 DRUGNAME Sodium bicarbonate DTD0381 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0383 TRANSPID DTD0383 DTD0383 GENENAME SLC4A2 DTD0383 PROTNAME Anion exchange protein 2 DTD0383 SYNONYMS AE 2; AE2; Anion exchanger 2; BND3L; EPB3L1; HKB3; MPB3L; NBND3; Non-erythroid band 3-like protein; SLC4A2; Solute carrier family 4 member 2 DTD0383 VADRUGID DR00138 DTD0383 DRUGNAME Bicarbonate DTD0383 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0384 TRANSPID DTD0384 DTD0384 GENENAME SLC4A3 DTD0384 PROTNAME Anion exchange protein 3 DTD0384 SYNONYMS AE 3; AE3; Anion exchanger 3; CAE3/BAE3; Cardiac/brain band 3-like protein; Neuronal band 3-like protein; SLC2C; SLC4A3; Solute carrier family 4 member 3 DTD0384 VADRUGID DR00138 DTD0384 DRUGNAME Bicarbonate DTD0384 DRUGSYNO 71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV) DTD0385 TRANSPID DTD0385 DTD0385 GENENAME SLC4A4 DTD0385 PROTNAME Electrogenic sodium bicarbonate cotransporter 1 DTD0385 SYNONYMS HNBC1; KNBC; NBC1; NBCE1; NBCe1-A; Na(+)/HCO3(-) cotransporter; SLC4A4; Sodium bicarbonate cotransporter; Solute carrier family 4 member 4; hhNMC; kNBC1; pNBC DTD0385 VADRUGID DR00038 DTD0385 DRUGNAME Sodium bicarbonate DTD0385 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0386 TRANSPID DTD0386 DTD0386 GENENAME SLC4A5 DTD0386 PROTNAME Electrogenic sodium bicarbonate cotransporter 4 DTD0386 SYNONYMS NBC4; NBCe2; SLC4A5; Solute carrier family 4 member 5 DTD0386 VADRUGID DR00038 DTD0386 DRUGNAME Sodium bicarbonate DTD0386 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0387 TRANSPID DTD0387 DTD0387 GENENAME SLC4A7 DTD0387 PROTNAME Sodium bicarbonate cotransporter 3 DTD0387 SYNONYMS BT; Bicarbonate transporter; Electroneutral Na/HCO(3) cotransporter; NBC2; NBC2B; NBC3; NBCn1; SBC2; SLC4A6; SLC4A7; Sodium bicarbonate cotransporter 2; Sodium bicarbonate cotransporter 2b; Solute carrier family 4 member 7 DTD0387 VADRUGID DR00038 DTD0387 DRUGNAME Sodium bicarbonate DTD0387 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0388 TRANSPID DTD0388 DTD0388 GENENAME SLC4A8 DTD0388 PROTNAME Electroneutral sodium bicarbonate exchanger 1 DTD0388 SYNONYMS Electroneutral Na(+)-driven Cl-HCO3 exchanger; KIAA0739; NDCBE; NDCBE1; SLC4A8; Solute carrier family 4 member 8; k-NBC3 DTD0388 VADRUGID DR00038 DTD0388 DRUGNAME Sodium bicarbonate DTD0388 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0389 TRANSPID DTD0389 DTD0389 GENENAME SLC4A9 DTD0389 PROTNAME Anion exchange protein 4 DTD0389 SYNONYMS AE 4; AE4; Anion exchanger 4; SBC5; SLC4A9; Sodium bicarbonate cotransporter 5; Solute carrier family 4 member 9 DTD0389 VADRUGID DR00038 DTD0389 DRUGNAME Sodium bicarbonate DTD0389 DRUGSYNO 800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal DTD0391 TRANSPID DTD0391 DTD0391 GENENAME OSTalpha DTD0391 PROTNAME Organic solute transporter subunit alpha DTD0391 SYNONYMS OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha DTD0391 VADRUGID DR00148 DTD0391 DRUGNAME Digoxin DTD0391 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0391 GENENAME SLC51A DTD0391 VADRUGID DR00102 DTD0391 DRUGNAME Dinoprostone DTD0391 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0391 VADRUGID DR01121 DTD0391 DRUGNAME Taurocholic acid DTD0391 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0391 VADRUGID DR00019 DTD0391 DRUGNAME Estrone sulfate DTD0391 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0392 TRANSPID DTD0392 DTD0392 GENENAME SLC51B DTD0392 PROTNAME Organic solute transporter subunit beta DTD0392 SYNONYMS OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta DTD0392 VADRUGID DR00148 DTD0392 DRUGNAME Digoxin DTD0392 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0392 GENENAME OSTbeta DTD0392 VADRUGID DR00102 DTD0392 DRUGNAME Dinoprostone DTD0392 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0392 VADRUGID DR00053 DTD0392 DRUGNAME Sodium taurocholate DTD0392 DRUGSYNO Sodium taurocholate (rectal gel, diabetes/ obesity) DTD0392 VADRUGID DR01121 DTD0392 DRUGNAME Taurocholic acid DTD0392 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0392 VADRUGID DR00019 DTD0392 DRUGNAME Estrone sulfate DTD0392 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0393 TRANSPID DTD0393 DTD0393 GENENAME SLC52A1 DTD0393 PROTNAME Riboflavin transporter 1 DTD0393 SYNONYMS GPCR42; GPR172B; PAR2; PERV-A receptor 2; Porcine endogenous retrovirus A receptor 2; Protein GPR172B; RBFVD; RFT1; RFVT1; SLC52A1; Solute carrier family 52, riboflavin transporter, member 1; hRFT1 DTD0393 VADRUGID DR00079 DTD0393 DRUGNAME Riboflavin DTD0393 DRUGSYNO (-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2 DTD0394 TRANSPID DTD0394 DTD0394 GENENAME SLC52A2 DTD0394 PROTNAME Riboflavin transporter 3 DTD0394 SYNONYMS BVVLS2; D15Ertd747e; GPCR41; GPR172A; PAR1; PERV-A receptor 1; Porcine endogenous retrovirus A receptor 1; Protein GPR172A; RFT3; RFVT2; SLC52A2; Solute carrier family 52, riboflavin transporter, member 2; hRFT3 DTD0394 VADRUGID DR00079 DTD0394 DRUGNAME Riboflavin DTD0394 DRUGSYNO (-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2 DTD0395 TRANSPID DTD0395 DTD0395 GENENAME SLC52A3 DTD0395 PROTNAME Riboflavin transporter 2 DTD0395 SYNONYMS BVVLS; BVVLS1; C20orf54; RFT2; RFVT3; SLC52A3; Solute carrier family 52, riboflavin transporter, member 3; bA371L19.1; hRFT2 DTD0395 VADRUGID DR00079 DTD0395 DRUGNAME Riboflavin DTD0395 DRUGSYNO (-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2 DTD0416 TRANSPID DTD0416 DTD0416 GENENAME SLC59A1 DTD0416 PROTNAME Major facilitator superfamily domain-containing protein 2A DTD0416 SYNONYMS 3-PGDH; 3PGDH; HEL-S-113; MFSD2; MFSD2A; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA; Sodium-dependent LPC symporter 1; Sodium-dependent lysophosphatidylcholine symporter 1 DTD0416 VADRUGID DR00274 DTD0416 DRUGNAME Docosahexaenoic acid DTD0416 DRUGSYNO (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid; 6217-54-5; AquaGrow Advantage; CCRIS 7670; CHEMBL367149; Cervonic acid; Doconexent; Doconexento; Doconexentum; Docosahexaenoate; Docosahexaenoic acid; Docosahexaenoic acid (all-Z); Doxonexent; Eicosapentaenoic acid/docosa-hexaenoic acid; Martek DHA HM; Ropufa 60; UNII-ZAD9OKH9JC; ZAD9OKH9JC; all-Z-Docosahexaenoic acid; all-cis-4,7,10,13,16,19-Docosahexaenoic acid; all-cis-DHA; all-cis-docosa-4,7,10,13,16,19-hexaenoic acid; cis-4,7,10,13,16,19-Docosahexaenoic acid DTD0416 VADRUGID DR00231 DTD0416 DRUGNAME Lysophosphatidylcholine DTD0416 DRUGSYNO 1-acetyl-sn-glycero-3-phosphocholine; 3,5,9-Trioxa-4-phosphaundecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-; AC1NSKBT; CHEBI:138424; GTPL2508; LMGP01050043; SCHEMBL19821626; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-trimethylazaniumylethyl phosphate DTD0418 TRANSPID DTD0418 DTD0418 GENENAME SLC5A1 DTD0418 PROTNAME Sodium/glucose cotransporter 1 DTD0418 SYNONYMS D22S675; High affinity sodium-glucose cotransporter; NAGT; Na(+)/glucose cotransporter 1; SGLT1; SLC5A1; Solute carrier family 5 member 1 DTD0418 VADRUGID DR00011 DTD0418 DRUGNAME 2-Deoxyglucose DTD0418 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0418 VADRUGID DR00198 DTD0418 DRUGNAME Fucose DTD0418 DRUGSYNO 6-Desoxygalactose; AKOS030212707; L-galactomethylose; SCHEMBL13092958 DTD0419 TRANSPID DTD0419 DTD0419 GENENAME SLC5A10 DTD0419 PROTNAME Sodium/glucose cotransporter 5 DTD0419 SYNONYMS Na(+)/glucose cotransporter 5; SGLT-5; SGLT5; SLC5A10; Solute carrier family 5 member 10 DTD0419 VADRUGID DR00011 DTD0419 DRUGNAME 2-Deoxyglucose DTD0419 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0420 TRANSPID DTD0420 DTD0420 GENENAME SLC5A11 DTD0420 PROTNAME Sodium/myo-inositol cotransporter 2 DTD0420 SYNONYMS KST1; Na(+)/myo-inositol cotransporter 2; RKST1; SGLT6; SLC5A11; SLGTX; SMIT2; Sodium-dependent glucose cotransporter; Sodium/glucose cotransporter KST1; Sodium/myo-inositol transporter 2; Solute carrier family 5 member 11 DTD0420 VADRUGID DR00122 DTD0420 DRUGNAME MYO-inositol DTD0420 DRUGSYNO 1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; 6917-35-7; 87-89-8; Allo-inositol; Cocositol; Cyclohexane-1,2,3,4,5,6-hexaol; Cyclohexitol; D-(+)-chiro-Inositol; D-chiro-Inositol; Dambose; Inosital; Inosite; Inositene; Inositina; Iso-inositol; Meat sugar; Mesoinosit; Mesoinosite; Muco-Inositol; Myoinosite; Neo-inositol; Phaseomannite; Phaseomannitol; Quercinitol; Scyllite; Scyllitol; Scyllo-inositol; cis-Inositol; cyclohexane-1,2,3,4,5,6-hexol; epi-Inositol; i-Inositol; inositol; meso-Inositol; mesoinositol DTD0421 TRANSPID DTD0421 DTD0421 GENENAME SLC5A12 DTD0421 PROTNAME Sodium-coupled monocarboxylate transporter 2 DTD0421 SYNONYMS Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; SLC5A12; SMCT2; Solute carrier family 5 member 12 DTD0421 VADRUGID DR00556 DTD0421 DRUGNAME Salicylic acid DTD0421 DRUGSYNO 2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon DTD0421 VADRUGID DR00987 DTD0421 DRUGNAME Gamma-hydroxybutyric acid DTD0421 DRUGSYNO 3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Anetamin; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; EB 27; GHB; Gam-OH; Gamma OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-Hydroxybutyric acid, sodium salt; Gamma-OH; Hydroxyb; Oxy-n-butyric acid; Oxybate; Oxybate sodium; SHB; Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; Sodium Oxybate (4-hydroxybutanoic acid); Somsanit; Utyric acid monosodium salt; WY 3478; Xyrem; Xyrem (TN) DTD0421 VADRUGID DR00703 DTD0421 DRUGNAME Benzoic acid DTD0421 DRUGSYNO 3230-EP2316457A1; 3230-EP2316825A1; 3230-EP2372017A1; 3230-EP2374454A1; 4-Carboxybenzenide; 766-76-7; AC1L18SS; AC1Q1HDY; AC1Q22CA; BDBM36181; Benzene formic acid; Benzenecarboxylate; Benzeneformate; Benzenemethanoate; Benzoic acid, ion(1-); CHEBI:16150; CJ-00025; CTK2H9612; DTXSID4043771; GTPL4565; LS-190261; NCGC00247905-01; Oracyclic acid; Phenyl carboxylic acid; Phenylcarboxylate; Phenylformate; Retarded BA; STL483236; Tennplas; WPYMKLBDIGXBTP-UHFFFAOYSA-M; ZB000218; ZINC328578076; benzoate anion; benzoic acid anion DTD0422 TRANSPID DTD0422 DTD0422 GENENAME SLC5A2 DTD0422 PROTNAME Sodium/glucose cotransporter 2 DTD0422 SYNONYMS Low affinity sodium-glucose cotransporter; Na(+)/glucose cotransporter 2; SGLT2; SLC5A2; Solute carrier family 5 member 2 DTD0422 VADRUGID DR00165 DTD0422 DRUGNAME D-glucose DTD0422 DRUGSYNO (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; 2280-44-6; CPC hydrate; Cartose Cerelose; Clearsweet 95; Clintose L; D-Glc; D-Glcp; D-Glucopyranose; D-Glucopyranose, anhydrous; D-Glucopyranoside; D-glucose-ring; DSSTox_CID_2910; EINECS 218-914-5; Glc; Glc-OH; Glucodin; Glucopyranose; Glucopyranose, D-; Glucopyranoside; Glucose 40; Glucose solution; Meritose; Meritose 200; Roferose ST; Staleydex 130; Staleydex 95M; glc-ring DTD0423 TRANSPID DTD0423 DTD0423 GENENAME SLC5A3 DTD0423 PROTNAME Sodium/myo-inositol cotransporter DTD0423 SYNONYMS BCW2; Na(+)/myo-inositol cotransporter; SLC5A3; SMIT; SMIT1; Sodium/myo-inositol transporter 1; Solute carrier family 5 member 3 DTD0423 VADRUGID DR00122 DTD0423 DRUGNAME MYO-inositol DTD0423 DRUGSYNO 1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; 6917-35-7; 87-89-8; Allo-inositol; Cocositol; Cyclohexane-1,2,3,4,5,6-hexaol; Cyclohexitol; D-(+)-chiro-Inositol; D-chiro-Inositol; Dambose; Inosital; Inosite; Inositene; Inositina; Iso-inositol; Meat sugar; Mesoinosit; Mesoinosite; Muco-Inositol; Myoinosite; Neo-inositol; Phaseomannite; Phaseomannitol; Quercinitol; Scyllite; Scyllitol; Scyllo-inositol; cis-Inositol; cyclohexane-1,2,3,4,5,6-hexol; epi-Inositol; i-Inositol; inositol; meso-Inositol; mesoinositol DTD0424 TRANSPID DTD0424 DTD0424 GENENAME SLC5A4 DTD0424 PROTNAME Sodium/glucose cotransporter 3 DTD0424 SYNONYMS DJ90G24.4; SAAT1; SGLT3; SLC5A4; Solute carrier family 5 member 4 DTD0424 VADRUGID DR00011 DTD0424 DRUGNAME 2-Deoxyglucose DTD0424 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0425 TRANSPID DTD0425 DTD0425 GENENAME SLC5A5 DTD0425 PROTNAME Sodium/iodide cotransporter DTD0425 SYNONYMS NIS; Na(+)/I(-) cotransporter; Na(+)/I(-) symporter; SLC5A5; Sodium-iodide symporter; Solute carrier family 5 member 5; TDH1 DTD0425 VADRUGID DR00009 DTD0425 DRUGNAME Nitrate DTD0425 DRUGSYNO 14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V) DTD0426 TRANSPID DTD0426 DTD0426 GENENAME SLC5A6 DTD0426 PROTNAME Sodium-dependent multivitamin transporter DTD0426 SYNONYMS Na(+)-dependent multivitamin transporter; SLC5A6; SMVT; Solute carrier family 5 member 6 DTD0426 VADRUGID DR00089 DTD0426 DRUGNAME Gabapentin enacarbil DTD0426 DRUGSYNO ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512 DTD0427 TRANSPID DTD0427 DTD0427 GENENAME SLC5A7 DTD0427 PROTNAME High affinity choline transporter 1 DTD0427 SYNONYMS CHT; CHT1; CMS20; HMN7A; Hemicholinium-3-sensitive choline transporter; SLC5A7; Solute carrier family 5 member 7 DTD0427 VADRUGID DR00025 DTD0427 DRUGNAME Triethylcholine DTD0427 DRUGSYNO 152-22-7 (chloride); 302-61-4; 5957-17-5 (iodide); 9B2PFY5LLZ; AC1L2YNS; BDBM50366913; CHEMBL318993; CHEMBL555023; Ethanaminium, N,N,N-triethyl-2-hydroxy-; GTPL4760; MCULE-9715160196; SCHEMBL476985; Triethyl (2-hydroxyethyl)ammonium chloride; Triethylaminoethanol; UNII-9B2PFY5LLZ; ZINC394634; triethyl(2-hydroxyethyl)azanium DTD0428 TRANSPID DTD0428 DTD0428 GENENAME SLC5A8 DTD0428 PROTNAME Sodium-coupled monocarboxylate transporter 1 DTD0428 SYNONYMS AIT; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; SLC5A8; SMCT; SMCT1; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 DTD0428 VADRUGID DR00156 DTD0428 DRUGNAME Propionate DTD0428 DRUGSYNO 28488-34-8; 3002-EP2374454A1; AC1L2XEZ; AC1Q2RL9; AKOS015901051; AKW5EM890C; BDBM50257201; Bugle; CH3-CH2-COO(-); CHEBI:17272; CHEMBL500826; CJ-04452; CTK4G1579; DTXSID90222279; EtCO2 anion; LS-190254; NCGC00159468-02; NCGC00159468-03; NCGC00159468-04; Propanoic acid, ion(1-); Propanoic acid,neodymium(3+) salt (9CI); Propionate ion; STL483862; Sentry Grain Preservative; UNII-AKW5EM890C; XBDQKXXYIPTUBI-UHFFFAOYSA-M; ZB014971; carboxylatoethane; ethanecarboxylate; metacetonate; propanate; pseudoacetate DTD0428 VADRUGID DR00089 DTD0428 DRUGNAME Gabapentin enacarbil DTD0428 DRUGSYNO ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512 DTD0429 TRANSPID DTD0429 DTD0429 GENENAME SLC5A9 DTD0429 PROTNAME Sodium/glucose cotransporter 4 DTD0429 SYNONYMS Na(+)/glucose cotransporter 4; SGLT4; SLC5A9; Solute carrier family 5 member 9; hSGLT4 DTD0429 VADRUGID DR00011 DTD0429 DRUGNAME 2-Deoxyglucose DTD0429 DRUGSYNO 2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX DTD0429 VADRUGID DR00043 DTD0429 DRUGNAME Fructose DTD0429 DRUGSYNO (3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, > D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose DTD0429 VADRUGID DR00202 DTD0429 DRUGNAME D-mannose DTD0429 DRUGSYNO Mannose DTD0435 TRANSPID DTD0435 DTD0435 GENENAME SLC63A2 DTD0435 PROTNAME Protein spinster homolog 2 DTD0435 SYNONYMS SPNS2; Spinster homolog 2 DTD0435 VADRUGID DR00118 DTD0435 DRUGNAME Sphingosine-1-phosphate DTD0435 DRUGSYNO (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate DTD0439 TRANSPID DTD0439 DTD0439 GENENAME SLC65A2 DTD0439 PROTNAME Niemann-Pick C1-like protein 1 DTD0439 SYNONYMS LDLCQ7; NPC1-like intracellular cholesterol transporter 1; NPC11L1; NPC1L1; SLC65A2 DTD0439 VADRUGID DR00036 DTD0439 DRUGNAME Cholesterol DTD0439 DRUGSYNO (-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P. DTD0440 TRANSPID DTD0440 DTD0440 GENENAME SLC6A1 DTD0440 PROTNAME Sodium- and chloride-dependent GABA transporter 1 DTD0440 SYNONYMS Solute carrier family 6 member 1; GAT-1; SLC6A1; GABATR; GABT1; GAT1 DTD0440 VADRUGID DR00831 DTD0440 DRUGNAME Gamma-aminobutyric acid DTD0440 DRUGSYNO 1956/12/2; 3-Carboxypropylamine; 4-Aminobutanoic acid; 4-amino-butanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminalon; Butyric acid, 4-amino-; GABA; GAMMA-AMINO-BUTANOIC ACID; Gaballon; Gamarex; Gamastan; Gammagee; Gammalon; Gammalone; Gammar; Gammasol; Gamulin; Immu-G; Mielogen; Mielomade; Piperidic acid; Piperidinic acid; Reanal; butanoic acid, 4-amino-; gamma-Amino butyric acid; gamma-Aminobutanoic acid; gamma-Aminobuttersaeure; gamma-Aminobutyric acid; gamma-amino-n-butyric acid; gamma-aminobutyric acid; omega-Aminobutyric acid DTD0443 TRANSPID DTD0443 DTD0443 GENENAME SLC6A11 DTD0443 PROTNAME Sodium- and chloride-dependent GABA transporter 3 DTD0443 SYNONYMS GABT3; GAT-3; GAT3; GAT4; SLC6A11; Solute carrier family 6 member 11 DTD0443 VADRUGID DR00306 DTD0443 DRUGNAME Beta-alanine DTD0443 DRUGSYNO .beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid DTD0444 TRANSPID DTD0444 DTD0444 GENENAME SLC6A12 DTD0444 PROTNAME Na(+)/Cl(-) betaine/GABA transporter DTD0444 SYNONYMS BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12 DTD0444 VADRUGID DR00242 DTD0444 DRUGNAME Glycine DTD0444 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0444 VADRUGID DR00179 DTD0444 DRUGNAME L-proline DTD0444 DRUGSYNO (-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin] DTD0444 VADRUGID DR00314 DTD0444 DRUGNAME Betaine DTD0444 DRUGSYNO Cystadane DTD0444 VADRUGID DR00054 DTD0444 DRUGNAME Quinine DTD0444 DRUGSYNO (+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652 DTD0444 VADRUGID DR00121 DTD0444 DRUGNAME Choline DTD0444 DRUGSYNO (2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine DTD0445 TRANSPID DTD0445 DTD0445 GENENAME SLC6A13 DTD0445 PROTNAME Sodium- and chloride-dependent GABA transporter 2 DTD0445 SYNONYMS GAT-2; GAT2; SLC6A13; Solute carrier family 6 member 13 DTD0445 VADRUGID DR00306 DTD0445 DRUGNAME Beta-alanine DTD0445 DRUGSYNO .beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid DTD0446 TRANSPID DTD0446 DTD0446 GENENAME SLC6A14 DTD0446 PROTNAME Amino acid transporter ATB0+ DTD0446 SYNONYMS Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+); BMIQ11; SLC6A14; Solute carrier family 6 member 14 DTD0446 VADRUGID DR00374 DTD0446 DRUGNAME Amino acids DTD0446 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0449 TRANSPID DTD0449 DTD0449 GENENAME SLC6A17 DTD0449 PROTNAME Sodium-dependent neurotransmitter transporter DTD0449 SYNONYMS NTT4; SLC6A17; Sodium-dependent neutral amino acid transporter SLC6A17; Solute carrier family 6 member 17 DTD0449 VADRUGID DR00374 DTD0449 DRUGNAME Amino acids DTD0449 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0450 TRANSPID DTD0450 DTD0450 GENENAME SLC6A18 DTD0450 PROTNAME Sodium-dependent neutral amino acid transporter B(0)AT3 DTD0450 SYNONYMS SLC6A18; Sodium- and chloride-dependent transporter XTRP2; Solute carrier family 6 member 18; Inactive sodium-dependent neutral amino acid transporter B(0)AT3; XTRP2; B(0)AT3; System B(0) neutral amino acid transporter AT3 DTD0450 VADRUGID DR00374 DTD0450 DRUGNAME Amino acids DTD0450 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0451 TRANSPID DTD0451 DTD0451 GENENAME SLC6A19 DTD0451 PROTNAME Sodium-dependent neutral amino acid transporter B(0)AT1 DTD0451 SYNONYMS B0AT1; HND; SLC6A19; Solute carrier family 6 member 19; System B(0) neutral amino acid transporter AT1 DTD0451 VADRUGID DR00374 DTD0451 DRUGNAME Amino acids DTD0451 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0452 TRANSPID DTD0452 DTD0452 GENENAME SLC6A2 DTD0452 PROTNAME Sodium-dependent noradrenaline transporter DTD0452 SYNONYMS NET; NET1; Norepinephrine transporter; SLC6A2; Solute carrier family 6 member 2 DTD0452 VADRUGID DR00084 DTD0452 DRUGNAME Amphetamine DTD0452 DRUGSYNO Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore DTD0452 VADRUGID DR00268 DTD0452 DRUGNAME Norepinephrine DTD0452 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0453 TRANSPID DTD0453 DTD0453 GENENAME SLC6A20 DTD0453 PROTNAME Sodium/imino-acid transporter 1 DTD0453 SYNONYMS SIT1; SLC6A20; Sodium- and chloride-dependent transporter XTRP3; Solute carrier family 6 member 20; Transporter rB21A homolog; XT3; XTRP3 DTD0453 VADRUGID DR00374 DTD0453 DRUGNAME Amino acids DTD0453 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0455 TRANSPID DTD0455 DTD0455 GENENAME SLC6A3 DTD0455 PROTNAME Sodium-dependent dopamine transporter DTD0455 SYNONYMS DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3 DTD0455 VADRUGID DR00084 DTD0455 DRUGNAME Amphetamine DTD0455 DRUGSYNO Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore DTD0455 VADRUGID DR01335 DTD0455 DRUGNAME Brexpiprazole DTD0455 DRUGSYNO OPC-34712 DTD0455 VADRUGID DR00283 DTD0455 DRUGNAME Dopamine DTD0455 DRUGSYNO (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine DTD0455 VADRUGID DR01328 DTD0455 DRUGNAME Benztropine DTD0455 DRUGSYNO benztropine; Benzatropine; Tropine benzohydryl ether; Benzatropinum; Benzatropina; Cogentin; Cogentinol; 3endo-benzhydryloxytropane; UNII-1NHL2J4X8K; Benztropinum; Cogentine; Cobrentin; Akitan; 3alpha-(diphenylmethoxy)tropane; HSDB 3014; NK 02; 1NHL2J4X8K; Benzatropinum [INN-Latin]; Benzatropina [INN-Spanish]; 3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane; 3alpha-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; NCGC00159471-02; (3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane DTD0455 VADRUGID DR01325 DTD0455 DRUGNAME Bretylium DTD0455 DRUGSYNO (2-bromobenzyl)ethyldimethylaminium; (2-bromophenyl)methyl-ethyl-dimethylazanium; (o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate; 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium; Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1); Bretylium tolsylate; Bretylium tosylate(USAN); Bretylum; N-(2-bromobenzyl)-N,N-dimethylethanaminium; N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium DTD0456 TRANSPID DTD0456 DTD0456 GENENAME SLC6A4 DTD0456 PROTNAME Sodium-dependent serotonin transporter DTD0456 SYNONYMS 5-HTT; 5-HTTLPR; 5HT transporter; 5HTT; HTT; OCD1; SERT; SERT1; SLC6A4; Solute carrier family 6 member 4; hSERT DTD0456 VADRUGID DR00189 DTD0456 DRUGNAME Serotonin DTD0456 DRUGSYNO 1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY DTD0456 VADRUGID DR01227 DTD0456 DRUGNAME Oxypertine DTD0456 DRUGSYNO 1H-Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-; 5,6-Dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indole; 5,6-Dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]-1H-indole; 5JGL4G25R7; BRN 0899339; DO 180; EINECS 205-818-3; Equipertine; Forit; Opertil; Oxipertina [INN-Spanish]; Oxipertine; Oxipertinum; Oxypertine [USAN:INN:BAN:JAN]; Oxypertinum [INN-Latin]; UNII-5JGL4G25R7; WIN 18501-2; XCWPUUGSGHNIDZ-UHFFFAOYSA-N; oxypertine DTD0457 TRANSPID DTD0457 DTD0457 GENENAME SLC6A5 DTD0457 PROTNAME Sodium- and chloride-dependent glycine transporter 2 DTD0457 SYNONYMS GlyT-2; GlyT2; HKPX3; SLC6A5; Solute carrier family 6 member 5 DTD0457 VADRUGID DR00242 DTD0457 DRUGNAME Glycine DTD0457 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0457 VADRUGID DR00268 DTD0457 DRUGNAME Norepinephrine DTD0457 DRUGSYNO (-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E DTD0457 VADRUGID DR00389 DTD0457 DRUGNAME Methylphenidate DTD0457 DRUGSYNO 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester; Alpha-Phenyl-2-piperidineacetic acid methyl ester; Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester; Attenta (TN); Biphentin (TN); C 4311; Calocain; Centedein; Centedrin; Centredin; Concerta; Concerta (TN); D-methylphenidate HCl; Daytrana; Daytrana (TN); Equasym (TN); METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R); Meridil; Metadate; Metadate CD; Metadate ER; Metadate ER (TN); MethyPatch; Methyl (2-phenyl-2-(2-piperidyl)acetate); Methyl 2-phenyl-2-piperidin-2-ylacetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Methyl phenidate; Methyl phenidyl acetate; Methyl phenidylacetate; Methyl phenyl(piperidin-2-yl)acetate; Methylfenidan; Methylin; Methylin (TN); Methylin ER; Methylofenidan; Methylphen; Methylphenidan; Methylphenidate (USAN/INN); Methylphenidate [INN:BAN]; Methylphenidatum; Methylphenidatum [INN-Latin]; Metilfenidato; Metilfenidato [INN-Spanish]; Metilfenidato [Italian]; Motiron (TN); PMS-Methylphenidate; Phenidylate; Plimasine; Riphenidate; Ritalin; Ritalin (TN); Ritalin LA; Ritalin LA (TN); Ritalin SR; Ritalin-SR; Ritaline; Ritcher works; Rubifen (TN); Tsentedrin DTD0458 TRANSPID DTD0458 DTD0458 GENENAME SLC6A6 DTD0458 PROTNAME Sodium- and chloride-dependent taurine transporter DTD0458 SYNONYMS SLC6A6; Solute carrier family 6 member 6; TAUT DTD0458 VADRUGID DR00167 DTD0458 DRUGNAME Taurine DTD0458 DRUGSYNO .beta.-Aminoethylsulfonic acid; 1-Aminoethane-2-sulfonic acid; 107-35-7; 1EQV5MLY3D; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine; 2-aminoethane-1-sulfonic acid; 2-aminoethanesulfonic acid; AI3-18307; Aminoethanesulfonic acid; CCRIS 4721; CHEBI:15891; EINECS 203-483-8; Ethanesulfonic acid, 2-amino-; FEMA No. 3813; L-Taurine; NCI-C60606; NSC 32428; NSC32428; O-Due; Taurina [Spanish]; Taurine [INN]; Taurinum [Latin]; UNII-1EQV5MLY3D; aminoethylsulfonic acid; beta-Aminoethylsulfonic acid; taufon; tauphon DTD0458 VADRUGID DR00306 DTD0458 DRUGNAME Beta-alanine DTD0458 DRUGSYNO .beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid DTD0459 TRANSPID DTD0459 DTD0459 GENENAME SLC6A7 DTD0459 PROTNAME Sodium-dependent proline transporter DTD0459 SYNONYMS PROT; SLC6A7; Solute carrier family 6 member 7 DTD0459 VADRUGID DR00179 DTD0459 DRUGNAME L-proline DTD0459 DRUGSYNO (-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin] DTD0460 TRANSPID DTD0460 DTD0460 GENENAME SLC6A8 DTD0460 PROTNAME Creatine transporter 1 DTD0460 SYNONYMS CCDS1; CRT; CRTR; CT1; CTR5; SLC6A8; Sodium- and chloride-dependent creatine transporter 1; Solute carrier family 6 member 8 DTD0460 VADRUGID DR00034 DTD0460 DRUGNAME Creatine ALS-08 DTD0460 DRUGSYNO AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; ALS-02; ALS-05; ALS-08; Creatine; Creatine (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; HD-02; PD-01, Avicena; PD-02; PD-04; PD-06 DTD0461 TRANSPID DTD0461 DTD0461 GENENAME SLC6A9 DTD0461 PROTNAME Sodium- and chloride-dependent glycine transporter 1 DTD0461 SYNONYMS GCENSG; GlyT-1; GlyT1; SLC6A9; Solute carrier family 6 member 9 DTD0461 VADRUGID DR00242 DTD0461 DRUGNAME Glycine DTD0461 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0461 VADRUGID DR00326 DTD0461 DRUGNAME Sarcosine DTD0461 DRUGSYNO (Methylamino)acetic acid; (Methylamino)ethanoic acid; 2-(methylamino)acetic acid; AI3-15410; Acetic acid, (methylamino)-; BRN 1699442; CHEBI:15611; CHEMBL304383; Cocoylsarcosine; EINECS 203-538-6; FSYKKLYZXJSNPZ-UHFFFAOYSA-N; Glycine, N-methyl-; H-Sar-OH; Methylamino-Acetic Acid; Methylaminoacetic acid; Methylglycine; N-Methyl glycine; N-Methylaminoacetic acid; N-methyl-Glycine; N-methylglycine; Polysarcosine; SAR; Sarcosin; Sarcosine, 98%; Sarcosinic acid; Sargosine hydrochloride; UNII-Z711V88R5F; Z711V88R5F DTD0462 TRANSPID DTD0462 DTD0462 GENENAME SLC7A1 DTD0462 PROTNAME High affinity cationic amino acid transporter 1 DTD0462 SYNONYMS ATRC1; CAT-1; CAT1; ERR; Ecotropic retroviral leukemia receptor homolog; Ecotropic retrovirus receptor homolog; HCAT1; REC1L; SLC7A1; Solute carrier family 7 member 1; System Y+ basic amino acid transporter DTD0462 VADRUGID DR00374 DTD0462 DRUGNAME Amino acids DTD0462 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0463 TRANSPID DTD0463 DTD0463 GENENAME SLC7A10 DTD0463 PROTNAME Asc-type amino acid transporter 1 DTD0463 SYNONYMS ASC1; Asc-1; HASC-1; SLC7A10; Solute carrier family 7 member 10 DTD0463 VADRUGID DR00374 DTD0463 DRUGNAME Amino acids DTD0463 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0464 TRANSPID DTD0464 DTD0464 GENENAME SLC7A11 DTD0464 PROTNAME Cystine/glutamate transporter DTD0464 SYNONYMS Amino acid transport system xc-; CCBR1; Calcium channel blocker resistance protein CCBR1; SLC7A11; Solute carrier family 7 member 11; xCT DTD0464 VADRUGID DR00005 DTD0464 DRUGNAME L-glutamic acid DTD0464 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0465 TRANSPID DTD0465 DTD0465 GENENAME SLC7A13 DTD0465 PROTNAME Sodium-independent aspartate/glutamate transporter 1 DTD0465 SYNONYMS AGT-1; AGT1; SLC7A13; Solute carrier family 7 member 13; X-amino acid transporter 2; XAT2 DTD0465 VADRUGID DR00005 DTD0465 DRUGNAME L-glutamic acid DTD0465 DRUGSYNO (2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid) DTD0468 TRANSPID DTD0468 DTD0468 GENENAME SLC7A2 DTD0468 PROTNAME Cationic amino acid transporter 2 DTD0468 SYNONYMS ATRC2; CAT-2; CAT2; HCAT2; Low affinity cationic amino acid transporter 2; SLC7A2; Solute carrier family 7 member 2 DTD0468 VADRUGID DR00065 DTD0468 DRUGNAME L-ornithine DTD0468 DRUGSYNO OKG; Ornithine DTD0469 TRANSPID DTD0469 DTD0469 GENENAME SLC7A3 DTD0469 PROTNAME Cationic amino acid transporter 3 DTD0469 SYNONYMS ATRC3; CAT-3; CAT3; Cationic amino acid transporter y+; SLC7A3; Solute carrier family 7 member 3 DTD0469 VADRUGID DR00374 DTD0469 DRUGNAME Amino acids DTD0469 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0471 TRANSPID DTD0471 DTD0471 GENENAME SLC7A5 DTD0471 PROTNAME L-type amino acid transporter 1 DTD0471 SYNONYMS 4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter DTD0471 VADRUGID DR01255 DTD0471 DRUGNAME Pregabalin DTD0471 DRUGSYNO Pregabalin (controlled-release, oral); Pregabalin (controlled-release, oral), Pfizer; Pregabalin CR DTD0471 VADRUGID DR00125 DTD0471 DRUGNAME Levodopa DTD0471 DRUGSYNO Levodopa (optimized formulation, Parkinson's disease); Levodopa (optimized formulation, Parkinson's disease), Orion; More effective levodopa (Parkinson's disease), Orion DTD0471 VADRUGID DR00217 DTD0471 DRUGNAME Gabapentin DTD0471 DRUGSYNO 1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID DTD0471 VADRUGID DR00024 DTD0471 DRUGNAME L-glutamine DTD0471 DRUGSYNO AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis DTD0471 VADRUGID DR00303 DTD0471 DRUGNAME L-leucine DTD0471 DRUGSYNO (2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine DTD0471 VADRUGID DR00282 DTD0471 DRUGNAME L-histidine DTD0471 DRUGSYNO Histidine DTD0473 TRANSPID DTD0473 DTD0473 GENENAME SLC7A6 DTD0473 PROTNAME Y+L amino acid transporter 2 DTD0473 SYNONYMS Cationic amino acid transporter, y+ system; KIAA0245; LAT-2; SLC7A6; Solute carrier family 7 member 6; Y+LAT2; y(+)L-type amino acid transporter 2; y+LAT-2 DTD0473 VADRUGID DR00374 DTD0473 DRUGNAME Amino acids DTD0473 DRUGSYNO Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10% DTD0475 TRANSPID DTD0475 DTD0475 GENENAME SLC7A8 DTD0475 PROTNAME L-type amino acid transporter 2 DTD0475 SYNONYMS LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2 DTD0475 VADRUGID DR00086 DTD0475 DRUGNAME L-tryptophan DTD0475 DRUGSYNO (-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin] DTD0475 VADRUGID DR00242 DTD0475 DRUGNAME Glycine DTD0475 DRUGSYNO (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine DTD0475 VADRUGID DR00266 DTD0475 DRUGNAME L-phenylalanine DTD0475 DRUGSYNO (2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin] DTD0475 VADRUGID DR00179 DTD0475 DRUGNAME L-proline DTD0475 DRUGSYNO (-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin] DTD0475 VADRUGID DR00020 DTD0475 DRUGNAME L-tyrosine DTD0475 DRUGSYNO (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; (S)-3-(p-Hydroxyphenyl)alanine; (S)-Tyrosine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 2-Amino-3-(p-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; 3-(p-Hydroxyphenyl)alanine; 4-Hydroxy-L-phenylalanine; 4ts1; Alpha-Amino-beta-(4-hydroxyphenyl)propionic acid; Beta-(p-Hydroxyphenyl)alanine; DD69927C-C6A8-4BC6-8E9A-0AB423B176E7; DTY; Free-Form L-Tyrosine; H-Tyr-OH; L-(-)-Tyrosine; L-2-Amino-3-p-hydroxyphenylpropanoic acid; L-Tyrosin; L-Tyrosine (9CI); L-Tyrosine (JAN); L-Tyrosine hydrochloride; L-Tyrosine, homopolymer; L-Tyrosine, monomer; L-p-Tyrosine; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours; P-Tyrosine; Rxosine; TYR NH3+ COOH; Tirosina; Tirosina [Spanish]; Tyr; Tyrosine; Tyrosine (USP/INN); Tyrosine (VAN); Tyrosine Power; Tyrosine [USAN:INN]; Tyrosine, L-(8CI); Tyrosinum; Tyrosinum [Latin] DTD0475 VADRUGID DR00142 DTD0475 DRUGNAME L-alanine DTD0475 DRUGSYNO (2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine DTD0476 TRANSPID DTD0476 DTD0476 GENENAME SLC7A9 DTD0476 PROTNAME Glycoprotein-associated amino acid transporter b0, +AT1 DTD0476 SYNONYMS BAT1; CSNU3; SLC7A9; Solute carrier family 7 member 9; b(0,+)-type amino acid transporter 1; b(0,+)AT1 DTD0476 VADRUGID DR00725 DTD0476 DRUGNAME L-citrulline DTD0476 DRUGSYNO (2S)-2-amino-5-(carbamoylamino)pentanoic acid; (S)-2-Amino-5-ureidopentanoic acid; 2-Amino-5-ureidovaleric acid; 372-75-8; Citrulline; Citrulline, L-; H-cit-oh; L(+)-citrulline; L-(+)-Citrulline; L-2-Amino-5-ureidovaleric acid; L-Cytrulline; L-Ornithine, N5-(aminocarbonyl)-; L-citrullin; N(delta)-Carbamylornithine; N5-(Aminocarbonyl)ornithine; N5-Carbamoyl-L-ornithine; N5-carbamoylornithine; Ornithine, N5-(aminocarbonyl)-; Sitrulline; alpha-Amino-delta-ureidovaleric acid; d-ureidonorvaline; delta-Ureidonorvaline DTD0499 TRANSPID DTD0499 DTD0499 GENENAME SLCO1C1 DTD0499 PROTNAME Organic anion transporting polypeptide 1C1 DTD0499 SYNONYMS OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter DTD0499 VADRUGID DR00208 DTD0499 DRUGNAME Estradiol-17beta-glucuronide DTD0499 DRUGSYNO [3H]-estradiol-17beta-glucuronide DTD0499 VADRUGID DR00107 DTD0499 DRUGNAME Levothyroxine DTD0499 DRUGSYNO (-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI) DTD0499 VADRUGID DR00173 DTD0499 DRUGNAME Liothyronine DTD0499 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0499 VADRUGID DR00102 DTD0499 DRUGNAME Dinoprostone DTD0499 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0500 TRANSPID DTD0500 DTD0500 GENENAME SLCO2A1 DTD0500 PROTNAME Organic anion transporting polypeptide 2A1 DTD0500 SYNONYMS MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1 DTD0500 VADRUGID DR00210 DTD0500 DRUGNAME Alprostadil DTD0500 DRUGSYNO (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros DTD0500 VADRUGID DR00102 DTD0500 DRUGNAME Dinoprostone DTD0500 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0500 VADRUGID DR00168 DTD0500 DRUGNAME Latanoprost DTD0500 DRUGSYNO AR-202; Catioprost; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; L1167_SIGMA; Latanoprost (JAN/USAN/INN); Latanoprost free acid; Nova-21027; PHXA-41; PhXA34 [as 15(R,S)-isomer]; PhXA41; Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; XA-41; XA41; Xalatan; Xalatan (TN) DTD0500 VADRUGID DR00099 DTD0500 DRUGNAME Iloprost DTD0500 DRUGSYNO ILOPROST; Ciloprost; Ventavis; Iloprostum; Endoprost; Ilomedin; ZK 36374; 78919-13-8; CHEMBL494; Iloprostum [Latin]; [3H]-Iloprost; Ventavis (TN); ZK-36374; (16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2; (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid; SR-05000001498; Iloprost [USAN:INN:BAN]; Ilomedine; BAY Q6256; (16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2) DTD0500 VADRUGID DR00007 DTD0500 DRUGNAME Prostaglandin f2Alpha DTD0500 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0501 TRANSPID DTD0501 DTD0501 GENENAME SLCO3A1 DTD0501 PROTNAME Organic anion transporting polypeptide 3A1 DTD0501 SYNONYMS OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1 DTD0501 VADRUGID DR00210 DTD0501 DRUGNAME Alprostadil DTD0501 DRUGSYNO (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros DTD0501 VADRUGID DR00102 DTD0501 DRUGNAME Dinoprostone DTD0501 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0501 VADRUGID DR00099 DTD0501 DRUGNAME Iloprost DTD0501 DRUGSYNO ILOPROST; Ciloprost; Ventavis; Iloprostum; Endoprost; Ilomedin; ZK 36374; 78919-13-8; CHEMBL494; Iloprostum [Latin]; [3H]-Iloprost; Ventavis (TN); ZK-36374; (16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2; (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid; SR-05000001498; Iloprost [USAN:INN:BAN]; Ilomedine; BAY Q6256; (16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2) DTD0501 VADRUGID DR00007 DTD0501 DRUGNAME Prostaglandin f2Alpha DTD0501 DRUGSYNO Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan DTD0501 VADRUGID DR00488 DTD0501 DRUGNAME Benzylpenicillin DTD0501 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0501 VADRUGID DR00019 DTD0501 DRUGNAME Estrone sulfate DTD0501 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0502 TRANSPID DTD0502 DTD0502 GENENAME SLCO4A1 DTD0502 PROTNAME Organic anion transporting polypeptide 4A1 DTD0502 SYNONYMS Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1 DTD0502 VADRUGID DR00173 DTD0502 DRUGNAME Liothyronine DTD0502 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0502 VADRUGID DR00102 DTD0502 DRUGNAME Dinoprostone DTD0502 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0502 VADRUGID DR01121 DTD0502 DRUGNAME Taurocholic acid DTD0502 DRUGSYNO 2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid DTD0502 VADRUGID DR00488 DTD0502 DRUGNAME Benzylpenicillin DTD0502 DRUGSYNO 6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen DTD0502 VADRUGID DR00019 DTD0502 DRUGNAME Estrone sulfate DTD0502 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0503 TRANSPID DTD0503 DTD0503 GENENAME SLCO4C1 DTD0503 PROTNAME Organic anion transporting polypeptide 4C1 DTD0503 SYNONYMS OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20 DTD0503 VADRUGID DR00148 DTD0503 DRUGNAME Digoxin DTD0503 DRUGSYNO (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN) DTD0503 VADRUGID DR00155 DTD0503 DRUGNAME Ouabain DTD0503 DRUGSYNO 3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin DTD0503 VADRUGID DR00173 DTD0503 DRUGNAME Liothyronine DTD0503 DRUGSYNO (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone DTD0503 VADRUGID DR00226 DTD0503 DRUGNAME Saxagliptin DTD0503 DRUGSYNO (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN) DTD0503 VADRUGID DR00019 DTD0503 DRUGNAME Estrone sulfate DTD0503 DRUGSYNO Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate DTD0504 TRANSPID DTD0504 DTD0504 GENENAME SLCO5A1 DTD0504 PROTNAME Organic anion transporting polypeptide 5A1 DTD0504 SYNONYMS OATP-J; OATP-RP4; OATP5A1; OATPJ; OATPRP4; Solute carrier organic anion transporter family member 5A1; SLC21A15; SLCO5A1; Solute carrier family 21 member 15; Organic anion transporter polypeptide-related protein 4 DTD0504 VADRUGID DR00102 DTD0504 DRUGNAME Dinoprostone DTD0504 DRUGSYNO (15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2 DTD0515 TRANSPID DTD0515 DTD0515 GENENAME ATP10A DTD0515 PROTNAME Probable phospholipid-transporting ATPase VA DTD0515 SYNONYMS ATP10A; ATP10C; ATPVA; ATPVC; ATPase class V type 10A; Aminophospholipid translocase VA; KIAA0566; P4-ATPase flippase complex alpha subunit ATP10A DTD0515 VADRUGID DR00294 DTD0515 DRUGNAME Phosphatidylethanolamine DTD0515 DRUGSYNO Cephalin DTD0533 TRANSPID DTD0533 DTD0533 GENENAME ATP7B DTD0533 PROTNAME Copper-transporting ATPase 2 DTD0533 SYNONYMS ATP7B; Copper pump 2; PWD; WC1; WND; Wilson disease-associated protein DTD0533 VADRUGID DR00291 DTD0533 DRUGNAME Cisplatin DTD0533 DRUGSYNO (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II) DTD0537 TRANSPID DTD0537 DTD0537 GENENAME RALBP1 DTD0537 PROTNAME RalBP1-associated Eps domain-containing protein 2 DTD0537 SYNONYMS POB1; Partner of RalBP1; REPS2; RIP1; RLIP1; RLIP76; RalBP1-interacting protein 2 DTD0537 VADRUGID DR00454 DTD0537 DRUGNAME Sunitinib DTD0537 DRUGSYNO 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN) DTD0537 VADRUGID DR00304 DTD0537 DRUGNAME Sorafenib DTD0537 DRUGSYNO 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum